Synthesis	O
and	O
characterization	O
of	O
photoreactive	O
insulin	B-Protein
-	I-Protein
like	I-Protein
growth	I-Protein
factor	I-Protein
1	I-Protein
derivatives	O
for	O
receptor	O
analysis	O
.	O
<EOS>	B-X
Recombinant	B-X
human	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
hIGF-1	B-X
)	B-X
was	B-X
reacted	B-X
with	B-X
4-azidosalicylic	B-X
acid	B-X
(	B-X
Asa	B-X
)	B-X
to	B-X
synthesize	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
.	B-X
Depending	B-X
on	B-X
the	B-X
time	B-X
of	B-X
reaction	B-X
and	B-X
the	B-X
Asa/IGF-1	B-X
ratio	B-X
,	B-X
a	B-X
mixture	B-X
of	B-X
mono-	B-X
,	B-X
bis-	B-X
,	B-X
and	B-X
trisacylated	B-X
derivatives	B-X
and	B-X
one	B-X
tetraacylated	B-X
derivative	B-X
was	B-X
produced	B-X
,	B-X
which	B-X
was	B-X
separated	B-X
by	B-X
reversed-phase	B-X
HPLC	B-X
.	B-X
After	B-X
iodination	B-X
of	B-X
the	B-X
three	B-X
monoacylated	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
,	B-X
the	B-X
specific	B-X
labeling	B-X
of	B-X
the	B-X
receptor	B-X
could	B-X
be	B-X
proved	B-X
.	B-X
Together	B-X
with	B-X
a	B-X
comparative	B-X
investigation	B-X
in	B-X
which	B-X
B29-Asa-insulin	B-X
was	B-X
used	B-X
,	B-X
the	B-X
results	B-X
suggest	B-X
corresponding	B-X
contact	B-X
areas	B-X
for	B-X
IGF-1	B-X
and	B-X
insulin	B-X
with	B-X
the	B-X
insulin	B-X
receptor	B-X
ectodomain	B-X
.	B-X

Recombinant	O
human	O
insulin	B-Protein
-	I-Protein
like	I-Protein
growth	I-Protein
factor	I-Protein
1	I-Protein
(	O
hIGF	B-Protein
-	I-Protein
1	I-Protein
)	O
was	O
reacted	O
with	O
4	O
-	O
azidosalicylic	O
acid	O
(	O
Asa	O
)	O
to	O
synthesize	O
photoreactive	O
IGF	B-Protein
-	I-Protein
1	I-Protein
derivatives	O
.	O
<EOS>	B-X
Recombinant	B-X
human	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
hIGF-1	B-X
)	B-X
was	B-X
reacted	B-X
with	B-X
4-azidosalicylic	B-X
acid	B-X
(	B-X
Asa	B-X
)	B-X
to	B-X
synthesize	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
.	B-X
Depending	B-X
on	B-X
the	B-X
time	B-X
of	B-X
reaction	B-X
and	B-X
the	B-X
Asa/IGF-1	B-X
ratio	B-X
,	B-X
a	B-X
mixture	B-X
of	B-X
mono-	B-X
,	B-X
bis-	B-X
,	B-X
and	B-X
trisacylated	B-X
derivatives	B-X
and	B-X
one	B-X
tetraacylated	B-X
derivative	B-X
was	B-X
produced	B-X
,	B-X
which	B-X
was	B-X
separated	B-X
by	B-X
reversed-phase	B-X
HPLC	B-X
.	B-X
After	B-X
iodination	B-X
of	B-X
the	B-X
three	B-X
monoacylated	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
,	B-X
the	B-X
specific	B-X
labeling	B-X
of	B-X
the	B-X
receptor	B-X
could	B-X
be	B-X
proved	B-X
.	B-X
Together	B-X
with	B-X
a	B-X
comparative	B-X
investigation	B-X
in	B-X
which	B-X
B29-Asa-insulin	B-X
was	B-X
used	B-X
,	B-X
the	B-X
results	B-X
suggest	B-X
corresponding	B-X
contact	B-X
areas	B-X
for	B-X
IGF-1	B-X
and	B-X
insulin	B-X
with	B-X
the	B-X
insulin	B-X
receptor	B-X
ectodomain	B-X
.	B-X

Depending	O
on	O
the	O
time	O
of	O
reaction	O
and	O
the	O
Asa	O
/	O
IGF	B-Protein
-	I-Protein
1	I-Protein
ratio	O
,	O
a	O
mixture	O
of	O
mono	O
-	O
,	O
bis	O
-	O
,	O
and	O
trisacylated	O
derivatives	O
and	O
one	O
tetraacylated	O
derivative	O
was	O
produced	O
,	O
which	O
was	O
separated	O
by	O
reversed	O
-	O
phase	O
HPLC	O
.	O
<EOS>	B-X
Recombinant	B-X
human	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
hIGF-1	B-X
)	B-X
was	B-X
reacted	B-X
with	B-X
4-azidosalicylic	B-X
acid	B-X
(	B-X
Asa	B-X
)	B-X
to	B-X
synthesize	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
.	B-X
Depending	B-X
on	B-X
the	B-X
time	B-X
of	B-X
reaction	B-X
and	B-X
the	B-X
Asa/IGF-1	B-X
ratio	B-X
,	B-X
a	B-X
mixture	B-X
of	B-X
mono-	B-X
,	B-X
bis-	B-X
,	B-X
and	B-X
trisacylated	B-X
derivatives	B-X
and	B-X
one	B-X
tetraacylated	B-X
derivative	B-X
was	B-X
produced	B-X
,	B-X
which	B-X
was	B-X
separated	B-X
by	B-X
reversed-phase	B-X
HPLC	B-X
.	B-X
HPLC	B-X
,	B-X
PAGE	B-X
,	B-X
and	B-X
MALDI	B-X
mass	B-X
spectrometry	B-X
were	B-X
used	B-X
to	B-X
determine	B-X
the	B-X
degree	B-X
of	B-X
the	B-X
acylation	B-X
and	B-X
location	B-X
of	B-X
the	B-X
photolabel	B-X
insertion	B-X
.	B-X
After	B-X
iodination	B-X
of	B-X
the	B-X
three	B-X
monoacylated	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
,	B-X
the	B-X
specific	B-X
labeling	B-X
of	B-X
the	B-X
receptor	B-X
could	B-X
be	B-X
proved	B-X
.	B-X
Together	B-X
with	B-X
a	B-X
comparative	B-X
investigation	B-X
in	B-X
which	B-X
B29-Asa-insulin	B-X
was	B-X
used	B-X
,	B-X
the	B-X
results	B-X
suggest	B-X
corresponding	B-X
contact	B-X
areas	B-X
for	B-X
IGF-1	B-X
and	B-X
insulin	B-X
with	B-X
the	B-X
insulin	B-X
receptor	B-X
ectodomain	B-X
.	B-X

HPLC	O
,	O
PAGE	O
,	O
and	O
MALDI	O
mass	O
spectrometry	O
were	O
used	O
to	O
determine	O
the	O
degree	O
of	O
the	O
acylation	O
and	O
location	O
of	O
the	O
photolabel	O
insertion	O
.	O
<EOS>	B-X
Depending	B-X
on	B-X
the	B-X
time	B-X
of	B-X
reaction	B-X
and	B-X
the	B-X
Asa/IGF-1	B-X
ratio	B-X
,	B-X
a	B-X
mixture	B-X
of	B-X
mono-	B-X
,	B-X
bis-	B-X
,	B-X
and	B-X
trisacylated	B-X
derivatives	B-X
and	B-X
one	B-X
tetraacylated	B-X
derivative	B-X
was	B-X
produced	B-X
,	B-X
which	B-X
was	B-X
separated	B-X
by	B-X
reversed-phase	B-X
HPLC	B-X
.	B-X
HPLC	B-X
,	B-X
PAGE	B-X
,	B-X
and	B-X
MALDI	B-X
mass	B-X
spectrometry	B-X
were	B-X
used	B-X
to	B-X
determine	B-X
the	B-X
degree	B-X
of	B-X
the	B-X
acylation	B-X
and	B-X
location	B-X
of	B-X
the	B-X
photolabel	B-X
insertion	B-X
.	B-X
Together	B-X
with	B-X
a	B-X
comparative	B-X
investigation	B-X
in	B-X
which	B-X
B29-Asa-insulin	B-X
was	B-X
used	B-X
,	B-X
the	B-X
results	B-X
suggest	B-X
corresponding	B-X
contact	B-X
areas	B-X
for	B-X
IGF-1	B-X
and	B-X
insulin	B-X
with	B-X
the	B-X
insulin	B-X
receptor	B-X
ectodomain	B-X
.	B-X

After	O
iodination	O
of	O
the	O
three	O
monoacylated	O
photoreactive	O
IGF	B-Protein
-	I-Protein
1	I-Protein
derivatives	O
,	O
the	O
specific	O
labeling	O
of	O
the	O
receptor	O
could	O
be	O
proved	O
.	O
<EOS>	B-X
Recombinant	B-X
human	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
hIGF-1	B-X
)	B-X
was	B-X
reacted	B-X
with	B-X
4-azidosalicylic	B-X
acid	B-X
(	B-X
Asa	B-X
)	B-X
to	B-X
synthesize	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
.	B-X
Depending	B-X
on	B-X
the	B-X
time	B-X
of	B-X
reaction	B-X
and	B-X
the	B-X
Asa/IGF-1	B-X
ratio	B-X
,	B-X
a	B-X
mixture	B-X
of	B-X
mono-	B-X
,	B-X
bis-	B-X
,	B-X
and	B-X
trisacylated	B-X
derivatives	B-X
and	B-X
one	B-X
tetraacylated	B-X
derivative	B-X
was	B-X
produced	B-X
,	B-X
which	B-X
was	B-X
separated	B-X
by	B-X
reversed-phase	B-X
HPLC	B-X
.	B-X
After	B-X
iodination	B-X
of	B-X
the	B-X
three	B-X
monoacylated	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
,	B-X
the	B-X
specific	B-X
labeling	B-X
of	B-X
the	B-X
receptor	B-X
could	B-X
be	B-X
proved	B-X
.	B-X
Together	B-X
with	B-X
a	B-X
comparative	B-X
investigation	B-X
in	B-X
which	B-X
B29-Asa-insulin	B-X
was	B-X
used	B-X
,	B-X
the	B-X
results	B-X
suggest	B-X
corresponding	B-X
contact	B-X
areas	B-X
for	B-X
IGF-1	B-X
and	B-X
insulin	B-X
with	B-X
the	B-X
insulin	B-X
receptor	B-X
ectodomain	B-X
.	B-X

Together	O
with	O
a	O
comparative	O
investigation	O
in	O
which	O
B29	O
-	O
Asa	O
-	O
insulin	B-Protein
was	O
used	O
,	O
the	O
results	O
suggest	O
corresponding	O
contact	O
areas	O
for	O
IGF	B-Protein
-	I-Protein
1	I-Protein
and	O
insulin	B-Protein
with	O
the	O
insulin	B-Protein
receptor	I-Protein
ectodomain	O
.	O
<EOS>	B-X
Recombinant	B-X
human	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
hIGF-1	B-X
)	B-X
was	B-X
reacted	B-X
with	B-X
4-azidosalicylic	B-X
acid	B-X
(	B-X
Asa	B-X
)	B-X
to	B-X
synthesize	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
.	B-X
Depending	B-X
on	B-X
the	B-X
time	B-X
of	B-X
reaction	B-X
and	B-X
the	B-X
Asa/IGF-1	B-X
ratio	B-X
,	B-X
a	B-X
mixture	B-X
of	B-X
mono-	B-X
,	B-X
bis-	B-X
,	B-X
and	B-X
trisacylated	B-X
derivatives	B-X
and	B-X
one	B-X
tetraacylated	B-X
derivative	B-X
was	B-X
produced	B-X
,	B-X
which	B-X
was	B-X
separated	B-X
by	B-X
reversed-phase	B-X
HPLC	B-X
.	B-X
HPLC	B-X
,	B-X
PAGE	B-X
,	B-X
and	B-X
MALDI	B-X
mass	B-X
spectrometry	B-X
were	B-X
used	B-X
to	B-X
determine	B-X
the	B-X
degree	B-X
of	B-X
the	B-X
acylation	B-X
and	B-X
location	B-X
of	B-X
the	B-X
photolabel	B-X
insertion	B-X
.	B-X
After	B-X
iodination	B-X
of	B-X
the	B-X
three	B-X
monoacylated	B-X
photoreactive	B-X
IGF-1	B-X
derivatives	B-X
,	B-X
the	B-X
specific	B-X
labeling	B-X
of	B-X
the	B-X
receptor	B-X
could	B-X
be	B-X
proved	B-X
.	B-X
Together	B-X
with	B-X
a	B-X
comparative	B-X
investigation	B-X
in	B-X
which	B-X
B29-Asa-insulin	B-X
was	B-X
used	B-X
,	B-X
the	B-X
results	B-X
suggest	B-X
corresponding	B-X
contact	B-X
areas	B-X
for	B-X
IGF-1	B-X
and	B-X
insulin	B-X
with	B-X
the	B-X
insulin	B-X
receptor	B-X
ectodomain	B-X
.	B-X

Cell	O
-	O
specific	O
glycoforms	O
of	O
sialoadhesin	B-Protein
and	O
CD45	B-Protein
are	O
counter	O
-	O
receptors	O
for	O
the	O
cysteine	O
-	O
rich	O
domain	O
of	O
the	O
mannose	O
receptor	O
.	O
<EOS>	B-X
We	B-X
previously	B-X
reported	B-X
that	B-X
CR-Fc	B-X
,	B-X
an	B-X
Fc	B-X
chimeric	B-X
protein	B-X
containing	B-X
the	B-X
cysteine-rich	B-X
(	B-X
CR	B-X
)	B-X
domain	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
,	B-X
binds	B-X
to	B-X
marginal	B-X
zone	B-X
metallophilic	B-X
macrophages	B-X
(	B-X
Mo	B-X
)	B-X
and	B-X
B	B-X
cell	B-X
areas	B-X
in	B-X
the	B-X
spleen	B-X
and	B-X
to	B-X
subcapsular	B-X
sinus	B-X
Mo	B-X
in	B-X
lymph	B-X
nodes	B-X
of	B-X
naive	B-X
mice	B-X
(	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
cells	B-X
)	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
we	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
two	B-X
of	B-X
these	B-X
ligands	B-X
as	B-X
sialoadhesin	B-X
(	B-X
Sn	B-X
)	B-X
,	B-X
an	B-X
Mo-specific	B-X
membrane	B-X
molecule	B-X
,	B-X
and	B-X
the	B-X
leukocyte	B-X
common	B-X
antigen	B-X
,	B-X
CD45	B-X
.	B-X
CR-Fc	B-X
bound	B-X
selectively	B-X
to	B-X
Sn	B-X
purified	B-X
from	B-X
spleen	B-X
and	B-X
lymph	B-X
nodes	B-X
and	B-X
to	B-X
two	B-X
low	B-X
molecular	B-X
weight	B-X
isoforms	B-X
of	B-X
CD45	B-X
in	B-X
a	B-X
sugar-dependent	B-X
manner	B-X
.	B-X
These	B-X
results	B-X
confirm	B-X
the	B-X
identification	B-X
of	B-X
the	B-X
CR	B-X
region	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
as	B-X
a	B-X
lectin	B-X
.	B-X

We	O
previously	O
reported	O
that	O
CR	O
-	O
Fc	O
,	O
an	O
Fc	O
chimeric	O
protein	O
containing	O
the	O
cysteine	O
-	O
rich	O
(	O
CR	O
)	O
domain	O
of	O
the	O
mannose	O
receptor	O
,	O
binds	O
to	O
marginal	O
zone	O
metallophilic	O
macrophages	O
(	O
Mo	O
)	O
and	O
B	O
cell	O
areas	O
in	O
the	O
spleen	O
and	O
to	O
subcapsular	O
sinus	O
Mo	O
in	O
lymph	O
nodes	O
of	O
naive	O
mice	O
(	O
CR	O
-	O
Fc	O
(	O
+	O
)	O
cells	O
)	O
.	O

Several	O
CR	O
-	O
Fc	O
ligands	O
were	O
found	O
in	O
spleen	O
and	O
lymph	O
node	O
tissue	O
lysates	O
using	O
ligand	O
blots	O
.	O
<EOS>	B-X
We	B-X
previously	B-X
reported	B-X
that	B-X
CR-Fc	B-X
,	B-X
an	B-X
Fc	B-X
chimeric	B-X
protein	B-X
containing	B-X
the	B-X
cysteine-rich	B-X
(	B-X
CR	B-X
)	B-X
domain	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
,	B-X
binds	B-X
to	B-X
marginal	B-X
zone	B-X
metallophilic	B-X
macrophages	B-X
(	B-X
Mo	B-X
)	B-X
and	B-X
B	B-X
cell	B-X
areas	B-X
in	B-X
the	B-X
spleen	B-X
and	B-X
to	B-X
subcapsular	B-X
sinus	B-X
Mo	B-X
in	B-X
lymph	B-X
nodes	B-X
of	B-X
naive	B-X
mice	B-X
(	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
cells	B-X
)	B-X
.	B-X
Several	B-X
CR-Fc	B-X
ligands	B-X
were	B-X
found	B-X
in	B-X
spleen	B-X
and	B-X
lymph	B-X
node	B-X
tissue	B-X
lysates	B-X
using	B-X
ligand	B-X
blots	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
we	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
two	B-X
of	B-X
these	B-X
ligands	B-X
as	B-X
sialoadhesin	B-X
(	B-X
Sn	B-X
)	B-X
,	B-X
an	B-X
Mo-specific	B-X
membrane	B-X
molecule	B-X
,	B-X
and	B-X
the	B-X
leukocyte	B-X
common	B-X
antigen	B-X
,	B-X
CD45	B-X
.	B-X
CR-Fc	B-X
bound	B-X
selectively	B-X
to	B-X
Sn	B-X
purified	B-X
from	B-X
spleen	B-X
and	B-X
lymph	B-X
nodes	B-X
and	B-X
to	B-X
two	B-X
low	B-X
molecular	B-X
weight	B-X
isoforms	B-X
of	B-X
CD45	B-X
in	B-X
a	B-X
sugar-dependent	B-X
manner	B-X
.	B-X
CR-Fc	B-X
binding	B-X
and	B-X
non-binding	B-X
forms	B-X
of	B-X
Sn	B-X
,	B-X
probably	B-X
derived	B-X
from	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
and	B-X
CR-Fc	B-X
(	B-X
-	B-X
)	B-X
cells	B-X
respectively	B-X
,	B-X
were	B-X
selected	B-X
from	B-X
spleen	B-X
lysates	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
glycan	B-X
pool	B-X
associated	B-X
with	B-X
the	B-X
CR-Fc-binding	B-X
form	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
charged	B-X
structures	B-X
resistant	B-X
to	B-X
sialidase	B-X
,	B-X
absent	B-X
in	B-X
the	B-X
non-binding	B-X
form	B-X
,	B-X
that	B-X
could	B-X
correspond	B-X
to	B-X
sulfated	B-X
structures	B-X
.	B-X
These	B-X
results	B-X
confirm	B-X
the	B-X
identification	B-X
of	B-X
the	B-X
CR	B-X
region	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
as	B-X
a	B-X
lectin	B-X
.	B-X

In	O
this	O
paper	O
we	O
report	O
the	O
identification	O
of	O
two	O
of	O
these	O
ligands	O
as	O
sialoadhesin	B-Protein
(	O
Sn	B-Protein
)	O
,	O
an	O
Mo	O
-	O
specific	O
membrane	O
molecule	O
,	O
and	O
the	O
leukocyte	O
common	O
antigen	O
,	O
CD45	B-Protein
.	O

CR	O
-	O
Fc	O
bound	O
selectively	O
to	O
Sn	B-Protein
purified	O
from	O
spleen	O
and	O
lymph	O
nodes	O
and	O
to	O
two	O
low	O
molecular	O
weight	O
isoforms	O
of	O
CD45	B-Protein
in	O
a	O
sugar	O
-	O
dependent	O
manner	O
.	O

CR	O
-	O
Fc	O
binding	O
and	O
non	O
-	O
binding	O
forms	O
of	O
Sn	B-Protein
,	O
probably	O
derived	O
from	O
CR	O
-	O
Fc	O
(	O
+	O
)	O
and	O
CR	O
-	O
Fc	O
(	O
-	O
)	O
cells	O
respectively	O
,	O
were	O
selected	O
from	O
spleen	O
lysates	O
.	O
<EOS>	B-X
We	B-X
previously	B-X
reported	B-X
that	B-X
CR-Fc	B-X
,	B-X
an	B-X
Fc	B-X
chimeric	B-X
protein	B-X
containing	B-X
the	B-X
cysteine-rich	B-X
(	B-X
CR	B-X
)	B-X
domain	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
,	B-X
binds	B-X
to	B-X
marginal	B-X
zone	B-X
metallophilic	B-X
macrophages	B-X
(	B-X
Mo	B-X
)	B-X
and	B-X
B	B-X
cell	B-X
areas	B-X
in	B-X
the	B-X
spleen	B-X
and	B-X
to	B-X
subcapsular	B-X
sinus	B-X
Mo	B-X
in	B-X
lymph	B-X
nodes	B-X
of	B-X
naive	B-X
mice	B-X
(	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
cells	B-X
)	B-X
.	B-X
Several	B-X
CR-Fc	B-X
ligands	B-X
were	B-X
found	B-X
in	B-X
spleen	B-X
and	B-X
lymph	B-X
node	B-X
tissue	B-X
lysates	B-X
using	B-X
ligand	B-X
blots	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
we	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
two	B-X
of	B-X
these	B-X
ligands	B-X
as	B-X
sialoadhesin	B-X
(	B-X
Sn	B-X
)	B-X
,	B-X
an	B-X
Mo-specific	B-X
membrane	B-X
molecule	B-X
,	B-X
and	B-X
the	B-X
leukocyte	B-X
common	B-X
antigen	B-X
,	B-X
CD45	B-X
.	B-X
CR-Fc	B-X
bound	B-X
selectively	B-X
to	B-X
Sn	B-X
purified	B-X
from	B-X
spleen	B-X
and	B-X
lymph	B-X
nodes	B-X
and	B-X
to	B-X
two	B-X
low	B-X
molecular	B-X
weight	B-X
isoforms	B-X
of	B-X
CD45	B-X
in	B-X
a	B-X
sugar-dependent	B-X
manner	B-X
.	B-X
CR-Fc	B-X
binding	B-X
and	B-X
non-binding	B-X
forms	B-X
of	B-X
Sn	B-X
,	B-X
probably	B-X
derived	B-X
from	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
and	B-X
CR-Fc	B-X
(	B-X
-	B-X
)	B-X
cells	B-X
respectively	B-X
,	B-X
were	B-X
selected	B-X
from	B-X
spleen	B-X
lysates	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
glycan	B-X
pool	B-X
associated	B-X
with	B-X
the	B-X
CR-Fc-binding	B-X
form	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
charged	B-X
structures	B-X
resistant	B-X
to	B-X
sialidase	B-X
,	B-X
absent	B-X
in	B-X
the	B-X
non-binding	B-X
form	B-X
,	B-X
that	B-X
could	B-X
correspond	B-X
to	B-X
sulfated	B-X
structures	B-X
.	B-X
These	B-X
results	B-X
confirm	B-X
the	B-X
identification	B-X
of	B-X
the	B-X
CR	B-X
region	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
as	B-X
a	B-X
lectin	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
that	B-X
the	B-X
same	B-X
glycoprotein	B-X
expressed	B-X
in	B-X
different	B-X
cells	B-X
of	B-X
the	B-X
same	B-X
organ	B-X
can	B-X
display	B-X
distinct	B-X
sugar	B-X
epitopes	B-X
that	B-X
determine	B-X
its	B-X
binding	B-X
properties	B-X
.	B-X

Analysis	O
of	O
the	O
glycan	O
pool	O
associated	O
with	O
the	O
CR	O
-	O
Fc	O
-	O
binding	O
form	O
revealed	O
the	O
presence	O
of	O
charged	O
structures	O
resistant	O
to	O
sialidase	O
,	O
absent	O
in	O
the	O
non	O
-	O
binding	O
form	O
,	O
that	O
could	O
correspond	O
to	O
sulfated	O
structures	O
.	O
<EOS>	B-X
We	B-X
previously	B-X
reported	B-X
that	B-X
CR-Fc	B-X
,	B-X
an	B-X
Fc	B-X
chimeric	B-X
protein	B-X
containing	B-X
the	B-X
cysteine-rich	B-X
(	B-X
CR	B-X
)	B-X
domain	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
,	B-X
binds	B-X
to	B-X
marginal	B-X
zone	B-X
metallophilic	B-X
macrophages	B-X
(	B-X
Mo	B-X
)	B-X
and	B-X
B	B-X
cell	B-X
areas	B-X
in	B-X
the	B-X
spleen	B-X
and	B-X
to	B-X
subcapsular	B-X
sinus	B-X
Mo	B-X
in	B-X
lymph	B-X
nodes	B-X
of	B-X
naive	B-X
mice	B-X
(	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
cells	B-X
)	B-X
.	B-X
Several	B-X
CR-Fc	B-X
ligands	B-X
were	B-X
found	B-X
in	B-X
spleen	B-X
and	B-X
lymph	B-X
node	B-X
tissue	B-X
lysates	B-X
using	B-X
ligand	B-X
blots	B-X
.	B-X
CR-Fc	B-X
bound	B-X
selectively	B-X
to	B-X
Sn	B-X
purified	B-X
from	B-X
spleen	B-X
and	B-X
lymph	B-X
nodes	B-X
and	B-X
to	B-X
two	B-X
low	B-X
molecular	B-X
weight	B-X
isoforms	B-X
of	B-X
CD45	B-X
in	B-X
a	B-X
sugar-dependent	B-X
manner	B-X
.	B-X
CR-Fc	B-X
binding	B-X
and	B-X
non-binding	B-X
forms	B-X
of	B-X
Sn	B-X
,	B-X
probably	B-X
derived	B-X
from	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
and	B-X
CR-Fc	B-X
(	B-X
-	B-X
)	B-X
cells	B-X
respectively	B-X
,	B-X
were	B-X
selected	B-X
from	B-X
spleen	B-X
lysates	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
glycan	B-X
pool	B-X
associated	B-X
with	B-X
the	B-X
CR-Fc-binding	B-X
form	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
charged	B-X
structures	B-X
resistant	B-X
to	B-X
sialidase	B-X
,	B-X
absent	B-X
in	B-X
the	B-X
non-binding	B-X
form	B-X
,	B-X
that	B-X
could	B-X
correspond	B-X
to	B-X
sulfated	B-X
structures	B-X
.	B-X
These	B-X
results	B-X
confirm	B-X
the	B-X
identification	B-X
of	B-X
the	B-X
CR	B-X
region	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
as	B-X
a	B-X
lectin	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
that	B-X
the	B-X
same	B-X
glycoprotein	B-X
expressed	B-X
in	B-X
different	B-X
cells	B-X
of	B-X
the	B-X
same	B-X
organ	B-X
can	B-X
display	B-X
distinct	B-X
sugar	B-X
epitopes	B-X
that	B-X
determine	B-X
its	B-X
binding	B-X
properties	B-X
.	B-X

These	O
results	O
confirm	O
the	O
identification	O
of	O
the	O
CR	O
region	O
of	O
the	O
mannose	O
receptor	O
as	O
a	O
lectin	O
.	O
<EOS>	B-X
We	B-X
previously	B-X
reported	B-X
that	B-X
CR-Fc	B-X
,	B-X
an	B-X
Fc	B-X
chimeric	B-X
protein	B-X
containing	B-X
the	B-X
cysteine-rich	B-X
(	B-X
CR	B-X
)	B-X
domain	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
,	B-X
binds	B-X
to	B-X
marginal	B-X
zone	B-X
metallophilic	B-X
macrophages	B-X
(	B-X
Mo	B-X
)	B-X
and	B-X
B	B-X
cell	B-X
areas	B-X
in	B-X
the	B-X
spleen	B-X
and	B-X
to	B-X
subcapsular	B-X
sinus	B-X
Mo	B-X
in	B-X
lymph	B-X
nodes	B-X
of	B-X
naive	B-X
mice	B-X
(	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
cells	B-X
)	B-X
.	B-X
Several	B-X
CR-Fc	B-X
ligands	B-X
were	B-X
found	B-X
in	B-X
spleen	B-X
and	B-X
lymph	B-X
node	B-X
tissue	B-X
lysates	B-X
using	B-X
ligand	B-X
blots	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
we	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
two	B-X
of	B-X
these	B-X
ligands	B-X
as	B-X
sialoadhesin	B-X
(	B-X
Sn	B-X
)	B-X
,	B-X
an	B-X
Mo-specific	B-X
membrane	B-X
molecule	B-X
,	B-X
and	B-X
the	B-X
leukocyte	B-X
common	B-X
antigen	B-X
,	B-X
CD45	B-X
.	B-X
CR-Fc	B-X
bound	B-X
selectively	B-X
to	B-X
Sn	B-X
purified	B-X
from	B-X
spleen	B-X
and	B-X
lymph	B-X
nodes	B-X
and	B-X
to	B-X
two	B-X
low	B-X
molecular	B-X
weight	B-X
isoforms	B-X
of	B-X
CD45	B-X
in	B-X
a	B-X
sugar-dependent	B-X
manner	B-X
.	B-X
CR-Fc	B-X
binding	B-X
and	B-X
non-binding	B-X
forms	B-X
of	B-X
Sn	B-X
,	B-X
probably	B-X
derived	B-X
from	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
and	B-X
CR-Fc	B-X
(	B-X
-	B-X
)	B-X
cells	B-X
respectively	B-X
,	B-X
were	B-X
selected	B-X
from	B-X
spleen	B-X
lysates	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
glycan	B-X
pool	B-X
associated	B-X
with	B-X
the	B-X
CR-Fc-binding	B-X
form	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
charged	B-X
structures	B-X
resistant	B-X
to	B-X
sialidase	B-X
,	B-X
absent	B-X
in	B-X
the	B-X
non-binding	B-X
form	B-X
,	B-X
that	B-X
could	B-X
correspond	B-X
to	B-X
sulfated	B-X
structures	B-X
.	B-X
These	B-X
results	B-X
confirm	B-X
the	B-X
identification	B-X
of	B-X
the	B-X
CR	B-X
region	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
as	B-X
a	B-X
lectin	B-X
.	B-X

We	O
also	O
demonstrate	O
that	O
the	O
same	O
glycoprotein	O
expressed	O
in	O
different	O
cells	O
of	O
the	O
same	O
organ	O
can	O
display	O
distinct	O
sugar	O
epitopes	O
that	O
determine	O
its	O
binding	O
properties	O
.	O
<EOS>	B-X
We	B-X
previously	B-X
reported	B-X
that	B-X
CR-Fc	B-X
,	B-X
an	B-X
Fc	B-X
chimeric	B-X
protein	B-X
containing	B-X
the	B-X
cysteine-rich	B-X
(	B-X
CR	B-X
)	B-X
domain	B-X
of	B-X
the	B-X
mannose	B-X
receptor	B-X
,	B-X
binds	B-X
to	B-X
marginal	B-X
zone	B-X
metallophilic	B-X
macrophages	B-X
(	B-X
Mo	B-X
)	B-X
and	B-X
B	B-X
cell	B-X
areas	B-X
in	B-X
the	B-X
spleen	B-X
and	B-X
to	B-X
subcapsular	B-X
sinus	B-X
Mo	B-X
in	B-X
lymph	B-X
nodes	B-X
of	B-X
naive	B-X
mice	B-X
(	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
cells	B-X
)	B-X
.	B-X
CR-Fc	B-X
bound	B-X
selectively	B-X
to	B-X
Sn	B-X
purified	B-X
from	B-X
spleen	B-X
and	B-X
lymph	B-X
nodes	B-X
and	B-X
to	B-X
two	B-X
low	B-X
molecular	B-X
weight	B-X
isoforms	B-X
of	B-X
CD45	B-X
in	B-X
a	B-X
sugar-dependent	B-X
manner	B-X
.	B-X
CR-Fc	B-X
binding	B-X
and	B-X
non-binding	B-X
forms	B-X
of	B-X
Sn	B-X
,	B-X
probably	B-X
derived	B-X
from	B-X
CR-Fc	B-X
(	B-X
+	B-X
)	B-X
and	B-X
CR-Fc	B-X
(	B-X
-	B-X
)	B-X
cells	B-X
respectively	B-X
,	B-X
were	B-X
selected	B-X
from	B-X
spleen	B-X
lysates	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
glycan	B-X
pool	B-X
associated	B-X
with	B-X
the	B-X
CR-Fc-binding	B-X
form	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
charged	B-X
structures	B-X
resistant	B-X
to	B-X
sialidase	B-X
,	B-X
absent	B-X
in	B-X
the	B-X
non-binding	B-X
form	B-X
,	B-X
that	B-X
could	B-X
correspond	B-X
to	B-X
sulfated	B-X
structures	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
that	B-X
the	B-X
same	B-X
glycoprotein	B-X
expressed	B-X
in	B-X
different	B-X
cells	B-X
of	B-X
the	B-X
same	B-X
organ	B-X
can	B-X
display	B-X
distinct	B-X
sugar	B-X
epitopes	B-X
that	B-X
determine	B-X
its	B-X
binding	B-X
properties	B-X
.	B-X

Disrupting	O
the	O
geranylgeranylation	O
at	O
the	O
C	O
-	O
termini	O
of	O
the	O
shrimp	O
Ras	B-Protein
by	O
depriving	O
guanine	O
nucleotide	O
binding	O
at	O
the	O
N	O
-	O
terminal	O
.	O

In	O
order	O
to	O
assess	O
the	O
effects	O
of	O
guanine	O
nucleotide	O
binding	O
on	O
the	O
geranylgeranylation	O
at	O
the	O
CAAX	O
box	O
of	O
the	O
shrimp	O
Ras	B-Protein
,	O
we	O
experimented	O
with	O
the	O
shrimp	O
Penaeus	O
japonicus	O
Ras	B-Protein
(	O
S	O
-	O
Ras	B-Protein
)	O
which	O
is	O
geranylgeranylated	O
at	O
the	O
C	O
-	O
termini	O
,	O
shares	O
85	O
%	O
homology	O
with	O
mammalian	O
K	B-Protein
(	I-Protein
B	I-Protein
)	I-Protein
-	I-Protein
Ras	I-Protein
protein	O
and	O
demonstrates	O
identity	O
in	O
the	O
guanine	O
nucleotide	O
binding	O
domains	O
(	O
Huang	O
C	O
-	O
F	O
,	O
Chuang	O
N	O
-	O
N	O
.	O
1999	O
.	O
J	O
Exp	O
Zool	O
283	O
:	O
510	O
-	O
521	O
)	O
.	O

Several	O
point	O
mutations	O
in	O
the	O
S	O
-	O
ras	B-Protein
gene	O
were	O
generated	O
at	O
codons	O
12	O
(	O
G12V	O
)	O
,	O
61	O
(	O
Q61K	O
)	O
,	O
and	O
116	O
(	O
N116I	O
)	O
.	O

The	O
bacterially	O
expressed	O
mutant	O
S	O
-	O
Ras	B-Protein
proteins	O
,	O
G12V	O
and	O
Q61K	O
,	O
were	O
bound	O
with	O
GTP	O
without	O
hydrolysis	O
.	O
<EOS>	B-X
In	B-X
order	B-X
to	B-X
assess	B-X
the	B-X
effects	B-X
of	B-X
guanine	B-X
nucleotide	B-X
binding	B-X
on	B-X
the	B-X
geranylgeranylation	B-X
at	B-X
the	B-X
CAAX	B-X
box	B-X
of	B-X
the	B-X
shrimp	B-X
Ras	B-X
,	B-X
we	B-X
experimented	B-X
with	B-X
the	B-X
shrimp	B-X
Penaeus	B-X
japonicus	B-X
Ras	B-X
(	B-X
S-Ras	B-X
)	B-X
which	B-X
is	B-X
geranylgeranylated	B-X
at	B-X
the	B-X
C-termini	B-X
,	B-X
shares	B-X
85	B-X
%	B-X
homology	B-X
with	B-X
mammalian	B-X
K	B-X
(	B-X
B	B-X
)	B-X
-Ras	B-X
protein	B-X
and	B-X
demonstrates	B-X
identity	B-X
in	B-X
the	B-X
guanine	B-X
nucleotide	B-X
binding	B-X
domains	B-X
(	B-X
Huang	B-X
C-F	B-X
,	B-X
Chuang	B-X
N-N.	B-X
1999	B-X
.	B-X
Several	B-X
point	B-X
mutations	B-X
in	B-X
the	B-X
S-ras	B-X
gene	B-X
were	B-X
generated	B-X
at	B-X
codons	B-X
12	B-X
(	B-X
G12V	B-X
)	B-X
,	B-X
61	B-X
(	B-X
Q61K	B-X
)	B-X
,	B-X
and	B-X
116	B-X
(	B-X
N116I	B-X
)	B-X
.	B-X
The	B-X
bacterially	B-X
expressed	B-X
mutant	B-X
S-Ras	B-X
proteins	B-X
,	B-X
G12V	B-X
and	B-X
Q61K	B-X
,	B-X
were	B-X
bound	B-X
with	B-X
GTP	B-X
without	B-X
hydrolysis	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
mutant	B-X
S-Ras	B-X
N116I	B-X
was	B-X
defective	B-X
in	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
any	B-X
guanine	B-X
nucleotides	B-X
.	B-X
J	B-X
Exp	B-X
Zool	B-X
281:565-573	B-X
)	B-X
was	B-X
unable	B-X
to	B-X
catalyze	B-X
the	B-X
transfer	B-X
of	B-X
[	B-X
(	B-X
3	B-X
)	B-X
H	B-X
]	B-X
-geranylgeranylpyrophosphate	B-X
to	B-X
this	B-X
mutant	B-X
N116I	B-X
but	B-X
very	B-X
competently	B-X
caused	B-X
the	B-X
geranylgeranylation	B-X
of	B-X
GTP-locked	B-X
mutants	B-X
,	B-X
G12V	B-X
and	B-X
Q61K	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
geranylgeranylation	B-X
at	B-X
the	B-X
CAAX	B-X
box	B-X
of	B-X
the	B-X
shrimp	B-X
Ras	B-X
protein	B-X
requires	B-X
the	B-X
proper	B-X
binding	B-X
of	B-X
guanine	B-X
nucleotide	B-X
at	B-X
its	B-X
N-terminal	B-X
region	B-X
.	B-X

In	O
contrast	O
,	O
the	O
mutant	O
S	O
-	O
Ras	B-Protein
N116I	O
was	O
defective	O
in	O
its	O
ability	O
to	O
bind	O
any	O
guanine	O
nucleotides	O
.	O
<EOS>	B-X
In	B-X
order	B-X
to	B-X
assess	B-X
the	B-X
effects	B-X
of	B-X
guanine	B-X
nucleotide	B-X
binding	B-X
on	B-X
the	B-X
geranylgeranylation	B-X
at	B-X
the	B-X
CAAX	B-X
box	B-X
of	B-X
the	B-X
shrimp	B-X
Ras	B-X
,	B-X
we	B-X
experimented	B-X
with	B-X
the	B-X
shrimp	B-X
Penaeus	B-X
japonicus	B-X
Ras	B-X
(	B-X
S-Ras	B-X
)	B-X
which	B-X
is	B-X
geranylgeranylated	B-X
at	B-X
the	B-X
C-termini	B-X
,	B-X
shares	B-X
85	B-X
%	B-X
homology	B-X
with	B-X
mammalian	B-X
K	B-X
(	B-X
B	B-X
)	B-X
-Ras	B-X
protein	B-X
and	B-X
demonstrates	B-X
identity	B-X
in	B-X
the	B-X
guanine	B-X
nucleotide	B-X
binding	B-X
domains	B-X
(	B-X
Huang	B-X
C-F	B-X
,	B-X
Chuang	B-X
N-N.	B-X
1999	B-X
.	B-X
Several	B-X
point	B-X
mutations	B-X
in	B-X
the	B-X
S-ras	B-X
gene	B-X
were	B-X
generated	B-X
at	B-X
codons	B-X
12	B-X
(	B-X
G12V	B-X
)	B-X
,	B-X
61	B-X
(	B-X
Q61K	B-X
)	B-X
,	B-X
and	B-X
116	B-X
(	B-X
N116I	B-X
)	B-X
.	B-X
The	B-X
bacterially	B-X
expressed	B-X
mutant	B-X
S-Ras	B-X
proteins	B-X
,	B-X
G12V	B-X
and	B-X
Q61K	B-X
,	B-X
were	B-X
bound	B-X
with	B-X
GTP	B-X
without	B-X
hydrolysis	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
mutant	B-X
S-Ras	B-X
N116I	B-X
was	B-X
defective	B-X
in	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
any	B-X
guanine	B-X
nucleotides	B-X
.	B-X
J	B-X
Exp	B-X
Zool	B-X
281:565-573	B-X
)	B-X
was	B-X
unable	B-X
to	B-X
catalyze	B-X
the	B-X
transfer	B-X
of	B-X
[	B-X
(	B-X
3	B-X
)	B-X
H	B-X
]	B-X
-geranylgeranylpyrophosphate	B-X
to	B-X
this	B-X
mutant	B-X
N116I	B-X
but	B-X
very	B-X
competently	B-X
caused	B-X
the	B-X
geranylgeranylation	B-X
of	B-X
GTP-locked	B-X
mutants	B-X
,	B-X
G12V	B-X
and	B-X
Q61K	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
geranylgeranylation	B-X
at	B-X
the	B-X
CAAX	B-X
box	B-X
of	B-X
the	B-X
shrimp	B-X
Ras	B-X
protein	B-X
requires	B-X
the	B-X
proper	B-X
binding	B-X
of	B-X
guanine	B-X
nucleotide	B-X
at	B-X
its	B-X
N-terminal	B-X
region	B-X
.	B-X

Autoradiography	O
studies	O
showed	O
that	O
the	O
purified	O
shrimp	O
protein	O
geranylgeranyltransferase	B-Protein
I	I-Protein
(	O
Lin	O
R	O
-	O
S	O
,	O
Chuang	O
N	O
-	O
N	O
.	O
1998	O
.	O
J	O
Exp	O
Zool	O
281	O
:	O
565	O
-	O
573	O
)	O
was	O
unable	O
to	O
catalyze	O
the	O
transfer	O
of	O
[	O
(	O
3	O
)	O
H	O
]	O
-	O
geranylgeranylpyrophosphate	O
to	O
this	O
mutant	O
N116I	O
but	O
very	O
competently	O
caused	O
the	O
geranylgeranylation	O
of	O
GTP	O
-	O
locked	O
mutants	O
,	O
G12V	O
and	O
Q61K	O
.	O

These	O
results	O
demonstrate	O
that	O
the	O
geranylgeranylation	O
at	O
the	O
CAAX	O
box	O
of	O
the	O
shrimp	O
Ras	B-Protein
protein	O
requires	O
the	O
proper	O
binding	O
of	O
guanine	O
nucleotide	O
at	O
its	O
N	O
-	O
terminal	O
region	O
.	O
<EOS>	B-X
In	B-X
order	B-X
to	B-X
assess	B-X
the	B-X
effects	B-X
of	B-X
guanine	B-X
nucleotide	B-X
binding	B-X
on	B-X
the	B-X
geranylgeranylation	B-X
at	B-X
the	B-X
CAAX	B-X
box	B-X
of	B-X
the	B-X
shrimp	B-X
Ras	B-X
,	B-X
we	B-X
experimented	B-X
with	B-X
the	B-X
shrimp	B-X
Penaeus	B-X
japonicus	B-X
Ras	B-X
(	B-X
S-Ras	B-X
)	B-X
which	B-X
is	B-X
geranylgeranylated	B-X
at	B-X
the	B-X
C-termini	B-X
,	B-X
shares	B-X
85	B-X
%	B-X
homology	B-X
with	B-X
mammalian	B-X
K	B-X
(	B-X
B	B-X
)	B-X
-Ras	B-X
protein	B-X
and	B-X
demonstrates	B-X
identity	B-X
in	B-X
the	B-X
guanine	B-X
nucleotide	B-X
binding	B-X
domains	B-X
(	B-X
Huang	B-X
C-F	B-X
,	B-X
Chuang	B-X
N-N.	B-X
1999	B-X
.	B-X
Several	B-X
point	B-X
mutations	B-X
in	B-X
the	B-X
S-ras	B-X
gene	B-X
were	B-X
generated	B-X
at	B-X
codons	B-X
12	B-X
(	B-X
G12V	B-X
)	B-X
,	B-X
61	B-X
(	B-X
Q61K	B-X
)	B-X
,	B-X
and	B-X
116	B-X
(	B-X
N116I	B-X
)	B-X
.	B-X
The	B-X
bacterially	B-X
expressed	B-X
mutant	B-X
S-Ras	B-X
proteins	B-X
,	B-X
G12V	B-X
and	B-X
Q61K	B-X
,	B-X
were	B-X
bound	B-X
with	B-X
GTP	B-X
without	B-X
hydrolysis	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
mutant	B-X
S-Ras	B-X
N116I	B-X
was	B-X
defective	B-X
in	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
any	B-X
guanine	B-X
nucleotides	B-X
.	B-X
Autoradiography	B-X
studies	B-X
showed	B-X
that	B-X
the	B-X
purified	B-X
shrimp	B-X
protein	B-X
geranylgeranyltransferase	B-X
I	B-X
(	B-X
Lin	B-X
R-S	B-X
,	B-X
Chuang	B-X
N-N.	B-X
1998	B-X
.	B-X
J	B-X
Exp	B-X
Zool	B-X
281:565-573	B-X
)	B-X
was	B-X
unable	B-X
to	B-X
catalyze	B-X
the	B-X
transfer	B-X
of	B-X
[	B-X
(	B-X
3	B-X
)	B-X
H	B-X
]	B-X
-geranylgeranylpyrophosphate	B-X
to	B-X
this	B-X
mutant	B-X
N116I	B-X
but	B-X
very	B-X
competently	B-X
caused	B-X
the	B-X
geranylgeranylation	B-X
of	B-X
GTP-locked	B-X
mutants	B-X
,	B-X
G12V	B-X
and	B-X
Q61K	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
geranylgeranylation	B-X
at	B-X
the	B-X
CAAX	B-X
box	B-X
of	B-X
the	B-X
shrimp	B-X
Ras	B-X
protein	B-X
requires	B-X
the	B-X
proper	B-X
binding	B-X
of	B-X
guanine	B-X
nucleotide	B-X
at	B-X
its	B-X
N-terminal	B-X
region	B-X
.	B-X

J	O
.	O
<EOS>	B-X
Heat	B-X
shock	B-X
proteins	B-X
of	B-X
40	B-X
kDa	B-X
(	B-X
Hsp40s	B-X
)	B-X
,	B-X
also	B-X
called	B-X
J	B-X
proteins	B-X
,	B-X
are	B-X
obligate	B-X
partners	B-X
of	B-X
Hsp70s	B-X
.	B-X
Via	B-X
their	B-X
highly	B-X
conserved	B-X
and	B-X
functionally	B-X
critical	B-X
J	B-X
domain	B-X
,	B-X
J	B-X
proteins	B-X
interact	B-X
and	B-X
modulate	B-X
the	B-X
activity	B-X
of	B-X
their	B-X
Hsp70	B-X
partners	B-X
.	B-X
Mutations	B-X
in	B-X
the	B-X
critical	B-X
residues	B-X
in	B-X
the	B-X
J	B-X
domain	B-X
often	B-X
result	B-X
in	B-X
the	B-X
null	B-X
phenotype	B-X
for	B-X
the	B-X
J	B-X
protein	B-X
in	B-X
question	B-X
.	B-X
However	B-X
,	B-X
as	B-X
more	B-X
J	B-X
proteins	B-X
have	B-X
been	B-X
characterized	B-X
,	B-X
it	B-X
is	B-X
becoming	B-X
increasingly	B-X
clear	B-X
that	B-X
a	B-X
significant	B-X
number	B-X
of	B-X
J	B-X
proteins	B-X
do	B-X
not	B-X
``	B-X
completely	B-X
''	B-X
rely	B-X
on	B-X
their	B-X
J	B-X
domains	B-X
to	B-X
carry	B-X
out	B-X
their	B-X
cellular	B-X
functions	B-X
,	B-X
as	B-X
previously	B-X
thought	B-X
.	B-X
In	B-X
some	B-X
cases	B-X
,	B-X
regions	B-X
outside	B-X
the	B-X
highly	B-X
conserved	B-X
J	B-X
domain	B-X
have	B-X
become	B-X
more	B-X
important	B-X
making	B-X
the	B-X
J	B-X
domain	B-X
dispensable	B-X
for	B-X
some	B-X
,	B-X
if	B-X
not	B-X
for	B-X
all	B-X
functions	B-X
of	B-X
a	B-X
J	B-X
protein	B-X
.	B-X
This	B-X
has	B-X
profound	B-X
effects	B-X
on	B-X
the	B-X
evolution	B-X
of	B-X
such	B-X
J	B-X
proteins	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
selected	B-X
examples	B-X
of	B-X
J	B-X
proteins	B-X
that	B-X
perform	B-X
J	B-X
domain	B-X
independent	B-X
functions	B-X
and	B-X
discuss	B-X
this	B-X
in	B-X
the	B-X
context	B-X
of	B-X
evolution	B-X
of	B-X
J	B-X
proteins	B-X
with	B-X
dispensable	B-X
J	B-X
domains	B-X
and	B-X
J-like	B-X
proteins	B-X
in	B-X
eukaryotes	B-X
.	B-X

Exp	O
.	O
<EOS>	B-X
Expandable	B-X
cages	B-X
(	B-X
EXP	B-X
)	B-X
are	B-X
being	B-X
more	B-X
frequently	B-X
utilized	B-X
in	B-X
transforaminal	B-X
lumbar	B-X
interbody	B-X
fusions	B-X
(	B-X
TLIF	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
homologies	B-X
of	B-X
three	B-X
Exp	B-X
proteins	B-X
to	B-X
transcriptional	B-X
regulators	B-X
,	B-X
methyltransferases	B-X
,	B-X
and	B-X
periplasmic	B-X
binding	B-X
proteins	B-X
were	B-X
found	B-X
.	B-X
We	B-X
used	B-X
a	B-X
spatial	B-X
cueing	B-X
task	B-X
to	B-X
test	B-X
whether	B-X
script	B-X
direction	B-X
and	B-X
the	B-X
grounding	B-X
of	B-X
time	B-X
in	B-X
Portuguese	B-X
(	B-X
LR	B-X
,	B-X
Exp	B-X
.	B-X
1	B-X
)	B-X
and	B-X
Arabic	B-X
(	B-X
RL	B-X
,	B-X
Exp	B-X
.	B-X
Temporal	B-X
words	B-X
(	B-X
e.g.	B-X
,	B-X
tomorrow	B-X
,	B-X
yesterday	B-X
)	B-X
were	B-X
presented	B-X
as	B-X
cues	B-X
in	B-X
two	B-X
modalities	B-X
:	B-X
visual	B-X
(	B-X
Exp	B-X
.	B-X
1-2	B-X
)	B-X
and	B-X
auditory	B-X
(	B-X
Exp	B-X
.	B-X
Gaze	B-X
movement	B-X
(	B-X
Exp	B-X
.	B-X
1	B-X
)	B-X
and	B-X
speed	B-X
of	B-X
discrimination	B-X
decisions	B-X
(	B-X
Exp	B-X
.	B-X
In	B-X
both	B-X
modalities	B-X
,	B-X
the	B-X
initial	B-X
eye-gaze	B-X
movement	B-X
(	B-X
Exp	B-X
.	B-X

Zool	O
.	O
<EOS>	B-X
CORRIGENDUM	B-X
.	B-X
Retraction	B-X
.	B-X
Inaugural	B-X
Editorial	B-X
.	B-X
ERRATUM	B-X
.	B-X

286	O
:	O
441	O
-	O
449	O
,	O
2000	O
.	O
<EOS>	B-X
286:441-449	B-X
,	B-X
2000	B-X
.	B-X

Akr1p	B-Protein
and	O
the	O
type	O
I	O
casein	O
kinases	O
act	O
prior	O
to	O
the	O
ubiquitination	O
step	O
of	O
yeast	O
endocytosis	O
:	O
Akr1p	B-Protein
is	O
required	O
for	O
kinase	O
localization	O
to	O
the	O
plasma	O
membrane	O
.	O

Ubiquitination	O
of	O
the	O
plasma	O
membrane	O
-	O
localized	O
yeast	O
a	B-Protein
-	I-Protein
factor	I-Protein
receptor	I-Protein
(	O
Ste3p	B-Protein
)	O
triggers	O
a	O
rapid	O
,	O
ligand	O
-	O
independent	O
endocytosis	O
leading	O
to	O
its	O
vacuolar	O
degradation	O
.	O
<EOS>	B-X
Ubiquitination	B-X
of	B-X
the	B-X
plasma	B-X
membrane-localized	B-X
yeast	B-X
a-factor	B-X
receptor	B-X
(	B-X
Ste3p	B-X
)	B-X
triggers	B-X
a	B-X
rapid	B-X
,	B-X
ligand-independent	B-X
endocytosis	B-X
leading	B-X
to	B-X
its	B-X
vacuolar	B-X
degradation	B-X
.	B-X
While	B-X
no	B-X
obvious	B-X
defect	B-X
was	B-X
seen	B-X
for	B-X
wild-type	B-X
Ste3p	B-X
phosphorylation	B-X
in	B-X
akr1	B-X
or	B-X
yck	B-X
mutant	B-X
backgrounds	B-X
,	B-X
examination	B-X
of	B-X
the	B-X
Delta320-413	B-X
Ste3p	B-X
deletion	B-X
mutant	B-X
phosphorylation	B-X
did	B-X
reveal	B-X
a	B-X
clear	B-X
defect	B-X
in	B-X
both	B-X
mutants	B-X
.	B-X
The	B-X
Delta320-413	B-X
deletion	B-X
removes	B-X
18	B-X
Ser-Thr	B-X
residues	B-X
(	B-X
possible	B-X
YCK-independent	B-X
phosphorylation	B-X
sites	B-X
)	B-X
yet	B-X
retains	B-X
the	B-X
15	B-X
Ser-Thr	B-X
residues	B-X
of	B-X
the	B-X
Ste3p	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Two	B-X
other	B-X
phenotypes	B-X
link	B-X
akr1	B-X
and	B-X
yck	B-X
mutants	B-X
:	B-X
both	B-X
are	B-X
defective	B-X
in	B-X
phosphorylation	B-X
of	B-X
wild-type	B-X
alpha-factor	B-X
receptor	B-X
,	B-X
and	B-X
while	B-X
both	B-X
are	B-X
defective	B-X
for	B-X
Ste3p	B-X
constitutive	B-X
internalization	B-X
,	B-X
both	B-X
remain	B-X
partially	B-X
competent	B-X
for	B-X
the	B-X
Ste3p	B-X
ligand-dependent	B-X
uptake	B-X
mode	B-X
.	B-X
Yck1p-Yck2p	B-X
may	B-X
be	B-X
the	B-X
function	B-X
responsible	B-X
in	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Akr1p	B-X
appears	B-X
to	B-X
function	B-X
in	B-X
localizing	B-X
Yck1p-Yck2p	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
a	B-X
localization	B-X
that	B-X
depends	B-X
on	B-X
prenylation	B-X
of	B-X
C-terminal	B-X
dicysteinyl	B-X
motifs	B-X
.	B-X
In	B-X
akr1Delta	B-X
cells	B-X
,	B-X
Yck2p	B-X
is	B-X
mislocalized	B-X
,	B-X
showing	B-X
a	B-X
diffuse	B-X
cytoplasmic	B-X
localization	B-X
identical	B-X
to	B-X
that	B-X
seen	B-X
for	B-X
a	B-X
Yck2p	B-X
mutant	B-X
that	B-X
lacks	B-X
the	B-X
C-terminal	B-X
Cys-Cys	B-X
,	B-X
indicating	B-X
a	B-X
likely	B-X
Akr1p	B-X
requirement	B-X
for	B-X
the	B-X
lipid	B-X
modification	B-X
of	B-X
Yck2p	B-X
,	B-X
for	B-X
prenylation	B-X
,	B-X
or	B-X
possibly	B-X
for	B-X
palmitoylation	B-X
.	B-X

This	O
report	O
identifies	O
two	O
mutants	O
that	O
block	O
uptake	O
by	O
blocking	O
ubiquitination	O
,	O
these	O
being	O
mutant	O
either	O
for	O
the	O
ankyrin	O
repeat	O
protein	O
Akr1p	B-Protein
or	O
for	O
the	O
redundant	O
type	O
I	O
casein	O
kinases	O
Yck1p	B-Protein
and	O
Yck2p	B-Protein
.	O
<EOS>	B-X
This	B-X
report	B-X
identifies	B-X
two	B-X
mutants	B-X
that	B-X
block	B-X
uptake	B-X
by	B-X
blocking	B-X
ubiquitination	B-X
,	B-X
these	B-X
being	B-X
mutant	B-X
either	B-X
for	B-X
the	B-X
ankyrin	B-X
repeat	B-X
protein	B-X
Akr1p	B-X
or	B-X
for	B-X
the	B-X
redundant	B-X
type	B-X
I	B-X
casein	B-X
kinases	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
.	B-X
While	B-X
no	B-X
obvious	B-X
defect	B-X
was	B-X
seen	B-X
for	B-X
wild-type	B-X
Ste3p	B-X
phosphorylation	B-X
in	B-X
akr1	B-X
or	B-X
yck	B-X
mutant	B-X
backgrounds	B-X
,	B-X
examination	B-X
of	B-X
the	B-X
Delta320-413	B-X
Ste3p	B-X
deletion	B-X
mutant	B-X
phosphorylation	B-X
did	B-X
reveal	B-X
a	B-X
clear	B-X
defect	B-X
in	B-X
both	B-X
mutants	B-X
.	B-X
The	B-X
Delta320-413	B-X
deletion	B-X
removes	B-X
18	B-X
Ser-Thr	B-X
residues	B-X
(	B-X
possible	B-X
YCK-independent	B-X
phosphorylation	B-X
sites	B-X
)	B-X
yet	B-X
retains	B-X
the	B-X
15	B-X
Ser-Thr	B-X
residues	B-X
of	B-X
the	B-X
Ste3p	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Two	B-X
other	B-X
phenotypes	B-X
link	B-X
akr1	B-X
and	B-X
yck	B-X
mutants	B-X
:	B-X
both	B-X
are	B-X
defective	B-X
in	B-X
phosphorylation	B-X
of	B-X
wild-type	B-X
alpha-factor	B-X
receptor	B-X
,	B-X
and	B-X
while	B-X
both	B-X
are	B-X
defective	B-X
for	B-X
Ste3p	B-X
constitutive	B-X
internalization	B-X
,	B-X
both	B-X
remain	B-X
partially	B-X
competent	B-X
for	B-X
the	B-X
Ste3p	B-X
ligand-dependent	B-X
uptake	B-X
mode	B-X
.	B-X
Yck1p-Yck2p	B-X
may	B-X
be	B-X
the	B-X
function	B-X
responsible	B-X
in	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Akr1p	B-X
appears	B-X
to	B-X
function	B-X
in	B-X
localizing	B-X
Yck1p-Yck2p	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
a	B-X
localization	B-X
that	B-X
depends	B-X
on	B-X
prenylation	B-X
of	B-X
C-terminal	B-X
dicysteinyl	B-X
motifs	B-X
.	B-X
In	B-X
akr1Delta	B-X
cells	B-X
,	B-X
Yck2p	B-X
is	B-X
mislocalized	B-X
,	B-X
showing	B-X
a	B-X
diffuse	B-X
cytoplasmic	B-X
localization	B-X
identical	B-X
to	B-X
that	B-X
seen	B-X
for	B-X
a	B-X
Yck2p	B-X
mutant	B-X
that	B-X
lacks	B-X
the	B-X
C-terminal	B-X
Cys-Cys	B-X
,	B-X
indicating	B-X
a	B-X
likely	B-X
Akr1p	B-X
requirement	B-X
for	B-X
the	B-X
lipid	B-X
modification	B-X
of	B-X
Yck2p	B-X
,	B-X
for	B-X
prenylation	B-X
,	B-X
or	B-X
possibly	B-X
for	B-X
palmitoylation	B-X
.	B-X

While	O
no	O
obvious	O
defect	O
was	O
seen	O
for	O
wild	O
-	O
type	O
Ste3p	B-Protein
phosphorylation	O
in	O
akr1	B-Protein
or	O
yck	O
mutant	O
backgrounds	O
,	O
examination	O
of	O
the	O
Delta320	O
-	O
413	O
Ste3p	B-Protein
deletion	O
mutant	O
phosphorylation	O
did	O
reveal	O
a	O
clear	O
defect	O
in	O
both	O
mutants	O
.	O
<EOS>	B-X
Ubiquitination	B-X
of	B-X
the	B-X
plasma	B-X
membrane-localized	B-X
yeast	B-X
a-factor	B-X
receptor	B-X
(	B-X
Ste3p	B-X
)	B-X
triggers	B-X
a	B-X
rapid	B-X
,	B-X
ligand-independent	B-X
endocytosis	B-X
leading	B-X
to	B-X
its	B-X
vacuolar	B-X
degradation	B-X
.	B-X
This	B-X
report	B-X
identifies	B-X
two	B-X
mutants	B-X
that	B-X
block	B-X
uptake	B-X
by	B-X
blocking	B-X
ubiquitination	B-X
,	B-X
these	B-X
being	B-X
mutant	B-X
either	B-X
for	B-X
the	B-X
ankyrin	B-X
repeat	B-X
protein	B-X
Akr1p	B-X
or	B-X
for	B-X
the	B-X
redundant	B-X
type	B-X
I	B-X
casein	B-X
kinases	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
.	B-X
While	B-X
no	B-X
obvious	B-X
defect	B-X
was	B-X
seen	B-X
for	B-X
wild-type	B-X
Ste3p	B-X
phosphorylation	B-X
in	B-X
akr1	B-X
or	B-X
yck	B-X
mutant	B-X
backgrounds	B-X
,	B-X
examination	B-X
of	B-X
the	B-X
Delta320-413	B-X
Ste3p	B-X
deletion	B-X
mutant	B-X
phosphorylation	B-X
did	B-X
reveal	B-X
a	B-X
clear	B-X
defect	B-X
in	B-X
both	B-X
mutants	B-X
.	B-X
The	B-X
Delta320-413	B-X
deletion	B-X
removes	B-X
18	B-X
Ser-Thr	B-X
residues	B-X
(	B-X
possible	B-X
YCK-independent	B-X
phosphorylation	B-X
sites	B-X
)	B-X
yet	B-X
retains	B-X
the	B-X
15	B-X
Ser-Thr	B-X
residues	B-X
of	B-X
the	B-X
Ste3p	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Two	B-X
other	B-X
phenotypes	B-X
link	B-X
akr1	B-X
and	B-X
yck	B-X
mutants	B-X
:	B-X
both	B-X
are	B-X
defective	B-X
in	B-X
phosphorylation	B-X
of	B-X
wild-type	B-X
alpha-factor	B-X
receptor	B-X
,	B-X
and	B-X
while	B-X
both	B-X
are	B-X
defective	B-X
for	B-X
Ste3p	B-X
constitutive	B-X
internalization	B-X
,	B-X
both	B-X
remain	B-X
partially	B-X
competent	B-X
for	B-X
the	B-X
Ste3p	B-X
ligand-dependent	B-X
uptake	B-X
mode	B-X
.	B-X
Yck1p-Yck2p	B-X
may	B-X
be	B-X
the	B-X
function	B-X
responsible	B-X
in	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
In	B-X
akr1Delta	B-X
cells	B-X
,	B-X
Yck2p	B-X
is	B-X
mislocalized	B-X
,	B-X
showing	B-X
a	B-X
diffuse	B-X
cytoplasmic	B-X
localization	B-X
identical	B-X
to	B-X
that	B-X
seen	B-X
for	B-X
a	B-X
Yck2p	B-X
mutant	B-X
that	B-X
lacks	B-X
the	B-X
C-terminal	B-X
Cys-Cys	B-X
,	B-X
indicating	B-X
a	B-X
likely	B-X
Akr1p	B-X
requirement	B-X
for	B-X
the	B-X
lipid	B-X
modification	B-X
of	B-X
Yck2p	B-X
,	B-X
for	B-X
prenylation	B-X
,	B-X
or	B-X
possibly	B-X
for	B-X
palmitoylation	B-X
.	B-X

The	O
Delta320	O
-	O
413	O
deletion	O
removes	O
18	O
Ser	O
-	O
Thr	O
residues	O
(	O
possible	O
YCK	O
-	O
independent	O
phosphorylation	O
sites	O
)	O
yet	O
retains	O
the	O
15	O
Ser	O
-	O
Thr	O
residues	O
of	O
the	O
Ste3p	B-Protein
PEST	O
-	O
like	O
ubiquitination	O
-	O
endocytosis	O
signal	O
.	O
<EOS>	B-X
Ubiquitination	B-X
of	B-X
the	B-X
plasma	B-X
membrane-localized	B-X
yeast	B-X
a-factor	B-X
receptor	B-X
(	B-X
Ste3p	B-X
)	B-X
triggers	B-X
a	B-X
rapid	B-X
,	B-X
ligand-independent	B-X
endocytosis	B-X
leading	B-X
to	B-X
its	B-X
vacuolar	B-X
degradation	B-X
.	B-X
This	B-X
report	B-X
identifies	B-X
two	B-X
mutants	B-X
that	B-X
block	B-X
uptake	B-X
by	B-X
blocking	B-X
ubiquitination	B-X
,	B-X
these	B-X
being	B-X
mutant	B-X
either	B-X
for	B-X
the	B-X
ankyrin	B-X
repeat	B-X
protein	B-X
Akr1p	B-X
or	B-X
for	B-X
the	B-X
redundant	B-X
type	B-X
I	B-X
casein	B-X
kinases	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
.	B-X
While	B-X
no	B-X
obvious	B-X
defect	B-X
was	B-X
seen	B-X
for	B-X
wild-type	B-X
Ste3p	B-X
phosphorylation	B-X
in	B-X
akr1	B-X
or	B-X
yck	B-X
mutant	B-X
backgrounds	B-X
,	B-X
examination	B-X
of	B-X
the	B-X
Delta320-413	B-X
Ste3p	B-X
deletion	B-X
mutant	B-X
phosphorylation	B-X
did	B-X
reveal	B-X
a	B-X
clear	B-X
defect	B-X
in	B-X
both	B-X
mutants	B-X
.	B-X
The	B-X
Delta320-413	B-X
deletion	B-X
removes	B-X
18	B-X
Ser-Thr	B-X
residues	B-X
(	B-X
possible	B-X
YCK-independent	B-X
phosphorylation	B-X
sites	B-X
)	B-X
yet	B-X
retains	B-X
the	B-X
15	B-X
Ser-Thr	B-X
residues	B-X
of	B-X
the	B-X
Ste3p	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Two	B-X
other	B-X
phenotypes	B-X
link	B-X
akr1	B-X
and	B-X
yck	B-X
mutants	B-X
:	B-X
both	B-X
are	B-X
defective	B-X
in	B-X
phosphorylation	B-X
of	B-X
wild-type	B-X
alpha-factor	B-X
receptor	B-X
,	B-X
and	B-X
while	B-X
both	B-X
are	B-X
defective	B-X
for	B-X
Ste3p	B-X
constitutive	B-X
internalization	B-X
,	B-X
both	B-X
remain	B-X
partially	B-X
competent	B-X
for	B-X
the	B-X
Ste3p	B-X
ligand-dependent	B-X
uptake	B-X
mode	B-X
.	B-X
Yck1p-Yck2p	B-X
may	B-X
be	B-X
the	B-X
function	B-X
responsible	B-X
in	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
In	B-X
akr1Delta	B-X
cells	B-X
,	B-X
Yck2p	B-X
is	B-X
mislocalized	B-X
,	B-X
showing	B-X
a	B-X
diffuse	B-X
cytoplasmic	B-X
localization	B-X
identical	B-X
to	B-X
that	B-X
seen	B-X
for	B-X
a	B-X
Yck2p	B-X
mutant	B-X
that	B-X
lacks	B-X
the	B-X
C-terminal	B-X
Cys-Cys	B-X
,	B-X
indicating	B-X
a	B-X
likely	B-X
Akr1p	B-X
requirement	B-X
for	B-X
the	B-X
lipid	B-X
modification	B-X
of	B-X
Yck2p	B-X
,	B-X
for	B-X
prenylation	B-X
,	B-X
or	B-X
possibly	B-X
for	B-X
palmitoylation	B-X
.	B-X

Two	O
other	O
phenotypes	O
link	O
akr1	B-Protein
and	O
yck	O
mutants	O
:	O
both	O
are	O
defective	O
in	O
phosphorylation	O
of	O
wild	O
-	O
type	O
alpha	B-Protein
-	I-Protein
factor	I-Protein
receptor	I-Protein
,	O
and	O
while	O
both	O
are	O
defective	O
for	O
Ste3p	B-Protein
constitutive	O
internalization	O
,	O
both	O
remain	O
partially	O
competent	O
for	O
the	O
Ste3p	B-Protein
ligand	O
-	O
dependent	O
uptake	O
mode	O
.	O
<EOS>	B-X
Ubiquitination	B-X
of	B-X
the	B-X
plasma	B-X
membrane-localized	B-X
yeast	B-X
a-factor	B-X
receptor	B-X
(	B-X
Ste3p	B-X
)	B-X
triggers	B-X
a	B-X
rapid	B-X
,	B-X
ligand-independent	B-X
endocytosis	B-X
leading	B-X
to	B-X
its	B-X
vacuolar	B-X
degradation	B-X
.	B-X
This	B-X
report	B-X
identifies	B-X
two	B-X
mutants	B-X
that	B-X
block	B-X
uptake	B-X
by	B-X
blocking	B-X
ubiquitination	B-X
,	B-X
these	B-X
being	B-X
mutant	B-X
either	B-X
for	B-X
the	B-X
ankyrin	B-X
repeat	B-X
protein	B-X
Akr1p	B-X
or	B-X
for	B-X
the	B-X
redundant	B-X
type	B-X
I	B-X
casein	B-X
kinases	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
.	B-X
While	B-X
no	B-X
obvious	B-X
defect	B-X
was	B-X
seen	B-X
for	B-X
wild-type	B-X
Ste3p	B-X
phosphorylation	B-X
in	B-X
akr1	B-X
or	B-X
yck	B-X
mutant	B-X
backgrounds	B-X
,	B-X
examination	B-X
of	B-X
the	B-X
Delta320-413	B-X
Ste3p	B-X
deletion	B-X
mutant	B-X
phosphorylation	B-X
did	B-X
reveal	B-X
a	B-X
clear	B-X
defect	B-X
in	B-X
both	B-X
mutants	B-X
.	B-X
The	B-X
Delta320-413	B-X
deletion	B-X
removes	B-X
18	B-X
Ser-Thr	B-X
residues	B-X
(	B-X
possible	B-X
YCK-independent	B-X
phosphorylation	B-X
sites	B-X
)	B-X
yet	B-X
retains	B-X
the	B-X
15	B-X
Ser-Thr	B-X
residues	B-X
of	B-X
the	B-X
Ste3p	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Two	B-X
other	B-X
phenotypes	B-X
link	B-X
akr1	B-X
and	B-X
yck	B-X
mutants	B-X
:	B-X
both	B-X
are	B-X
defective	B-X
in	B-X
phosphorylation	B-X
of	B-X
wild-type	B-X
alpha-factor	B-X
receptor	B-X
,	B-X
and	B-X
while	B-X
both	B-X
are	B-X
defective	B-X
for	B-X
Ste3p	B-X
constitutive	B-X
internalization	B-X
,	B-X
both	B-X
remain	B-X
partially	B-X
competent	B-X
for	B-X
the	B-X
Ste3p	B-X
ligand-dependent	B-X
uptake	B-X
mode	B-X
.	B-X
Yck1p-Yck2p	B-X
may	B-X
be	B-X
the	B-X
function	B-X
responsible	B-X
in	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
In	B-X
akr1Delta	B-X
cells	B-X
,	B-X
Yck2p	B-X
is	B-X
mislocalized	B-X
,	B-X
showing	B-X
a	B-X
diffuse	B-X
cytoplasmic	B-X
localization	B-X
identical	B-X
to	B-X
that	B-X
seen	B-X
for	B-X
a	B-X
Yck2p	B-X
mutant	B-X
that	B-X
lacks	B-X
the	B-X
C-terminal	B-X
Cys-Cys	B-X
,	B-X
indicating	B-X
a	B-X
likely	B-X
Akr1p	B-X
requirement	B-X
for	B-X
the	B-X
lipid	B-X
modification	B-X
of	B-X
Yck2p	B-X
,	B-X
for	B-X
prenylation	B-X
,	B-X
or	B-X
possibly	B-X
for	B-X
palmitoylation	B-X
.	B-X

Yck1p	B-Protein
-	O
Yck2p	B-Protein
may	O
be	O
the	O
function	O
responsible	O
in	O
phosphorylation	O
of	O
the	O
PEST	O
-	O
like	O
ubiquitination	O
-	O
endocytosis	O
signal	O
.	O
<EOS>	B-X
Ubiquitination	B-X
of	B-X
the	B-X
plasma	B-X
membrane-localized	B-X
yeast	B-X
a-factor	B-X
receptor	B-X
(	B-X
Ste3p	B-X
)	B-X
triggers	B-X
a	B-X
rapid	B-X
,	B-X
ligand-independent	B-X
endocytosis	B-X
leading	B-X
to	B-X
its	B-X
vacuolar	B-X
degradation	B-X
.	B-X
This	B-X
report	B-X
identifies	B-X
two	B-X
mutants	B-X
that	B-X
block	B-X
uptake	B-X
by	B-X
blocking	B-X
ubiquitination	B-X
,	B-X
these	B-X
being	B-X
mutant	B-X
either	B-X
for	B-X
the	B-X
ankyrin	B-X
repeat	B-X
protein	B-X
Akr1p	B-X
or	B-X
for	B-X
the	B-X
redundant	B-X
type	B-X
I	B-X
casein	B-X
kinases	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
.	B-X
While	B-X
no	B-X
obvious	B-X
defect	B-X
was	B-X
seen	B-X
for	B-X
wild-type	B-X
Ste3p	B-X
phosphorylation	B-X
in	B-X
akr1	B-X
or	B-X
yck	B-X
mutant	B-X
backgrounds	B-X
,	B-X
examination	B-X
of	B-X
the	B-X
Delta320-413	B-X
Ste3p	B-X
deletion	B-X
mutant	B-X
phosphorylation	B-X
did	B-X
reveal	B-X
a	B-X
clear	B-X
defect	B-X
in	B-X
both	B-X
mutants	B-X
.	B-X
The	B-X
Delta320-413	B-X
deletion	B-X
removes	B-X
18	B-X
Ser-Thr	B-X
residues	B-X
(	B-X
possible	B-X
YCK-independent	B-X
phosphorylation	B-X
sites	B-X
)	B-X
yet	B-X
retains	B-X
the	B-X
15	B-X
Ser-Thr	B-X
residues	B-X
of	B-X
the	B-X
Ste3p	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Two	B-X
other	B-X
phenotypes	B-X
link	B-X
akr1	B-X
and	B-X
yck	B-X
mutants	B-X
:	B-X
both	B-X
are	B-X
defective	B-X
in	B-X
phosphorylation	B-X
of	B-X
wild-type	B-X
alpha-factor	B-X
receptor	B-X
,	B-X
and	B-X
while	B-X
both	B-X
are	B-X
defective	B-X
for	B-X
Ste3p	B-X
constitutive	B-X
internalization	B-X
,	B-X
both	B-X
remain	B-X
partially	B-X
competent	B-X
for	B-X
the	B-X
Ste3p	B-X
ligand-dependent	B-X
uptake	B-X
mode	B-X
.	B-X
Yck1p-Yck2p	B-X
may	B-X
be	B-X
the	B-X
function	B-X
responsible	B-X
in	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST-like	B-X
ubiquitination-endocytosis	B-X
signal	B-X
.	B-X
Akr1p	B-X
appears	B-X
to	B-X
function	B-X
in	B-X
localizing	B-X
Yck1p-Yck2p	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
a	B-X
localization	B-X
that	B-X
depends	B-X
on	B-X
prenylation	B-X
of	B-X
C-terminal	B-X
dicysteinyl	B-X
motifs	B-X
.	B-X
In	B-X
akr1Delta	B-X
cells	B-X
,	B-X
Yck2p	B-X
is	B-X
mislocalized	B-X
,	B-X
showing	B-X
a	B-X
diffuse	B-X
cytoplasmic	B-X
localization	B-X
identical	B-X
to	B-X
that	B-X
seen	B-X
for	B-X
a	B-X
Yck2p	B-X
mutant	B-X
that	B-X
lacks	B-X
the	B-X
C-terminal	B-X
Cys-Cys	B-X
,	B-X
indicating	B-X
a	B-X
likely	B-X
Akr1p	B-X
requirement	B-X
for	B-X
the	B-X
lipid	B-X
modification	B-X
of	B-X
Yck2p	B-X
,	B-X
for	B-X
prenylation	B-X
,	B-X
or	B-X
possibly	B-X
for	B-X
palmitoylation	B-X
.	B-X

Akr1p	B-Protein
appears	O
to	O
function	O
in	O
localizing	O
Yck1p	B-Protein
-	O
Yck2p	B-Protein
to	O
the	O
plasma	O
membrane	O
,	O
a	O
localization	O
that	O
depends	O
on	O
prenylation	O
of	O
C	O
-	O
terminal	O
dicysteinyl	O
motifs	O
.	O

In	O
akr1Delta	B-Protein
cells	O
,	O
Yck2p	B-Protein
is	O
mislocalized	O
,	O
showing	O
a	O
diffuse	O
cytoplasmic	O
localization	O
identical	O
to	O
that	O
seen	O
for	O
a	O
Yck2p	B-Protein
mutant	O
that	O
lacks	O
the	O
C	O
-	O
terminal	O
Cys	O
-	O
Cys	O
,	O
indicating	O
a	O
likely	O
Akr1p	B-Protein
requirement	O
for	O
the	O
lipid	O
modification	O
of	O
Yck2p	B-Protein
,	O
for	O
prenylation	O
,	O
or	O
possibly	O
for	O
palmitoylation	O
.	O
<EOS>	B-X
A	B-X
modifies	B-X
the	B-X
conformation	B-X
of	B-X
the	B-X
NMDAR	B-X
C-terminal	B-X
domain	B-X
(	B-X
CTD	B-X
)	B-X
and	B-X
its	B-X
interaction	B-X
with	B-X
protein	B-X
phosphatase	B-X
1	B-X
(	B-X
PP1	B-X
)	B-X
,	B-X
producing	B-X
synaptic	B-X
weakening	B-X
.	B-X
Higher	B-X
endogenous	B-X
levels	B-X
or	B-X
overexpression	B-X
of	B-X
PSD-95	B-X
block	B-X
A-induced	B-X
effects	B-X
on	B-X
the	B-X
NMDAR	B-X
CTD	B-X
conformation	B-X
,	B-X
its	B-X
interaction	B-X
with	B-X
PP1	B-X
,	B-X
and	B-X
synaptic	B-X
weakening	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
increased	B-X
PSD-95	B-X
protects	B-X
synapses	B-X
from	B-X
A	B-X
toxicity	B-X
,	B-X
suggesting	B-X
that	B-X
low	B-X
levels	B-X
of	B-X
synaptic	B-X
PSD-95	B-X
may	B-X
be	B-X
a	B-X
molecular	B-X
sign	B-X
indicating	B-X
synapse	B-X
vulnerability	B-X
to	B-X
A	B-X
.	B-X
Importantly	B-X
,	B-X
pharmacological	B-X
inhibition	B-X
of	B-X
its	B-X
depalmitoylation	B-X
increases	B-X
PSD-95	B-X
at	B-X
synapses	B-X
and	B-X
rescues	B-X
deficits	B-X
caused	B-X
by	B-X
A	B-X
,	B-X
possibly	B-X
opening	B-X
a	B-X
therapeutic	B-X
avenue	B-X
against	B-X
Alzheimer	B-X
's	B-X
disease	B-X
.	B-X

The	O
Drosophila	O
UBC9	B-Protein
homologue	O
lesswright	B-Protein
mediates	O
the	O
disjunction	O
of	O
homologues	O
in	O
meiosis	O
I	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
other	B-X
organisms	B-X
,	B-X
the	B-X
UBC9	B-X
(	B-X
ubiquitin-conjugating	B-X
9	B-X
)	B-X
protein	B-X
modifies	B-X
the	B-X
function	B-X
of	B-X
many	B-X
different	B-X
target	B-X
proteins	B-X
through	B-X
covalent	B-X
attachment	B-X
of	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SMT-3/SUMO	B-X
.	B-X

BACKGROUND	O
:	O
In	O
Saccharomyces	O
cerevisiae	O
and	O
other	O
organisms	O
,	O
the	O
UBC9	B-Protein
(	O
ubiquitin	B-Protein
-	I-Protein
conjugating	I-Protein
9	I-Protein
)	O
protein	O
modifies	O
the	O
function	O
of	O
many	O
different	O
target	O
proteins	O
through	O
covalent	O
attachment	O
of	O
the	O
ubiquitin	O
-	O
like	O
protein	O
SMT	B-Protein
-	I-Protein
3	I-Protein
/	O
SUMO	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
other	B-X
organisms	B-X
,	B-X
the	B-X
UBC9	B-X
(	B-X
ubiquitin-conjugating	B-X
9	B-X
)	B-X
protein	B-X
modifies	B-X
the	B-X
function	B-X
of	B-X
many	B-X
different	B-X
target	B-X
proteins	B-X
through	B-X
covalent	B-X
attachment	B-X
of	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SMT-3/SUMO	B-X
.	B-X

RESULTS	O
:	O
Using	O
a	O
second	O
-	O
site	O
suppression	O
screen	O
of	O
a	O
mutation	O
in	O
the	O
nod	O
locus	O
with	O
a	O
variable	O
meiotic	O
phenotype	O
,	O
we	O
have	O
identified	O
mutations	O
in	O
the	O
Drosophila	O
melanogaster	O
UBC9	B-Protein
homologue	O
,	O
encoded	O
by	O
the	O
gene	O
lesswright	B-Protein
(	O
lwr	B-Protein
)	O
.	O
lwr	B-Protein
mutations	O
dominantly	O
suppress	O
the	O
nondisjunction	O
and	O
cytological	O
defects	O
of	O
female	O
meiotic	O
mutations	O
that	O
affect	O
spindle	O
formation	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
other	B-X
organisms	B-X
,	B-X
the	B-X
UBC9	B-X
(	B-X
ubiquitin-conjugating	B-X
9	B-X
)	B-X
protein	B-X
modifies	B-X
the	B-X
function	B-X
of	B-X
many	B-X
different	B-X
target	B-X
proteins	B-X
through	B-X
covalent	B-X
attachment	B-X
of	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SMT-3/SUMO	B-X
.	B-X

The	O
lwr	B-Protein
lethal	O
phenotype	O
is	O
rescued	O
by	O
a	O
Drosophila	O
UBC9	B-Protein
/	O
lwr	B-Protein
transgene	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
other	B-X
organisms	B-X
,	B-X
the	B-X
UBC9	B-X
(	B-X
ubiquitin-conjugating	B-X
9	B-X
)	B-X
protein	B-X
modifies	B-X
the	B-X
function	B-X
of	B-X
many	B-X
different	B-X
target	B-X
proteins	B-X
through	B-X
covalent	B-X
attachment	B-X
of	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SMT-3/SUMO	B-X
.	B-X

CONCLUSIONS	O
:	O
We	O
suggest	O
that	O
LWR	B-Protein
mediates	O
the	O
dissociation	O
of	O
heterochromatic	O
regions	O
of	O
homologues	O
at	O
the	O
end	O
of	O
meiotic	O
prophase	O
I	O
.	O

Our	O
model	O
proposes	O
that	O
when	O
there	O
is	O
less	O
LWR	B-Protein
protein	O
,	O
homologues	O
remain	O
together	O
longer	O
,	O
allowing	O
for	O
more	O
normal	O
spindle	O
formation	O
in	O
mutant	O
backgrounds	O
and	O
therefore	O
more	O
accurate	O
meiotic	O
chromosome	O
segregation	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
other	B-X
organisms	B-X
,	B-X
the	B-X
UBC9	B-X
(	B-X
ubiquitin-conjugating	B-X
9	B-X
)	B-X
protein	B-X
modifies	B-X
the	B-X
function	B-X
of	B-X
many	B-X
different	B-X
target	B-X
proteins	B-X
through	B-X
covalent	B-X
attachment	B-X
of	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SMT-3/SUMO	B-X
.	B-X

Solution	O
structure	O
of	O
the	O
lipoyl	O
domain	O
of	O
the	O
chimeric	O
dihydrolipoyl	O
dehydrogenase	O
P64K	B-Protein
from	O
Neisseria	O
meningitidis	O
.	O
<EOS>	B-X
The	B-X
antigenic	B-X
P64K	B-X
protein	B-X
from	B-X
the	B-X
pathogenic	B-X
bacterium	B-X
Neisseria	B-X
meningitidis	B-X
is	B-X
found	B-X
in	B-X
the	B-X
outer	B-X
membrane	B-X
of	B-X
the	B-X
cell	B-X
,	B-X
and	B-X
consists	B-X
of	B-X
two	B-X
parts	B-X
:	B-X
an	B-X
81-residue	B-X
N-terminal	B-X
region	B-X
and	B-X
a	B-X
482-residue	B-X
C-terminal	B-X
region	B-X
.	B-X
The	B-X
amino-acid	B-X
sequence	B-X
of	B-X
the	B-X
N-terminal	B-X
region	B-X
is	B-X
homologous	B-X
with	B-X
the	B-X
lipoyl	B-X
domains	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
(	B-X
E2	B-X
)	B-X
components	B-X
,	B-X
and	B-X
that	B-X
of	B-X
the	B-X
C-terminal	B-X
region	B-X
with	B-X
the	B-X
dihydrolipoyl	B-X
dehydrogenase	B-X
(	B-X
E3	B-X
)	B-X
components	B-X
,	B-X
of	B-X
2-oxo	B-X
acid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
.	B-X
The	B-X
two	B-X
parts	B-X
are	B-X
separated	B-X
by	B-X
a	B-X
long	B-X
linker	B-X
region	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
linker	B-X
regions	B-X
in	B-X
the	B-X
E2	B-X
chains	B-X
of	B-X
2-oxo	B-X
acid	B-X
dehydrogenase	B-X
complexes	B-X
,	B-X
and	B-X
it	B-X
is	B-X
likely	B-X
this	B-X
region	B-X
is	B-X
conformationally	B-X
flexible	B-X
.	B-X
A	B-X
subgene	B-X
encoding	B-X
the	B-X
P64K	B-X
lipoyl	B-X
domain	B-X
was	B-X
created	B-X
and	B-X
over-expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
.	B-X
The	B-X
solution	B-X
structure	B-X
of	B-X
the	B-X
apo-domain	B-X
was	B-X
determined	B-X
by	B-X
means	B-X
of	B-X
heteronuclear	B-X
NMR	B-X
spectroscopy	B-X
and	B-X
found	B-X
to	B-X
be	B-X
a	B-X
flattened	B-X
beta	B-X
barrel	B-X
composed	B-X
of	B-X
two	B-X
four-stranded	B-X
antiparallel	B-X
beta	B-X
sheets	B-X
.	B-X
The	B-X
lysine	B-X
residue	B-X
that	B-X
becomes	B-X
lipoylated	B-X
is	B-X
in	B-X
an	B-X
exposed	B-X
beta	B-X
turn	B-X
that	B-X
,	B-X
from	B-X
a	B-X
[	B-X
1H	B-X
]	B-X
-15N	B-X
heteronuclear	B-X
Overhauser	B-X
effect	B-X
experiment	B-X
,	B-X
appears	B-X
to	B-X
enjoy	B-X
substantial	B-X
local	B-X
motion	B-X
.	B-X
This	B-X
structure	B-X
of	B-X
a	B-X
lipoyl	B-X
domain	B-X
derived	B-X
from	B-X
a	B-X
dihydrolipoyl	B-X
dehydrogenase	B-X
resembles	B-X
that	B-X
of	B-X
lipoyl	B-X
domains	B-X
normally	B-X
found	B-X
as	B-X
part	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
2-oxo	B-X
acid	B-X
dehydrogenase	B-X
complexes	B-X
and	B-X
will	B-X
assist	B-X
in	B-X
furthering	B-X
the	B-X
understanding	B-X
of	B-X
its	B-X
function	B-X
in	B-X
a	B-X
multienzyme	B-X
complex	B-X
and	B-X
in	B-X
the	B-X
membrane-bound	B-X
P64K	B-X
protein	B-X
itself	B-X
.	B-X

The	O
antigenic	O
P64K	B-Protein
protein	O
from	O
the	O
pathogenic	O
bacterium	O
Neisseria	O
meningitidis	O
is	O
found	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
cell	O
,	O
and	O
consists	O
of	O
two	O
parts	O
:	O
an	O
81	O
-	O
residue	O
N	O
-	O
terminal	O
region	O
and	O
a	O
482	O
-	O
residue	O
C	O
-	O
terminal	O
region	O
.	O

The	O
amino	O
-	O
acid	O
sequence	O
of	O
the	O
N	O
-	O
terminal	O
region	O
is	O
homologous	O
with	O
the	O
lipoyl	O
domains	O
of	O
the	O
dihydrolipoyl	O
acyltransferase	O
(	O
E2	O
)	O
components	O
,	O
and	O
that	O
of	O
the	O
C	O
-	O
terminal	O
region	O
with	O
the	O
dihydrolipoyl	O
dehydrogenase	O
(	O
E3	O
)	O
components	O
,	O
of	O
2	O
-	O
oxo	O
acid	O
dehydrogenase	O
multienzyme	O
complexes	O
.	O

The	O
two	O
parts	O
are	O
separated	O
by	O
a	O
long	O
linker	O
region	O
,	O
similar	O
to	O
the	O
linker	O
regions	O
in	O
the	O
E2	O
chains	O
of	O
2	O
-	O
oxo	O
acid	O
dehydrogenase	O
complexes	O
,	O
and	O
it	O
is	O
likely	O
this	O
region	O
is	O
conformationally	O
flexible	O
.	O

A	O
subgene	O
encoding	O
the	O
P64K	B-Protein
lipoyl	O
domain	O
was	O
created	O
and	O
over	O
-	O
expressed	O
in	O
Escherichia	O
coli	O
.	O
<EOS>	B-X
The	B-X
antigenic	B-X
P64K	B-X
protein	B-X
from	B-X
the	B-X
pathogenic	B-X
bacterium	B-X
Neisseria	B-X
meningitidis	B-X
is	B-X
found	B-X
in	B-X
the	B-X
outer	B-X
membrane	B-X
of	B-X
the	B-X
cell	B-X
,	B-X
and	B-X
consists	B-X
of	B-X
two	B-X
parts	B-X
:	B-X
an	B-X
81-residue	B-X
N-terminal	B-X
region	B-X
and	B-X
a	B-X
482-residue	B-X
C-terminal	B-X
region	B-X
.	B-X
The	B-X
amino-acid	B-X
sequence	B-X
of	B-X
the	B-X
N-terminal	B-X
region	B-X
is	B-X
homologous	B-X
with	B-X
the	B-X
lipoyl	B-X
domains	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
(	B-X
E2	B-X
)	B-X
components	B-X
,	B-X
and	B-X
that	B-X
of	B-X
the	B-X
C-terminal	B-X
region	B-X
with	B-X
the	B-X
dihydrolipoyl	B-X
dehydrogenase	B-X
(	B-X
E3	B-X
)	B-X
components	B-X
,	B-X
of	B-X
2-oxo	B-X
acid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
.	B-X
A	B-X
subgene	B-X
encoding	B-X
the	B-X
P64K	B-X
lipoyl	B-X
domain	B-X
was	B-X
created	B-X
and	B-X
over-expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
.	B-X
The	B-X
product	B-X
was	B-X
capable	B-X
of	B-X
post-translational	B-X
modification	B-X
by	B-X
the	B-X
lipoate	B-X
protein	B-X
ligase	B-X
but	B-X
not	B-X
aberrant	B-X
modification	B-X
by	B-X
the	B-X
biotin	B-X
protein	B-X
ligase	B-X
of	B-X
E.	B-X
coli	B-X
.	B-X
The	B-X
solution	B-X
structure	B-X
of	B-X
the	B-X
apo-domain	B-X
was	B-X
determined	B-X
by	B-X
means	B-X
of	B-X
heteronuclear	B-X
NMR	B-X
spectroscopy	B-X
and	B-X
found	B-X
to	B-X
be	B-X
a	B-X
flattened	B-X
beta	B-X
barrel	B-X
composed	B-X
of	B-X
two	B-X
four-stranded	B-X
antiparallel	B-X
beta	B-X
sheets	B-X
.	B-X
The	B-X
lysine	B-X
residue	B-X
that	B-X
becomes	B-X
lipoylated	B-X
is	B-X
in	B-X
an	B-X
exposed	B-X
beta	B-X
turn	B-X
that	B-X
,	B-X
from	B-X
a	B-X
[	B-X
1H	B-X
]	B-X
-15N	B-X
heteronuclear	B-X
Overhauser	B-X
effect	B-X
experiment	B-X
,	B-X
appears	B-X
to	B-X
enjoy	B-X
substantial	B-X
local	B-X
motion	B-X
.	B-X
This	B-X
structure	B-X
of	B-X
a	B-X
lipoyl	B-X
domain	B-X
derived	B-X
from	B-X
a	B-X
dihydrolipoyl	B-X
dehydrogenase	B-X
resembles	B-X
that	B-X
of	B-X
lipoyl	B-X
domains	B-X
normally	B-X
found	B-X
as	B-X
part	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
2-oxo	B-X
acid	B-X
dehydrogenase	B-X
complexes	B-X
and	B-X
will	B-X
assist	B-X
in	B-X
furthering	B-X
the	B-X
understanding	B-X
of	B-X
its	B-X
function	B-X
in	B-X
a	B-X
multienzyme	B-X
complex	B-X
and	B-X
in	B-X
the	B-X
membrane-bound	B-X
P64K	B-X
protein	B-X
itself	B-X
.	B-X

The	O
product	O
was	O
capable	O
of	O
post	O
-	O
translational	O
modification	O
by	O
the	O
lipoate	B-Protein
protein	I-Protein
ligase	I-Protein
but	O
not	O
aberrant	O
modification	O
by	O
the	O
biotin	B-Protein
protein	I-Protein
ligase	I-Protein
of	O
E	O
.	O
coli	O
.	O
<EOS>	B-X
Genes	B-X
encoding	B-X
the	B-X
dihydrolipoyl	B-X
acetyltransferase	B-X
(	B-X
E2	B-X
)	B-X
and	B-X
dihydrolipoyl	B-X
dehydrogenase	B-X
(	B-X
E3	B-X
)	B-X
components	B-X
of	B-X
the	B-X
pyruvate	B-X
dehydrogenase	B-X
(	B-X
PDH	B-X
)	B-X
multienzyme	B-X
complex	B-X
from	B-X
Bacillus	B-X
stearothermophilus	B-X
were	B-X
overexpressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
.	B-X
The	B-X
E2	B-X
component	B-X
was	B-X
purified	B-X
as	B-X
a	B-X
large	B-X
soluble	B-X
aggregate	B-X
(	B-X
molecular	B-X
mass	B-X
>	B-X
1	B-X
x	B-X
10	B-X
(	B-X
6	B-X
)	B-X
Da	B-X
)	B-X
with	B-X
the	B-X
characteristic	B-X
532	B-X
symmetry	B-X
of	B-X
an	B-X
icosahedral	B-X
(	B-X
60-mer	B-X
)	B-X
structure	B-X
,	B-X
and	B-X
the	B-X
E3	B-X
as	B-X
a	B-X
homodimer	B-X
with	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
110	B-X
kDa	B-X
.	B-X
The	B-X
recombinant	B-X
E2	B-X
component	B-X
in	B-X
vitro	B-X
was	B-X
capable	B-X
of	B-X
binding	B-X
either	B-X
60	B-X
E3	B-X
(	B-X
alpha2	B-X
)	B-X
dimers	B-X
or	B-X
60	B-X
heterotetramers	B-X
(	B-X
alpha2beta2	B-X
)	B-X
of	B-X
the	B-X
pyruvate	B-X
decarboxylase	B-X
(	B-X
E1	B-X
)	B-X
component	B-X
(	B-X
also	B-X
the	B-X
product	B-X
of	B-X
B.	B-X
stearothermophilus	B-X
genes	B-X
overexpressed	B-X
in	B-X
E.	B-X
coli	B-X
)	B-X
.	B-X
Assembling	B-X
the	B-X
E2	B-X
polypeptide	B-X
chain	B-X
into	B-X
the	B-X
icosahedral	B-X
E2	B-X
core	B-X
did	B-X
not	B-X
impose	B-X
any	B-X
restriction	B-X
on	B-X
the	B-X
binding	B-X
of	B-X
E1	B-X
or	B-X
E3	B-X
to	B-X
the	B-X
peripheral	B-X
subunit-binding	B-X
domain	B-X
in	B-X
each	B-X
E2	B-X
chain	B-X
.	B-X
The	B-X
lipoyl	B-X
domain	B-X
of	B-X
the	B-X
recombinant	B-X
E2	B-X
protein	B-X
was	B-X
found	B-X
to	B-X
be	B-X
unlipoylated	B-X
,	B-X
but	B-X
it	B-X
could	B-X
be	B-X
correctly	B-X
post-translationally	B-X
modified	B-X
in	B-X
vitro	B-X
using	B-X
a	B-X
recombinant	B-X
lipoate	B-X
protein	B-X
ligase	B-X
from	B-X
E.	B-X
coli	B-X
.	B-X
The	B-X
lipoylated	B-X
E2	B-X
component	B-X
was	B-X
able	B-X
to	B-X
bind	B-X
recombinant	B-X
E1	B-X
and	B-X
E3	B-X
components	B-X
in	B-X
vitro	B-X
to	B-X
generate	B-X
a	B-X
PDH	B-X
complex	B-X
with	B-X
a	B-X
catalytic	B-X
activity	B-X
comparable	B-X
with	B-X
that	B-X
of	B-X
the	B-X
wild-type	B-X
enzyme	B-X
.	B-X
Reversible	B-X
unfolding	B-X
of	B-X
the	B-X
recombinant	B-X
E2	B-X
and	B-X
E3	B-X
components	B-X
in	B-X
6	B-X
M	B-X
guanidine	B-X
hydrochloride	B-X
was	B-X
possible	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
chaperonins	B-X
,	B-X
with	B-X
recoveries	B-X
of	B-X
enzymic	B-X
activities	B-X
of	B-X
95	B-X
%	B-X
and	B-X
85	B-X
%	B-X
,	B-X
respectively	B-X
.	B-X
However	B-X
,	B-X
only	B-X
26	B-X
%	B-X
of	B-X
the	B-X
E1	B-X
enzyme	B-X
activity	B-X
was	B-X
recovered	B-X
under	B-X
the	B-X
same	B-X
conditions	B-X
as	B-X
a	B-X
result	B-X
of	B-X
irreversible	B-X
denaturation	B-X
of	B-X
both	B-X
E1alpha	B-X
and	B-X
E1beta	B-X
.	B-X
This	B-X
represents	B-X
the	B-X
first	B-X
complete	B-X
post-translational	B-X
modification	B-X
and	B-X
assembly	B-X
of	B-X
a	B-X
fully	B-X
active	B-X
PDH	B-X
complex	B-X
from	B-X
recombinant	B-X
proteins	B-X
in	B-X
vitro	B-X
.	B-X

The	O
solution	O
structure	O
of	O
the	O
apo	O
-	O
domain	O
was	O
determined	O
by	O
means	O
of	O
heteronuclear	O
NMR	O
spectroscopy	O
and	O
found	O
to	O
be	O
a	O
flattened	O
beta	O
barrel	O
composed	O
of	O
two	O
four	O
-	O
stranded	O
antiparallel	O
beta	O
sheets	O
.	O
<EOS>	B-X
The	B-X
antigenic	B-X
P64K	B-X
protein	B-X
from	B-X
the	B-X
pathogenic	B-X
bacterium	B-X
Neisseria	B-X
meningitidis	B-X
is	B-X
found	B-X
in	B-X
the	B-X
outer	B-X
membrane	B-X
of	B-X
the	B-X
cell	B-X
,	B-X
and	B-X
consists	B-X
of	B-X
two	B-X
parts	B-X
:	B-X
an	B-X
81-residue	B-X
N-terminal	B-X
region	B-X
and	B-X
a	B-X
482-residue	B-X
C-terminal	B-X
region	B-X
.	B-X
The	B-X
amino-acid	B-X
sequence	B-X
of	B-X
the	B-X
N-terminal	B-X
region	B-X
is	B-X
homologous	B-X
with	B-X
the	B-X
lipoyl	B-X
domains	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
(	B-X
E2	B-X
)	B-X
components	B-X
,	B-X
and	B-X
that	B-X
of	B-X
the	B-X
C-terminal	B-X
region	B-X
with	B-X
the	B-X
dihydrolipoyl	B-X
dehydrogenase	B-X
(	B-X
E3	B-X
)	B-X
components	B-X
,	B-X
of	B-X
2-oxo	B-X
acid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
.	B-X
The	B-X
two	B-X
parts	B-X
are	B-X
separated	B-X
by	B-X
a	B-X
long	B-X
linker	B-X
region	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
linker	B-X
regions	B-X
in	B-X
the	B-X
E2	B-X
chains	B-X
of	B-X
2-oxo	B-X
acid	B-X
dehydrogenase	B-X
complexes	B-X
,	B-X
and	B-X
it	B-X
is	B-X
likely	B-X
this	B-X
region	B-X
is	B-X
conformationally	B-X
flexible	B-X
.	B-X
A	B-X
subgene	B-X
encoding	B-X
the	B-X
P64K	B-X
lipoyl	B-X
domain	B-X
was	B-X
created	B-X
and	B-X
over-expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
.	B-X
The	B-X
solution	B-X
structure	B-X
of	B-X
the	B-X
apo-domain	B-X
was	B-X
determined	B-X
by	B-X
means	B-X
of	B-X
heteronuclear	B-X
NMR	B-X
spectroscopy	B-X
and	B-X
found	B-X
to	B-X
be	B-X
a	B-X
flattened	B-X
beta	B-X
barrel	B-X
composed	B-X
of	B-X
two	B-X
four-stranded	B-X
antiparallel	B-X
beta	B-X
sheets	B-X
.	B-X
The	B-X
lysine	B-X
residue	B-X
that	B-X
becomes	B-X
lipoylated	B-X
is	B-X
in	B-X
an	B-X
exposed	B-X
beta	B-X
turn	B-X
that	B-X
,	B-X
from	B-X
a	B-X
[	B-X
1H	B-X
]	B-X
-15N	B-X
heteronuclear	B-X
Overhauser	B-X
effect	B-X
experiment	B-X
,	B-X
appears	B-X
to	B-X
enjoy	B-X
substantial	B-X
local	B-X
motion	B-X
.	B-X
This	B-X
structure	B-X
of	B-X
a	B-X
lipoyl	B-X
domain	B-X
derived	B-X
from	B-X
a	B-X
dihydrolipoyl	B-X
dehydrogenase	B-X
resembles	B-X
that	B-X
of	B-X
lipoyl	B-X
domains	B-X
normally	B-X
found	B-X
as	B-X
part	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
2-oxo	B-X
acid	B-X
dehydrogenase	B-X
complexes	B-X
and	B-X
will	B-X
assist	B-X
in	B-X
furthering	B-X
the	B-X
understanding	B-X
of	B-X
its	B-X
function	B-X
in	B-X
a	B-X
multienzyme	B-X
complex	B-X
and	B-X
in	B-X
the	B-X
membrane-bound	B-X
P64K	B-X
protein	B-X
itself	B-X
.	B-X

The	O
lysine	O
residue	O
that	O
becomes	O
lipoylated	O
is	O
in	O
an	O
exposed	O
beta	O
turn	O
that	O
,	O
from	O
a	O
[	O
1H	O
]	O
-	O
15N	O
heteronuclear	O
Overhauser	O
effect	O
experiment	O
,	O
appears	O
to	O
enjoy	O
substantial	O
local	O
motion	O
.	O

This	O
structure	O
of	O
a	O
lipoyl	O
domain	O
derived	O
from	O
a	O
dihydrolipoyl	O
dehydrogenase	O
resembles	O
that	O
of	O
lipoyl	O
domains	O
normally	O
found	O
as	O
part	O
of	O
the	O
dihydrolipoyl	O
acyltransferase	O
component	O
of	O
2	O
-	O
oxo	O
acid	O
dehydrogenase	O
complexes	O
and	O
will	O
assist	O
in	O
furthering	O
the	O
understanding	O
of	O
its	O
function	O
in	O
a	O
multienzyme	O
complex	O
and	O
in	O
the	O
membrane	O
-	O
bound	O
P64K	B-Protein
protein	O
itself	O
.	O

PARP	B-Protein
-	I-Protein
1	I-Protein
modifies	O
the	O
effectiveness	O
of	O
p53	B-Protein
-	O
mediated	O
DNA	O
damage	O
response	O
.	O
<EOS>	B-X
The	B-X
tumour	B-X
suppressor	B-X
protein	B-X
p53	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
cell	B-X
's	B-X
decision	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
undergo	B-X
apoptosis	B-X
following	B-X
a	B-X
genotoxic	B-X
insult	B-X
.	B-X
p53	B-X
is	B-X
stabilized	B-X
and	B-X
activated	B-X
after	B-X
DNA	B-X
damage	B-X
,	B-X
however	B-X
the	B-X
cascade	B-X
of	B-X
events	B-X
signalling	B-X
from	B-X
DNA	B-X
lesions	B-X
to	B-X
p53	B-X
stabilization	B-X
and	B-X
activation	B-X
is	B-X
still	B-X
controversial	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribosylation	B-X
)	B-X
of	B-X
different	B-X
nuclear	B-X
acceptors	B-X
by	B-X
PARP-1	B-X
is	B-X
an	B-X
early	B-X
event	B-X
when	B-X
a	B-X
single	B-X
strand	B-X
DNA	B-X
lesion	B-X
is	B-X
produced	B-X
.	B-X
We	B-X
present	B-X
here	B-X
evidences	B-X
that	B-X
interplay	B-X
between	B-X
PARP-1	B-X
and	B-X
p53	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
type	B-X
of	B-X
damage	B-X
induced	B-X
to	B-X
DNA	B-X
.	B-X
Primary	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
parp-1	B-X
-/-	B-X
mice	B-X
exhibited	B-X
decreased	B-X
p53	B-X
accumulation	B-X
and	B-X
activation	B-X
following	B-X
gamma-irradiation	B-X
compared	B-X
to	B-X
parp-1	B-X
proficient	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
treatment	B-X
with	B-X
the	B-X
single	B-X
alkylating	B-X
agent	B-X
2'-methyl-2'-nitrose-urea	B-X
(	B-X
MNU	B-X
)	B-X
,	B-X
resulted	B-X
in	B-X
the	B-X
rapid	B-X
and	B-X
sustained	B-X
accumulation	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
parp-1-deficient	B-X
cells	B-X
,	B-X
while	B-X
very	B-X
little	B-X
accumulation	B-X
was	B-X
observed	B-X
in	B-X
parp-1	B-X
+/+	B-X
cells	B-X
.	B-X
After	B-X
IR	B-X
,	B-X
the	B-X
turnover	B-X
of	B-X
the	B-X
p53	B-X
inhibitory	B-X
protein	B-X
MDM-2	B-X
is	B-X
perturbed	B-X
and	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
serine-15	B-X
is	B-X
blunted	B-X
in	B-X
parp-1	B-X
-/-	B-X
cells	B-X
.	B-X
PARP-1	B-X
is	B-X
determinant	B-X
in	B-X
the	B-X
cytotoxic	B-X
response	B-X
to	B-X
alkylating	B-X
agents	B-X
but	B-X
only	B-X
partially	B-X
contributes	B-X
to	B-X
radiation-induced	B-X
cell	B-X
killing	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
colony	B-X
forming	B-X
assay	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
PARP-1	B-X
participates	B-X
in	B-X
the	B-X
p53	B-X
response	B-X
following	B-X
irradiation	B-X
,	B-X
resides	B-X
upstream	B-X
of	B-X
p53	B-X
and	B-X
indirectly	B-X
modulates	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
key	B-X
substrates	B-X
in	B-X
this	B-X
pathway	B-X
while	B-X
treatment	B-X
with	B-X
MNU	B-X
results	B-X
in	B-X
an	B-X
enhanced	B-X
p53-mediated	B-X
response	B-X
in	B-X
parp-1-null	B-X
cells	B-X
.	B-X

The	O
tumour	O
suppressor	O
protein	O
p53	B-Protein
plays	O
a	O
key	O
role	O
in	O
the	O
cell	O
'	O
s	O
decision	O
to	O
arrest	O
the	O
cell	O
cycle	O
or	O
undergo	O
apoptosis	O
following	O
a	O
genotoxic	O
insult	O
.	O
<EOS>	B-X
Cells	B-X
experiencing	B-X
DNA	B-X
damage	B-X
undergo	B-X
a	B-X
complex	B-X
response	B-X
entailing	B-X
cell-cycle	B-X
arrest	B-X
,	B-X
DNA	B-X
repair	B-X
and	B-X
apoptosis	B-X
,	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
the	B-X
three	B-X
being	B-X
modulated	B-X
by	B-X
the	B-X
extent	B-X
of	B-X
the	B-X
lesion	B-X
.	B-X
The	B-X
observation	B-X
that	B-X
Abl	B-X
interacts	B-X
in	B-X
the	B-X
nucleus	B-X
with	B-X
several	B-X
proteins	B-X
involved	B-X
in	B-X
different	B-X
aspects	B-X
of	B-X
DNA	B-X
repair	B-X
has	B-X
led	B-X
to	B-X
the	B-X
hypothesis	B-X
that	B-X
this	B-X
kinase	B-X
is	B-X
part	B-X
of	B-X
the	B-X
damage-sensing	B-X
mechanism	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanistic	B-X
details	B-X
underlying	B-X
the	B-X
role	B-X
of	B-X
Abl	B-X
in	B-X
DNA	B-X
repair	B-X
remain	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
will	B-X
review	B-X
the	B-X
evidence	B-X
supporting	B-X
our	B-X
current	B-X
understanding	B-X
of	B-X
Abl	B-X
activation	B-X
following	B-X
DNA	B-X
insults	B-X
,	B-X
while	B-X
focusing	B-X
on	B-X
the	B-X
relevance	B-X
of	B-X
these	B-X
mechanisms	B-X
in	B-X
protecting	B-X
DNA-injured	B-X
germ	B-X
cells	B-X
.	B-X
A	B-X
p53-related	B-X
protein	B-X
,	B-X
TAp63	B-X
,	B-X
is	B-X
an	B-X
important	B-X
immediate	B-X
downstream	B-X
effector	B-X
of	B-X
this	B-X
pathway	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
observations	B-X
are	B-X
consistent	B-X
with	B-X
the	B-X
evolutionary	B-X
conserved	B-X
relationship	B-X
between	B-X
DNA	B-X
damage	B-X
and	B-X
activation	B-X
of	B-X
the	B-X
p53	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
,	B-X
while	B-X
shedding	B-X
light	B-X
on	B-X
the	B-X
key	B-X
role	B-X
of	B-X
Abl	B-X
in	B-X
dictating	B-X
the	B-X
fate	B-X
of	B-X
germ	B-X
cells	B-X
upon	B-X
genotoxic	B-X
insults	B-X
.	B-X

p53	B-Protein
is	O
stabilized	O
and	O
activated	O
after	O
DNA	O
damage	O
,	O
however	O
the	O
cascade	O
of	O
events	O
signalling	O
from	O
DNA	O
lesions	O
to	O
p53	B-Protein
stabilization	O
and	O
activation	O
is	O
still	O
controversial	O
.	O
<EOS>	B-X
The	B-X
tumour	B-X
suppressor	B-X
protein	B-X
p53	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
cell	B-X
's	B-X
decision	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
undergo	B-X
apoptosis	B-X
following	B-X
a	B-X
genotoxic	B-X
insult	B-X
.	B-X
p53	B-X
is	B-X
stabilized	B-X
and	B-X
activated	B-X
after	B-X
DNA	B-X
damage	B-X
,	B-X
however	B-X
the	B-X
cascade	B-X
of	B-X
events	B-X
signalling	B-X
from	B-X
DNA	B-X
lesions	B-X
to	B-X
p53	B-X
stabilization	B-X
and	B-X
activation	B-X
is	B-X
still	B-X
controversial	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribosylation	B-X
)	B-X
of	B-X
different	B-X
nuclear	B-X
acceptors	B-X
by	B-X
PARP-1	B-X
is	B-X
an	B-X
early	B-X
event	B-X
when	B-X
a	B-X
single	B-X
strand	B-X
DNA	B-X
lesion	B-X
is	B-X
produced	B-X
.	B-X
We	B-X
present	B-X
here	B-X
evidences	B-X
that	B-X
interplay	B-X
between	B-X
PARP-1	B-X
and	B-X
p53	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
type	B-X
of	B-X
damage	B-X
induced	B-X
to	B-X
DNA	B-X
.	B-X
Primary	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
parp-1	B-X
-/-	B-X
mice	B-X
exhibited	B-X
decreased	B-X
p53	B-X
accumulation	B-X
and	B-X
activation	B-X
following	B-X
gamma-irradiation	B-X
compared	B-X
to	B-X
parp-1	B-X
proficient	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
treatment	B-X
with	B-X
the	B-X
single	B-X
alkylating	B-X
agent	B-X
2'-methyl-2'-nitrose-urea	B-X
(	B-X
MNU	B-X
)	B-X
,	B-X
resulted	B-X
in	B-X
the	B-X
rapid	B-X
and	B-X
sustained	B-X
accumulation	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
parp-1-deficient	B-X
cells	B-X
,	B-X
while	B-X
very	B-X
little	B-X
accumulation	B-X
was	B-X
observed	B-X
in	B-X
parp-1	B-X
+/+	B-X
cells	B-X
.	B-X
After	B-X
IR	B-X
,	B-X
the	B-X
turnover	B-X
of	B-X
the	B-X
p53	B-X
inhibitory	B-X
protein	B-X
MDM-2	B-X
is	B-X
perturbed	B-X
and	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
serine-15	B-X
is	B-X
blunted	B-X
in	B-X
parp-1	B-X
-/-	B-X
cells	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
PARP-1	B-X
participates	B-X
in	B-X
the	B-X
p53	B-X
response	B-X
following	B-X
irradiation	B-X
,	B-X
resides	B-X
upstream	B-X
of	B-X
p53	B-X
and	B-X
indirectly	B-X
modulates	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
key	B-X
substrates	B-X
in	B-X
this	B-X
pathway	B-X
while	B-X
treatment	B-X
with	B-X
MNU	B-X
results	B-X
in	B-X
an	B-X
enhanced	B-X
p53-mediated	B-X
response	B-X
in	B-X
parp-1-null	B-X
cells	B-X
.	B-X

Poly	O
(	O
ADP	O
-	O
ribosylation	O
)	O
of	O
different	O
nuclear	O
acceptors	O
by	O
PARP	B-Protein
-	I-Protein
1	I-Protein
is	O
an	O
early	O
event	O
when	O
a	O
single	O
strand	O
DNA	O
lesion	O
is	O
produced	O
.	O
<EOS>	B-X
p53	B-X
is	B-X
stabilized	B-X
and	B-X
activated	B-X
after	B-X
DNA	B-X
damage	B-X
,	B-X
however	B-X
the	B-X
cascade	B-X
of	B-X
events	B-X
signalling	B-X
from	B-X
DNA	B-X
lesions	B-X
to	B-X
p53	B-X
stabilization	B-X
and	B-X
activation	B-X
is	B-X
still	B-X
controversial	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribosylation	B-X
)	B-X
of	B-X
different	B-X
nuclear	B-X
acceptors	B-X
by	B-X
PARP-1	B-X
is	B-X
an	B-X
early	B-X
event	B-X
when	B-X
a	B-X
single	B-X
strand	B-X
DNA	B-X
lesion	B-X
is	B-X
produced	B-X
.	B-X
We	B-X
present	B-X
here	B-X
evidences	B-X
that	B-X
interplay	B-X
between	B-X
PARP-1	B-X
and	B-X
p53	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
type	B-X
of	B-X
damage	B-X
induced	B-X
to	B-X
DNA	B-X
.	B-X
Primary	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
parp-1	B-X
-/-	B-X
mice	B-X
exhibited	B-X
decreased	B-X
p53	B-X
accumulation	B-X
and	B-X
activation	B-X
following	B-X
gamma-irradiation	B-X
compared	B-X
to	B-X
parp-1	B-X
proficient	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
treatment	B-X
with	B-X
the	B-X
single	B-X
alkylating	B-X
agent	B-X
2'-methyl-2'-nitrose-urea	B-X
(	B-X
MNU	B-X
)	B-X
,	B-X
resulted	B-X
in	B-X
the	B-X
rapid	B-X
and	B-X
sustained	B-X
accumulation	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
parp-1-deficient	B-X
cells	B-X
,	B-X
while	B-X
very	B-X
little	B-X
accumulation	B-X
was	B-X
observed	B-X
in	B-X
parp-1	B-X
+/+	B-X
cells	B-X
.	B-X
After	B-X
IR	B-X
,	B-X
the	B-X
turnover	B-X
of	B-X
the	B-X
p53	B-X
inhibitory	B-X
protein	B-X
MDM-2	B-X
is	B-X
perturbed	B-X
and	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
serine-15	B-X
is	B-X
blunted	B-X
in	B-X
parp-1	B-X
-/-	B-X
cells	B-X
.	B-X
PARP-1	B-X
is	B-X
determinant	B-X
in	B-X
the	B-X
cytotoxic	B-X
response	B-X
to	B-X
alkylating	B-X
agents	B-X
but	B-X
only	B-X
partially	B-X
contributes	B-X
to	B-X
radiation-induced	B-X
cell	B-X
killing	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
colony	B-X
forming	B-X
assay	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
PARP-1	B-X
participates	B-X
in	B-X
the	B-X
p53	B-X
response	B-X
following	B-X
irradiation	B-X
,	B-X
resides	B-X
upstream	B-X
of	B-X
p53	B-X
and	B-X
indirectly	B-X
modulates	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
key	B-X
substrates	B-X
in	B-X
this	B-X
pathway	B-X
while	B-X
treatment	B-X
with	B-X
MNU	B-X
results	B-X
in	B-X
an	B-X
enhanced	B-X
p53-mediated	B-X
response	B-X
in	B-X
parp-1-null	B-X
cells	B-X
.	B-X

We	O
present	O
here	O
evidences	O
that	O
interplay	O
between	O
PARP	B-Protein
-	I-Protein
1	I-Protein
and	O
p53	B-Protein
is	O
dependent	O
on	O
the	O
type	O
of	O
damage	O
induced	O
to	O
DNA	O
.	O
<EOS>	B-X
The	B-X
tumour	B-X
suppressor	B-X
protein	B-X
p53	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
cell	B-X
's	B-X
decision	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
undergo	B-X
apoptosis	B-X
following	B-X
a	B-X
genotoxic	B-X
insult	B-X
.	B-X
p53	B-X
is	B-X
stabilized	B-X
and	B-X
activated	B-X
after	B-X
DNA	B-X
damage	B-X
,	B-X
however	B-X
the	B-X
cascade	B-X
of	B-X
events	B-X
signalling	B-X
from	B-X
DNA	B-X
lesions	B-X
to	B-X
p53	B-X
stabilization	B-X
and	B-X
activation	B-X
is	B-X
still	B-X
controversial	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribosylation	B-X
)	B-X
of	B-X
different	B-X
nuclear	B-X
acceptors	B-X
by	B-X
PARP-1	B-X
is	B-X
an	B-X
early	B-X
event	B-X
when	B-X
a	B-X
single	B-X
strand	B-X
DNA	B-X
lesion	B-X
is	B-X
produced	B-X
.	B-X
We	B-X
present	B-X
here	B-X
evidences	B-X
that	B-X
interplay	B-X
between	B-X
PARP-1	B-X
and	B-X
p53	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
type	B-X
of	B-X
damage	B-X
induced	B-X
to	B-X
DNA	B-X
.	B-X
Primary	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
parp-1	B-X
-/-	B-X
mice	B-X
exhibited	B-X
decreased	B-X
p53	B-X
accumulation	B-X
and	B-X
activation	B-X
following	B-X
gamma-irradiation	B-X
compared	B-X
to	B-X
parp-1	B-X
proficient	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
treatment	B-X
with	B-X
the	B-X
single	B-X
alkylating	B-X
agent	B-X
2'-methyl-2'-nitrose-urea	B-X
(	B-X
MNU	B-X
)	B-X
,	B-X
resulted	B-X
in	B-X
the	B-X
rapid	B-X
and	B-X
sustained	B-X
accumulation	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
parp-1-deficient	B-X
cells	B-X
,	B-X
while	B-X
very	B-X
little	B-X
accumulation	B-X
was	B-X
observed	B-X
in	B-X
parp-1	B-X
+/+	B-X
cells	B-X
.	B-X
After	B-X
IR	B-X
,	B-X
the	B-X
turnover	B-X
of	B-X
the	B-X
p53	B-X
inhibitory	B-X
protein	B-X
MDM-2	B-X
is	B-X
perturbed	B-X
and	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
serine-15	B-X
is	B-X
blunted	B-X
in	B-X
parp-1	B-X
-/-	B-X
cells	B-X
.	B-X
PARP-1	B-X
is	B-X
determinant	B-X
in	B-X
the	B-X
cytotoxic	B-X
response	B-X
to	B-X
alkylating	B-X
agents	B-X
but	B-X
only	B-X
partially	B-X
contributes	B-X
to	B-X
radiation-induced	B-X
cell	B-X
killing	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
colony	B-X
forming	B-X
assay	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
PARP-1	B-X
participates	B-X
in	B-X
the	B-X
p53	B-X
response	B-X
following	B-X
irradiation	B-X
,	B-X
resides	B-X
upstream	B-X
of	B-X
p53	B-X
and	B-X
indirectly	B-X
modulates	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
key	B-X
substrates	B-X
in	B-X
this	B-X
pathway	B-X
while	B-X
treatment	B-X
with	B-X
MNU	B-X
results	B-X
in	B-X
an	B-X
enhanced	B-X
p53-mediated	B-X
response	B-X
in	B-X
parp-1-null	B-X
cells	B-X
.	B-X

Primary	O
mouse	O
embryonic	O
fibroblasts	O
derived	O
from	O
parp	B-Protein
-	I-Protein
1	I-Protein
-	O
/	O
-	O
mice	O
exhibited	O
decreased	O
p53	B-Protein
accumulation	O
and	O
activation	O
following	O
gamma	O
-	O
irradiation	O
compared	O
to	O
parp	B-Protein
-	I-Protein
1	I-Protein
proficient	O
cells	O
.	O
<EOS>	B-X
The	B-X
tumour	B-X
suppressor	B-X
protein	B-X
p53	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
cell	B-X
's	B-X
decision	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
undergo	B-X
apoptosis	B-X
following	B-X
a	B-X
genotoxic	B-X
insult	B-X
.	B-X
p53	B-X
is	B-X
stabilized	B-X
and	B-X
activated	B-X
after	B-X
DNA	B-X
damage	B-X
,	B-X
however	B-X
the	B-X
cascade	B-X
of	B-X
events	B-X
signalling	B-X
from	B-X
DNA	B-X
lesions	B-X
to	B-X
p53	B-X
stabilization	B-X
and	B-X
activation	B-X
is	B-X
still	B-X
controversial	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribosylation	B-X
)	B-X
of	B-X
different	B-X
nuclear	B-X
acceptors	B-X
by	B-X
PARP-1	B-X
is	B-X
an	B-X
early	B-X
event	B-X
when	B-X
a	B-X
single	B-X
strand	B-X
DNA	B-X
lesion	B-X
is	B-X
produced	B-X
.	B-X
We	B-X
present	B-X
here	B-X
evidences	B-X
that	B-X
interplay	B-X
between	B-X
PARP-1	B-X
and	B-X
p53	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
type	B-X
of	B-X
damage	B-X
induced	B-X
to	B-X
DNA	B-X
.	B-X
Primary	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
parp-1	B-X
-/-	B-X
mice	B-X
exhibited	B-X
decreased	B-X
p53	B-X
accumulation	B-X
and	B-X
activation	B-X
following	B-X
gamma-irradiation	B-X
compared	B-X
to	B-X
parp-1	B-X
proficient	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
treatment	B-X
with	B-X
the	B-X
single	B-X
alkylating	B-X
agent	B-X
2'-methyl-2'-nitrose-urea	B-X
(	B-X
MNU	B-X
)	B-X
,	B-X
resulted	B-X
in	B-X
the	B-X
rapid	B-X
and	B-X
sustained	B-X
accumulation	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
parp-1-deficient	B-X
cells	B-X
,	B-X
while	B-X
very	B-X
little	B-X
accumulation	B-X
was	B-X
observed	B-X
in	B-X
parp-1	B-X
+/+	B-X
cells	B-X
.	B-X
After	B-X
IR	B-X
,	B-X
the	B-X
turnover	B-X
of	B-X
the	B-X
p53	B-X
inhibitory	B-X
protein	B-X
MDM-2	B-X
is	B-X
perturbed	B-X
and	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
serine-15	B-X
is	B-X
blunted	B-X
in	B-X
parp-1	B-X
-/-	B-X
cells	B-X
.	B-X
PARP-1	B-X
is	B-X
determinant	B-X
in	B-X
the	B-X
cytotoxic	B-X
response	B-X
to	B-X
alkylating	B-X
agents	B-X
but	B-X
only	B-X
partially	B-X
contributes	B-X
to	B-X
radiation-induced	B-X
cell	B-X
killing	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
colony	B-X
forming	B-X
assay	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
PARP-1	B-X
participates	B-X
in	B-X
the	B-X
p53	B-X
response	B-X
following	B-X
irradiation	B-X
,	B-X
resides	B-X
upstream	B-X
of	B-X
p53	B-X
and	B-X
indirectly	B-X
modulates	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
key	B-X
substrates	B-X
in	B-X
this	B-X
pathway	B-X
while	B-X
treatment	B-X
with	B-X
MNU	B-X
results	B-X
in	B-X
an	B-X
enhanced	B-X
p53-mediated	B-X
response	B-X
in	B-X
parp-1-null	B-X
cells	B-X
.	B-X

On	O
the	O
other	O
hand	O
,	O
treatment	O
with	O
the	O
single	O
alkylating	O
agent	O
2	O
'	O
-	O
methyl	O
-	O
2	O
'	O
-	O
nitrose	O
-	O
urea	O
(	O
MNU	O
)	O
,	O
resulted	O
in	O
the	O
rapid	O
and	O
sustained	O
accumulation	O
and	O
activation	O
of	O
p53	B-Protein
in	O
parp	B-Protein
-	I-Protein
1	I-Protein
-	O
deficient	O
cells	O
,	O
while	O
very	O
little	O
accumulation	O
was	O
observed	O
in	O
parp	B-Protein
-	I-Protein
1	I-Protein
+	O
/	O
+	O
cells	O
.	O
<EOS>	B-X
The	B-X
tumour	B-X
suppressor	B-X
protein	B-X
p53	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
cell	B-X
's	B-X
decision	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
undergo	B-X
apoptosis	B-X
following	B-X
a	B-X
genotoxic	B-X
insult	B-X
.	B-X
p53	B-X
is	B-X
stabilized	B-X
and	B-X
activated	B-X
after	B-X
DNA	B-X
damage	B-X
,	B-X
however	B-X
the	B-X
cascade	B-X
of	B-X
events	B-X
signalling	B-X
from	B-X
DNA	B-X
lesions	B-X
to	B-X
p53	B-X
stabilization	B-X
and	B-X
activation	B-X
is	B-X
still	B-X
controversial	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribosylation	B-X
)	B-X
of	B-X
different	B-X
nuclear	B-X
acceptors	B-X
by	B-X
PARP-1	B-X
is	B-X
an	B-X
early	B-X
event	B-X
when	B-X
a	B-X
single	B-X
strand	B-X
DNA	B-X
lesion	B-X
is	B-X
produced	B-X
.	B-X
We	B-X
present	B-X
here	B-X
evidences	B-X
that	B-X
interplay	B-X
between	B-X
PARP-1	B-X
and	B-X
p53	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
type	B-X
of	B-X
damage	B-X
induced	B-X
to	B-X
DNA	B-X
.	B-X
Primary	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
parp-1	B-X
-/-	B-X
mice	B-X
exhibited	B-X
decreased	B-X
p53	B-X
accumulation	B-X
and	B-X
activation	B-X
following	B-X
gamma-irradiation	B-X
compared	B-X
to	B-X
parp-1	B-X
proficient	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
treatment	B-X
with	B-X
the	B-X
single	B-X
alkylating	B-X
agent	B-X
2'-methyl-2'-nitrose-urea	B-X
(	B-X
MNU	B-X
)	B-X
,	B-X
resulted	B-X
in	B-X
the	B-X
rapid	B-X
and	B-X
sustained	B-X
accumulation	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
parp-1-deficient	B-X
cells	B-X
,	B-X
while	B-X
very	B-X
little	B-X
accumulation	B-X
was	B-X
observed	B-X
in	B-X
parp-1	B-X
+/+	B-X
cells	B-X
.	B-X
After	B-X
IR	B-X
,	B-X
the	B-X
turnover	B-X
of	B-X
the	B-X
p53	B-X
inhibitory	B-X
protein	B-X
MDM-2	B-X
is	B-X
perturbed	B-X
and	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
serine-15	B-X
is	B-X
blunted	B-X
in	B-X
parp-1	B-X
-/-	B-X
cells	B-X
.	B-X
PARP-1	B-X
is	B-X
determinant	B-X
in	B-X
the	B-X
cytotoxic	B-X
response	B-X
to	B-X
alkylating	B-X
agents	B-X
but	B-X
only	B-X
partially	B-X
contributes	B-X
to	B-X
radiation-induced	B-X
cell	B-X
killing	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
colony	B-X
forming	B-X
assay	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
PARP-1	B-X
participates	B-X
in	B-X
the	B-X
p53	B-X
response	B-X
following	B-X
irradiation	B-X
,	B-X
resides	B-X
upstream	B-X
of	B-X
p53	B-X
and	B-X
indirectly	B-X
modulates	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
key	B-X
substrates	B-X
in	B-X
this	B-X
pathway	B-X
while	B-X
treatment	B-X
with	B-X
MNU	B-X
results	B-X
in	B-X
an	B-X
enhanced	B-X
p53-mediated	B-X
response	B-X
in	B-X
parp-1-null	B-X
cells	B-X
.	B-X

After	O
IR	O
,	O
the	O
turnover	O
of	O
the	O
p53	B-Protein
inhibitory	O
protein	O
MDM	B-Protein
-	I-Protein
2	I-Protein
is	O
perturbed	O
and	O
the	O
level	O
of	O
phosphorylation	O
of	O
p53	B-Protein
at	O
serine	O
-	O
15	O
is	O
blunted	O
in	O
parp	B-Protein
-	I-Protein
1	I-Protein
-	O
/	O
-	O
cells	O
.	O
<EOS>	B-X
The	B-X
tumour	B-X
suppressor	B-X
protein	B-X
p53	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
cell	B-X
's	B-X
decision	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
undergo	B-X
apoptosis	B-X
following	B-X
a	B-X
genotoxic	B-X
insult	B-X
.	B-X
p53	B-X
is	B-X
stabilized	B-X
and	B-X
activated	B-X
after	B-X
DNA	B-X
damage	B-X
,	B-X
however	B-X
the	B-X
cascade	B-X
of	B-X
events	B-X
signalling	B-X
from	B-X
DNA	B-X
lesions	B-X
to	B-X
p53	B-X
stabilization	B-X
and	B-X
activation	B-X
is	B-X
still	B-X
controversial	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribosylation	B-X
)	B-X
of	B-X
different	B-X
nuclear	B-X
acceptors	B-X
by	B-X
PARP-1	B-X
is	B-X
an	B-X
early	B-X
event	B-X
when	B-X
a	B-X
single	B-X
strand	B-X
DNA	B-X
lesion	B-X
is	B-X
produced	B-X
.	B-X
We	B-X
present	B-X
here	B-X
evidences	B-X
that	B-X
interplay	B-X
between	B-X
PARP-1	B-X
and	B-X
p53	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
type	B-X
of	B-X
damage	B-X
induced	B-X
to	B-X
DNA	B-X
.	B-X
Primary	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
parp-1	B-X
-/-	B-X
mice	B-X
exhibited	B-X
decreased	B-X
p53	B-X
accumulation	B-X
and	B-X
activation	B-X
following	B-X
gamma-irradiation	B-X
compared	B-X
to	B-X
parp-1	B-X
proficient	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
treatment	B-X
with	B-X
the	B-X
single	B-X
alkylating	B-X
agent	B-X
2'-methyl-2'-nitrose-urea	B-X
(	B-X
MNU	B-X
)	B-X
,	B-X
resulted	B-X
in	B-X
the	B-X
rapid	B-X
and	B-X
sustained	B-X
accumulation	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
parp-1-deficient	B-X
cells	B-X
,	B-X
while	B-X
very	B-X
little	B-X
accumulation	B-X
was	B-X
observed	B-X
in	B-X
parp-1	B-X
+/+	B-X
cells	B-X
.	B-X
After	B-X
IR	B-X
,	B-X
the	B-X
turnover	B-X
of	B-X
the	B-X
p53	B-X
inhibitory	B-X
protein	B-X
MDM-2	B-X
is	B-X
perturbed	B-X
and	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
serine-15	B-X
is	B-X
blunted	B-X
in	B-X
parp-1	B-X
-/-	B-X
cells	B-X
.	B-X
PARP-1	B-X
is	B-X
determinant	B-X
in	B-X
the	B-X
cytotoxic	B-X
response	B-X
to	B-X
alkylating	B-X
agents	B-X
but	B-X
only	B-X
partially	B-X
contributes	B-X
to	B-X
radiation-induced	B-X
cell	B-X
killing	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
colony	B-X
forming	B-X
assay	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
PARP-1	B-X
participates	B-X
in	B-X
the	B-X
p53	B-X
response	B-X
following	B-X
irradiation	B-X
,	B-X
resides	B-X
upstream	B-X
of	B-X
p53	B-X
and	B-X
indirectly	B-X
modulates	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
key	B-X
substrates	B-X
in	B-X
this	B-X
pathway	B-X
while	B-X
treatment	B-X
with	B-X
MNU	B-X
results	B-X
in	B-X
an	B-X
enhanced	B-X
p53-mediated	B-X
response	B-X
in	B-X
parp-1-null	B-X
cells	B-X
.	B-X

PARP	B-Protein
-	I-Protein
1	I-Protein
is	O
determinant	O
in	O
the	O
cytotoxic	O
response	O
to	O
alkylating	O
agents	O
but	O
only	O
partially	O
contributes	O
to	O
radiation	O
-	O
induced	O
cell	O
killing	O
,	O
as	O
determined	O
by	O
colony	O
forming	O
assay	O
.	O
<EOS>	B-X
The	B-X
tumour	B-X
suppressor	B-X
protein	B-X
p53	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
cell	B-X
's	B-X
decision	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
undergo	B-X
apoptosis	B-X
following	B-X
a	B-X
genotoxic	B-X
insult	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribosylation	B-X
)	B-X
of	B-X
different	B-X
nuclear	B-X
acceptors	B-X
by	B-X
PARP-1	B-X
is	B-X
an	B-X
early	B-X
event	B-X
when	B-X
a	B-X
single	B-X
strand	B-X
DNA	B-X
lesion	B-X
is	B-X
produced	B-X
.	B-X
We	B-X
present	B-X
here	B-X
evidences	B-X
that	B-X
interplay	B-X
between	B-X
PARP-1	B-X
and	B-X
p53	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
type	B-X
of	B-X
damage	B-X
induced	B-X
to	B-X
DNA	B-X
.	B-X
Primary	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
parp-1	B-X
-/-	B-X
mice	B-X
exhibited	B-X
decreased	B-X
p53	B-X
accumulation	B-X
and	B-X
activation	B-X
following	B-X
gamma-irradiation	B-X
compared	B-X
to	B-X
parp-1	B-X
proficient	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
treatment	B-X
with	B-X
the	B-X
single	B-X
alkylating	B-X
agent	B-X
2'-methyl-2'-nitrose-urea	B-X
(	B-X
MNU	B-X
)	B-X
,	B-X
resulted	B-X
in	B-X
the	B-X
rapid	B-X
and	B-X
sustained	B-X
accumulation	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
parp-1-deficient	B-X
cells	B-X
,	B-X
while	B-X
very	B-X
little	B-X
accumulation	B-X
was	B-X
observed	B-X
in	B-X
parp-1	B-X
+/+	B-X
cells	B-X
.	B-X
After	B-X
IR	B-X
,	B-X
the	B-X
turnover	B-X
of	B-X
the	B-X
p53	B-X
inhibitory	B-X
protein	B-X
MDM-2	B-X
is	B-X
perturbed	B-X
and	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
serine-15	B-X
is	B-X
blunted	B-X
in	B-X
parp-1	B-X
-/-	B-X
cells	B-X
.	B-X
PARP-1	B-X
is	B-X
determinant	B-X
in	B-X
the	B-X
cytotoxic	B-X
response	B-X
to	B-X
alkylating	B-X
agents	B-X
but	B-X
only	B-X
partially	B-X
contributes	B-X
to	B-X
radiation-induced	B-X
cell	B-X
killing	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
colony	B-X
forming	B-X
assay	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
PARP-1	B-X
participates	B-X
in	B-X
the	B-X
p53	B-X
response	B-X
following	B-X
irradiation	B-X
,	B-X
resides	B-X
upstream	B-X
of	B-X
p53	B-X
and	B-X
indirectly	B-X
modulates	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
of	B-X
key	B-X
substrates	B-X
in	B-X
this	B-X
pathway	B-X
while	B-X
treatment	B-X
with	B-X
MNU	B-X
results	B-X
in	B-X
an	B-X
enhanced	B-X
p53-mediated	B-X
response	B-X
in	B-X
parp-1-null	B-X
cells	B-X
.	B-X

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
PARP	B-Protein
-	I-Protein
1	I-Protein
participates	O
in	O
the	O
p53	B-Protein
response	O
following	O
irradiation	O
,	O
resides	O
upstream	O
of	O
p53	B-Protein
and	O
indirectly	O
modulates	O
the	O
level	O
of	O
phosphorylation	O
of	O
key	O
substrates	O
in	O
this	O
pathway	O
while	O
treatment	O
with	O
MNU	O
results	O
in	O
an	O
enhanced	O
p53	B-Protein
-	O
mediated	O
response	O
in	O
parp	B-Protein
-	I-Protein
1	I-Protein
-	O
null	O
cells	O
.	O

[	O
Monoclonal	O
antibodies	O
against	O
protein	O
Daxx	B-Protein
and	O
its	O
localization	O
in	O
nuclear	O
domains	O
10	O
]	O
<EOS>	B-X
Nuclear	B-X
domains	B-X
10	B-X
(	B-X
ND10	B-X
)	B-X
were	B-X
first	B-X
detected	B-X
occasionally	B-X
using	B-X
antibodies	B-X
to	B-X
an	B-X
antigen	B-X
of	B-X
unknown	B-X
nature	B-X
(	B-X
Ascoli	B-X
,	B-X
Maul	B-X
,	B-X
1991	B-X
)	B-X
.	B-X
Further	B-X
on	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
locality	B-X
of	B-X
the	B-X
number	B-X
of	B-X
proteins	B-X
(	B-X
PML	B-X
,	B-X
Sp	B-X
100	B-X
,	B-X
pRB	B-X
)	B-X
(	B-X
Sterndorf	B-X
et	B-X
al.	B-X
,	B-X
1992	B-X
;	B-X
Kamitani	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
)	B-X
,	B-X
the	B-X
majority	B-X
of	B-X
which	B-X
are	B-X
modified	B-X
with	B-X
ubiquitin-like	B-X
small	B-X
proteins-modifiers	B-X
(	B-X
SUMO	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
primary	B-X
localization	B-X
,	B-X
transcription	B-X
and	B-X
replication	B-X
of	B-X
some	B-X
DNA-viruses	B-X
(	B-X
SV40	B-X
,	B-X
virus	B-X
of	B-X
simple	B-X
herpes	B-X
1	B-X
,	B-X
adenovirus	B-X
5	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
;	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
)	B-X
.	B-X
Except	B-X
for	B-X
SV40	B-X
,	B-X
these	B-X
viruses	B-X
produce	B-X
proteins	B-X
able	B-X
to	B-X
modify	B-X
ND10	B-X
,	B-X
or	B-X
leading	B-X
to	B-X
degradation	B-X
of	B-X
ND10-associated	B-X
proteins	B-X
(	B-X
Maul	B-X
et	B-X
al.	B-X
,	B-X
1993	B-X
;	B-X
Maul	B-X
,	B-X
Everett	B-X
,	B-X
1994	B-X
)	B-X
.	B-X
This	B-X
degradation	B-X
is	B-X
accompanied	B-X
with	B-X
protein	B-X
desumofication	B-X
and	B-X
,	B-X
later	B-X
,	B-X
with	B-X
hydrolysis	B-X
on	B-X
the	B-X
ubiquitin-proteosomal	B-X
way	B-X
(	B-X
Everett	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
,	B-X
1999	B-X
)	B-X
.	B-X
Cell	B-X
incubation	B-X
with	B-X
interferon	B-X
leads	B-X
to	B-X
augmentation	B-X
of	B-X
the	B-X
number	B-X
and	B-X
dimension	B-X
of	B-X
ND10	B-X
owing	B-X
to	B-X
increased	B-X
expression	B-X
of	B-X
Sp100	B-X
and	B-X
PML	B-X
(	B-X
Lavau	B-X
et	B-X
al.	B-X
,	B-X
1995	B-X
;	B-X
Grotzinger	B-X
et	B-X
al.	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
all	B-X
,	B-X
these	B-X
data	B-X
make	B-X
it	B-X
possible	B-X
to	B-X
put	B-X
forward	B-X
a	B-X
hypothesis	B-X
that	B-X
ND10	B-X
may	B-X
represent	B-X
a	B-X
peculiar	B-X
cell	B-X
storage	B-X
(	B-X
``	B-X
dpt	B-X
''	B-X
)	B-X
of	B-X
proteins	B-X
regulated	B-X
according	B-X
to	B-X
the	B-X
``	B-X
accumulation-drop	B-X
''	B-X
principle	B-X
(	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
;	B-X
Maul	B-X
,	B-X
1998	B-X
)	B-X
.	B-X

Nuclear	O
domains	O
10	O
(	O
ND10	O
)	O
were	O
first	O
detected	O
occasionally	O
using	O
antibodies	O
to	O
an	O
antigen	O
of	O
unknown	O
nature	O
(	O
Ascoli	O
,	O
Maul	O
,	O
1991	O
)	O
.	O

Further	O
on	O
it	O
was	O
shown	O
that	O
ND10	O
were	O
sites	O
of	O
locality	O
of	O
the	O
number	O
of	O
proteins	O
(	O
PML	B-Protein
,	O
Sp	B-Protein
100	I-Protein
,	O
pRB	B-Protein
)	O
(	O
Sterndorf	O
et	O
al	O
.	O
,	O
1992	O
;	O
Kamitani	O
et	O
al	O
.	O
,	O
1998	O
)	O
,	O
the	O
majority	O
of	O
which	O
are	O
modified	O
with	O
ubiquitin	B-Protein
-	O
like	O
small	O
proteins	O
-	O
modifiers	O
(	O
SUMO	O
)	O
(	O
Ishov	O
,	O
Maul	O
,	O
1996	O
)	O
.	O
<EOS>	B-X
Nuclear	B-X
domains	B-X
10	B-X
(	B-X
ND10	B-X
)	B-X
were	B-X
first	B-X
detected	B-X
occasionally	B-X
using	B-X
antibodies	B-X
to	B-X
an	B-X
antigen	B-X
of	B-X
unknown	B-X
nature	B-X
(	B-X
Ascoli	B-X
,	B-X
Maul	B-X
,	B-X
1991	B-X
)	B-X
.	B-X
Further	B-X
on	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
locality	B-X
of	B-X
the	B-X
number	B-X
of	B-X
proteins	B-X
(	B-X
PML	B-X
,	B-X
Sp	B-X
100	B-X
,	B-X
pRB	B-X
)	B-X
(	B-X
Sterndorf	B-X
et	B-X
al.	B-X
,	B-X
1992	B-X
;	B-X
Kamitani	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
)	B-X
,	B-X
the	B-X
majority	B-X
of	B-X
which	B-X
are	B-X
modified	B-X
with	B-X
ubiquitin-like	B-X
small	B-X
proteins-modifiers	B-X
(	B-X
SUMO	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
primary	B-X
localization	B-X
,	B-X
transcription	B-X
and	B-X
replication	B-X
of	B-X
some	B-X
DNA-viruses	B-X
(	B-X
SV40	B-X
,	B-X
virus	B-X
of	B-X
simple	B-X
herpes	B-X
1	B-X
,	B-X
adenovirus	B-X
5	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
;	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
)	B-X
.	B-X
Except	B-X
for	B-X
SV40	B-X
,	B-X
these	B-X
viruses	B-X
produce	B-X
proteins	B-X
able	B-X
to	B-X
modify	B-X
ND10	B-X
,	B-X
or	B-X
leading	B-X
to	B-X
degradation	B-X
of	B-X
ND10-associated	B-X
proteins	B-X
(	B-X
Maul	B-X
et	B-X
al.	B-X
,	B-X
1993	B-X
;	B-X
Maul	B-X
,	B-X
Everett	B-X
,	B-X
1994	B-X
)	B-X
.	B-X
This	B-X
degradation	B-X
is	B-X
accompanied	B-X
with	B-X
protein	B-X
desumofication	B-X
and	B-X
,	B-X
later	B-X
,	B-X
with	B-X
hydrolysis	B-X
on	B-X
the	B-X
ubiquitin-proteosomal	B-X
way	B-X
(	B-X
Everett	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
,	B-X
1999	B-X
)	B-X
.	B-X
Cell	B-X
incubation	B-X
with	B-X
interferon	B-X
leads	B-X
to	B-X
augmentation	B-X
of	B-X
the	B-X
number	B-X
and	B-X
dimension	B-X
of	B-X
ND10	B-X
owing	B-X
to	B-X
increased	B-X
expression	B-X
of	B-X
Sp100	B-X
and	B-X
PML	B-X
(	B-X
Lavau	B-X
et	B-X
al.	B-X
,	B-X
1995	B-X
;	B-X
Grotzinger	B-X
et	B-X
al.	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
all	B-X
,	B-X
these	B-X
data	B-X
make	B-X
it	B-X
possible	B-X
to	B-X
put	B-X
forward	B-X
a	B-X
hypothesis	B-X
that	B-X
ND10	B-X
may	B-X
represent	B-X
a	B-X
peculiar	B-X
cell	B-X
storage	B-X
(	B-X
``	B-X
dpt	B-X
''	B-X
)	B-X
of	B-X
proteins	B-X
regulated	B-X
according	B-X
to	B-X
the	B-X
``	B-X
accumulation-drop	B-X
''	B-X
principle	B-X
(	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
;	B-X
Maul	B-X
,	B-X
1998	B-X
)	B-X
.	B-X
However	B-X
,	B-X
this	B-X
hypothesis	B-X
requires	B-X
further	B-X
factual	B-X
grounds	B-X
.	B-X

In	O
addition	O
,	O
it	O
was	O
shown	O
that	O
ND10	O
were	O
sites	O
of	O
primary	O
localization	O
,	O
transcription	O
and	O
replication	O
of	O
some	O
DNA	O
-	O
viruses	O
(	O
SV40	O
,	O
virus	O
of	O
simple	O
herpes	O
1	O
,	O
adenovirus	O
5	O
)	O
(	O
Ishov	O
,	O
Maul	O
,	O
1996	O
;	O
Ishov	O
et	O
al	O
.	O
,	O
1997	O
)	O
.	O
<EOS>	B-X
Nuclear	B-X
domains	B-X
10	B-X
(	B-X
ND10	B-X
)	B-X
were	B-X
first	B-X
detected	B-X
occasionally	B-X
using	B-X
antibodies	B-X
to	B-X
an	B-X
antigen	B-X
of	B-X
unknown	B-X
nature	B-X
(	B-X
Ascoli	B-X
,	B-X
Maul	B-X
,	B-X
1991	B-X
)	B-X
.	B-X
Further	B-X
on	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
locality	B-X
of	B-X
the	B-X
number	B-X
of	B-X
proteins	B-X
(	B-X
PML	B-X
,	B-X
Sp	B-X
100	B-X
,	B-X
pRB	B-X
)	B-X
(	B-X
Sterndorf	B-X
et	B-X
al.	B-X
,	B-X
1992	B-X
;	B-X
Kamitani	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
)	B-X
,	B-X
the	B-X
majority	B-X
of	B-X
which	B-X
are	B-X
modified	B-X
with	B-X
ubiquitin-like	B-X
small	B-X
proteins-modifiers	B-X
(	B-X
SUMO	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
primary	B-X
localization	B-X
,	B-X
transcription	B-X
and	B-X
replication	B-X
of	B-X
some	B-X
DNA-viruses	B-X
(	B-X
SV40	B-X
,	B-X
virus	B-X
of	B-X
simple	B-X
herpes	B-X
1	B-X
,	B-X
adenovirus	B-X
5	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
;	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
)	B-X
.	B-X
Except	B-X
for	B-X
SV40	B-X
,	B-X
these	B-X
viruses	B-X
produce	B-X
proteins	B-X
able	B-X
to	B-X
modify	B-X
ND10	B-X
,	B-X
or	B-X
leading	B-X
to	B-X
degradation	B-X
of	B-X
ND10-associated	B-X
proteins	B-X
(	B-X
Maul	B-X
et	B-X
al.	B-X
,	B-X
1993	B-X
;	B-X
Maul	B-X
,	B-X
Everett	B-X
,	B-X
1994	B-X
)	B-X
.	B-X
This	B-X
degradation	B-X
is	B-X
accompanied	B-X
with	B-X
protein	B-X
desumofication	B-X
and	B-X
,	B-X
later	B-X
,	B-X
with	B-X
hydrolysis	B-X
on	B-X
the	B-X
ubiquitin-proteosomal	B-X
way	B-X
(	B-X
Everett	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
,	B-X
1999	B-X
)	B-X
.	B-X
Cell	B-X
incubation	B-X
with	B-X
interferon	B-X
leads	B-X
to	B-X
augmentation	B-X
of	B-X
the	B-X
number	B-X
and	B-X
dimension	B-X
of	B-X
ND10	B-X
owing	B-X
to	B-X
increased	B-X
expression	B-X
of	B-X
Sp100	B-X
and	B-X
PML	B-X
(	B-X
Lavau	B-X
et	B-X
al.	B-X
,	B-X
1995	B-X
;	B-X
Grotzinger	B-X
et	B-X
al.	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
all	B-X
,	B-X
these	B-X
data	B-X
make	B-X
it	B-X
possible	B-X
to	B-X
put	B-X
forward	B-X
a	B-X
hypothesis	B-X
that	B-X
ND10	B-X
may	B-X
represent	B-X
a	B-X
peculiar	B-X
cell	B-X
storage	B-X
(	B-X
``	B-X
dpt	B-X
''	B-X
)	B-X
of	B-X
proteins	B-X
regulated	B-X
according	B-X
to	B-X
the	B-X
``	B-X
accumulation-drop	B-X
''	B-X
principle	B-X
(	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
;	B-X
Maul	B-X
,	B-X
1998	B-X
)	B-X
.	B-X
However	B-X
,	B-X
this	B-X
hypothesis	B-X
requires	B-X
further	B-X
factual	B-X
grounds	B-X
.	B-X

Except	O
for	O
SV40	O
,	O
these	O
viruses	O
produce	O
proteins	O
able	O
to	O
modify	O
ND10	O
,	O
or	O
leading	O
to	O
degradation	O
of	O
ND10	O
-	O
associated	O
proteins	O
(	O
Maul	O
et	O
al	O
.	O
,	O
1993	O
;	O
Maul	O
,	O
Everett	O
,	O
1994	O
)	O
.	O
<EOS>	B-X
Nuclear	B-X
domains	B-X
10	B-X
(	B-X
ND10	B-X
)	B-X
were	B-X
first	B-X
detected	B-X
occasionally	B-X
using	B-X
antibodies	B-X
to	B-X
an	B-X
antigen	B-X
of	B-X
unknown	B-X
nature	B-X
(	B-X
Ascoli	B-X
,	B-X
Maul	B-X
,	B-X
1991	B-X
)	B-X
.	B-X
Further	B-X
on	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
locality	B-X
of	B-X
the	B-X
number	B-X
of	B-X
proteins	B-X
(	B-X
PML	B-X
,	B-X
Sp	B-X
100	B-X
,	B-X
pRB	B-X
)	B-X
(	B-X
Sterndorf	B-X
et	B-X
al.	B-X
,	B-X
1992	B-X
;	B-X
Kamitani	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
)	B-X
,	B-X
the	B-X
majority	B-X
of	B-X
which	B-X
are	B-X
modified	B-X
with	B-X
ubiquitin-like	B-X
small	B-X
proteins-modifiers	B-X
(	B-X
SUMO	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
primary	B-X
localization	B-X
,	B-X
transcription	B-X
and	B-X
replication	B-X
of	B-X
some	B-X
DNA-viruses	B-X
(	B-X
SV40	B-X
,	B-X
virus	B-X
of	B-X
simple	B-X
herpes	B-X
1	B-X
,	B-X
adenovirus	B-X
5	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
;	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
)	B-X
.	B-X
Except	B-X
for	B-X
SV40	B-X
,	B-X
these	B-X
viruses	B-X
produce	B-X
proteins	B-X
able	B-X
to	B-X
modify	B-X
ND10	B-X
,	B-X
or	B-X
leading	B-X
to	B-X
degradation	B-X
of	B-X
ND10-associated	B-X
proteins	B-X
(	B-X
Maul	B-X
et	B-X
al.	B-X
,	B-X
1993	B-X
;	B-X
Maul	B-X
,	B-X
Everett	B-X
,	B-X
1994	B-X
)	B-X
.	B-X
This	B-X
degradation	B-X
is	B-X
accompanied	B-X
with	B-X
protein	B-X
desumofication	B-X
and	B-X
,	B-X
later	B-X
,	B-X
with	B-X
hydrolysis	B-X
on	B-X
the	B-X
ubiquitin-proteosomal	B-X
way	B-X
(	B-X
Everett	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
,	B-X
1999	B-X
)	B-X
.	B-X
Cell	B-X
incubation	B-X
with	B-X
interferon	B-X
leads	B-X
to	B-X
augmentation	B-X
of	B-X
the	B-X
number	B-X
and	B-X
dimension	B-X
of	B-X
ND10	B-X
owing	B-X
to	B-X
increased	B-X
expression	B-X
of	B-X
Sp100	B-X
and	B-X
PML	B-X
(	B-X
Lavau	B-X
et	B-X
al.	B-X
,	B-X
1995	B-X
;	B-X
Grotzinger	B-X
et	B-X
al.	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
all	B-X
,	B-X
these	B-X
data	B-X
make	B-X
it	B-X
possible	B-X
to	B-X
put	B-X
forward	B-X
a	B-X
hypothesis	B-X
that	B-X
ND10	B-X
may	B-X
represent	B-X
a	B-X
peculiar	B-X
cell	B-X
storage	B-X
(	B-X
``	B-X
dpt	B-X
''	B-X
)	B-X
of	B-X
proteins	B-X
regulated	B-X
according	B-X
to	B-X
the	B-X
``	B-X
accumulation-drop	B-X
''	B-X
principle	B-X
(	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
;	B-X
Maul	B-X
,	B-X
1998	B-X
)	B-X
.	B-X
However	B-X
,	B-X
this	B-X
hypothesis	B-X
requires	B-X
further	B-X
factual	B-X
grounds	B-X
.	B-X

This	O
degradation	O
is	O
accompanied	O
with	O
protein	O
desumofication	O
and	O
,	O
later	O
,	O
with	O
hydrolysis	O
on	O
the	O
ubiquitin	B-Protein
-	O
proteosomal	O
way	O
(	O
Everett	O
et	O
al	O
.	O
,	O
1998	O
,	O
1999	O
)	O
.	O

Cell	O
incubation	O
with	O
interferon	O
leads	O
to	O
augmentation	O
of	O
the	O
number	O
and	O
dimension	O
of	O
ND10	O
owing	O
to	O
increased	O
expression	O
of	O
Sp100	B-Protein
and	O
PML	B-Protein
(	O
Lavau	O
et	O
al	O
.	O
,	O
1995	O
;	O
Grotzinger	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O
<EOS>	B-X
Nuclear	B-X
domains	B-X
10	B-X
(	B-X
ND10	B-X
)	B-X
were	B-X
first	B-X
detected	B-X
occasionally	B-X
using	B-X
antibodies	B-X
to	B-X
an	B-X
antigen	B-X
of	B-X
unknown	B-X
nature	B-X
(	B-X
Ascoli	B-X
,	B-X
Maul	B-X
,	B-X
1991	B-X
)	B-X
.	B-X
Further	B-X
on	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
locality	B-X
of	B-X
the	B-X
number	B-X
of	B-X
proteins	B-X
(	B-X
PML	B-X
,	B-X
Sp	B-X
100	B-X
,	B-X
pRB	B-X
)	B-X
(	B-X
Sterndorf	B-X
et	B-X
al.	B-X
,	B-X
1992	B-X
;	B-X
Kamitani	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
)	B-X
,	B-X
the	B-X
majority	B-X
of	B-X
which	B-X
are	B-X
modified	B-X
with	B-X
ubiquitin-like	B-X
small	B-X
proteins-modifiers	B-X
(	B-X
SUMO	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
it	B-X
was	B-X
shown	B-X
that	B-X
ND10	B-X
were	B-X
sites	B-X
of	B-X
primary	B-X
localization	B-X
,	B-X
transcription	B-X
and	B-X
replication	B-X
of	B-X
some	B-X
DNA-viruses	B-X
(	B-X
SV40	B-X
,	B-X
virus	B-X
of	B-X
simple	B-X
herpes	B-X
1	B-X
,	B-X
adenovirus	B-X
5	B-X
)	B-X
(	B-X
Ishov	B-X
,	B-X
Maul	B-X
,	B-X
1996	B-X
;	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
)	B-X
.	B-X
Except	B-X
for	B-X
SV40	B-X
,	B-X
these	B-X
viruses	B-X
produce	B-X
proteins	B-X
able	B-X
to	B-X
modify	B-X
ND10	B-X
,	B-X
or	B-X
leading	B-X
to	B-X
degradation	B-X
of	B-X
ND10-associated	B-X
proteins	B-X
(	B-X
Maul	B-X
et	B-X
al.	B-X
,	B-X
1993	B-X
;	B-X
Maul	B-X
,	B-X
Everett	B-X
,	B-X
1994	B-X
)	B-X
.	B-X
This	B-X
degradation	B-X
is	B-X
accompanied	B-X
with	B-X
protein	B-X
desumofication	B-X
and	B-X
,	B-X
later	B-X
,	B-X
with	B-X
hydrolysis	B-X
on	B-X
the	B-X
ubiquitin-proteosomal	B-X
way	B-X
(	B-X
Everett	B-X
et	B-X
al.	B-X
,	B-X
1998	B-X
,	B-X
1999	B-X
)	B-X
.	B-X
Cell	B-X
incubation	B-X
with	B-X
interferon	B-X
leads	B-X
to	B-X
augmentation	B-X
of	B-X
the	B-X
number	B-X
and	B-X
dimension	B-X
of	B-X
ND10	B-X
owing	B-X
to	B-X
increased	B-X
expression	B-X
of	B-X
Sp100	B-X
and	B-X
PML	B-X
(	B-X
Lavau	B-X
et	B-X
al.	B-X
,	B-X
1995	B-X
;	B-X
Grotzinger	B-X
et	B-X
al.	B-X
,	B-X
1996	B-X
)	B-X
.	B-X
In	B-X
all	B-X
,	B-X
these	B-X
data	B-X
make	B-X
it	B-X
possible	B-X
to	B-X
put	B-X
forward	B-X
a	B-X
hypothesis	B-X
that	B-X
ND10	B-X
may	B-X
represent	B-X
a	B-X
peculiar	B-X
cell	B-X
storage	B-X
(	B-X
``	B-X
dpt	B-X
''	B-X
)	B-X
of	B-X
proteins	B-X
regulated	B-X
according	B-X
to	B-X
the	B-X
``	B-X
accumulation-drop	B-X
''	B-X
principle	B-X
(	B-X
Ishov	B-X
et	B-X
al.	B-X
,	B-X
1997	B-X
;	B-X
Maul	B-X
,	B-X
1998	B-X
)	B-X
.	B-X
However	B-X
,	B-X
this	B-X
hypothesis	B-X
requires	B-X
further	B-X
factual	B-X
grounds	B-X
.	B-X

In	O
all	O
,	O
these	O
data	O
make	O
it	O
possible	O
to	O
put	O
forward	O
a	O
hypothesis	O
that	O
ND10	O
may	O
represent	O
a	O
peculiar	O
cell	O
storage	O
(	O
"	O
d	O
e	O
p	O
o	O
t	O
"	O
)	O
of	O
proteins	O
regulated	O
according	O
to	O
the	O
"	O
accumulation	O
-	O
drop	O
"	O
principle	O
(	O
Ishov	O
et	O
al	O
.	O
,	O
1997	O
;	O
Maul	O
,	O
1998	O
)	O
.	O

However	O
,	O
this	O
hypothesis	O
requires	O
further	O
factual	O
grounds	O
.	O
<EOS>	B-X
Reaching	B-X
a	B-X
global	B-X
view	B-X
of	B-X
brain	B-X
organization	B-X
requires	B-X
assembling	B-X
evidence	B-X
on	B-X
widely	B-X
different	B-X
mental	B-X
processes	B-X
and	B-X
mechanisms	B-X
.	B-X
However	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
sought	B-X
additional	B-X
factors	B-X
which	B-X
influence	B-X
scene	B-X
time	B-X
or	B-X
quantify	B-X
the	B-X
impact	B-X
of	B-X
mission	B-X
characteristics	B-X
or	B-X
therapeutic	B-X
interventions	B-X
on	B-X
scene	B-X
time.Hypothesis/Problem	B-X
:	B-X
The	B-X
goal	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
specific	B-X
interventions	B-X
,	B-X
patient	B-X
demographics	B-X
,	B-X
or	B-X
mission	B-X
characteristics	B-X
that	B-X
increase	B-X
scene	B-X
time	B-X
and	B-X
quantify	B-X
their	B-X
impact	B-X
on	B-X
scene	B-X
time	B-X
.	B-X
In	B-X
the	B-X
conduct	B-X
of	B-X
public/private	B-X
research	B-X
relationships	B-X
,	B-X
all	B-X
relevant	B-X
parties	B-X
shall	B-X
:	B-X
1	B-X
)	B-X
conduct	B-X
or	B-X
sponsor	B-X
research	B-X
that	B-X
is	B-X
factual	B-X
,	B-X
transparent	B-X
,	B-X
and	B-X
designed	B-X
objectively	B-X
;	B-X
according	B-X
to	B-X
accepted	B-X
principles	B-X
of	B-X
scientific	B-X
inquiry	B-X
,	B-X
the	B-X
research	B-X
design	B-X
will	B-X
generate	B-X
an	B-X
appropriately	B-X
phrased	B-X
hypothesis	B-X
and	B-X
the	B-X
research	B-X
will	B-X
answer	B-X
the	B-X
appropriate	B-X
questions	B-X
,	B-X
rather	B-X
than	B-X
favor	B-X
a	B-X
particular	B-X
outcome	B-X
;	B-X
2	B-X
)	B-X
require	B-X
control	B-X
of	B-X
both	B-X
study	B-X
design	B-X
and	B-X
research	B-X
itself	B-X
to	B-X
remain	B-X
with	B-X
scientific	B-X
investigators	B-X
;	B-X
3	B-X
)	B-X
not	B-X
offer	B-X
or	B-X
accept	B-X
remuneration	B-X
geared	B-X
to	B-X
the	B-X
outcome	B-X
of	B-X
a	B-X
research	B-X
project	B-X
;	B-X
4	B-X
)	B-X
prior	B-X
to	B-X
the	B-X
commencement	B-X
of	B-X
studies	B-X
,	B-X
ensure	B-X
that	B-X
there	B-X
is	B-X
a	B-X
written	B-X
agreement	B-X
that	B-X
the	B-X
investigative	B-X
team	B-X
has	B-X
the	B-X
freedom	B-X
and	B-X
obligation	B-X
to	B-X
attempt	B-X
to	B-X
publish	B-X
the	B-X
findings	B-X
within	B-X
some	B-X
specified	B-X
time-frame	B-X
;	B-X
5	B-X
)	B-X
require	B-X
,	B-X
in	B-X
publications	B-X
and	B-X
conference	B-X
presentations	B-X
,	B-X
full	B-X
signed	B-X
disclosure	B-X
of	B-X
all	B-X
financial	B-X
interests	B-X
;	B-X
6	B-X
)	B-X
not	B-X
participate	B-X
in	B-X
undisclosed	B-X
paid	B-X
authorship	B-X
arrangements	B-X
in	B-X
industry-sponsored	B-X
publications	B-X
or	B-X
presentations	B-X
;	B-X
7	B-X
)	B-X
guarantee	B-X
accessibility	B-X
to	B-X
all	B-X
data	B-X
and	B-X
control	B-X
of	B-X
statistical	B-X
analysis	B-X
by	B-X
investigators	B-X
and	B-X
appropriate	B-X
auditors/reviewers	B-X
;	B-X
and	B-X
8	B-X
)	B-X
require	B-X
that	B-X
academic	B-X
researchers	B-X
,	B-X
when	B-X
they	B-X
work	B-X
in	B-X
contract	B-X
research	B-X
organizations	B-X
(	B-X
CRO	B-X
)	B-X
or	B-X
act	B-X
as	B-X
contract	B-X
researchers	B-X
,	B-X
make	B-X
clear	B-X
statements	B-X
of	B-X
their	B-X
affiliation	B-X
;	B-X
require	B-X
that	B-X
such	B-X
researchers	B-X
publish	B-X
only	B-X
under	B-X
the	B-X
auspices	B-X
of	B-X
the	B-X
CRO	B-X
.	B-X
However	B-X
,	B-X
current	B-X
implementations	B-X
are	B-X
limited	B-X
by	B-X
a	B-X
combination	B-X
of	B-X
both	B-X
architecture	B-X
design	B-X
and	B-X
relatively	B-X
small	B-X
datasets	B-X
.	B-X
Our	B-X
results	B-X
support	B-X
our	B-X
initial	B-X
hypothesis	B-X
that	B-X
customized	B-X
,	B-X
purpose-built	B-X
neural	B-X
networks	B-X
provide	B-X
improved	B-X
performance	B-X
over	B-X
networks	B-X
derived	B-X
from	B-X
pre-trained	B-X
imaging	B-X
data	B-X
sets	B-X
.	B-X

The	O
SUMO	O
ubiquitin	B-Protein
-	O
protein	O
isopeptide	O
ligase	O
family	O
member	O
Miz1	B-Protein
/	O
PIASxbeta	B-Protein
/	O
Siz2	B-Protein
is	O
a	O
transcriptional	O
cofactor	O
for	O
TFII	B-Protein
-	I-Protein
I	I-Protein
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
previously	B-X
that	B-X
a	B-X
TFII-I-related	B-X
protein	B-X
,	B-X
hMusTRD1/BEN	B-X
,	B-X
represses	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
.	B-X
The	B-X
repression	B-X
by	B-X
hMusTRD1/BEN	B-X
was	B-X
hypothesized	B-X
to	B-X
occur	B-X
via	B-X
a	B-X
two-step	B-X
competition	B-X
mechanism	B-X
involving	B-X
a	B-X
cytoplasmic	B-X
shuttling	B-X
factor	B-X
and	B-X
a	B-X
nuclear	B-X
cofactor	B-X
required	B-X
for	B-X
transcriptional	B-X
activation	B-X
of	B-X
TFII-I	B-X
.	B-X
Employing	B-X
a	B-X
two-hybrid	B-X
approach	B-X
with	B-X
both	B-X
yeast	B-X
genomic	B-X
and	B-X
mouse	B-X
cDNA	B-X
libraries	B-X
in	B-X
parallel	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
the	B-X
RING-like	B-X
zinc	B-X
finger	B-X
containing	B-X
Miz1/PIASxbeta/Siz2	B-X
,	B-X
which	B-X
is	B-X
a	B-X
ubiquitin-protein	B-X
isopeptide	B-X
ligase	B-X
in	B-X
the	B-X
SUMO	B-X
pathway	B-X
,	B-X
as	B-X
the	B-X
potential	B-X
nuclear	B-X
cofactor	B-X
that	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
.	B-X
First	B-X
,	B-X
the	B-X
interactions	B-X
are	B-X
biochemically	B-X
confirmed	B-X
in	B-X
mammalian	B-X
cells	B-X
where	B-X
Miz1/mPIASxbeta	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
when	B-X
these	B-X
proteins	B-X
are	B-X
ectopically	B-X
co-expressed	B-X
.	B-X
Second	B-X
,	B-X
co-expression	B-X
of	B-X
a	B-X
nuclear	B-X
localization	B-X
signal-deficient	B-X
mutant	B-X
of	B-X
Miz1/mPIASxbeta	B-X
with	B-X
wild	B-X
type	B-X
TFII-I	B-X
fails	B-X
to	B-X
alter	B-X
the	B-X
subcellular	B-X
localization	B-X
of	B-X
the	B-X
former	B-X
.	B-X
Finally	B-X
,	B-X
ectopically	B-X
expressed	B-X
Miz1/mPIASxbeta	B-X
augments	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
and	B-X
relieves	B-X
the	B-X
repression	B-X
exerted	B-X
by	B-X
a	B-X
mutant	B-X
hMusTRD1/BEN	B-X
that	B-X
co-localized	B-X
with	B-X
TFII-I	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X

We	O
have	O
shown	O
previously	O
that	O
a	O
TFII	B-Protein
-	I-Protein
I	I-Protein
-	O
related	O
protein	O
,	O
hMusTRD1	B-Protein
/	I-Protein
BEN	I-Protein
,	O
represses	O
transcriptional	O
activity	O
of	O
TFII	B-Protein
-	I-Protein
I	I-Protein
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
previously	B-X
that	B-X
a	B-X
TFII-I-related	B-X
protein	B-X
,	B-X
hMusTRD1/BEN	B-X
,	B-X
represses	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
.	B-X
The	B-X
repression	B-X
by	B-X
hMusTRD1/BEN	B-X
was	B-X
hypothesized	B-X
to	B-X
occur	B-X
via	B-X
a	B-X
two-step	B-X
competition	B-X
mechanism	B-X
involving	B-X
a	B-X
cytoplasmic	B-X
shuttling	B-X
factor	B-X
and	B-X
a	B-X
nuclear	B-X
cofactor	B-X
required	B-X
for	B-X
transcriptional	B-X
activation	B-X
of	B-X
TFII-I	B-X
.	B-X
Employing	B-X
a	B-X
two-hybrid	B-X
approach	B-X
with	B-X
both	B-X
yeast	B-X
genomic	B-X
and	B-X
mouse	B-X
cDNA	B-X
libraries	B-X
in	B-X
parallel	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
the	B-X
RING-like	B-X
zinc	B-X
finger	B-X
containing	B-X
Miz1/PIASxbeta/Siz2	B-X
,	B-X
which	B-X
is	B-X
a	B-X
ubiquitin-protein	B-X
isopeptide	B-X
ligase	B-X
in	B-X
the	B-X
SUMO	B-X
pathway	B-X
,	B-X
as	B-X
the	B-X
potential	B-X
nuclear	B-X
cofactor	B-X
that	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
.	B-X
First	B-X
,	B-X
the	B-X
interactions	B-X
are	B-X
biochemically	B-X
confirmed	B-X
in	B-X
mammalian	B-X
cells	B-X
where	B-X
Miz1/mPIASxbeta	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
when	B-X
these	B-X
proteins	B-X
are	B-X
ectopically	B-X
co-expressed	B-X
.	B-X
Second	B-X
,	B-X
co-expression	B-X
of	B-X
a	B-X
nuclear	B-X
localization	B-X
signal-deficient	B-X
mutant	B-X
of	B-X
Miz1/mPIASxbeta	B-X
with	B-X
wild	B-X
type	B-X
TFII-I	B-X
fails	B-X
to	B-X
alter	B-X
the	B-X
subcellular	B-X
localization	B-X
of	B-X
the	B-X
former	B-X
.	B-X
Finally	B-X
,	B-X
ectopically	B-X
expressed	B-X
Miz1/mPIASxbeta	B-X
augments	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
and	B-X
relieves	B-X
the	B-X
repression	B-X
exerted	B-X
by	B-X
a	B-X
mutant	B-X
hMusTRD1/BEN	B-X
that	B-X
co-localized	B-X
with	B-X
TFII-I	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X

The	O
repression	O
by	O
hMusTRD1	B-Protein
/	I-Protein
BEN	I-Protein
was	O
hypothesized	O
to	O
occur	O
via	O
a	O
two	O
-	O
step	O
competition	O
mechanism	O
involving	O
a	O
cytoplasmic	O
shuttling	O
factor	O
and	O
a	O
nuclear	O
cofactor	O
required	O
for	O
transcriptional	O
activation	O
of	O
TFII	B-Protein
-	I-Protein
I	I-Protein
.	O

Employing	O
a	O
two	O
-	O
hybrid	O
approach	O
with	O
both	O
yeast	O
genomic	O
and	O
mouse	O
cDNA	O
libraries	O
in	O
parallel	O
,	O
we	O
have	O
identified	O
the	O
RING	O
-	O
like	O
zinc	O
finger	O
containing	O
Miz1	B-Protein
/	O
PIASxbeta	B-Protein
/	O
Siz2	B-Protein
,	O
which	O
is	O
a	O
ubiquitin	B-Protein
-	O
protein	O
isopeptide	O
ligase	O
in	O
the	O
SUMO	O
pathway	O
,	O
as	O
the	O
potential	O
nuclear	O
cofactor	O
that	O
interacts	O
with	O
both	O
TFII	B-Protein
-	I-Protein
I	I-Protein
and	O
hMusTRD1	B-Protein
/	I-Protein
BEN	I-Protein
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
previously	B-X
that	B-X
a	B-X
TFII-I-related	B-X
protein	B-X
,	B-X
hMusTRD1/BEN	B-X
,	B-X
represses	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
.	B-X
The	B-X
repression	B-X
by	B-X
hMusTRD1/BEN	B-X
was	B-X
hypothesized	B-X
to	B-X
occur	B-X
via	B-X
a	B-X
two-step	B-X
competition	B-X
mechanism	B-X
involving	B-X
a	B-X
cytoplasmic	B-X
shuttling	B-X
factor	B-X
and	B-X
a	B-X
nuclear	B-X
cofactor	B-X
required	B-X
for	B-X
transcriptional	B-X
activation	B-X
of	B-X
TFII-I	B-X
.	B-X
Employing	B-X
a	B-X
two-hybrid	B-X
approach	B-X
with	B-X
both	B-X
yeast	B-X
genomic	B-X
and	B-X
mouse	B-X
cDNA	B-X
libraries	B-X
in	B-X
parallel	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
the	B-X
RING-like	B-X
zinc	B-X
finger	B-X
containing	B-X
Miz1/PIASxbeta/Siz2	B-X
,	B-X
which	B-X
is	B-X
a	B-X
ubiquitin-protein	B-X
isopeptide	B-X
ligase	B-X
in	B-X
the	B-X
SUMO	B-X
pathway	B-X
,	B-X
as	B-X
the	B-X
potential	B-X
nuclear	B-X
cofactor	B-X
that	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
.	B-X
First	B-X
,	B-X
the	B-X
interactions	B-X
are	B-X
biochemically	B-X
confirmed	B-X
in	B-X
mammalian	B-X
cells	B-X
where	B-X
Miz1/mPIASxbeta	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
when	B-X
these	B-X
proteins	B-X
are	B-X
ectopically	B-X
co-expressed	B-X
.	B-X
Second	B-X
,	B-X
co-expression	B-X
of	B-X
a	B-X
nuclear	B-X
localization	B-X
signal-deficient	B-X
mutant	B-X
of	B-X
Miz1/mPIASxbeta	B-X
with	B-X
wild	B-X
type	B-X
TFII-I	B-X
fails	B-X
to	B-X
alter	B-X
the	B-X
subcellular	B-X
localization	B-X
of	B-X
the	B-X
former	B-X
.	B-X
Finally	B-X
,	B-X
ectopically	B-X
expressed	B-X
Miz1/mPIASxbeta	B-X
augments	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
and	B-X
relieves	B-X
the	B-X
repression	B-X
exerted	B-X
by	B-X
a	B-X
mutant	B-X
hMusTRD1/BEN	B-X
that	B-X
co-localized	B-X
with	B-X
TFII-I	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X

Our	O
conclusion	O
is	O
based	O
on	O
the	O
following	O
observations	O
.	O
<EOS>	B-X
Severity	B-X
of	B-X
PD	B-X
is	B-X
usually	B-X
assessed	B-X
by	B-X
means	B-X
of	B-X
the	B-X
motor	B-X
and	B-X
disability-based	B-X
Hoehn	B-X
and	B-X
Yahr	B-X
staging	B-X
(	B-X
HY	B-X
)	B-X
,	B-X
or	B-X
clinician	B-X
and	B-X
patient	B-X
global	B-X
perceptions	B-X
.	B-X
The	B-X
objective	B-X
of	B-X
the	B-X
present	B-X
study	B-X
is	B-X
to	B-X
determine	B-X
cut-off	B-X
points	B-X
for	B-X
PD	B-X
severity	B-X
levels	B-X
based	B-X
on	B-X
the	B-X
MDS-UPDRS	B-X
.	B-X
Over	B-X
the	B-X
last	B-X
decade	B-X
,	B-X
we	B-X
have	B-X
seen	B-X
the	B-X
emergence	B-X
of	B-X
tissue-based	B-X
genomic	B-X
prognostic	B-X
markers	B-X
that	B-X
can	B-X
be	B-X
used	B-X
for	B-X
decision-making	B-X
regarding	B-X
the	B-X
need	B-X
for	B-X
treatment	B-X
.	B-X
This	B-X
advice	B-X
lacks	B-X
evidence	B-X
and	B-X
is	B-X
merely	B-X
based	B-X
on	B-X
experts	B-X
'	B-X
opinion	B-X
.	B-X

First	O
,	O
the	O
interactions	O
are	O
biochemically	O
confirmed	O
in	O
mammalian	O
cells	O
where	O
Miz1	B-Protein
/	O
mPIASxbeta	B-Protein
interacts	O
with	O
both	O
TFII	B-Protein
-	I-Protein
I	I-Protein
and	O
hMusTRD1	B-Protein
/	I-Protein
BEN	I-Protein
when	O
these	O
proteins	O
are	O
ectopically	O
co	O
-	O
expressed	O
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
previously	B-X
that	B-X
a	B-X
TFII-I-related	B-X
protein	B-X
,	B-X
hMusTRD1/BEN	B-X
,	B-X
represses	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
.	B-X
The	B-X
repression	B-X
by	B-X
hMusTRD1/BEN	B-X
was	B-X
hypothesized	B-X
to	B-X
occur	B-X
via	B-X
a	B-X
two-step	B-X
competition	B-X
mechanism	B-X
involving	B-X
a	B-X
cytoplasmic	B-X
shuttling	B-X
factor	B-X
and	B-X
a	B-X
nuclear	B-X
cofactor	B-X
required	B-X
for	B-X
transcriptional	B-X
activation	B-X
of	B-X
TFII-I	B-X
.	B-X
Employing	B-X
a	B-X
two-hybrid	B-X
approach	B-X
with	B-X
both	B-X
yeast	B-X
genomic	B-X
and	B-X
mouse	B-X
cDNA	B-X
libraries	B-X
in	B-X
parallel	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
the	B-X
RING-like	B-X
zinc	B-X
finger	B-X
containing	B-X
Miz1/PIASxbeta/Siz2	B-X
,	B-X
which	B-X
is	B-X
a	B-X
ubiquitin-protein	B-X
isopeptide	B-X
ligase	B-X
in	B-X
the	B-X
SUMO	B-X
pathway	B-X
,	B-X
as	B-X
the	B-X
potential	B-X
nuclear	B-X
cofactor	B-X
that	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
.	B-X
Our	B-X
conclusion	B-X
is	B-X
based	B-X
on	B-X
the	B-X
following	B-X
observations	B-X
.	B-X
First	B-X
,	B-X
the	B-X
interactions	B-X
are	B-X
biochemically	B-X
confirmed	B-X
in	B-X
mammalian	B-X
cells	B-X
where	B-X
Miz1/mPIASxbeta	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
when	B-X
these	B-X
proteins	B-X
are	B-X
ectopically	B-X
co-expressed	B-X
.	B-X
Second	B-X
,	B-X
co-expression	B-X
of	B-X
a	B-X
nuclear	B-X
localization	B-X
signal-deficient	B-X
mutant	B-X
of	B-X
Miz1/mPIASxbeta	B-X
with	B-X
wild	B-X
type	B-X
TFII-I	B-X
fails	B-X
to	B-X
alter	B-X
the	B-X
subcellular	B-X
localization	B-X
of	B-X
the	B-X
former	B-X
.	B-X
Finally	B-X
,	B-X
ectopically	B-X
expressed	B-X
Miz1/mPIASxbeta	B-X
augments	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
and	B-X
relieves	B-X
the	B-X
repression	B-X
exerted	B-X
by	B-X
a	B-X
mutant	B-X
hMusTRD1/BEN	B-X
that	B-X
co-localized	B-X
with	B-X
TFII-I	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X

Second	O
,	O
co	O
-	O
expression	O
of	O
a	O
nuclear	O
localization	O
signal	O
-	O
deficient	O
mutant	O
of	O
Miz1	B-Protein
/	O
mPIASxbeta	B-Protein
with	O
wild	O
type	O
TFII	B-Protein
-	I-Protein
I	I-Protein
fails	O
to	O
alter	O
the	O
subcellular	O
localization	O
of	O
the	O
former	O
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
previously	B-X
that	B-X
a	B-X
TFII-I-related	B-X
protein	B-X
,	B-X
hMusTRD1/BEN	B-X
,	B-X
represses	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
.	B-X
The	B-X
repression	B-X
by	B-X
hMusTRD1/BEN	B-X
was	B-X
hypothesized	B-X
to	B-X
occur	B-X
via	B-X
a	B-X
two-step	B-X
competition	B-X
mechanism	B-X
involving	B-X
a	B-X
cytoplasmic	B-X
shuttling	B-X
factor	B-X
and	B-X
a	B-X
nuclear	B-X
cofactor	B-X
required	B-X
for	B-X
transcriptional	B-X
activation	B-X
of	B-X
TFII-I	B-X
.	B-X
Employing	B-X
a	B-X
two-hybrid	B-X
approach	B-X
with	B-X
both	B-X
yeast	B-X
genomic	B-X
and	B-X
mouse	B-X
cDNA	B-X
libraries	B-X
in	B-X
parallel	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
the	B-X
RING-like	B-X
zinc	B-X
finger	B-X
containing	B-X
Miz1/PIASxbeta/Siz2	B-X
,	B-X
which	B-X
is	B-X
a	B-X
ubiquitin-protein	B-X
isopeptide	B-X
ligase	B-X
in	B-X
the	B-X
SUMO	B-X
pathway	B-X
,	B-X
as	B-X
the	B-X
potential	B-X
nuclear	B-X
cofactor	B-X
that	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
.	B-X
Our	B-X
conclusion	B-X
is	B-X
based	B-X
on	B-X
the	B-X
following	B-X
observations	B-X
.	B-X
First	B-X
,	B-X
the	B-X
interactions	B-X
are	B-X
biochemically	B-X
confirmed	B-X
in	B-X
mammalian	B-X
cells	B-X
where	B-X
Miz1/mPIASxbeta	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
when	B-X
these	B-X
proteins	B-X
are	B-X
ectopically	B-X
co-expressed	B-X
.	B-X
Second	B-X
,	B-X
co-expression	B-X
of	B-X
a	B-X
nuclear	B-X
localization	B-X
signal-deficient	B-X
mutant	B-X
of	B-X
Miz1/mPIASxbeta	B-X
with	B-X
wild	B-X
type	B-X
TFII-I	B-X
fails	B-X
to	B-X
alter	B-X
the	B-X
subcellular	B-X
localization	B-X
of	B-X
the	B-X
former	B-X
.	B-X
Finally	B-X
,	B-X
ectopically	B-X
expressed	B-X
Miz1/mPIASxbeta	B-X
augments	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
and	B-X
relieves	B-X
the	B-X
repression	B-X
exerted	B-X
by	B-X
a	B-X
mutant	B-X
hMusTRD1/BEN	B-X
that	B-X
co-localized	B-X
with	B-X
TFII-I	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X

Finally	O
,	O
ectopically	O
expressed	O
Miz1	B-Protein
/	O
mPIASxbeta	B-Protein
augments	O
the	O
transcriptional	O
activity	O
of	O
TFII	B-Protein
-	I-Protein
I	I-Protein
and	O
relieves	O
the	O
repression	O
exerted	O
by	O
a	O
mutant	O
hMusTRD1	B-Protein
/	I-Protein
BEN	I-Protein
that	O
co	O
-	O
localized	O
with	O
TFII	B-Protein
-	I-Protein
I	I-Protein
in	O
the	O
nucleus	O
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
previously	B-X
that	B-X
a	B-X
TFII-I-related	B-X
protein	B-X
,	B-X
hMusTRD1/BEN	B-X
,	B-X
represses	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
.	B-X
The	B-X
repression	B-X
by	B-X
hMusTRD1/BEN	B-X
was	B-X
hypothesized	B-X
to	B-X
occur	B-X
via	B-X
a	B-X
two-step	B-X
competition	B-X
mechanism	B-X
involving	B-X
a	B-X
cytoplasmic	B-X
shuttling	B-X
factor	B-X
and	B-X
a	B-X
nuclear	B-X
cofactor	B-X
required	B-X
for	B-X
transcriptional	B-X
activation	B-X
of	B-X
TFII-I	B-X
.	B-X
Employing	B-X
a	B-X
two-hybrid	B-X
approach	B-X
with	B-X
both	B-X
yeast	B-X
genomic	B-X
and	B-X
mouse	B-X
cDNA	B-X
libraries	B-X
in	B-X
parallel	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
the	B-X
RING-like	B-X
zinc	B-X
finger	B-X
containing	B-X
Miz1/PIASxbeta/Siz2	B-X
,	B-X
which	B-X
is	B-X
a	B-X
ubiquitin-protein	B-X
isopeptide	B-X
ligase	B-X
in	B-X
the	B-X
SUMO	B-X
pathway	B-X
,	B-X
as	B-X
the	B-X
potential	B-X
nuclear	B-X
cofactor	B-X
that	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
.	B-X
Our	B-X
conclusion	B-X
is	B-X
based	B-X
on	B-X
the	B-X
following	B-X
observations	B-X
.	B-X
First	B-X
,	B-X
the	B-X
interactions	B-X
are	B-X
biochemically	B-X
confirmed	B-X
in	B-X
mammalian	B-X
cells	B-X
where	B-X
Miz1/mPIASxbeta	B-X
interacts	B-X
with	B-X
both	B-X
TFII-I	B-X
and	B-X
hMusTRD1/BEN	B-X
when	B-X
these	B-X
proteins	B-X
are	B-X
ectopically	B-X
co-expressed	B-X
.	B-X
Second	B-X
,	B-X
co-expression	B-X
of	B-X
a	B-X
nuclear	B-X
localization	B-X
signal-deficient	B-X
mutant	B-X
of	B-X
Miz1/mPIASxbeta	B-X
with	B-X
wild	B-X
type	B-X
TFII-I	B-X
fails	B-X
to	B-X
alter	B-X
the	B-X
subcellular	B-X
localization	B-X
of	B-X
the	B-X
former	B-X
.	B-X
Finally	B-X
,	B-X
ectopically	B-X
expressed	B-X
Miz1/mPIASxbeta	B-X
augments	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
TFII-I	B-X
and	B-X
relieves	B-X
the	B-X
repression	B-X
exerted	B-X
by	B-X
a	B-X
mutant	B-X
hMusTRD1/BEN	B-X
that	B-X
co-localized	B-X
with	B-X
TFII-I	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X

Modulation	O
of	O
p120E4F	B-Protein
transcriptional	O
activity	O
by	O
the	O
Gam1	B-Protein
adenoviral	O
early	O
protein	O
.	O
<EOS>	B-X
Gam1	B-X
,	B-X
an	B-X
early	B-X
adenoviral	B-X
CELO	B-X
protein	B-X
,	B-X
is	B-X
required	B-X
for	B-X
viral	B-X
replication	B-X
.	B-X
Consistent	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
histone	B-X
deacetylation	B-X
by	B-X
HDAC1	B-X
,	B-X
Gam1	B-X
activates	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
the	B-X
cellular	B-X
transcription	B-X
factor	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
as	B-X
a	B-X
Gam1	B-X
interaction	B-X
partner	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
interacts	B-X
with	B-X
HDAC1	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
that	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
alleviated	B-X
by	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
or	B-X
by	B-X
overexpressing	B-X
Gam1	B-X
.	B-X
A	B-X
mutant	B-X
E4	B-X
promoter	B-X
unresponsive	B-X
to	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
also	B-X
not	B-X
stimulated	B-X
by	B-X
Gam1	B-X
.	B-X
Moreover	B-X
,	B-X
our	B-X
cofractionation	B-X
experiments	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
,	B-X
HDAC1	B-X
and	B-X
Gam1	B-X
may	B-X
be	B-X
concomitantly	B-X
present	B-X
in	B-X
protein	B-X
complexes	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
Gam1	B-X
activates	B-X
E4-dependent	B-X
transcription	B-X
possibly	B-X
by	B-X
inactivating	B-X
HDAC1	B-X
.	B-X

Gam1	B-Protein
,	O
an	O
early	O
adenoviral	O
CELO	O
protein	O
,	O
is	O
required	O
for	O
viral	O
replication	O
.	O
<EOS>	B-X
Gam1	B-X
,	B-X
an	B-X
early	B-X
adenoviral	B-X
CELO	B-X
protein	B-X
,	B-X
is	B-X
required	B-X
for	B-X
viral	B-X
replication	B-X
.	B-X
Consistent	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
histone	B-X
deacetylation	B-X
by	B-X
HDAC1	B-X
,	B-X
Gam1	B-X
activates	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
the	B-X
cellular	B-X
transcription	B-X
factor	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
as	B-X
a	B-X
Gam1	B-X
interaction	B-X
partner	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
interacts	B-X
with	B-X
HDAC1	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
that	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
alleviated	B-X
by	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
or	B-X
by	B-X
overexpressing	B-X
Gam1	B-X
.	B-X
A	B-X
mutant	B-X
E4	B-X
promoter	B-X
unresponsive	B-X
to	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
also	B-X
not	B-X
stimulated	B-X
by	B-X
Gam1	B-X
.	B-X
Moreover	B-X
,	B-X
our	B-X
cofractionation	B-X
experiments	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
,	B-X
HDAC1	B-X
and	B-X
Gam1	B-X
may	B-X
be	B-X
concomitantly	B-X
present	B-X
in	B-X
protein	B-X
complexes	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
Gam1	B-X
activates	B-X
E4-dependent	B-X
transcription	B-X
possibly	B-X
by	B-X
inactivating	B-X
HDAC1	B-X
.	B-X

Consistent	O
with	O
its	O
ability	O
to	O
inhibit	O
histone	B-Protein
deacetylation	O
by	O
HDAC1	B-Protein
,	O
Gam1	B-Protein
activates	O
transcription	O
.	O
<EOS>	B-X
Gam1	B-X
,	B-X
an	B-X
early	B-X
adenoviral	B-X
CELO	B-X
protein	B-X
,	B-X
is	B-X
required	B-X
for	B-X
viral	B-X
replication	B-X
.	B-X
Consistent	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
histone	B-X
deacetylation	B-X
by	B-X
HDAC1	B-X
,	B-X
Gam1	B-X
activates	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
the	B-X
cellular	B-X
transcription	B-X
factor	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
as	B-X
a	B-X
Gam1	B-X
interaction	B-X
partner	B-X
.	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
is	B-X
a	B-X
low-abundance	B-X
transcription	B-X
factor	B-X
that	B-X
represses	B-X
the	B-X
adenovirus	B-X
E4	B-X
promoter	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
interacts	B-X
with	B-X
HDAC1	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
that	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
alleviated	B-X
by	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
or	B-X
by	B-X
overexpressing	B-X
Gam1	B-X
.	B-X
A	B-X
mutant	B-X
E4	B-X
promoter	B-X
unresponsive	B-X
to	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
also	B-X
not	B-X
stimulated	B-X
by	B-X
Gam1	B-X
.	B-X
Moreover	B-X
,	B-X
our	B-X
cofractionation	B-X
experiments	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
,	B-X
HDAC1	B-X
and	B-X
Gam1	B-X
may	B-X
be	B-X
concomitantly	B-X
present	B-X
in	B-X
protein	B-X
complexes	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
Gam1	B-X
activates	B-X
E4-dependent	B-X
transcription	B-X
possibly	B-X
by	B-X
inactivating	B-X
HDAC1	B-X
.	B-X

In	O
this	O
report	O
,	O
we	O
identify	O
the	O
cellular	O
transcription	O
factor	O
p120	B-Protein
(	O
E4F	B-Protein
)	O
as	O
a	O
Gam1	B-Protein
interaction	O
partner	O
.	O
<EOS>	B-X
Gam1	B-X
,	B-X
an	B-X
early	B-X
adenoviral	B-X
CELO	B-X
protein	B-X
,	B-X
is	B-X
required	B-X
for	B-X
viral	B-X
replication	B-X
.	B-X
Consistent	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
histone	B-X
deacetylation	B-X
by	B-X
HDAC1	B-X
,	B-X
Gam1	B-X
activates	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
the	B-X
cellular	B-X
transcription	B-X
factor	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
as	B-X
a	B-X
Gam1	B-X
interaction	B-X
partner	B-X
.	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
is	B-X
a	B-X
low-abundance	B-X
transcription	B-X
factor	B-X
that	B-X
represses	B-X
the	B-X
adenovirus	B-X
E4	B-X
promoter	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
interacts	B-X
with	B-X
HDAC1	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
that	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
alleviated	B-X
by	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
or	B-X
by	B-X
overexpressing	B-X
Gam1	B-X
.	B-X
A	B-X
mutant	B-X
E4	B-X
promoter	B-X
unresponsive	B-X
to	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
also	B-X
not	B-X
stimulated	B-X
by	B-X
Gam1	B-X
.	B-X
Moreover	B-X
,	B-X
our	B-X
cofractionation	B-X
experiments	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
,	B-X
HDAC1	B-X
and	B-X
Gam1	B-X
may	B-X
be	B-X
concomitantly	B-X
present	B-X
in	B-X
protein	B-X
complexes	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
Gam1	B-X
activates	B-X
E4-dependent	B-X
transcription	B-X
possibly	B-X
by	B-X
inactivating	B-X
HDAC1	B-X
.	B-X

p120	B-Protein
(	O
E4F	B-Protein
)	O
is	O
a	O
low	O
-	O
abundance	O
transcription	O
factor	O
that	O
represses	O
the	O
adenovirus	O
E4	B-Protein
promoter	O
.	O
<EOS>	B-X
Consistent	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
histone	B-X
deacetylation	B-X
by	B-X
HDAC1	B-X
,	B-X
Gam1	B-X
activates	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
the	B-X
cellular	B-X
transcription	B-X
factor	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
as	B-X
a	B-X
Gam1	B-X
interaction	B-X
partner	B-X
.	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
is	B-X
a	B-X
low-abundance	B-X
transcription	B-X
factor	B-X
that	B-X
represses	B-X
the	B-X
adenovirus	B-X
E4	B-X
promoter	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
interacts	B-X
with	B-X
HDAC1	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
that	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
alleviated	B-X
by	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
or	B-X
by	B-X
overexpressing	B-X
Gam1	B-X
.	B-X
A	B-X
mutant	B-X
E4	B-X
promoter	B-X
unresponsive	B-X
to	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
also	B-X
not	B-X
stimulated	B-X
by	B-X
Gam1	B-X
.	B-X
Moreover	B-X
,	B-X
our	B-X
cofractionation	B-X
experiments	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
,	B-X
HDAC1	B-X
and	B-X
Gam1	B-X
may	B-X
be	B-X
concomitantly	B-X
present	B-X
in	B-X
protein	B-X
complexes	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
Gam1	B-X
activates	B-X
E4-dependent	B-X
transcription	B-X
possibly	B-X
by	B-X
inactivating	B-X
HDAC1	B-X
.	B-X

Here	O
we	O
demonstrate	O
that	O
p120	B-Protein
(	O
E4F	B-Protein
)	O
interacts	O
with	O
HDAC1	B-Protein
in	O
vivo	O
and	O
in	O
vitro	O
,	O
and	O
that	O
E4F	B-Protein
-	O
mediated	O
transcriptional	O
repression	O
is	O
alleviated	O
by	O
the	O
HDAC	O
inhibitor	O
trichostatin	O
A	O
or	O
by	O
overexpressing	O
Gam1	B-Protein
.	O
<EOS>	B-X
Gam1	B-X
,	B-X
an	B-X
early	B-X
adenoviral	B-X
CELO	B-X
protein	B-X
,	B-X
is	B-X
required	B-X
for	B-X
viral	B-X
replication	B-X
.	B-X
Consistent	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
histone	B-X
deacetylation	B-X
by	B-X
HDAC1	B-X
,	B-X
Gam1	B-X
activates	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
the	B-X
cellular	B-X
transcription	B-X
factor	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
as	B-X
a	B-X
Gam1	B-X
interaction	B-X
partner	B-X
.	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
is	B-X
a	B-X
low-abundance	B-X
transcription	B-X
factor	B-X
that	B-X
represses	B-X
the	B-X
adenovirus	B-X
E4	B-X
promoter	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
interacts	B-X
with	B-X
HDAC1	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
that	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
alleviated	B-X
by	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
or	B-X
by	B-X
overexpressing	B-X
Gam1	B-X
.	B-X
A	B-X
mutant	B-X
E4	B-X
promoter	B-X
unresponsive	B-X
to	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
also	B-X
not	B-X
stimulated	B-X
by	B-X
Gam1	B-X
.	B-X
Moreover	B-X
,	B-X
our	B-X
cofractionation	B-X
experiments	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
,	B-X
HDAC1	B-X
and	B-X
Gam1	B-X
may	B-X
be	B-X
concomitantly	B-X
present	B-X
in	B-X
protein	B-X
complexes	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
Gam1	B-X
activates	B-X
E4-dependent	B-X
transcription	B-X
possibly	B-X
by	B-X
inactivating	B-X
HDAC1	B-X
.	B-X

A	O
mutant	O
E4	B-Protein
promoter	O
unresponsive	O
to	O
E4F	B-Protein
-	O
mediated	O
transcriptional	O
repression	O
is	O
also	O
not	O
stimulated	O
by	O
Gam1	B-Protein
.	O

Moreover	O
,	O
our	O
cofractionation	O
experiments	O
demonstrate	O
that	O
p120	B-Protein
(	O
E4F	B-Protein
)	O
,	O
HDAC1	B-Protein
and	O
Gam1	B-Protein
may	O
be	O
concomitantly	O
present	O
in	O
protein	O
complexes	O
.	O
<EOS>	B-X
Gam1	B-X
,	B-X
an	B-X
early	B-X
adenoviral	B-X
CELO	B-X
protein	B-X
,	B-X
is	B-X
required	B-X
for	B-X
viral	B-X
replication	B-X
.	B-X
Consistent	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
histone	B-X
deacetylation	B-X
by	B-X
HDAC1	B-X
,	B-X
Gam1	B-X
activates	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
the	B-X
cellular	B-X
transcription	B-X
factor	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
as	B-X
a	B-X
Gam1	B-X
interaction	B-X
partner	B-X
.	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
is	B-X
a	B-X
low-abundance	B-X
transcription	B-X
factor	B-X
that	B-X
represses	B-X
the	B-X
adenovirus	B-X
E4	B-X
promoter	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
interacts	B-X
with	B-X
HDAC1	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
that	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
alleviated	B-X
by	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
or	B-X
by	B-X
overexpressing	B-X
Gam1	B-X
.	B-X
A	B-X
mutant	B-X
E4	B-X
promoter	B-X
unresponsive	B-X
to	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
also	B-X
not	B-X
stimulated	B-X
by	B-X
Gam1	B-X
.	B-X
Moreover	B-X
,	B-X
our	B-X
cofractionation	B-X
experiments	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
,	B-X
HDAC1	B-X
and	B-X
Gam1	B-X
may	B-X
be	B-X
concomitantly	B-X
present	B-X
in	B-X
protein	B-X
complexes	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
Gam1	B-X
activates	B-X
E4-dependent	B-X
transcription	B-X
possibly	B-X
by	B-X
inactivating	B-X
HDAC1	B-X
.	B-X

We	O
conclude	O
that	O
Gam1	B-Protein
activates	O
E4	B-Protein
-	O
dependent	O
transcription	O
possibly	O
by	O
inactivating	O
HDAC1	B-Protein
.	O
<EOS>	B-X
Gam1	B-X
,	B-X
an	B-X
early	B-X
adenoviral	B-X
CELO	B-X
protein	B-X
,	B-X
is	B-X
required	B-X
for	B-X
viral	B-X
replication	B-X
.	B-X
Consistent	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
histone	B-X
deacetylation	B-X
by	B-X
HDAC1	B-X
,	B-X
Gam1	B-X
activates	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
the	B-X
cellular	B-X
transcription	B-X
factor	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
as	B-X
a	B-X
Gam1	B-X
interaction	B-X
partner	B-X
.	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
is	B-X
a	B-X
low-abundance	B-X
transcription	B-X
factor	B-X
that	B-X
represses	B-X
the	B-X
adenovirus	B-X
E4	B-X
promoter	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
interacts	B-X
with	B-X
HDAC1	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
that	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
alleviated	B-X
by	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
trichostatin	B-X
A	B-X
or	B-X
by	B-X
overexpressing	B-X
Gam1	B-X
.	B-X
A	B-X
mutant	B-X
E4	B-X
promoter	B-X
unresponsive	B-X
to	B-X
E4F-mediated	B-X
transcriptional	B-X
repression	B-X
is	B-X
also	B-X
not	B-X
stimulated	B-X
by	B-X
Gam1	B-X
.	B-X
Moreover	B-X
,	B-X
our	B-X
cofractionation	B-X
experiments	B-X
demonstrate	B-X
that	B-X
p120	B-X
(	B-X
E4F	B-X
)	B-X
,	B-X
HDAC1	B-X
and	B-X
Gam1	B-X
may	B-X
be	B-X
concomitantly	B-X
present	B-X
in	B-X
protein	B-X
complexes	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
Gam1	B-X
activates	B-X
E4-dependent	B-X
transcription	B-X
possibly	B-X
by	B-X
inactivating	B-X
HDAC1	B-X
.	B-X

The	O
B	O
cell	O
-	O
specific	O
major	O
raft	O
protein	O
,	O
Raftlin	B-Protein
,	O
is	O
necessary	O
for	O
the	O
integrity	O
of	O
lipid	O
raft	O
and	O
BCR	O
signal	O
transduction	O
.	O

Recent	O
evidence	O
indicates	O
that	O
membrane	O
microdomains	O
,	O
termed	O
lipid	O
rafts	O
,	O
have	O
a	O
role	O
in	O
B	O
-	O
cell	O
activation	O
as	O
platforms	O
for	O
B	O
-	O
cell	O
antigen	O
receptor	O
(	O
BCR	O
)	O
signal	O
initiation	O
.	O

To	O
gain	O
an	O
insight	O
into	O
the	O
possible	O
functioning	O
of	O
lipid	O
rafts	O
in	O
B	O
cells	O
,	O
we	O
applied	O
liquid	O
chromatography	O
electrospray	O
ionization	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
ESI	O
-	O
MS	O
/	O
MS	O
)	O
methodologies	O
to	O
the	O
identification	O
of	O
proteins	O
that	O
co	O
-	O
purified	O
with	O
lipid	O
rafts	O
of	O
Raji	O
cells	O
.	O

Among	O
these	O
raft	O
proteins	O
,	O
we	O
characterized	O
a	O
novel	O
protein	O
termed	O
Raftlin	B-Protein
(	O
raft	B-Protein
-	I-Protein
linking	I-Protein
protein	I-Protein
)	O
.	O
<EOS>	B-X
Recent	B-X
evidence	B-X
indicates	B-X
that	B-X
membrane	B-X
microdomains	B-X
,	B-X
termed	B-X
lipid	B-X
rafts	B-X
,	B-X
have	B-X
a	B-X
role	B-X
in	B-X
B-cell	B-X
activation	B-X
as	B-X
platforms	B-X
for	B-X
B-cell	B-X
antigen	B-X
receptor	B-X
(	B-X
BCR	B-X
)	B-X
signal	B-X
initiation	B-X
.	B-X
To	B-X
gain	B-X
an	B-X
insight	B-X
into	B-X
the	B-X
possible	B-X
functioning	B-X
of	B-X
lipid	B-X
rafts	B-X
in	B-X
B	B-X
cells	B-X
,	B-X
we	B-X
applied	B-X
liquid	B-X
chromatography	B-X
electrospray	B-X
ionization	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
LC-ESI-MS/MS	B-X
)	B-X
methodologies	B-X
to	B-X
the	B-X
identification	B-X
of	B-X
proteins	B-X
that	B-X
co-purified	B-X
with	B-X
lipid	B-X
rafts	B-X
of	B-X
Raji	B-X
cells	B-X
.	B-X
Among	B-X
these	B-X
raft	B-X
proteins	B-X
,	B-X
we	B-X
characterized	B-X
a	B-X
novel	B-X
protein	B-X
termed	B-X
Raftlin	B-X
(	B-X
raft-linking	B-X
protein	B-X
)	B-X
.	B-X
Like	B-X
the	B-X
Src	B-X
family	B-X
kinase	B-X
,	B-X
Raftlin	B-X
is	B-X
localized	B-X
exclusively	B-X
in	B-X
lipid	B-X
rafts	B-X
by	B-X
fatty	B-X
acylation	B-X
of	B-X
N-terminal	B-X
Gly2	B-X
and	B-X
Cys3	B-X
,	B-X
and	B-X
is	B-X
co-localized	B-X
with	B-X
BCR	B-X
before	B-X
and	B-X
after	B-X
BCR	B-X
stimulation	B-X
.	B-X
Disruption	B-X
of	B-X
the	B-X
Raftlin	B-X
gene	B-X
in	B-X
the	B-X
DT40	B-X
B-cell	B-X
line	B-X
resulted	B-X
in	B-X
a	B-X
marked	B-X
reduction	B-X
in	B-X
the	B-X
quantity	B-X
of	B-X
lipid	B-X
raft	B-X
components	B-X
,	B-X
including	B-X
Lyn	B-X
and	B-X
ganglioside	B-X
GM1	B-X
,	B-X
while	B-X
overexpression	B-X
of	B-X
Raftlin	B-X
increased	B-X
the	B-X
content	B-X
of	B-X
raft	B-X
protein	B-X
.	B-X
Moreover	B-X
,	B-X
BCR-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
and	B-X
calcium	B-X
mobilization	B-X
were	B-X
impaired	B-X
by	B-X
the	B-X
lack	B-X
of	B-X
Raftlin	B-X
and	B-X
actually	B-X
potentiated	B-X
by	B-X
overexpression	B-X
of	B-X
Raftlin	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Raftlin	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
formation	B-X
and/or	B-X
maintenance	B-X
of	B-X
lipid	B-X
rafts	B-X
,	B-X
therefore	B-X
regulating	B-X
BCR-mediated	B-X
signaling	B-X
.	B-X

Like	O
the	O
Src	O
family	O
kinase	O
,	O
Raftlin	B-Protein
is	O
localized	O
exclusively	O
in	O
lipid	O
rafts	O
by	O
fatty	O
acylation	O
of	O
N	O
-	O
terminal	O
Gly2	O
and	O
Cys3	O
,	O
and	O
is	O
co	O
-	O
localized	O
with	O
BCR	O
before	O
and	O
after	O
BCR	O
stimulation	O
.	O

Disruption	O
of	O
the	O
Raftlin	B-Protein
gene	O
in	O
the	O
DT40	O
B	O
-	O
cell	O
line	O
resulted	O
in	O
a	O
marked	O
reduction	O
in	O
the	O
quantity	O
of	O
lipid	O
raft	O
components	O
,	O
including	O
Lyn	B-Protein
and	O
ganglioside	O
GM1	O
,	O
while	O
overexpression	O
of	O
Raftlin	B-Protein
increased	O
the	O
content	O
of	O
raft	O
protein	O
.	O

Moreover	O
,	O
BCR	O
-	O
mediated	O
tyrosine	O
phosphorylation	O
and	O
calcium	O
mobilization	O
were	O
impaired	O
by	O
the	O
lack	O
of	O
Raftlin	B-Protein
and	O
actually	O
potentiated	O
by	O
overexpression	O
of	O
Raftlin	B-Protein
.	O
<EOS>	B-X
Recent	B-X
evidence	B-X
indicates	B-X
that	B-X
membrane	B-X
microdomains	B-X
,	B-X
termed	B-X
lipid	B-X
rafts	B-X
,	B-X
have	B-X
a	B-X
role	B-X
in	B-X
B-cell	B-X
activation	B-X
as	B-X
platforms	B-X
for	B-X
B-cell	B-X
antigen	B-X
receptor	B-X
(	B-X
BCR	B-X
)	B-X
signal	B-X
initiation	B-X
.	B-X
Among	B-X
these	B-X
raft	B-X
proteins	B-X
,	B-X
we	B-X
characterized	B-X
a	B-X
novel	B-X
protein	B-X
termed	B-X
Raftlin	B-X
(	B-X
raft-linking	B-X
protein	B-X
)	B-X
.	B-X
Like	B-X
the	B-X
Src	B-X
family	B-X
kinase	B-X
,	B-X
Raftlin	B-X
is	B-X
localized	B-X
exclusively	B-X
in	B-X
lipid	B-X
rafts	B-X
by	B-X
fatty	B-X
acylation	B-X
of	B-X
N-terminal	B-X
Gly2	B-X
and	B-X
Cys3	B-X
,	B-X
and	B-X
is	B-X
co-localized	B-X
with	B-X
BCR	B-X
before	B-X
and	B-X
after	B-X
BCR	B-X
stimulation	B-X
.	B-X
Disruption	B-X
of	B-X
the	B-X
Raftlin	B-X
gene	B-X
in	B-X
the	B-X
DT40	B-X
B-cell	B-X
line	B-X
resulted	B-X
in	B-X
a	B-X
marked	B-X
reduction	B-X
in	B-X
the	B-X
quantity	B-X
of	B-X
lipid	B-X
raft	B-X
components	B-X
,	B-X
including	B-X
Lyn	B-X
and	B-X
ganglioside	B-X
GM1	B-X
,	B-X
while	B-X
overexpression	B-X
of	B-X
Raftlin	B-X
increased	B-X
the	B-X
content	B-X
of	B-X
raft	B-X
protein	B-X
.	B-X
Moreover	B-X
,	B-X
BCR-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
and	B-X
calcium	B-X
mobilization	B-X
were	B-X
impaired	B-X
by	B-X
the	B-X
lack	B-X
of	B-X
Raftlin	B-X
and	B-X
actually	B-X
potentiated	B-X
by	B-X
overexpression	B-X
of	B-X
Raftlin	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Raftlin	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
formation	B-X
and/or	B-X
maintenance	B-X
of	B-X
lipid	B-X
rafts	B-X
,	B-X
therefore	B-X
regulating	B-X
BCR-mediated	B-X
signaling	B-X
.	B-X

These	O
data	O
suggest	O
that	O
Raftlin	B-Protein
plays	O
a	O
pivotal	O
role	O
in	O
the	O
formation	O
and	O
/	O
or	O
maintenance	O
of	O
lipid	O
rafts	O
,	O
therefore	O
regulating	O
BCR	O
-	O
mediated	O
signaling	O
.	O
<EOS>	B-X
Recent	B-X
evidence	B-X
indicates	B-X
that	B-X
membrane	B-X
microdomains	B-X
,	B-X
termed	B-X
lipid	B-X
rafts	B-X
,	B-X
have	B-X
a	B-X
role	B-X
in	B-X
B-cell	B-X
activation	B-X
as	B-X
platforms	B-X
for	B-X
B-cell	B-X
antigen	B-X
receptor	B-X
(	B-X
BCR	B-X
)	B-X
signal	B-X
initiation	B-X
.	B-X
To	B-X
gain	B-X
an	B-X
insight	B-X
into	B-X
the	B-X
possible	B-X
functioning	B-X
of	B-X
lipid	B-X
rafts	B-X
in	B-X
B	B-X
cells	B-X
,	B-X
we	B-X
applied	B-X
liquid	B-X
chromatography	B-X
electrospray	B-X
ionization	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
LC-ESI-MS/MS	B-X
)	B-X
methodologies	B-X
to	B-X
the	B-X
identification	B-X
of	B-X
proteins	B-X
that	B-X
co-purified	B-X
with	B-X
lipid	B-X
rafts	B-X
of	B-X
Raji	B-X
cells	B-X
.	B-X
Among	B-X
these	B-X
raft	B-X
proteins	B-X
,	B-X
we	B-X
characterized	B-X
a	B-X
novel	B-X
protein	B-X
termed	B-X
Raftlin	B-X
(	B-X
raft-linking	B-X
protein	B-X
)	B-X
.	B-X
Like	B-X
the	B-X
Src	B-X
family	B-X
kinase	B-X
,	B-X
Raftlin	B-X
is	B-X
localized	B-X
exclusively	B-X
in	B-X
lipid	B-X
rafts	B-X
by	B-X
fatty	B-X
acylation	B-X
of	B-X
N-terminal	B-X
Gly2	B-X
and	B-X
Cys3	B-X
,	B-X
and	B-X
is	B-X
co-localized	B-X
with	B-X
BCR	B-X
before	B-X
and	B-X
after	B-X
BCR	B-X
stimulation	B-X
.	B-X
Disruption	B-X
of	B-X
the	B-X
Raftlin	B-X
gene	B-X
in	B-X
the	B-X
DT40	B-X
B-cell	B-X
line	B-X
resulted	B-X
in	B-X
a	B-X
marked	B-X
reduction	B-X
in	B-X
the	B-X
quantity	B-X
of	B-X
lipid	B-X
raft	B-X
components	B-X
,	B-X
including	B-X
Lyn	B-X
and	B-X
ganglioside	B-X
GM1	B-X
,	B-X
while	B-X
overexpression	B-X
of	B-X
Raftlin	B-X
increased	B-X
the	B-X
content	B-X
of	B-X
raft	B-X
protein	B-X
.	B-X
Moreover	B-X
,	B-X
BCR-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
and	B-X
calcium	B-X
mobilization	B-X
were	B-X
impaired	B-X
by	B-X
the	B-X
lack	B-X
of	B-X
Raftlin	B-X
and	B-X
actually	B-X
potentiated	B-X
by	B-X
overexpression	B-X
of	B-X
Raftlin	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Raftlin	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
formation	B-X
and/or	B-X
maintenance	B-X
of	B-X
lipid	B-X
rafts	B-X
,	B-X
therefore	B-X
regulating	B-X
BCR-mediated	B-X
signaling	B-X
.	B-X

Molecular	O
evolution	O
of	O
the	O
Rab	B-Protein
-	I-Protein
escort	I-Protein
-	I-Protein
protein	I-Protein
/	O
guanine	B-Protein
-	I-Protein
nucleotide	I-Protein
-	I-Protein
dissociation	I-Protein
-	I-Protein
inhibitor	I-Protein
superfamily	O
.	O
<EOS>	B-X
Prenylation	B-X
of	B-X
Rab	B-X
GTPases	B-X
regulating	B-X
vesicle	B-X
traffic	B-X
by	B-X
Rab	B-X
geranylgeranyltransferase	B-X
(	B-X
RabGGTase	B-X
)	B-X
requires	B-X
a	B-X
complex	B-X
formed	B-X
by	B-X
the	B-X
association	B-X
of	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
with	B-X
Rab-escort-protein	B-X
(	B-X
REP	B-X
)	B-X
,	B-X
the	B-X
choroideremia-gene-product	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
disease	B-X
,	B-X
leading	B-X
to	B-X
loss	B-X
of	B-X
vision	B-X
.	B-X
After	B-X
delivery	B-X
to	B-X
the	B-X
membrane	B-X
by	B-X
the	B-X
REP-Rab	B-X
complex	B-X
,	B-X
subsequent	B-X
recycling	B-X
to	B-X
the	B-X
cytosol	B-X
requires	B-X
the	B-X
REP-related	B-X
guanine-nucleotide-dissociation-inhibitor	B-X
(	B-X
GDI	B-X
)	B-X
.	B-X
Although	B-X
REP	B-X
and	B-X
GDI	B-X
share	B-X
common	B-X
Rab-binding	B-X
properties	B-X
,	B-X
GDI	B-X
can	B-X
not	B-X
assist	B-X
in	B-X
Rab	B-X
prenylation	B-X
and	B-X
REP	B-X
can	B-X
not	B-X
retrieve	B-X
Rab	B-X
proteins	B-X
from	B-X
the	B-X
membranes	B-X
.	B-X
We	B-X
have	B-X
now	B-X
isolated	B-X
REP	B-X
mutant	B-X
proteins	B-X
that	B-X
are	B-X
able	B-X
to	B-X
partially	B-X
function	B-X
as	B-X
both	B-X
REP	B-X
and	B-X
GDI	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
molecular	B-X
insight	B-X
into	B-X
the	B-X
functional	B-X
and	B-X
evolutionary	B-X
organization	B-X
of	B-X
the	B-X
REP/GDI	B-X
superfamily	B-X
.	B-X

Prenylation	O
of	O
Rab	O
GTPases	O
regulating	O
vesicle	O
traffic	O
by	O
Rab	O
geranylgeranyltransferase	O
(	O
RabGGTase	O
)	O
requires	O
a	O
complex	O
formed	O
by	O
the	O
association	O
of	O
newly	O
synthesized	O
Rab	O
proteins	O
with	O
Rab	B-Protein
-	I-Protein
escort	I-Protein
-	I-Protein
protein	I-Protein
(	O
REP	B-Protein
)	O
,	O
the	O
choroideremia	B-Protein
-	O
gene	O
-	O
product	O
that	O
is	O
mutated	O
in	O
disease	O
,	O
leading	O
to	O
loss	O
of	O
vision	O
.	O
<EOS>	B-X
Prenylation	B-X
of	B-X
Rab	B-X
GTPases	B-X
regulating	B-X
vesicle	B-X
traffic	B-X
by	B-X
Rab	B-X
geranylgeranyltransferase	B-X
(	B-X
RabGGTase	B-X
)	B-X
requires	B-X
a	B-X
complex	B-X
formed	B-X
by	B-X
the	B-X
association	B-X
of	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
with	B-X
Rab-escort-protein	B-X
(	B-X
REP	B-X
)	B-X
,	B-X
the	B-X
choroideremia-gene-product	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
disease	B-X
,	B-X
leading	B-X
to	B-X
loss	B-X
of	B-X
vision	B-X
.	B-X
After	B-X
delivery	B-X
to	B-X
the	B-X
membrane	B-X
by	B-X
the	B-X
REP-Rab	B-X
complex	B-X
,	B-X
subsequent	B-X
recycling	B-X
to	B-X
the	B-X
cytosol	B-X
requires	B-X
the	B-X
REP-related	B-X
guanine-nucleotide-dissociation-inhibitor	B-X
(	B-X
GDI	B-X
)	B-X
.	B-X
Although	B-X
REP	B-X
and	B-X
GDI	B-X
share	B-X
common	B-X
Rab-binding	B-X
properties	B-X
,	B-X
GDI	B-X
can	B-X
not	B-X
assist	B-X
in	B-X
Rab	B-X
prenylation	B-X
and	B-X
REP	B-X
can	B-X
not	B-X
retrieve	B-X
Rab	B-X
proteins	B-X
from	B-X
the	B-X
membranes	B-X
.	B-X
We	B-X
have	B-X
now	B-X
isolated	B-X
REP	B-X
mutant	B-X
proteins	B-X
that	B-X
are	B-X
able	B-X
to	B-X
partially	B-X
function	B-X
as	B-X
both	B-X
REP	B-X
and	B-X
GDI	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
molecular	B-X
insight	B-X
into	B-X
the	B-X
functional	B-X
and	B-X
evolutionary	B-X
organization	B-X
of	B-X
the	B-X
REP/GDI	B-X
superfamily	B-X
.	B-X

After	O
delivery	O
to	O
the	O
membrane	O
by	O
the	O
REP	B-Protein
-	O
Rab	O
complex	O
,	O
subsequent	O
recycling	O
to	O
the	O
cytosol	O
requires	O
the	O
REP	B-Protein
-	O
related	O
guanine	B-Protein
-	I-Protein
nucleotide	I-Protein
-	I-Protein
dissociation	I-Protein
-	I-Protein
inhibitor	I-Protein
(	O
GDI	B-Protein
)	O
.	O

Although	O
REP	B-Protein
and	O
GDI	B-Protein
share	O
common	O
Rab	O
-	O
binding	O
properties	O
,	O
GDI	B-Protein
cannot	O
assist	O
in	O
Rab	O
prenylation	O
and	O
REP	B-Protein
cannot	O
retrieve	O
Rab	O
proteins	O
from	O
the	O
membranes	O
.	O
<EOS>	B-X
Prenylation	B-X
of	B-X
Rab	B-X
GTPases	B-X
regulating	B-X
vesicle	B-X
traffic	B-X
by	B-X
Rab	B-X
geranylgeranyltransferase	B-X
(	B-X
RabGGTase	B-X
)	B-X
requires	B-X
a	B-X
complex	B-X
formed	B-X
by	B-X
the	B-X
association	B-X
of	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
with	B-X
Rab-escort-protein	B-X
(	B-X
REP	B-X
)	B-X
,	B-X
the	B-X
choroideremia-gene-product	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
disease	B-X
,	B-X
leading	B-X
to	B-X
loss	B-X
of	B-X
vision	B-X
.	B-X
After	B-X
delivery	B-X
to	B-X
the	B-X
membrane	B-X
by	B-X
the	B-X
REP-Rab	B-X
complex	B-X
,	B-X
subsequent	B-X
recycling	B-X
to	B-X
the	B-X
cytosol	B-X
requires	B-X
the	B-X
REP-related	B-X
guanine-nucleotide-dissociation-inhibitor	B-X
(	B-X
GDI	B-X
)	B-X
.	B-X
Although	B-X
REP	B-X
and	B-X
GDI	B-X
share	B-X
common	B-X
Rab-binding	B-X
properties	B-X
,	B-X
GDI	B-X
can	B-X
not	B-X
assist	B-X
in	B-X
Rab	B-X
prenylation	B-X
and	B-X
REP	B-X
can	B-X
not	B-X
retrieve	B-X
Rab	B-X
proteins	B-X
from	B-X
the	B-X
membranes	B-X
.	B-X
We	B-X
have	B-X
now	B-X
isolated	B-X
REP	B-X
mutant	B-X
proteins	B-X
that	B-X
are	B-X
able	B-X
to	B-X
partially	B-X
function	B-X
as	B-X
both	B-X
REP	B-X
and	B-X
GDI	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
molecular	B-X
insight	B-X
into	B-X
the	B-X
functional	B-X
and	B-X
evolutionary	B-X
organization	B-X
of	B-X
the	B-X
REP/GDI	B-X
superfamily	B-X
.	B-X

We	O
have	O
now	O
isolated	O
REP	B-Protein
mutant	O
proteins	O
that	O
are	O
able	O
to	O
partially	O
function	O
as	O
both	O
REP	B-Protein
and	O
GDI	B-Protein
.	O
<EOS>	B-X
Prenylation	B-X
of	B-X
Rab	B-X
GTPases	B-X
regulating	B-X
vesicle	B-X
traffic	B-X
by	B-X
Rab	B-X
geranylgeranyltransferase	B-X
(	B-X
RabGGTase	B-X
)	B-X
requires	B-X
a	B-X
complex	B-X
formed	B-X
by	B-X
the	B-X
association	B-X
of	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
with	B-X
Rab-escort-protein	B-X
(	B-X
REP	B-X
)	B-X
,	B-X
the	B-X
choroideremia-gene-product	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
disease	B-X
,	B-X
leading	B-X
to	B-X
loss	B-X
of	B-X
vision	B-X
.	B-X
After	B-X
delivery	B-X
to	B-X
the	B-X
membrane	B-X
by	B-X
the	B-X
REP-Rab	B-X
complex	B-X
,	B-X
subsequent	B-X
recycling	B-X
to	B-X
the	B-X
cytosol	B-X
requires	B-X
the	B-X
REP-related	B-X
guanine-nucleotide-dissociation-inhibitor	B-X
(	B-X
GDI	B-X
)	B-X
.	B-X
Although	B-X
REP	B-X
and	B-X
GDI	B-X
share	B-X
common	B-X
Rab-binding	B-X
properties	B-X
,	B-X
GDI	B-X
can	B-X
not	B-X
assist	B-X
in	B-X
Rab	B-X
prenylation	B-X
and	B-X
REP	B-X
can	B-X
not	B-X
retrieve	B-X
Rab	B-X
proteins	B-X
from	B-X
the	B-X
membranes	B-X
.	B-X
We	B-X
have	B-X
now	B-X
isolated	B-X
REP	B-X
mutant	B-X
proteins	B-X
that	B-X
are	B-X
able	B-X
to	B-X
partially	B-X
function	B-X
as	B-X
both	B-X
REP	B-X
and	B-X
GDI	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
molecular	B-X
insight	B-X
into	B-X
the	B-X
functional	B-X
and	B-X
evolutionary	B-X
organization	B-X
of	B-X
the	B-X
REP/GDI	B-X
superfamily	B-X
.	B-X

These	O
results	O
provide	O
molecular	O
insight	O
into	O
the	O
functional	O
and	O
evolutionary	O
organization	O
of	O
the	O
REP	B-Protein
/	O
GDI	B-Protein
superfamily	O
.	O
<EOS>	B-X
Prenylation	B-X
of	B-X
Rab	B-X
GTPases	B-X
regulating	B-X
vesicle	B-X
traffic	B-X
by	B-X
Rab	B-X
geranylgeranyltransferase	B-X
(	B-X
RabGGTase	B-X
)	B-X
requires	B-X
a	B-X
complex	B-X
formed	B-X
by	B-X
the	B-X
association	B-X
of	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
with	B-X
Rab-escort-protein	B-X
(	B-X
REP	B-X
)	B-X
,	B-X
the	B-X
choroideremia-gene-product	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
disease	B-X
,	B-X
leading	B-X
to	B-X
loss	B-X
of	B-X
vision	B-X
.	B-X
After	B-X
delivery	B-X
to	B-X
the	B-X
membrane	B-X
by	B-X
the	B-X
REP-Rab	B-X
complex	B-X
,	B-X
subsequent	B-X
recycling	B-X
to	B-X
the	B-X
cytosol	B-X
requires	B-X
the	B-X
REP-related	B-X
guanine-nucleotide-dissociation-inhibitor	B-X
(	B-X
GDI	B-X
)	B-X
.	B-X
Although	B-X
REP	B-X
and	B-X
GDI	B-X
share	B-X
common	B-X
Rab-binding	B-X
properties	B-X
,	B-X
GDI	B-X
can	B-X
not	B-X
assist	B-X
in	B-X
Rab	B-X
prenylation	B-X
and	B-X
REP	B-X
can	B-X
not	B-X
retrieve	B-X
Rab	B-X
proteins	B-X
from	B-X
the	B-X
membranes	B-X
.	B-X
We	B-X
have	B-X
now	B-X
isolated	B-X
REP	B-X
mutant	B-X
proteins	B-X
that	B-X
are	B-X
able	B-X
to	B-X
partially	B-X
function	B-X
as	B-X
both	B-X
REP	B-X
and	B-X
GDI	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
molecular	B-X
insight	B-X
into	B-X
the	B-X
functional	B-X
and	B-X
evolutionary	B-X
organization	B-X
of	B-X
the	B-X
REP/GDI	B-X
superfamily	B-X
.	B-X

Synthesis	O
of	O
functionalized	O
rab	O
GTPases	O
by	O
a	O
combination	O
of	O
solution	O
-	O
or	O
solid	O
-	O
phase	O
lipopeptide	O
synthesis	O
with	O
expressed	O
protein	O
ligation	O
.	O
<EOS>	B-X
Prenylated	B-X
proteins	B-X
with	B-X
non-native	B-X
functionalities	B-X
are	B-X
generally	B-X
very	B-X
difficult	B-X
to	B-X
obtain	B-X
by	B-X
recombinant	B-X
or	B-X
enzymatic	B-X
means	B-X
.	B-X
The	B-X
semisynthesis	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
guanosine	B-X
triphosphatases	B-X
(	B-X
GTPases	B-X
)	B-X
from	B-X
recombinant	B-X
proteins	B-X
and	B-X
synthetic	B-X
prenylated	B-X
peptides	B-X
depends	B-X
largely	B-X
on	B-X
the	B-X
availability	B-X
of	B-X
functionalised	B-X
prenylated	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
proteins	B-X
'	B-X
native	B-X
structure	B-X
or	B-X
modifications	B-X
thereof	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
and	B-X
compare	B-X
solution-phase	B-X
and	B-X
solid-phase	B-X
strategies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
prenylated	B-X
C	B-X
terminus	B-X
of	B-X
Rab7	B-X
GTPase	B-X
.	B-X
The	B-X
solid-phase	B-X
with	B-X
utilisation	B-X
of	B-X
a	B-X
hydrazide	B-X
linker	B-X
emerges	B-X
as	B-X
the	B-X
more	B-X
favourable	B-X
approach	B-X
.	B-X
It	B-X
allows	B-X
a	B-X
fast	B-X
and	B-X
practical	B-X
synthesis	B-X
of	B-X
pure	B-X
peptides	B-X
and	B-X
gives	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
flexibility	B-X
in	B-X
their	B-X
modification	B-X
.	B-X
To	B-X
facilitate	B-X
the	B-X
analysis	B-X
of	B-X
semisynthetic	B-X
proteins	B-X
,	B-X
the	B-X
synthesised	B-X
peptides	B-X
were	B-X
equipped	B-X
with	B-X
a	B-X
fluorescent	B-X
group	B-X
.	B-X
The	B-X
position	B-X
of	B-X
the	B-X
incorporated	B-X
fluorescent	B-X
groups	B-X
in	B-X
the	B-X
peptides	B-X
did	B-X
not	B-X
influence	B-X
the	B-X
protein-ligation	B-X
reaction	B-X
,	B-X
as	B-X
the	B-X
generated	B-X
peptides	B-X
could	B-X
be	B-X
ligated	B-X
onto	B-X
thioester-tagged	B-X
Rab7	B-X
.	B-X
However	B-X
,	B-X
it	B-X
was	B-X
found	B-X
that	B-X
the	B-X
positioning	B-X
of	B-X
the	B-X
fluorescent	B-X
group	B-X
had	B-X
an	B-X
influence	B-X
on	B-X
the	B-X
functionality	B-X
of	B-X
the	B-X
Rab7	B-X
proteins	B-X
;	B-X
analysis	B-X
of	B-X
the	B-X
interaction	B-X
of	B-X
the	B-X
semisynthetic	B-X
Rab7	B-X
proteins	B-X
with	B-X
REP	B-X
(	B-X
Rab	B-X
escort	B-X
protein	B-X
)	B-X
and	B-X
GDI	B-X
(	B-X
guanosine	B-X
diphosphate	B-X
dissociation	B-X
inhibitor	B-X
)	B-X
molecules	B-X
revealed	B-X
that	B-X
modification	B-X
of	B-X
the	B-X
peptide	B-X
side	B-X
chains	B-X
or	B-X
of	B-X
the	B-X
C-terminal	B-X
isoprenoid	B-X
did	B-X
not	B-X
significantly	B-X
interfere	B-X
with	B-X
complex	B-X
formation	B-X
.	B-X

Prenylated	O
proteins	O
with	O
non	O
-	O
native	O
functionalities	O
are	O
generally	O
very	O
difficult	O
to	O
obtain	O
by	O
recombinant	O
or	O
enzymatic	O
means	O
.	O
<EOS>	B-X
Like	B-X
nucleic	B-X
acids	B-X
and	B-X
proteins	B-X
,	B-X
oligo-	B-X
and	B-X
polysaccharides	B-X
are	B-X
ubiquitous	B-X
,	B-X
and	B-X
they	B-X
are	B-X
a	B-X
biochemical	B-X
platform	B-X
for	B-X
establishing	B-X
molecular	B-X
messages	B-X
.	B-X
The	B-X
enzymatic	B-X
machinery	B-X
for	B-X
glycan	B-X
biosynthesis	B-X
(	B-X
writers	B-X
)	B-X
realizes	B-X
this	B-X
enormous	B-X
potential	B-X
for	B-X
building	B-X
a	B-X
large	B-X
vocabulary	B-X
.	B-X
It	B-X
includes	B-X
possibilities	B-X
for	B-X
dynamic	B-X
editing/erasing	B-X
as	B-X
known	B-X
from	B-X
nucleic	B-X
acids	B-X
and	B-X
proteins	B-X
.	B-X
Lactose-derived	B-X
non-digestible	B-X
oligosaccharides	B-X
are	B-X
prominent	B-X
components	B-X
of	B-X
functional	B-X
foods	B-X
.	B-X
GOS	B-X
are	B-X
currently	B-X
produced	B-X
enzymatically	B-X
in	B-X
a	B-X
kinetically-controlled	B-X
reaction	B-X
of	B-X
lactose	B-X
transgalactosylation	B-X
catalyzed	B-X
by	B-X
-galactosidases	B-X
from	B-X
different	B-X
microbial	B-X
strains	B-X
.	B-X
The	B-X
enzymatic	B-X
synthesis	B-X
of	B-X
GOS	B-X
,	B-X
although	B-X
being	B-X
an	B-X
established	B-X
technology	B-X
,	B-X
still	B-X
offers	B-X
many	B-X
technological	B-X
challenges	B-X
and	B-X
opportunities	B-X
for	B-X
further	B-X
development	B-X
that	B-X
has	B-X
to	B-X
be	B-X
considered	B-X
within	B-X
the	B-X
framework	B-X
of	B-X
functional	B-X
foods	B-X
which	B-X
is	B-X
the	B-X
most	B-X
rapidly	B-X
expanding	B-X
market	B-X
within	B-X
the	B-X
food	B-X
sector	B-X
.	B-X
This	B-X
means	B-X
that	B-X
the	B-X
product	B-X
or	B-X
reaction	B-X
(	B-X
raw	B-X
GOS	B-X
)	B-X
contains	B-X
significant	B-X
amounts	B-X
of	B-X
residual	B-X
lactose	B-X
and	B-X
monosaccharides	B-X
(	B-X
glucose	B-X
and	B-X
galactose	B-X
)	B-X
.	B-X
Low	B-X
yields	B-X
impose	B-X
a	B-X
burden	B-X
on	B-X
downstream	B-X
processing	B-X
to	B-X
obtain	B-X
a	B-X
GOS	B-X
product	B-X
of	B-X
the	B-X
required	B-X
purity	B-X
.	B-X

The	O
semisynthesis	O
of	O
preparative	O
amounts	O
of	O
prenylated	O
Rab	O
guanosine	O
triphosphatases	O
(	O
GTPases	O
)	O
from	O
recombinant	O
proteins	O
and	O
synthetic	O
prenylated	O
peptides	O
depends	O
largely	O
on	O
the	O
availability	O
of	O
functionalised	O
prenylated	O
peptides	O
corresponding	O
to	O
the	O
proteins	O
'	O
native	O
structure	O
or	O
modifications	O
thereof	O
.	O
<EOS>	B-X
This	B-X
could	B-X
have	B-X
important	B-X
implications	B-X
for	B-X
the	B-X
development	B-X
and	B-X
application	B-X
of	B-X
both	B-X
epigenetic	B-X
therapies	B-X
and	B-X
cancer	B-X
immunotherapies	B-X
,	B-X
and	B-X
combinations	B-X
thereof	B-X
.	B-X
We	B-X
review	B-X
advances	B-X
in	B-X
designing	B-X
the	B-X
binding	B-X
loops	B-X
,	B-X
scaffolds	B-X
,	B-X
domain	B-X
interfaces	B-X
,	B-X
constant	B-X
regions	B-X
,	B-X
post-translational	B-X
and	B-X
chemical	B-X
modifications	B-X
,	B-X
and	B-X
bispecific	B-X
architectures	B-X
of	B-X
antibodies	B-X
and	B-X
fragments	B-X
thereof	B-X
to	B-X
improve	B-X
their	B-X
bioactivity	B-X
.	B-X
The	B-X
composition	B-X
of	B-X
this	B-X
microbial	B-X
community	B-X
is	B-X
host	B-X
specific	B-X
,	B-X
evolving	B-X
throughout	B-X
an	B-X
individual	B-X
's	B-X
lifetime	B-X
and	B-X
susceptible	B-X
to	B-X
both	B-X
exogenous	B-X
and	B-X
endogenous	B-X
modifications	B-X
.	B-X
Recent	B-X
renewed	B-X
interest	B-X
in	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
this	B-X
``	B-X
organ	B-X
''	B-X
has	B-X
illuminated	B-X
its	B-X
central	B-X
position	B-X
in	B-X
health	B-X
and	B-X
disease	B-X
.	B-X
The	B-X
overall	B-X
balance	B-X
in	B-X
the	B-X
composition	B-X
of	B-X
the	B-X
gut	B-X
microbial	B-X
community	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
presence	B-X
or	B-X
absence	B-X
of	B-X
key	B-X
species	B-X
capable	B-X
of	B-X
effecting	B-X
specific	B-X
responses	B-X
,	B-X
is	B-X
important	B-X
in	B-X
ensuring	B-X
homeostasis	B-X
or	B-X
lack	B-X
thereof	B-X
at	B-X
the	B-X
intestinal	B-X
mucosa	B-X
and	B-X
beyond	B-X
.	B-X
The	B-X
mechanisms	B-X
through	B-X
which	B-X
microbiota	B-X
exerts	B-X
its	B-X
beneficial	B-X
or	B-X
detrimental	B-X
influences	B-X
remain	B-X
largely	B-X
undefined	B-X
,	B-X
but	B-X
include	B-X
elaboration	B-X
of	B-X
signaling	B-X
molecules	B-X
and	B-X
recognition	B-X
of	B-X
bacterial	B-X
epitopes	B-X
by	B-X
both	B-X
intestinal	B-X
epithelial	B-X
and	B-X
mucosal	B-X
immune	B-X
cells	B-X
.	B-X

Here	O
,	O
we	O
describe	O
and	O
compare	O
solution	O
-	O
phase	O
and	O
solid	O
-	O
phase	O
strategies	O
for	O
the	O
generation	O
of	O
peptides	O
corresponding	O
to	O
the	O
prenylated	O
C	O
terminus	O
of	O
Rab7	B-Protein
GTPase	O
.	O

The	O
solid	O
-	O
phase	O
with	O
utilisation	O
of	O
a	O
hydrazide	O
linker	O
emerges	O
as	O
the	O
more	O
favourable	O
approach	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
and	B-X
compare	B-X
solution-phase	B-X
and	B-X
solid-phase	B-X
strategies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
prenylated	B-X
C	B-X
terminus	B-X
of	B-X
Rab7	B-X
GTPase	B-X
.	B-X
The	B-X
solid-phase	B-X
with	B-X
utilisation	B-X
of	B-X
a	B-X
hydrazide	B-X
linker	B-X
emerges	B-X
as	B-X
the	B-X
more	B-X
favourable	B-X
approach	B-X
.	B-X
Using	B-X
the	B-X
described	B-X
approach	B-X
,	B-X
we	B-X
introduced	B-X
fluorophores	B-X
at	B-X
several	B-X
different	B-X
positions	B-X
of	B-X
the	B-X
Rab7	B-X
C	B-X
terminus	B-X
.	B-X

It	O
allows	O
a	O
fast	O
and	O
practical	O
synthesis	O
of	O
pure	O
peptides	O
and	O
gives	O
a	O
high	O
degree	O
of	O
flexibility	O
in	O
their	O
modification	O
.	O
<EOS>	B-X
The	B-X
semisynthesis	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
guanosine	B-X
triphosphatases	B-X
(	B-X
GTPases	B-X
)	B-X
from	B-X
recombinant	B-X
proteins	B-X
and	B-X
synthetic	B-X
prenylated	B-X
peptides	B-X
depends	B-X
largely	B-X
on	B-X
the	B-X
availability	B-X
of	B-X
functionalised	B-X
prenylated	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
proteins	B-X
'	B-X
native	B-X
structure	B-X
or	B-X
modifications	B-X
thereof	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
and	B-X
compare	B-X
solution-phase	B-X
and	B-X
solid-phase	B-X
strategies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
prenylated	B-X
C	B-X
terminus	B-X
of	B-X
Rab7	B-X
GTPase	B-X
.	B-X
It	B-X
allows	B-X
a	B-X
fast	B-X
and	B-X
practical	B-X
synthesis	B-X
of	B-X
pure	B-X
peptides	B-X
and	B-X
gives	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
flexibility	B-X
in	B-X
their	B-X
modification	B-X
.	B-X
To	B-X
facilitate	B-X
the	B-X
analysis	B-X
of	B-X
semisynthetic	B-X
proteins	B-X
,	B-X
the	B-X
synthesised	B-X
peptides	B-X
were	B-X
equipped	B-X
with	B-X
a	B-X
fluorescent	B-X
group	B-X
.	B-X
The	B-X
position	B-X
of	B-X
the	B-X
incorporated	B-X
fluorescent	B-X
groups	B-X
in	B-X
the	B-X
peptides	B-X
did	B-X
not	B-X
influence	B-X
the	B-X
protein-ligation	B-X
reaction	B-X
,	B-X
as	B-X
the	B-X
generated	B-X
peptides	B-X
could	B-X
be	B-X
ligated	B-X
onto	B-X
thioester-tagged	B-X
Rab7	B-X
.	B-X
However	B-X
,	B-X
it	B-X
was	B-X
found	B-X
that	B-X
the	B-X
positioning	B-X
of	B-X
the	B-X
fluorescent	B-X
group	B-X
had	B-X
an	B-X
influence	B-X
on	B-X
the	B-X
functionality	B-X
of	B-X
the	B-X
Rab7	B-X
proteins	B-X
;	B-X
analysis	B-X
of	B-X
the	B-X
interaction	B-X
of	B-X
the	B-X
semisynthetic	B-X
Rab7	B-X
proteins	B-X
with	B-X
REP	B-X
(	B-X
Rab	B-X
escort	B-X
protein	B-X
)	B-X
and	B-X
GDI	B-X
(	B-X
guanosine	B-X
diphosphate	B-X
dissociation	B-X
inhibitor	B-X
)	B-X
molecules	B-X
revealed	B-X
that	B-X
modification	B-X
of	B-X
the	B-X
peptide	B-X
side	B-X
chains	B-X
or	B-X
of	B-X
the	B-X
C-terminal	B-X
isoprenoid	B-X
did	B-X
not	B-X
significantly	B-X
interfere	B-X
with	B-X
complex	B-X
formation	B-X
.	B-X
However	B-X
,	B-X
functionalisation	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
was	B-X
found	B-X
to	B-X
have	B-X
an	B-X
adverse	B-X
effect	B-X
on	B-X
complex	B-X
formation	B-X
and	B-X
stability	B-X
,	B-X
possibly	B-X
reflecting	B-X
low	B-X
structural	B-X
flexibility	B-X
of	B-X
the	B-X
Rab	B-X
GDI/REP	B-X
molecules	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
lipid-binding	B-X
site	B-X
.	B-X

To	O
facilitate	O
the	O
analysis	O
of	O
semisynthetic	O
proteins	O
,	O
the	O
synthesised	O
peptides	O
were	O
equipped	O
with	O
a	O
fluorescent	O
group	O
.	O
<EOS>	B-X
Prenylated	B-X
proteins	B-X
with	B-X
non-native	B-X
functionalities	B-X
are	B-X
generally	B-X
very	B-X
difficult	B-X
to	B-X
obtain	B-X
by	B-X
recombinant	B-X
or	B-X
enzymatic	B-X
means	B-X
.	B-X
The	B-X
semisynthesis	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
guanosine	B-X
triphosphatases	B-X
(	B-X
GTPases	B-X
)	B-X
from	B-X
recombinant	B-X
proteins	B-X
and	B-X
synthetic	B-X
prenylated	B-X
peptides	B-X
depends	B-X
largely	B-X
on	B-X
the	B-X
availability	B-X
of	B-X
functionalised	B-X
prenylated	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
proteins	B-X
'	B-X
native	B-X
structure	B-X
or	B-X
modifications	B-X
thereof	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
and	B-X
compare	B-X
solution-phase	B-X
and	B-X
solid-phase	B-X
strategies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
prenylated	B-X
C	B-X
terminus	B-X
of	B-X
Rab7	B-X
GTPase	B-X
.	B-X
It	B-X
allows	B-X
a	B-X
fast	B-X
and	B-X
practical	B-X
synthesis	B-X
of	B-X
pure	B-X
peptides	B-X
and	B-X
gives	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
flexibility	B-X
in	B-X
their	B-X
modification	B-X
.	B-X
To	B-X
facilitate	B-X
the	B-X
analysis	B-X
of	B-X
semisynthetic	B-X
proteins	B-X
,	B-X
the	B-X
synthesised	B-X
peptides	B-X
were	B-X
equipped	B-X
with	B-X
a	B-X
fluorescent	B-X
group	B-X
.	B-X
The	B-X
position	B-X
of	B-X
the	B-X
incorporated	B-X
fluorescent	B-X
groups	B-X
in	B-X
the	B-X
peptides	B-X
did	B-X
not	B-X
influence	B-X
the	B-X
protein-ligation	B-X
reaction	B-X
,	B-X
as	B-X
the	B-X
generated	B-X
peptides	B-X
could	B-X
be	B-X
ligated	B-X
onto	B-X
thioester-tagged	B-X
Rab7	B-X
.	B-X
However	B-X
,	B-X
it	B-X
was	B-X
found	B-X
that	B-X
the	B-X
positioning	B-X
of	B-X
the	B-X
fluorescent	B-X
group	B-X
had	B-X
an	B-X
influence	B-X
on	B-X
the	B-X
functionality	B-X
of	B-X
the	B-X
Rab7	B-X
proteins	B-X
;	B-X
analysis	B-X
of	B-X
the	B-X
interaction	B-X
of	B-X
the	B-X
semisynthetic	B-X
Rab7	B-X
proteins	B-X
with	B-X
REP	B-X
(	B-X
Rab	B-X
escort	B-X
protein	B-X
)	B-X
and	B-X
GDI	B-X
(	B-X
guanosine	B-X
diphosphate	B-X
dissociation	B-X
inhibitor	B-X
)	B-X
molecules	B-X
revealed	B-X
that	B-X
modification	B-X
of	B-X
the	B-X
peptide	B-X
side	B-X
chains	B-X
or	B-X
of	B-X
the	B-X
C-terminal	B-X
isoprenoid	B-X
did	B-X
not	B-X
significantly	B-X
interfere	B-X
with	B-X
complex	B-X
formation	B-X
.	B-X

Using	O
the	O
described	O
approach	O
,	O
we	O
introduced	O
fluorophores	O
at	O
several	O
different	O
positions	O
of	O
the	O
Rab7	B-Protein
C	O
terminus	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
and	B-X
compare	B-X
solution-phase	B-X
and	B-X
solid-phase	B-X
strategies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
prenylated	B-X
C	B-X
terminus	B-X
of	B-X
Rab7	B-X
GTPase	B-X
.	B-X
The	B-X
solid-phase	B-X
with	B-X
utilisation	B-X
of	B-X
a	B-X
hydrazide	B-X
linker	B-X
emerges	B-X
as	B-X
the	B-X
more	B-X
favourable	B-X
approach	B-X
.	B-X
Using	B-X
the	B-X
described	B-X
approach	B-X
,	B-X
we	B-X
introduced	B-X
fluorophores	B-X
at	B-X
several	B-X
different	B-X
positions	B-X
of	B-X
the	B-X
Rab7	B-X
C	B-X
terminus	B-X
.	B-X
The	B-X
position	B-X
of	B-X
the	B-X
incorporated	B-X
fluorescent	B-X
groups	B-X
in	B-X
the	B-X
peptides	B-X
did	B-X
not	B-X
influence	B-X
the	B-X
protein-ligation	B-X
reaction	B-X
,	B-X
as	B-X
the	B-X
generated	B-X
peptides	B-X
could	B-X
be	B-X
ligated	B-X
onto	B-X
thioester-tagged	B-X
Rab7	B-X
.	B-X
However	B-X
,	B-X
it	B-X
was	B-X
found	B-X
that	B-X
the	B-X
positioning	B-X
of	B-X
the	B-X
fluorescent	B-X
group	B-X
had	B-X
an	B-X
influence	B-X
on	B-X
the	B-X
functionality	B-X
of	B-X
the	B-X
Rab7	B-X
proteins	B-X
;	B-X
analysis	B-X
of	B-X
the	B-X
interaction	B-X
of	B-X
the	B-X
semisynthetic	B-X
Rab7	B-X
proteins	B-X
with	B-X
REP	B-X
(	B-X
Rab	B-X
escort	B-X
protein	B-X
)	B-X
and	B-X
GDI	B-X
(	B-X
guanosine	B-X
diphosphate	B-X
dissociation	B-X
inhibitor	B-X
)	B-X
molecules	B-X
revealed	B-X
that	B-X
modification	B-X
of	B-X
the	B-X
peptide	B-X
side	B-X
chains	B-X
or	B-X
of	B-X
the	B-X
C-terminal	B-X
isoprenoid	B-X
did	B-X
not	B-X
significantly	B-X
interfere	B-X
with	B-X
complex	B-X
formation	B-X
.	B-X
However	B-X
,	B-X
functionalisation	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
was	B-X
found	B-X
to	B-X
have	B-X
an	B-X
adverse	B-X
effect	B-X
on	B-X
complex	B-X
formation	B-X
and	B-X
stability	B-X
,	B-X
possibly	B-X
reflecting	B-X
low	B-X
structural	B-X
flexibility	B-X
of	B-X
the	B-X
Rab	B-X
GDI/REP	B-X
molecules	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
lipid-binding	B-X
site	B-X
.	B-X

The	O
position	O
of	O
the	O
incorporated	O
fluorescent	O
groups	O
in	O
the	O
peptides	O
did	O
not	O
influence	O
the	O
protein	O
-	O
ligation	O
reaction	O
,	O
as	O
the	O
generated	O
peptides	O
could	O
be	O
ligated	O
onto	O
thioester	O
-	O
tagged	O
Rab7	B-Protein
.	O
<EOS>	B-X
In	B-X
recent	B-X
years	B-X
,	B-X
a	B-X
number	B-X
of	B-X
studies	B-X
have	B-X
been	B-X
focused	B-X
on	B-X
the	B-X
structural	B-X
evaluation	B-X
of	B-X
protein	B-X
complexes	B-X
in	B-X
order	B-X
to	B-X
get	B-X
mechanistic	B-X
insights	B-X
into	B-X
how	B-X
proteins	B-X
communicate	B-X
at	B-X
the	B-X
molecular	B-X
level	B-X
within	B-X
the	B-X
cell	B-X
.	B-X
Specific	B-X
sites	B-X
of	B-X
protein-aquaporin	B-X
interaction	B-X
have	B-X
been	B-X
evaluated	B-X
and	B-X
new	B-X
forms	B-X
of	B-X
regulation	B-X
of	B-X
aquaporins	B-X
described	B-X
,	B-X
based	B-X
on	B-X
these	B-X
associations	B-X
.	B-X
Heterotetramerizations	B-X
of	B-X
aquaporin	B-X
isoforms	B-X
are	B-X
considered	B-X
as	B-X
novel	B-X
regulatory	B-X
mechanisms	B-X
for	B-X
plasma	B-X
membrane	B-X
(	B-X
PIPs	B-X
)	B-X
and	B-X
tonoplast	B-X
(	B-X
TIPs	B-X
)	B-X
proteins	B-X
,	B-X
influencing	B-X
their	B-X
intrinsic	B-X
permeability	B-X
and	B-X
trafficking	B-X
dynamics	B-X
in	B-X
the	B-X
adaptive	B-X
response	B-X
to	B-X
changing	B-X
environmental	B-X
conditions	B-X
.	B-X
However	B-X
,	B-X
protein-protein	B-X
interaction	B-X
is	B-X
an	B-X
extensive	B-X
theme	B-X
that	B-X
is	B-X
difficult	B-X
to	B-X
tackle	B-X
and	B-X
new	B-X
methodologies	B-X
are	B-X
being	B-X
used	B-X
to	B-X
study	B-X
the	B-X
physical	B-X
interactions	B-X
involved	B-X
.	B-X
Bimolecular	B-X
fluorescence	B-X
complementation	B-X
and	B-X
the	B-X
identification	B-X
of	B-X
cross-linked	B-X
peptides	B-X
based	B-X
on	B-X
tandem	B-X
mass	B-X
spectra	B-X
,	B-X
that	B-X
are	B-X
complementary	B-X
to	B-X
other	B-X
methodologies	B-X
such	B-X
as	B-X
heterologous	B-X
expression	B-X
,	B-X
co-precipitation	B-X
assays	B-X
or	B-X
confocal	B-X
fluorescence	B-X
microscopy	B-X
,	B-X
are	B-X
discussed	B-X
in	B-X
this	B-X
review	B-X
.	B-X
The	B-X
chemical	B-X
composition	B-X
and	B-X
the	B-X
physical	B-X
characteristics	B-X
of	B-X
the	B-X
lipid	B-X
bilayer	B-X
also	B-X
influence	B-X
many	B-X
aspects	B-X
of	B-X
membrane	B-X
aquaporins	B-X
,	B-X
including	B-X
their	B-X
functionality	B-X
.	B-X
The	B-X
molecular	B-X
driving	B-X
forces	B-X
stabilizing	B-X
the	B-X
positions	B-X
of	B-X
the	B-X
lipids	B-X
around	B-X
aquaporins	B-X
could	B-X
define	B-X
their	B-X
activity	B-X
,	B-X
thereby	B-X
altering	B-X
the	B-X
conformational	B-X
properties	B-X
.	B-X

However	O
,	O
it	O
was	O
found	O
that	O
the	O
positioning	O
of	O
the	O
fluorescent	O
group	O
had	O
an	O
influence	O
on	O
the	O
functionality	O
of	O
the	O
Rab7	B-Protein
proteins	O
;	O
analysis	O
of	O
the	O
interaction	O
of	O
the	O
semisynthetic	O
Rab7	B-Protein
proteins	O
with	O
REP	O
(	O
Rab	O
escort	O
protein	O
)	O
and	O
GDI	O
(	O
guanosine	O
diphosphate	O
dissociation	O
inhibitor	O
)	O
molecules	O
revealed	O
that	O
modification	O
of	O
the	O
peptide	O
side	O
chains	O
or	O
of	O
the	O
C	O
-	O
terminal	O
isoprenoid	O
did	O
not	O
significantly	O
interfere	O
with	O
complex	O
formation	O
.	O
<EOS>	B-X
Prenylated	B-X
proteins	B-X
with	B-X
non-native	B-X
functionalities	B-X
are	B-X
generally	B-X
very	B-X
difficult	B-X
to	B-X
obtain	B-X
by	B-X
recombinant	B-X
or	B-X
enzymatic	B-X
means	B-X
.	B-X
The	B-X
semisynthesis	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
guanosine	B-X
triphosphatases	B-X
(	B-X
GTPases	B-X
)	B-X
from	B-X
recombinant	B-X
proteins	B-X
and	B-X
synthetic	B-X
prenylated	B-X
peptides	B-X
depends	B-X
largely	B-X
on	B-X
the	B-X
availability	B-X
of	B-X
functionalised	B-X
prenylated	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
proteins	B-X
'	B-X
native	B-X
structure	B-X
or	B-X
modifications	B-X
thereof	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
and	B-X
compare	B-X
solution-phase	B-X
and	B-X
solid-phase	B-X
strategies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
prenylated	B-X
C	B-X
terminus	B-X
of	B-X
Rab7	B-X
GTPase	B-X
.	B-X
It	B-X
allows	B-X
a	B-X
fast	B-X
and	B-X
practical	B-X
synthesis	B-X
of	B-X
pure	B-X
peptides	B-X
and	B-X
gives	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
flexibility	B-X
in	B-X
their	B-X
modification	B-X
.	B-X
To	B-X
facilitate	B-X
the	B-X
analysis	B-X
of	B-X
semisynthetic	B-X
proteins	B-X
,	B-X
the	B-X
synthesised	B-X
peptides	B-X
were	B-X
equipped	B-X
with	B-X
a	B-X
fluorescent	B-X
group	B-X
.	B-X
Using	B-X
the	B-X
described	B-X
approach	B-X
,	B-X
we	B-X
introduced	B-X
fluorophores	B-X
at	B-X
several	B-X
different	B-X
positions	B-X
of	B-X
the	B-X
Rab7	B-X
C	B-X
terminus	B-X
.	B-X
The	B-X
position	B-X
of	B-X
the	B-X
incorporated	B-X
fluorescent	B-X
groups	B-X
in	B-X
the	B-X
peptides	B-X
did	B-X
not	B-X
influence	B-X
the	B-X
protein-ligation	B-X
reaction	B-X
,	B-X
as	B-X
the	B-X
generated	B-X
peptides	B-X
could	B-X
be	B-X
ligated	B-X
onto	B-X
thioester-tagged	B-X
Rab7	B-X
.	B-X
However	B-X
,	B-X
it	B-X
was	B-X
found	B-X
that	B-X
the	B-X
positioning	B-X
of	B-X
the	B-X
fluorescent	B-X
group	B-X
had	B-X
an	B-X
influence	B-X
on	B-X
the	B-X
functionality	B-X
of	B-X
the	B-X
Rab7	B-X
proteins	B-X
;	B-X
analysis	B-X
of	B-X
the	B-X
interaction	B-X
of	B-X
the	B-X
semisynthetic	B-X
Rab7	B-X
proteins	B-X
with	B-X
REP	B-X
(	B-X
Rab	B-X
escort	B-X
protein	B-X
)	B-X
and	B-X
GDI	B-X
(	B-X
guanosine	B-X
diphosphate	B-X
dissociation	B-X
inhibitor	B-X
)	B-X
molecules	B-X
revealed	B-X
that	B-X
modification	B-X
of	B-X
the	B-X
peptide	B-X
side	B-X
chains	B-X
or	B-X
of	B-X
the	B-X
C-terminal	B-X
isoprenoid	B-X
did	B-X
not	B-X
significantly	B-X
interfere	B-X
with	B-X
complex	B-X
formation	B-X
.	B-X
However	B-X
,	B-X
functionalisation	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
was	B-X
found	B-X
to	B-X
have	B-X
an	B-X
adverse	B-X
effect	B-X
on	B-X
complex	B-X
formation	B-X
and	B-X
stability	B-X
,	B-X
possibly	B-X
reflecting	B-X
low	B-X
structural	B-X
flexibility	B-X
of	B-X
the	B-X
Rab	B-X
GDI/REP	B-X
molecules	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
lipid-binding	B-X
site	B-X
.	B-X

However	O
,	O
functionalisation	O
of	O
the	O
C	O
terminus	O
was	O
found	O
to	O
have	O
an	O
adverse	O
effect	O
on	O
complex	O
formation	O
and	O
stability	O
,	O
possibly	O
reflecting	O
low	O
structural	O
flexibility	O
of	O
the	O
Rab	O
GDI	O
/	O
REP	O
molecules	O
in	O
the	O
vicinity	O
of	O
the	O
lipid	O
-	O
binding	O
site	O
.	O

Application	O
of	O
protein	O
semisynthesis	O
for	O
the	O
construction	O
of	O
functionalized	O
posttranslationally	O
modified	O
rab	O
GTPases	O
.	O
<EOS>	B-X
Rab	B-X
GTPases	B-X
represent	B-X
a	B-X
family	B-X
of	B-X
key	B-X
membrane	B-X
traffic	B-X
regulators	B-X
in	B-X
eukaryotic	B-X
cells	B-X
.	B-X
To	B-X
exert	B-X
their	B-X
function	B-X
,	B-X
Rab	B-X
proteins	B-X
must	B-X
be	B-X
modified	B-X
with	B-X
one	B-X
or	B-X
two	B-X
geranylgeranyl	B-X
moieties	B-X
.	B-X
In	B-X
vivo	B-X
the	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
are	B-X
recruited	B-X
by	B-X
Rab	B-X
escort	B-X
protein	B-X
(	B-X
REP	B-X
)	B-X
that	B-X
presents	B-X
them	B-X
to	B-X
the	B-X
Rab	B-X
geranylgeranyl	B-X
transferase	B-X
(	B-X
Rab	B-X
GGTase	B-X
)	B-X
,	B-X
which	B-X
transfers	B-X
one	B-X
or	B-X
two	B-X
geranylgeranyl	B-X
moieties	B-X
to	B-X
the	B-X
C-terminal	B-X
cysteines	B-X
.	B-X
Detailed	B-X
understanding	B-X
of	B-X
the	B-X
mechanism	B-X
of	B-X
prenylation	B-X
reaction	B-X
and	B-X
subsequent	B-X
membrane	B-X
delivery	B-X
of	B-X
Rab	B-X
proteins	B-X
to	B-X
the	B-X
target	B-X
membranes	B-X
were	B-X
hampered	B-X
by	B-X
lack	B-X
of	B-X
efficient	B-X
technologies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
GTPases	B-X
.	B-X
To	B-X
circumvent	B-X
this	B-X
problem	B-X
,	B-X
we	B-X
developed	B-X
an	B-X
approach	B-X
that	B-X
combines	B-X
recombinant	B-X
protein	B-X
production	B-X
,	B-X
chemical	B-X
synthesis	B-X
of	B-X
lipidated	B-X
peptides	B-X
with	B-X
precisely	B-X
designed	B-X
and	B-X
readily	B-X
alterable	B-X
structures	B-X
,	B-X
and	B-X
a	B-X
technique	B-X
for	B-X
peptide-to-protein	B-X
ligation	B-X
.	B-X
Using	B-X
this	B-X
approach	B-X
,	B-X
we	B-X
generated	B-X
a	B-X
number	B-X
of	B-X
semisynthetic	B-X
prenylated	B-X
Rab	B-X
GTPases	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
proteins	B-X
were	B-X
also	B-X
supplemented	B-X
with	B-X
fluorophores	B-X
,	B-X
which	B-X
enabled	B-X
us	B-X
to	B-X
develop	B-X
a	B-X
fluorescence-based	B-X
in	B-X
vitro	B-X
prenylation	B-X
assay	B-X
.	B-X
The	B-X
approach	B-X
described	B-X
allows	B-X
production	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
GTPases	B-X
,	B-X
which	B-X
was	B-X
demonstrated	B-X
by	B-X
generation	B-X
and	B-X
crystallization	B-X
of	B-X
a	B-X
monoprenylated	B-X
YPT1	B-X
:	B-X
Rab	B-X
GDI	B-X
complex	B-X
.	B-X

Rab	O
GTPases	O
represent	O
a	O
family	O
of	O
key	O
membrane	O
traffic	O
regulators	O
in	O
eukaryotic	O
cells	O
.	O
<EOS>	B-X
Rab/Ypt	B-X
guanosine	B-X
triphosphatases	B-X
(	B-X
GTPases	B-X
)	B-X
represent	B-X
a	B-X
family	B-X
of	B-X
key	B-X
membrane	B-X
traffic	B-X
regulators	B-X
in	B-X
eukaryotic	B-X
cells	B-X
.	B-X
For	B-X
their	B-X
function	B-X
Rab/Ypt	B-X
proteins	B-X
require	B-X
double	B-X
modification	B-X
with	B-X
two	B-X
covalently	B-X
bound	B-X
geranylgeranyl	B-X
lipid	B-X
moieties	B-X
at	B-X
the	B-X
C-terminus	B-X
.	B-X
We	B-X
generated	B-X
prenylated	B-X
RabGTPases	B-X
using	B-X
a	B-X
combination	B-X
of	B-X
chemical	B-X
synthesis	B-X
and	B-X
protein	B-X
engineering	B-X
.	B-X
We	B-X
developed	B-X
solution	B-X
phase	B-X
and	B-X
solid	B-X
phase	B-X
strategies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
peptides	B-X
corresponding	B-X
to	B-X
the	B-X
prenylated	B-X
C-terminus	B-X
of	B-X
Rab7	B-X
GTPase	B-X
in	B-X
preparative	B-X
amounts	B-X
enabling	B-X
us	B-X
to	B-X
crystallize	B-X
the	B-X
mono-prenylated	B-X
Ypt1	B-X
:	B-X
RabGDI	B-X
complex	B-X
.	B-X
The	B-X
structure	B-X
of	B-X
the	B-X
complex	B-X
provides	B-X
a	B-X
structural	B-X
basis	B-X
for	B-X
the	B-X
ability	B-X
of	B-X
RabGDI	B-X
to	B-X
inhibit	B-X
the	B-X
release	B-X
of	B-X
nucleotide	B-X
by	B-X
Rab	B-X
proteins	B-X
and	B-X
a	B-X
molecular	B-X
basis	B-X
for	B-X
understanding	B-X
a	B-X
RabGDI	B-X
mutant	B-X
that	B-X
causes	B-X
mental	B-X
retardation	B-X
in	B-X
humans	B-X
.	B-X

To	O
exert	O
their	O
function	O
,	O
Rab	O
proteins	O
must	O
be	O
modified	O
with	O
one	O
or	O
two	O
geranylgeranyl	O
moieties	O
.	O
<EOS>	B-X
(	B-X
Bacterio	B-X
)	B-X
chlorophylls	B-X
are	B-X
modified	B-X
tetrapyrroles	B-X
that	B-X
are	B-X
used	B-X
by	B-X
phototrophic	B-X
organisms	B-X
to	B-X
harvest	B-X
solar	B-X
energy	B-X
,	B-X
powering	B-X
the	B-X
metabolic	B-X
processes	B-X
that	B-X
sustain	B-X
most	B-X
of	B-X
the	B-X
life	B-X
on	B-X
Earth	B-X
.	B-X
(	B-X
Bacterio	B-X
)	B-X
chlorophylls	B-X
are	B-X
coordinated	B-X
by	B-X
proteins	B-X
that	B-X
form	B-X
macromolecular	B-X
assemblies	B-X
to	B-X
absorb	B-X
light	B-X
and	B-X
transfer	B-X
excitation	B-X
energy	B-X
to	B-X
a	B-X
special	B-X
pair	B-X
of	B-X
redox-active	B-X
(	B-X
bacterio	B-X
)	B-X
chlorophyll	B-X
molecules	B-X
in	B-X
the	B-X
photosynthetic	B-X
reaction	B-X
centre	B-X
.	B-X
The	B-X
reduction	B-X
of	B-X
the	B-X
isoprenoid	B-X
'tail	B-X
'	B-X
and	B-X
its	B-X
addition	B-X
to	B-X
the	B-X
macrocycle	B-X
are	B-X
the	B-X
final	B-X
stages	B-X
in	B-X
(	B-X
bacterio	B-X
)	B-X
chlorophyll	B-X
biosynthesis	B-X
and	B-X
are	B-X
catalysed	B-X
by	B-X
two	B-X
enzymes	B-X
,	B-X
geranylgeranyl	B-X
reductase	B-X
and	B-X
(	B-X
bacterio	B-X
)	B-X
chlorophyll	B-X
synthase	B-X
.	B-X
These	B-X
enzymes	B-X
work	B-X
in	B-X
conjunction	B-X
with	B-X
photosynthetic	B-X
complex	B-X
assembly	B-X
factors	B-X
and	B-X
the	B-X
membrane	B-X
biogenesis	B-X
machinery	B-X
to	B-X
synchronize	B-X
delivery	B-X
of	B-X
the	B-X
pigments	B-X
to	B-X
the	B-X
proteins	B-X
that	B-X
coordinate	B-X
them	B-X
.	B-X

This	O
modification	O
enables	O
them	O
to	O
reversibly	O
associate	O
with	O
intracellular	O
membranes	O
.	O
<EOS>	B-X
Geranylgeranylation	B-X
is	B-X
a	B-X
post-translational	B-X
modification	B-X
of	B-X
Rab	B-X
GTPases	B-X
that	B-X
enables	B-X
them	B-X
to	B-X
associate	B-X
reversibly	B-X
with	B-X
intracellular	B-X
membranes	B-X
.	B-X
Geranylgeranylation	B-X
of	B-X
Rab	B-X
proteins	B-X
is	B-X
critical	B-X
for	B-X
their	B-X
activity	B-X
in	B-X
controlling	B-X
intracellular	B-X
membrane	B-X
transport	B-X
.	B-X
This	B-X
modification	B-X
enables	B-X
them	B-X
to	B-X
reversibly	B-X
associate	B-X
with	B-X
intracellular	B-X
membranes	B-X
.	B-X
Detailed	B-X
understanding	B-X
of	B-X
the	B-X
mechanism	B-X
of	B-X
prenylation	B-X
reaction	B-X
and	B-X
subsequent	B-X
membrane	B-X
delivery	B-X
of	B-X
Rab	B-X
proteins	B-X
to	B-X
the	B-X
target	B-X
membranes	B-X
were	B-X
hampered	B-X
by	B-X
lack	B-X
of	B-X
efficient	B-X
technologies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
GTPases	B-X
.	B-X

In	O
vivo	O
the	O
newly	O
synthesized	O
Rab	O
proteins	O
are	O
recruited	O
by	O
Rab	O
escort	O
protein	O
(	O
REP	O
)	O
that	O
presents	O
them	O
to	O
the	O
Rab	O
geranylgeranyl	O
transferase	O
(	O
Rab	O
GGTase	O
)	O
,	O
which	O
transfers	O
one	O
or	O
two	O
geranylgeranyl	O
moieties	O
to	O
the	O
C	O
-	O
terminal	O
cysteines	O
.	O

Detailed	O
understanding	O
of	O
the	O
mechanism	O
of	O
prenylation	O
reaction	O
and	O
subsequent	O
membrane	O
delivery	O
of	O
Rab	O
proteins	O
to	O
the	O
target	O
membranes	O
were	O
hampered	O
by	O
lack	O
of	O
efficient	O
technologies	O
for	O
the	O
generation	O
of	O
preparative	O
amounts	O
of	O
prenylated	O
Rab	O
GTPases	O
.	O

To	O
circumvent	O
this	O
problem	O
,	O
we	O
developed	O
an	O
approach	O
that	O
combines	O
recombinant	O
protein	O
production	O
,	O
chemical	O
synthesis	O
of	O
lipidated	O
peptides	O
with	O
precisely	O
designed	O
and	O
readily	O
alterable	O
structures	O
,	O
and	O
a	O
technique	O
for	O
peptide	O
-	O
to	O
-	O
protein	O
ligation	O
.	O

Using	O
this	O
approach	O
,	O
we	O
generated	O
a	O
number	O
of	O
semisynthetic	O
prenylated	O
Rab	O
GTPases	O
.	O
<EOS>	B-X
Rab	B-X
GTPases	B-X
represent	B-X
a	B-X
family	B-X
of	B-X
key	B-X
membrane	B-X
traffic	B-X
regulators	B-X
in	B-X
eukaryotic	B-X
cells	B-X
.	B-X
To	B-X
exert	B-X
their	B-X
function	B-X
,	B-X
Rab	B-X
proteins	B-X
must	B-X
be	B-X
modified	B-X
with	B-X
one	B-X
or	B-X
two	B-X
geranylgeranyl	B-X
moieties	B-X
.	B-X
In	B-X
vivo	B-X
the	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
are	B-X
recruited	B-X
by	B-X
Rab	B-X
escort	B-X
protein	B-X
(	B-X
REP	B-X
)	B-X
that	B-X
presents	B-X
them	B-X
to	B-X
the	B-X
Rab	B-X
geranylgeranyl	B-X
transferase	B-X
(	B-X
Rab	B-X
GGTase	B-X
)	B-X
,	B-X
which	B-X
transfers	B-X
one	B-X
or	B-X
two	B-X
geranylgeranyl	B-X
moieties	B-X
to	B-X
the	B-X
C-terminal	B-X
cysteines	B-X
.	B-X
Detailed	B-X
understanding	B-X
of	B-X
the	B-X
mechanism	B-X
of	B-X
prenylation	B-X
reaction	B-X
and	B-X
subsequent	B-X
membrane	B-X
delivery	B-X
of	B-X
Rab	B-X
proteins	B-X
to	B-X
the	B-X
target	B-X
membranes	B-X
were	B-X
hampered	B-X
by	B-X
lack	B-X
of	B-X
efficient	B-X
technologies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
GTPases	B-X
.	B-X
To	B-X
circumvent	B-X
this	B-X
problem	B-X
,	B-X
we	B-X
developed	B-X
an	B-X
approach	B-X
that	B-X
combines	B-X
recombinant	B-X
protein	B-X
production	B-X
,	B-X
chemical	B-X
synthesis	B-X
of	B-X
lipidated	B-X
peptides	B-X
with	B-X
precisely	B-X
designed	B-X
and	B-X
readily	B-X
alterable	B-X
structures	B-X
,	B-X
and	B-X
a	B-X
technique	B-X
for	B-X
peptide-to-protein	B-X
ligation	B-X
.	B-X
Using	B-X
this	B-X
approach	B-X
,	B-X
we	B-X
generated	B-X
a	B-X
number	B-X
of	B-X
semisynthetic	B-X
prenylated	B-X
Rab	B-X
GTPases	B-X
.	B-X
The	B-X
approach	B-X
described	B-X
allows	B-X
production	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
GTPases	B-X
,	B-X
which	B-X
was	B-X
demonstrated	B-X
by	B-X
generation	B-X
and	B-X
crystallization	B-X
of	B-X
a	B-X
monoprenylated	B-X
YPT1	B-X
:	B-X
Rab	B-X
GDI	B-X
complex	B-X
.	B-X

Some	O
of	O
the	O
proteins	O
were	O
also	O
supplemented	O
with	O
fluorophores	O
,	O
which	O
enabled	O
us	O
to	O
develop	O
a	O
fluorescence	O
-	O
based	O
in	O
vitro	O
prenylation	O
assay	O
.	O
<EOS>	B-X
To	B-X
exert	B-X
their	B-X
function	B-X
,	B-X
Rab	B-X
proteins	B-X
must	B-X
be	B-X
modified	B-X
with	B-X
one	B-X
or	B-X
two	B-X
geranylgeranyl	B-X
moieties	B-X
.	B-X
In	B-X
vivo	B-X
the	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
are	B-X
recruited	B-X
by	B-X
Rab	B-X
escort	B-X
protein	B-X
(	B-X
REP	B-X
)	B-X
that	B-X
presents	B-X
them	B-X
to	B-X
the	B-X
Rab	B-X
geranylgeranyl	B-X
transferase	B-X
(	B-X
Rab	B-X
GGTase	B-X
)	B-X
,	B-X
which	B-X
transfers	B-X
one	B-X
or	B-X
two	B-X
geranylgeranyl	B-X
moieties	B-X
to	B-X
the	B-X
C-terminal	B-X
cysteines	B-X
.	B-X
Detailed	B-X
understanding	B-X
of	B-X
the	B-X
mechanism	B-X
of	B-X
prenylation	B-X
reaction	B-X
and	B-X
subsequent	B-X
membrane	B-X
delivery	B-X
of	B-X
Rab	B-X
proteins	B-X
to	B-X
the	B-X
target	B-X
membranes	B-X
were	B-X
hampered	B-X
by	B-X
lack	B-X
of	B-X
efficient	B-X
technologies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
GTPases	B-X
.	B-X
To	B-X
circumvent	B-X
this	B-X
problem	B-X
,	B-X
we	B-X
developed	B-X
an	B-X
approach	B-X
that	B-X
combines	B-X
recombinant	B-X
protein	B-X
production	B-X
,	B-X
chemical	B-X
synthesis	B-X
of	B-X
lipidated	B-X
peptides	B-X
with	B-X
precisely	B-X
designed	B-X
and	B-X
readily	B-X
alterable	B-X
structures	B-X
,	B-X
and	B-X
a	B-X
technique	B-X
for	B-X
peptide-to-protein	B-X
ligation	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
proteins	B-X
were	B-X
also	B-X
supplemented	B-X
with	B-X
fluorophores	B-X
,	B-X
which	B-X
enabled	B-X
us	B-X
to	B-X
develop	B-X
a	B-X
fluorescence-based	B-X
in	B-X
vitro	B-X
prenylation	B-X
assay	B-X
.	B-X

The	O
approach	O
described	O
allows	O
production	O
of	O
preparative	O
amounts	O
of	O
prenylated	O
GTPases	O
,	O
which	O
was	O
demonstrated	O
by	O
generation	O
and	O
crystallization	O
of	O
a	O
monoprenylated	O
YPT1	B-Protein
:	O
Rab	B-Protein
GDI	I-Protein
complex	O
.	O
<EOS>	B-X
Rab	B-X
GTPases	B-X
represent	B-X
a	B-X
family	B-X
of	B-X
key	B-X
membrane	B-X
traffic	B-X
regulators	B-X
in	B-X
eukaryotic	B-X
cells	B-X
.	B-X
To	B-X
exert	B-X
their	B-X
function	B-X
,	B-X
Rab	B-X
proteins	B-X
must	B-X
be	B-X
modified	B-X
with	B-X
one	B-X
or	B-X
two	B-X
geranylgeranyl	B-X
moieties	B-X
.	B-X
In	B-X
vivo	B-X
the	B-X
newly	B-X
synthesized	B-X
Rab	B-X
proteins	B-X
are	B-X
recruited	B-X
by	B-X
Rab	B-X
escort	B-X
protein	B-X
(	B-X
REP	B-X
)	B-X
that	B-X
presents	B-X
them	B-X
to	B-X
the	B-X
Rab	B-X
geranylgeranyl	B-X
transferase	B-X
(	B-X
Rab	B-X
GGTase	B-X
)	B-X
,	B-X
which	B-X
transfers	B-X
one	B-X
or	B-X
two	B-X
geranylgeranyl	B-X
moieties	B-X
to	B-X
the	B-X
C-terminal	B-X
cysteines	B-X
.	B-X
Detailed	B-X
understanding	B-X
of	B-X
the	B-X
mechanism	B-X
of	B-X
prenylation	B-X
reaction	B-X
and	B-X
subsequent	B-X
membrane	B-X
delivery	B-X
of	B-X
Rab	B-X
proteins	B-X
to	B-X
the	B-X
target	B-X
membranes	B-X
were	B-X
hampered	B-X
by	B-X
lack	B-X
of	B-X
efficient	B-X
technologies	B-X
for	B-X
the	B-X
generation	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
Rab	B-X
GTPases	B-X
.	B-X
To	B-X
circumvent	B-X
this	B-X
problem	B-X
,	B-X
we	B-X
developed	B-X
an	B-X
approach	B-X
that	B-X
combines	B-X
recombinant	B-X
protein	B-X
production	B-X
,	B-X
chemical	B-X
synthesis	B-X
of	B-X
lipidated	B-X
peptides	B-X
with	B-X
precisely	B-X
designed	B-X
and	B-X
readily	B-X
alterable	B-X
structures	B-X
,	B-X
and	B-X
a	B-X
technique	B-X
for	B-X
peptide-to-protein	B-X
ligation	B-X
.	B-X
Using	B-X
this	B-X
approach	B-X
,	B-X
we	B-X
generated	B-X
a	B-X
number	B-X
of	B-X
semisynthetic	B-X
prenylated	B-X
Rab	B-X
GTPases	B-X
.	B-X
The	B-X
approach	B-X
described	B-X
allows	B-X
production	B-X
of	B-X
preparative	B-X
amounts	B-X
of	B-X
prenylated	B-X
GTPases	B-X
,	B-X
which	B-X
was	B-X
demonstrated	B-X
by	B-X
generation	B-X
and	B-X
crystallization	B-X
of	B-X
a	B-X
monoprenylated	B-X
YPT1	B-X
:	B-X
Rab	B-X
GDI	B-X
complex	B-X
.	B-X

Simple	O
histone	B-Protein
acetylation	O
plays	O
a	O
complex	O
role	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
.	O

Eukaryotic	O
DNA	O
is	O
packaged	O
into	O
chromatin	O
by	O
histone	B-Protein
proteins	O
,	O
which	O
assemble	O
the	O
DNA	O
into	O
an	O
organized	O
,	O
higher	O
-	O
order	O
structure	O
.	O
<EOS>	B-X
DNA	B-X
in	B-X
higher	B-X
eukaryotes	B-X
is	B-X
packaged	B-X
with	B-X
histone	B-X
proteins	B-X
to	B-X
form	B-X
nucleosomes	B-X
which	B-X
are	B-X
further	B-X
assembled	B-X
into	B-X
higher-order	B-X
chromatin	B-X
fibres	B-X
to	B-X
protect	B-X
and	B-X
regulate	B-X
access	B-X
to	B-X
the	B-X
genetic	B-X
information	B-X
.	B-X
Chromatin	B-X
folding	B-X
above	B-X
the	B-X
nucleosomal	B-X
level	B-X
is	B-X
controversial	B-X
with	B-X
differing	B-X
views	B-X
proposing	B-X
unfolded	B-X
irregular	B-X
structures	B-X
through	B-X
to	B-X
highly	B-X
organised	B-X
chromatin	B-X
fibres	B-X
.	B-X
Using	B-X
a	B-X
combination	B-X
of	B-X
techniques	B-X
including	B-X
sedimentation	B-X
studies	B-X
,	B-X
electron	B-X
microscopy	B-X
and	B-X
superresolution	B-X
imaging	B-X
views	B-X
are	B-X
converging	B-X
to	B-X
indicate	B-X
that	B-X
local	B-X
chromatin	B-X
is	B-X
organised	B-X
into	B-X
a	B-X
fibre	B-X
,	B-X
peppered	B-X
with	B-X
numerous	B-X
discontinuities	B-X
and	B-X
points	B-X
of	B-X
flexibility	B-X
.	B-X
Reconciliation	B-X
of	B-X
different	B-X
views	B-X
suggests	B-X
that	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
data	B-X
are	B-X
generally	B-X
consistent	B-X
but	B-X
questions	B-X
remain	B-X
on	B-X
how	B-X
chromatin	B-X
packaging	B-X
is	B-X
altered	B-X
by	B-X
cellular	B-X
processes	B-X
such	B-X
as	B-X
transcription	B-X
,	B-X
enzymatic	B-X
chromatin	B-X
remodelling	B-X
and	B-X
elusive	B-X
DNA	B-X
supercoiling	B-X
.	B-X

The	O
precise	O
organization	O
of	O
chromatin	O
is	O
essential	O
for	O
faithful	O
execution	O
of	O
DNA	O
-	O
mediated	O
reactions	O
such	O
as	O
transcription	O
,	O
DNA	O
replication	O
,	O
DNA	O
repair	O
and	O
DNA	O
recombination	O
.	O
<EOS>	B-X
Eukaryotic	B-X
DNA	B-X
is	B-X
packaged	B-X
into	B-X
chromatin	B-X
by	B-X
histone	B-X
proteins	B-X
,	B-X
which	B-X
assemble	B-X
the	B-X
DNA	B-X
into	B-X
an	B-X
organized	B-X
,	B-X
higher-order	B-X
structure	B-X
.	B-X
The	B-X
precise	B-X
organization	B-X
of	B-X
chromatin	B-X
is	B-X
essential	B-X
for	B-X
faithful	B-X
execution	B-X
of	B-X
DNA-mediated	B-X
reactions	B-X
such	B-X
as	B-X
transcription	B-X
,	B-X
DNA	B-X
replication	B-X
,	B-X
DNA	B-X
repair	B-X
and	B-X
DNA	B-X
recombination	B-X
.	B-X
The	B-X
organization	B-X
of	B-X
chromatin	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
regulated	B-X
by	B-X
a	B-X
variety	B-X
of	B-X
post-translational	B-X
modifications	B-X
of	B-X
histones	B-X
,	B-X
such	B-X
as	B-X
acetylation	B-X
,	B-X
methylation	B-X
,	B-X
phosphorylation	B-X
,	B-X
ubiquitination	B-X
,	B-X
SUMOylation	B-X
and	B-X
poly-ADP-ribosylation	B-X
.	B-X
Since	B-X
then	B-X
,	B-X
a	B-X
great	B-X
deal	B-X
of	B-X
evidence	B-X
has	B-X
accumulated	B-X
showing	B-X
that	B-X
not	B-X
only	B-X
transcription	B-X
but	B-X
other	B-X
DNA-mediated	B-X
reactions	B-X
also	B-X
are	B-X
regulated	B-X
by	B-X
histone	B-X
acetylation	B-X
.	B-X
With	B-X
regard	B-X
to	B-X
the	B-X
putative	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
by	B-X
which	B-X
histone	B-X
acetylation	B-X
regulates	B-X
the	B-X
flow	B-X
of	B-X
genetic	B-X
information	B-X
,	B-X
site-specific	B-X
modification	B-X
and	B-X
recognition	B-X
of	B-X
acetylated	B-X
histone/DNA	B-X
complexes	B-X
have	B-X
been	B-X
postulated	B-X
.	B-X
Elucidation	B-X
of	B-X
the	B-X
downstream	B-X
effects	B-X
of	B-X
histone	B-X
modification	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
identification	B-X
,	B-X
isolation	B-X
and	B-X
characterization	B-X
of	B-X
the	B-X
relevant	B-X
factors	B-X
involved	B-X
,	B-X
have	B-X
aided	B-X
in	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DNA	B-X
activity	B-X
by	B-X
histones	B-X
.	B-X
Currently	B-X
,	B-X
state-of-the-art	B-X
technologies	B-X
that	B-X
enable	B-X
genome-wide	B-X
analysis	B-X
are	B-X
allowing	B-X
insight	B-X
into	B-X
a	B-X
critical	B-X
and	B-X
interesting	B-X
question	B-X
in	B-X
eukaryotic	B-X
transcription	B-X
:	B-X
are	B-X
the	B-X
principles	B-X
that	B-X
govern	B-X
transcription	B-X
of	B-X
individual	B-X
gene	B-X
loci	B-X
applicable	B-X
to	B-X
the	B-X
genome	B-X
as	B-X
a	B-X
whole	B-X
?	B-X

The	O
organization	O
of	O
chromatin	O
is	O
considered	O
to	O
be	O
regulated	O
by	O
a	O
variety	O
of	O
post	O
-	O
translational	O
modifications	O
of	O
histones	B-Protein
,	O
such	O
as	O
acetylation	O
,	O
methylation	O
,	O
phosphorylation	O
,	O
ubiquitination	O
,	O
SUMOylation	O
and	O
poly	O
-	O
ADP	O
-	O
ribosylation	O
.	O
<EOS>	B-X
Eukaryotic	B-X
DNA	B-X
is	B-X
packaged	B-X
into	B-X
chromatin	B-X
by	B-X
histone	B-X
proteins	B-X
,	B-X
which	B-X
assemble	B-X
the	B-X
DNA	B-X
into	B-X
an	B-X
organized	B-X
,	B-X
higher-order	B-X
structure	B-X
.	B-X
The	B-X
precise	B-X
organization	B-X
of	B-X
chromatin	B-X
is	B-X
essential	B-X
for	B-X
faithful	B-X
execution	B-X
of	B-X
DNA-mediated	B-X
reactions	B-X
such	B-X
as	B-X
transcription	B-X
,	B-X
DNA	B-X
replication	B-X
,	B-X
DNA	B-X
repair	B-X
and	B-X
DNA	B-X
recombination	B-X
.	B-X
The	B-X
organization	B-X
of	B-X
chromatin	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
regulated	B-X
by	B-X
a	B-X
variety	B-X
of	B-X
post-translational	B-X
modifications	B-X
of	B-X
histones	B-X
,	B-X
such	B-X
as	B-X
acetylation	B-X
,	B-X
methylation	B-X
,	B-X
phosphorylation	B-X
,	B-X
ubiquitination	B-X
,	B-X
SUMOylation	B-X
and	B-X
poly-ADP-ribosylation	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
histone	B-X
acetylation	B-X
and	B-X
gene	B-X
expression	B-X
was	B-X
first	B-X
observed	B-X
in	B-X
1964	B-X
.	B-X
Since	B-X
then	B-X
,	B-X
a	B-X
great	B-X
deal	B-X
of	B-X
evidence	B-X
has	B-X
accumulated	B-X
showing	B-X
that	B-X
not	B-X
only	B-X
transcription	B-X
but	B-X
other	B-X
DNA-mediated	B-X
reactions	B-X
also	B-X
are	B-X
regulated	B-X
by	B-X
histone	B-X
acetylation	B-X
.	B-X
With	B-X
regard	B-X
to	B-X
the	B-X
putative	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
by	B-X
which	B-X
histone	B-X
acetylation	B-X
regulates	B-X
the	B-X
flow	B-X
of	B-X
genetic	B-X
information	B-X
,	B-X
site-specific	B-X
modification	B-X
and	B-X
recognition	B-X
of	B-X
acetylated	B-X
histone/DNA	B-X
complexes	B-X
have	B-X
been	B-X
postulated	B-X
.	B-X
Elucidation	B-X
of	B-X
the	B-X
downstream	B-X
effects	B-X
of	B-X
histone	B-X
modification	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
identification	B-X
,	B-X
isolation	B-X
and	B-X
characterization	B-X
of	B-X
the	B-X
relevant	B-X
factors	B-X
involved	B-X
,	B-X
have	B-X
aided	B-X
in	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DNA	B-X
activity	B-X
by	B-X
histones	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
the	B-X
recent	B-X
progress	B-X
on	B-X
histone	B-X
modifications	B-X
,	B-X
with	B-X
an	B-X
emphasis	B-X
on	B-X
the	B-X
role	B-X
of	B-X
histone	B-X
acetylation	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X

The	O
relationship	O
between	O
histone	B-Protein
acetylation	O
and	O
gene	O
expression	O
was	O
first	O
observed	O
in	O
1964	O
.	O
<EOS>	B-X
Eukaryotic	B-X
DNA	B-X
is	B-X
packaged	B-X
into	B-X
chromatin	B-X
by	B-X
histone	B-X
proteins	B-X
,	B-X
which	B-X
assemble	B-X
the	B-X
DNA	B-X
into	B-X
an	B-X
organized	B-X
,	B-X
higher-order	B-X
structure	B-X
.	B-X
The	B-X
organization	B-X
of	B-X
chromatin	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
regulated	B-X
by	B-X
a	B-X
variety	B-X
of	B-X
post-translational	B-X
modifications	B-X
of	B-X
histones	B-X
,	B-X
such	B-X
as	B-X
acetylation	B-X
,	B-X
methylation	B-X
,	B-X
phosphorylation	B-X
,	B-X
ubiquitination	B-X
,	B-X
SUMOylation	B-X
and	B-X
poly-ADP-ribosylation	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
histone	B-X
acetylation	B-X
and	B-X
gene	B-X
expression	B-X
was	B-X
first	B-X
observed	B-X
in	B-X
1964	B-X
.	B-X
Since	B-X
then	B-X
,	B-X
a	B-X
great	B-X
deal	B-X
of	B-X
evidence	B-X
has	B-X
accumulated	B-X
showing	B-X
that	B-X
not	B-X
only	B-X
transcription	B-X
but	B-X
other	B-X
DNA-mediated	B-X
reactions	B-X
also	B-X
are	B-X
regulated	B-X
by	B-X
histone	B-X
acetylation	B-X
.	B-X
With	B-X
regard	B-X
to	B-X
the	B-X
putative	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
by	B-X
which	B-X
histone	B-X
acetylation	B-X
regulates	B-X
the	B-X
flow	B-X
of	B-X
genetic	B-X
information	B-X
,	B-X
site-specific	B-X
modification	B-X
and	B-X
recognition	B-X
of	B-X
acetylated	B-X
histone/DNA	B-X
complexes	B-X
have	B-X
been	B-X
postulated	B-X
.	B-X
Elucidation	B-X
of	B-X
the	B-X
downstream	B-X
effects	B-X
of	B-X
histone	B-X
modification	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
identification	B-X
,	B-X
isolation	B-X
and	B-X
characterization	B-X
of	B-X
the	B-X
relevant	B-X
factors	B-X
involved	B-X
,	B-X
have	B-X
aided	B-X
in	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DNA	B-X
activity	B-X
by	B-X
histones	B-X
.	B-X
Currently	B-X
,	B-X
state-of-the-art	B-X
technologies	B-X
that	B-X
enable	B-X
genome-wide	B-X
analysis	B-X
are	B-X
allowing	B-X
insight	B-X
into	B-X
a	B-X
critical	B-X
and	B-X
interesting	B-X
question	B-X
in	B-X
eukaryotic	B-X
transcription	B-X
:	B-X
are	B-X
the	B-X
principles	B-X
that	B-X
govern	B-X
transcription	B-X
of	B-X
individual	B-X
gene	B-X
loci	B-X
applicable	B-X
to	B-X
the	B-X
genome	B-X
as	B-X
a	B-X
whole	B-X
?	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
the	B-X
recent	B-X
progress	B-X
on	B-X
histone	B-X
modifications	B-X
,	B-X
with	B-X
an	B-X
emphasis	B-X
on	B-X
the	B-X
role	B-X
of	B-X
histone	B-X
acetylation	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X

Since	O
then	O
,	O
a	O
great	O
deal	O
of	O
evidence	O
has	O
accumulated	O
showing	O
that	O
not	O
only	O
transcription	O
but	O
other	O
DNA	O
-	O
mediated	O
reactions	O
also	O
are	O
regulated	O
by	O
histone	B-Protein
acetylation	O
.	O
<EOS>	B-X
A	B-X
great	B-X
deal	B-X
has	B-X
already	B-X
been	B-X
learned	B-X
from	B-X
the	B-X
analysis	B-X
of	B-X
beta	B-X
2m-mutant	B-X
mice	B-X
,	B-X
but	B-X
it	B-X
is	B-X
clear	B-X
that	B-X
a	B-X
great	B-X
deal	B-X
remains	B-X
to	B-X
be	B-X
learned	B-X
.	B-X
This	B-X
has	B-X
occurred	B-X
primarily	B-X
in	B-X
instances	B-X
in	B-X
which	B-X
the	B-X
class	B-X
I-deficient	B-X
mice	B-X
fail	B-X
to	B-X
express	B-X
an	B-X
expected	B-X
phenotype	B-X
--	B-X
for	B-X
example	B-X
,	B-X
in	B-X
studies	B-X
showing	B-X
that	B-X
beta	B-X
2m-	B-X
mice	B-X
make	B-X
adequate	B-X
protective	B-X
immune	B-X
responses	B-X
against	B-X
certain	B-X
intracellular	B-X
pathogens	B-X
,	B-X
and	B-X
are	B-X
able	B-X
to	B-X
reject	B-X
some	B-X
allogeneic	B-X
tissues	B-X
with	B-X
a	B-X
relatively	B-X
normal	B-X
pace	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
combining	B-X
the	B-X
use	B-X
of	B-X
beta	B-X
2m-	B-X
mice	B-X
with	B-X
other	B-X
methods	B-X
(	B-X
for	B-X
example	B-X
,	B-X
antibody-mediated	B-X
depletion	B-X
of	B-X
CD8+	B-X
T	B-X
cells	B-X
)	B-X
is	B-X
usually	B-X
adequate	B-X
to	B-X
circumvent	B-X
these	B-X
difficulties	B-X
.	B-X
It	B-X
remains	B-X
to	B-X
be	B-X
seen	B-X
whether	B-X
other	B-X
better	B-X
class	B-X
I	B-X
deficiencies	B-X
can	B-X
be	B-X
engineered	B-X
--	B-X
for	B-X
example	B-X
,	B-X
large	B-X
deletions	B-X
of	B-X
class	B-X
I	B-X
genes	B-X
or	B-X
mutations	B-X
in	B-X
transcription	B-X
factors	B-X
essential	B-X
for	B-X
class	B-X
I	B-X
gene	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
in	B-X
lieu	B-X
of	B-X
one	B-X
major	B-X
arm	B-X
of	B-X
the	B-X
immune	B-X
system	B-X
,	B-X
compensatory	B-X
immune	B-X
mechanisms	B-X
are	B-X
in	B-X
many	B-X
cases	B-X
able	B-X
to	B-X
deal	B-X
with	B-X
infection	B-X
.	B-X
Nevertheless	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
a	B-X
very	B-X
important	B-X
role	B-X
for	B-X
class	B-X
I-directed	B-X
responses	B-X
in	B-X
clearing	B-X
infections	B-X
mediated	B-X
by	B-X
various	B-X
viral	B-X
and	B-X
parasitic	B-X
agents	B-X
,	B-X
particularly	B-X
in	B-X
the	B-X
case	B-X
of	B-X
more	B-X
severe	B-X
conditions	B-X
of	B-X
infection	B-X
.	B-X
Although	B-X
the	B-X
class	B-X
I-deficient	B-X
mice	B-X
were	B-X
initially	B-X
considered	B-X
primarily	B-X
a	B-X
vehicle	B-X
for	B-X
analysis	B-X
of	B-X
the	B-X
role	B-X
of	B-X
CD8+	B-X
T	B-X
cells	B-X
,	B-X
evidence	B-X
is	B-X
accumulating	B-X
that	B-X
they	B-X
manifest	B-X
deficiencies	B-X
in	B-X
several	B-X
other	B-X
types	B-X
of	B-X
lymphocytes	B-X
,	B-X
including	B-X
NK	B-X
cells	B-X
,	B-X
TCR	B-X
alpha	B-X
beta+CD4-CD8-	B-X
cells	B-X
,	B-X
and	B-X
a	B-X
subset	B-X
of	B-X
TCR	B-X
gamma	B-X
delta+	B-X
cells	B-X
.	B-X

With	O
regard	O
to	O
the	O
putative	O
mechanism	O
(	O
s	O
)	O
by	O
which	O
histone	B-Protein
acetylation	O
regulates	O
the	O
flow	O
of	O
genetic	O
information	O
,	O
site	O
-	O
specific	O
modification	O
and	O
recognition	O
of	O
acetylated	O
histone	B-Protein
/	O
DNA	O
complexes	O
have	O
been	O
postulated	O
.	O

Elucidation	O
of	O
the	O
downstream	O
effects	O
of	O
histone	B-Protein
modification	O
,	O
as	O
well	O
as	O
the	O
identification	O
,	O
isolation	O
and	O
characterization	O
of	O
the	O
relevant	O
factors	O
involved	O
,	O
have	O
aided	O
in	O
our	O
understanding	O
of	O
the	O
mechanisms	O
of	O
regulation	O
of	O
DNA	O
activity	O
by	O
histones	B-Protein
.	O
<EOS>	B-X
Eukaryotic	B-X
DNA	B-X
is	B-X
packaged	B-X
into	B-X
chromatin	B-X
by	B-X
histone	B-X
proteins	B-X
,	B-X
which	B-X
assemble	B-X
the	B-X
DNA	B-X
into	B-X
an	B-X
organized	B-X
,	B-X
higher-order	B-X
structure	B-X
.	B-X
The	B-X
precise	B-X
organization	B-X
of	B-X
chromatin	B-X
is	B-X
essential	B-X
for	B-X
faithful	B-X
execution	B-X
of	B-X
DNA-mediated	B-X
reactions	B-X
such	B-X
as	B-X
transcription	B-X
,	B-X
DNA	B-X
replication	B-X
,	B-X
DNA	B-X
repair	B-X
and	B-X
DNA	B-X
recombination	B-X
.	B-X
The	B-X
organization	B-X
of	B-X
chromatin	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
regulated	B-X
by	B-X
a	B-X
variety	B-X
of	B-X
post-translational	B-X
modifications	B-X
of	B-X
histones	B-X
,	B-X
such	B-X
as	B-X
acetylation	B-X
,	B-X
methylation	B-X
,	B-X
phosphorylation	B-X
,	B-X
ubiquitination	B-X
,	B-X
SUMOylation	B-X
and	B-X
poly-ADP-ribosylation	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
histone	B-X
acetylation	B-X
and	B-X
gene	B-X
expression	B-X
was	B-X
first	B-X
observed	B-X
in	B-X
1964	B-X
.	B-X
Since	B-X
then	B-X
,	B-X
a	B-X
great	B-X
deal	B-X
of	B-X
evidence	B-X
has	B-X
accumulated	B-X
showing	B-X
that	B-X
not	B-X
only	B-X
transcription	B-X
but	B-X
other	B-X
DNA-mediated	B-X
reactions	B-X
also	B-X
are	B-X
regulated	B-X
by	B-X
histone	B-X
acetylation	B-X
.	B-X
With	B-X
regard	B-X
to	B-X
the	B-X
putative	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
by	B-X
which	B-X
histone	B-X
acetylation	B-X
regulates	B-X
the	B-X
flow	B-X
of	B-X
genetic	B-X
information	B-X
,	B-X
site-specific	B-X
modification	B-X
and	B-X
recognition	B-X
of	B-X
acetylated	B-X
histone/DNA	B-X
complexes	B-X
have	B-X
been	B-X
postulated	B-X
.	B-X
Elucidation	B-X
of	B-X
the	B-X
downstream	B-X
effects	B-X
of	B-X
histone	B-X
modification	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
identification	B-X
,	B-X
isolation	B-X
and	B-X
characterization	B-X
of	B-X
the	B-X
relevant	B-X
factors	B-X
involved	B-X
,	B-X
have	B-X
aided	B-X
in	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DNA	B-X
activity	B-X
by	B-X
histones	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
the	B-X
recent	B-X
progress	B-X
on	B-X
histone	B-X
modifications	B-X
,	B-X
with	B-X
an	B-X
emphasis	B-X
on	B-X
the	B-X
role	B-X
of	B-X
histone	B-X
acetylation	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X

Currently	O
,	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
technologies	O
that	O
enable	O
genome	O
-	O
wide	O
analysis	O
are	O
allowing	O
insight	O
into	O
a	O
critical	O
and	O
interesting	O
question	O
in	O
eukaryotic	O
transcription	O
:	O
are	O
the	O
principles	O
that	O
govern	O
transcription	O
of	O
individual	O
gene	O
loci	O
applicable	O
to	O
the	O
genome	O
as	O
a	O
whole	O
?	O

Here	O
,	O
we	O
review	O
the	O
recent	O
progress	O
on	O
histone	B-Protein
modifications	O
,	O
with	O
an	O
emphasis	O
on	O
the	O
role	O
of	O
histone	B-Protein
acetylation	O
in	O
gene	O
expression	O
.	O
<EOS>	B-X
Eukaryotic	B-X
DNA	B-X
is	B-X
packaged	B-X
into	B-X
chromatin	B-X
by	B-X
histone	B-X
proteins	B-X
,	B-X
which	B-X
assemble	B-X
the	B-X
DNA	B-X
into	B-X
an	B-X
organized	B-X
,	B-X
higher-order	B-X
structure	B-X
.	B-X
The	B-X
organization	B-X
of	B-X
chromatin	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
regulated	B-X
by	B-X
a	B-X
variety	B-X
of	B-X
post-translational	B-X
modifications	B-X
of	B-X
histones	B-X
,	B-X
such	B-X
as	B-X
acetylation	B-X
,	B-X
methylation	B-X
,	B-X
phosphorylation	B-X
,	B-X
ubiquitination	B-X
,	B-X
SUMOylation	B-X
and	B-X
poly-ADP-ribosylation	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
histone	B-X
acetylation	B-X
and	B-X
gene	B-X
expression	B-X
was	B-X
first	B-X
observed	B-X
in	B-X
1964	B-X
.	B-X
Since	B-X
then	B-X
,	B-X
a	B-X
great	B-X
deal	B-X
of	B-X
evidence	B-X
has	B-X
accumulated	B-X
showing	B-X
that	B-X
not	B-X
only	B-X
transcription	B-X
but	B-X
other	B-X
DNA-mediated	B-X
reactions	B-X
also	B-X
are	B-X
regulated	B-X
by	B-X
histone	B-X
acetylation	B-X
.	B-X
With	B-X
regard	B-X
to	B-X
the	B-X
putative	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
by	B-X
which	B-X
histone	B-X
acetylation	B-X
regulates	B-X
the	B-X
flow	B-X
of	B-X
genetic	B-X
information	B-X
,	B-X
site-specific	B-X
modification	B-X
and	B-X
recognition	B-X
of	B-X
acetylated	B-X
histone/DNA	B-X
complexes	B-X
have	B-X
been	B-X
postulated	B-X
.	B-X
Elucidation	B-X
of	B-X
the	B-X
downstream	B-X
effects	B-X
of	B-X
histone	B-X
modification	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
identification	B-X
,	B-X
isolation	B-X
and	B-X
characterization	B-X
of	B-X
the	B-X
relevant	B-X
factors	B-X
involved	B-X
,	B-X
have	B-X
aided	B-X
in	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DNA	B-X
activity	B-X
by	B-X
histones	B-X
.	B-X
Currently	B-X
,	B-X
state-of-the-art	B-X
technologies	B-X
that	B-X
enable	B-X
genome-wide	B-X
analysis	B-X
are	B-X
allowing	B-X
insight	B-X
into	B-X
a	B-X
critical	B-X
and	B-X
interesting	B-X
question	B-X
in	B-X
eukaryotic	B-X
transcription	B-X
:	B-X
are	B-X
the	B-X
principles	B-X
that	B-X
govern	B-X
transcription	B-X
of	B-X
individual	B-X
gene	B-X
loci	B-X
applicable	B-X
to	B-X
the	B-X
genome	B-X
as	B-X
a	B-X
whole	B-X
?	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
the	B-X
recent	B-X
progress	B-X
on	B-X
histone	B-X
modifications	B-X
,	B-X
with	B-X
an	B-X
emphasis	B-X
on	B-X
the	B-X
role	B-X
of	B-X
histone	B-X
acetylation	B-X
in	B-X
gene	B-X
expression	B-X
.	B-X

PIAS3	B-Protein
induction	O
of	O
PRB	B-Protein
sumoylation	O
represses	O
PRB	B-Protein
transactivation	O
by	O
destabilizing	O
its	O
retention	O
in	O
the	O
nucleus	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
progesterone	B-X
,	B-X
protein	B-X
inhibitor	B-X
of	B-X
activated	B-X
STAT-3	B-X
(	B-X
PIAS3	B-X
)	B-X
significantly	B-X
inhibited	B-X
the	B-X
PR	B-X
transcriptional	B-X
activity	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
progesterone-responsive	B-X
genes	B-X
.	B-X
Reduction	B-X
of	B-X
endogenous	B-X
PIAS3	B-X
by	B-X
PIAS3	B-X
small-interfering	B-X
RNA	B-X
enhanced	B-X
PR	B-X
transactivation	B-X
in	B-X
a	B-X
ligand-dependent	B-X
manner	B-X
.	B-X
PIAS3	B-X
interacted	B-X
with	B-X
PR	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
and	B-X
the	B-X
interaction	B-X
was	B-X
enhanced	B-X
by	B-X
progesterone	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
suggested	B-X
that	B-X
PIAS3	B-X
strongly	B-X
induced	B-X
PRB	B-X
sumoylation	B-X
at	B-X
three	B-X
sites	B-X
,	B-X
Lys-7	B-X
,	B-X
Lys-388	B-X
and	B-X
Lys-531	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
novel	B-X
roles	B-X
in	B-X
PRB	B-X
nuclear	B-X
retention	B-X
and	B-X
transactivation	B-X
were	B-X
identified	B-X
for	B-X
these	B-X
sites	B-X
.	B-X
Our	B-X
data	B-X
also	B-X
suggested	B-X
that	B-X
PIAS3	B-X
was	B-X
recruited	B-X
in	B-X
a	B-X
largely	B-X
hormone-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
a	B-X
progesterone-responsive	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
PIAS3	B-X
inhibited	B-X
the	B-X
DNA-binding	B-X
activity	B-X
of	B-X
PR	B-X
and	B-X
influenced	B-X
its	B-X
nuclear	B-X
export	B-X
as	B-X
well	B-X
as	B-X
PR	B-X
transactivation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
strongly	B-X
suggested	B-X
that	B-X
PIAS3	B-X
played	B-X
an	B-X
important	B-X
physiological	B-X
role	B-X
in	B-X
PR	B-X
function	B-X
.	B-X

Progesterone	B-Protein
receptor	I-Protein
(	O
PR	B-Protein
)	O
plays	O
a	O
critical	O
role	O
in	O
cell	O
proliferation	O
and	O
differentiation	O
,	O
and	O
its	O
transcriptional	O
activity	O
is	O
known	O
to	O
be	O
modulated	O
by	O
cofactor	O
proteins	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrated	O
that	O
in	O
the	O
presence	O
of	O
progesterone	O
,	O
protein	B-Protein
inhibitor	I-Protein
of	I-Protein
activated	I-Protein
STAT	I-Protein
-	I-Protein
3	I-Protein
(	O
PIAS3	B-Protein
)	O
significantly	O
inhibited	O
the	O
PR	B-Protein
transcriptional	O
activity	O
and	O
the	O
expression	O
of	O
progesterone	O
-	O
responsive	O
genes	O
.	O
<EOS>	B-X
Progesterone	B-X
receptor	B-X
(	B-X
PR	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
cell	B-X
proliferation	B-X
and	B-X
differentiation	B-X
,	B-X
and	B-X
its	B-X
transcriptional	B-X
activity	B-X
is	B-X
known	B-X
to	B-X
be	B-X
modulated	B-X
by	B-X
cofactor	B-X
proteins	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
progesterone	B-X
,	B-X
protein	B-X
inhibitor	B-X
of	B-X
activated	B-X
STAT-3	B-X
(	B-X
PIAS3	B-X
)	B-X
significantly	B-X
inhibited	B-X
the	B-X
PR	B-X
transcriptional	B-X
activity	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
progesterone-responsive	B-X
genes	B-X
.	B-X
Reduction	B-X
of	B-X
endogenous	B-X
PIAS3	B-X
by	B-X
PIAS3	B-X
small-interfering	B-X
RNA	B-X
enhanced	B-X
PR	B-X
transactivation	B-X
in	B-X
a	B-X
ligand-dependent	B-X
manner	B-X
.	B-X
PIAS3	B-X
interacted	B-X
with	B-X
PR	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
and	B-X
the	B-X
interaction	B-X
was	B-X
enhanced	B-X
by	B-X
progesterone	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
suggested	B-X
that	B-X
PIAS3	B-X
strongly	B-X
induced	B-X
PRB	B-X
sumoylation	B-X
at	B-X
three	B-X
sites	B-X
,	B-X
Lys-7	B-X
,	B-X
Lys-388	B-X
and	B-X
Lys-531	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
novel	B-X
roles	B-X
in	B-X
PRB	B-X
nuclear	B-X
retention	B-X
and	B-X
transactivation	B-X
were	B-X
identified	B-X
for	B-X
these	B-X
sites	B-X
.	B-X
Our	B-X
data	B-X
also	B-X
suggested	B-X
that	B-X
PIAS3	B-X
was	B-X
recruited	B-X
in	B-X
a	B-X
largely	B-X
hormone-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
a	B-X
progesterone-responsive	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
PIAS3	B-X
inhibited	B-X
the	B-X
DNA-binding	B-X
activity	B-X
of	B-X
PR	B-X
and	B-X
influenced	B-X
its	B-X
nuclear	B-X
export	B-X
as	B-X
well	B-X
as	B-X
PR	B-X
transactivation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
strongly	B-X
suggested	B-X
that	B-X
PIAS3	B-X
played	B-X
an	B-X
important	B-X
physiological	B-X
role	B-X
in	B-X
PR	B-X
function	B-X
.	B-X

Reduction	O
of	O
endogenous	O
PIAS3	B-Protein
by	O
PIAS3	B-Protein
small	O
-	O
interfering	O
RNA	O
enhanced	O
PR	B-Protein
transactivation	O
in	O
a	O
ligand	O
-	O
dependent	O
manner	O
.	O

PIAS3	B-Protein
interacted	O
with	O
PR	B-Protein
both	O
in	O
vitro	O
and	O
in	O
vivo	O
and	O
the	O
interaction	O
was	O
enhanced	O
by	O
progesterone	O
.	O
<EOS>	B-X
Progesterone	B-X
receptor	B-X
(	B-X
PR	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
cell	B-X
proliferation	B-X
and	B-X
differentiation	B-X
,	B-X
and	B-X
its	B-X
transcriptional	B-X
activity	B-X
is	B-X
known	B-X
to	B-X
be	B-X
modulated	B-X
by	B-X
cofactor	B-X
proteins	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
progesterone	B-X
,	B-X
protein	B-X
inhibitor	B-X
of	B-X
activated	B-X
STAT-3	B-X
(	B-X
PIAS3	B-X
)	B-X
significantly	B-X
inhibited	B-X
the	B-X
PR	B-X
transcriptional	B-X
activity	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
progesterone-responsive	B-X
genes	B-X
.	B-X
Reduction	B-X
of	B-X
endogenous	B-X
PIAS3	B-X
by	B-X
PIAS3	B-X
small-interfering	B-X
RNA	B-X
enhanced	B-X
PR	B-X
transactivation	B-X
in	B-X
a	B-X
ligand-dependent	B-X
manner	B-X
.	B-X
PIAS3	B-X
interacted	B-X
with	B-X
PR	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
and	B-X
the	B-X
interaction	B-X
was	B-X
enhanced	B-X
by	B-X
progesterone	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
suggested	B-X
that	B-X
PIAS3	B-X
strongly	B-X
induced	B-X
PRB	B-X
sumoylation	B-X
at	B-X
three	B-X
sites	B-X
,	B-X
Lys-7	B-X
,	B-X
Lys-388	B-X
and	B-X
Lys-531	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
novel	B-X
roles	B-X
in	B-X
PRB	B-X
nuclear	B-X
retention	B-X
and	B-X
transactivation	B-X
were	B-X
identified	B-X
for	B-X
these	B-X
sites	B-X
.	B-X
Our	B-X
data	B-X
also	B-X
suggested	B-X
that	B-X
PIAS3	B-X
was	B-X
recruited	B-X
in	B-X
a	B-X
largely	B-X
hormone-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
a	B-X
progesterone-responsive	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
PIAS3	B-X
inhibited	B-X
the	B-X
DNA-binding	B-X
activity	B-X
of	B-X
PR	B-X
and	B-X
influenced	B-X
its	B-X
nuclear	B-X
export	B-X
as	B-X
well	B-X
as	B-X
PR	B-X
transactivation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
strongly	B-X
suggested	B-X
that	B-X
PIAS3	B-X
played	B-X
an	B-X
important	B-X
physiological	B-X
role	B-X
in	B-X
PR	B-X
function	B-X
.	B-X

Furthermore	O
,	O
our	O
findings	O
suggested	O
that	O
PIAS3	B-Protein
strongly	O
induced	O
PRB	B-Protein
sumoylation	O
at	O
three	O
sites	O
,	O
Lys	O
-	O
7	O
,	O
Lys	O
-	O
388	O
and	O
Lys	O
-	O
531	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
progesterone	B-X
,	B-X
protein	B-X
inhibitor	B-X
of	B-X
activated	B-X
STAT-3	B-X
(	B-X
PIAS3	B-X
)	B-X
significantly	B-X
inhibited	B-X
the	B-X
PR	B-X
transcriptional	B-X
activity	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
progesterone-responsive	B-X
genes	B-X
.	B-X
Reduction	B-X
of	B-X
endogenous	B-X
PIAS3	B-X
by	B-X
PIAS3	B-X
small-interfering	B-X
RNA	B-X
enhanced	B-X
PR	B-X
transactivation	B-X
in	B-X
a	B-X
ligand-dependent	B-X
manner	B-X
.	B-X
PIAS3	B-X
interacted	B-X
with	B-X
PR	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
and	B-X
the	B-X
interaction	B-X
was	B-X
enhanced	B-X
by	B-X
progesterone	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
suggested	B-X
that	B-X
PIAS3	B-X
strongly	B-X
induced	B-X
PRB	B-X
sumoylation	B-X
at	B-X
three	B-X
sites	B-X
,	B-X
Lys-7	B-X
,	B-X
Lys-388	B-X
and	B-X
Lys-531	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
novel	B-X
roles	B-X
in	B-X
PRB	B-X
nuclear	B-X
retention	B-X
and	B-X
transactivation	B-X
were	B-X
identified	B-X
for	B-X
these	B-X
sites	B-X
.	B-X
Our	B-X
data	B-X
also	B-X
suggested	B-X
that	B-X
PIAS3	B-X
was	B-X
recruited	B-X
in	B-X
a	B-X
largely	B-X
hormone-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
a	B-X
progesterone-responsive	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
PIAS3	B-X
inhibited	B-X
the	B-X
DNA-binding	B-X
activity	B-X
of	B-X
PR	B-X
and	B-X
influenced	B-X
its	B-X
nuclear	B-X
export	B-X
as	B-X
well	B-X
as	B-X
PR	B-X
transactivation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
strongly	B-X
suggested	B-X
that	B-X
PIAS3	B-X
played	B-X
an	B-X
important	B-X
physiological	B-X
role	B-X
in	B-X
PR	B-X
function	B-X
.	B-X

In	O
addition	O
,	O
novel	O
roles	O
in	O
PRB	B-Protein
nuclear	O
retention	O
and	O
transactivation	O
were	O
identified	O
for	O
these	O
sites	O
.	O
<EOS>	B-X
Reduction	B-X
of	B-X
endogenous	B-X
PIAS3	B-X
by	B-X
PIAS3	B-X
small-interfering	B-X
RNA	B-X
enhanced	B-X
PR	B-X
transactivation	B-X
in	B-X
a	B-X
ligand-dependent	B-X
manner	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
suggested	B-X
that	B-X
PIAS3	B-X
strongly	B-X
induced	B-X
PRB	B-X
sumoylation	B-X
at	B-X
three	B-X
sites	B-X
,	B-X
Lys-7	B-X
,	B-X
Lys-388	B-X
and	B-X
Lys-531	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
novel	B-X
roles	B-X
in	B-X
PRB	B-X
nuclear	B-X
retention	B-X
and	B-X
transactivation	B-X
were	B-X
identified	B-X
for	B-X
these	B-X
sites	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
PIAS3	B-X
inhibited	B-X
the	B-X
DNA-binding	B-X
activity	B-X
of	B-X
PR	B-X
and	B-X
influenced	B-X
its	B-X
nuclear	B-X
export	B-X
as	B-X
well	B-X
as	B-X
PR	B-X
transactivation	B-X
.	B-X

Our	O
data	O
also	O
suggested	O
that	O
PIAS3	B-Protein
was	O
recruited	O
in	O
a	O
largely	O
hormone	O
-	O
dependent	O
manner	O
in	O
response	O
to	O
a	O
progesterone	O
-	O
responsive	O
promoter	O
.	O

Finally	O
,	O
we	O
demonstrated	O
that	O
PIAS3	B-Protein
inhibited	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
PR	B-Protein
and	O
influenced	O
its	O
nuclear	O
export	O
as	O
well	O
as	O
PR	B-Protein
transactivation	O
.	O
<EOS>	B-X
Progesterone	B-X
receptor	B-X
(	B-X
PR	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
cell	B-X
proliferation	B-X
and	B-X
differentiation	B-X
,	B-X
and	B-X
its	B-X
transcriptional	B-X
activity	B-X
is	B-X
known	B-X
to	B-X
be	B-X
modulated	B-X
by	B-X
cofactor	B-X
proteins	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
progesterone	B-X
,	B-X
protein	B-X
inhibitor	B-X
of	B-X
activated	B-X
STAT-3	B-X
(	B-X
PIAS3	B-X
)	B-X
significantly	B-X
inhibited	B-X
the	B-X
PR	B-X
transcriptional	B-X
activity	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
progesterone-responsive	B-X
genes	B-X
.	B-X
Reduction	B-X
of	B-X
endogenous	B-X
PIAS3	B-X
by	B-X
PIAS3	B-X
small-interfering	B-X
RNA	B-X
enhanced	B-X
PR	B-X
transactivation	B-X
in	B-X
a	B-X
ligand-dependent	B-X
manner	B-X
.	B-X
PIAS3	B-X
interacted	B-X
with	B-X
PR	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
and	B-X
the	B-X
interaction	B-X
was	B-X
enhanced	B-X
by	B-X
progesterone	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
suggested	B-X
that	B-X
PIAS3	B-X
strongly	B-X
induced	B-X
PRB	B-X
sumoylation	B-X
at	B-X
three	B-X
sites	B-X
,	B-X
Lys-7	B-X
,	B-X
Lys-388	B-X
and	B-X
Lys-531	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
novel	B-X
roles	B-X
in	B-X
PRB	B-X
nuclear	B-X
retention	B-X
and	B-X
transactivation	B-X
were	B-X
identified	B-X
for	B-X
these	B-X
sites	B-X
.	B-X
Our	B-X
data	B-X
also	B-X
suggested	B-X
that	B-X
PIAS3	B-X
was	B-X
recruited	B-X
in	B-X
a	B-X
largely	B-X
hormone-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
a	B-X
progesterone-responsive	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
PIAS3	B-X
inhibited	B-X
the	B-X
DNA-binding	B-X
activity	B-X
of	B-X
PR	B-X
and	B-X
influenced	B-X
its	B-X
nuclear	B-X
export	B-X
as	B-X
well	B-X
as	B-X
PR	B-X
transactivation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
strongly	B-X
suggested	B-X
that	B-X
PIAS3	B-X
played	B-X
an	B-X
important	B-X
physiological	B-X
role	B-X
in	B-X
PR	B-X
function	B-X
.	B-X

Taken	O
together	O
,	O
these	O
data	O
strongly	O
suggested	O
that	O
PIAS3	B-Protein
played	O
an	O
important	O
physiological	O
role	O
in	O
PR	B-Protein
function	O
.	O
<EOS>	B-X
Progesterone	B-X
receptor	B-X
(	B-X
PR	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
cell	B-X
proliferation	B-X
and	B-X
differentiation	B-X
,	B-X
and	B-X
its	B-X
transcriptional	B-X
activity	B-X
is	B-X
known	B-X
to	B-X
be	B-X
modulated	B-X
by	B-X
cofactor	B-X
proteins	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
progesterone	B-X
,	B-X
protein	B-X
inhibitor	B-X
of	B-X
activated	B-X
STAT-3	B-X
(	B-X
PIAS3	B-X
)	B-X
significantly	B-X
inhibited	B-X
the	B-X
PR	B-X
transcriptional	B-X
activity	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
progesterone-responsive	B-X
genes	B-X
.	B-X
Reduction	B-X
of	B-X
endogenous	B-X
PIAS3	B-X
by	B-X
PIAS3	B-X
small-interfering	B-X
RNA	B-X
enhanced	B-X
PR	B-X
transactivation	B-X
in	B-X
a	B-X
ligand-dependent	B-X
manner	B-X
.	B-X
PIAS3	B-X
interacted	B-X
with	B-X
PR	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
and	B-X
the	B-X
interaction	B-X
was	B-X
enhanced	B-X
by	B-X
progesterone	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
suggested	B-X
that	B-X
PIAS3	B-X
strongly	B-X
induced	B-X
PRB	B-X
sumoylation	B-X
at	B-X
three	B-X
sites	B-X
,	B-X
Lys-7	B-X
,	B-X
Lys-388	B-X
and	B-X
Lys-531	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
novel	B-X
roles	B-X
in	B-X
PRB	B-X
nuclear	B-X
retention	B-X
and	B-X
transactivation	B-X
were	B-X
identified	B-X
for	B-X
these	B-X
sites	B-X
.	B-X
Our	B-X
data	B-X
also	B-X
suggested	B-X
that	B-X
PIAS3	B-X
was	B-X
recruited	B-X
in	B-X
a	B-X
largely	B-X
hormone-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
a	B-X
progesterone-responsive	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
PIAS3	B-X
inhibited	B-X
the	B-X
DNA-binding	B-X
activity	B-X
of	B-X
PR	B-X
and	B-X
influenced	B-X
its	B-X
nuclear	B-X
export	B-X
as	B-X
well	B-X
as	B-X
PR	B-X
transactivation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
strongly	B-X
suggested	B-X
that	B-X
PIAS3	B-X
played	B-X
an	B-X
important	B-X
physiological	B-X
role	B-X
in	B-X
PR	B-X
function	B-X
.	B-X

Herpes	O
simplex	O
virus	O
protein	O
UL11	B-Protein
but	O
not	O
UL51	B-Protein
is	O
associated	O
with	O
lipid	O
rafts	O
.	O
<EOS>	B-X
Earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
the	B-X
UL11	B-X
gene	B-X
of	B-X
herpes	B-X
simplex	B-X
virus	B-X
encodes	B-X
a	B-X
myristylated	B-X
virion	B-X
protein	B-X
and	B-X
that	B-X
the	B-X
UL11	B-X
gene	B-X
enables	B-X
efficient	B-X
virion	B-X
envelopment	B-X
and	B-X
export	B-X
from	B-X
infected	B-X
cells	B-X
.	B-X
A	B-X
rabbit	B-X
polyclonal	B-X
antibody	B-X
directed	B-X
against	B-X
an	B-X
affinity-purified	B-X
UL11-glutathione-S-transferase	B-X
fusion	B-X
protein	B-X
was	B-X
made	B-X
and	B-X
used	B-X
to	B-X
study	B-X
the	B-X
properties	B-X
of	B-X
the	B-X
UL11	B-X
protein	B-X
and	B-X
its	B-X
distribution	B-X
in	B-X
infected	B-X
cells	B-X
.	B-X
We	B-X
report	B-X
the	B-X
following	B-X
:	B-X
(	B-X
i	B-X
)	B-X
UL11	B-X
protein	B-X
formed	B-X
up	B-X
to	B-X
five	B-X
bands	B-X
(	B-X
apparent	B-X
M	B-X
(	B-X
r	B-X
)	B-X
s	B-X
,	B-X
17,000	B-X
to	B-X
22,000	B-X
)	B-X
in	B-X
denaturing	B-X
polyacrylamide	B-X
gels	B-X
;	B-X
(	B-X
ii	B-X
)	B-X
fluorescent-antibody	B-X
studies	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
UL11	B-X
protein	B-X
in	B-X
the	B-X
perinuclear	B-X
space	B-X
and	B-X
in	B-X
sites	B-X
within	B-X
the	B-X
nucleus	B-X
;	B-X
(	B-X
iii	B-X
)	B-X
immune	B-X
electron	B-X
microscopic	B-X
studies	B-X
indicated	B-X
that	B-X
the	B-X
UL11	B-X
gene	B-X
products	B-X
were	B-X
associated	B-X
with	B-X
the	B-X
inner	B-X
nuclear	B-X
membrane	B-X
,	B-X
with	B-X
cytoplasmic	B-X
membranes	B-X
and	B-X
ribbon-like	B-X
cytoplasmic	B-X
structures	B-X
resembling	B-X
membranous	B-X
organelles	B-X
,	B-X
with	B-X
nuclear	B-X
bodies	B-X
shown	B-X
by	B-X
fluorescence	B-X
microscopy	B-X
to	B-X
be	B-X
different	B-X
from	B-X
nucleoli	B-X
in	B-X
which	B-X
US11	B-X
protein	B-X
accumulates	B-X
,	B-X
and	B-X
with	B-X
enveloped	B-X
virions	B-X
but	B-X
not	B-X
with	B-X
nuclear	B-X
capsids	B-X
;	B-X
and	B-X
(	B-X
iv	B-X
)	B-X
the	B-X
nuclear	B-X
bodies	B-X
containing	B-X
UL11	B-X
protein	B-X
were	B-X
reminiscent	B-X
both	B-X
of	B-X
type	B-X
IV	B-X
morphotypes	B-X
consisting	B-X
of	B-X
an	B-X
electron-dense	B-X
core	B-X
containing	B-X
the	B-X
UL11	B-X
proteins	B-X
surrounded	B-X
by	B-X
a	B-X
more	B-X
electron-transluscent	B-X
core	B-X
and	B-X
of	B-X
type	B-X
V	B-X
morphotypes	B-X
consisting	B-X
of	B-X
material	B-X
homogenous	B-X
in	B-X
electron	B-X
opacity	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
(	B-X
i	B-X
)	B-X
the	B-X
UL11	B-X
protein	B-X
is	B-X
processed	B-X
after	B-X
synthesis	B-X
;	B-X
(	B-X
ii	B-X
)	B-X
the	B-X
localization	B-X
of	B-X
UL11	B-X
protein	B-X
with	B-X
virions	B-X
and	B-X
membranes	B-X
is	B-X
consistent	B-X
with	B-X
the	B-X
hypothesis	B-X
that	B-X
UL11	B-X
plays	B-X
a	B-X
role	B-X
in	B-X
the	B-X
transport	B-X
of	B-X
virions	B-X
to	B-X
the	B-X
extracellular	B-X
space	B-X
;	B-X
and	B-X
(	B-X
iii	B-X
)	B-X
although	B-X
the	B-X
significance	B-X
of	B-X
the	B-X
association	B-X
of	B-X
UL11	B-X
proteins	B-X
with	B-X
nuclear	B-X
bodies	B-X
is	B-X
unknown	B-X
,	B-X
the	B-X
results	B-X
indicate	B-X
that	B-X
nuclear	B-X
bodies	B-X
differ	B-X
with	B-X
respect	B-X
to	B-X
their	B-X
morphologies	B-X
and	B-X
contents	B-X
of	B-X
viral	B-X
protein	B-X
and	B-X
suggest	B-X
that	B-X
UL11	B-X
protein	B-X
may	B-X
have	B-X
more	B-X
than	B-X
one	B-X
function	B-X
in	B-X
the	B-X
infected	B-X
cell	B-X
.	B-X

The	O
UL11	B-Protein
and	O
UL51	B-Protein
gene	O
products	O
of	O
herpes	O
simplex	O
virus	O
(	O
HSV	O
)	O
are	O
membrane	O
-	O
associated	O
tegument	O
proteins	O
that	O
are	O
incorporated	O
into	O
the	O
HSV	O
virion	O
.	O
<EOS>	B-X
The	B-X
UL11	B-X
and	B-X
UL51	B-X
gene	B-X
products	B-X
of	B-X
herpes	B-X
simplex	B-X
virus	B-X
(	B-X
HSV	B-X
)	B-X
are	B-X
membrane-associated	B-X
tegument	B-X
proteins	B-X
that	B-X
are	B-X
incorporated	B-X
into	B-X
the	B-X
HSV	B-X
virion	B-X
.	B-X
UL11	B-X
and	B-X
UL51	B-X
are	B-X
conserved	B-X
throughout	B-X
the	B-X
herpesvirus	B-X
family	B-X
.	B-X
Both	B-X
UL11	B-X
and	B-X
UL51	B-X
,	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
,	B-X
are	B-X
involved	B-X
in	B-X
virion	B-X
envelopment	B-X
and/or	B-X
egress	B-X
.	B-X
Both	B-X
proteins	B-X
are	B-X
fatty	B-X
acylated	B-X
:	B-X
UL11	B-X
is	B-X
both	B-X
acylated	B-X
by	B-X
myristoic	B-X
and	B-X
palmitoic	B-X
acids	B-X
and	B-X
UL51	B-X
is	B-X
monoacylated	B-X
by	B-X
palmitoic	B-X
acid	B-X
.	B-X
Using	B-X
confocal	B-X
microscopy	B-X
and	B-X
sucrose	B-X
gradient	B-X
fractionations	B-X
in	B-X
transfected	B-X
or	B-X
HSV-infected	B-X
cells	B-X
,	B-X
we	B-X
found	B-X
that	B-X
HSV-2	B-X
UL11	B-X
but	B-X
not	B-X
UL51	B-X
was	B-X
associated	B-X
with	B-X
lipid	B-X
rafts	B-X
.	B-X
The	B-X
dual	B-X
acylation	B-X
of	B-X
UL11	B-X
was	B-X
necessary	B-X
for	B-X
lipid	B-X
raft	B-X
association	B-X
,	B-X
as	B-X
mutations	B-X
in	B-X
the	B-X
myristoylation	B-X
or	B-X
palmitoylation	B-X
sites	B-X
prevented	B-X
lipid	B-X
raft	B-X
association	B-X
.	B-X
These	B-X
differences	B-X
in	B-X
lipid	B-X
raft	B-X
association	B-X
may	B-X
contribute	B-X
to	B-X
the	B-X
functional	B-X
differences	B-X
between	B-X
UL11	B-X
and	B-X
UL51	B-X
.	B-X

UL11	B-Protein
and	O
UL51	B-Protein
are	O
conserved	O
throughout	O
the	O
herpesvirus	O
family	O
.	O
<EOS>	B-X
The	B-X
UL11	B-X
and	B-X
UL51	B-X
gene	B-X
products	B-X
of	B-X
herpes	B-X
simplex	B-X
virus	B-X
(	B-X
HSV	B-X
)	B-X
are	B-X
membrane-associated	B-X
tegument	B-X
proteins	B-X
that	B-X
are	B-X
incorporated	B-X
into	B-X
the	B-X
HSV	B-X
virion	B-X
.	B-X
UL11	B-X
and	B-X
UL51	B-X
are	B-X
conserved	B-X
throughout	B-X
the	B-X
herpesvirus	B-X
family	B-X
.	B-X
Both	B-X
UL11	B-X
and	B-X
UL51	B-X
,	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
,	B-X
are	B-X
involved	B-X
in	B-X
virion	B-X
envelopment	B-X
and/or	B-X
egress	B-X
.	B-X
Both	B-X
proteins	B-X
are	B-X
fatty	B-X
acylated	B-X
:	B-X
UL11	B-X
is	B-X
both	B-X
acylated	B-X
by	B-X
myristoic	B-X
and	B-X
palmitoic	B-X
acids	B-X
and	B-X
UL51	B-X
is	B-X
monoacylated	B-X
by	B-X
palmitoic	B-X
acid	B-X
.	B-X
Using	B-X
confocal	B-X
microscopy	B-X
and	B-X
sucrose	B-X
gradient	B-X
fractionations	B-X
in	B-X
transfected	B-X
or	B-X
HSV-infected	B-X
cells	B-X
,	B-X
we	B-X
found	B-X
that	B-X
HSV-2	B-X
UL11	B-X
but	B-X
not	B-X
UL51	B-X
was	B-X
associated	B-X
with	B-X
lipid	B-X
rafts	B-X
.	B-X
The	B-X
dual	B-X
acylation	B-X
of	B-X
UL11	B-X
was	B-X
necessary	B-X
for	B-X
lipid	B-X
raft	B-X
association	B-X
,	B-X
as	B-X
mutations	B-X
in	B-X
the	B-X
myristoylation	B-X
or	B-X
palmitoylation	B-X
sites	B-X
prevented	B-X
lipid	B-X
raft	B-X
association	B-X
.	B-X
These	B-X
differences	B-X
in	B-X
lipid	B-X
raft	B-X
association	B-X
may	B-X
contribute	B-X
to	B-X
the	B-X
functional	B-X
differences	B-X
between	B-X
UL11	B-X
and	B-X
UL51	B-X
.	B-X

Both	O
UL11	B-Protein
and	O
UL51	B-Protein
,	O
either	O
singly	O
or	O
in	O
combination	O
,	O
are	O
involved	O
in	O
virion	O
envelopment	O
and	O
/	O
or	O
egress	O
.	O
<EOS>	B-X
The	B-X
leukocytes	B-X
entering	B-X
the	B-X
lymph	B-X
node	B-X
via	B-X
the	B-X
sinus	B-X
system	B-X
and	B-X
the	B-X
lymphocytes	B-X
egressing	B-X
from	B-X
the	B-X
parenchyma	B-X
migrate	B-X
through	B-X
the	B-X
lymphatic	B-X
endothelial	B-X
cell	B-X
layer	B-X
.	B-X
HSV-1	B-X
has	B-X
evolved	B-X
a	B-X
complex	B-X
mechanism	B-X
of	B-X
nuclear	B-X
egress	B-X
whereby	B-X
nascent	B-X
capsids	B-X
bud	B-X
on	B-X
the	B-X
inner	B-X
nuclear	B-X
membrane	B-X
to	B-X
form	B-X
perinuclear	B-X
virions	B-X
that	B-X
subsequently	B-X
fuse	B-X
with	B-X
the	B-X
outer	B-X
nuclear	B-X
membrane	B-X
,	B-X
releasing	B-X
capsids	B-X
into	B-X
the	B-X
cytosol	B-X
.	B-X
The	B-X
viral-encoded	B-X
nuclear	B-X
egress	B-X
complex	B-X
(	B-X
NEC	B-X
)	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
this	B-X
vesicle-mediated	B-X
nucleocytoplasmic	B-X
transport	B-X
.	B-X
This	B-X
review	B-X
summarizes	B-X
our	B-X
current	B-X
understanding	B-X
of	B-X
the	B-X
cellular	B-X
and	B-X
viral	B-X
factors	B-X
involved	B-X
in	B-X
the	B-X
nuclear	B-X
egress	B-X
of	B-X
HSV-1	B-X
capsids	B-X
.	B-X

Both	O
proteins	O
are	O
fatty	O
acylated	O
:	O
UL11	B-Protein
is	O
both	O
acylated	O
by	O
myristoic	O
and	O
palmitoic	O
acids	O
and	O
UL51	B-Protein
is	O
monoacylated	O
by	O
palmitoic	O
acid	O
.	O
<EOS>	B-X
The	B-X
UL11	B-X
and	B-X
UL51	B-X
gene	B-X
products	B-X
of	B-X
herpes	B-X
simplex	B-X
virus	B-X
(	B-X
HSV	B-X
)	B-X
are	B-X
membrane-associated	B-X
tegument	B-X
proteins	B-X
that	B-X
are	B-X
incorporated	B-X
into	B-X
the	B-X
HSV	B-X
virion	B-X
.	B-X
UL11	B-X
and	B-X
UL51	B-X
are	B-X
conserved	B-X
throughout	B-X
the	B-X
herpesvirus	B-X
family	B-X
.	B-X
Both	B-X
UL11	B-X
and	B-X
UL51	B-X
,	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
,	B-X
are	B-X
involved	B-X
in	B-X
virion	B-X
envelopment	B-X
and/or	B-X
egress	B-X
.	B-X
Both	B-X
proteins	B-X
are	B-X
fatty	B-X
acylated	B-X
:	B-X
UL11	B-X
is	B-X
both	B-X
acylated	B-X
by	B-X
myristoic	B-X
and	B-X
palmitoic	B-X
acids	B-X
and	B-X
UL51	B-X
is	B-X
monoacylated	B-X
by	B-X
palmitoic	B-X
acid	B-X
.	B-X
Using	B-X
confocal	B-X
microscopy	B-X
and	B-X
sucrose	B-X
gradient	B-X
fractionations	B-X
in	B-X
transfected	B-X
or	B-X
HSV-infected	B-X
cells	B-X
,	B-X
we	B-X
found	B-X
that	B-X
HSV-2	B-X
UL11	B-X
but	B-X
not	B-X
UL51	B-X
was	B-X
associated	B-X
with	B-X
lipid	B-X
rafts	B-X
.	B-X
The	B-X
dual	B-X
acylation	B-X
of	B-X
UL11	B-X
was	B-X
necessary	B-X
for	B-X
lipid	B-X
raft	B-X
association	B-X
,	B-X
as	B-X
mutations	B-X
in	B-X
the	B-X
myristoylation	B-X
or	B-X
palmitoylation	B-X
sites	B-X
prevented	B-X
lipid	B-X
raft	B-X
association	B-X
.	B-X
These	B-X
differences	B-X
in	B-X
lipid	B-X
raft	B-X
association	B-X
may	B-X
contribute	B-X
to	B-X
the	B-X
functional	B-X
differences	B-X
between	B-X
UL11	B-X
and	B-X
UL51	B-X
.	B-X

Using	O
confocal	O
microscopy	O
and	O
sucrose	O
gradient	O
fractionations	O
in	O
transfected	O
or	O
HSV	O
-	O
infected	O
cells	O
,	O
we	O
found	O
that	O
HSV	O
-	O
2	O
UL11	B-Protein
but	O
not	O
UL51	B-Protein
was	O
associated	O
with	O
lipid	O
rafts	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
(	B-X
HSV	B-X
)	B-X
acquires	B-X
envelope	B-X
by	B-X
budding	B-X
into	B-X
trans-Golgi	B-X
network	B-X
(	B-X
TGN	B-X
)	B-X
-derived	B-X
vesicles	B-X
.	B-X
Previous	B-X
studies	B-X
showed	B-X
that	B-X
the	B-X
UL11	B-X
gene	B-X
product	B-X
enables	B-X
efficient	B-X
virion	B-X
envelopment	B-X
and	B-X
export	B-X
from	B-X
infected	B-X
cells	B-X
and	B-X
is	B-X
incorporated	B-X
into	B-X
virions	B-X
as	B-X
tegument	B-X
protein	B-X
.	B-X
At	B-X
its	B-X
N-terminus	B-X
,	B-X
UL11	B-X
is	B-X
dually	B-X
acylated	B-X
by	B-X
myristoic	B-X
and	B-X
palmitoic	B-X
acids	B-X
.	B-X
Fatty	B-X
acylation	B-X
of	B-X
UL11	B-X
provides	B-X
both	B-X
membrane	B-X
binding	B-X
strength	B-X
and	B-X
Golgi-targeting	B-X
specificity	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
UL11	B-X
interacts	B-X
with	B-X
UL56	B-X
protein	B-X
,	B-X
a	B-X
tail-anchored	B-X
type	B-X
II	B-X
membrane	B-X
protein	B-X
encoded	B-X
by	B-X
HSV	B-X
,	B-X
which	B-X
associated	B-X
with	B-X
the	B-X
Golgi	B-X
apparatus	B-X
and	B-X
cytoplasmic	B-X
vesicles	B-X
.	B-X
We	B-X
previously	B-X
showed	B-X
that	B-X
UL56	B-X
is	B-X
involved	B-X
in	B-X
vesicular	B-X
transport	B-X
in	B-X
infected	B-X
cells	B-X
.	B-X
The	B-X
UL11-UL56	B-X
complex	B-X
localized	B-X
to	B-X
the	B-X
perinuclear	B-X
region	B-X
of	B-X
the	B-X
cytoplasm	B-X
in	B-X
infected	B-X
cells	B-X
.	B-X
Fatty	B-X
acylation	B-X
of	B-X
UL11	B-X
was	B-X
important	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
the	B-X
UL11-UL56	B-X
protein	B-X
complex	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
identify	B-X
a	B-X
novel	B-X
interaction	B-X
between	B-X
two	B-X
HSV	B-X
proteins	B-X
facilitated	B-X
by	B-X
mutual	B-X
interactions	B-X
with	B-X
Golgi-derived	B-X
vesicles	B-X
.	B-X

The	O
dual	O
acylation	O
of	O
UL11	B-Protein
was	O
necessary	O
for	O
lipid	O
raft	O
association	O
,	O
as	O
mutations	O
in	O
the	O
myristoylation	O
or	O
palmitoylation	O
sites	O
prevented	O
lipid	O
raft	O
association	O
.	O
<EOS>	B-X
The	B-X
UL11	B-X
and	B-X
UL51	B-X
gene	B-X
products	B-X
of	B-X
herpes	B-X
simplex	B-X
virus	B-X
(	B-X
HSV	B-X
)	B-X
are	B-X
membrane-associated	B-X
tegument	B-X
proteins	B-X
that	B-X
are	B-X
incorporated	B-X
into	B-X
the	B-X
HSV	B-X
virion	B-X
.	B-X
UL11	B-X
and	B-X
UL51	B-X
are	B-X
conserved	B-X
throughout	B-X
the	B-X
herpesvirus	B-X
family	B-X
.	B-X
Both	B-X
UL11	B-X
and	B-X
UL51	B-X
,	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
,	B-X
are	B-X
involved	B-X
in	B-X
virion	B-X
envelopment	B-X
and/or	B-X
egress	B-X
.	B-X
Both	B-X
proteins	B-X
are	B-X
fatty	B-X
acylated	B-X
:	B-X
UL11	B-X
is	B-X
both	B-X
acylated	B-X
by	B-X
myristoic	B-X
and	B-X
palmitoic	B-X
acids	B-X
and	B-X
UL51	B-X
is	B-X
monoacylated	B-X
by	B-X
palmitoic	B-X
acid	B-X
.	B-X
Using	B-X
confocal	B-X
microscopy	B-X
and	B-X
sucrose	B-X
gradient	B-X
fractionations	B-X
in	B-X
transfected	B-X
or	B-X
HSV-infected	B-X
cells	B-X
,	B-X
we	B-X
found	B-X
that	B-X
HSV-2	B-X
UL11	B-X
but	B-X
not	B-X
UL51	B-X
was	B-X
associated	B-X
with	B-X
lipid	B-X
rafts	B-X
.	B-X
The	B-X
dual	B-X
acylation	B-X
of	B-X
UL11	B-X
was	B-X
necessary	B-X
for	B-X
lipid	B-X
raft	B-X
association	B-X
,	B-X
as	B-X
mutations	B-X
in	B-X
the	B-X
myristoylation	B-X
or	B-X
palmitoylation	B-X
sites	B-X
prevented	B-X
lipid	B-X
raft	B-X
association	B-X
.	B-X
These	B-X
differences	B-X
in	B-X
lipid	B-X
raft	B-X
association	B-X
may	B-X
contribute	B-X
to	B-X
the	B-X
functional	B-X
differences	B-X
between	B-X
UL11	B-X
and	B-X
UL51	B-X
.	B-X

These	O
differences	O
in	O
lipid	O
raft	O
association	O
may	O
contribute	O
to	O
the	O
functional	O
differences	O
between	O
UL11	B-Protein
and	O
UL51	B-Protein
.	O

Localization	O
of	O
the	O
TIG3	B-Protein
transglutaminase	O
interaction	O
domain	O
and	O
demonstration	O
that	O
the	O
amino	O
-	O
terminal	O
region	O
is	O
required	O
for	O
TIG3	B-Protein
function	O
as	O
a	O
keratinocyte	O
differentiation	O
regulator	O
.	O
<EOS>	B-X
Tazarotene-induced	B-X
gene	B-X
3	B-X
(	B-X
TIG3	B-X
)	B-X
regulates	B-X
keratinocyte	B-X
terminal	B-X
differentiation	B-X
by	B-X
activating	B-X
type	B-X
I	B-X
transglutaminase	B-X
(	B-X
TG1	B-X
)	B-X
.	B-X
TIG3	B-X
consists	B-X
of	B-X
an	B-X
amino-terminal	B-X
(	B-X
N-terminal	B-X
)	B-X
segment	B-X
,	B-X
that	B-X
encodes	B-X
several	B-X
conserved	B-X
motifs	B-X
,	B-X
and	B-X
a	B-X
carboxy-terminal	B-X
(	B-X
C-terminal	B-X
)	B-X
membrane-anchoring	B-X
domain	B-X
.	B-X
By	B-X
producing	B-X
a	B-X
series	B-X
of	B-X
truncation	B-X
mutants	B-X
that	B-X
remove	B-X
segments	B-X
of	B-X
the	B-X
N-terminal	B-X
region	B-X
,	B-X
and	B-X
monitoring	B-X
the	B-X
ability	B-X
of	B-X
each	B-X
mutant	B-X
to	B-X
co-precipitate	B-X
TG1	B-X
,	B-X
function	B-X
as	B-X
a	B-X
TG1	B-X
substrate	B-X
,	B-X
or	B-X
functionally	B-X
localize	B-X
with	B-X
TG1	B-X
in	B-X
cells	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
TIG3	B-X
domain	B-X
that	B-X
interacts	B-X
with	B-X
TG1	B-X
is	B-X
located	B-X
within	B-X
a	B-X
TIG3	B-X
segment	B-X
spanning	B-X
amino	B-X
acids	B-X
112-164	B-X
.	B-X
Although	B-X
they	B-X
bind	B-X
TG1	B-X
,	B-X
TIG3	B-X
mutants	B-X
lacking	B-X
the	B-X
conserved	B-X
N-terminal	B-X
region	B-X
drive	B-X
apoptosis-like	B-X
cell	B-X
death	B-X
characterized	B-X
by	B-X
cell	B-X
rounding	B-X
,	B-X
membrane	B-X
blebbing	B-X
,	B-X
cytochrome	B-X
c	B-X
release	B-X
,	B-X
procaspase-3	B-X
and	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
(	B-X
PARP	B-X
)	B-X
cleavage	B-X
,	B-X
and	B-X
reduced	B-X
p53	B-X
and	B-X
p21	B-X
levels	B-X
.	B-X
Compared	B-X
with	B-X
TIG3	B-X
,	B-X
these	B-X
truncated	B-X
mutants	B-X
have	B-X
an	B-X
increased	B-X
tendency	B-X
to	B-X
associate	B-X
with	B-X
membranes	B-X
.	B-X
A	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
membrane-anchoring	B-X
domain	B-X
is	B-X
inactive	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
TIG3	B-X
interaction	B-X
with	B-X
TG1	B-X
does	B-X
not	B-X
require	B-X
the	B-X
N-terminal	B-X
conserved	B-X
domains	B-X
,	B-X
that	B-X
the	B-X
TIG3	B-X
N-terminal	B-X
region	B-X
is	B-X
required	B-X
for	B-X
TIG3-dependent	B-X
keratinocyte	B-X
differentiation	B-X
,	B-X
that	B-X
its	B-X
removal	B-X
converts	B-X
TIG3	B-X
into	B-X
a	B-X
proapoptotic	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
this	B-X
change	B-X
in	B-X
action	B-X
of	B-X
TIG3	B-X
is	B-X
associated	B-X
with	B-X
an	B-X
intracellular	B-X
redistribution	B-X
.	B-X

Tazarotene	B-Protein
-	I-Protein
induced	I-Protein
gene	I-Protein
3	I-Protein
(	O
TIG3	B-Protein
)	O
regulates	O
keratinocyte	O
terminal	O
differentiation	O
by	O
activating	O
type	B-Protein
I	I-Protein
transglutaminase	I-Protein
(	O
TG1	B-Protein
)	O
.	O
<EOS>	B-X
Keratinocytes	B-X
undergo	B-X
a	B-X
process	B-X
of	B-X
terminal	B-X
cell	B-X
differentiation	B-X
that	B-X
results	B-X
in	B-X
the	B-X
construction	B-X
of	B-X
a	B-X
multilayered	B-X
epithelium	B-X
designed	B-X
to	B-X
produce	B-X
a	B-X
structure	B-X
that	B-X
functions	B-X
to	B-X
protect	B-X
the	B-X
body	B-X
from	B-X
dehydration	B-X
,	B-X
abrasion	B-X
and	B-X
infection	B-X
.	B-X
Type	B-X
I	B-X
transglutaminase	B-X
(	B-X
TG1	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
that	B-X
catalyzes	B-X
the	B-X
formation	B-X
of	B-X
epsilon-	B-X
(	B-X
gamma-glutamyl	B-X
)	B-X
lysine	B-X
bonds	B-X
,	B-X
is	B-X
the	B-X
key	B-X
protein	B-X
responsible	B-X
for	B-X
generation	B-X
of	B-X
the	B-X
crosslinks	B-X
.	B-X
The	B-X
mechanisms	B-X
that	B-X
lead	B-X
to	B-X
activation	B-X
of	B-X
transglutaminase	B-X
during	B-X
terminal	B-X
differentiation	B-X
are	B-X
not	B-X
well	B-X
understood	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
protein	B-X
that	B-X
interacts	B-X
with	B-X
TG1	B-X
and	B-X
regulates	B-X
its	B-X
activity	B-X
.	B-X
This	B-X
protein	B-X
,	B-X
tazarotene-induced	B-X
gene	B-X
3	B-X
(	B-X
TIG3	B-X
)	B-X
,	B-X
is	B-X
expressed	B-X
in	B-X
the	B-X
differentiated	B-X
layers	B-X
of	B-X
the	B-X
epidermis	B-X
and	B-X
its	B-X
expression	B-X
is	B-X
associated	B-X
with	B-X
transglutaminase	B-X
activation	B-X
and	B-X
cornified	B-X
envelope	B-X
formation	B-X
.	B-X
We	B-X
describe	B-X
a	B-X
novel	B-X
mechanism	B-X
whereby	B-X
TIG3	B-X
regulates	B-X
TG1	B-X
activity	B-X
.	B-X

TIG3	B-Protein
consists	O
of	O
an	O
amino	O
-	O
terminal	O
(	O
N	O
-	O
terminal	O
)	O
segment	O
,	O
that	O
encodes	O
several	O
conserved	O
motifs	O
,	O
and	O
a	O
carboxy	O
-	O
terminal	O
(	O
C	O
-	O
terminal	O
)	O
membrane	O
-	O
anchoring	O
domain	O
.	O

By	O
producing	O
a	O
series	O
of	O
truncation	O
mutants	O
that	O
remove	O
segments	O
of	O
the	O
N	O
-	O
terminal	O
region	O
,	O
and	O
monitoring	O
the	O
ability	O
of	O
each	O
mutant	O
to	O
co	O
-	O
precipitate	O
TG1	B-Protein
,	O
function	O
as	O
a	O
TG1	B-Protein
substrate	O
,	O
or	O
functionally	O
localize	O
with	O
TG1	O
in	O
cells	O
,	O
we	O
show	O
that	O
the	O
TIG3	B-Protein
domain	O
that	O
interacts	O
with	O
TG1	B-Protein
is	O
located	O
within	O
a	O
TIG3	B-Protein
segment	O
spanning	O
amino	O
acids	O
112	O
-	O
164	O
.	O
<EOS>	B-X
Tazarotene-induced	B-X
gene	B-X
3	B-X
(	B-X
TIG3	B-X
)	B-X
regulates	B-X
keratinocyte	B-X
terminal	B-X
differentiation	B-X
by	B-X
activating	B-X
type	B-X
I	B-X
transglutaminase	B-X
(	B-X
TG1	B-X
)	B-X
.	B-X
TIG3	B-X
consists	B-X
of	B-X
an	B-X
amino-terminal	B-X
(	B-X
N-terminal	B-X
)	B-X
segment	B-X
,	B-X
that	B-X
encodes	B-X
several	B-X
conserved	B-X
motifs	B-X
,	B-X
and	B-X
a	B-X
carboxy-terminal	B-X
(	B-X
C-terminal	B-X
)	B-X
membrane-anchoring	B-X
domain	B-X
.	B-X
By	B-X
producing	B-X
a	B-X
series	B-X
of	B-X
truncation	B-X
mutants	B-X
that	B-X
remove	B-X
segments	B-X
of	B-X
the	B-X
N-terminal	B-X
region	B-X
,	B-X
and	B-X
monitoring	B-X
the	B-X
ability	B-X
of	B-X
each	B-X
mutant	B-X
to	B-X
co-precipitate	B-X
TG1	B-X
,	B-X
function	B-X
as	B-X
a	B-X
TG1	B-X
substrate	B-X
,	B-X
or	B-X
functionally	B-X
localize	B-X
with	B-X
TG1	B-X
in	B-X
cells	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
TIG3	B-X
domain	B-X
that	B-X
interacts	B-X
with	B-X
TG1	B-X
is	B-X
located	B-X
within	B-X
a	B-X
TIG3	B-X
segment	B-X
spanning	B-X
amino	B-X
acids	B-X
112-164	B-X
.	B-X
Although	B-X
they	B-X
bind	B-X
TG1	B-X
,	B-X
TIG3	B-X
mutants	B-X
lacking	B-X
the	B-X
conserved	B-X
N-terminal	B-X
region	B-X
drive	B-X
apoptosis-like	B-X
cell	B-X
death	B-X
characterized	B-X
by	B-X
cell	B-X
rounding	B-X
,	B-X
membrane	B-X
blebbing	B-X
,	B-X
cytochrome	B-X
c	B-X
release	B-X
,	B-X
procaspase-3	B-X
and	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
(	B-X
PARP	B-X
)	B-X
cleavage	B-X
,	B-X
and	B-X
reduced	B-X
p53	B-X
and	B-X
p21	B-X
levels	B-X
.	B-X
Compared	B-X
with	B-X
TIG3	B-X
,	B-X
these	B-X
truncated	B-X
mutants	B-X
have	B-X
an	B-X
increased	B-X
tendency	B-X
to	B-X
associate	B-X
with	B-X
membranes	B-X
.	B-X
A	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
membrane-anchoring	B-X
domain	B-X
is	B-X
inactive	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
TIG3	B-X
interaction	B-X
with	B-X
TG1	B-X
does	B-X
not	B-X
require	B-X
the	B-X
N-terminal	B-X
conserved	B-X
domains	B-X
,	B-X
that	B-X
the	B-X
TIG3	B-X
N-terminal	B-X
region	B-X
is	B-X
required	B-X
for	B-X
TIG3-dependent	B-X
keratinocyte	B-X
differentiation	B-X
,	B-X
that	B-X
its	B-X
removal	B-X
converts	B-X
TIG3	B-X
into	B-X
a	B-X
proapoptotic	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
this	B-X
change	B-X
in	B-X
action	B-X
of	B-X
TIG3	B-X
is	B-X
associated	B-X
with	B-X
an	B-X
intracellular	B-X
redistribution	B-X
.	B-X

Although	O
they	O
bind	O
TG1	B-Protein
,	O
TIG3	B-Protein
mutants	O
lacking	O
the	O
conserved	O
N	O
-	O
terminal	O
region	O
drive	O
apoptosis	O
-	O
like	O
cell	O
death	O
characterized	O
by	O
cell	O
rounding	O
,	O
membrane	O
blebbing	O
,	O
cytochrome	B-Protein
c	I-Protein
release	O
,	O
procaspase	B-Protein
-	I-Protein
3	I-Protein
and	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
(	O
PARP	O
)	O
cleavage	O
,	O
and	O
reduced	O
p53	B-Protein
and	O
p21	B-Protein
levels	O
.	O
<EOS>	B-X
Tazarotene-induced	B-X
gene	B-X
3	B-X
(	B-X
TIG3	B-X
)	B-X
regulates	B-X
keratinocyte	B-X
terminal	B-X
differentiation	B-X
by	B-X
activating	B-X
type	B-X
I	B-X
transglutaminase	B-X
(	B-X
TG1	B-X
)	B-X
.	B-X
TIG3	B-X
consists	B-X
of	B-X
an	B-X
amino-terminal	B-X
(	B-X
N-terminal	B-X
)	B-X
segment	B-X
,	B-X
that	B-X
encodes	B-X
several	B-X
conserved	B-X
motifs	B-X
,	B-X
and	B-X
a	B-X
carboxy-terminal	B-X
(	B-X
C-terminal	B-X
)	B-X
membrane-anchoring	B-X
domain	B-X
.	B-X
By	B-X
producing	B-X
a	B-X
series	B-X
of	B-X
truncation	B-X
mutants	B-X
that	B-X
remove	B-X
segments	B-X
of	B-X
the	B-X
N-terminal	B-X
region	B-X
,	B-X
and	B-X
monitoring	B-X
the	B-X
ability	B-X
of	B-X
each	B-X
mutant	B-X
to	B-X
co-precipitate	B-X
TG1	B-X
,	B-X
function	B-X
as	B-X
a	B-X
TG1	B-X
substrate	B-X
,	B-X
or	B-X
functionally	B-X
localize	B-X
with	B-X
TG1	B-X
in	B-X
cells	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
TIG3	B-X
domain	B-X
that	B-X
interacts	B-X
with	B-X
TG1	B-X
is	B-X
located	B-X
within	B-X
a	B-X
TIG3	B-X
segment	B-X
spanning	B-X
amino	B-X
acids	B-X
112-164	B-X
.	B-X
Although	B-X
they	B-X
bind	B-X
TG1	B-X
,	B-X
TIG3	B-X
mutants	B-X
lacking	B-X
the	B-X
conserved	B-X
N-terminal	B-X
region	B-X
drive	B-X
apoptosis-like	B-X
cell	B-X
death	B-X
characterized	B-X
by	B-X
cell	B-X
rounding	B-X
,	B-X
membrane	B-X
blebbing	B-X
,	B-X
cytochrome	B-X
c	B-X
release	B-X
,	B-X
procaspase-3	B-X
and	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
(	B-X
PARP	B-X
)	B-X
cleavage	B-X
,	B-X
and	B-X
reduced	B-X
p53	B-X
and	B-X
p21	B-X
levels	B-X
.	B-X
Compared	B-X
with	B-X
TIG3	B-X
,	B-X
these	B-X
truncated	B-X
mutants	B-X
have	B-X
an	B-X
increased	B-X
tendency	B-X
to	B-X
associate	B-X
with	B-X
membranes	B-X
.	B-X
A	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
membrane-anchoring	B-X
domain	B-X
is	B-X
inactive	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
TIG3	B-X
interaction	B-X
with	B-X
TG1	B-X
does	B-X
not	B-X
require	B-X
the	B-X
N-terminal	B-X
conserved	B-X
domains	B-X
,	B-X
that	B-X
the	B-X
TIG3	B-X
N-terminal	B-X
region	B-X
is	B-X
required	B-X
for	B-X
TIG3-dependent	B-X
keratinocyte	B-X
differentiation	B-X
,	B-X
that	B-X
its	B-X
removal	B-X
converts	B-X
TIG3	B-X
into	B-X
a	B-X
proapoptotic	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
this	B-X
change	B-X
in	B-X
action	B-X
of	B-X
TIG3	B-X
is	B-X
associated	B-X
with	B-X
an	B-X
intracellular	B-X
redistribution	B-X
.	B-X

Compared	O
with	O
TIG3	B-Protein
,	O
these	O
truncated	O
mutants	O
have	O
an	O
increased	O
tendency	O
to	O
associate	O
with	O
membranes	O
.	O
<EOS>	B-X
Tazarotene-induced	B-X
gene	B-X
3	B-X
(	B-X
TIG3	B-X
)	B-X
regulates	B-X
keratinocyte	B-X
terminal	B-X
differentiation	B-X
by	B-X
activating	B-X
type	B-X
I	B-X
transglutaminase	B-X
(	B-X
TG1	B-X
)	B-X
.	B-X
TIG3	B-X
consists	B-X
of	B-X
an	B-X
amino-terminal	B-X
(	B-X
N-terminal	B-X
)	B-X
segment	B-X
,	B-X
that	B-X
encodes	B-X
several	B-X
conserved	B-X
motifs	B-X
,	B-X
and	B-X
a	B-X
carboxy-terminal	B-X
(	B-X
C-terminal	B-X
)	B-X
membrane-anchoring	B-X
domain	B-X
.	B-X
By	B-X
producing	B-X
a	B-X
series	B-X
of	B-X
truncation	B-X
mutants	B-X
that	B-X
remove	B-X
segments	B-X
of	B-X
the	B-X
N-terminal	B-X
region	B-X
,	B-X
and	B-X
monitoring	B-X
the	B-X
ability	B-X
of	B-X
each	B-X
mutant	B-X
to	B-X
co-precipitate	B-X
TG1	B-X
,	B-X
function	B-X
as	B-X
a	B-X
TG1	B-X
substrate	B-X
,	B-X
or	B-X
functionally	B-X
localize	B-X
with	B-X
TG1	B-X
in	B-X
cells	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
TIG3	B-X
domain	B-X
that	B-X
interacts	B-X
with	B-X
TG1	B-X
is	B-X
located	B-X
within	B-X
a	B-X
TIG3	B-X
segment	B-X
spanning	B-X
amino	B-X
acids	B-X
112-164	B-X
.	B-X
Although	B-X
they	B-X
bind	B-X
TG1	B-X
,	B-X
TIG3	B-X
mutants	B-X
lacking	B-X
the	B-X
conserved	B-X
N-terminal	B-X
region	B-X
drive	B-X
apoptosis-like	B-X
cell	B-X
death	B-X
characterized	B-X
by	B-X
cell	B-X
rounding	B-X
,	B-X
membrane	B-X
blebbing	B-X
,	B-X
cytochrome	B-X
c	B-X
release	B-X
,	B-X
procaspase-3	B-X
and	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
(	B-X
PARP	B-X
)	B-X
cleavage	B-X
,	B-X
and	B-X
reduced	B-X
p53	B-X
and	B-X
p21	B-X
levels	B-X
.	B-X
Compared	B-X
with	B-X
TIG3	B-X
,	B-X
these	B-X
truncated	B-X
mutants	B-X
have	B-X
an	B-X
increased	B-X
tendency	B-X
to	B-X
associate	B-X
with	B-X
membranes	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
TIG3	B-X
interaction	B-X
with	B-X
TG1	B-X
does	B-X
not	B-X
require	B-X
the	B-X
N-terminal	B-X
conserved	B-X
domains	B-X
,	B-X
that	B-X
the	B-X
TIG3	B-X
N-terminal	B-X
region	B-X
is	B-X
required	B-X
for	B-X
TIG3-dependent	B-X
keratinocyte	B-X
differentiation	B-X
,	B-X
that	B-X
its	B-X
removal	B-X
converts	B-X
TIG3	B-X
into	B-X
a	B-X
proapoptotic	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
this	B-X
change	B-X
in	B-X
action	B-X
of	B-X
TIG3	B-X
is	B-X
associated	B-X
with	B-X
an	B-X
intracellular	B-X
redistribution	B-X
.	B-X

A	O
mutant	O
lacking	O
the	O
C	O
-	O
terminal	O
membrane	O
-	O
anchoring	O
domain	O
is	O
inactive	O
.	O

These	O
findings	O
suggest	O
that	O
TIG3	B-Protein
interaction	O
with	O
TG1	B-Protein
does	O
not	O
require	O
the	O
N	O
-	O
terminal	O
conserved	O
domains	O
,	O
that	O
the	O
TIG3	B-Protein
N	O
-	O
terminal	O
region	O
is	O
required	O
for	O
TIG3	B-Protein
-	O
dependent	O
keratinocyte	O
differentiation	O
,	O
that	O
its	O
removal	O
converts	O
TIG3	B-Protein
into	O
a	O
proapoptotic	O
protein	O
,	O
and	O
that	O
this	O
change	O
in	O
action	O
of	O
TIG3	B-Protein
is	O
associated	O
with	O
an	O
intracellular	O
redistribution	O
.	O
<EOS>	B-X
Tazarotene-induced	B-X
gene	B-X
3	B-X
(	B-X
TIG3	B-X
)	B-X
regulates	B-X
keratinocyte	B-X
terminal	B-X
differentiation	B-X
by	B-X
activating	B-X
type	B-X
I	B-X
transglutaminase	B-X
(	B-X
TG1	B-X
)	B-X
.	B-X
TIG3	B-X
consists	B-X
of	B-X
an	B-X
amino-terminal	B-X
(	B-X
N-terminal	B-X
)	B-X
segment	B-X
,	B-X
that	B-X
encodes	B-X
several	B-X
conserved	B-X
motifs	B-X
,	B-X
and	B-X
a	B-X
carboxy-terminal	B-X
(	B-X
C-terminal	B-X
)	B-X
membrane-anchoring	B-X
domain	B-X
.	B-X
By	B-X
producing	B-X
a	B-X
series	B-X
of	B-X
truncation	B-X
mutants	B-X
that	B-X
remove	B-X
segments	B-X
of	B-X
the	B-X
N-terminal	B-X
region	B-X
,	B-X
and	B-X
monitoring	B-X
the	B-X
ability	B-X
of	B-X
each	B-X
mutant	B-X
to	B-X
co-precipitate	B-X
TG1	B-X
,	B-X
function	B-X
as	B-X
a	B-X
TG1	B-X
substrate	B-X
,	B-X
or	B-X
functionally	B-X
localize	B-X
with	B-X
TG1	B-X
in	B-X
cells	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
TIG3	B-X
domain	B-X
that	B-X
interacts	B-X
with	B-X
TG1	B-X
is	B-X
located	B-X
within	B-X
a	B-X
TIG3	B-X
segment	B-X
spanning	B-X
amino	B-X
acids	B-X
112-164	B-X
.	B-X
Although	B-X
they	B-X
bind	B-X
TG1	B-X
,	B-X
TIG3	B-X
mutants	B-X
lacking	B-X
the	B-X
conserved	B-X
N-terminal	B-X
region	B-X
drive	B-X
apoptosis-like	B-X
cell	B-X
death	B-X
characterized	B-X
by	B-X
cell	B-X
rounding	B-X
,	B-X
membrane	B-X
blebbing	B-X
,	B-X
cytochrome	B-X
c	B-X
release	B-X
,	B-X
procaspase-3	B-X
and	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
(	B-X
PARP	B-X
)	B-X
cleavage	B-X
,	B-X
and	B-X
reduced	B-X
p53	B-X
and	B-X
p21	B-X
levels	B-X
.	B-X
Compared	B-X
with	B-X
TIG3	B-X
,	B-X
these	B-X
truncated	B-X
mutants	B-X
have	B-X
an	B-X
increased	B-X
tendency	B-X
to	B-X
associate	B-X
with	B-X
membranes	B-X
.	B-X
A	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
membrane-anchoring	B-X
domain	B-X
is	B-X
inactive	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
TIG3	B-X
interaction	B-X
with	B-X
TG1	B-X
does	B-X
not	B-X
require	B-X
the	B-X
N-terminal	B-X
conserved	B-X
domains	B-X
,	B-X
that	B-X
the	B-X
TIG3	B-X
N-terminal	B-X
region	B-X
is	B-X
required	B-X
for	B-X
TIG3-dependent	B-X
keratinocyte	B-X
differentiation	B-X
,	B-X
that	B-X
its	B-X
removal	B-X
converts	B-X
TIG3	B-X
into	B-X
a	B-X
proapoptotic	B-X
protein	B-X
,	B-X
and	B-X
that	B-X
this	B-X
change	B-X
in	B-X
action	B-X
of	B-X
TIG3	B-X
is	B-X
associated	B-X
with	B-X
an	B-X
intracellular	B-X
redistribution	B-X
.	B-X

Altered	O
pattern	O
of	O
Cul	B-Protein
-	I-Protein
1	I-Protein
protein	O
expression	O
and	O
neddylation	O
in	O
human	O
lung	O
tumours	O
:	O
relationships	O
with	O
CAND1	B-Protein
and	O
cyclin	B-Protein
E	I-Protein
protein	O
levels	O
.	O
<EOS>	B-X
The	B-X
Cul-1	B-X
protein	B-X
is	B-X
the	B-X
scaffold	B-X
element	B-X
of	B-X
SCF	B-X
complexes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
proteasomal	B-X
degradation	B-X
of	B-X
numerous	B-X
proteins	B-X
regulating	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Owing	B-X
to	B-X
this	B-X
central	B-X
role	B-X
in	B-X
cell	B-X
growth	B-X
control	B-X
,	B-X
aberrant	B-X
expression	B-X
of	B-X
the	B-X
components	B-X
of	B-X
SCF	B-X
is	B-X
thought	B-X
to	B-X
play	B-X
a	B-X
role	B-X
during	B-X
tumourigenesis	B-X
.	B-X
Nothing	B-X
is	B-X
known	B-X
about	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
analysed	B-X
its	B-X
status	B-X
in	B-X
a	B-X
series	B-X
of	B-X
128	B-X
human	B-X
lung	B-X
carcinomas	B-X
,	B-X
comprising	B-X
50	B-X
non-small	B-X
cell	B-X
lung	B-X
cancers	B-X
(	B-X
NSCLCs	B-X
;	B-X
29	B-X
squamous	B-X
cell	B-X
carcinomas	B-X
and	B-X
21	B-X
adenocarcinomas	B-X
)	B-X
and	B-X
78	B-X
neuroendocrine	B-X
(	B-X
NE	B-X
)	B-X
lung	B-X
tumours	B-X
(	B-X
24	B-X
typical	B-X
and	B-X
atypical	B-X
carcinoids	B-X
,	B-X
19	B-X
large	B-X
cell	B-X
NE	B-X
carcinomas	B-X
and	B-X
35	B-X
small	B-X
cell	B-X
lung	B-X
carcinomas	B-X
)	B-X
,	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
We	B-X
report	B-X
for	B-X
the	B-X
first	B-X
time	B-X
an	B-X
altered	B-X
pattern	B-X
of	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
;	B-X
indeed	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Cul-1	B-X
expression	B-X
is	B-X
up-regulated	B-X
in	B-X
40	B-X
%	B-X
(	B-X
51/128	B-X
)	B-X
of	B-X
all	B-X
lung	B-X
tumours	B-X
as	B-X
compared	B-X
to	B-X
normal	B-X
lung	B-X
tissues	B-X
,	B-X
including	B-X
34	B-X
%	B-X
(	B-X
17/50	B-X
)	B-X
,	B-X
75	B-X
%	B-X
(	B-X
18/24	B-X
)	B-X
and	B-X
30	B-X
%	B-X
(	B-X
16/54	B-X
)	B-X
of	B-X
NSCLCs	B-X
,	B-X
carcinoids	B-X
and	B-X
high	B-X
grade	B-X
neuroendocrine	B-X
lung	B-X
carcinomas	B-X
,	B-X
respectively	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
high	B-X
levels	B-X
of	B-X
Cul-1	B-X
protein	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
low	B-X
KI67	B-X
proliferative	B-X
index	B-X
(	B-X
p	B-X
=	B-X
0.005	B-X
)	B-X
and	B-X
with	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
cyclin	B-X
E	B-X
oncoprotein	B-X
(	B-X
p	B-X
=	B-X
0.0003	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
major	B-X
targets	B-X
of	B-X
SCF	B-X
complexes	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
up-regulation	B-X
of	B-X
Cul-1	B-X
could	B-X
protect	B-X
cells	B-X
from	B-X
hyperproliferative	B-X
signals	B-X
through	B-X
cyclin	B-X
E	B-X
down-regulation	B-X
.	B-X
Cul-1	B-X
is	B-X
modified	B-X
by	B-X
neddylation	B-X
,	B-X
a	B-X
post-translational	B-X
modification	B-X
that	B-X
grafts	B-X
ubiquitin-like	B-X
Nedd8/Rub1	B-X
residues	B-X
and	B-X
controls	B-X
Cul-1	B-X
activity	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
neddylated	B-X
forms	B-X
of	B-X
Cul-1	B-X
are	B-X
specifically	B-X
expressed	B-X
in	B-X
high-grade	B-X
NE	B-X
lung	B-X
tumours	B-X
and	B-X
are	B-X
associated	B-X
with	B-X
down-regulation	B-X
of	B-X
the	B-X
Cul-1	B-X
inhibitor	B-X
CAND1	B-X
(	B-X
p	B-X
=	B-X
0.03	B-X
)	B-X
and	B-X
a	B-X
high	B-X
level	B-X
of	B-X
cyclin	B-X
E	B-X
(	B-X
p	B-X
=	B-X
0.0002	B-X
)	B-X
.	B-X
These	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
alterations	B-X
in	B-X
the	B-X
Cul-1	B-X
neddylation/deneddylation	B-X
pathway	B-X
could	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
these	B-X
highly	B-X
aggressive	B-X
lung	B-X
tumours	B-X
.	B-X

The	O
Cul	B-Protein
-	I-Protein
1	I-Protein
protein	O
is	O
the	O
scaffold	O
element	O
of	O
SCF	O
complexes	O
that	O
are	O
involved	O
in	O
the	O
proteasomal	O
degradation	O
of	O
numerous	O
proteins	O
regulating	O
cell	O
cycle	O
progression	O
.	O
<EOS>	B-X
The	B-X
Cul-1	B-X
protein	B-X
is	B-X
the	B-X
scaffold	B-X
element	B-X
of	B-X
SCF	B-X
complexes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
proteasomal	B-X
degradation	B-X
of	B-X
numerous	B-X
proteins	B-X
regulating	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Owing	B-X
to	B-X
this	B-X
central	B-X
role	B-X
in	B-X
cell	B-X
growth	B-X
control	B-X
,	B-X
aberrant	B-X
expression	B-X
of	B-X
the	B-X
components	B-X
of	B-X
SCF	B-X
is	B-X
thought	B-X
to	B-X
play	B-X
a	B-X
role	B-X
during	B-X
tumourigenesis	B-X
.	B-X
Nothing	B-X
is	B-X
known	B-X
about	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
analysed	B-X
its	B-X
status	B-X
in	B-X
a	B-X
series	B-X
of	B-X
128	B-X
human	B-X
lung	B-X
carcinomas	B-X
,	B-X
comprising	B-X
50	B-X
non-small	B-X
cell	B-X
lung	B-X
cancers	B-X
(	B-X
NSCLCs	B-X
;	B-X
29	B-X
squamous	B-X
cell	B-X
carcinomas	B-X
and	B-X
21	B-X
adenocarcinomas	B-X
)	B-X
and	B-X
78	B-X
neuroendocrine	B-X
(	B-X
NE	B-X
)	B-X
lung	B-X
tumours	B-X
(	B-X
24	B-X
typical	B-X
and	B-X
atypical	B-X
carcinoids	B-X
,	B-X
19	B-X
large	B-X
cell	B-X
NE	B-X
carcinomas	B-X
and	B-X
35	B-X
small	B-X
cell	B-X
lung	B-X
carcinomas	B-X
)	B-X
,	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
We	B-X
report	B-X
for	B-X
the	B-X
first	B-X
time	B-X
an	B-X
altered	B-X
pattern	B-X
of	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
;	B-X
indeed	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Cul-1	B-X
expression	B-X
is	B-X
up-regulated	B-X
in	B-X
40	B-X
%	B-X
(	B-X
51/128	B-X
)	B-X
of	B-X
all	B-X
lung	B-X
tumours	B-X
as	B-X
compared	B-X
to	B-X
normal	B-X
lung	B-X
tissues	B-X
,	B-X
including	B-X
34	B-X
%	B-X
(	B-X
17/50	B-X
)	B-X
,	B-X
75	B-X
%	B-X
(	B-X
18/24	B-X
)	B-X
and	B-X
30	B-X
%	B-X
(	B-X
16/54	B-X
)	B-X
of	B-X
NSCLCs	B-X
,	B-X
carcinoids	B-X
and	B-X
high	B-X
grade	B-X
neuroendocrine	B-X
lung	B-X
carcinomas	B-X
,	B-X
respectively	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
high	B-X
levels	B-X
of	B-X
Cul-1	B-X
protein	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
low	B-X
KI67	B-X
proliferative	B-X
index	B-X
(	B-X
p	B-X
=	B-X
0.005	B-X
)	B-X
and	B-X
with	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
cyclin	B-X
E	B-X
oncoprotein	B-X
(	B-X
p	B-X
=	B-X
0.0003	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
major	B-X
targets	B-X
of	B-X
SCF	B-X
complexes	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
up-regulation	B-X
of	B-X
Cul-1	B-X
could	B-X
protect	B-X
cells	B-X
from	B-X
hyperproliferative	B-X
signals	B-X
through	B-X
cyclin	B-X
E	B-X
down-regulation	B-X
.	B-X
Cul-1	B-X
is	B-X
modified	B-X
by	B-X
neddylation	B-X
,	B-X
a	B-X
post-translational	B-X
modification	B-X
that	B-X
grafts	B-X
ubiquitin-like	B-X
Nedd8/Rub1	B-X
residues	B-X
and	B-X
controls	B-X
Cul-1	B-X
activity	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
neddylated	B-X
forms	B-X
of	B-X
Cul-1	B-X
are	B-X
specifically	B-X
expressed	B-X
in	B-X
high-grade	B-X
NE	B-X
lung	B-X
tumours	B-X
and	B-X
are	B-X
associated	B-X
with	B-X
down-regulation	B-X
of	B-X
the	B-X
Cul-1	B-X
inhibitor	B-X
CAND1	B-X
(	B-X
p	B-X
=	B-X
0.03	B-X
)	B-X
and	B-X
a	B-X
high	B-X
level	B-X
of	B-X
cyclin	B-X
E	B-X
(	B-X
p	B-X
=	B-X
0.0002	B-X
)	B-X
.	B-X
These	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
alterations	B-X
in	B-X
the	B-X
Cul-1	B-X
neddylation/deneddylation	B-X
pathway	B-X
could	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
these	B-X
highly	B-X
aggressive	B-X
lung	B-X
tumours	B-X
.	B-X

Owing	O
to	O
this	O
central	O
role	O
in	O
cell	O
growth	O
control	O
,	O
aberrant	O
expression	O
of	O
the	O
components	O
of	O
SCF	O
is	O
thought	O
to	O
play	O
a	O
role	O
during	O
tumourigenesis	O
.	O
<EOS>	B-X
The	B-X
Cul-1	B-X
protein	B-X
is	B-X
the	B-X
scaffold	B-X
element	B-X
of	B-X
SCF	B-X
complexes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
proteasomal	B-X
degradation	B-X
of	B-X
numerous	B-X
proteins	B-X
regulating	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Owing	B-X
to	B-X
this	B-X
central	B-X
role	B-X
in	B-X
cell	B-X
growth	B-X
control	B-X
,	B-X
aberrant	B-X
expression	B-X
of	B-X
the	B-X
components	B-X
of	B-X
SCF	B-X
is	B-X
thought	B-X
to	B-X
play	B-X
a	B-X
role	B-X
during	B-X
tumourigenesis	B-X
.	B-X
Nothing	B-X
is	B-X
known	B-X
about	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
analysed	B-X
its	B-X
status	B-X
in	B-X
a	B-X
series	B-X
of	B-X
128	B-X
human	B-X
lung	B-X
carcinomas	B-X
,	B-X
comprising	B-X
50	B-X
non-small	B-X
cell	B-X
lung	B-X
cancers	B-X
(	B-X
NSCLCs	B-X
;	B-X
29	B-X
squamous	B-X
cell	B-X
carcinomas	B-X
and	B-X
21	B-X
adenocarcinomas	B-X
)	B-X
and	B-X
78	B-X
neuroendocrine	B-X
(	B-X
NE	B-X
)	B-X
lung	B-X
tumours	B-X
(	B-X
24	B-X
typical	B-X
and	B-X
atypical	B-X
carcinoids	B-X
,	B-X
19	B-X
large	B-X
cell	B-X
NE	B-X
carcinomas	B-X
and	B-X
35	B-X
small	B-X
cell	B-X
lung	B-X
carcinomas	B-X
)	B-X
,	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
We	B-X
report	B-X
for	B-X
the	B-X
first	B-X
time	B-X
an	B-X
altered	B-X
pattern	B-X
of	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
;	B-X
indeed	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Cul-1	B-X
expression	B-X
is	B-X
up-regulated	B-X
in	B-X
40	B-X
%	B-X
(	B-X
51/128	B-X
)	B-X
of	B-X
all	B-X
lung	B-X
tumours	B-X
as	B-X
compared	B-X
to	B-X
normal	B-X
lung	B-X
tissues	B-X
,	B-X
including	B-X
34	B-X
%	B-X
(	B-X
17/50	B-X
)	B-X
,	B-X
75	B-X
%	B-X
(	B-X
18/24	B-X
)	B-X
and	B-X
30	B-X
%	B-X
(	B-X
16/54	B-X
)	B-X
of	B-X
NSCLCs	B-X
,	B-X
carcinoids	B-X
and	B-X
high	B-X
grade	B-X
neuroendocrine	B-X
lung	B-X
carcinomas	B-X
,	B-X
respectively	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
high	B-X
levels	B-X
of	B-X
Cul-1	B-X
protein	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
low	B-X
KI67	B-X
proliferative	B-X
index	B-X
(	B-X
p	B-X
=	B-X
0.005	B-X
)	B-X
and	B-X
with	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
cyclin	B-X
E	B-X
oncoprotein	B-X
(	B-X
p	B-X
=	B-X
0.0003	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
major	B-X
targets	B-X
of	B-X
SCF	B-X
complexes	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
up-regulation	B-X
of	B-X
Cul-1	B-X
could	B-X
protect	B-X
cells	B-X
from	B-X
hyperproliferative	B-X
signals	B-X
through	B-X
cyclin	B-X
E	B-X
down-regulation	B-X
.	B-X
Cul-1	B-X
is	B-X
modified	B-X
by	B-X
neddylation	B-X
,	B-X
a	B-X
post-translational	B-X
modification	B-X
that	B-X
grafts	B-X
ubiquitin-like	B-X
Nedd8/Rub1	B-X
residues	B-X
and	B-X
controls	B-X
Cul-1	B-X
activity	B-X
.	B-X

Nothing	O
is	O
known	O
about	O
Cul	B-Protein
-	I-Protein
1	I-Protein
expression	O
in	O
human	O
tumours	O
.	O
<EOS>	B-X
The	B-X
Cul-1	B-X
protein	B-X
is	B-X
the	B-X
scaffold	B-X
element	B-X
of	B-X
SCF	B-X
complexes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
proteasomal	B-X
degradation	B-X
of	B-X
numerous	B-X
proteins	B-X
regulating	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Owing	B-X
to	B-X
this	B-X
central	B-X
role	B-X
in	B-X
cell	B-X
growth	B-X
control	B-X
,	B-X
aberrant	B-X
expression	B-X
of	B-X
the	B-X
components	B-X
of	B-X
SCF	B-X
is	B-X
thought	B-X
to	B-X
play	B-X
a	B-X
role	B-X
during	B-X
tumourigenesis	B-X
.	B-X
Nothing	B-X
is	B-X
known	B-X
about	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
analysed	B-X
its	B-X
status	B-X
in	B-X
a	B-X
series	B-X
of	B-X
128	B-X
human	B-X
lung	B-X
carcinomas	B-X
,	B-X
comprising	B-X
50	B-X
non-small	B-X
cell	B-X
lung	B-X
cancers	B-X
(	B-X
NSCLCs	B-X
;	B-X
29	B-X
squamous	B-X
cell	B-X
carcinomas	B-X
and	B-X
21	B-X
adenocarcinomas	B-X
)	B-X
and	B-X
78	B-X
neuroendocrine	B-X
(	B-X
NE	B-X
)	B-X
lung	B-X
tumours	B-X
(	B-X
24	B-X
typical	B-X
and	B-X
atypical	B-X
carcinoids	B-X
,	B-X
19	B-X
large	B-X
cell	B-X
NE	B-X
carcinomas	B-X
and	B-X
35	B-X
small	B-X
cell	B-X
lung	B-X
carcinomas	B-X
)	B-X
,	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
We	B-X
report	B-X
for	B-X
the	B-X
first	B-X
time	B-X
an	B-X
altered	B-X
pattern	B-X
of	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
;	B-X
indeed	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Cul-1	B-X
expression	B-X
is	B-X
up-regulated	B-X
in	B-X
40	B-X
%	B-X
(	B-X
51/128	B-X
)	B-X
of	B-X
all	B-X
lung	B-X
tumours	B-X
as	B-X
compared	B-X
to	B-X
normal	B-X
lung	B-X
tissues	B-X
,	B-X
including	B-X
34	B-X
%	B-X
(	B-X
17/50	B-X
)	B-X
,	B-X
75	B-X
%	B-X
(	B-X
18/24	B-X
)	B-X
and	B-X
30	B-X
%	B-X
(	B-X
16/54	B-X
)	B-X
of	B-X
NSCLCs	B-X
,	B-X
carcinoids	B-X
and	B-X
high	B-X
grade	B-X
neuroendocrine	B-X
lung	B-X
carcinomas	B-X
,	B-X
respectively	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
high	B-X
levels	B-X
of	B-X
Cul-1	B-X
protein	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
low	B-X
KI67	B-X
proliferative	B-X
index	B-X
(	B-X
p	B-X
=	B-X
0.005	B-X
)	B-X
and	B-X
with	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
cyclin	B-X
E	B-X
oncoprotein	B-X
(	B-X
p	B-X
=	B-X
0.0003	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
major	B-X
targets	B-X
of	B-X
SCF	B-X
complexes	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
up-regulation	B-X
of	B-X
Cul-1	B-X
could	B-X
protect	B-X
cells	B-X
from	B-X
hyperproliferative	B-X
signals	B-X
through	B-X
cyclin	B-X
E	B-X
down-regulation	B-X
.	B-X
Cul-1	B-X
is	B-X
modified	B-X
by	B-X
neddylation	B-X
,	B-X
a	B-X
post-translational	B-X
modification	B-X
that	B-X
grafts	B-X
ubiquitin-like	B-X
Nedd8/Rub1	B-X
residues	B-X
and	B-X
controls	B-X
Cul-1	B-X
activity	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
neddylated	B-X
forms	B-X
of	B-X
Cul-1	B-X
are	B-X
specifically	B-X
expressed	B-X
in	B-X
high-grade	B-X
NE	B-X
lung	B-X
tumours	B-X
and	B-X
are	B-X
associated	B-X
with	B-X
down-regulation	B-X
of	B-X
the	B-X
Cul-1	B-X
inhibitor	B-X
CAND1	B-X
(	B-X
p	B-X
=	B-X
0.03	B-X
)	B-X
and	B-X
a	B-X
high	B-X
level	B-X
of	B-X
cyclin	B-X
E	B-X
(	B-X
p	B-X
=	B-X
0.0002	B-X
)	B-X
.	B-X
These	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
alterations	B-X
in	B-X
the	B-X
Cul-1	B-X
neddylation/deneddylation	B-X
pathway	B-X
could	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
these	B-X
highly	B-X
aggressive	B-X
lung	B-X
tumours	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
have	O
analysed	O
its	O
status	O
in	O
a	O
series	O
of	O
128	O
human	O
lung	O
carcinomas	O
,	O
comprising	O
50	O
non	O
-	O
small	O
cell	O
lung	O
cancers	O
(	O
NSCLCs	O
;	O
29	O
squamous	O
cell	O
carcinomas	O
and	O
21	O
adenocarcinomas	O
)	O
and	O
78	O
neuroendocrine	O
(	O
NE	O
)	O
lung	O
tumours	O
(	O
24	O
typical	O
and	O
atypical	O
carcinoids	O
,	O
19	O
large	O
cell	O
NE	O
carcinomas	O
and	O
35	O
small	O
cell	O
lung	O
carcinomas	O
)	O
,	O
using	O
immunohistochemistry	O
.	O

We	O
report	O
for	O
the	O
first	O
time	O
an	O
altered	O
pattern	O
of	O
Cul	B-Protein
-	I-Protein
1	I-Protein
expression	O
in	O
human	O
tumours	O
;	O
indeed	O
,	O
we	O
show	O
that	O
Cul	B-Protein
-	I-Protein
1	I-Protein
expression	O
is	O
up	O
-	O
regulated	O
in	O
40	O
%	O
(	O
51	O
/	O
128	O
)	O
of	O
all	O
lung	O
tumours	O
as	O
compared	O
to	O
normal	O
lung	O
tissues	O
,	O
including	O
34	O
%	O
(	O
17	O
/	O
50	O
)	O
,	O
75	O
%	O
(	O
18	O
/	O
24	O
)	O
and	O
30	O
%	O
(	O
16	O
/	O
54	O
)	O
of	O
NSCLCs	O
,	O
carcinoids	O
and	O
high	O
grade	O
neuroendocrine	O
lung	O
carcinomas	O
,	O
respectively	O
.	O
<EOS>	B-X
The	B-X
Cul-1	B-X
protein	B-X
is	B-X
the	B-X
scaffold	B-X
element	B-X
of	B-X
SCF	B-X
complexes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
proteasomal	B-X
degradation	B-X
of	B-X
numerous	B-X
proteins	B-X
regulating	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Owing	B-X
to	B-X
this	B-X
central	B-X
role	B-X
in	B-X
cell	B-X
growth	B-X
control	B-X
,	B-X
aberrant	B-X
expression	B-X
of	B-X
the	B-X
components	B-X
of	B-X
SCF	B-X
is	B-X
thought	B-X
to	B-X
play	B-X
a	B-X
role	B-X
during	B-X
tumourigenesis	B-X
.	B-X
Nothing	B-X
is	B-X
known	B-X
about	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
analysed	B-X
its	B-X
status	B-X
in	B-X
a	B-X
series	B-X
of	B-X
128	B-X
human	B-X
lung	B-X
carcinomas	B-X
,	B-X
comprising	B-X
50	B-X
non-small	B-X
cell	B-X
lung	B-X
cancers	B-X
(	B-X
NSCLCs	B-X
;	B-X
29	B-X
squamous	B-X
cell	B-X
carcinomas	B-X
and	B-X
21	B-X
adenocarcinomas	B-X
)	B-X
and	B-X
78	B-X
neuroendocrine	B-X
(	B-X
NE	B-X
)	B-X
lung	B-X
tumours	B-X
(	B-X
24	B-X
typical	B-X
and	B-X
atypical	B-X
carcinoids	B-X
,	B-X
19	B-X
large	B-X
cell	B-X
NE	B-X
carcinomas	B-X
and	B-X
35	B-X
small	B-X
cell	B-X
lung	B-X
carcinomas	B-X
)	B-X
,	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
We	B-X
report	B-X
for	B-X
the	B-X
first	B-X
time	B-X
an	B-X
altered	B-X
pattern	B-X
of	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
;	B-X
indeed	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Cul-1	B-X
expression	B-X
is	B-X
up-regulated	B-X
in	B-X
40	B-X
%	B-X
(	B-X
51/128	B-X
)	B-X
of	B-X
all	B-X
lung	B-X
tumours	B-X
as	B-X
compared	B-X
to	B-X
normal	B-X
lung	B-X
tissues	B-X
,	B-X
including	B-X
34	B-X
%	B-X
(	B-X
17/50	B-X
)	B-X
,	B-X
75	B-X
%	B-X
(	B-X
18/24	B-X
)	B-X
and	B-X
30	B-X
%	B-X
(	B-X
16/54	B-X
)	B-X
of	B-X
NSCLCs	B-X
,	B-X
carcinoids	B-X
and	B-X
high	B-X
grade	B-X
neuroendocrine	B-X
lung	B-X
carcinomas	B-X
,	B-X
respectively	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
high	B-X
levels	B-X
of	B-X
Cul-1	B-X
protein	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
low	B-X
KI67	B-X
proliferative	B-X
index	B-X
(	B-X
p	B-X
=	B-X
0.005	B-X
)	B-X
and	B-X
with	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
cyclin	B-X
E	B-X
oncoprotein	B-X
(	B-X
p	B-X
=	B-X
0.0003	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
major	B-X
targets	B-X
of	B-X
SCF	B-X
complexes	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
up-regulation	B-X
of	B-X
Cul-1	B-X
could	B-X
protect	B-X
cells	B-X
from	B-X
hyperproliferative	B-X
signals	B-X
through	B-X
cyclin	B-X
E	B-X
down-regulation	B-X
.	B-X
Cul-1	B-X
is	B-X
modified	B-X
by	B-X
neddylation	B-X
,	B-X
a	B-X
post-translational	B-X
modification	B-X
that	B-X
grafts	B-X
ubiquitin-like	B-X
Nedd8/Rub1	B-X
residues	B-X
and	B-X
controls	B-X
Cul-1	B-X
activity	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
neddylated	B-X
forms	B-X
of	B-X
Cul-1	B-X
are	B-X
specifically	B-X
expressed	B-X
in	B-X
high-grade	B-X
NE	B-X
lung	B-X
tumours	B-X
and	B-X
are	B-X
associated	B-X
with	B-X
down-regulation	B-X
of	B-X
the	B-X
Cul-1	B-X
inhibitor	B-X
CAND1	B-X
(	B-X
p	B-X
=	B-X
0.03	B-X
)	B-X
and	B-X
a	B-X
high	B-X
level	B-X
of	B-X
cyclin	B-X
E	B-X
(	B-X
p	B-X
=	B-X
0.0002	B-X
)	B-X
.	B-X
These	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
alterations	B-X
in	B-X
the	B-X
Cul-1	B-X
neddylation/deneddylation	B-X
pathway	B-X
could	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
these	B-X
highly	B-X
aggressive	B-X
lung	B-X
tumours	B-X
.	B-X

Furthermore	O
,	O
we	O
demonstrate	O
that	O
high	O
levels	O
of	O
Cul	B-Protein
-	I-Protein
1	I-Protein
protein	O
are	O
associated	O
with	O
a	O
low	O
KI67	O
proliferative	O
index	O
(	O
p	O
=	O
0	O
.	O
005	O
)	O
and	O
with	O
a	O
decrease	O
in	O
the	O
cyclin	B-Protein
E	I-Protein
oncoprotein	O
(	O
p	O
=	O
0	O
.	O
0003	O
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
SCF	O
complexes	O
.	O

These	O
data	O
suggest	O
that	O
up	O
-	O
regulation	O
of	O
Cul	B-Protein
-	I-Protein
1	I-Protein
could	O
protect	O
cells	O
from	O
hyperproliferative	O
signals	O
through	O
cyclin	B-Protein
E	I-Protein
down	O
-	O
regulation	O
.	O
<EOS>	B-X
The	B-X
Cul-1	B-X
protein	B-X
is	B-X
the	B-X
scaffold	B-X
element	B-X
of	B-X
SCF	B-X
complexes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
proteasomal	B-X
degradation	B-X
of	B-X
numerous	B-X
proteins	B-X
regulating	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Nothing	B-X
is	B-X
known	B-X
about	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
analysed	B-X
its	B-X
status	B-X
in	B-X
a	B-X
series	B-X
of	B-X
128	B-X
human	B-X
lung	B-X
carcinomas	B-X
,	B-X
comprising	B-X
50	B-X
non-small	B-X
cell	B-X
lung	B-X
cancers	B-X
(	B-X
NSCLCs	B-X
;	B-X
29	B-X
squamous	B-X
cell	B-X
carcinomas	B-X
and	B-X
21	B-X
adenocarcinomas	B-X
)	B-X
and	B-X
78	B-X
neuroendocrine	B-X
(	B-X
NE	B-X
)	B-X
lung	B-X
tumours	B-X
(	B-X
24	B-X
typical	B-X
and	B-X
atypical	B-X
carcinoids	B-X
,	B-X
19	B-X
large	B-X
cell	B-X
NE	B-X
carcinomas	B-X
and	B-X
35	B-X
small	B-X
cell	B-X
lung	B-X
carcinomas	B-X
)	B-X
,	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
We	B-X
report	B-X
for	B-X
the	B-X
first	B-X
time	B-X
an	B-X
altered	B-X
pattern	B-X
of	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
;	B-X
indeed	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Cul-1	B-X
expression	B-X
is	B-X
up-regulated	B-X
in	B-X
40	B-X
%	B-X
(	B-X
51/128	B-X
)	B-X
of	B-X
all	B-X
lung	B-X
tumours	B-X
as	B-X
compared	B-X
to	B-X
normal	B-X
lung	B-X
tissues	B-X
,	B-X
including	B-X
34	B-X
%	B-X
(	B-X
17/50	B-X
)	B-X
,	B-X
75	B-X
%	B-X
(	B-X
18/24	B-X
)	B-X
and	B-X
30	B-X
%	B-X
(	B-X
16/54	B-X
)	B-X
of	B-X
NSCLCs	B-X
,	B-X
carcinoids	B-X
and	B-X
high	B-X
grade	B-X
neuroendocrine	B-X
lung	B-X
carcinomas	B-X
,	B-X
respectively	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
high	B-X
levels	B-X
of	B-X
Cul-1	B-X
protein	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
low	B-X
KI67	B-X
proliferative	B-X
index	B-X
(	B-X
p	B-X
=	B-X
0.005	B-X
)	B-X
and	B-X
with	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
cyclin	B-X
E	B-X
oncoprotein	B-X
(	B-X
p	B-X
=	B-X
0.0003	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
major	B-X
targets	B-X
of	B-X
SCF	B-X
complexes	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
up-regulation	B-X
of	B-X
Cul-1	B-X
could	B-X
protect	B-X
cells	B-X
from	B-X
hyperproliferative	B-X
signals	B-X
through	B-X
cyclin	B-X
E	B-X
down-regulation	B-X
.	B-X
Cul-1	B-X
is	B-X
modified	B-X
by	B-X
neddylation	B-X
,	B-X
a	B-X
post-translational	B-X
modification	B-X
that	B-X
grafts	B-X
ubiquitin-like	B-X
Nedd8/Rub1	B-X
residues	B-X
and	B-X
controls	B-X
Cul-1	B-X
activity	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
neddylated	B-X
forms	B-X
of	B-X
Cul-1	B-X
are	B-X
specifically	B-X
expressed	B-X
in	B-X
high-grade	B-X
NE	B-X
lung	B-X
tumours	B-X
and	B-X
are	B-X
associated	B-X
with	B-X
down-regulation	B-X
of	B-X
the	B-X
Cul-1	B-X
inhibitor	B-X
CAND1	B-X
(	B-X
p	B-X
=	B-X
0.03	B-X
)	B-X
and	B-X
a	B-X
high	B-X
level	B-X
of	B-X
cyclin	B-X
E	B-X
(	B-X
p	B-X
=	B-X
0.0002	B-X
)	B-X
.	B-X
These	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
alterations	B-X
in	B-X
the	B-X
Cul-1	B-X
neddylation/deneddylation	B-X
pathway	B-X
could	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
these	B-X
highly	B-X
aggressive	B-X
lung	B-X
tumours	B-X
.	B-X

Cul	B-Protein
-	I-Protein
1	I-Protein
is	O
modified	O
by	O
neddylation	O
,	O
a	O
post	O
-	O
translational	O
modification	O
that	O
grafts	O
ubiquitin	B-Protein
-	O
like	O
Nedd8	B-Protein
/	O
Rub1	B-Protein
residues	O
and	O
controls	O
Cul	B-Protein
-	I-Protein
1	I-Protein
activity	O
.	O
<EOS>	B-X
The	B-X
Cul-1	B-X
protein	B-X
is	B-X
the	B-X
scaffold	B-X
element	B-X
of	B-X
SCF	B-X
complexes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
proteasomal	B-X
degradation	B-X
of	B-X
numerous	B-X
proteins	B-X
regulating	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Nothing	B-X
is	B-X
known	B-X
about	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
analysed	B-X
its	B-X
status	B-X
in	B-X
a	B-X
series	B-X
of	B-X
128	B-X
human	B-X
lung	B-X
carcinomas	B-X
,	B-X
comprising	B-X
50	B-X
non-small	B-X
cell	B-X
lung	B-X
cancers	B-X
(	B-X
NSCLCs	B-X
;	B-X
29	B-X
squamous	B-X
cell	B-X
carcinomas	B-X
and	B-X
21	B-X
adenocarcinomas	B-X
)	B-X
and	B-X
78	B-X
neuroendocrine	B-X
(	B-X
NE	B-X
)	B-X
lung	B-X
tumours	B-X
(	B-X
24	B-X
typical	B-X
and	B-X
atypical	B-X
carcinoids	B-X
,	B-X
19	B-X
large	B-X
cell	B-X
NE	B-X
carcinomas	B-X
and	B-X
35	B-X
small	B-X
cell	B-X
lung	B-X
carcinomas	B-X
)	B-X
,	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
We	B-X
report	B-X
for	B-X
the	B-X
first	B-X
time	B-X
an	B-X
altered	B-X
pattern	B-X
of	B-X
Cul-1	B-X
expression	B-X
in	B-X
human	B-X
tumours	B-X
;	B-X
indeed	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Cul-1	B-X
expression	B-X
is	B-X
up-regulated	B-X
in	B-X
40	B-X
%	B-X
(	B-X
51/128	B-X
)	B-X
of	B-X
all	B-X
lung	B-X
tumours	B-X
as	B-X
compared	B-X
to	B-X
normal	B-X
lung	B-X
tissues	B-X
,	B-X
including	B-X
34	B-X
%	B-X
(	B-X
17/50	B-X
)	B-X
,	B-X
75	B-X
%	B-X
(	B-X
18/24	B-X
)	B-X
and	B-X
30	B-X
%	B-X
(	B-X
16/54	B-X
)	B-X
of	B-X
NSCLCs	B-X
,	B-X
carcinoids	B-X
and	B-X
high	B-X
grade	B-X
neuroendocrine	B-X
lung	B-X
carcinomas	B-X
,	B-X
respectively	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
high	B-X
levels	B-X
of	B-X
Cul-1	B-X
protein	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
low	B-X
KI67	B-X
proliferative	B-X
index	B-X
(	B-X
p	B-X
=	B-X
0.005	B-X
)	B-X
and	B-X
with	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
cyclin	B-X
E	B-X
oncoprotein	B-X
(	B-X
p	B-X
=	B-X
0.0003	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
major	B-X
targets	B-X
of	B-X
SCF	B-X
complexes	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
up-regulation	B-X
of	B-X
Cul-1	B-X
could	B-X
protect	B-X
cells	B-X
from	B-X
hyperproliferative	B-X
signals	B-X
through	B-X
cyclin	B-X
E	B-X
down-regulation	B-X
.	B-X
Cul-1	B-X
is	B-X
modified	B-X
by	B-X
neddylation	B-X
,	B-X
a	B-X
post-translational	B-X
modification	B-X
that	B-X
grafts	B-X
ubiquitin-like	B-X
Nedd8/Rub1	B-X
residues	B-X
and	B-X
controls	B-X
Cul-1	B-X
activity	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
neddylated	B-X
forms	B-X
of	B-X
Cul-1	B-X
are	B-X
specifically	B-X
expressed	B-X
in	B-X
high-grade	B-X
NE	B-X
lung	B-X
tumours	B-X
and	B-X
are	B-X
associated	B-X
with	B-X
down-regulation	B-X
of	B-X
the	B-X
Cul-1	B-X
inhibitor	B-X
CAND1	B-X
(	B-X
p	B-X
=	B-X
0.03	B-X
)	B-X
and	B-X
a	B-X
high	B-X
level	B-X
of	B-X
cyclin	B-X
E	B-X
(	B-X
p	B-X
=	B-X
0.0002	B-X
)	B-X
.	B-X
These	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
alterations	B-X
in	B-X
the	B-X
Cul-1	B-X
neddylation/deneddylation	B-X
pathway	B-X
could	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
these	B-X
highly	B-X
aggressive	B-X
lung	B-X
tumours	B-X
.	B-X

We	O
also	O
provide	O
evidence	O
that	O
neddylated	O
forms	O
of	O
Cul	B-Protein
-	I-Protein
1	I-Protein
are	O
specifically	O
expressed	O
in	O
high	O
-	O
grade	O
NE	O
lung	O
tumours	O
and	O
are	O
associated	O
with	O
down	O
-	O
regulation	O
of	O
the	O
Cul	B-Protein
-	I-Protein
1	I-Protein
inhibitor	O
CAND1	B-Protein
(	O
p	O
=	O
0	O
.	O
03	O
)	O
and	O
a	O
high	O
level	O
of	O
cyclin	B-Protein
E	I-Protein
(	O
p	O
=	O
0	O
.	O
0002	O
)	O
.	O

These	O
data	O
support	O
the	O
notion	O
that	O
alterations	O
in	O
the	O
Cul	B-Protein
-	I-Protein
1	I-Protein
neddylation	O
/	O
deneddylation	O
pathway	O
could	O
contribute	O
to	O
the	O
development	O
of	O
these	O
highly	O
aggressive	O
lung	O
tumours	O
.	O

Polyunsaturated	O
fatty	O
acids	O
block	O
platelet	O
-	O
activating	O
factor	O
-	O
induced	O
phosphatidylinositol	O
3	O
kinase	O
/	O
Akt	O
-	O
mediated	O
apoptosis	O
in	O
intestinal	O
epithelial	O
cells	O
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
earlier	B-X
that	B-X
platelet-activating	B-X
factor	B-X
(	B-X
PAF	B-X
)	B-X
causes	B-X
apoptosis	B-X
in	B-X
enterocytes	B-X
via	B-X
a	B-X
mechanism	B-X
that	B-X
involves	B-X
Bax	B-X
translocation	B-X
to	B-X
mitochondria	B-X
,	B-X
followed	B-X
by	B-X
caspase	B-X
activation	B-X
and	B-X
DNA	B-X
fragmentation	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
rat	B-X
small	B-X
intestinal	B-X
epithelial	B-X
cells	B-X
(	B-X
IEC-6	B-X
)	B-X
,	B-X
these	B-X
downstream	B-X
apoptotic	B-X
effects	B-X
are	B-X
mediated	B-X
by	B-X
a	B-X
PAF-induced	B-X
inhibition	B-X
of	B-X
the	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI	B-X
3-kinase	B-X
)	B-X
/protein	B-X
kinase	B-X
B	B-X
(	B-X
Akt	B-X
)	B-X
signaling	B-X
pathway	B-X
.	B-X
Treatment	B-X
with	B-X
PAF	B-X
results	B-X
in	B-X
rapid	B-X
dephosphorylation	B-X
of	B-X
Akt	B-X
,	B-X
phosphoinositide-dependent	B-X
kinase-1	B-X
,	B-X
and	B-X
the	B-X
YXXM	B-X
p85	B-X
binding	B-X
motif	B-X
of	B-X
several	B-X
proteins	B-X
and	B-X
redistribution	B-X
of	B-X
Akt-pleckstrin	B-X
homology	B-X
domain-green	B-X
fluorescent	B-X
protein	B-X
,	B-X
i.e.	B-X
,	B-X
an	B-X
in	B-X
vivo	B-X
phosphatidylinositol	B-X
(	B-X
3,4,5	B-X
)	B-X
-trisphosphate	B-X
sensor	B-X
,	B-X
from	B-X
membrane	B-X
to	B-X
cytosol	B-X
.	B-X
The	B-X
proapoptotic	B-X
effects	B-X
of	B-X
PAF	B-X
were	B-X
inhibited	B-X
by	B-X
both	B-X
n-3	B-X
and	B-X
n-6	B-X
polyunsaturated	B-X
fatty	B-X
acids	B-X
but	B-X
not	B-X
by	B-X
a	B-X
saturated	B-X
fatty	B-X
acid	B-X
palmitate	B-X
.	B-X
Indomethacin	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
prostaglandin	B-X
biosynthesis	B-X
,	B-X
did	B-X
not	B-X
influence	B-X
the	B-X
baseline	B-X
or	B-X
PAF-induced	B-X
apoptosis	B-X
,	B-X
but	B-X
2-bromopalmitate	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
protein	B-X
palmitoylation	B-X
,	B-X
inhibited	B-X
all	B-X
of	B-X
the	B-X
proapoptotic	B-X
effects	B-X
of	B-X
PAF	B-X
.	B-X
Our	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
an	B-X
inhibition	B-X
of	B-X
the	B-X
PI	B-X
3-kinase/Akt	B-X
signaling	B-X
pathway	B-X
is	B-X
the	B-X
main	B-X
mechanism	B-X
of	B-X
PAF-induced	B-X
apoptosis	B-X
in	B-X
enterocytes	B-X
and	B-X
that	B-X
polyunsaturated	B-X
fatty	B-X
acids	B-X
block	B-X
this	B-X
mechanism	B-X
very	B-X
early	B-X
in	B-X
the	B-X
signaling	B-X
cascade	B-X
independently	B-X
of	B-X
any	B-X
effect	B-X
on	B-X
prostaglandin	B-X
synthesis	B-X
,	B-X
and	B-X
probably	B-X
directly	B-X
via	B-X
an	B-X
effect	B-X
on	B-X
protein	B-X
palmitoylation	B-X
.	B-X

We	O
have	O
shown	O
earlier	O
that	O
platelet	O
-	O
activating	O
factor	O
(	O
PAF	O
)	O
causes	O
apoptosis	O
in	O
enterocytes	O
via	O
a	O
mechanism	O
that	O
involves	O
Bax	B-Protein
translocation	O
to	O
mitochondria	O
,	O
followed	O
by	O
caspase	O
activation	O
and	O
DNA	O
fragmentation	O
.	O

Herein	O
we	O
report	O
that	O
,	O
in	O
rat	O
small	O
intestinal	O
epithelial	O
cells	O
(	O
IEC	O
-	O
6	O
)	O
,	O
these	O
downstream	O
apoptotic	O
effects	O
are	O
mediated	O
by	O
a	O
PAF	O
-	O
induced	O
inhibition	O
of	O
the	O
phosphatidylinositol	O
3	O
-	O
kinase	O
(	O
PI	O
3	O
-	O
kinase	O
)	O
/	O
protein	O
kinase	O
B	O
(	O
Akt	O
)	O
signaling	O
pathway	O
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
earlier	B-X
that	B-X
platelet-activating	B-X
factor	B-X
(	B-X
PAF	B-X
)	B-X
causes	B-X
apoptosis	B-X
in	B-X
enterocytes	B-X
via	B-X
a	B-X
mechanism	B-X
that	B-X
involves	B-X
Bax	B-X
translocation	B-X
to	B-X
mitochondria	B-X
,	B-X
followed	B-X
by	B-X
caspase	B-X
activation	B-X
and	B-X
DNA	B-X
fragmentation	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
rat	B-X
small	B-X
intestinal	B-X
epithelial	B-X
cells	B-X
(	B-X
IEC-6	B-X
)	B-X
,	B-X
these	B-X
downstream	B-X
apoptotic	B-X
effects	B-X
are	B-X
mediated	B-X
by	B-X
a	B-X
PAF-induced	B-X
inhibition	B-X
of	B-X
the	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI	B-X
3-kinase	B-X
)	B-X
/protein	B-X
kinase	B-X
B	B-X
(	B-X
Akt	B-X
)	B-X
signaling	B-X
pathway	B-X
.	B-X
Treatment	B-X
with	B-X
PAF	B-X
results	B-X
in	B-X
rapid	B-X
dephosphorylation	B-X
of	B-X
Akt	B-X
,	B-X
phosphoinositide-dependent	B-X
kinase-1	B-X
,	B-X
and	B-X
the	B-X
YXXM	B-X
p85	B-X
binding	B-X
motif	B-X
of	B-X
several	B-X
proteins	B-X
and	B-X
redistribution	B-X
of	B-X
Akt-pleckstrin	B-X
homology	B-X
domain-green	B-X
fluorescent	B-X
protein	B-X
,	B-X
i.e.	B-X
,	B-X
an	B-X
in	B-X
vivo	B-X
phosphatidylinositol	B-X
(	B-X
3,4,5	B-X
)	B-X
-trisphosphate	B-X
sensor	B-X
,	B-X
from	B-X
membrane	B-X
to	B-X
cytosol	B-X
.	B-X
The	B-X
proapoptotic	B-X
effects	B-X
of	B-X
PAF	B-X
were	B-X
inhibited	B-X
by	B-X
both	B-X
n-3	B-X
and	B-X
n-6	B-X
polyunsaturated	B-X
fatty	B-X
acids	B-X
but	B-X
not	B-X
by	B-X
a	B-X
saturated	B-X
fatty	B-X
acid	B-X
palmitate	B-X
.	B-X
Indomethacin	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
prostaglandin	B-X
biosynthesis	B-X
,	B-X
did	B-X
not	B-X
influence	B-X
the	B-X
baseline	B-X
or	B-X
PAF-induced	B-X
apoptosis	B-X
,	B-X
but	B-X
2-bromopalmitate	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
protein	B-X
palmitoylation	B-X
,	B-X
inhibited	B-X
all	B-X
of	B-X
the	B-X
proapoptotic	B-X
effects	B-X
of	B-X
PAF	B-X
.	B-X
Our	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
an	B-X
inhibition	B-X
of	B-X
the	B-X
PI	B-X
3-kinase/Akt	B-X
signaling	B-X
pathway	B-X
is	B-X
the	B-X
main	B-X
mechanism	B-X
of	B-X
PAF-induced	B-X
apoptosis	B-X
in	B-X
enterocytes	B-X
and	B-X
that	B-X
polyunsaturated	B-X
fatty	B-X
acids	B-X
block	B-X
this	B-X
mechanism	B-X
very	B-X
early	B-X
in	B-X
the	B-X
signaling	B-X
cascade	B-X
independently	B-X
of	B-X
any	B-X
effect	B-X
on	B-X
prostaglandin	B-X
synthesis	B-X
,	B-X
and	B-X
probably	B-X
directly	B-X
via	B-X
an	B-X
effect	B-X
on	B-X
protein	B-X
palmitoylation	B-X
.	B-X

Treatment	O
with	O
PAF	O
results	O
in	O
rapid	O
dephosphorylation	O
of	O
Akt	O
,	O
phosphoinositide	B-Protein
-	I-Protein
dependent	I-Protein
kinase	I-Protein
-	I-Protein
1	I-Protein
,	O
and	O
the	O
YXXM	O
p85	B-Protein
binding	O
motif	O
of	O
several	O
proteins	O
and	O
redistribution	O
of	O
Akt	O
-	O
pleckstrin	O
homology	O
domain	O
-	O
green	O
fluorescent	O
protein	O
,	O
i	O
.	O
e	O
.	O
,	O
an	O
in	O
vivo	O
phosphatidylinositol	O
(	O
3	O
,	O
4	O
,	O
5	O
)	O
-	O
trisphosphate	O
sensor	O
,	O
from	O
membrane	O
to	O
cytosol	O
.	O

The	O
proapoptotic	O
effects	O
of	O
PAF	O
were	O
inhibited	O
by	O
both	O
n	O
-	O
3	O
and	O
n	O
-	O
6	O
polyunsaturated	O
fatty	O
acids	O
but	O
not	O
by	O
a	O
saturated	O
fatty	O
acid	O
palmitate	O
.	O

Indomethacin	O
,	O
an	O
inhibitor	O
of	O
prostaglandin	O
biosynthesis	O
,	O
did	O
not	O
influence	O
the	O
baseline	O
or	O
PAF	O
-	O
induced	O
apoptosis	O
,	O
but	O
2	O
-	O
bromopalmitate	O
,	O
an	O
inhibitor	O
of	O
protein	O
palmitoylation	O
,	O
inhibited	O
all	O
of	O
the	O
proapoptotic	O
effects	O
of	O
PAF	O
.	O
<EOS>	B-X
The	B-X
isolated	B-X
perfused	B-X
rabbit	B-X
heart	B-X
has	B-X
the	B-X
capacity	B-X
to	B-X
rapidly	B-X
synthesize	B-X
,	B-X
release	B-X
,	B-X
and	B-X
inactivate	B-X
prostaglandins	B-X
(	B-X
PGs	B-X
)	B-X
which	B-X
can	B-X
readily	B-X
modulate	B-X
coronary	B-X
resistance	B-X
and	B-X
cardiac	B-X
performance	B-X
.	B-X
Prostaglandin	B-X
synthetase	B-X
converts	B-X
arachidonic	B-X
acid	B-X
to	B-X
prostaglandin-like	B-X
substance	B-X
in	B-X
one	B-X
passage	B-X
across	B-X
the	B-X
heart	B-X
.	B-X
There	B-X
is	B-X
little	B-X
evidence	B-X
of	B-X
functional	B-X
prostaglandin	B-X
dehydrogenase	B-X
activity	B-X
.	B-X
Arachidonic	B-X
acid	B-X
and	B-X
bradykinin	B-X
produce	B-X
a	B-X
concentration-dependent	B-X
decrease	B-X
in	B-X
coronary	B-X
resistance	B-X
directly	B-X
associated	B-X
with	B-X
PG-like	B-X
substance	B-X
biosynthesis	B-X
and	B-X
release	B-X
.	B-X
An	B-X
inhibitor	B-X
of	B-X
bradykinin	B-X
destruction	B-X
,	B-X
the	B-X
nonapeptide	B-X
SQ-20881	B-X
,	B-X
markedly	B-X
enhanced	B-X
both	B-X
the	B-X
coronary	B-X
vasodilation	B-X
and	B-X
PG-like	B-X
substance	B-X
release	B-X
produced	B-X
by	B-X
cardiac	B-X
injection	B-X
of	B-X
bradykinin	B-X
.	B-X
Indomethacin	B-X
inhibited	B-X
both	B-X
the	B-X
myocardial	B-X
prostaglandin	B-X
biosynthesis	B-X
and	B-X
the	B-X
decrease	B-X
in	B-X
coronary	B-X
resistance	B-X
induced	B-X
by	B-X
bradykinin	B-X
and	B-X
arachidonic	B-X
acid	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
direct	B-X
effects	B-X
on	B-X
coronary	B-X
vascular	B-X
smooth	B-X
muscle	B-X
,	B-X
prostaglandins	B-X
produced	B-X
in	B-X
the	B-X
heart	B-X
apparently	B-X
exert	B-X
a	B-X
modulating	B-X
influence	B-X
on	B-X
efferent	B-X
autonomic	B-X
and	B-X
on	B-X
afferent	B-X
cardiovascular	B-X
and	B-X
pain	B-X
reflexes	B-X
.	B-X

Our	O
data	O
strongly	O
suggest	O
that	O
an	O
inhibition	O
of	O
the	O
PI	O
3	O
-	O
kinase	O
/	O
Akt	O
signaling	O
pathway	O
is	O
the	O
main	O
mechanism	O
of	O
PAF	O
-	O
induced	O
apoptosis	O
in	O
enterocytes	O
and	O
that	O
polyunsaturated	O
fatty	O
acids	O
block	O
this	O
mechanism	O
very	O
early	O
in	O
the	O
signaling	O
cascade	O
independently	O
of	O
any	O
effect	O
on	O
prostaglandin	O
synthesis	O
,	O
and	O
probably	O
directly	O
via	O
an	O
effect	O
on	O
protein	O
palmitoylation	O
.	O
<EOS>	B-X
We	B-X
have	B-X
shown	B-X
earlier	B-X
that	B-X
platelet-activating	B-X
factor	B-X
(	B-X
PAF	B-X
)	B-X
causes	B-X
apoptosis	B-X
in	B-X
enterocytes	B-X
via	B-X
a	B-X
mechanism	B-X
that	B-X
involves	B-X
Bax	B-X
translocation	B-X
to	B-X
mitochondria	B-X
,	B-X
followed	B-X
by	B-X
caspase	B-X
activation	B-X
and	B-X
DNA	B-X
fragmentation	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
rat	B-X
small	B-X
intestinal	B-X
epithelial	B-X
cells	B-X
(	B-X
IEC-6	B-X
)	B-X
,	B-X
these	B-X
downstream	B-X
apoptotic	B-X
effects	B-X
are	B-X
mediated	B-X
by	B-X
a	B-X
PAF-induced	B-X
inhibition	B-X
of	B-X
the	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI	B-X
3-kinase	B-X
)	B-X
/protein	B-X
kinase	B-X
B	B-X
(	B-X
Akt	B-X
)	B-X
signaling	B-X
pathway	B-X
.	B-X
Treatment	B-X
with	B-X
PAF	B-X
results	B-X
in	B-X
rapid	B-X
dephosphorylation	B-X
of	B-X
Akt	B-X
,	B-X
phosphoinositide-dependent	B-X
kinase-1	B-X
,	B-X
and	B-X
the	B-X
YXXM	B-X
p85	B-X
binding	B-X
motif	B-X
of	B-X
several	B-X
proteins	B-X
and	B-X
redistribution	B-X
of	B-X
Akt-pleckstrin	B-X
homology	B-X
domain-green	B-X
fluorescent	B-X
protein	B-X
,	B-X
i.e.	B-X
,	B-X
an	B-X
in	B-X
vivo	B-X
phosphatidylinositol	B-X
(	B-X
3,4,5	B-X
)	B-X
-trisphosphate	B-X
sensor	B-X
,	B-X
from	B-X
membrane	B-X
to	B-X
cytosol	B-X
.	B-X
The	B-X
proapoptotic	B-X
effects	B-X
of	B-X
PAF	B-X
were	B-X
inhibited	B-X
by	B-X
both	B-X
n-3	B-X
and	B-X
n-6	B-X
polyunsaturated	B-X
fatty	B-X
acids	B-X
but	B-X
not	B-X
by	B-X
a	B-X
saturated	B-X
fatty	B-X
acid	B-X
palmitate	B-X
.	B-X
Indomethacin	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
prostaglandin	B-X
biosynthesis	B-X
,	B-X
did	B-X
not	B-X
influence	B-X
the	B-X
baseline	B-X
or	B-X
PAF-induced	B-X
apoptosis	B-X
,	B-X
but	B-X
2-bromopalmitate	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
protein	B-X
palmitoylation	B-X
,	B-X
inhibited	B-X
all	B-X
of	B-X
the	B-X
proapoptotic	B-X
effects	B-X
of	B-X
PAF	B-X
.	B-X
Our	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
an	B-X
inhibition	B-X
of	B-X
the	B-X
PI	B-X
3-kinase/Akt	B-X
signaling	B-X
pathway	B-X
is	B-X
the	B-X
main	B-X
mechanism	B-X
of	B-X
PAF-induced	B-X
apoptosis	B-X
in	B-X
enterocytes	B-X
and	B-X
that	B-X
polyunsaturated	B-X
fatty	B-X
acids	B-X
block	B-X
this	B-X
mechanism	B-X
very	B-X
early	B-X
in	B-X
the	B-X
signaling	B-X
cascade	B-X
independently	B-X
of	B-X
any	B-X
effect	B-X
on	B-X
prostaglandin	B-X
synthesis	B-X
,	B-X
and	B-X
probably	B-X
directly	B-X
via	B-X
an	B-X
effect	B-X
on	B-X
protein	B-X
palmitoylation	B-X
.	B-X

Ubiquitylation	O
is	O
required	O
for	O
degradation	O
of	O
transmembrane	O
surface	O
proteins	O
in	O
trypanosomes	O
.	O
<EOS>	B-X
The	B-X
surface	B-X
of	B-X
Trypanosoma	B-X
brucei	B-X
is	B-X
dominated	B-X
by	B-X
glycosyl-phosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
-anchored	B-X
proteins	B-X
,	B-X
and	B-X
endocytosis	B-X
is	B-X
clathrin	B-X
dependent	B-X
.	B-X
The	B-X
vast	B-X
majority	B-X
of	B-X
internalized	B-X
GPI-anchored	B-X
protein	B-X
is	B-X
efficiently	B-X
recycled	B-X
,	B-X
while	B-X
the	B-X
processes	B-X
by	B-X
which	B-X
transmembrane	B-X
domain	B-X
(	B-X
TMD	B-X
)	B-X
proteins	B-X
are	B-X
internalized	B-X
and	B-X
sorted	B-X
are	B-X
unknown	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
internalization	B-X
of	B-X
invariant	B-X
surface	B-X
glycoprotein	B-X
(	B-X
ISG	B-X
)	B-X
65	B-X
,	B-X
a	B-X
trypanosome	B-X
TMD	B-X
protein	B-X
,	B-X
involves	B-X
ubiquitylation	B-X
and	B-X
also	B-X
requires	B-X
clathrin	B-X
.	B-X
We	B-X
find	B-X
a	B-X
hierarchical	B-X
requirement	B-X
for	B-X
cytoplasmic	B-X
lysine	B-X
residues	B-X
in	B-X
internalization	B-X
and	B-X
turnover	B-X
,	B-X
and	B-X
a	B-X
single	B-X
position-specific	B-X
lysine	B-X
is	B-X
sufficient	B-X
for	B-X
degradation	B-X
,	B-X
surface	B-X
removal	B-X
and	B-X
attachment	B-X
of	B-X
oligoubiquitin	B-X
chains	B-X
.	B-X
Ubiquitylation	B-X
is	B-X
context	B-X
dependent	B-X
as	B-X
provision	B-X
of	B-X
additional	B-X
lysine	B-X
residues	B-X
by	B-X
C-terminal	B-X
fusion	B-X
of	B-X
neuronal	B-X
precursor	B-X
cell-expressed	B-X
developmentally	B-X
downregulated	B-X
protein	B-X
(	B-X
NEDD	B-X
)	B-X
8	B-X
fails	B-X
to	B-X
support	B-X
ubiquitylation	B-X
.	B-X
Attachment	B-X
of	B-X
NEDD8	B-X
leads	B-X
to	B-X
degradation	B-X
by	B-X
a	B-X
second	B-X
ubiquitin-independent	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
degradation	B-X
of	B-X
ubiquitylated	B-X
or	B-X
NEDDylated	B-X
substrate	B-X
takes	B-X
place	B-X
in	B-X
an	B-X
acidic	B-X
compartment	B-X
and	B-X
is	B-X
proteosome	B-X
independent	B-X
.	B-X
Significantly	B-X
,	B-X
in	B-X
non-opisthokont	B-X
lineages	B-X
,	B-X
Rsp5p	B-X
or	B-X
c-Cbl	B-X
,	B-X
the	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
acting	B-X
on	B-X
endocytic	B-X
cargo	B-X
,	B-X
are	B-X
absent	B-X
but	B-X
Uba1	B-X
class	B-X
genes	B-X
are	B-X
present	B-X
and	B-X
are	B-X
required	B-X
for	B-X
cell	B-X
viability	B-X
and	B-X
ISG65	B-X
ubiquitylation	B-X
.	B-X
Hence	B-X
,	B-X
ubiquitylation	B-X
is	B-X
an	B-X
evolutionarily	B-X
conserved	B-X
mechanism	B-X
for	B-X
internalization	B-X
of	B-X
surface	B-X
proteins	B-X
,	B-X
but	B-X
aspects	B-X
of	B-X
the	B-X
machinery	B-X
differ	B-X
substantially	B-X
between	B-X
the	B-X
major	B-X
eukaryotic	B-X
lineages	B-X
.	B-X

The	O
surface	O
of	O
Trypanosoma	O
brucei	O
is	O
dominated	O
by	O
glycosyl	O
-	O
phosphatidylinositol	O
(	O
GPI	O
)	O
-	O
anchored	O
proteins	O
,	O
and	O
endocytosis	O
is	O
clathrin	O
dependent	O
.	O
<EOS>	B-X
The	B-X
surface	B-X
of	B-X
Trypanosoma	B-X
brucei	B-X
is	B-X
dominated	B-X
by	B-X
glycosyl-phosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
-anchored	B-X
proteins	B-X
,	B-X
and	B-X
endocytosis	B-X
is	B-X
clathrin	B-X
dependent	B-X
.	B-X
The	B-X
vast	B-X
majority	B-X
of	B-X
internalized	B-X
GPI-anchored	B-X
protein	B-X
is	B-X
efficiently	B-X
recycled	B-X
,	B-X
while	B-X
the	B-X
processes	B-X
by	B-X
which	B-X
transmembrane	B-X
domain	B-X
(	B-X
TMD	B-X
)	B-X
proteins	B-X
are	B-X
internalized	B-X
and	B-X
sorted	B-X
are	B-X
unknown	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
internalization	B-X
of	B-X
invariant	B-X
surface	B-X
glycoprotein	B-X
(	B-X
ISG	B-X
)	B-X
65	B-X
,	B-X
a	B-X
trypanosome	B-X
TMD	B-X
protein	B-X
,	B-X
involves	B-X
ubiquitylation	B-X
and	B-X
also	B-X
requires	B-X
clathrin	B-X
.	B-X
We	B-X
find	B-X
a	B-X
hierarchical	B-X
requirement	B-X
for	B-X
cytoplasmic	B-X
lysine	B-X
residues	B-X
in	B-X
internalization	B-X
and	B-X
turnover	B-X
,	B-X
and	B-X
a	B-X
single	B-X
position-specific	B-X
lysine	B-X
is	B-X
sufficient	B-X
for	B-X
degradation	B-X
,	B-X
surface	B-X
removal	B-X
and	B-X
attachment	B-X
of	B-X
oligoubiquitin	B-X
chains	B-X
.	B-X
Ubiquitylation	B-X
is	B-X
context	B-X
dependent	B-X
as	B-X
provision	B-X
of	B-X
additional	B-X
lysine	B-X
residues	B-X
by	B-X
C-terminal	B-X
fusion	B-X
of	B-X
neuronal	B-X
precursor	B-X
cell-expressed	B-X
developmentally	B-X
downregulated	B-X
protein	B-X
(	B-X
NEDD	B-X
)	B-X
8	B-X
fails	B-X
to	B-X
support	B-X
ubiquitylation	B-X
.	B-X
Attachment	B-X
of	B-X
NEDD8	B-X
leads	B-X
to	B-X
degradation	B-X
by	B-X
a	B-X
second	B-X
ubiquitin-independent	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
degradation	B-X
of	B-X
ubiquitylated	B-X
or	B-X
NEDDylated	B-X
substrate	B-X
takes	B-X
place	B-X
in	B-X
an	B-X
acidic	B-X
compartment	B-X
and	B-X
is	B-X
proteosome	B-X
independent	B-X
.	B-X
Hence	B-X
,	B-X
ubiquitylation	B-X
is	B-X
an	B-X
evolutionarily	B-X
conserved	B-X
mechanism	B-X
for	B-X
internalization	B-X
of	B-X
surface	B-X
proteins	B-X
,	B-X
but	B-X
aspects	B-X
of	B-X
the	B-X
machinery	B-X
differ	B-X
substantially	B-X
between	B-X
the	B-X
major	B-X
eukaryotic	B-X
lineages	B-X
.	B-X

The	O
vast	O
majority	O
of	O
internalized	O
GPI	O
-	O
anchored	O
protein	O
is	O
efficiently	O
recycled	O
,	O
while	O
the	O
processes	O
by	O
which	O
transmembrane	O
domain	O
(	O
TMD	O
)	O
proteins	O
are	O
internalized	O
and	O
sorted	O
are	O
unknown	O
.	O
<EOS>	B-X
The	B-X
surface	B-X
of	B-X
Trypanosoma	B-X
brucei	B-X
is	B-X
dominated	B-X
by	B-X
glycosyl-phosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
-anchored	B-X
proteins	B-X
,	B-X
and	B-X
endocytosis	B-X
is	B-X
clathrin	B-X
dependent	B-X
.	B-X
The	B-X
vast	B-X
majority	B-X
of	B-X
internalized	B-X
GPI-anchored	B-X
protein	B-X
is	B-X
efficiently	B-X
recycled	B-X
,	B-X
while	B-X
the	B-X
processes	B-X
by	B-X
which	B-X
transmembrane	B-X
domain	B-X
(	B-X
TMD	B-X
)	B-X
proteins	B-X
are	B-X
internalized	B-X
and	B-X
sorted	B-X
are	B-X
unknown	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
internalization	B-X
of	B-X
invariant	B-X
surface	B-X
glycoprotein	B-X
(	B-X
ISG	B-X
)	B-X
65	B-X
,	B-X
a	B-X
trypanosome	B-X
TMD	B-X
protein	B-X
,	B-X
involves	B-X
ubiquitylation	B-X
and	B-X
also	B-X
requires	B-X
clathrin	B-X
.	B-X
Ubiquitylation	B-X
is	B-X
context	B-X
dependent	B-X
as	B-X
provision	B-X
of	B-X
additional	B-X
lysine	B-X
residues	B-X
by	B-X
C-terminal	B-X
fusion	B-X
of	B-X
neuronal	B-X
precursor	B-X
cell-expressed	B-X
developmentally	B-X
downregulated	B-X
protein	B-X
(	B-X
NEDD	B-X
)	B-X
8	B-X
fails	B-X
to	B-X
support	B-X
ubiquitylation	B-X
.	B-X
Hence	B-X
,	B-X
ubiquitylation	B-X
is	B-X
an	B-X
evolutionarily	B-X
conserved	B-X
mechanism	B-X
for	B-X
internalization	B-X
of	B-X
surface	B-X
proteins	B-X
,	B-X
but	B-X
aspects	B-X
of	B-X
the	B-X
machinery	B-X
differ	B-X
substantially	B-X
between	B-X
the	B-X
major	B-X
eukaryotic	B-X
lineages	B-X
.	B-X

We	O
demonstrate	O
that	O
internalization	O
of	O
invariant	B-Protein
surface	I-Protein
glycoprotein	I-Protein
(	I-Protein
ISG	I-Protein
)	I-Protein
65	I-Protein
,	O
a	O
trypanosome	O
TMD	O
protein	O
,	O
involves	O
ubiquitylation	O
and	O
also	O
requires	O
clathrin	O
.	O
<EOS>	B-X
The	B-X
surface	B-X
of	B-X
Trypanosoma	B-X
brucei	B-X
is	B-X
dominated	B-X
by	B-X
glycosyl-phosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
-anchored	B-X
proteins	B-X
,	B-X
and	B-X
endocytosis	B-X
is	B-X
clathrin	B-X
dependent	B-X
.	B-X
The	B-X
vast	B-X
majority	B-X
of	B-X
internalized	B-X
GPI-anchored	B-X
protein	B-X
is	B-X
efficiently	B-X
recycled	B-X
,	B-X
while	B-X
the	B-X
processes	B-X
by	B-X
which	B-X
transmembrane	B-X
domain	B-X
(	B-X
TMD	B-X
)	B-X
proteins	B-X
are	B-X
internalized	B-X
and	B-X
sorted	B-X
are	B-X
unknown	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
internalization	B-X
of	B-X
invariant	B-X
surface	B-X
glycoprotein	B-X
(	B-X
ISG	B-X
)	B-X
65	B-X
,	B-X
a	B-X
trypanosome	B-X
TMD	B-X
protein	B-X
,	B-X
involves	B-X
ubiquitylation	B-X
and	B-X
also	B-X
requires	B-X
clathrin	B-X
.	B-X
We	B-X
find	B-X
a	B-X
hierarchical	B-X
requirement	B-X
for	B-X
cytoplasmic	B-X
lysine	B-X
residues	B-X
in	B-X
internalization	B-X
and	B-X
turnover	B-X
,	B-X
and	B-X
a	B-X
single	B-X
position-specific	B-X
lysine	B-X
is	B-X
sufficient	B-X
for	B-X
degradation	B-X
,	B-X
surface	B-X
removal	B-X
and	B-X
attachment	B-X
of	B-X
oligoubiquitin	B-X
chains	B-X
.	B-X
Ubiquitylation	B-X
is	B-X
context	B-X
dependent	B-X
as	B-X
provision	B-X
of	B-X
additional	B-X
lysine	B-X
residues	B-X
by	B-X
C-terminal	B-X
fusion	B-X
of	B-X
neuronal	B-X
precursor	B-X
cell-expressed	B-X
developmentally	B-X
downregulated	B-X
protein	B-X
(	B-X
NEDD	B-X
)	B-X
8	B-X
fails	B-X
to	B-X
support	B-X
ubiquitylation	B-X
.	B-X
Significantly	B-X
,	B-X
in	B-X
non-opisthokont	B-X
lineages	B-X
,	B-X
Rsp5p	B-X
or	B-X
c-Cbl	B-X
,	B-X
the	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
acting	B-X
on	B-X
endocytic	B-X
cargo	B-X
,	B-X
are	B-X
absent	B-X
but	B-X
Uba1	B-X
class	B-X
genes	B-X
are	B-X
present	B-X
and	B-X
are	B-X
required	B-X
for	B-X
cell	B-X
viability	B-X
and	B-X
ISG65	B-X
ubiquitylation	B-X
.	B-X
Hence	B-X
,	B-X
ubiquitylation	B-X
is	B-X
an	B-X
evolutionarily	B-X
conserved	B-X
mechanism	B-X
for	B-X
internalization	B-X
of	B-X
surface	B-X
proteins	B-X
,	B-X
but	B-X
aspects	B-X
of	B-X
the	B-X
machinery	B-X
differ	B-X
substantially	B-X
between	B-X
the	B-X
major	B-X
eukaryotic	B-X
lineages	B-X
.	B-X

We	O
find	O
a	O
hierarchical	O
requirement	O
for	O
cytoplasmic	O
lysine	O
residues	O
in	O
internalization	O
and	O
turnover	O
,	O
and	O
a	O
single	O
position	O
-	O
specific	O
lysine	O
is	O
sufficient	O
for	O
degradation	O
,	O
surface	O
removal	O
and	O
attachment	O
of	O
oligoubiquitin	B-Protein
chains	O
.	O

Ubiquitylation	O
is	O
context	O
dependent	O
as	O
provision	O
of	O
additional	O
lysine	O
residues	O
by	O
C	O
-	O
terminal	O
fusion	O
of	O
neuronal	B-Protein
precursor	I-Protein
cell	I-Protein
-	I-Protein
expressed	I-Protein
developmentally	I-Protein
downregulated	I-Protein
protein	I-Protein
(	I-Protein
NEDD	I-Protein
)	I-Protein
8	I-Protein
fails	O
to	O
support	O
ubiquitylation	O
.	O

Attachment	O
of	O
NEDD8	B-Protein
leads	O
to	O
degradation	O
by	O
a	O
second	O
ubiquitin	B-Protein
-	O
independent	O
pathway	O
.	O
<EOS>	B-X
We	B-X
find	B-X
a	B-X
hierarchical	B-X
requirement	B-X
for	B-X
cytoplasmic	B-X
lysine	B-X
residues	B-X
in	B-X
internalization	B-X
and	B-X
turnover	B-X
,	B-X
and	B-X
a	B-X
single	B-X
position-specific	B-X
lysine	B-X
is	B-X
sufficient	B-X
for	B-X
degradation	B-X
,	B-X
surface	B-X
removal	B-X
and	B-X
attachment	B-X
of	B-X
oligoubiquitin	B-X
chains	B-X
.	B-X
Attachment	B-X
of	B-X
NEDD8	B-X
leads	B-X
to	B-X
degradation	B-X
by	B-X
a	B-X
second	B-X
ubiquitin-independent	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
degradation	B-X
of	B-X
ubiquitylated	B-X
or	B-X
NEDDylated	B-X
substrate	B-X
takes	B-X
place	B-X
in	B-X
an	B-X
acidic	B-X
compartment	B-X
and	B-X
is	B-X
proteosome	B-X
independent	B-X
.	B-X
Significantly	B-X
,	B-X
in	B-X
non-opisthokont	B-X
lineages	B-X
,	B-X
Rsp5p	B-X
or	B-X
c-Cbl	B-X
,	B-X
the	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
acting	B-X
on	B-X
endocytic	B-X
cargo	B-X
,	B-X
are	B-X
absent	B-X
but	B-X
Uba1	B-X
class	B-X
genes	B-X
are	B-X
present	B-X
and	B-X
are	B-X
required	B-X
for	B-X
cell	B-X
viability	B-X
and	B-X
ISG65	B-X
ubiquitylation	B-X
.	B-X

Moreover	O
,	O
degradation	O
of	O
ubiquitylated	O
or	O
NEDDylated	O
substrate	O
takes	O
place	O
in	O
an	O
acidic	O
compartment	O
and	O
is	O
proteosome	O
independent	O
.	O
<EOS>	B-X
Moreover	B-X
,	B-X
we	B-X
indicate	B-X
how	B-X
current	B-X
knowledge	B-X
could	B-X
be	B-X
exploited	B-X
for	B-X
the	B-X
development	B-X
of	B-X
new	B-X
clinical	B-X
therapies	B-X
.	B-X
Ubiquitination	B-X
,	B-X
an	B-X
important	B-X
type	B-X
of	B-X
protein	B-X
posttranslational	B-X
modification	B-X
(	B-X
PTM	B-X
)	B-X
,	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
controlling	B-X
substrate	B-X
degradation	B-X
and	B-X
subsequently	B-X
mediates	B-X
the	B-X
``	B-X
quantity	B-X
''	B-X
and	B-X
``	B-X
quality	B-X
''	B-X
of	B-X
various	B-X
proteins	B-X
,	B-X
serving	B-X
to	B-X
ensure	B-X
cell	B-X
homeostasis	B-X
and	B-X
guarantee	B-X
life	B-X
activities	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
ubiquitination	B-X
of	B-X
core	B-X
stem	B-X
cell	B-X
regulator	B-X
triplets	B-X
(	B-X
Nanog	B-X
,	B-X
Oct4	B-X
and	B-X
Sox2	B-X
)	B-X
and	B-X
members	B-X
of	B-X
the	B-X
Wnt	B-X
and	B-X
Hippo-YAP	B-X
signaling	B-X
pathways	B-X
participates	B-X
in	B-X
the	B-X
maintenance	B-X
of	B-X
CSC	B-X
stemness	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
the	B-X
latest	B-X
progress	B-X
in	B-X
understanding	B-X
the	B-X
substrates	B-X
for	B-X
ubiquitination	B-X
and	B-X
their	B-X
special	B-X
functions	B-X
in	B-X
tumor	B-X
metabolism	B-X
regulation	B-X
,	B-X
TME	B-X
modulation	B-X
and	B-X
CSC	B-X
stemness	B-X
maintenance	B-X
.	B-X
Moreover	B-X
,	B-X
potential	B-X
therapeutic	B-X
targets	B-X
for	B-X
cancer	B-X
are	B-X
reviewed	B-X
,	B-X
as	B-X
are	B-X
the	B-X
therapeutic	B-X
effects	B-X
of	B-X
targeted	B-X
drugs	B-X
.	B-X

Significantly	O
,	O
in	O
non	O
-	O
opisthokont	O
lineages	O
,	O
Rsp5p	B-Protein
or	O
c	B-Protein
-	I-Protein
Cbl	I-Protein
,	O
the	O
E3	O
ubiquitin	B-Protein
ligases	O
acting	O
on	O
endocytic	O
cargo	O
,	O
are	O
absent	O
but	O
Uba1	B-Protein
class	O
genes	O
are	O
present	O
and	O
are	O
required	O
for	O
cell	O
viability	O
and	O
ISG65	B-Protein
ubiquitylation	O
.	O
<EOS>	B-X
The	B-X
surface	B-X
of	B-X
Trypanosoma	B-X
brucei	B-X
is	B-X
dominated	B-X
by	B-X
glycosyl-phosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
-anchored	B-X
proteins	B-X
,	B-X
and	B-X
endocytosis	B-X
is	B-X
clathrin	B-X
dependent	B-X
.	B-X
The	B-X
vast	B-X
majority	B-X
of	B-X
internalized	B-X
GPI-anchored	B-X
protein	B-X
is	B-X
efficiently	B-X
recycled	B-X
,	B-X
while	B-X
the	B-X
processes	B-X
by	B-X
which	B-X
transmembrane	B-X
domain	B-X
(	B-X
TMD	B-X
)	B-X
proteins	B-X
are	B-X
internalized	B-X
and	B-X
sorted	B-X
are	B-X
unknown	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
internalization	B-X
of	B-X
invariant	B-X
surface	B-X
glycoprotein	B-X
(	B-X
ISG	B-X
)	B-X
65	B-X
,	B-X
a	B-X
trypanosome	B-X
TMD	B-X
protein	B-X
,	B-X
involves	B-X
ubiquitylation	B-X
and	B-X
also	B-X
requires	B-X
clathrin	B-X
.	B-X
We	B-X
find	B-X
a	B-X
hierarchical	B-X
requirement	B-X
for	B-X
cytoplasmic	B-X
lysine	B-X
residues	B-X
in	B-X
internalization	B-X
and	B-X
turnover	B-X
,	B-X
and	B-X
a	B-X
single	B-X
position-specific	B-X
lysine	B-X
is	B-X
sufficient	B-X
for	B-X
degradation	B-X
,	B-X
surface	B-X
removal	B-X
and	B-X
attachment	B-X
of	B-X
oligoubiquitin	B-X
chains	B-X
.	B-X
Ubiquitylation	B-X
is	B-X
context	B-X
dependent	B-X
as	B-X
provision	B-X
of	B-X
additional	B-X
lysine	B-X
residues	B-X
by	B-X
C-terminal	B-X
fusion	B-X
of	B-X
neuronal	B-X
precursor	B-X
cell-expressed	B-X
developmentally	B-X
downregulated	B-X
protein	B-X
(	B-X
NEDD	B-X
)	B-X
8	B-X
fails	B-X
to	B-X
support	B-X
ubiquitylation	B-X
.	B-X
Attachment	B-X
of	B-X
NEDD8	B-X
leads	B-X
to	B-X
degradation	B-X
by	B-X
a	B-X
second	B-X
ubiquitin-independent	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
degradation	B-X
of	B-X
ubiquitylated	B-X
or	B-X
NEDDylated	B-X
substrate	B-X
takes	B-X
place	B-X
in	B-X
an	B-X
acidic	B-X
compartment	B-X
and	B-X
is	B-X
proteosome	B-X
independent	B-X
.	B-X
Significantly	B-X
,	B-X
in	B-X
non-opisthokont	B-X
lineages	B-X
,	B-X
Rsp5p	B-X
or	B-X
c-Cbl	B-X
,	B-X
the	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
acting	B-X
on	B-X
endocytic	B-X
cargo	B-X
,	B-X
are	B-X
absent	B-X
but	B-X
Uba1	B-X
class	B-X
genes	B-X
are	B-X
present	B-X
and	B-X
are	B-X
required	B-X
for	B-X
cell	B-X
viability	B-X
and	B-X
ISG65	B-X
ubiquitylation	B-X
.	B-X
Hence	B-X
,	B-X
ubiquitylation	B-X
is	B-X
an	B-X
evolutionarily	B-X
conserved	B-X
mechanism	B-X
for	B-X
internalization	B-X
of	B-X
surface	B-X
proteins	B-X
,	B-X
but	B-X
aspects	B-X
of	B-X
the	B-X
machinery	B-X
differ	B-X
substantially	B-X
between	B-X
the	B-X
major	B-X
eukaryotic	B-X
lineages	B-X
.	B-X

Hence	O
,	O
ubiquitylation	O
is	O
an	O
evolutionarily	O
conserved	O
mechanism	O
for	O
internalization	O
of	O
surface	O
proteins	O
,	O
but	O
aspects	O
of	O
the	O
machinery	O
differ	O
substantially	O
between	O
the	O
major	O
eukaryotic	O
lineages	O
.	O
<EOS>	B-X
The	B-X
surface	B-X
of	B-X
Trypanosoma	B-X
brucei	B-X
is	B-X
dominated	B-X
by	B-X
glycosyl-phosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
-anchored	B-X
proteins	B-X
,	B-X
and	B-X
endocytosis	B-X
is	B-X
clathrin	B-X
dependent	B-X
.	B-X
The	B-X
vast	B-X
majority	B-X
of	B-X
internalized	B-X
GPI-anchored	B-X
protein	B-X
is	B-X
efficiently	B-X
recycled	B-X
,	B-X
while	B-X
the	B-X
processes	B-X
by	B-X
which	B-X
transmembrane	B-X
domain	B-X
(	B-X
TMD	B-X
)	B-X
proteins	B-X
are	B-X
internalized	B-X
and	B-X
sorted	B-X
are	B-X
unknown	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
internalization	B-X
of	B-X
invariant	B-X
surface	B-X
glycoprotein	B-X
(	B-X
ISG	B-X
)	B-X
65	B-X
,	B-X
a	B-X
trypanosome	B-X
TMD	B-X
protein	B-X
,	B-X
involves	B-X
ubiquitylation	B-X
and	B-X
also	B-X
requires	B-X
clathrin	B-X
.	B-X
We	B-X
find	B-X
a	B-X
hierarchical	B-X
requirement	B-X
for	B-X
cytoplasmic	B-X
lysine	B-X
residues	B-X
in	B-X
internalization	B-X
and	B-X
turnover	B-X
,	B-X
and	B-X
a	B-X
single	B-X
position-specific	B-X
lysine	B-X
is	B-X
sufficient	B-X
for	B-X
degradation	B-X
,	B-X
surface	B-X
removal	B-X
and	B-X
attachment	B-X
of	B-X
oligoubiquitin	B-X
chains	B-X
.	B-X
Ubiquitylation	B-X
is	B-X
context	B-X
dependent	B-X
as	B-X
provision	B-X
of	B-X
additional	B-X
lysine	B-X
residues	B-X
by	B-X
C-terminal	B-X
fusion	B-X
of	B-X
neuronal	B-X
precursor	B-X
cell-expressed	B-X
developmentally	B-X
downregulated	B-X
protein	B-X
(	B-X
NEDD	B-X
)	B-X
8	B-X
fails	B-X
to	B-X
support	B-X
ubiquitylation	B-X
.	B-X
Significantly	B-X
,	B-X
in	B-X
non-opisthokont	B-X
lineages	B-X
,	B-X
Rsp5p	B-X
or	B-X
c-Cbl	B-X
,	B-X
the	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
acting	B-X
on	B-X
endocytic	B-X
cargo	B-X
,	B-X
are	B-X
absent	B-X
but	B-X
Uba1	B-X
class	B-X
genes	B-X
are	B-X
present	B-X
and	B-X
are	B-X
required	B-X
for	B-X
cell	B-X
viability	B-X
and	B-X
ISG65	B-X
ubiquitylation	B-X
.	B-X
Hence	B-X
,	B-X
ubiquitylation	B-X
is	B-X
an	B-X
evolutionarily	B-X
conserved	B-X
mechanism	B-X
for	B-X
internalization	B-X
of	B-X
surface	B-X
proteins	B-X
,	B-X
but	B-X
aspects	B-X
of	B-X
the	B-X
machinery	B-X
differ	B-X
substantially	B-X
between	B-X
the	B-X
major	B-X
eukaryotic	B-X
lineages	B-X
.	B-X

Innate	O
link	O
between	O
NF	O
-	O
kappaB	O
activity	O
and	O
ubiquitin	B-Protein
-	O
like	O
modifiers	O
.	O
<EOS>	B-X
Among	B-X
the	B-X
several	B-X
signalling	B-X
pathways	B-X
regulated	B-X
by	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
proteins	B-X
,	B-X
the	B-X
one	B-X
activating	B-X
NF-kappaB	B-X
(	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
)	B-X
is	B-X
certainly	B-X
one	B-X
of	B-X
the	B-X
best	B-X
characterized	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
transcription	B-X
factor	B-X
by	B-X
members	B-X
of	B-X
the	B-X
ubiquitin	B-X
family	B-X
occurs	B-X
at	B-X
various	B-X
levels	B-X
,	B-X
imposing	B-X
overlapping	B-X
controls	B-X
of	B-X
security	B-X
of	B-X
intriguing	B-X
complexity	B-X
.	B-X
The	B-X
formation	B-X
of	B-X
active	B-X
macromolecular	B-X
complexes	B-X
such	B-X
as	B-X
the	B-X
IKK	B-X
[	B-X
IkappaB	B-X
(	B-X
inhibitory	B-X
kappaB	B-X
)	B-X
kinase	B-X
]	B-X
complex	B-X
is	B-X
tightly	B-X
regulated	B-X
by	B-X
these	B-X
post-translational	B-X
modifications	B-X
probably	B-X
due	B-X
to	B-X
the	B-X
fact	B-X
that	B-X
many	B-X
signals	B-X
converge	B-X
on	B-X
this	B-X
signal	B-X
's	B-X
roundabout	B-X
.	B-X
An	B-X
additional	B-X
,	B-X
very	B-X
important	B-X
level	B-X
of	B-X
NF-kappaB	B-X
control	B-X
occurs	B-X
through	B-X
the	B-X
partial	B-X
or	B-X
total	B-X
proteolysis	B-X
of	B-X
precursor	B-X
and	B-X
inhibitor	B-X
molecules	B-X
exerted	B-X
by	B-X
the	B-X
ubiquitin-proteasome	B-X
pathway	B-X
.	B-X
Regulation	B-X
at	B-X
this	B-X
level	B-X
implicates	B-X
various	B-X
conjugating	B-X
and	B-X
de-conjugating	B-X
activities	B-X
for	B-X
ubiquitin	B-X
,	B-X
SUMO	B-X
(	B-X
small	B-X
ubiquitin-related	B-X
modifier	B-X
)	B-X
and	B-X
NEDD8	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
summarize	B-X
some	B-X
of	B-X
these	B-X
events	B-X
and	B-X
underline	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
interconnecting	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
conjugating	B-X
pathways	B-X
that	B-X
determine	B-X
the	B-X
status	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
critical	B-X
transcription	B-X
factor	B-X
.	B-X

Among	O
the	O
several	O
signalling	O
pathways	O
regulated	O
by	O
ubiquitin	B-Protein
and	O
ubiquitin	B-Protein
-	O
like	O
proteins	O
,	O
the	O
one	O
activating	O
NF	O
-	O
kappaB	O
(	O
nuclear	O
factor	O
kappaB	O
)	O
is	O
certainly	O
one	O
of	O
the	O
best	O
characterized	O
.	O
<EOS>	B-X
Among	B-X
the	B-X
several	B-X
signalling	B-X
pathways	B-X
regulated	B-X
by	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
proteins	B-X
,	B-X
the	B-X
one	B-X
activating	B-X
NF-kappaB	B-X
(	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
)	B-X
is	B-X
certainly	B-X
one	B-X
of	B-X
the	B-X
best	B-X
characterized	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
transcription	B-X
factor	B-X
by	B-X
members	B-X
of	B-X
the	B-X
ubiquitin	B-X
family	B-X
occurs	B-X
at	B-X
various	B-X
levels	B-X
,	B-X
imposing	B-X
overlapping	B-X
controls	B-X
of	B-X
security	B-X
of	B-X
intriguing	B-X
complexity	B-X
.	B-X
The	B-X
formation	B-X
of	B-X
active	B-X
macromolecular	B-X
complexes	B-X
such	B-X
as	B-X
the	B-X
IKK	B-X
[	B-X
IkappaB	B-X
(	B-X
inhibitory	B-X
kappaB	B-X
)	B-X
kinase	B-X
]	B-X
complex	B-X
is	B-X
tightly	B-X
regulated	B-X
by	B-X
these	B-X
post-translational	B-X
modifications	B-X
probably	B-X
due	B-X
to	B-X
the	B-X
fact	B-X
that	B-X
many	B-X
signals	B-X
converge	B-X
on	B-X
this	B-X
signal	B-X
's	B-X
roundabout	B-X
.	B-X
An	B-X
additional	B-X
,	B-X
very	B-X
important	B-X
level	B-X
of	B-X
NF-kappaB	B-X
control	B-X
occurs	B-X
through	B-X
the	B-X
partial	B-X
or	B-X
total	B-X
proteolysis	B-X
of	B-X
precursor	B-X
and	B-X
inhibitor	B-X
molecules	B-X
exerted	B-X
by	B-X
the	B-X
ubiquitin-proteasome	B-X
pathway	B-X
.	B-X
Regulation	B-X
at	B-X
this	B-X
level	B-X
implicates	B-X
various	B-X
conjugating	B-X
and	B-X
de-conjugating	B-X
activities	B-X
for	B-X
ubiquitin	B-X
,	B-X
SUMO	B-X
(	B-X
small	B-X
ubiquitin-related	B-X
modifier	B-X
)	B-X
and	B-X
NEDD8	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
summarize	B-X
some	B-X
of	B-X
these	B-X
events	B-X
and	B-X
underline	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
interconnecting	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
conjugating	B-X
pathways	B-X
that	B-X
determine	B-X
the	B-X
status	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
critical	B-X
transcription	B-X
factor	B-X
.	B-X

The	O
regulation	O
of	O
the	O
activity	O
of	O
this	O
transcription	O
factor	O
by	O
members	O
of	O
the	O
ubiquitin	B-Protein
family	O
occurs	O
at	O
various	O
levels	O
,	O
imposing	O
overlapping	O
controls	O
of	O
security	O
of	O
intriguing	O
complexity	O
.	O
<EOS>	B-X
Among	B-X
the	B-X
several	B-X
signalling	B-X
pathways	B-X
regulated	B-X
by	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
proteins	B-X
,	B-X
the	B-X
one	B-X
activating	B-X
NF-kappaB	B-X
(	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
)	B-X
is	B-X
certainly	B-X
one	B-X
of	B-X
the	B-X
best	B-X
characterized	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
transcription	B-X
factor	B-X
by	B-X
members	B-X
of	B-X
the	B-X
ubiquitin	B-X
family	B-X
occurs	B-X
at	B-X
various	B-X
levels	B-X
,	B-X
imposing	B-X
overlapping	B-X
controls	B-X
of	B-X
security	B-X
of	B-X
intriguing	B-X
complexity	B-X
.	B-X
An	B-X
additional	B-X
,	B-X
very	B-X
important	B-X
level	B-X
of	B-X
NF-kappaB	B-X
control	B-X
occurs	B-X
through	B-X
the	B-X
partial	B-X
or	B-X
total	B-X
proteolysis	B-X
of	B-X
precursor	B-X
and	B-X
inhibitor	B-X
molecules	B-X
exerted	B-X
by	B-X
the	B-X
ubiquitin-proteasome	B-X
pathway	B-X
.	B-X
Regulation	B-X
at	B-X
this	B-X
level	B-X
implicates	B-X
various	B-X
conjugating	B-X
and	B-X
de-conjugating	B-X
activities	B-X
for	B-X
ubiquitin	B-X
,	B-X
SUMO	B-X
(	B-X
small	B-X
ubiquitin-related	B-X
modifier	B-X
)	B-X
and	B-X
NEDD8	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
summarize	B-X
some	B-X
of	B-X
these	B-X
events	B-X
and	B-X
underline	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
interconnecting	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
conjugating	B-X
pathways	B-X
that	B-X
determine	B-X
the	B-X
status	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
critical	B-X
transcription	B-X
factor	B-X
.	B-X

The	O
formation	O
of	O
active	O
macromolecular	O
complexes	O
such	O
as	O
the	O
IKK	O
[	O
IkappaB	O
(	O
inhibitory	O
kappaB	O
)	O
kinase	O
]	O
complex	O
is	O
tightly	O
regulated	O
by	O
these	O
post	O
-	O
translational	O
modifications	O
probably	O
due	O
to	O
the	O
fact	O
that	O
many	O
signals	O
converge	O
on	O
this	O
signal	O
'	O
s	O
roundabout	O
.	O

An	O
additional	O
,	O
very	O
important	O
level	O
of	O
NF	O
-	O
kappaB	O
control	O
occurs	O
through	O
the	O
partial	O
or	O
total	O
proteolysis	O
of	O
precursor	O
and	O
inhibitor	O
molecules	O
exerted	O
by	O
the	O
ubiquitin	B-Protein
-	O
proteasome	O
pathway	O
.	O
<EOS>	B-X
Among	B-X
the	B-X
several	B-X
signalling	B-X
pathways	B-X
regulated	B-X
by	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
proteins	B-X
,	B-X
the	B-X
one	B-X
activating	B-X
NF-kappaB	B-X
(	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
)	B-X
is	B-X
certainly	B-X
one	B-X
of	B-X
the	B-X
best	B-X
characterized	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
transcription	B-X
factor	B-X
by	B-X
members	B-X
of	B-X
the	B-X
ubiquitin	B-X
family	B-X
occurs	B-X
at	B-X
various	B-X
levels	B-X
,	B-X
imposing	B-X
overlapping	B-X
controls	B-X
of	B-X
security	B-X
of	B-X
intriguing	B-X
complexity	B-X
.	B-X
The	B-X
formation	B-X
of	B-X
active	B-X
macromolecular	B-X
complexes	B-X
such	B-X
as	B-X
the	B-X
IKK	B-X
[	B-X
IkappaB	B-X
(	B-X
inhibitory	B-X
kappaB	B-X
)	B-X
kinase	B-X
]	B-X
complex	B-X
is	B-X
tightly	B-X
regulated	B-X
by	B-X
these	B-X
post-translational	B-X
modifications	B-X
probably	B-X
due	B-X
to	B-X
the	B-X
fact	B-X
that	B-X
many	B-X
signals	B-X
converge	B-X
on	B-X
this	B-X
signal	B-X
's	B-X
roundabout	B-X
.	B-X
An	B-X
additional	B-X
,	B-X
very	B-X
important	B-X
level	B-X
of	B-X
NF-kappaB	B-X
control	B-X
occurs	B-X
through	B-X
the	B-X
partial	B-X
or	B-X
total	B-X
proteolysis	B-X
of	B-X
precursor	B-X
and	B-X
inhibitor	B-X
molecules	B-X
exerted	B-X
by	B-X
the	B-X
ubiquitin-proteasome	B-X
pathway	B-X
.	B-X
Regulation	B-X
at	B-X
this	B-X
level	B-X
implicates	B-X
various	B-X
conjugating	B-X
and	B-X
de-conjugating	B-X
activities	B-X
for	B-X
ubiquitin	B-X
,	B-X
SUMO	B-X
(	B-X
small	B-X
ubiquitin-related	B-X
modifier	B-X
)	B-X
and	B-X
NEDD8	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
summarize	B-X
some	B-X
of	B-X
these	B-X
events	B-X
and	B-X
underline	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
interconnecting	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
conjugating	B-X
pathways	B-X
that	B-X
determine	B-X
the	B-X
status	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
critical	B-X
transcription	B-X
factor	B-X
.	B-X

Regulation	O
at	O
this	O
level	O
implicates	O
various	O
conjugating	O
and	O
de	O
-	O
conjugating	O
activities	O
for	O
ubiquitin	B-Protein
,	O
SUMO	O
(	O
small	O
ubiquitin	B-Protein
-	O
related	O
modifier	O
)	O
and	O
NEDD8	B-Protein
.	O
<EOS>	B-X
Among	B-X
the	B-X
several	B-X
signalling	B-X
pathways	B-X
regulated	B-X
by	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
proteins	B-X
,	B-X
the	B-X
one	B-X
activating	B-X
NF-kappaB	B-X
(	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
)	B-X
is	B-X
certainly	B-X
one	B-X
of	B-X
the	B-X
best	B-X
characterized	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
transcription	B-X
factor	B-X
by	B-X
members	B-X
of	B-X
the	B-X
ubiquitin	B-X
family	B-X
occurs	B-X
at	B-X
various	B-X
levels	B-X
,	B-X
imposing	B-X
overlapping	B-X
controls	B-X
of	B-X
security	B-X
of	B-X
intriguing	B-X
complexity	B-X
.	B-X
An	B-X
additional	B-X
,	B-X
very	B-X
important	B-X
level	B-X
of	B-X
NF-kappaB	B-X
control	B-X
occurs	B-X
through	B-X
the	B-X
partial	B-X
or	B-X
total	B-X
proteolysis	B-X
of	B-X
precursor	B-X
and	B-X
inhibitor	B-X
molecules	B-X
exerted	B-X
by	B-X
the	B-X
ubiquitin-proteasome	B-X
pathway	B-X
.	B-X
Regulation	B-X
at	B-X
this	B-X
level	B-X
implicates	B-X
various	B-X
conjugating	B-X
and	B-X
de-conjugating	B-X
activities	B-X
for	B-X
ubiquitin	B-X
,	B-X
SUMO	B-X
(	B-X
small	B-X
ubiquitin-related	B-X
modifier	B-X
)	B-X
and	B-X
NEDD8	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
summarize	B-X
some	B-X
of	B-X
these	B-X
events	B-X
and	B-X
underline	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
interconnecting	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
conjugating	B-X
pathways	B-X
that	B-X
determine	B-X
the	B-X
status	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
critical	B-X
transcription	B-X
factor	B-X
.	B-X

Here	O
,	O
we	O
summarize	O
some	O
of	O
these	O
events	O
and	O
underline	O
the	O
importance	O
of	O
the	O
interconnecting	O
ubiquitin	B-Protein
and	O
ubiquitin	B-Protein
-	O
like	O
conjugating	O
pathways	O
that	O
determine	O
the	O
status	O
of	O
the	O
activity	O
of	O
this	O
critical	O
transcription	O
factor	O
.	O
<EOS>	B-X
Among	B-X
the	B-X
several	B-X
signalling	B-X
pathways	B-X
regulated	B-X
by	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
proteins	B-X
,	B-X
the	B-X
one	B-X
activating	B-X
NF-kappaB	B-X
(	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
)	B-X
is	B-X
certainly	B-X
one	B-X
of	B-X
the	B-X
best	B-X
characterized	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
transcription	B-X
factor	B-X
by	B-X
members	B-X
of	B-X
the	B-X
ubiquitin	B-X
family	B-X
occurs	B-X
at	B-X
various	B-X
levels	B-X
,	B-X
imposing	B-X
overlapping	B-X
controls	B-X
of	B-X
security	B-X
of	B-X
intriguing	B-X
complexity	B-X
.	B-X
An	B-X
additional	B-X
,	B-X
very	B-X
important	B-X
level	B-X
of	B-X
NF-kappaB	B-X
control	B-X
occurs	B-X
through	B-X
the	B-X
partial	B-X
or	B-X
total	B-X
proteolysis	B-X
of	B-X
precursor	B-X
and	B-X
inhibitor	B-X
molecules	B-X
exerted	B-X
by	B-X
the	B-X
ubiquitin-proteasome	B-X
pathway	B-X
.	B-X
Regulation	B-X
at	B-X
this	B-X
level	B-X
implicates	B-X
various	B-X
conjugating	B-X
and	B-X
de-conjugating	B-X
activities	B-X
for	B-X
ubiquitin	B-X
,	B-X
SUMO	B-X
(	B-X
small	B-X
ubiquitin-related	B-X
modifier	B-X
)	B-X
and	B-X
NEDD8	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
summarize	B-X
some	B-X
of	B-X
these	B-X
events	B-X
and	B-X
underline	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
interconnecting	B-X
ubiquitin	B-X
and	B-X
ubiquitin-like	B-X
conjugating	B-X
pathways	B-X
that	B-X
determine	B-X
the	B-X
status	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
this	B-X
critical	B-X
transcription	B-X
factor	B-X
.	B-X

Identification	O
of	O
G	O
protein	O
alpha	O
subunit	O
-	O
palmitoylating	O
enzyme	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
alpha	B-X
subunit	B-X
(	B-X
Galpha	B-X
)	B-X
is	B-X
targeted	B-X
to	B-X
the	B-X
cytoplasmic	B-X
face	B-X
of	B-X
the	B-X
plasma	B-X
membrane	B-X
through	B-X
reversible	B-X
lipid	B-X
palmitoylation	B-X
and	B-X
relays	B-X
signals	B-X
from	B-X
G-protein-coupled	B-X
receptors	B-X
(	B-X
GPCRs	B-X
)	B-X
to	B-X
its	B-X
effectors	B-X
.	B-X
By	B-X
screening	B-X
23	B-X
DHHC	B-X
motif	B-X
(	B-X
Asp-His-His-Cys	B-X
)	B-X
palmitoyl	B-X
acyl-transferases	B-X
,	B-X
we	B-X
identified	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
as	B-X
Galpha	B-X
palmitoylating	B-X
enzymes	B-X
.	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
robustly	B-X
palmitoylated	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
,	B-X
Galpha	B-X
(	B-X
s	B-X
)	B-X
,	B-X
and	B-X
Galpha	B-X
(	B-X
i2	B-X
)	B-X
in	B-X
HEK293T	B-X
cells	B-X
.	B-X
Knockdown	B-X
of	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
decreased	B-X
Galpha	B-X
(	B-X
q/11	B-X
)	B-X
palmitoylation	B-X
and	B-X
relocalized	B-X
it	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Photoconversion	B-X
analysis	B-X
revealed	B-X
that	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
rapidly	B-X
shuttles	B-X
between	B-X
the	B-X
plasma	B-X
membrane	B-X
and	B-X
the	B-X
Golgi	B-X
apparatus	B-X
,	B-X
where	B-X
DHHC3	B-X
specifically	B-X
localizes	B-X
.	B-X
Fluorescence	B-X
recovery	B-X
after	B-X
photobleaching	B-X
studies	B-X
showed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
are	B-X
necessary	B-X
for	B-X
this	B-X
continuous	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
shuttling	B-X
.	B-X
Furthermore	B-X
,	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
knockdown	B-X
blocked	B-X
the	B-X
alpha	B-X
(	B-X
1A	B-X
)	B-X
-adrenergic	B-X
receptor/Galpha	B-X
(	B-X
q/11	B-X
)	B-X
-mediated	B-X
signaling	B-X
pathway	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
findings	B-X
revealed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
regulate	B-X
GPCR-mediated	B-X
signal	B-X
transduction	B-X
by	B-X
controlling	B-X
Galpha	B-X
localization	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

The	O
heterotrimeric	O
G	O
protein	O
alpha	O
subunit	O
(	O
Galpha	O
)	O
is	O
targeted	O
to	O
the	O
cytoplasmic	O
face	O
of	O
the	O
plasma	O
membrane	O
through	O
reversible	O
lipid	O
palmitoylation	O
and	O
relays	O
signals	O
from	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
to	O
its	O
effectors	O
.	O

By	O
screening	O
23	O
DHHC	O
motif	O
(	O
Asp	O
-	O
His	O
-	O
His	O
-	O
Cys	O
)	O
palmitoyl	O
acyl	O
-	O
transferases	O
,	O
we	O
identified	O
DHHC3	B-Protein
and	O
DHHC7	B-Protein
as	O
Galpha	O
palmitoylating	O
enzymes	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
alpha	B-X
subunit	B-X
(	B-X
Galpha	B-X
)	B-X
is	B-X
targeted	B-X
to	B-X
the	B-X
cytoplasmic	B-X
face	B-X
of	B-X
the	B-X
plasma	B-X
membrane	B-X
through	B-X
reversible	B-X
lipid	B-X
palmitoylation	B-X
and	B-X
relays	B-X
signals	B-X
from	B-X
G-protein-coupled	B-X
receptors	B-X
(	B-X
GPCRs	B-X
)	B-X
to	B-X
its	B-X
effectors	B-X
.	B-X
By	B-X
screening	B-X
23	B-X
DHHC	B-X
motif	B-X
(	B-X
Asp-His-His-Cys	B-X
)	B-X
palmitoyl	B-X
acyl-transferases	B-X
,	B-X
we	B-X
identified	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
as	B-X
Galpha	B-X
palmitoylating	B-X
enzymes	B-X
.	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
robustly	B-X
palmitoylated	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
,	B-X
Galpha	B-X
(	B-X
s	B-X
)	B-X
,	B-X
and	B-X
Galpha	B-X
(	B-X
i2	B-X
)	B-X
in	B-X
HEK293T	B-X
cells	B-X
.	B-X
Knockdown	B-X
of	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
decreased	B-X
Galpha	B-X
(	B-X
q/11	B-X
)	B-X
palmitoylation	B-X
and	B-X
relocalized	B-X
it	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Photoconversion	B-X
analysis	B-X
revealed	B-X
that	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
rapidly	B-X
shuttles	B-X
between	B-X
the	B-X
plasma	B-X
membrane	B-X
and	B-X
the	B-X
Golgi	B-X
apparatus	B-X
,	B-X
where	B-X
DHHC3	B-X
specifically	B-X
localizes	B-X
.	B-X
Fluorescence	B-X
recovery	B-X
after	B-X
photobleaching	B-X
studies	B-X
showed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
are	B-X
necessary	B-X
for	B-X
this	B-X
continuous	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
shuttling	B-X
.	B-X
Furthermore	B-X
,	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
knockdown	B-X
blocked	B-X
the	B-X
alpha	B-X
(	B-X
1A	B-X
)	B-X
-adrenergic	B-X
receptor/Galpha	B-X
(	B-X
q/11	B-X
)	B-X
-mediated	B-X
signaling	B-X
pathway	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
findings	B-X
revealed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
regulate	B-X
GPCR-mediated	B-X
signal	B-X
transduction	B-X
by	B-X
controlling	B-X
Galpha	B-X
localization	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

DHHC3	B-Protein
and	O
DHHC7	B-Protein
robustly	O
palmitoylated	O
Galpha	B-Protein
(	I-Protein
q	I-Protein
)	I-Protein
,	O
Galpha	B-Protein
(	I-Protein
s	I-Protein
)	I-Protein
,	O
and	O
Galpha	B-Protein
(	I-Protein
i2	I-Protein
)	I-Protein
in	O
HEK293T	O
cells	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
alpha	B-X
subunit	B-X
(	B-X
Galpha	B-X
)	B-X
is	B-X
targeted	B-X
to	B-X
the	B-X
cytoplasmic	B-X
face	B-X
of	B-X
the	B-X
plasma	B-X
membrane	B-X
through	B-X
reversible	B-X
lipid	B-X
palmitoylation	B-X
and	B-X
relays	B-X
signals	B-X
from	B-X
G-protein-coupled	B-X
receptors	B-X
(	B-X
GPCRs	B-X
)	B-X
to	B-X
its	B-X
effectors	B-X
.	B-X
By	B-X
screening	B-X
23	B-X
DHHC	B-X
motif	B-X
(	B-X
Asp-His-His-Cys	B-X
)	B-X
palmitoyl	B-X
acyl-transferases	B-X
,	B-X
we	B-X
identified	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
as	B-X
Galpha	B-X
palmitoylating	B-X
enzymes	B-X
.	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
robustly	B-X
palmitoylated	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
,	B-X
Galpha	B-X
(	B-X
s	B-X
)	B-X
,	B-X
and	B-X
Galpha	B-X
(	B-X
i2	B-X
)	B-X
in	B-X
HEK293T	B-X
cells	B-X
.	B-X
Knockdown	B-X
of	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
decreased	B-X
Galpha	B-X
(	B-X
q/11	B-X
)	B-X
palmitoylation	B-X
and	B-X
relocalized	B-X
it	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Photoconversion	B-X
analysis	B-X
revealed	B-X
that	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
rapidly	B-X
shuttles	B-X
between	B-X
the	B-X
plasma	B-X
membrane	B-X
and	B-X
the	B-X
Golgi	B-X
apparatus	B-X
,	B-X
where	B-X
DHHC3	B-X
specifically	B-X
localizes	B-X
.	B-X
Fluorescence	B-X
recovery	B-X
after	B-X
photobleaching	B-X
studies	B-X
showed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
are	B-X
necessary	B-X
for	B-X
this	B-X
continuous	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
shuttling	B-X
.	B-X
Furthermore	B-X
,	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
knockdown	B-X
blocked	B-X
the	B-X
alpha	B-X
(	B-X
1A	B-X
)	B-X
-adrenergic	B-X
receptor/Galpha	B-X
(	B-X
q/11	B-X
)	B-X
-mediated	B-X
signaling	B-X
pathway	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
findings	B-X
revealed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
regulate	B-X
GPCR-mediated	B-X
signal	B-X
transduction	B-X
by	B-X
controlling	B-X
Galpha	B-X
localization	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

Knockdown	O
of	O
DHHC3	B-Protein
and	O
DHHC7	B-Protein
decreased	O
Galpha	B-Protein
(	I-Protein
q	I-Protein
/	O
11	B-Protein
)	I-Protein
palmitoylation	O
and	O
relocalized	O
it	O
from	O
the	O
plasma	O
membrane	O
into	O
the	O
cytoplasm	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
alpha	B-X
subunit	B-X
(	B-X
Galpha	B-X
)	B-X
is	B-X
targeted	B-X
to	B-X
the	B-X
cytoplasmic	B-X
face	B-X
of	B-X
the	B-X
plasma	B-X
membrane	B-X
through	B-X
reversible	B-X
lipid	B-X
palmitoylation	B-X
and	B-X
relays	B-X
signals	B-X
from	B-X
G-protein-coupled	B-X
receptors	B-X
(	B-X
GPCRs	B-X
)	B-X
to	B-X
its	B-X
effectors	B-X
.	B-X
By	B-X
screening	B-X
23	B-X
DHHC	B-X
motif	B-X
(	B-X
Asp-His-His-Cys	B-X
)	B-X
palmitoyl	B-X
acyl-transferases	B-X
,	B-X
we	B-X
identified	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
as	B-X
Galpha	B-X
palmitoylating	B-X
enzymes	B-X
.	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
robustly	B-X
palmitoylated	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
,	B-X
Galpha	B-X
(	B-X
s	B-X
)	B-X
,	B-X
and	B-X
Galpha	B-X
(	B-X
i2	B-X
)	B-X
in	B-X
HEK293T	B-X
cells	B-X
.	B-X
Knockdown	B-X
of	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
decreased	B-X
Galpha	B-X
(	B-X
q/11	B-X
)	B-X
palmitoylation	B-X
and	B-X
relocalized	B-X
it	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Photoconversion	B-X
analysis	B-X
revealed	B-X
that	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
rapidly	B-X
shuttles	B-X
between	B-X
the	B-X
plasma	B-X
membrane	B-X
and	B-X
the	B-X
Golgi	B-X
apparatus	B-X
,	B-X
where	B-X
DHHC3	B-X
specifically	B-X
localizes	B-X
.	B-X
Fluorescence	B-X
recovery	B-X
after	B-X
photobleaching	B-X
studies	B-X
showed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
are	B-X
necessary	B-X
for	B-X
this	B-X
continuous	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
shuttling	B-X
.	B-X
Furthermore	B-X
,	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
knockdown	B-X
blocked	B-X
the	B-X
alpha	B-X
(	B-X
1A	B-X
)	B-X
-adrenergic	B-X
receptor/Galpha	B-X
(	B-X
q/11	B-X
)	B-X
-mediated	B-X
signaling	B-X
pathway	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
findings	B-X
revealed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
regulate	B-X
GPCR-mediated	B-X
signal	B-X
transduction	B-X
by	B-X
controlling	B-X
Galpha	B-X
localization	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

Photoconversion	O
analysis	O
revealed	O
that	O
Galpha	B-Protein
(	I-Protein
q	I-Protein
)	I-Protein
rapidly	O
shuttles	O
between	O
the	O
plasma	O
membrane	O
and	O
the	O
Golgi	O
apparatus	O
,	O
where	O
DHHC3	B-Protein
specifically	O
localizes	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
alpha	B-X
subunit	B-X
(	B-X
Galpha	B-X
)	B-X
is	B-X
targeted	B-X
to	B-X
the	B-X
cytoplasmic	B-X
face	B-X
of	B-X
the	B-X
plasma	B-X
membrane	B-X
through	B-X
reversible	B-X
lipid	B-X
palmitoylation	B-X
and	B-X
relays	B-X
signals	B-X
from	B-X
G-protein-coupled	B-X
receptors	B-X
(	B-X
GPCRs	B-X
)	B-X
to	B-X
its	B-X
effectors	B-X
.	B-X
By	B-X
screening	B-X
23	B-X
DHHC	B-X
motif	B-X
(	B-X
Asp-His-His-Cys	B-X
)	B-X
palmitoyl	B-X
acyl-transferases	B-X
,	B-X
we	B-X
identified	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
as	B-X
Galpha	B-X
palmitoylating	B-X
enzymes	B-X
.	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
robustly	B-X
palmitoylated	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
,	B-X
Galpha	B-X
(	B-X
s	B-X
)	B-X
,	B-X
and	B-X
Galpha	B-X
(	B-X
i2	B-X
)	B-X
in	B-X
HEK293T	B-X
cells	B-X
.	B-X
Knockdown	B-X
of	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
decreased	B-X
Galpha	B-X
(	B-X
q/11	B-X
)	B-X
palmitoylation	B-X
and	B-X
relocalized	B-X
it	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Photoconversion	B-X
analysis	B-X
revealed	B-X
that	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
rapidly	B-X
shuttles	B-X
between	B-X
the	B-X
plasma	B-X
membrane	B-X
and	B-X
the	B-X
Golgi	B-X
apparatus	B-X
,	B-X
where	B-X
DHHC3	B-X
specifically	B-X
localizes	B-X
.	B-X
Fluorescence	B-X
recovery	B-X
after	B-X
photobleaching	B-X
studies	B-X
showed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
are	B-X
necessary	B-X
for	B-X
this	B-X
continuous	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
shuttling	B-X
.	B-X
Furthermore	B-X
,	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
knockdown	B-X
blocked	B-X
the	B-X
alpha	B-X
(	B-X
1A	B-X
)	B-X
-adrenergic	B-X
receptor/Galpha	B-X
(	B-X
q/11	B-X
)	B-X
-mediated	B-X
signaling	B-X
pathway	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
findings	B-X
revealed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
regulate	B-X
GPCR-mediated	B-X
signal	B-X
transduction	B-X
by	B-X
controlling	B-X
Galpha	B-X
localization	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

Fluorescence	O
recovery	O
after	O
photobleaching	O
studies	O
showed	O
that	O
DHHC3	B-Protein
and	O
DHHC7	B-Protein
are	O
necessary	O
for	O
this	O
continuous	O
Galpha	B-Protein
(	I-Protein
q	I-Protein
)	I-Protein
shuttling	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
alpha	B-X
subunit	B-X
(	B-X
Galpha	B-X
)	B-X
is	B-X
targeted	B-X
to	B-X
the	B-X
cytoplasmic	B-X
face	B-X
of	B-X
the	B-X
plasma	B-X
membrane	B-X
through	B-X
reversible	B-X
lipid	B-X
palmitoylation	B-X
and	B-X
relays	B-X
signals	B-X
from	B-X
G-protein-coupled	B-X
receptors	B-X
(	B-X
GPCRs	B-X
)	B-X
to	B-X
its	B-X
effectors	B-X
.	B-X
By	B-X
screening	B-X
23	B-X
DHHC	B-X
motif	B-X
(	B-X
Asp-His-His-Cys	B-X
)	B-X
palmitoyl	B-X
acyl-transferases	B-X
,	B-X
we	B-X
identified	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
as	B-X
Galpha	B-X
palmitoylating	B-X
enzymes	B-X
.	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
robustly	B-X
palmitoylated	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
,	B-X
Galpha	B-X
(	B-X
s	B-X
)	B-X
,	B-X
and	B-X
Galpha	B-X
(	B-X
i2	B-X
)	B-X
in	B-X
HEK293T	B-X
cells	B-X
.	B-X
Knockdown	B-X
of	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
decreased	B-X
Galpha	B-X
(	B-X
q/11	B-X
)	B-X
palmitoylation	B-X
and	B-X
relocalized	B-X
it	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Photoconversion	B-X
analysis	B-X
revealed	B-X
that	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
rapidly	B-X
shuttles	B-X
between	B-X
the	B-X
plasma	B-X
membrane	B-X
and	B-X
the	B-X
Golgi	B-X
apparatus	B-X
,	B-X
where	B-X
DHHC3	B-X
specifically	B-X
localizes	B-X
.	B-X
Fluorescence	B-X
recovery	B-X
after	B-X
photobleaching	B-X
studies	B-X
showed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
are	B-X
necessary	B-X
for	B-X
this	B-X
continuous	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
shuttling	B-X
.	B-X
Furthermore	B-X
,	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
knockdown	B-X
blocked	B-X
the	B-X
alpha	B-X
(	B-X
1A	B-X
)	B-X
-adrenergic	B-X
receptor/Galpha	B-X
(	B-X
q/11	B-X
)	B-X
-mediated	B-X
signaling	B-X
pathway	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
findings	B-X
revealed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
regulate	B-X
GPCR-mediated	B-X
signal	B-X
transduction	B-X
by	B-X
controlling	B-X
Galpha	B-X
localization	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

Furthermore	O
,	O
DHHC3	B-Protein
and	O
DHHC7	B-Protein
knockdown	O
blocked	O
the	O
alpha	B-Protein
(	I-Protein
1A	I-Protein
)	I-Protein
-	I-Protein
adrenergic	I-Protein
receptor	I-Protein
/	O
Galpha	B-Protein
(	I-Protein
q	I-Protein
/	O
11	B-Protein
)	I-Protein
-	O
mediated	O
signaling	O
pathway	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
alpha	B-X
subunit	B-X
(	B-X
Galpha	B-X
)	B-X
is	B-X
targeted	B-X
to	B-X
the	B-X
cytoplasmic	B-X
face	B-X
of	B-X
the	B-X
plasma	B-X
membrane	B-X
through	B-X
reversible	B-X
lipid	B-X
palmitoylation	B-X
and	B-X
relays	B-X
signals	B-X
from	B-X
G-protein-coupled	B-X
receptors	B-X
(	B-X
GPCRs	B-X
)	B-X
to	B-X
its	B-X
effectors	B-X
.	B-X
By	B-X
screening	B-X
23	B-X
DHHC	B-X
motif	B-X
(	B-X
Asp-His-His-Cys	B-X
)	B-X
palmitoyl	B-X
acyl-transferases	B-X
,	B-X
we	B-X
identified	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
as	B-X
Galpha	B-X
palmitoylating	B-X
enzymes	B-X
.	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
robustly	B-X
palmitoylated	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
,	B-X
Galpha	B-X
(	B-X
s	B-X
)	B-X
,	B-X
and	B-X
Galpha	B-X
(	B-X
i2	B-X
)	B-X
in	B-X
HEK293T	B-X
cells	B-X
.	B-X
Knockdown	B-X
of	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
decreased	B-X
Galpha	B-X
(	B-X
q/11	B-X
)	B-X
palmitoylation	B-X
and	B-X
relocalized	B-X
it	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Photoconversion	B-X
analysis	B-X
revealed	B-X
that	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
rapidly	B-X
shuttles	B-X
between	B-X
the	B-X
plasma	B-X
membrane	B-X
and	B-X
the	B-X
Golgi	B-X
apparatus	B-X
,	B-X
where	B-X
DHHC3	B-X
specifically	B-X
localizes	B-X
.	B-X
Fluorescence	B-X
recovery	B-X
after	B-X
photobleaching	B-X
studies	B-X
showed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
are	B-X
necessary	B-X
for	B-X
this	B-X
continuous	B-X
Galpha	B-X
(	B-X
q	B-X
)	B-X
shuttling	B-X
.	B-X
Furthermore	B-X
,	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
knockdown	B-X
blocked	B-X
the	B-X
alpha	B-X
(	B-X
1A	B-X
)	B-X
-adrenergic	B-X
receptor/Galpha	B-X
(	B-X
q/11	B-X
)	B-X
-mediated	B-X
signaling	B-X
pathway	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
findings	B-X
revealed	B-X
that	B-X
DHHC3	B-X
and	B-X
DHHC7	B-X
regulate	B-X
GPCR-mediated	B-X
signal	B-X
transduction	B-X
by	B-X
controlling	B-X
Galpha	B-X
localization	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

Together	O
,	O
our	O
findings	O
revealed	O
that	O
DHHC3	B-Protein
and	O
DHHC7	B-Protein
regulate	O
GPCR	O
-	O
mediated	O
signal	O
transduction	O
by	O
controlling	O
Galpha	O
localization	O
to	O
the	O
plasma	O
membrane	O
.	O

Context	O
-	O
dependent	O
substrate	O
recognition	O
by	O
protein	O
farnesyltransferase	O
.	O
<EOS>	B-X
Prenylation	B-X
is	B-X
a	B-X
posttranslational	B-X
modification	B-X
whereby	B-X
C-terminal	B-X
lipidation	B-X
leads	B-X
to	B-X
protein	B-X
localization	B-X
to	B-X
membranes	B-X
.	B-X
A	B-X
C-terminal	B-X
``	B-X
Ca	B-X
(	B-X
1	B-X
)	B-X
a	B-X
(	B-X
2	B-X
)	B-X
X	B-X
''	B-X
sequence	B-X
has	B-X
been	B-X
proposed	B-X
as	B-X
the	B-X
recognition	B-X
motif	B-X
for	B-X
two	B-X
prenylation	B-X
enzymes	B-X
,	B-X
protein	B-X
farnesyltransferase	B-X
(	B-X
FTase	B-X
)	B-X
and	B-X
protein	B-X
geranylgeranyltransferase	B-X
type	B-X
I	B-X
.	B-X
To	B-X
define	B-X
the	B-X
parameters	B-X
involved	B-X
in	B-X
recognition	B-X
of	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
residue	B-X
,	B-X
we	B-X
performed	B-X
structure-activity	B-X
analysis	B-X
which	B-X
indicates	B-X
that	B-X
FTase	B-X
discriminates	B-X
between	B-X
peptide	B-X
substrates	B-X
based	B-X
on	B-X
both	B-X
the	B-X
hydrophobicity	B-X
and	B-X
steric	B-X
volume	B-X
of	B-X
the	B-X
side	B-X
chain	B-X
at	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
position	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
is	B-X
also	B-X
affected	B-X
by	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
adjacent	B-X
X	B-X
residue	B-X
,	B-X
leading	B-X
to	B-X
context-dependent	B-X
substrate	B-X
recognition	B-X
.	B-X
Context-dependent	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
suggests	B-X
that	B-X
FTase	B-X
recognizes	B-X
the	B-X
sequence	B-X
downstream	B-X
of	B-X
the	B-X
conserved	B-X
cysteine	B-X
as	B-X
a	B-X
set	B-X
of	B-X
two	B-X
or	B-X
three	B-X
cooperative	B-X
,	B-X
interconnected	B-X
recognition	B-X
elements	B-X
as	B-X
opposed	B-X
to	B-X
three	B-X
independent	B-X
amino	B-X
acids	B-X
.	B-X
These	B-X
findings	B-X
expand	B-X
the	B-X
pool	B-X
of	B-X
proposed	B-X
FTase	B-X
substrates	B-X
in	B-X
cells	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
recognition	B-X
of	B-X
substrates	B-X
performed	B-X
by	B-X
FTase	B-X
will	B-X
aid	B-X
in	B-X
both	B-X
designing	B-X
new	B-X
FTase	B-X
inhibitors	B-X
as	B-X
therapeutic	B-X
agents	B-X
and	B-X
characterizing	B-X
proteins	B-X
involved	B-X
in	B-X
prenylation-dependent	B-X
cellular	B-X
pathways	B-X
.	B-X

Prenylation	O
is	O
a	O
posttranslational	O
modification	O
whereby	O
C	O
-	O
terminal	O
lipidation	O
leads	O
to	O
protein	O
localization	O
to	O
membranes	O
.	O
<EOS>	B-X
Prenylation	B-X
is	B-X
a	B-X
posttranslational	B-X
modification	B-X
whereby	B-X
C-terminal	B-X
lipidation	B-X
leads	B-X
to	B-X
protein	B-X
localization	B-X
to	B-X
membranes	B-X
.	B-X
A	B-X
C-terminal	B-X
``	B-X
Ca	B-X
(	B-X
1	B-X
)	B-X
a	B-X
(	B-X
2	B-X
)	B-X
X	B-X
''	B-X
sequence	B-X
has	B-X
been	B-X
proposed	B-X
as	B-X
the	B-X
recognition	B-X
motif	B-X
for	B-X
two	B-X
prenylation	B-X
enzymes	B-X
,	B-X
protein	B-X
farnesyltransferase	B-X
(	B-X
FTase	B-X
)	B-X
and	B-X
protein	B-X
geranylgeranyltransferase	B-X
type	B-X
I.	B-X
Context-dependent	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
suggests	B-X
that	B-X
FTase	B-X
recognizes	B-X
the	B-X
sequence	B-X
downstream	B-X
of	B-X
the	B-X
conserved	B-X
cysteine	B-X
as	B-X
a	B-X
set	B-X
of	B-X
two	B-X
or	B-X
three	B-X
cooperative	B-X
,	B-X
interconnected	B-X
recognition	B-X
elements	B-X
as	B-X
opposed	B-X
to	B-X
three	B-X
independent	B-X
amino	B-X
acids	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
recognition	B-X
of	B-X
substrates	B-X
performed	B-X
by	B-X
FTase	B-X
will	B-X
aid	B-X
in	B-X
both	B-X
designing	B-X
new	B-X
FTase	B-X
inhibitors	B-X
as	B-X
therapeutic	B-X
agents	B-X
and	B-X
characterizing	B-X
proteins	B-X
involved	B-X
in	B-X
prenylation-dependent	B-X
cellular	B-X
pathways	B-X
.	B-X

A	O
C	O
-	O
terminal	O
"	O
Ca	O
(	O
1	O
)	O
a	O
(	O
2	O
)	O
X	O
"	O
sequence	O
has	O
been	O
proposed	O
as	O
the	O
recognition	O
motif	O
for	O
two	O
prenylation	O
enzymes	O
,	O
protein	O
farnesyltransferase	O
(	O
FTase	O
)	O
and	O
protein	O
geranylgeranyltransferase	O
type	O
I	O
.	O

To	O
define	O
the	O
parameters	O
involved	O
in	O
recognition	O
of	O
the	O
a	O
(	O
2	O
)	O
residue	O
,	O
we	O
performed	O
structure	O
-	O
activity	O
analysis	O
which	O
indicates	O
that	O
FTase	O
discriminates	O
between	O
peptide	O
substrates	O
based	O
on	O
both	O
the	O
hydrophobicity	O
and	O
steric	O
volume	O
of	O
the	O
side	O
chain	O
at	O
the	O
a	O
(	O
2	O
)	O
position	O
.	O

For	O
nonpolar	O
side	O
chains	O
,	O
the	O
dependence	O
of	O
the	O
reactivity	O
on	O
side	O
chain	O
volume	O
at	O
this	O
position	O
forms	O
a	O
pyramidal	O
pattern	O
with	O
a	O
maximal	O
activity	O
near	O
the	O
steric	O
volume	O
of	O
valine	O
.	O
<EOS>	B-X
To	B-X
define	B-X
the	B-X
parameters	B-X
involved	B-X
in	B-X
recognition	B-X
of	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
residue	B-X
,	B-X
we	B-X
performed	B-X
structure-activity	B-X
analysis	B-X
which	B-X
indicates	B-X
that	B-X
FTase	B-X
discriminates	B-X
between	B-X
peptide	B-X
substrates	B-X
based	B-X
on	B-X
both	B-X
the	B-X
hydrophobicity	B-X
and	B-X
steric	B-X
volume	B-X
of	B-X
the	B-X
side	B-X
chain	B-X
at	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
position	B-X
.	B-X
For	B-X
nonpolar	B-X
side	B-X
chains	B-X
,	B-X
the	B-X
dependence	B-X
of	B-X
the	B-X
reactivity	B-X
on	B-X
side	B-X
chain	B-X
volume	B-X
at	B-X
this	B-X
position	B-X
forms	B-X
a	B-X
pyramidal	B-X
pattern	B-X
with	B-X
a	B-X
maximal	B-X
activity	B-X
near	B-X
the	B-X
steric	B-X
volume	B-X
of	B-X
valine	B-X
.	B-X

This	O
discrimination	O
occurs	O
at	O
a	O
step	O
in	O
the	O
kinetic	O
mechanism	O
that	O
is	O
at	O
or	O
before	O
the	O
farnesylation	O
step	O
.	O
<EOS>	B-X
It	B-X
exhibits	B-X
antidepressant	B-X
activity	B-X
by	B-X
a	B-X
novel	B-X
mechanism	B-X
of	B-X
action	B-X
,	B-X
antibiotic	B-X
activity	B-X
against	B-X
gram-positive	B-X
bacteria	B-X
,	B-X
and	B-X
antitumoral	B-X
activity	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
first	B-X
prenylation	B-X
step	B-X
is	B-X
catalyzed	B-X
by	B-X
a	B-X
soluble	B-X
and	B-X
ion-dependent	B-X
dimethylallyltransferase	B-X
.	B-X
This	B-X
review	B-X
describes	B-X
the	B-X
carbazole	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
which	B-X
includes	B-X
a	B-X
key	B-X
step	B-X
in	B-X
enzymatic	B-X
formation	B-X
of	B-X
a	B-X
tricyclic	B-X
carbazole	B-X
skeleton	B-X
,	B-X
followed	B-X
by	B-X
modifications	B-X
such	B-X
as	B-X
prenylation	B-X
and	B-X
hydroxylation	B-X
in	B-X
the	B-X
skeleton	B-X
.	B-X
Farnesylation	B-X
of	B-X
the	B-X
L-HDAg	B-X
is	B-X
the	B-X
limiting	B-X
step	B-X
for	B-X
anchoring	B-X
this	B-X
RNP	B-X
to	B-X
HBsAg	B-X
,	B-X
and	B-X
thus	B-X
for	B-X
assembling	B-X
,	B-X
secreting	B-X
and	B-X
propagating	B-X
virion	B-X
particles	B-X
.	B-X

Furthermore	O
,	O
a	O
(	O
2	O
)	O
selectivity	O
is	O
also	O
affected	O
by	O
the	O
identity	O
of	O
the	O
adjacent	O
X	O
residue	O
,	O
leading	O
to	O
context	O
-	O
dependent	O
substrate	O
recognition	O
.	O
<EOS>	B-X
A	B-X
C-terminal	B-X
``	B-X
Ca	B-X
(	B-X
1	B-X
)	B-X
a	B-X
(	B-X
2	B-X
)	B-X
X	B-X
''	B-X
sequence	B-X
has	B-X
been	B-X
proposed	B-X
as	B-X
the	B-X
recognition	B-X
motif	B-X
for	B-X
two	B-X
prenylation	B-X
enzymes	B-X
,	B-X
protein	B-X
farnesyltransferase	B-X
(	B-X
FTase	B-X
)	B-X
and	B-X
protein	B-X
geranylgeranyltransferase	B-X
type	B-X
I	B-X
.	B-X
To	B-X
define	B-X
the	B-X
parameters	B-X
involved	B-X
in	B-X
recognition	B-X
of	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
residue	B-X
,	B-X
we	B-X
performed	B-X
structure-activity	B-X
analysis	B-X
which	B-X
indicates	B-X
that	B-X
FTase	B-X
discriminates	B-X
between	B-X
peptide	B-X
substrates	B-X
based	B-X
on	B-X
both	B-X
the	B-X
hydrophobicity	B-X
and	B-X
steric	B-X
volume	B-X
of	B-X
the	B-X
side	B-X
chain	B-X
at	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
position	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
is	B-X
also	B-X
affected	B-X
by	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
adjacent	B-X
X	B-X
residue	B-X
,	B-X
leading	B-X
to	B-X
context-dependent	B-X
substrate	B-X
recognition	B-X
.	B-X
Context-dependent	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
suggests	B-X
that	B-X
FTase	B-X
recognizes	B-X
the	B-X
sequence	B-X
downstream	B-X
of	B-X
the	B-X
conserved	B-X
cysteine	B-X
as	B-X
a	B-X
set	B-X
of	B-X
two	B-X
or	B-X
three	B-X
cooperative	B-X
,	B-X
interconnected	B-X
recognition	B-X
elements	B-X
as	B-X
opposed	B-X
to	B-X
three	B-X
independent	B-X
amino	B-X
acids	B-X
.	B-X
These	B-X
findings	B-X
expand	B-X
the	B-X
pool	B-X
of	B-X
proposed	B-X
FTase	B-X
substrates	B-X
in	B-X
cells	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
recognition	B-X
of	B-X
substrates	B-X
performed	B-X
by	B-X
FTase	B-X
will	B-X
aid	B-X
in	B-X
both	B-X
designing	B-X
new	B-X
FTase	B-X
inhibitors	B-X
as	B-X
therapeutic	B-X
agents	B-X
and	B-X
characterizing	B-X
proteins	B-X
involved	B-X
in	B-X
prenylation-dependent	B-X
cellular	B-X
pathways	B-X
.	B-X

Context	O
-	O
dependent	O
a	O
(	O
2	O
)	O
selectivity	O
suggests	O
that	O
FTase	O
recognizes	O
the	O
sequence	O
downstream	O
of	O
the	O
conserved	O
cysteine	O
as	O
a	O
set	O
of	O
two	O
or	O
three	O
cooperative	O
,	O
interconnected	O
recognition	O
elements	O
as	O
opposed	O
to	O
three	O
independent	O
amino	O
acids	O
.	O
<EOS>	B-X
A	B-X
C-terminal	B-X
``	B-X
Ca	B-X
(	B-X
1	B-X
)	B-X
a	B-X
(	B-X
2	B-X
)	B-X
X	B-X
''	B-X
sequence	B-X
has	B-X
been	B-X
proposed	B-X
as	B-X
the	B-X
recognition	B-X
motif	B-X
for	B-X
two	B-X
prenylation	B-X
enzymes	B-X
,	B-X
protein	B-X
farnesyltransferase	B-X
(	B-X
FTase	B-X
)	B-X
and	B-X
protein	B-X
geranylgeranyltransferase	B-X
type	B-X
I	B-X
.	B-X
To	B-X
define	B-X
the	B-X
parameters	B-X
involved	B-X
in	B-X
recognition	B-X
of	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
residue	B-X
,	B-X
we	B-X
performed	B-X
structure-activity	B-X
analysis	B-X
which	B-X
indicates	B-X
that	B-X
FTase	B-X
discriminates	B-X
between	B-X
peptide	B-X
substrates	B-X
based	B-X
on	B-X
both	B-X
the	B-X
hydrophobicity	B-X
and	B-X
steric	B-X
volume	B-X
of	B-X
the	B-X
side	B-X
chain	B-X
at	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
position	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
is	B-X
also	B-X
affected	B-X
by	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
adjacent	B-X
X	B-X
residue	B-X
,	B-X
leading	B-X
to	B-X
context-dependent	B-X
substrate	B-X
recognition	B-X
.	B-X
Context-dependent	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
suggests	B-X
that	B-X
FTase	B-X
recognizes	B-X
the	B-X
sequence	B-X
downstream	B-X
of	B-X
the	B-X
conserved	B-X
cysteine	B-X
as	B-X
a	B-X
set	B-X
of	B-X
two	B-X
or	B-X
three	B-X
cooperative	B-X
,	B-X
interconnected	B-X
recognition	B-X
elements	B-X
as	B-X
opposed	B-X
to	B-X
three	B-X
independent	B-X
amino	B-X
acids	B-X
.	B-X
These	B-X
findings	B-X
expand	B-X
the	B-X
pool	B-X
of	B-X
proposed	B-X
FTase	B-X
substrates	B-X
in	B-X
cells	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
recognition	B-X
of	B-X
substrates	B-X
performed	B-X
by	B-X
FTase	B-X
will	B-X
aid	B-X
in	B-X
both	B-X
designing	B-X
new	B-X
FTase	B-X
inhibitors	B-X
as	B-X
therapeutic	B-X
agents	B-X
and	B-X
characterizing	B-X
proteins	B-X
involved	B-X
in	B-X
prenylation-dependent	B-X
cellular	B-X
pathways	B-X
.	B-X

These	O
findings	O
expand	O
the	O
pool	O
of	O
proposed	O
FTase	O
substrates	O
in	O
cells	O
.	O
<EOS>	B-X
A	B-X
C-terminal	B-X
``	B-X
Ca	B-X
(	B-X
1	B-X
)	B-X
a	B-X
(	B-X
2	B-X
)	B-X
X	B-X
''	B-X
sequence	B-X
has	B-X
been	B-X
proposed	B-X
as	B-X
the	B-X
recognition	B-X
motif	B-X
for	B-X
two	B-X
prenylation	B-X
enzymes	B-X
,	B-X
protein	B-X
farnesyltransferase	B-X
(	B-X
FTase	B-X
)	B-X
and	B-X
protein	B-X
geranylgeranyltransferase	B-X
type	B-X
I	B-X
.	B-X
To	B-X
define	B-X
the	B-X
parameters	B-X
involved	B-X
in	B-X
recognition	B-X
of	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
residue	B-X
,	B-X
we	B-X
performed	B-X
structure-activity	B-X
analysis	B-X
which	B-X
indicates	B-X
that	B-X
FTase	B-X
discriminates	B-X
between	B-X
peptide	B-X
substrates	B-X
based	B-X
on	B-X
both	B-X
the	B-X
hydrophobicity	B-X
and	B-X
steric	B-X
volume	B-X
of	B-X
the	B-X
side	B-X
chain	B-X
at	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
position	B-X
.	B-X
Context-dependent	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
suggests	B-X
that	B-X
FTase	B-X
recognizes	B-X
the	B-X
sequence	B-X
downstream	B-X
of	B-X
the	B-X
conserved	B-X
cysteine	B-X
as	B-X
a	B-X
set	B-X
of	B-X
two	B-X
or	B-X
three	B-X
cooperative	B-X
,	B-X
interconnected	B-X
recognition	B-X
elements	B-X
as	B-X
opposed	B-X
to	B-X
three	B-X
independent	B-X
amino	B-X
acids	B-X
.	B-X
These	B-X
findings	B-X
expand	B-X
the	B-X
pool	B-X
of	B-X
proposed	B-X
FTase	B-X
substrates	B-X
in	B-X
cells	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
recognition	B-X
of	B-X
substrates	B-X
performed	B-X
by	B-X
FTase	B-X
will	B-X
aid	B-X
in	B-X
both	B-X
designing	B-X
new	B-X
FTase	B-X
inhibitors	B-X
as	B-X
therapeutic	B-X
agents	B-X
and	B-X
characterizing	B-X
proteins	B-X
involved	B-X
in	B-X
prenylation-dependent	B-X
cellular	B-X
pathways	B-X
.	B-X

A	O
better	O
understanding	O
of	O
the	O
molecular	O
recognition	O
of	O
substrates	O
performed	O
by	O
FTase	O
will	O
aid	O
in	O
both	O
designing	O
new	O
FTase	O
inhibitors	O
as	O
therapeutic	O
agents	O
and	O
characterizing	O
proteins	O
involved	O
in	O
prenylation	O
-	O
dependent	O
cellular	O
pathways	O
.	O
<EOS>	B-X
A	B-X
C-terminal	B-X
``	B-X
Ca	B-X
(	B-X
1	B-X
)	B-X
a	B-X
(	B-X
2	B-X
)	B-X
X	B-X
''	B-X
sequence	B-X
has	B-X
been	B-X
proposed	B-X
as	B-X
the	B-X
recognition	B-X
motif	B-X
for	B-X
two	B-X
prenylation	B-X
enzymes	B-X
,	B-X
protein	B-X
farnesyltransferase	B-X
(	B-X
FTase	B-X
)	B-X
and	B-X
protein	B-X
geranylgeranyltransferase	B-X
type	B-X
I	B-X
.	B-X
To	B-X
define	B-X
the	B-X
parameters	B-X
involved	B-X
in	B-X
recognition	B-X
of	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
residue	B-X
,	B-X
we	B-X
performed	B-X
structure-activity	B-X
analysis	B-X
which	B-X
indicates	B-X
that	B-X
FTase	B-X
discriminates	B-X
between	B-X
peptide	B-X
substrates	B-X
based	B-X
on	B-X
both	B-X
the	B-X
hydrophobicity	B-X
and	B-X
steric	B-X
volume	B-X
of	B-X
the	B-X
side	B-X
chain	B-X
at	B-X
the	B-X
a	B-X
(	B-X
2	B-X
)	B-X
position	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
is	B-X
also	B-X
affected	B-X
by	B-X
the	B-X
identity	B-X
of	B-X
the	B-X
adjacent	B-X
X	B-X
residue	B-X
,	B-X
leading	B-X
to	B-X
context-dependent	B-X
substrate	B-X
recognition	B-X
.	B-X
Context-dependent	B-X
a	B-X
(	B-X
2	B-X
)	B-X
selectivity	B-X
suggests	B-X
that	B-X
FTase	B-X
recognizes	B-X
the	B-X
sequence	B-X
downstream	B-X
of	B-X
the	B-X
conserved	B-X
cysteine	B-X
as	B-X
a	B-X
set	B-X
of	B-X
two	B-X
or	B-X
three	B-X
cooperative	B-X
,	B-X
interconnected	B-X
recognition	B-X
elements	B-X
as	B-X
opposed	B-X
to	B-X
three	B-X
independent	B-X
amino	B-X
acids	B-X
.	B-X
These	B-X
findings	B-X
expand	B-X
the	B-X
pool	B-X
of	B-X
proposed	B-X
FTase	B-X
substrates	B-X
in	B-X
cells	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
recognition	B-X
of	B-X
substrates	B-X
performed	B-X
by	B-X
FTase	B-X
will	B-X
aid	B-X
in	B-X
both	B-X
designing	B-X
new	B-X
FTase	B-X
inhibitors	B-X
as	B-X
therapeutic	B-X
agents	B-X
and	B-X
characterizing	B-X
proteins	B-X
involved	B-X
in	B-X
prenylation-dependent	B-X
cellular	B-X
pathways	B-X
.	B-X

Lysophosphatidic	B-Protein
acid	I-Protein
2	I-Protein
receptor	I-Protein
-	O
mediated	O
supramolecular	O
complex	O
formation	O
regulates	O
its	O
antiapoptotic	O
effect	O
.	O
<EOS>	B-X
The	B-X
G	B-X
protein-coupled	B-X
lysophosphatidic	B-X
acid	B-X
2	B-X
(	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
)	B-X
receptor	B-X
elicits	B-X
prosurvival	B-X
responses	B-X
to	B-X
prevent	B-X
and	B-X
rescue	B-X
cells	B-X
from	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
G	B-X
protein-coupled	B-X
signals	B-X
are	B-X
not	B-X
sufficient	B-X
for	B-X
the	B-X
full	B-X
protective	B-X
effect	B-X
of	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
.	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
differs	B-X
from	B-X
other	B-X
LPA	B-X
receptor	B-X
subtypes	B-X
in	B-X
the	B-X
C-terminal	B-X
tail	B-X
,	B-X
where	B-X
it	B-X
contains	B-X
a	B-X
zinc	B-X
finger-binding	B-X
motif	B-X
for	B-X
the	B-X
interactions	B-X
with	B-X
LIM	B-X
domain-containing	B-X
TRIP6	B-X
and	B-X
proapoptotic	B-X
Siva-1	B-X
,	B-X
and	B-X
a	B-X
PDZ-binding	B-X
motif	B-X
through	B-X
which	B-X
it	B-X
complexes	B-X
with	B-X
the	B-X
NHERF2	B-X
scaffold	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
a	B-X
unique	B-X
CXXC	B-X
motif	B-X
of	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
responsible	B-X
for	B-X
the	B-X
binding	B-X
to	B-X
TRIP6	B-X
and	B-X
Siva-1	B-X
,	B-X
and	B-X
demonstrate	B-X
that	B-X
disruption	B-X
of	B-X
these	B-X
macromolecular	B-X
complexes	B-X
or	B-X
knockdown	B-X
of	B-X
TRIP6	B-X
or	B-X
NHERF2	B-X
expression	B-X
attenuates	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
-mediated	B-X
protection	B-X
from	B-X
chemotherapeutic	B-X
agent-induced	B-X
apoptosis	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
knockdown	B-X
of	B-X
Siva-1	B-X
expression	B-X
enhances	B-X
this	B-X
effect	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
PDZ-mediated	B-X
direct	B-X
interaction	B-X
between	B-X
TRIP6	B-X
and	B-X
NHERF2	B-X
facilitates	B-X
their	B-X
interaction	B-X
with	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
G	B-X
protein-activated	B-X
signals	B-X
,	B-X
the	B-X
cooperation	B-X
embedded	B-X
in	B-X
the	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
-TRIP6-NHERF2	B-X
ternary	B-X
complex	B-X
provides	B-X
a	B-X
novel	B-X
ligand-dependent	B-X
signal	B-X
amplification	B-X
mechanism	B-X
that	B-X
is	B-X
required	B-X
for	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
-mediated	B-X
full	B-X
activation	B-X
of	B-X
antiapoptotic	B-X
signaling	B-X
.	B-X

The	O
G	O
protein	O
-	O
coupled	O
lysophosphatidic	B-Protein
acid	I-Protein
2	I-Protein
(	I-Protein
LPA	I-Protein
(	I-Protein
2	I-Protein
)	I-Protein
)	I-Protein
receptor	I-Protein
elicits	O
prosurvival	O
responses	O
to	O
prevent	O
and	O
rescue	O
cells	O
from	O
apoptosis	O
.	O

However	O
,	O
G	O
protein	O
-	O
coupled	O
signals	O
are	O
not	O
sufficient	O
for	O
the	O
full	O
protective	O
effect	O
of	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	I-Protein
.	O
<EOS>	B-X
G-protein-coupled	B-X
receptors	B-X
(	B-X
GPCRs	B-X
)	B-X
relay	B-X
numerous	B-X
extracellular	B-X
signals	B-X
by	B-X
triggering	B-X
intracellular	B-X
signaling	B-X
through	B-X
coupling	B-X
with	B-X
G	B-X
proteins	B-X
and	B-X
arrestins	B-X
.	B-X
Recent	B-X
breakthroughs	B-X
in	B-X
the	B-X
structural	B-X
determination	B-X
of	B-X
GPCRs	B-X
and	B-X
GPCR-transducer	B-X
complexes	B-X
represent	B-X
important	B-X
steps	B-X
toward	B-X
deciphering	B-X
GPCR	B-X
signal	B-X
transduction	B-X
at	B-X
a	B-X
molecular	B-X
level	B-X
.	B-X
A	B-X
full	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
basis	B-X
of	B-X
GPCR-mediated	B-X
signaling	B-X
requires	B-X
elucidation	B-X
of	B-X
the	B-X
dynamics	B-X
of	B-X
receptors	B-X
and	B-X
their	B-X
transducer	B-X
complexes	B-X
as	B-X
well	B-X
as	B-X
their	B-X
energy	B-X
landscapes	B-X
and	B-X
conformational	B-X
transition	B-X
rates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
summarize	B-X
current	B-X
insights	B-X
into	B-X
the	B-X
structural	B-X
plasticity	B-X
of	B-X
GPCR-G-protein	B-X
and	B-X
GPCR-arrestin	B-X
complexes	B-X
that	B-X
underlies	B-X
the	B-X
regulation	B-X
of	B-X
the	B-X
receptor	B-X
's	B-X
intracellular	B-X
signaling	B-X
profile	B-X
.	B-X

LPA	B-Protein
(	I-Protein
2	I-Protein
)	I-Protein
differs	O
from	O
other	O
LPA	O
receptor	O
subtypes	O
in	O
the	O
C	O
-	O
terminal	O
tail	O
,	O
where	O
it	O
contains	O
a	O
zinc	O
finger	O
-	O
binding	O
motif	O
for	O
the	O
interactions	O
with	O
LIM	O
domain	O
-	O
containing	O
TRIP6	B-Protein
and	O
proapoptotic	O
Siva	B-Protein
-	I-Protein
1	I-Protein
,	O
and	O
a	O
PDZ	O
-	O
binding	O
motif	O
through	O
which	O
it	O
complexes	O
with	O
the	O
NHERF2	B-Protein
scaffold	O
protein	O
.	O

In	O
this	O
report	O
,	O
we	O
identify	O
a	O
unique	O
CXXC	O
motif	O
of	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	I-Protein
responsible	O
for	O
the	O
binding	O
to	O
TRIP6	B-Protein
and	O
Siva	B-Protein
-	I-Protein
1	I-Protein
,	O
and	O
demonstrate	O
that	O
disruption	O
of	O
these	O
macromolecular	O
complexes	O
or	O
knockdown	O
of	O
TRIP6	B-Protein
or	O
NHERF2	B-Protein
expression	O
attenuates	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	I-Protein
-	O
mediated	O
protection	O
from	O
chemotherapeutic	O
agent	O
-	O
induced	O
apoptosis	O
.	O

In	O
contrast	O
,	O
knockdown	O
of	O
Siva	B-Protein
-	I-Protein
1	I-Protein
expression	O
enhances	O
this	O
effect	O
.	O
<EOS>	B-X
However	B-X
,	B-X
G	B-X
protein-coupled	B-X
signals	B-X
are	B-X
not	B-X
sufficient	B-X
for	B-X
the	B-X
full	B-X
protective	B-X
effect	B-X
of	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
.	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
differs	B-X
from	B-X
other	B-X
LPA	B-X
receptor	B-X
subtypes	B-X
in	B-X
the	B-X
C-terminal	B-X
tail	B-X
,	B-X
where	B-X
it	B-X
contains	B-X
a	B-X
zinc	B-X
finger-binding	B-X
motif	B-X
for	B-X
the	B-X
interactions	B-X
with	B-X
LIM	B-X
domain-containing	B-X
TRIP6	B-X
and	B-X
proapoptotic	B-X
Siva-1	B-X
,	B-X
and	B-X
a	B-X
PDZ-binding	B-X
motif	B-X
through	B-X
which	B-X
it	B-X
complexes	B-X
with	B-X
the	B-X
NHERF2	B-X
scaffold	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
a	B-X
unique	B-X
CXXC	B-X
motif	B-X
of	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
responsible	B-X
for	B-X
the	B-X
binding	B-X
to	B-X
TRIP6	B-X
and	B-X
Siva-1	B-X
,	B-X
and	B-X
demonstrate	B-X
that	B-X
disruption	B-X
of	B-X
these	B-X
macromolecular	B-X
complexes	B-X
or	B-X
knockdown	B-X
of	B-X
TRIP6	B-X
or	B-X
NHERF2	B-X
expression	B-X
attenuates	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
-mediated	B-X
protection	B-X
from	B-X
chemotherapeutic	B-X
agent-induced	B-X
apoptosis	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
knockdown	B-X
of	B-X
Siva-1	B-X
expression	B-X
enhances	B-X
this	B-X
effect	B-X
.	B-X

Furthermore	O
,	O
a	O
PDZ	O
-	O
mediated	O
direct	O
interaction	O
between	O
TRIP6	B-Protein
and	O
NHERF2	B-Protein
facilitates	O
their	O
interaction	O
with	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	I-Protein
.	O
<EOS>	B-X
The	B-X
G	B-X
protein-coupled	B-X
lysophosphatidic	B-X
acid	B-X
2	B-X
(	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
)	B-X
receptor	B-X
elicits	B-X
prosurvival	B-X
responses	B-X
to	B-X
prevent	B-X
and	B-X
rescue	B-X
cells	B-X
from	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
G	B-X
protein-coupled	B-X
signals	B-X
are	B-X
not	B-X
sufficient	B-X
for	B-X
the	B-X
full	B-X
protective	B-X
effect	B-X
of	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
.	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
differs	B-X
from	B-X
other	B-X
LPA	B-X
receptor	B-X
subtypes	B-X
in	B-X
the	B-X
C-terminal	B-X
tail	B-X
,	B-X
where	B-X
it	B-X
contains	B-X
a	B-X
zinc	B-X
finger-binding	B-X
motif	B-X
for	B-X
the	B-X
interactions	B-X
with	B-X
LIM	B-X
domain-containing	B-X
TRIP6	B-X
and	B-X
proapoptotic	B-X
Siva-1	B-X
,	B-X
and	B-X
a	B-X
PDZ-binding	B-X
motif	B-X
through	B-X
which	B-X
it	B-X
complexes	B-X
with	B-X
the	B-X
NHERF2	B-X
scaffold	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identify	B-X
a	B-X
unique	B-X
CXXC	B-X
motif	B-X
of	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
responsible	B-X
for	B-X
the	B-X
binding	B-X
to	B-X
TRIP6	B-X
and	B-X
Siva-1	B-X
,	B-X
and	B-X
demonstrate	B-X
that	B-X
disruption	B-X
of	B-X
these	B-X
macromolecular	B-X
complexes	B-X
or	B-X
knockdown	B-X
of	B-X
TRIP6	B-X
or	B-X
NHERF2	B-X
expression	B-X
attenuates	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
-mediated	B-X
protection	B-X
from	B-X
chemotherapeutic	B-X
agent-induced	B-X
apoptosis	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
PDZ-mediated	B-X
direct	B-X
interaction	B-X
between	B-X
TRIP6	B-X
and	B-X
NHERF2	B-X
facilitates	B-X
their	B-X
interaction	B-X
with	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
G	B-X
protein-activated	B-X
signals	B-X
,	B-X
the	B-X
cooperation	B-X
embedded	B-X
in	B-X
the	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
-TRIP6-NHERF2	B-X
ternary	B-X
complex	B-X
provides	B-X
a	B-X
novel	B-X
ligand-dependent	B-X
signal	B-X
amplification	B-X
mechanism	B-X
that	B-X
is	B-X
required	B-X
for	B-X
LPA	B-X
(	B-X
2	B-X
)	B-X
-mediated	B-X
full	B-X
activation	B-X
of	B-X
antiapoptotic	B-X
signaling	B-X
.	B-X

Together	O
,	O
these	O
results	O
suggest	O
that	O
in	O
addition	O
to	O
G	O
protein	O
-	O
activated	O
signals	O
,	O
the	O
cooperation	O
embedded	O
in	O
the	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	I-Protein
-	O
TRIP6	B-Protein
-	O
NHERF2	B-Protein
ternary	O
complex	O
provides	O
a	O
novel	O
ligand	O
-	O
dependent	O
signal	O
amplification	O
mechanism	O
that	O
is	O
required	O
for	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	I-Protein
-	O
mediated	O
full	O
activation	O
of	O
antiapoptotic	O
signaling	O
.	O

A	O
functional	O
screen	O
implicates	O
microRNA	B-Protein
-	I-Protein
138	I-Protein
-	O
dependent	O
regulation	O
of	O
the	O
depalmitoylation	O
enzyme	O
APT1	B-Protein
in	O
dendritic	O
spine	O
morphogenesis	O
.	O
<EOS>	B-X
The	B-X
microRNA	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
synaptic	B-X
protein	B-X
synthesis	B-X
and	B-X
ultimately	B-X
in	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
,	B-X
a	B-X
phenomenon	B-X
associated	B-X
with	B-X
long-lasting	B-X
forms	B-X
of	B-X
memory	B-X
.	B-X
However	B-X
,	B-X
the	B-X
particular	B-X
microRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
involved	B-X
are	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
specific	B-X
miRNAs	B-X
that	B-X
function	B-X
at	B-X
synapses	B-X
to	B-X
control	B-X
dendritic	B-X
spine	B-X
structure	B-X
by	B-X
performing	B-X
a	B-X
functional	B-X
screen	B-X
.	B-X
One	B-X
of	B-X
the	B-X
identified	B-X
miRNAs	B-X
,	B-X
miR-138	B-X
,	B-X
is	B-X
highly	B-X
enriched	B-X
in	B-X
the	B-X
brain	B-X
,	B-X
localized	B-X
within	B-X
dendrites	B-X
and	B-X
negatively	B-X
regulates	B-X
the	B-X
size	B-X
of	B-X
dendritic	B-X
spines	B-X
in	B-X
rat	B-X
hippocampal	B-X
neurons	B-X
.	B-X
miR-138	B-X
controls	B-X
the	B-X
expression	B-X
of	B-X
acyl	B-X
protein	B-X
thioesterase	B-X
1	B-X
(	B-X
APT1	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
regulating	B-X
the	B-X
palmitoylation	B-X
status	B-X
of	B-X
proteins	B-X
that	B-X
are	B-X
known	B-X
to	B-X
function	B-X
at	B-X
the	B-X
synapse	B-X
,	B-X
including	B-X
the	B-X
alpha	B-X
(	B-X
13	B-X
)	B-X
subunits	B-X
of	B-X
G	B-X
proteins	B-X
(	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
)	B-X
.	B-X
RNA-interference-mediated	B-X
knockdown	B-X
of	B-X
APT1	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
membrane-localized	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
both	B-X
suppress	B-X
spine	B-X
enlargement	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
miR-138	B-X
,	B-X
suggesting	B-X
that	B-X
APT1-regulated	B-X
depalmitoylation	B-X
of	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
might	B-X
be	B-X
an	B-X
important	B-X
downstream	B-X
event	B-X
of	B-X
miR-138	B-X
function	B-X
.	B-X
Our	B-X
results	B-X
uncover	B-X
a	B-X
previously	B-X
unknown	B-X
miRNA-dependent	B-X
mechanism	B-X
in	B-X
neurons	B-X
and	B-X
demonstrate	B-X
a	B-X
previously	B-X
unrecognized	B-X
complexity	B-X
of	B-X
miRNA-dependent	B-X
control	B-X
of	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
.	B-X

The	O
microRNA	O
pathway	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
synaptic	O
protein	O
synthesis	O
and	O
ultimately	O
in	O
dendritic	O
spine	O
morphogenesis	O
,	O
a	O
phenomenon	O
associated	O
with	O
long	O
-	O
lasting	O
forms	O
of	O
memory	O
.	O
<EOS>	B-X
The	B-X
microRNA	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
synaptic	B-X
protein	B-X
synthesis	B-X
and	B-X
ultimately	B-X
in	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
,	B-X
a	B-X
phenomenon	B-X
associated	B-X
with	B-X
long-lasting	B-X
forms	B-X
of	B-X
memory	B-X
.	B-X
However	B-X
,	B-X
the	B-X
particular	B-X
microRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
involved	B-X
are	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
specific	B-X
miRNAs	B-X
that	B-X
function	B-X
at	B-X
synapses	B-X
to	B-X
control	B-X
dendritic	B-X
spine	B-X
structure	B-X
by	B-X
performing	B-X
a	B-X
functional	B-X
screen	B-X
.	B-X
One	B-X
of	B-X
the	B-X
identified	B-X
miRNAs	B-X
,	B-X
miR-138	B-X
,	B-X
is	B-X
highly	B-X
enriched	B-X
in	B-X
the	B-X
brain	B-X
,	B-X
localized	B-X
within	B-X
dendrites	B-X
and	B-X
negatively	B-X
regulates	B-X
the	B-X
size	B-X
of	B-X
dendritic	B-X
spines	B-X
in	B-X
rat	B-X
hippocampal	B-X
neurons	B-X
.	B-X
miR-138	B-X
controls	B-X
the	B-X
expression	B-X
of	B-X
acyl	B-X
protein	B-X
thioesterase	B-X
1	B-X
(	B-X
APT1	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
regulating	B-X
the	B-X
palmitoylation	B-X
status	B-X
of	B-X
proteins	B-X
that	B-X
are	B-X
known	B-X
to	B-X
function	B-X
at	B-X
the	B-X
synapse	B-X
,	B-X
including	B-X
the	B-X
alpha	B-X
(	B-X
13	B-X
)	B-X
subunits	B-X
of	B-X
G	B-X
proteins	B-X
(	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
)	B-X
.	B-X
RNA-interference-mediated	B-X
knockdown	B-X
of	B-X
APT1	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
membrane-localized	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
both	B-X
suppress	B-X
spine	B-X
enlargement	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
miR-138	B-X
,	B-X
suggesting	B-X
that	B-X
APT1-regulated	B-X
depalmitoylation	B-X
of	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
might	B-X
be	B-X
an	B-X
important	B-X
downstream	B-X
event	B-X
of	B-X
miR-138	B-X
function	B-X
.	B-X
Our	B-X
results	B-X
uncover	B-X
a	B-X
previously	B-X
unknown	B-X
miRNA-dependent	B-X
mechanism	B-X
in	B-X
neurons	B-X
and	B-X
demonstrate	B-X
a	B-X
previously	B-X
unrecognized	B-X
complexity	B-X
of	B-X
miRNA-dependent	B-X
control	B-X
of	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
.	B-X

However	O
,	O
the	O
particular	O
microRNAs	O
(	O
miRNAs	O
)	O
involved	O
are	O
largely	O
unknown	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
overall	B-X
biological	B-X
role	B-X
and	B-X
clinical	B-X
significance	B-X
of	B-X
HOTAIR	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
MicroRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
are	B-X
small	B-X
(	B-X
21-nucleotides	B-X
)	B-X
non-coding	B-X
RNAs	B-X
found	B-X
in	B-X
plant	B-X
and	B-X
animals	B-X
.	B-X
Plant	B-X
miRNAs	B-X
have	B-X
some	B-X
distinct	B-X
characteristics	B-X
compared	B-X
to	B-X
their	B-X
animal	B-X
counterparts	B-X
,	B-X
including	B-X
greater	B-X
evolutionary	B-X
conservation	B-X
and	B-X
unique	B-X
miRNA	B-X
processing	B-X
methods	B-X
.	B-X
MiRNAs	B-X
participate	B-X
in	B-X
the	B-X
transformation	B-X
of	B-X
plant	B-X
growth	B-X
and	B-X
development	B-X
and	B-X
directly	B-X
monitor	B-X
progression	B-X
of	B-X
these	B-X
processes	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
certain	B-X
morphological	B-X
characteristics	B-X
by	B-X
regulating	B-X
transcription	B-X
factor	B-X
genes	B-X
involved	B-X
in	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
.	B-X
In	B-X
woody	B-X
plants	B-X
,	B-X
a	B-X
large	B-X
and	B-X
rapidly	B-X
increasing	B-X
number	B-X
of	B-X
miRNAs	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
but	B-X
their	B-X
biological	B-X
functions	B-X
are	B-X
largely	B-X
unknown	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
we	B-X
discuss	B-X
the	B-X
potential	B-X
roles	B-X
of	B-X
these	B-X
miRNAs	B-X
in	B-X
growth	B-X
,	B-X
development	B-X
,	B-X
and	B-X
biotic	B-X
and	B-X
abiotic	B-X
stresses	B-X
responses	B-X
in	B-X
woody	B-X
plants	B-X
.	B-X

Here	O
we	O
identify	O
specific	O
miRNAs	O
that	O
function	O
at	O
synapses	O
to	O
control	O
dendritic	O
spine	O
structure	O
by	O
performing	O
a	O
functional	O
screen	O
.	O
<EOS>	B-X
The	B-X
microRNA	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
synaptic	B-X
protein	B-X
synthesis	B-X
and	B-X
ultimately	B-X
in	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
,	B-X
a	B-X
phenomenon	B-X
associated	B-X
with	B-X
long-lasting	B-X
forms	B-X
of	B-X
memory	B-X
.	B-X
However	B-X
,	B-X
the	B-X
particular	B-X
microRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
involved	B-X
are	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
specific	B-X
miRNAs	B-X
that	B-X
function	B-X
at	B-X
synapses	B-X
to	B-X
control	B-X
dendritic	B-X
spine	B-X
structure	B-X
by	B-X
performing	B-X
a	B-X
functional	B-X
screen	B-X
.	B-X
One	B-X
of	B-X
the	B-X
identified	B-X
miRNAs	B-X
,	B-X
miR-138	B-X
,	B-X
is	B-X
highly	B-X
enriched	B-X
in	B-X
the	B-X
brain	B-X
,	B-X
localized	B-X
within	B-X
dendrites	B-X
and	B-X
negatively	B-X
regulates	B-X
the	B-X
size	B-X
of	B-X
dendritic	B-X
spines	B-X
in	B-X
rat	B-X
hippocampal	B-X
neurons	B-X
.	B-X
miR-138	B-X
controls	B-X
the	B-X
expression	B-X
of	B-X
acyl	B-X
protein	B-X
thioesterase	B-X
1	B-X
(	B-X
APT1	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
regulating	B-X
the	B-X
palmitoylation	B-X
status	B-X
of	B-X
proteins	B-X
that	B-X
are	B-X
known	B-X
to	B-X
function	B-X
at	B-X
the	B-X
synapse	B-X
,	B-X
including	B-X
the	B-X
alpha	B-X
(	B-X
13	B-X
)	B-X
subunits	B-X
of	B-X
G	B-X
proteins	B-X
(	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
)	B-X
.	B-X
RNA-interference-mediated	B-X
knockdown	B-X
of	B-X
APT1	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
membrane-localized	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
both	B-X
suppress	B-X
spine	B-X
enlargement	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
miR-138	B-X
,	B-X
suggesting	B-X
that	B-X
APT1-regulated	B-X
depalmitoylation	B-X
of	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
might	B-X
be	B-X
an	B-X
important	B-X
downstream	B-X
event	B-X
of	B-X
miR-138	B-X
function	B-X
.	B-X
Our	B-X
results	B-X
uncover	B-X
a	B-X
previously	B-X
unknown	B-X
miRNA-dependent	B-X
mechanism	B-X
in	B-X
neurons	B-X
and	B-X
demonstrate	B-X
a	B-X
previously	B-X
unrecognized	B-X
complexity	B-X
of	B-X
miRNA-dependent	B-X
control	B-X
of	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
.	B-X

One	O
of	O
the	O
identified	O
miRNAs	O
,	O
miR	B-Protein
-	I-Protein
138	I-Protein
,	O
is	O
highly	O
enriched	O
in	O
the	O
brain	O
,	O
localized	O
within	O
dendrites	O
and	O
negatively	O
regulates	O
the	O
size	O
of	O
dendritic	O
spines	O
in	O
rat	O
hippocampal	O
neurons	O
.	O
<EOS>	B-X
The	B-X
microRNA	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
synaptic	B-X
protein	B-X
synthesis	B-X
and	B-X
ultimately	B-X
in	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
,	B-X
a	B-X
phenomenon	B-X
associated	B-X
with	B-X
long-lasting	B-X
forms	B-X
of	B-X
memory	B-X
.	B-X
However	B-X
,	B-X
the	B-X
particular	B-X
microRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
involved	B-X
are	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
specific	B-X
miRNAs	B-X
that	B-X
function	B-X
at	B-X
synapses	B-X
to	B-X
control	B-X
dendritic	B-X
spine	B-X
structure	B-X
by	B-X
performing	B-X
a	B-X
functional	B-X
screen	B-X
.	B-X
One	B-X
of	B-X
the	B-X
identified	B-X
miRNAs	B-X
,	B-X
miR-138	B-X
,	B-X
is	B-X
highly	B-X
enriched	B-X
in	B-X
the	B-X
brain	B-X
,	B-X
localized	B-X
within	B-X
dendrites	B-X
and	B-X
negatively	B-X
regulates	B-X
the	B-X
size	B-X
of	B-X
dendritic	B-X
spines	B-X
in	B-X
rat	B-X
hippocampal	B-X
neurons	B-X
.	B-X
miR-138	B-X
controls	B-X
the	B-X
expression	B-X
of	B-X
acyl	B-X
protein	B-X
thioesterase	B-X
1	B-X
(	B-X
APT1	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
regulating	B-X
the	B-X
palmitoylation	B-X
status	B-X
of	B-X
proteins	B-X
that	B-X
are	B-X
known	B-X
to	B-X
function	B-X
at	B-X
the	B-X
synapse	B-X
,	B-X
including	B-X
the	B-X
alpha	B-X
(	B-X
13	B-X
)	B-X
subunits	B-X
of	B-X
G	B-X
proteins	B-X
(	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
)	B-X
.	B-X
RNA-interference-mediated	B-X
knockdown	B-X
of	B-X
APT1	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
membrane-localized	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
both	B-X
suppress	B-X
spine	B-X
enlargement	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
miR-138	B-X
,	B-X
suggesting	B-X
that	B-X
APT1-regulated	B-X
depalmitoylation	B-X
of	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
might	B-X
be	B-X
an	B-X
important	B-X
downstream	B-X
event	B-X
of	B-X
miR-138	B-X
function	B-X
.	B-X
Our	B-X
results	B-X
uncover	B-X
a	B-X
previously	B-X
unknown	B-X
miRNA-dependent	B-X
mechanism	B-X
in	B-X
neurons	B-X
and	B-X
demonstrate	B-X
a	B-X
previously	B-X
unrecognized	B-X
complexity	B-X
of	B-X
miRNA-dependent	B-X
control	B-X
of	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
.	B-X

miR	B-Protein
-	I-Protein
138	I-Protein
controls	O
the	O
expression	O
of	O
acyl	B-Protein
protein	I-Protein
thioesterase	I-Protein
1	I-Protein
(	O
APT1	B-Protein
)	O
,	O
an	O
enzyme	O
regulating	O
the	O
palmitoylation	O
status	O
of	O
proteins	O
that	O
are	O
known	O
to	O
function	O
at	O
the	O
synapse	O
,	O
including	O
the	O
alpha	O
(	O
13	O
)	O
subunits	O
of	O
G	O
proteins	O
(	O
Galpha	B-Protein
(	I-Protein
13	I-Protein
)	I-Protein
)	O
.	O

RNA	O
-	O
interference	O
-	O
mediated	O
knockdown	O
of	O
APT1	B-Protein
and	O
the	O
expression	O
of	O
membrane	O
-	O
localized	O
Galpha	B-Protein
(	I-Protein
13	I-Protein
)	I-Protein
both	O
suppress	O
spine	O
enlargement	O
caused	O
by	O
inhibition	O
of	O
miR	B-Protein
-	I-Protein
138	I-Protein
,	O
suggesting	O
that	O
APT1	B-Protein
-	O
regulated	O
depalmitoylation	O
of	O
Galpha	B-Protein
(	I-Protein
13	I-Protein
)	I-Protein
might	O
be	O
an	O
important	O
downstream	O
event	O
of	O
miR	B-Protein
-	I-Protein
138	I-Protein
function	O
.	O

Our	O
results	O
uncover	O
a	O
previously	O
unknown	O
miRNA	O
-	O
dependent	O
mechanism	O
in	O
neurons	O
and	O
demonstrate	O
a	O
previously	O
unrecognized	O
complexity	O
of	O
miRNA	O
-	O
dependent	O
control	O
of	O
dendritic	O
spine	O
morphogenesis	O
.	O
<EOS>	B-X
The	B-X
microRNA	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
synaptic	B-X
protein	B-X
synthesis	B-X
and	B-X
ultimately	B-X
in	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
,	B-X
a	B-X
phenomenon	B-X
associated	B-X
with	B-X
long-lasting	B-X
forms	B-X
of	B-X
memory	B-X
.	B-X
However	B-X
,	B-X
the	B-X
particular	B-X
microRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
involved	B-X
are	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
specific	B-X
miRNAs	B-X
that	B-X
function	B-X
at	B-X
synapses	B-X
to	B-X
control	B-X
dendritic	B-X
spine	B-X
structure	B-X
by	B-X
performing	B-X
a	B-X
functional	B-X
screen	B-X
.	B-X
One	B-X
of	B-X
the	B-X
identified	B-X
miRNAs	B-X
,	B-X
miR-138	B-X
,	B-X
is	B-X
highly	B-X
enriched	B-X
in	B-X
the	B-X
brain	B-X
,	B-X
localized	B-X
within	B-X
dendrites	B-X
and	B-X
negatively	B-X
regulates	B-X
the	B-X
size	B-X
of	B-X
dendritic	B-X
spines	B-X
in	B-X
rat	B-X
hippocampal	B-X
neurons	B-X
.	B-X
miR-138	B-X
controls	B-X
the	B-X
expression	B-X
of	B-X
acyl	B-X
protein	B-X
thioesterase	B-X
1	B-X
(	B-X
APT1	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
regulating	B-X
the	B-X
palmitoylation	B-X
status	B-X
of	B-X
proteins	B-X
that	B-X
are	B-X
known	B-X
to	B-X
function	B-X
at	B-X
the	B-X
synapse	B-X
,	B-X
including	B-X
the	B-X
alpha	B-X
(	B-X
13	B-X
)	B-X
subunits	B-X
of	B-X
G	B-X
proteins	B-X
(	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
)	B-X
.	B-X
RNA-interference-mediated	B-X
knockdown	B-X
of	B-X
APT1	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
membrane-localized	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
both	B-X
suppress	B-X
spine	B-X
enlargement	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
miR-138	B-X
,	B-X
suggesting	B-X
that	B-X
APT1-regulated	B-X
depalmitoylation	B-X
of	B-X
Galpha	B-X
(	B-X
13	B-X
)	B-X
might	B-X
be	B-X
an	B-X
important	B-X
downstream	B-X
event	B-X
of	B-X
miR-138	B-X
function	B-X
.	B-X
Our	B-X
results	B-X
uncover	B-X
a	B-X
previously	B-X
unknown	B-X
miRNA-dependent	B-X
mechanism	B-X
in	B-X
neurons	B-X
and	B-X
demonstrate	B-X
a	B-X
previously	B-X
unrecognized	B-X
complexity	B-X
of	B-X
miRNA-dependent	B-X
control	B-X
of	B-X
dendritic	B-X
spine	B-X
morphogenesis	B-X
.	B-X

Four	O
flavonoids	O
from	O
Echinosophora	O
koreensis	O
and	O
their	O
effects	O
on	O
alcohol	O
metabolizing	O
enzymes	O
.	O
<EOS>	B-X
A	B-X
new	B-X
prenylated	B-X
dihydroflavonol	B-X
,	B-X
3-hydroxy-kenusanone	B-X
B	B-X
1	B-X
,	B-X
as	B-X
well	B-X
as	B-X
three	B-X
other	B-X
known	B-X
isoflavanones	B-X
,	B-X
sophoronol	B-X
2	B-X
,	B-X
sophoraisoflavanone	B-X
A	B-X
3	B-X
and	B-X
kenusanone	B-X
H	B-X
4	B-X
,	B-X
were	B-X
isolated	B-X
from	B-X
the	B-X
rhizomes	B-X
of	B-X
Echinosophora	B-X
koreensis	B-X
.	B-X
All	B-X
four	B-X
flavonoids	B-X
enhanced	B-X
the	B-X
activities	B-X
of	B-X
alcohol	B-X
metabolizing	B-X
enzymes	B-X
such	B-X
as	B-X
alcohol	B-X
dehydrogenase	B-X
(	B-X
ADH	B-X
)	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
(	B-X
ALDH	B-X
)	B-X
at	B-X
micromolar	B-X
concentrations	B-X
.	B-X
Sophoronol	B-X
2	B-X
showed	B-X
a	B-X
nine-fold	B-X
increased	B-X
activation	B-X
of	B-X
alcohol	B-X
dehydrogenase	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
than	B-X
a	B-X
negative	B-X
control	B-X
group	B-X
at	B-X
concentrations	B-X
of	B-X
100	B-X
microg/mL	B-X
and	B-X
50	B-X
microg/mL	B-X
,	B-X
respectively	B-X
.	B-X
This	B-X
study	B-X
suggests	B-X
that	B-X
prenylated	B-X
flavonoids	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
prevent	B-X
'hangovers	B-X
'	B-X
after	B-X
alcohol	B-X
intake	B-X
.	B-X

A	O
new	O
prenylated	O
dihydroflavonol	O
,	O
3	O
-	O
hydroxy	O
-	O
kenusanone	O
B	O
1	O
,	O
as	O
well	O
as	O
three	O
other	O
known	O
isoflavanones	O
,	O
sophoronol	O
2	O
,	O
sophoraisoflavanone	O
A	O
3	O
and	O
kenusanone	O
H	O
4	O
,	O
were	O
isolated	O
from	O
the	O
rhizomes	O
of	O
Echinosophora	O
koreensis	O
.	O
<EOS>	B-X
A	B-X
new	B-X
prenylated	B-X
dihydroflavonol	B-X
,	B-X
3-hydroxy-kenusanone	B-X
B	B-X
1	B-X
,	B-X
as	B-X
well	B-X
as	B-X
three	B-X
other	B-X
known	B-X
isoflavanones	B-X
,	B-X
sophoronol	B-X
2	B-X
,	B-X
sophoraisoflavanone	B-X
A	B-X
3	B-X
and	B-X
kenusanone	B-X
H	B-X
4	B-X
,	B-X
were	B-X
isolated	B-X
from	B-X
the	B-X
rhizomes	B-X
of	B-X
Echinosophora	B-X
koreensis	B-X
.	B-X
The	B-X
structures	B-X
of	B-X
these	B-X
compounds	B-X
were	B-X
elucidated	B-X
using	B-X
spectroscopic	B-X
analyses	B-X
that	B-X
included	B-X
extensive	B-X
2D	B-X
NMR	B-X
,	B-X
optical	B-X
rotation	B-X
spectrometry	B-X
and	B-X
mass	B-X
spectrometry	B-X
.	B-X
All	B-X
four	B-X
flavonoids	B-X
enhanced	B-X
the	B-X
activities	B-X
of	B-X
alcohol	B-X
metabolizing	B-X
enzymes	B-X
such	B-X
as	B-X
alcohol	B-X
dehydrogenase	B-X
(	B-X
ADH	B-X
)	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
(	B-X
ALDH	B-X
)	B-X
at	B-X
micromolar	B-X
concentrations	B-X
.	B-X
Sophoronol	B-X
2	B-X
showed	B-X
a	B-X
nine-fold	B-X
increased	B-X
activation	B-X
of	B-X
alcohol	B-X
dehydrogenase	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
than	B-X
a	B-X
negative	B-X
control	B-X
group	B-X
at	B-X
concentrations	B-X
of	B-X
100	B-X
microg/mL	B-X
and	B-X
50	B-X
microg/mL	B-X
,	B-X
respectively	B-X
.	B-X
This	B-X
study	B-X
suggests	B-X
that	B-X
prenylated	B-X
flavonoids	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
prevent	B-X
'hangovers	B-X
'	B-X
after	B-X
alcohol	B-X
intake	B-X
.	B-X

The	O
structures	O
of	O
these	O
compounds	O
were	O
elucidated	O
using	O
spectroscopic	O
analyses	O
that	O
included	O
extensive	O
2D	O
NMR	O
,	O
optical	O
rotation	O
spectrometry	O
and	O
mass	O
spectrometry	O
.	O
<EOS>	B-X
The	B-X
structures	B-X
of	B-X
these	B-X
compounds	B-X
were	B-X
elucidated	B-X
using	B-X
spectroscopic	B-X
analyses	B-X
that	B-X
included	B-X
extensive	B-X
2D	B-X
NMR	B-X
,	B-X
optical	B-X
rotation	B-X
spectrometry	B-X
and	B-X
mass	B-X
spectrometry	B-X
.	B-X

All	O
four	O
flavonoids	O
enhanced	O
the	O
activities	O
of	O
alcohol	O
metabolizing	O
enzymes	O
such	O
as	O
alcohol	O
dehydrogenase	O
(	O
ADH	O
)	O
and	O
aldehyde	O
dehydrogenase	O
(	O
ALDH	O
)	O
at	O
micromolar	O
concentrations	O
.	O
<EOS>	B-X
All	B-X
four	B-X
flavonoids	B-X
enhanced	B-X
the	B-X
activities	B-X
of	B-X
alcohol	B-X
metabolizing	B-X
enzymes	B-X
such	B-X
as	B-X
alcohol	B-X
dehydrogenase	B-X
(	B-X
ADH	B-X
)	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
(	B-X
ALDH	B-X
)	B-X
at	B-X
micromolar	B-X
concentrations	B-X
.	B-X
Sophoronol	B-X
2	B-X
showed	B-X
a	B-X
nine-fold	B-X
increased	B-X
activation	B-X
of	B-X
alcohol	B-X
dehydrogenase	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
than	B-X
a	B-X
negative	B-X
control	B-X
group	B-X
at	B-X
concentrations	B-X
of	B-X
100	B-X
microg/mL	B-X
and	B-X
50	B-X
microg/mL	B-X
,	B-X
respectively	B-X
.	B-X
This	B-X
study	B-X
suggests	B-X
that	B-X
prenylated	B-X
flavonoids	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
prevent	B-X
'hangovers	B-X
'	B-X
after	B-X
alcohol	B-X
intake	B-X
.	B-X

Sophoronol	O
2	O
showed	O
a	O
nine	O
-	O
fold	O
increased	O
activation	O
of	O
alcohol	O
dehydrogenase	O
and	O
aldehyde	O
dehydrogenase	O
than	O
a	O
negative	O
control	O
group	O
at	O
concentrations	O
of	O
100	O
microg	O
/	O
mL	O
and	O
50	O
microg	O
/	O
mL	O
,	O
respectively	O
.	O
<EOS>	B-X
A	B-X
new	B-X
prenylated	B-X
dihydroflavonol	B-X
,	B-X
3-hydroxy-kenusanone	B-X
B	B-X
1	B-X
,	B-X
as	B-X
well	B-X
as	B-X
three	B-X
other	B-X
known	B-X
isoflavanones	B-X
,	B-X
sophoronol	B-X
2	B-X
,	B-X
sophoraisoflavanone	B-X
A	B-X
3	B-X
and	B-X
kenusanone	B-X
H	B-X
4	B-X
,	B-X
were	B-X
isolated	B-X
from	B-X
the	B-X
rhizomes	B-X
of	B-X
Echinosophora	B-X
koreensis	B-X
.	B-X
The	B-X
structures	B-X
of	B-X
these	B-X
compounds	B-X
were	B-X
elucidated	B-X
using	B-X
spectroscopic	B-X
analyses	B-X
that	B-X
included	B-X
extensive	B-X
2D	B-X
NMR	B-X
,	B-X
optical	B-X
rotation	B-X
spectrometry	B-X
and	B-X
mass	B-X
spectrometry	B-X
.	B-X
All	B-X
four	B-X
flavonoids	B-X
enhanced	B-X
the	B-X
activities	B-X
of	B-X
alcohol	B-X
metabolizing	B-X
enzymes	B-X
such	B-X
as	B-X
alcohol	B-X
dehydrogenase	B-X
(	B-X
ADH	B-X
)	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
(	B-X
ALDH	B-X
)	B-X
at	B-X
micromolar	B-X
concentrations	B-X
.	B-X
Sophoronol	B-X
2	B-X
showed	B-X
a	B-X
nine-fold	B-X
increased	B-X
activation	B-X
of	B-X
alcohol	B-X
dehydrogenase	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
than	B-X
a	B-X
negative	B-X
control	B-X
group	B-X
at	B-X
concentrations	B-X
of	B-X
100	B-X
microg/mL	B-X
and	B-X
50	B-X
microg/mL	B-X
,	B-X
respectively	B-X
.	B-X
This	B-X
study	B-X
suggests	B-X
that	B-X
prenylated	B-X
flavonoids	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
prevent	B-X
'hangovers	B-X
'	B-X
after	B-X
alcohol	B-X
intake	B-X
.	B-X

This	O
study	O
suggests	O
that	O
prenylated	O
flavonoids	O
have	O
the	O
potential	O
to	O
prevent	O
'	O
hangovers	O
'	O
after	O
alcohol	O
intake	O
.	O
<EOS>	B-X
A	B-X
new	B-X
prenylated	B-X
dihydroflavonol	B-X
,	B-X
3-hydroxy-kenusanone	B-X
B	B-X
1	B-X
,	B-X
as	B-X
well	B-X
as	B-X
three	B-X
other	B-X
known	B-X
isoflavanones	B-X
,	B-X
sophoronol	B-X
2	B-X
,	B-X
sophoraisoflavanone	B-X
A	B-X
3	B-X
and	B-X
kenusanone	B-X
H	B-X
4	B-X
,	B-X
were	B-X
isolated	B-X
from	B-X
the	B-X
rhizomes	B-X
of	B-X
Echinosophora	B-X
koreensis	B-X
.	B-X
All	B-X
four	B-X
flavonoids	B-X
enhanced	B-X
the	B-X
activities	B-X
of	B-X
alcohol	B-X
metabolizing	B-X
enzymes	B-X
such	B-X
as	B-X
alcohol	B-X
dehydrogenase	B-X
(	B-X
ADH	B-X
)	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
(	B-X
ALDH	B-X
)	B-X
at	B-X
micromolar	B-X
concentrations	B-X
.	B-X
Sophoronol	B-X
2	B-X
showed	B-X
a	B-X
nine-fold	B-X
increased	B-X
activation	B-X
of	B-X
alcohol	B-X
dehydrogenase	B-X
and	B-X
aldehyde	B-X
dehydrogenase	B-X
than	B-X
a	B-X
negative	B-X
control	B-X
group	B-X
at	B-X
concentrations	B-X
of	B-X
100	B-X
microg/mL	B-X
and	B-X
50	B-X
microg/mL	B-X
,	B-X
respectively	B-X
.	B-X
This	B-X
study	B-X
suggests	B-X
that	B-X
prenylated	B-X
flavonoids	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
prevent	B-X
'hangovers	B-X
'	B-X
after	B-X
alcohol	B-X
intake	B-X
.	B-X

A	O
unique	O
lipoylation	O
system	O
in	O
the	O
Archaea	O
.	O
<EOS>	B-X
Post-translational	B-X
lipoylation	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
these	B-X
complexes	B-X
is	B-X
essential	B-X
for	B-X
their	B-X
activity	B-X
,	B-X
the	B-X
lipoyllysine	B-X
moiety	B-X
performing	B-X
the	B-X
transfer	B-X
of	B-X
substrates	B-X
and	B-X
intermediates	B-X
between	B-X
the	B-X
different	B-X
active	B-X
sites	B-X
within	B-X
these	B-X
multienzyme	B-X
systems	B-X
.	B-X
Crucially	B-X
,	B-X
the	B-X
E.	B-X
coli	B-X
host	B-X
carries	B-X
out	B-X
the	B-X
required	B-X
lipoylation	B-X
of	B-X
the	B-X
archaeal	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
.	B-X
Because	B-X
active	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
have	B-X
never	B-X
been	B-X
detected	B-X
in	B-X
any	B-X
archaeon	B-X
,	B-X
the	B-X
question	B-X
arises	B-X
as	B-X
to	B-X
whether	B-X
Archaea	B-X
possess	B-X
a	B-X
functional	B-X
lipoylation	B-X
system	B-X
.	B-X
acidophilum	B-X
proteins	B-X
are	B-X
required	B-X
for	B-X
lipoylation	B-X
of	B-X
the	B-X
acyltransferase	B-X
,	B-X
and	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
associate	B-X
together	B-X
to	B-X
carry	B-X
out	B-X
this	B-X
post-translational	B-X
modification	B-X
.	B-X
From	B-X
the	B-X
published	B-X
DNA	B-X
sequences	B-X
,	B-X
we	B-X
suggest	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
transcriptional	B-X
and	B-X
translational	B-X
regulatory	B-X
elements	B-X
,	B-X
and	B-X
furthermore	B-X
we	B-X
present	B-X
preliminary	B-X
evidence	B-X
that	B-X
lipoylation	B-X
occurs	B-X
in	B-X
vivo	B-X
in	B-X
Tp	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
the	B-X
lipoylation	B-X
machinery	B-X
in	B-X
the	B-X
Archaea	B-X
,	B-X
which	B-X
is	B-X
unique	B-X
in	B-X
that	B-X
the	B-X
catalytic	B-X
activity	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
separate	B-X
gene	B-X
products	B-X
.	B-X

Lipoylation	O
in	O
Thermoplasma	O
acidophilum	O
requires	O
two	O
proteins	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
the	B-X
thermophilic	B-X
archaeon	B-X
,	B-X
Thermoplasma	B-X
acidophilum	B-X
,	B-X
has	B-X
a	B-X
four-gene	B-X
cluster	B-X
encoding	B-X
the	B-X
components	B-X
of	B-X
such	B-X
a	B-X
complex	B-X
,	B-X
which	B-X
,	B-X
when	B-X
recombinantly	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
,	B-X
can	B-X
be	B-X
assembled	B-X
into	B-X
an	B-X
active	B-X
multienzyme	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
and	B-X
heterologous	B-X
expression	B-X
of	B-X
two	B-X
genes	B-X
from	B-X
Tp	B-X
.	B-X
acidophilum	B-X
whose	B-X
protein	B-X
products	B-X
together	B-X
show	B-X
significant	B-X
sequence	B-X
identity	B-X
with	B-X
the	B-X
single	B-X
lipoate	B-X
protein	B-X
ligase	B-X
enzyme	B-X
of	B-X
bacteria	B-X
.	B-X
acidophilum	B-X
proteins	B-X
are	B-X
required	B-X
for	B-X
lipoylation	B-X
of	B-X
the	B-X
acyltransferase	B-X
,	B-X
and	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
associate	B-X
together	B-X
to	B-X
carry	B-X
out	B-X
this	B-X
post-translational	B-X
modification	B-X
.	B-X
acidophilum	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
the	B-X
lipoylation	B-X
machinery	B-X
in	B-X
the	B-X
Archaea	B-X
,	B-X
which	B-X
is	B-X
unique	B-X
in	B-X
that	B-X
the	B-X
catalytic	B-X
activity	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
separate	B-X
gene	B-X
products	B-X
.	B-X

Members	O
of	O
the	O
2	O
-	O
oxoacid	O
dehydrogenase	O
multienzyme	O
complex	O
family	O
play	O
a	O
key	O
role	O
in	O
the	O
pathways	O
of	O
central	O
metabolism	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complex	B-X
family	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathways	B-X
of	B-X
central	B-X
metabolism	B-X
.	B-X
Post-translational	B-X
lipoylation	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
these	B-X
complexes	B-X
is	B-X
essential	B-X
for	B-X
their	B-X
activity	B-X
,	B-X
the	B-X
lipoyllysine	B-X
moiety	B-X
performing	B-X
the	B-X
transfer	B-X
of	B-X
substrates	B-X
and	B-X
intermediates	B-X
between	B-X
the	B-X
different	B-X
active	B-X
sites	B-X
within	B-X
these	B-X
multienzyme	B-X
systems	B-X
.	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
the	B-X
thermophilic	B-X
archaeon	B-X
,	B-X
Thermoplasma	B-X
acidophilum	B-X
,	B-X
has	B-X
a	B-X
four-gene	B-X
cluster	B-X
encoding	B-X
the	B-X
components	B-X
of	B-X
such	B-X
a	B-X
complex	B-X
,	B-X
which	B-X
,	B-X
when	B-X
recombinantly	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
,	B-X
can	B-X
be	B-X
assembled	B-X
into	B-X
an	B-X
active	B-X
multienzyme	B-X
in	B-X
vitro	B-X
.	B-X
Because	B-X
active	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
have	B-X
never	B-X
been	B-X
detected	B-X
in	B-X
any	B-X
archaeon	B-X
,	B-X
the	B-X
question	B-X
arises	B-X
as	B-X
to	B-X
whether	B-X
Archaea	B-X
possess	B-X
a	B-X
functional	B-X
lipoylation	B-X
system	B-X
.	B-X

Post	O
-	O
translational	O
lipoylation	O
of	O
the	O
dihydrolipoyl	O
acyltransferase	O
component	O
of	O
these	O
complexes	O
is	O
essential	O
for	O
their	O
activity	O
,	O
the	O
lipoyllysine	O
moiety	O
performing	O
the	O
transfer	O
of	O
substrates	O
and	O
intermediates	O
between	O
the	O
different	O
active	O
sites	O
within	O
these	O
multienzyme	O
systems	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complex	B-X
family	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathways	B-X
of	B-X
central	B-X
metabolism	B-X
.	B-X
Post-translational	B-X
lipoylation	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
these	B-X
complexes	B-X
is	B-X
essential	B-X
for	B-X
their	B-X
activity	B-X
,	B-X
the	B-X
lipoyllysine	B-X
moiety	B-X
performing	B-X
the	B-X
transfer	B-X
of	B-X
substrates	B-X
and	B-X
intermediates	B-X
between	B-X
the	B-X
different	B-X
active	B-X
sites	B-X
within	B-X
these	B-X
multienzyme	B-X
systems	B-X
.	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
the	B-X
thermophilic	B-X
archaeon	B-X
,	B-X
Thermoplasma	B-X
acidophilum	B-X
,	B-X
has	B-X
a	B-X
four-gene	B-X
cluster	B-X
encoding	B-X
the	B-X
components	B-X
of	B-X
such	B-X
a	B-X
complex	B-X
,	B-X
which	B-X
,	B-X
when	B-X
recombinantly	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
,	B-X
can	B-X
be	B-X
assembled	B-X
into	B-X
an	B-X
active	B-X
multienzyme	B-X
in	B-X
vitro	B-X
.	B-X
Crucially	B-X
,	B-X
the	B-X
E.	B-X
coli	B-X
host	B-X
carries	B-X
out	B-X
the	B-X
required	B-X
lipoylation	B-X
of	B-X
the	B-X
archaeal	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
.	B-X
Because	B-X
active	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
have	B-X
never	B-X
been	B-X
detected	B-X
in	B-X
any	B-X
archaeon	B-X
,	B-X
the	B-X
question	B-X
arises	B-X
as	B-X
to	B-X
whether	B-X
Archaea	B-X
possess	B-X
a	B-X
functional	B-X
lipoylation	B-X
system	B-X
.	B-X
acidophilum	B-X
proteins	B-X
are	B-X
required	B-X
for	B-X
lipoylation	B-X
of	B-X
the	B-X
acyltransferase	B-X
,	B-X
and	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
associate	B-X
together	B-X
to	B-X
carry	B-X
out	B-X
this	B-X
post-translational	B-X
modification	B-X
.	B-X
From	B-X
the	B-X
published	B-X
DNA	B-X
sequences	B-X
,	B-X
we	B-X
suggest	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
transcriptional	B-X
and	B-X
translational	B-X
regulatory	B-X
elements	B-X
,	B-X
and	B-X
furthermore	B-X
we	B-X
present	B-X
preliminary	B-X
evidence	B-X
that	B-X
lipoylation	B-X
occurs	B-X
in	B-X
vivo	B-X
in	B-X
Tp	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
the	B-X
lipoylation	B-X
machinery	B-X
in	B-X
the	B-X
Archaea	B-X
,	B-X
which	B-X
is	B-X
unique	B-X
in	B-X
that	B-X
the	B-X
catalytic	B-X
activity	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
separate	B-X
gene	B-X
products	B-X
.	B-X

We	O
have	O
previously	O
shown	O
that	O
the	O
thermophilic	O
archaeon	O
,	O
Thermoplasma	O
acidophilum	O
,	O
has	O
a	O
four	O
-	O
gene	O
cluster	O
encoding	O
the	O
components	O
of	O
such	O
a	O
complex	O
,	O
which	O
,	O
when	O
recombinantly	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
can	O
be	O
assembled	O
into	O
an	O
active	O
multienzyme	O
in	O
vitro	O
.	O

Crucially	O
,	O
the	O
E	O
.	O
coli	O
host	O
carries	O
out	O
the	O
required	O
lipoylation	O
of	O
the	O
archaeal	O
dihydrolipoyl	O
acyltransferase	O
component	O
.	O

Because	O
active	O
2	O
-	O
oxoacid	O
dehydrogenase	O
multienzyme	O
complexes	O
have	O
never	O
been	O
detected	O
in	O
any	O
archaeon	O
,	O
the	O
question	O
arises	O
as	O
to	O
whether	O
Archaea	O
possess	O
a	O
functional	O
lipoylation	O
system	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complex	B-X
family	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathways	B-X
of	B-X
central	B-X
metabolism	B-X
.	B-X
Post-translational	B-X
lipoylation	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
these	B-X
complexes	B-X
is	B-X
essential	B-X
for	B-X
their	B-X
activity	B-X
,	B-X
the	B-X
lipoyllysine	B-X
moiety	B-X
performing	B-X
the	B-X
transfer	B-X
of	B-X
substrates	B-X
and	B-X
intermediates	B-X
between	B-X
the	B-X
different	B-X
active	B-X
sites	B-X
within	B-X
these	B-X
multienzyme	B-X
systems	B-X
.	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
the	B-X
thermophilic	B-X
archaeon	B-X
,	B-X
Thermoplasma	B-X
acidophilum	B-X
,	B-X
has	B-X
a	B-X
four-gene	B-X
cluster	B-X
encoding	B-X
the	B-X
components	B-X
of	B-X
such	B-X
a	B-X
complex	B-X
,	B-X
which	B-X
,	B-X
when	B-X
recombinantly	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
,	B-X
can	B-X
be	B-X
assembled	B-X
into	B-X
an	B-X
active	B-X
multienzyme	B-X
in	B-X
vitro	B-X
.	B-X
Crucially	B-X
,	B-X
the	B-X
E.	B-X
coli	B-X
host	B-X
carries	B-X
out	B-X
the	B-X
required	B-X
lipoylation	B-X
of	B-X
the	B-X
archaeal	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
.	B-X
Because	B-X
active	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
have	B-X
never	B-X
been	B-X
detected	B-X
in	B-X
any	B-X
archaeon	B-X
,	B-X
the	B-X
question	B-X
arises	B-X
as	B-X
to	B-X
whether	B-X
Archaea	B-X
possess	B-X
a	B-X
functional	B-X
lipoylation	B-X
system	B-X
.	B-X
acidophilum	B-X
proteins	B-X
are	B-X
required	B-X
for	B-X
lipoylation	B-X
of	B-X
the	B-X
acyltransferase	B-X
,	B-X
and	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
associate	B-X
together	B-X
to	B-X
carry	B-X
out	B-X
this	B-X
post-translational	B-X
modification	B-X
.	B-X
From	B-X
the	B-X
published	B-X
DNA	B-X
sequences	B-X
,	B-X
we	B-X
suggest	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
transcriptional	B-X
and	B-X
translational	B-X
regulatory	B-X
elements	B-X
,	B-X
and	B-X
furthermore	B-X
we	B-X
present	B-X
preliminary	B-X
evidence	B-X
that	B-X
lipoylation	B-X
occurs	B-X
in	B-X
vivo	B-X
in	B-X
Tp	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
the	B-X
lipoylation	B-X
machinery	B-X
in	B-X
the	B-X
Archaea	B-X
,	B-X
which	B-X
is	B-X
unique	B-X
in	B-X
that	B-X
the	B-X
catalytic	B-X
activity	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
separate	B-X
gene	B-X
products	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
report	O
the	O
cloning	O
and	O
heterologous	O
expression	O
of	O
two	O
genes	O
from	O
Tp	O
.	O
acidophilum	O
whose	O
protein	O
products	O
together	O
show	O
significant	O
sequence	O
identity	O
with	O
the	O
single	O
lipoate	O
protein	O
ligase	O
enzyme	O
of	O
bacteria	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complex	B-X
family	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathways	B-X
of	B-X
central	B-X
metabolism	B-X
.	B-X
Post-translational	B-X
lipoylation	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
these	B-X
complexes	B-X
is	B-X
essential	B-X
for	B-X
their	B-X
activity	B-X
,	B-X
the	B-X
lipoyllysine	B-X
moiety	B-X
performing	B-X
the	B-X
transfer	B-X
of	B-X
substrates	B-X
and	B-X
intermediates	B-X
between	B-X
the	B-X
different	B-X
active	B-X
sites	B-X
within	B-X
these	B-X
multienzyme	B-X
systems	B-X
.	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
the	B-X
thermophilic	B-X
archaeon	B-X
,	B-X
Thermoplasma	B-X
acidophilum	B-X
,	B-X
has	B-X
a	B-X
four-gene	B-X
cluster	B-X
encoding	B-X
the	B-X
components	B-X
of	B-X
such	B-X
a	B-X
complex	B-X
,	B-X
which	B-X
,	B-X
when	B-X
recombinantly	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
,	B-X
can	B-X
be	B-X
assembled	B-X
into	B-X
an	B-X
active	B-X
multienzyme	B-X
in	B-X
vitro	B-X
.	B-X
Because	B-X
active	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
have	B-X
never	B-X
been	B-X
detected	B-X
in	B-X
any	B-X
archaeon	B-X
,	B-X
the	B-X
question	B-X
arises	B-X
as	B-X
to	B-X
whether	B-X
Archaea	B-X
possess	B-X
a	B-X
functional	B-X
lipoylation	B-X
system	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
and	B-X
heterologous	B-X
expression	B-X
of	B-X
two	B-X
genes	B-X
from	B-X
Tp	B-X
.	B-X
acidophilum	B-X
whose	B-X
protein	B-X
products	B-X
together	B-X
show	B-X
significant	B-X
sequence	B-X
identity	B-X
with	B-X
the	B-X
single	B-X
lipoate	B-X
protein	B-X
ligase	B-X
enzyme	B-X
of	B-X
bacteria	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
both	B-X
recombinantly	B-X
expressed	B-X
Tp	B-X
.	B-X
acidophilum	B-X
proteins	B-X
are	B-X
required	B-X
for	B-X
lipoylation	B-X
of	B-X
the	B-X
acyltransferase	B-X
,	B-X
and	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
associate	B-X
together	B-X
to	B-X
carry	B-X
out	B-X
this	B-X
post-translational	B-X
modification	B-X
.	B-X
From	B-X
the	B-X
published	B-X
DNA	B-X
sequences	B-X
,	B-X
we	B-X
suggest	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
transcriptional	B-X
and	B-X
translational	B-X
regulatory	B-X
elements	B-X
,	B-X
and	B-X
furthermore	B-X
we	B-X
present	B-X
preliminary	B-X
evidence	B-X
that	B-X
lipoylation	B-X
occurs	B-X
in	B-X
vivo	B-X
in	B-X
Tp	B-X
.	B-X
acidophilum	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
the	B-X
lipoylation	B-X
machinery	B-X
in	B-X
the	B-X
Archaea	B-X
,	B-X
which	B-X
is	B-X
unique	B-X
in	B-X
that	B-X
the	B-X
catalytic	B-X
activity	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
separate	B-X
gene	B-X
products	B-X
.	B-X

We	O
demonstrate	O
that	O
both	O
recombinantly	O
expressed	O
Tp	O
.	O
acidophilum	O
proteins	O
are	O
required	O
for	O
lipoylation	O
of	O
the	O
acyltransferase	O
,	O
and	O
that	O
the	O
two	O
proteins	O
associate	O
together	O
to	O
carry	O
out	O
this	O
post	O
-	O
translational	O
modification	O
.	O
<EOS>	B-X
Post-translational	B-X
lipoylation	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
these	B-X
complexes	B-X
is	B-X
essential	B-X
for	B-X
their	B-X
activity	B-X
,	B-X
the	B-X
lipoyllysine	B-X
moiety	B-X
performing	B-X
the	B-X
transfer	B-X
of	B-X
substrates	B-X
and	B-X
intermediates	B-X
between	B-X
the	B-X
different	B-X
active	B-X
sites	B-X
within	B-X
these	B-X
multienzyme	B-X
systems	B-X
.	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
the	B-X
thermophilic	B-X
archaeon	B-X
,	B-X
Thermoplasma	B-X
acidophilum	B-X
,	B-X
has	B-X
a	B-X
four-gene	B-X
cluster	B-X
encoding	B-X
the	B-X
components	B-X
of	B-X
such	B-X
a	B-X
complex	B-X
,	B-X
which	B-X
,	B-X
when	B-X
recombinantly	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
,	B-X
can	B-X
be	B-X
assembled	B-X
into	B-X
an	B-X
active	B-X
multienzyme	B-X
in	B-X
vitro	B-X
.	B-X
Crucially	B-X
,	B-X
the	B-X
E.	B-X
coli	B-X
host	B-X
carries	B-X
out	B-X
the	B-X
required	B-X
lipoylation	B-X
of	B-X
the	B-X
archaeal	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
.	B-X
Because	B-X
active	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
have	B-X
never	B-X
been	B-X
detected	B-X
in	B-X
any	B-X
archaeon	B-X
,	B-X
the	B-X
question	B-X
arises	B-X
as	B-X
to	B-X
whether	B-X
Archaea	B-X
possess	B-X
a	B-X
functional	B-X
lipoylation	B-X
system	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
and	B-X
heterologous	B-X
expression	B-X
of	B-X
two	B-X
genes	B-X
from	B-X
Tp	B-X
.	B-X
acidophilum	B-X
whose	B-X
protein	B-X
products	B-X
together	B-X
show	B-X
significant	B-X
sequence	B-X
identity	B-X
with	B-X
the	B-X
single	B-X
lipoate	B-X
protein	B-X
ligase	B-X
enzyme	B-X
of	B-X
bacteria	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
both	B-X
recombinantly	B-X
expressed	B-X
Tp	B-X
.	B-X
acidophilum	B-X
proteins	B-X
are	B-X
required	B-X
for	B-X
lipoylation	B-X
of	B-X
the	B-X
acyltransferase	B-X
,	B-X
and	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
associate	B-X
together	B-X
to	B-X
carry	B-X
out	B-X
this	B-X
post-translational	B-X
modification	B-X
.	B-X
From	B-X
the	B-X
published	B-X
DNA	B-X
sequences	B-X
,	B-X
we	B-X
suggest	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
transcriptional	B-X
and	B-X
translational	B-X
regulatory	B-X
elements	B-X
,	B-X
and	B-X
furthermore	B-X
we	B-X
present	B-X
preliminary	B-X
evidence	B-X
that	B-X
lipoylation	B-X
occurs	B-X
in	B-X
vivo	B-X
in	B-X
Tp	B-X
.	B-X
acidophilum	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
the	B-X
lipoylation	B-X
machinery	B-X
in	B-X
the	B-X
Archaea	B-X
,	B-X
which	B-X
is	B-X
unique	B-X
in	B-X
that	B-X
the	B-X
catalytic	B-X
activity	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
separate	B-X
gene	B-X
products	B-X
.	B-X

From	O
the	O
published	O
DNA	O
sequences	O
,	O
we	O
suggest	O
the	O
presence	O
of	O
functional	O
transcriptional	O
and	O
translational	O
regulatory	O
elements	O
,	O
and	O
furthermore	O
we	O
present	O
preliminary	O
evidence	O
that	O
lipoylation	O
occurs	O
in	O
vivo	O
in	O
Tp	O
.	O
acidophilum	O
.	O
<EOS>	B-X
Post-translational	B-X
lipoylation	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
these	B-X
complexes	B-X
is	B-X
essential	B-X
for	B-X
their	B-X
activity	B-X
,	B-X
the	B-X
lipoyllysine	B-X
moiety	B-X
performing	B-X
the	B-X
transfer	B-X
of	B-X
substrates	B-X
and	B-X
intermediates	B-X
between	B-X
the	B-X
different	B-X
active	B-X
sites	B-X
within	B-X
these	B-X
multienzyme	B-X
systems	B-X
.	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
the	B-X
thermophilic	B-X
archaeon	B-X
,	B-X
Thermoplasma	B-X
acidophilum	B-X
,	B-X
has	B-X
a	B-X
four-gene	B-X
cluster	B-X
encoding	B-X
the	B-X
components	B-X
of	B-X
such	B-X
a	B-X
complex	B-X
,	B-X
which	B-X
,	B-X
when	B-X
recombinantly	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
,	B-X
can	B-X
be	B-X
assembled	B-X
into	B-X
an	B-X
active	B-X
multienzyme	B-X
in	B-X
vitro	B-X
.	B-X
Crucially	B-X
,	B-X
the	B-X
E.	B-X
coli	B-X
host	B-X
carries	B-X
out	B-X
the	B-X
required	B-X
lipoylation	B-X
of	B-X
the	B-X
archaeal	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
.	B-X
Because	B-X
active	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
have	B-X
never	B-X
been	B-X
detected	B-X
in	B-X
any	B-X
archaeon	B-X
,	B-X
the	B-X
question	B-X
arises	B-X
as	B-X
to	B-X
whether	B-X
Archaea	B-X
possess	B-X
a	B-X
functional	B-X
lipoylation	B-X
system	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
and	B-X
heterologous	B-X
expression	B-X
of	B-X
two	B-X
genes	B-X
from	B-X
Tp	B-X
.	B-X
acidophilum	B-X
whose	B-X
protein	B-X
products	B-X
together	B-X
show	B-X
significant	B-X
sequence	B-X
identity	B-X
with	B-X
the	B-X
single	B-X
lipoate	B-X
protein	B-X
ligase	B-X
enzyme	B-X
of	B-X
bacteria	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
both	B-X
recombinantly	B-X
expressed	B-X
Tp	B-X
.	B-X
acidophilum	B-X
proteins	B-X
are	B-X
required	B-X
for	B-X
lipoylation	B-X
of	B-X
the	B-X
acyltransferase	B-X
,	B-X
and	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
associate	B-X
together	B-X
to	B-X
carry	B-X
out	B-X
this	B-X
post-translational	B-X
modification	B-X
.	B-X
From	B-X
the	B-X
published	B-X
DNA	B-X
sequences	B-X
,	B-X
we	B-X
suggest	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
transcriptional	B-X
and	B-X
translational	B-X
regulatory	B-X
elements	B-X
,	B-X
and	B-X
furthermore	B-X
we	B-X
present	B-X
preliminary	B-X
evidence	B-X
that	B-X
lipoylation	B-X
occurs	B-X
in	B-X
vivo	B-X
in	B-X
Tp	B-X
.	B-X
acidophilum	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
the	B-X
lipoylation	B-X
machinery	B-X
in	B-X
the	B-X
Archaea	B-X
,	B-X
which	B-X
is	B-X
unique	B-X
in	B-X
that	B-X
the	B-X
catalytic	B-X
activity	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
separate	B-X
gene	B-X
products	B-X
.	B-X

This	O
is	O
the	O
first	O
report	O
of	O
the	O
lipoylation	O
machinery	O
in	O
the	O
Archaea	O
,	O
which	O
is	O
unique	O
in	O
that	O
the	O
catalytic	O
activity	O
is	O
dependent	O
on	O
two	O
separate	O
gene	O
products	O
.	O
<EOS>	B-X
Post-translational	B-X
lipoylation	B-X
of	B-X
the	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
of	B-X
these	B-X
complexes	B-X
is	B-X
essential	B-X
for	B-X
their	B-X
activity	B-X
,	B-X
the	B-X
lipoyllysine	B-X
moiety	B-X
performing	B-X
the	B-X
transfer	B-X
of	B-X
substrates	B-X
and	B-X
intermediates	B-X
between	B-X
the	B-X
different	B-X
active	B-X
sites	B-X
within	B-X
these	B-X
multienzyme	B-X
systems	B-X
.	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
the	B-X
thermophilic	B-X
archaeon	B-X
,	B-X
Thermoplasma	B-X
acidophilum	B-X
,	B-X
has	B-X
a	B-X
four-gene	B-X
cluster	B-X
encoding	B-X
the	B-X
components	B-X
of	B-X
such	B-X
a	B-X
complex	B-X
,	B-X
which	B-X
,	B-X
when	B-X
recombinantly	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
,	B-X
can	B-X
be	B-X
assembled	B-X
into	B-X
an	B-X
active	B-X
multienzyme	B-X
in	B-X
vitro	B-X
.	B-X
Crucially	B-X
,	B-X
the	B-X
E.	B-X
coli	B-X
host	B-X
carries	B-X
out	B-X
the	B-X
required	B-X
lipoylation	B-X
of	B-X
the	B-X
archaeal	B-X
dihydrolipoyl	B-X
acyltransferase	B-X
component	B-X
.	B-X
Because	B-X
active	B-X
2-oxoacid	B-X
dehydrogenase	B-X
multienzyme	B-X
complexes	B-X
have	B-X
never	B-X
been	B-X
detected	B-X
in	B-X
any	B-X
archaeon	B-X
,	B-X
the	B-X
question	B-X
arises	B-X
as	B-X
to	B-X
whether	B-X
Archaea	B-X
possess	B-X
a	B-X
functional	B-X
lipoylation	B-X
system	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
and	B-X
heterologous	B-X
expression	B-X
of	B-X
two	B-X
genes	B-X
from	B-X
Tp	B-X
.	B-X
acidophilum	B-X
whose	B-X
protein	B-X
products	B-X
together	B-X
show	B-X
significant	B-X
sequence	B-X
identity	B-X
with	B-X
the	B-X
single	B-X
lipoate	B-X
protein	B-X
ligase	B-X
enzyme	B-X
of	B-X
bacteria	B-X
.	B-X
acidophilum	B-X
proteins	B-X
are	B-X
required	B-X
for	B-X
lipoylation	B-X
of	B-X
the	B-X
acyltransferase	B-X
,	B-X
and	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
associate	B-X
together	B-X
to	B-X
carry	B-X
out	B-X
this	B-X
post-translational	B-X
modification	B-X
.	B-X
From	B-X
the	B-X
published	B-X
DNA	B-X
sequences	B-X
,	B-X
we	B-X
suggest	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
transcriptional	B-X
and	B-X
translational	B-X
regulatory	B-X
elements	B-X
,	B-X
and	B-X
furthermore	B-X
we	B-X
present	B-X
preliminary	B-X
evidence	B-X
that	B-X
lipoylation	B-X
occurs	B-X
in	B-X
vivo	B-X
in	B-X
Tp	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
the	B-X
lipoylation	B-X
machinery	B-X
in	B-X
the	B-X
Archaea	B-X
,	B-X
which	B-X
is	B-X
unique	B-X
in	B-X
that	B-X
the	B-X
catalytic	B-X
activity	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
separate	B-X
gene	B-X
products	B-X
.	B-X

Molecular	O
basis	O
of	O
canonical	O
and	O
bactericidal	O
autophagy	O
.	O
<EOS>	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
current	B-X
understanding	B-X
of	B-X
three	B-X
of	B-X
the	B-X
basic	B-X
components	B-X
of	B-X
the	B-X
canonical	B-X
autophagy	B-X
machinery-LC3	B-X
,	B-X
the	B-X
Atg16L	B-X
complex	B-X
and	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
(	B-X
PI3P	B-X
)	B-X
-which	B-X
are	B-X
dynamically	B-X
associated	B-X
with	B-X
the	B-X
autophagic	B-X
structure	B-X
.	B-X
Further	B-X
,	B-X
their	B-X
relation	B-X
to	B-X
bactericidal	B-X
autophagy	B-X
(	B-X
i.e	B-X
.	B-X

Autophagy	O
is	O
a	O
catabolic	O
process	O
by	O
which	O
cells	O
degrade	O
their	O
own	O
cytoplasmic	O
constituents	O
.	O
<EOS>	B-X
Although	B-X
ageing	B-X
is	B-X
a	B-X
multifactorial	B-X
process	B-X
with	B-X
many	B-X
mechanisms	B-X
contributing	B-X
to	B-X
the	B-X
decline	B-X
,	B-X
the	B-X
intracellular	B-X
accumulation	B-X
of	B-X
damaged	B-X
proteins	B-X
and	B-X
mitochondria	B-X
is	B-X
a	B-X
feature	B-X
common	B-X
to	B-X
all	B-X
aged	B-X
cells	B-X
.	B-X
Autophagy	B-X
(	B-X
cellular	B-X
self-eating	B-X
)	B-X
-	B-X
a	B-X
lysosome-mediated	B-X
catabolic	B-X
process	B-X
of	B-X
eukaryotic	B-X
cells	B-X
to	B-X
digest	B-X
their	B-X
own	B-X
constituents	B-X
-	B-X
is	B-X
a	B-X
major	B-X
route	B-X
for	B-X
the	B-X
bulk	B-X
degradation	B-X
of	B-X
aberrant	B-X
cytosolic	B-X
macromolecules	B-X
and	B-X
organelles	B-X
.	B-X
Plant	B-X
cells	B-X
use	B-X
autophagy	B-X
to	B-X
degrade	B-X
their	B-X
own	B-X
cytoplasm	B-X
in	B-X
vacuoles	B-X
,	B-X
thereby	B-X
not	B-X
only	B-X
recycling	B-X
their	B-X
breakdown	B-X
products	B-X
,	B-X
but	B-X
also	B-X
ensuring	B-X
the	B-X
homeostasis	B-X
of	B-X
essential	B-X
cytoplasmic	B-X
constituents	B-X
and	B-X
organelles	B-X
.	B-X
Plants	B-X
and	B-X
other	B-X
eukaryotes	B-X
have	B-X
a	B-X
conserved	B-X
set	B-X
of	B-X
core	B-X
Autophagy-related	B-X
(	B-X
ATG	B-X
)	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
biogenesis	B-X
of	B-X
the	B-X
autophagosome	B-X
,	B-X
the	B-X
main	B-X
autophagic	B-X
compartment	B-X
destined	B-X
for	B-X
the	B-X
lytic	B-X
vacuole	B-X
.	B-X

Cells	O
respond	O
to	O
the	O
stress	O
response	O
of	O
nutrient	O
deficiency	O
by	O
degrading	O
a	O
portion	O
of	O
their	O
cellular	O
components	O
to	O
produce	O
amino	O
acids	O
and	O
energy	O
.	O

Recently	O
,	O
it	O
became	O
evident	O
that	O
the	O
autophagic	O
machinery	O
is	O
also	O
involved	O
in	O
a	O
kind	O
of	O
innate	O
immune	O
system	O
.	O

Some	O
bacteria	O
that	O
invade	O
mammalian	O
cells	O
are	O
eventually	O
entrapped	O
in	O
an	O
autophagic	O
membrane	O
structure	O
.	O

In	O
this	O
review	O
,	O
we	O
describe	O
the	O
current	O
understanding	O
of	O
three	O
of	O
the	O
basic	O
components	O
of	O
the	O
canonical	O
autophagy	O
machinery	O
-	O
LC3	O
,	O
the	O
Atg16L	O
complex	O
and	O
phosphatidylinositol	O
3	O
-	O
phosphate	O
(	O
PI3P	O
)	O
-	O
which	O
are	O
dynamically	O
associated	O
with	O
the	O
autophagic	O
structure	O
.	O
<EOS>	B-X
Cells	B-X
respond	B-X
to	B-X
the	B-X
stress	B-X
response	B-X
of	B-X
nutrient	B-X
deficiency	B-X
by	B-X
degrading	B-X
a	B-X
portion	B-X
of	B-X
their	B-X
cellular	B-X
components	B-X
to	B-X
produce	B-X
amino	B-X
acids	B-X
and	B-X
energy	B-X
.	B-X
Recently	B-X
,	B-X
it	B-X
became	B-X
evident	B-X
that	B-X
the	B-X
autophagic	B-X
machinery	B-X
is	B-X
also	B-X
involved	B-X
in	B-X
a	B-X
kind	B-X
of	B-X
innate	B-X
immune	B-X
system	B-X
.	B-X
Some	B-X
bacteria	B-X
that	B-X
invade	B-X
mammalian	B-X
cells	B-X
are	B-X
eventually	B-X
entrapped	B-X
in	B-X
an	B-X
autophagic	B-X
membrane	B-X
structure	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
current	B-X
understanding	B-X
of	B-X
three	B-X
of	B-X
the	B-X
basic	B-X
components	B-X
of	B-X
the	B-X
canonical	B-X
autophagy	B-X
machinery-LC3	B-X
,	B-X
the	B-X
Atg16L	B-X
complex	B-X
and	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
(	B-X
PI3P	B-X
)	B-X
-which	B-X
are	B-X
dynamically	B-X
associated	B-X
with	B-X
the	B-X
autophagic	B-X
structure	B-X
.	B-X
LC3	B-X
is	B-X
proposed	B-X
to	B-X
function	B-X
in	B-X
autophagosome	B-X
closure	B-X
,	B-X
whereas	B-X
the	B-X
Atg16L	B-X
complex	B-X
functions	B-X
as	B-X
an	B-X
E3-like	B-X
protein	B-X
in	B-X
ubiquitination-like	B-X
reactions	B-X
in	B-X
the	B-X
LC3	B-X
lipidation	B-X
system	B-X
.	B-X
PI3P	B-X
is	B-X
a	B-X
key	B-X
determinant	B-X
of	B-X
the	B-X
autophagic	B-X
membrane	B-X
.	B-X
Further	B-X
,	B-X
their	B-X
relation	B-X
to	B-X
bactericidal	B-X
autophagy	B-X
(	B-X
i.e	B-X
.	B-X

LC3	O
is	O
proposed	O
to	O
function	O
in	O
autophagosome	O
closure	O
,	O
whereas	O
the	O
Atg16L	O
complex	O
functions	O
as	O
an	O
E3	O
-	O
like	O
protein	O
in	O
ubiquitination	O
-	O
like	O
reactions	O
in	O
the	O
LC3	O
lipidation	O
system	O
.	O
<EOS>	B-X
Recently	B-X
,	B-X
it	B-X
became	B-X
evident	B-X
that	B-X
the	B-X
autophagic	B-X
machinery	B-X
is	B-X
also	B-X
involved	B-X
in	B-X
a	B-X
kind	B-X
of	B-X
innate	B-X
immune	B-X
system	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
current	B-X
understanding	B-X
of	B-X
three	B-X
of	B-X
the	B-X
basic	B-X
components	B-X
of	B-X
the	B-X
canonical	B-X
autophagy	B-X
machinery-LC3	B-X
,	B-X
the	B-X
Atg16L	B-X
complex	B-X
and	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
(	B-X
PI3P	B-X
)	B-X
-which	B-X
are	B-X
dynamically	B-X
associated	B-X
with	B-X
the	B-X
autophagic	B-X
structure	B-X
.	B-X
LC3	B-X
is	B-X
proposed	B-X
to	B-X
function	B-X
in	B-X
autophagosome	B-X
closure	B-X
,	B-X
whereas	B-X
the	B-X
Atg16L	B-X
complex	B-X
functions	B-X
as	B-X
an	B-X
E3-like	B-X
protein	B-X
in	B-X
ubiquitination-like	B-X
reactions	B-X
in	B-X
the	B-X
LC3	B-X
lipidation	B-X
system	B-X
.	B-X

PI3P	O
is	O
a	O
key	O
determinant	O
of	O
the	O
autophagic	O
membrane	O
.	O
<EOS>	B-X
Recently	B-X
,	B-X
it	B-X
became	B-X
evident	B-X
that	B-X
the	B-X
autophagic	B-X
machinery	B-X
is	B-X
also	B-X
involved	B-X
in	B-X
a	B-X
kind	B-X
of	B-X
innate	B-X
immune	B-X
system	B-X
.	B-X
Some	B-X
bacteria	B-X
that	B-X
invade	B-X
mammalian	B-X
cells	B-X
are	B-X
eventually	B-X
entrapped	B-X
in	B-X
an	B-X
autophagic	B-X
membrane	B-X
structure	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
current	B-X
understanding	B-X
of	B-X
three	B-X
of	B-X
the	B-X
basic	B-X
components	B-X
of	B-X
the	B-X
canonical	B-X
autophagy	B-X
machinery-LC3	B-X
,	B-X
the	B-X
Atg16L	B-X
complex	B-X
and	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
(	B-X
PI3P	B-X
)	B-X
-which	B-X
are	B-X
dynamically	B-X
associated	B-X
with	B-X
the	B-X
autophagic	B-X
structure	B-X
.	B-X
PI3P	B-X
is	B-X
a	B-X
key	B-X
determinant	B-X
of	B-X
the	B-X
autophagic	B-X
membrane	B-X
.	B-X

Further	O
,	O
their	O
relation	O
to	O
bactericidal	O
autophagy	O
(	O
i	O
.	O
e	O
.	O
xenophagy	O
)	O
will	O
be	O
introduced	O
.	O

Three	O
-	O
dimensional	O
organization	O
of	O
promyelocytic	O
leukemia	O
nuclear	O
bodies	O
.	O
<EOS>	B-X
Promyelocytic	B-X
leukemia	B-X
nuclear	B-X
bodies	B-X
(	B-X
PML-NBs	B-X
)	B-X
are	B-X
mobile	B-X
subnuclear	B-X
organelles	B-X
formed	B-X
by	B-X
PML	B-X
and	B-X
Sp100	B-X
protein	B-X
.	B-X
During	B-X
interphase	B-X
PML-NBs	B-X
adopt	B-X
a	B-X
spherical	B-X
organization	B-X
characterized	B-X
by	B-X
the	B-X
assembly	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
proteins	B-X
into	B-X
patches	B-X
within	B-X
a	B-X
50-	B-X
to	B-X
100-nm-thick	B-X
shell	B-X
.	B-X
From	B-X
our	B-X
findings	B-X
,	B-X
we	B-X
derived	B-X
a	B-X
model	B-X
that	B-X
explains	B-X
how	B-X
the	B-X
three-dimensional	B-X
organization	B-X
of	B-X
PML-NBs	B-X
serves	B-X
to	B-X
concentrate	B-X
different	B-X
biological	B-X
activities	B-X
while	B-X
allowing	B-X
for	B-X
an	B-X
efficient	B-X
exchange	B-X
of	B-X
components	B-X
.	B-X
In	B-X
stark	B-X
contrast	B-X
,	B-X
very	B-X
little	B-X
is	B-X
known	B-X
about	B-X
how	B-X
these	B-X
processes	B-X
are	B-X
integrated	B-X
into	B-X
the	B-X
structural	B-X
framework	B-X
of	B-X
the	B-X
cell	B-X
nucleus	B-X
and	B-X
how	B-X
they	B-X
are	B-X
spatially	B-X
and	B-X
temporally	B-X
co-ordinated	B-X
within	B-X
the	B-X
three-dimensional	B-X
confines	B-X
of	B-X
the	B-X
nucleus	B-X
.	B-X
It	B-X
is	B-X
also	B-X
largely	B-X
unknown	B-X
how	B-X
nuclear	B-X
architecture	B-X
affects	B-X
gene	B-X
expression	B-X
.	B-X
In	B-X
order	B-X
to	B-X
understand	B-X
how	B-X
genomes	B-X
are	B-X
organized	B-X
,	B-X
and	B-X
how	B-X
they	B-X
function	B-X
,	B-X
the	B-X
basic	B-X
principles	B-X
that	B-X
govern	B-X
nuclear	B-X
architecture	B-X
and	B-X
function	B-X
must	B-X
be	B-X
uncovered	B-X
.	B-X
It	B-X
has	B-X
become	B-X
clear	B-X
that	B-X
the	B-X
nucleus	B-X
contains	B-X
distinct	B-X
compartments	B-X
and	B-X
that	B-X
many	B-X
nuclear	B-X
components	B-X
are	B-X
highly	B-X
dynamic	B-X
.	B-X
We	B-X
summarize	B-X
recent	B-X
observations	B-X
regarding	B-X
the	B-X
dynamic	B-X
properties	B-X
of	B-X
chromatin	B-X
,	B-X
mRNA	B-X
and	B-X
nuclear	B-X
proteins	B-X
,	B-X
and	B-X
we	B-X
consider	B-X
the	B-X
implications	B-X
these	B-X
findings	B-X
have	B-X
for	B-X
the	B-X
organization	B-X
of	B-X
nuclear	B-X
processes	B-X
and	B-X
gene	B-X
expression	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
speculate	B-X
that	B-X
self-organization	B-X
might	B-X
play	B-X
a	B-X
substantial	B-X
role	B-X
in	B-X
establishing	B-X
and	B-X
maintaining	B-X
nuclear	B-X
organization	B-X
.	B-X

Promyelocytic	O
leukemia	O
nuclear	O
bodies	O
(	O
PML	O
-	O
NBs	O
)	O
are	O
mobile	O
subnuclear	O
organelles	O
formed	O
by	O
PML	B-Protein
and	O
Sp100	B-Protein
protein	O
.	O
<EOS>	B-X
Promyelocytic	B-X
leukemia	B-X
nuclear	B-X
bodies	B-X
(	B-X
PML-NBs	B-X
)	B-X
are	B-X
mobile	B-X
subnuclear	B-X
organelles	B-X
formed	B-X
by	B-X
PML	B-X
and	B-X
Sp100	B-X
protein	B-X
.	B-X
We	B-X
have	B-X
conducted	B-X
high-resolution	B-X
4Pi	B-X
fluorescence	B-X
laser-scanning	B-X
microscopy	B-X
studies	B-X
complemented	B-X
with	B-X
correlative	B-X
electron	B-X
microscopy	B-X
and	B-X
investigations	B-X
of	B-X
the	B-X
accessibility	B-X
of	B-X
the	B-X
PML-NB	B-X
subcompartment	B-X
.	B-X
During	B-X
interphase	B-X
PML-NBs	B-X
adopt	B-X
a	B-X
spherical	B-X
organization	B-X
characterized	B-X
by	B-X
the	B-X
assembly	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
proteins	B-X
into	B-X
patches	B-X
within	B-X
a	B-X
50-	B-X
to	B-X
100-nm-thick	B-X
shell	B-X
.	B-X
This	B-X
spherical	B-X
shell	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
imposes	B-X
little	B-X
constraint	B-X
to	B-X
the	B-X
exchange	B-X
of	B-X
components	B-X
between	B-X
the	B-X
PML-NB	B-X
interior	B-X
and	B-X
the	B-X
nucleoplasm	B-X
.	B-X
Post-translational	B-X
SUMO	B-X
modifications	B-X
,	B-X
telomere	B-X
repeats	B-X
and	B-X
heterochromatin	B-X
protein	B-X
1	B-X
were	B-X
found	B-X
to	B-X
localize	B-X
in	B-X
characteristic	B-X
patterns	B-X
with	B-X
respect	B-X
to	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
From	B-X
our	B-X
findings	B-X
,	B-X
we	B-X
derived	B-X
a	B-X
model	B-X
that	B-X
explains	B-X
how	B-X
the	B-X
three-dimensional	B-X
organization	B-X
of	B-X
PML-NBs	B-X
serves	B-X
to	B-X
concentrate	B-X
different	B-X
biological	B-X
activities	B-X
while	B-X
allowing	B-X
for	B-X
an	B-X
efficient	B-X
exchange	B-X
of	B-X
components	B-X
.	B-X

They	O
have	O
been	O
reported	O
to	O
have	O
a	O
role	O
in	O
transcription	O
,	O
DNA	O
replication	O
and	O
repair	O
,	O
telomere	O
lengthening	O
,	O
cell	O
cycle	O
control	O
and	O
tumor	O
suppression	O
.	O
<EOS>	B-X
They	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
have	B-X
a	B-X
role	B-X
in	B-X
transcription	B-X
,	B-X
DNA	B-X
replication	B-X
and	B-X
repair	B-X
,	B-X
telomere	B-X
lengthening	B-X
,	B-X
cell	B-X
cycle	B-X
control	B-X
and	B-X
tumor	B-X
suppression	B-X
.	B-X
Post-translational	B-X
SUMO	B-X
modifications	B-X
,	B-X
telomere	B-X
repeats	B-X
and	B-X
heterochromatin	B-X
protein	B-X
1	B-X
were	B-X
found	B-X
to	B-X
localize	B-X
in	B-X
characteristic	B-X
patterns	B-X
with	B-X
respect	B-X
to	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X

We	O
have	O
conducted	O
high	O
-	O
resolution	O
4Pi	O
fluorescence	O
laser	O
-	O
scanning	O
microscopy	O
studies	O
complemented	O
with	O
correlative	O
electron	O
microscopy	O
and	O
investigations	O
of	O
the	O
accessibility	O
of	O
the	O
PML	O
-	O
NB	O
subcompartment	O
.	O
<EOS>	B-X
Promyelocytic	B-X
leukemia	B-X
nuclear	B-X
bodies	B-X
(	B-X
PML-NBs	B-X
)	B-X
are	B-X
mobile	B-X
subnuclear	B-X
organelles	B-X
formed	B-X
by	B-X
PML	B-X
and	B-X
Sp100	B-X
protein	B-X
.	B-X
We	B-X
have	B-X
conducted	B-X
high-resolution	B-X
4Pi	B-X
fluorescence	B-X
laser-scanning	B-X
microscopy	B-X
studies	B-X
complemented	B-X
with	B-X
correlative	B-X
electron	B-X
microscopy	B-X
and	B-X
investigations	B-X
of	B-X
the	B-X
accessibility	B-X
of	B-X
the	B-X
PML-NB	B-X
subcompartment	B-X
.	B-X
During	B-X
interphase	B-X
PML-NBs	B-X
adopt	B-X
a	B-X
spherical	B-X
organization	B-X
characterized	B-X
by	B-X
the	B-X
assembly	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
proteins	B-X
into	B-X
patches	B-X
within	B-X
a	B-X
50-	B-X
to	B-X
100-nm-thick	B-X
shell	B-X
.	B-X
This	B-X
spherical	B-X
shell	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
imposes	B-X
little	B-X
constraint	B-X
to	B-X
the	B-X
exchange	B-X
of	B-X
components	B-X
between	B-X
the	B-X
PML-NB	B-X
interior	B-X
and	B-X
the	B-X
nucleoplasm	B-X
.	B-X
Post-translational	B-X
SUMO	B-X
modifications	B-X
,	B-X
telomere	B-X
repeats	B-X
and	B-X
heterochromatin	B-X
protein	B-X
1	B-X
were	B-X
found	B-X
to	B-X
localize	B-X
in	B-X
characteristic	B-X
patterns	B-X
with	B-X
respect	B-X
to	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
From	B-X
our	B-X
findings	B-X
,	B-X
we	B-X
derived	B-X
a	B-X
model	B-X
that	B-X
explains	B-X
how	B-X
the	B-X
three-dimensional	B-X
organization	B-X
of	B-X
PML-NBs	B-X
serves	B-X
to	B-X
concentrate	B-X
different	B-X
biological	B-X
activities	B-X
while	B-X
allowing	B-X
for	B-X
an	B-X
efficient	B-X
exchange	B-X
of	B-X
components	B-X
.	B-X

During	O
interphase	O
PML	O
-	O
NBs	O
adopt	O
a	O
spherical	O
organization	O
characterized	O
by	O
the	O
assembly	O
of	O
PML	B-Protein
and	O
Sp100	B-Protein
proteins	O
into	O
patches	O
within	O
a	O
50	O
-	O
to	O
100	O
-	O
nm	O
-	O
thick	O
shell	O
.	O
<EOS>	B-X
Promyelocytic	B-X
leukemia	B-X
nuclear	B-X
bodies	B-X
(	B-X
PML-NBs	B-X
)	B-X
are	B-X
mobile	B-X
subnuclear	B-X
organelles	B-X
formed	B-X
by	B-X
PML	B-X
and	B-X
Sp100	B-X
protein	B-X
.	B-X
We	B-X
have	B-X
conducted	B-X
high-resolution	B-X
4Pi	B-X
fluorescence	B-X
laser-scanning	B-X
microscopy	B-X
studies	B-X
complemented	B-X
with	B-X
correlative	B-X
electron	B-X
microscopy	B-X
and	B-X
investigations	B-X
of	B-X
the	B-X
accessibility	B-X
of	B-X
the	B-X
PML-NB	B-X
subcompartment	B-X
.	B-X
During	B-X
interphase	B-X
PML-NBs	B-X
adopt	B-X
a	B-X
spherical	B-X
organization	B-X
characterized	B-X
by	B-X
the	B-X
assembly	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
proteins	B-X
into	B-X
patches	B-X
within	B-X
a	B-X
50-	B-X
to	B-X
100-nm-thick	B-X
shell	B-X
.	B-X
This	B-X
spherical	B-X
shell	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
imposes	B-X
little	B-X
constraint	B-X
to	B-X
the	B-X
exchange	B-X
of	B-X
components	B-X
between	B-X
the	B-X
PML-NB	B-X
interior	B-X
and	B-X
the	B-X
nucleoplasm	B-X
.	B-X
Post-translational	B-X
SUMO	B-X
modifications	B-X
,	B-X
telomere	B-X
repeats	B-X
and	B-X
heterochromatin	B-X
protein	B-X
1	B-X
were	B-X
found	B-X
to	B-X
localize	B-X
in	B-X
characteristic	B-X
patterns	B-X
with	B-X
respect	B-X
to	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
From	B-X
our	B-X
findings	B-X
,	B-X
we	B-X
derived	B-X
a	B-X
model	B-X
that	B-X
explains	B-X
how	B-X
the	B-X
three-dimensional	B-X
organization	B-X
of	B-X
PML-NBs	B-X
serves	B-X
to	B-X
concentrate	B-X
different	B-X
biological	B-X
activities	B-X
while	B-X
allowing	B-X
for	B-X
an	B-X
efficient	B-X
exchange	B-X
of	B-X
components	B-X
.	B-X

This	O
spherical	O
shell	O
of	O
PML	B-Protein
and	O
Sp100	B-Protein
imposes	O
little	O
constraint	O
to	O
the	O
exchange	O
of	O
components	O
between	O
the	O
PML	O
-	O
NB	O
interior	O
and	O
the	O
nucleoplasm	O
.	O

Post	O
-	O
translational	O
SUMO	O
modifications	O
,	O
telomere	O
repeats	O
and	O
heterochromatin	B-Protein
protein	I-Protein
1	I-Protein
were	O
found	O
to	O
localize	O
in	O
characteristic	O
patterns	O
with	O
respect	O
to	O
PML	B-Protein
and	O
Sp100	B-Protein
.	O
<EOS>	B-X
Promyelocytic	B-X
leukemia	B-X
nuclear	B-X
bodies	B-X
(	B-X
PML-NBs	B-X
)	B-X
are	B-X
mobile	B-X
subnuclear	B-X
organelles	B-X
formed	B-X
by	B-X
PML	B-X
and	B-X
Sp100	B-X
protein	B-X
.	B-X
They	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
have	B-X
a	B-X
role	B-X
in	B-X
transcription	B-X
,	B-X
DNA	B-X
replication	B-X
and	B-X
repair	B-X
,	B-X
telomere	B-X
lengthening	B-X
,	B-X
cell	B-X
cycle	B-X
control	B-X
and	B-X
tumor	B-X
suppression	B-X
.	B-X
We	B-X
have	B-X
conducted	B-X
high-resolution	B-X
4Pi	B-X
fluorescence	B-X
laser-scanning	B-X
microscopy	B-X
studies	B-X
complemented	B-X
with	B-X
correlative	B-X
electron	B-X
microscopy	B-X
and	B-X
investigations	B-X
of	B-X
the	B-X
accessibility	B-X
of	B-X
the	B-X
PML-NB	B-X
subcompartment	B-X
.	B-X
During	B-X
interphase	B-X
PML-NBs	B-X
adopt	B-X
a	B-X
spherical	B-X
organization	B-X
characterized	B-X
by	B-X
the	B-X
assembly	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
proteins	B-X
into	B-X
patches	B-X
within	B-X
a	B-X
50-	B-X
to	B-X
100-nm-thick	B-X
shell	B-X
.	B-X
This	B-X
spherical	B-X
shell	B-X
of	B-X
PML	B-X
and	B-X
Sp100	B-X
imposes	B-X
little	B-X
constraint	B-X
to	B-X
the	B-X
exchange	B-X
of	B-X
components	B-X
between	B-X
the	B-X
PML-NB	B-X
interior	B-X
and	B-X
the	B-X
nucleoplasm	B-X
.	B-X
Post-translational	B-X
SUMO	B-X
modifications	B-X
,	B-X
telomere	B-X
repeats	B-X
and	B-X
heterochromatin	B-X
protein	B-X
1	B-X
were	B-X
found	B-X
to	B-X
localize	B-X
in	B-X
characteristic	B-X
patterns	B-X
with	B-X
respect	B-X
to	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
From	B-X
our	B-X
findings	B-X
,	B-X
we	B-X
derived	B-X
a	B-X
model	B-X
that	B-X
explains	B-X
how	B-X
the	B-X
three-dimensional	B-X
organization	B-X
of	B-X
PML-NBs	B-X
serves	B-X
to	B-X
concentrate	B-X
different	B-X
biological	B-X
activities	B-X
while	B-X
allowing	B-X
for	B-X
an	B-X
efficient	B-X
exchange	B-X
of	B-X
components	B-X
.	B-X

From	O
our	O
findings	O
,	O
we	O
derived	O
a	O
model	O
that	O
explains	O
how	O
the	O
three	O
-	O
dimensional	O
organization	O
of	O
PML	O
-	O
NBs	O
serves	O
to	O
concentrate	O
different	O
biological	O
activities	O
while	O
allowing	O
for	O
an	O
efficient	O
exchange	O
of	O
components	O
.	O

The	O
structure	O
of	O
dopamine	O
induced	O
alpha	B-Protein
-	I-Protein
synuclein	I-Protein
oligomers	O
.	O
<EOS>	B-X
Importantly	B-X
,	B-X
the	B-X
aggregate-membrane	B-X
interaction	B-X
that	B-X
drives	B-X
ferroptosis	B-X
depends	B-X
both	B-X
on	B-X
the	B-X
conformational	B-X
structure	B-X
of	B-X
the	B-X
aggregate	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
oxidation	B-X
state	B-X
of	B-X
the	B-X
lipid	B-X
membrane	B-X
.	B-X
We	B-X
generated	B-X
human	B-X
stem	B-X
cell-derived	B-X
models	B-X
of	B-X
synucleinopathy	B-X
,	B-X
characterized	B-X
by	B-X
the	B-X
intracellular	B-X
formation	B-X
of	B-X
-synuclein	B-X
aggregates	B-X
that	B-X
bind	B-X
to	B-X
membranes	B-X
.	B-X
In	B-X
human	B-X
iPSC-derived	B-X
neurons	B-X
with	B-X
SNCA	B-X
triplication	B-X
,	B-X
physiological	B-X
concentrations	B-X
of	B-X
glutamate	B-X
and	B-X
dopamine	B-X
induce	B-X
abnormal	B-X
calcium	B-X
signaling	B-X
owing	B-X
to	B-X
the	B-X
incorporation	B-X
of	B-X
excess	B-X
-synuclein	B-X
oligomers	B-X
into	B-X
membranes	B-X
,	B-X
leading	B-X
to	B-X
altered	B-X
membrane	B-X
conductance	B-X
and	B-X
abnormal	B-X
calcium	B-X
influx	B-X
.	B-X
-synuclein	B-X
oligomers	B-X
further	B-X
induce	B-X
lipid	B-X
peroxidation	B-X
.	B-X
Inhibition	B-X
of	B-X
lipid	B-X
peroxidation	B-X
,	B-X
and	B-X
reduction	B-X
of	B-X
iron-dependent	B-X
accumulation	B-X
of	B-X
free	B-X
radicals	B-X
,	B-X
further	B-X
prevents	B-X
oligomer-induced	B-X
toxicity	B-X
in	B-X
human	B-X
neurons	B-X
.	B-X

Inclusions	O
of	O
aggregated	O
alpha	B-Protein
-	I-Protein
synuclein	I-Protein
(	O
alpha	B-Protein
-	I-Protein
syn	I-Protein
)	O
in	O
dopaminergic	O
neurons	O
are	O
a	O
characteristic	O
histological	O
marker	O
of	O
Parkinson	O
'	O
s	O
disease	O
(	O
PD	O
)	O
.	O
<EOS>	B-X
Inclusions	B-X
of	B-X
aggregated	B-X
alpha-synuclein	B-X
(	B-X
alpha-syn	B-X
)	B-X
in	B-X
dopaminergic	B-X
neurons	B-X
are	B-X
a	B-X
characteristic	B-X
histological	B-X
marker	B-X
of	B-X
Parkinson	B-X
's	B-X
disease	B-X
(	B-X
PD	B-X
)	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
alpha-syn	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
dopamine	B-X
(	B-X
DA	B-X
)	B-X
at	B-X
physiological	B-X
pH	B-X
forms	B-X
SDS-resistant	B-X
non-amyloidogenic	B-X
oligomers	B-X
.	B-X
We	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
biophysical	B-X
techniques	B-X
,	B-X
including	B-X
sedimentation	B-X
velocity	B-X
analysis	B-X
,	B-X
small	B-X
angle	B-X
X-ray	B-X
scattering	B-X
(	B-X
SAXS	B-X
)	B-X
and	B-X
circular	B-X
dichroism	B-X
spectroscopy	B-X
to	B-X
study	B-X
the	B-X
characteristics	B-X
of	B-X
alpha-syn	B-X
oligomers	B-X
formed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
DA	B-X
.	B-X
Our	B-X
SAXS	B-X
data	B-X
show	B-X
that	B-X
the	B-X
trimers	B-X
formed	B-X
by	B-X
the	B-X
action	B-X
of	B-X
DA	B-X
on	B-X
alpha-syn	B-X
consist	B-X
of	B-X
overlapping	B-X
worm-like	B-X
monomers	B-X
,	B-X
with	B-X
no	B-X
end-to-end	B-X
associations	B-X
.	B-X
We	B-X
propose	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
these	B-X
and	B-X
earlier	B-X
data	B-X
that	B-X
oxidation	B-X
of	B-X
the	B-X
four	B-X
methionine	B-X
residues	B-X
at	B-X
the	B-X
C-	B-X
and	B-X
N-terminal	B-X
ends	B-X
of	B-X
alpha-syn	B-X
molecules	B-X
prevents	B-X
their	B-X
end-to-end	B-X
association	B-X
and	B-X
stabilises	B-X
oligomers	B-X
formed	B-X
by	B-X
cross	B-X
linking	B-X
with	B-X
DA-quinone/DA-melanin	B-X
,	B-X
which	B-X
are	B-X
formed	B-X
as	B-X
a	B-X
result	B-X
of	B-X
the	B-X
redox	B-X
process	B-X
,	B-X
thus	B-X
inhibiting	B-X
formation	B-X
of	B-X
the	B-X
beta-sheet	B-X
structure	B-X
found	B-X
in	B-X
other	B-X
pre-fibrillar	B-X
forms	B-X
of	B-X
alpha-syn	B-X
.	B-X

In	O
vitro	O
,	O
alpha	B-Protein
-	I-Protein
syn	I-Protein
in	O
the	O
presence	O
of	O
dopamine	O
(	O
DA	O
)	O
at	O
physiological	O
pH	O
forms	O
SDS	O
-	O
resistant	O
non	O
-	O
amyloidogenic	O
oligomers	O
.	O
<EOS>	B-X
Inclusions	B-X
of	B-X
aggregated	B-X
alpha-synuclein	B-X
(	B-X
alpha-syn	B-X
)	B-X
in	B-X
dopaminergic	B-X
neurons	B-X
are	B-X
a	B-X
characteristic	B-X
histological	B-X
marker	B-X
of	B-X
Parkinson	B-X
's	B-X
disease	B-X
(	B-X
PD	B-X
)	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
alpha-syn	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
dopamine	B-X
(	B-X
DA	B-X
)	B-X
at	B-X
physiological	B-X
pH	B-X
forms	B-X
SDS-resistant	B-X
non-amyloidogenic	B-X
oligomers	B-X
.	B-X
We	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
biophysical	B-X
techniques	B-X
,	B-X
including	B-X
sedimentation	B-X
velocity	B-X
analysis	B-X
,	B-X
small	B-X
angle	B-X
X-ray	B-X
scattering	B-X
(	B-X
SAXS	B-X
)	B-X
and	B-X
circular	B-X
dichroism	B-X
spectroscopy	B-X
to	B-X
study	B-X
the	B-X
characteristics	B-X
of	B-X
alpha-syn	B-X
oligomers	B-X
formed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
DA	B-X
.	B-X
Our	B-X
SAXS	B-X
data	B-X
show	B-X
that	B-X
the	B-X
trimers	B-X
formed	B-X
by	B-X
the	B-X
action	B-X
of	B-X
DA	B-X
on	B-X
alpha-syn	B-X
consist	B-X
of	B-X
overlapping	B-X
worm-like	B-X
monomers	B-X
,	B-X
with	B-X
no	B-X
end-to-end	B-X
associations	B-X
.	B-X
This	B-X
lack	B-X
of	B-X
structure	B-X
contrasts	B-X
with	B-X
the	B-X
well-established	B-X
,	B-X
extensive	B-X
beta-sheet	B-X
structure	B-X
of	B-X
the	B-X
amyloid	B-X
fibril	B-X
form	B-X
of	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
pre-fibrillar	B-X
oligomers	B-X
.	B-X
We	B-X
propose	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
these	B-X
and	B-X
earlier	B-X
data	B-X
that	B-X
oxidation	B-X
of	B-X
the	B-X
four	B-X
methionine	B-X
residues	B-X
at	B-X
the	B-X
C-	B-X
and	B-X
N-terminal	B-X
ends	B-X
of	B-X
alpha-syn	B-X
molecules	B-X
prevents	B-X
their	B-X
end-to-end	B-X
association	B-X
and	B-X
stabilises	B-X
oligomers	B-X
formed	B-X
by	B-X
cross	B-X
linking	B-X
with	B-X
DA-quinone/DA-melanin	B-X
,	B-X
which	B-X
are	B-X
formed	B-X
as	B-X
a	B-X
result	B-X
of	B-X
the	B-X
redox	B-X
process	B-X
,	B-X
thus	B-X
inhibiting	B-X
formation	B-X
of	B-X
the	B-X
beta-sheet	B-X
structure	B-X
found	B-X
in	B-X
other	B-X
pre-fibrillar	B-X
forms	B-X
of	B-X
alpha-syn	B-X
.	B-X

We	O
used	O
a	O
combination	O
of	O
biophysical	O
techniques	O
,	O
including	O
sedimentation	O
velocity	O
analysis	O
,	O
small	O
angle	O
X	O
-	O
ray	O
scattering	O
(	O
SAXS	O
)	O
and	O
circular	O
dichroism	O
spectroscopy	O
to	O
study	O
the	O
characteristics	O
of	O
alpha	B-Protein
-	I-Protein
syn	I-Protein
oligomers	O
formed	O
in	O
the	O
presence	O
of	O
DA	O
.	O

Our	O
SAXS	O
data	O
show	O
that	O
the	O
trimers	O
formed	O
by	O
the	O
action	O
of	O
DA	O
on	O
alpha	B-Protein
-	I-Protein
syn	I-Protein
consist	O
of	O
overlapping	O
worm	O
-	O
like	O
monomers	O
,	O
with	O
no	O
end	O
-	O
to	O
-	O
end	O
associations	O
.	O

This	O
lack	O
of	O
structure	O
contrasts	O
with	O
the	O
well	O
-	O
established	O
,	O
extensive	O
beta	O
-	O
sheet	O
structure	O
of	O
the	O
amyloid	B-Protein
fibril	O
form	O
of	O
the	O
protein	O
and	O
its	O
pre	O
-	O
fibrillar	O
oligomers	O
.	O
<EOS>	B-X
In	B-X
vitro	B-X
,	B-X
alpha-syn	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
dopamine	B-X
(	B-X
DA	B-X
)	B-X
at	B-X
physiological	B-X
pH	B-X
forms	B-X
SDS-resistant	B-X
non-amyloidogenic	B-X
oligomers	B-X
.	B-X
We	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
biophysical	B-X
techniques	B-X
,	B-X
including	B-X
sedimentation	B-X
velocity	B-X
analysis	B-X
,	B-X
small	B-X
angle	B-X
X-ray	B-X
scattering	B-X
(	B-X
SAXS	B-X
)	B-X
and	B-X
circular	B-X
dichroism	B-X
spectroscopy	B-X
to	B-X
study	B-X
the	B-X
characteristics	B-X
of	B-X
alpha-syn	B-X
oligomers	B-X
formed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
DA	B-X
.	B-X
Our	B-X
SAXS	B-X
data	B-X
show	B-X
that	B-X
the	B-X
trimers	B-X
formed	B-X
by	B-X
the	B-X
action	B-X
of	B-X
DA	B-X
on	B-X
alpha-syn	B-X
consist	B-X
of	B-X
overlapping	B-X
worm-like	B-X
monomers	B-X
,	B-X
with	B-X
no	B-X
end-to-end	B-X
associations	B-X
.	B-X
This	B-X
lack	B-X
of	B-X
structure	B-X
contrasts	B-X
with	B-X
the	B-X
well-established	B-X
,	B-X
extensive	B-X
beta-sheet	B-X
structure	B-X
of	B-X
the	B-X
amyloid	B-X
fibril	B-X
form	B-X
of	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
pre-fibrillar	B-X
oligomers	B-X
.	B-X
We	B-X
propose	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
these	B-X
and	B-X
earlier	B-X
data	B-X
that	B-X
oxidation	B-X
of	B-X
the	B-X
four	B-X
methionine	B-X
residues	B-X
at	B-X
the	B-X
C-	B-X
and	B-X
N-terminal	B-X
ends	B-X
of	B-X
alpha-syn	B-X
molecules	B-X
prevents	B-X
their	B-X
end-to-end	B-X
association	B-X
and	B-X
stabilises	B-X
oligomers	B-X
formed	B-X
by	B-X
cross	B-X
linking	B-X
with	B-X
DA-quinone/DA-melanin	B-X
,	B-X
which	B-X
are	B-X
formed	B-X
as	B-X
a	B-X
result	B-X
of	B-X
the	B-X
redox	B-X
process	B-X
,	B-X
thus	B-X
inhibiting	B-X
formation	B-X
of	B-X
the	B-X
beta-sheet	B-X
structure	B-X
found	B-X
in	B-X
other	B-X
pre-fibrillar	B-X
forms	B-X
of	B-X
alpha-syn	B-X
.	B-X

We	O
propose	O
on	O
the	O
basis	O
of	O
these	O
and	O
earlier	O
data	O
that	O
oxidation	O
of	O
the	O
four	O
methionine	O
residues	O
at	O
the	O
C	O
-	O
and	O
N	O
-	O
terminal	O
ends	O
of	O
alpha	B-Protein
-	I-Protein
syn	I-Protein
molecules	O
prevents	O
their	O
end	O
-	O
to	O
-	O
end	O
association	O
and	O
stabilises	O
oligomers	O
formed	O
by	O
cross	O
linking	O
with	O
DA	O
-	O
quinone	O
/	O
DA	O
-	O
melanin	O
,	O
which	O
are	O
formed	O
as	O
a	O
result	O
of	O
the	O
redox	O
process	O
,	O
thus	O
inhibiting	O
formation	O
of	O
the	O
beta	O
-	O
sheet	O
structure	O
found	O
in	O
other	O
pre	O
-	O
fibrillar	O
forms	O
of	O
alpha	B-Protein
-	I-Protein
syn	I-Protein
.	O

NEDD8	B-Protein
-	O
targeting	O
drug	O
MLN4924	O
elicits	O
DNA	O
rereplication	O
by	O
stabilizing	O
Cdt1	B-Protein
in	O
S	O
phase	O
,	O
triggering	O
checkpoint	O
activation	O
,	O
apoptosis	O
,	O
and	O
senescence	O
in	O
cancer	O
cells	O
.	O

MLN4924	O
is	O
a	O
first	O
-	O
in	O
-	O
class	O
experimental	O
cancer	O
drug	O
that	O
inhibits	O
the	O
NEDD8	B-Protein
-	O
activating	O
enzyme	O
,	O
thereby	O
inhibiting	O
cullin	O
-	O
RING	O
E3	O
ubiquitin	B-Protein
ligases	O
and	O
stabilizing	O
many	O
cullin	O
substrates	O
.	O
<EOS>	B-X
MLN4924	B-X
is	B-X
a	B-X
first-in-class	B-X
experimental	B-X
cancer	B-X
drug	B-X
that	B-X
inhibits	B-X
the	B-X
NEDD8-activating	B-X
enzyme	B-X
,	B-X
thereby	B-X
inhibiting	B-X
cullin-RING	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
and	B-X
stabilizing	B-X
many	B-X
cullin	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
MLN4924	B-X
inhibits	B-X
cancer	B-X
cell	B-X
proliferation	B-X
has	B-X
not	B-X
been	B-X
defined	B-X
,	B-X
although	B-X
it	B-X
is	B-X
accompanied	B-X
by	B-X
DNA	B-X
rereplication	B-X
and	B-X
attendant	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
stabilization	B-X
of	B-X
the	B-X
DNA	B-X
replication	B-X
factor	B-X
Cdt1	B-X
,	B-X
a	B-X
substrate	B-X
of	B-X
cullins	B-X
1	B-X
and	B-X
4	B-X
,	B-X
is	B-X
critical	B-X
for	B-X
MLN4924	B-X
to	B-X
trigger	B-X
DNA	B-X
rereplication	B-X
and	B-X
inhibit	B-X
cell	B-X
proliferation	B-X
.	B-X
Even	B-X
only	B-X
1	B-X
hour	B-X
of	B-X
exposure	B-X
to	B-X
MLN4924	B-X
,	B-X
which	B-X
was	B-X
sufficient	B-X
to	B-X
elevate	B-X
Cdt1	B-X
for	B-X
4-5	B-X
hours	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
sufficient	B-X
to	B-X
induce	B-X
DNA	B-X
rereplication	B-X
and	B-X
to	B-X
activate	B-X
apoptosis	B-X
and	B-X
senescence	B-X
pathways	B-X
.	B-X
Cells	B-X
in	B-X
S	B-X
phase	B-X
were	B-X
most	B-X
susceptible	B-X
,	B-X
suggesting	B-X
that	B-X
MLN4924	B-X
will	B-X
be	B-X
most	B-X
toxic	B-X
on	B-X
highly	B-X
proliferating	B-X
cancers	B-X
.	B-X
Although	B-X
MLN4924-induced	B-X
cell	B-X
senescence	B-X
seems	B-X
to	B-X
be	B-X
dependent	B-X
on	B-X
induction	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
downstream	B-X
effector	B-X
p21	B-X
(	B-X
Waf1	B-X
)	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
p21	B-X
(	B-X
-/-	B-X
)	B-X
cells	B-X
were	B-X
even	B-X
more	B-X
susceptible	B-X
than	B-X
wild-type	B-X
cells	B-X
to	B-X
MLN4924	B-X
.	B-X
Our	B-X
results	B-X
suggested	B-X
that	B-X
apoptosis	B-X
,	B-X
not	B-X
senescence	B-X
,	B-X
might	B-X
be	B-X
more	B-X
important	B-X
for	B-X
the	B-X
antiproliferative	B-X
effect	B-X
of	B-X
MLN4924	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
show	B-X
that	B-X
transient	B-X
exposure	B-X
to	B-X
this	B-X
new	B-X
investigational	B-X
drug	B-X
should	B-X
be	B-X
useful	B-X
for	B-X
controlling	B-X
p53-negative	B-X
cancer	B-X
cells	B-X
,	B-X
which	B-X
often	B-X
pose	B-X
significant	B-X
clinical	B-X
challenge	B-X
.	B-X

The	O
mechanism	O
by	O
which	O
MLN4924	O
inhibits	O
cancer	O
cell	O
proliferation	O
has	O
not	O
been	O
defined	O
,	O
although	O
it	O
is	O
accompanied	O
by	O
DNA	O
rereplication	O
and	O
attendant	O
DNA	O
damage	O
.	O
<EOS>	B-X
To	B-X
explore	B-X
the	B-X
neddylation	B-X
pathway	B-X
,	B-X
found	B-X
to	B-X
be	B-X
highly	B-X
activated	B-X
in	B-X
various	B-X
cancers	B-X
,	B-X
as	B-X
a	B-X
potential	B-X
therapeutic	B-X
target	B-X
in	B-X
endometrial	B-X
carcinoma	B-X
,	B-X
one	B-X
of	B-X
the	B-X
three	B-X
most	B-X
frequent	B-X
malignant	B-X
tumours	B-X
in	B-X
the	B-X
female	B-X
reproductive	B-X
system	B-X
.	B-X
The	B-X
Absence	B-X
of	B-X
PTEN	B-X
in	B-X
Breast	B-X
Cancer	B-X
Is	B-X
a	B-X
Driver	B-X
of	B-X
MLN4924	B-X
Resistance	B-X
.	B-X
The	B-X
molecular	B-X
mechanism	B-X
that	B-X
regulates	B-X
ciliary	B-X
dynamics	B-X
remains	B-X
elusive	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
an	B-X
unexpected	B-X
finding	B-X
that	B-X
MLN4924	B-X
,	B-X
a	B-X
small	B-X
molecule	B-X
inhibitor	B-X
of	B-X
NEDD8-activating	B-X
enzyme	B-X
(	B-X
NAE	B-X
)	B-X
,	B-X
blocks	B-X
primary	B-X
ciliary	B-X
formation	B-X
by	B-X
inhibiting	B-X
synthesis/assembly	B-X
and	B-X
promoting	B-X
disassembly	B-X
.	B-X
This	B-X
is	B-X
mainly	B-X
mediated	B-X
by	B-X
MLN4924-induced	B-X
phosphorylation	B-X
of	B-X
AKT1	B-X
at	B-X
Ser473	B-X
under	B-X
serum-starved	B-X
,	B-X
ciliary-promoting	B-X
conditions	B-X
.	B-X
Indeed	B-X
,	B-X
pharmaceutical	B-X
inhibition	B-X
(	B-X
by	B-X
MK2206	B-X
)	B-X
or	B-X
genetic	B-X
depletion	B-X
(	B-X
via	B-X
siRNA	B-X
)	B-X
of	B-X
AKT1	B-X
rescues	B-X
MLN4924	B-X
effect	B-X
,	B-X
indicating	B-X
its	B-X
causal	B-X
role	B-X
.	B-X

Here	O
we	O
show	O
that	O
stabilization	O
of	O
the	O
DNA	O
replication	O
factor	O
Cdt1	B-Protein
,	O
a	O
substrate	O
of	O
cullins	B-Protein
1	I-Protein
and	O
4	B-Protein
,	O
is	O
critical	O
for	O
MLN4924	O
to	O
trigger	O
DNA	O
rereplication	O
and	O
inhibit	O
cell	O
proliferation	O
.	O
<EOS>	B-X
MLN4924	B-X
is	B-X
a	B-X
first-in-class	B-X
experimental	B-X
cancer	B-X
drug	B-X
that	B-X
inhibits	B-X
the	B-X
NEDD8-activating	B-X
enzyme	B-X
,	B-X
thereby	B-X
inhibiting	B-X
cullin-RING	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
and	B-X
stabilizing	B-X
many	B-X
cullin	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
MLN4924	B-X
inhibits	B-X
cancer	B-X
cell	B-X
proliferation	B-X
has	B-X
not	B-X
been	B-X
defined	B-X
,	B-X
although	B-X
it	B-X
is	B-X
accompanied	B-X
by	B-X
DNA	B-X
rereplication	B-X
and	B-X
attendant	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
stabilization	B-X
of	B-X
the	B-X
DNA	B-X
replication	B-X
factor	B-X
Cdt1	B-X
,	B-X
a	B-X
substrate	B-X
of	B-X
cullins	B-X
1	B-X
and	B-X
4	B-X
,	B-X
is	B-X
critical	B-X
for	B-X
MLN4924	B-X
to	B-X
trigger	B-X
DNA	B-X
rereplication	B-X
and	B-X
inhibit	B-X
cell	B-X
proliferation	B-X
.	B-X
Even	B-X
only	B-X
1	B-X
hour	B-X
of	B-X
exposure	B-X
to	B-X
MLN4924	B-X
,	B-X
which	B-X
was	B-X
sufficient	B-X
to	B-X
elevate	B-X
Cdt1	B-X
for	B-X
4-5	B-X
hours	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
sufficient	B-X
to	B-X
induce	B-X
DNA	B-X
rereplication	B-X
and	B-X
to	B-X
activate	B-X
apoptosis	B-X
and	B-X
senescence	B-X
pathways	B-X
.	B-X
Cells	B-X
in	B-X
S	B-X
phase	B-X
were	B-X
most	B-X
susceptible	B-X
,	B-X
suggesting	B-X
that	B-X
MLN4924	B-X
will	B-X
be	B-X
most	B-X
toxic	B-X
on	B-X
highly	B-X
proliferating	B-X
cancers	B-X
.	B-X
Although	B-X
MLN4924-induced	B-X
cell	B-X
senescence	B-X
seems	B-X
to	B-X
be	B-X
dependent	B-X
on	B-X
induction	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
downstream	B-X
effector	B-X
p21	B-X
(	B-X
Waf1	B-X
)	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
p21	B-X
(	B-X
-/-	B-X
)	B-X
cells	B-X
were	B-X
even	B-X
more	B-X
susceptible	B-X
than	B-X
wild-type	B-X
cells	B-X
to	B-X
MLN4924	B-X
.	B-X
Our	B-X
results	B-X
suggested	B-X
that	B-X
apoptosis	B-X
,	B-X
not	B-X
senescence	B-X
,	B-X
might	B-X
be	B-X
more	B-X
important	B-X
for	B-X
the	B-X
antiproliferative	B-X
effect	B-X
of	B-X
MLN4924	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
show	B-X
that	B-X
transient	B-X
exposure	B-X
to	B-X
this	B-X
new	B-X
investigational	B-X
drug	B-X
should	B-X
be	B-X
useful	B-X
for	B-X
controlling	B-X
p53-negative	B-X
cancer	B-X
cells	B-X
,	B-X
which	B-X
often	B-X
pose	B-X
significant	B-X
clinical	B-X
challenge	B-X
.	B-X

Even	O
only	O
1	O
hour	O
of	O
exposure	O
to	O
MLN4924	O
,	O
which	O
was	O
sufficient	O
to	O
elevate	O
Cdt1	B-Protein
for	O
4	O
-	O
5	O
hours	O
,	O
was	O
found	O
to	O
be	O
sufficient	O
to	O
induce	O
DNA	O
rereplication	O
and	O
to	O
activate	O
apoptosis	O
and	O
senescence	O
pathways	O
.	O
<EOS>	B-X
MLN4924	B-X
is	B-X
a	B-X
first-in-class	B-X
experimental	B-X
cancer	B-X
drug	B-X
that	B-X
inhibits	B-X
the	B-X
NEDD8-activating	B-X
enzyme	B-X
,	B-X
thereby	B-X
inhibiting	B-X
cullin-RING	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
and	B-X
stabilizing	B-X
many	B-X
cullin	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
MLN4924	B-X
inhibits	B-X
cancer	B-X
cell	B-X
proliferation	B-X
has	B-X
not	B-X
been	B-X
defined	B-X
,	B-X
although	B-X
it	B-X
is	B-X
accompanied	B-X
by	B-X
DNA	B-X
rereplication	B-X
and	B-X
attendant	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
stabilization	B-X
of	B-X
the	B-X
DNA	B-X
replication	B-X
factor	B-X
Cdt1	B-X
,	B-X
a	B-X
substrate	B-X
of	B-X
cullins	B-X
1	B-X
and	B-X
4	B-X
,	B-X
is	B-X
critical	B-X
for	B-X
MLN4924	B-X
to	B-X
trigger	B-X
DNA	B-X
rereplication	B-X
and	B-X
inhibit	B-X
cell	B-X
proliferation	B-X
.	B-X
Even	B-X
only	B-X
1	B-X
hour	B-X
of	B-X
exposure	B-X
to	B-X
MLN4924	B-X
,	B-X
which	B-X
was	B-X
sufficient	B-X
to	B-X
elevate	B-X
Cdt1	B-X
for	B-X
4-5	B-X
hours	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
sufficient	B-X
to	B-X
induce	B-X
DNA	B-X
rereplication	B-X
and	B-X
to	B-X
activate	B-X
apoptosis	B-X
and	B-X
senescence	B-X
pathways	B-X
.	B-X
Cells	B-X
in	B-X
S	B-X
phase	B-X
were	B-X
most	B-X
susceptible	B-X
,	B-X
suggesting	B-X
that	B-X
MLN4924	B-X
will	B-X
be	B-X
most	B-X
toxic	B-X
on	B-X
highly	B-X
proliferating	B-X
cancers	B-X
.	B-X
Although	B-X
MLN4924-induced	B-X
cell	B-X
senescence	B-X
seems	B-X
to	B-X
be	B-X
dependent	B-X
on	B-X
induction	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
downstream	B-X
effector	B-X
p21	B-X
(	B-X
Waf1	B-X
)	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
p21	B-X
(	B-X
-/-	B-X
)	B-X
cells	B-X
were	B-X
even	B-X
more	B-X
susceptible	B-X
than	B-X
wild-type	B-X
cells	B-X
to	B-X
MLN4924	B-X
.	B-X
Our	B-X
results	B-X
suggested	B-X
that	B-X
apoptosis	B-X
,	B-X
not	B-X
senescence	B-X
,	B-X
might	B-X
be	B-X
more	B-X
important	B-X
for	B-X
the	B-X
antiproliferative	B-X
effect	B-X
of	B-X
MLN4924	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
show	B-X
that	B-X
transient	B-X
exposure	B-X
to	B-X
this	B-X
new	B-X
investigational	B-X
drug	B-X
should	B-X
be	B-X
useful	B-X
for	B-X
controlling	B-X
p53-negative	B-X
cancer	B-X
cells	B-X
,	B-X
which	B-X
often	B-X
pose	B-X
significant	B-X
clinical	B-X
challenge	B-X
.	B-X

Cells	O
in	O
S	O
phase	O
were	O
most	O
susceptible	O
,	O
suggesting	O
that	O
MLN4924	O
will	O
be	O
most	O
toxic	O
on	O
highly	O
proliferating	O
cancers	O
.	O

Although	O
MLN4924	O
-	O
induced	O
cell	O
senescence	O
seems	O
to	O
be	O
dependent	O
on	O
induction	O
of	O
p53	B-Protein
and	O
its	O
downstream	O
effector	O
p21	B-Protein
(	O
Waf1	B-Protein
)	O
,	O
we	O
found	O
that	O
p53	B-Protein
(	O
-	O
/	O
-	O
)	O
and	O
p21	B-Protein
(	O
-	O
/	O
-	O
)	O
cells	O
were	O
even	O
more	O
susceptible	O
than	O
wild	O
-	O
type	O
cells	O
to	O
MLN4924	O
.	O

Our	O
results	O
suggested	O
that	O
apoptosis	O
,	O
not	O
senescence	O
,	O
might	O
be	O
more	O
important	O
for	O
the	O
antiproliferative	O
effect	O
of	O
MLN4924	O
.	O
<EOS>	B-X
An	B-X
understanding	B-X
of	B-X
the	B-X
underlying	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
is	B-X
important	B-X
as	B-X
it	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
many	B-X
diseases	B-X
.	B-X
In	B-X
some	B-X
,	B-X
the	B-X
problem	B-X
is	B-X
due	B-X
to	B-X
too	B-X
much	B-X
apoptosis	B-X
,	B-X
such	B-X
as	B-X
in	B-X
the	B-X
case	B-X
of	B-X
degenerative	B-X
diseases	B-X
while	B-X
in	B-X
others	B-X
,	B-X
too	B-X
little	B-X
apoptosis	B-X
is	B-X
the	B-X
culprit	B-X
.	B-X
Cancer	B-X
is	B-X
one	B-X
of	B-X
the	B-X
scenarios	B-X
where	B-X
too	B-X
little	B-X
apoptosis	B-X
occurs	B-X
,	B-X
resulting	B-X
in	B-X
malignant	B-X
cells	B-X
that	B-X
will	B-X
not	B-X
die	B-X
.	B-X
The	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
is	B-X
complex	B-X
and	B-X
involves	B-X
many	B-X
pathways	B-X
.	B-X
Despite	B-X
being	B-X
the	B-X
cause	B-X
of	B-X
problem	B-X
,	B-X
apoptosis	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
treatment	B-X
of	B-X
cancer	B-X
as	B-X
it	B-X
is	B-X
a	B-X
popular	B-X
target	B-X
of	B-X
many	B-X
treatment	B-X
strategies	B-X
.	B-X
The	B-X
abundance	B-X
of	B-X
literature	B-X
suggests	B-X
that	B-X
targeting	B-X
apoptosis	B-X
in	B-X
cancer	B-X
is	B-X
feasible	B-X
.	B-X
However	B-X
,	B-X
many	B-X
troubling	B-X
questions	B-X
arise	B-X
with	B-X
the	B-X
use	B-X
of	B-X
new	B-X
drugs	B-X
or	B-X
treatment	B-X
strategies	B-X
that	B-X
are	B-X
designed	B-X
to	B-X
enhance	B-X
apoptosis	B-X
and	B-X
critical	B-X
tests	B-X
must	B-X
be	B-X
passed	B-X
before	B-X
they	B-X
can	B-X
be	B-X
used	B-X
safely	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X

Furthermore	O
,	O
our	O
findings	O
show	O
that	O
transient	O
exposure	O
to	O
this	O
new	O
investigational	O
drug	O
should	O
be	O
useful	O
for	O
controlling	O
p53	B-Protein
-	O
negative	O
cancer	O
cells	O
,	O
which	O
often	O
pose	O
significant	O
clinical	O
challenge	O
.	O
<EOS>	B-X
MLN4924	B-X
is	B-X
a	B-X
first-in-class	B-X
experimental	B-X
cancer	B-X
drug	B-X
that	B-X
inhibits	B-X
the	B-X
NEDD8-activating	B-X
enzyme	B-X
,	B-X
thereby	B-X
inhibiting	B-X
cullin-RING	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
and	B-X
stabilizing	B-X
many	B-X
cullin	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
MLN4924	B-X
inhibits	B-X
cancer	B-X
cell	B-X
proliferation	B-X
has	B-X
not	B-X
been	B-X
defined	B-X
,	B-X
although	B-X
it	B-X
is	B-X
accompanied	B-X
by	B-X
DNA	B-X
rereplication	B-X
and	B-X
attendant	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
stabilization	B-X
of	B-X
the	B-X
DNA	B-X
replication	B-X
factor	B-X
Cdt1	B-X
,	B-X
a	B-X
substrate	B-X
of	B-X
cullins	B-X
1	B-X
and	B-X
4	B-X
,	B-X
is	B-X
critical	B-X
for	B-X
MLN4924	B-X
to	B-X
trigger	B-X
DNA	B-X
rereplication	B-X
and	B-X
inhibit	B-X
cell	B-X
proliferation	B-X
.	B-X
Even	B-X
only	B-X
1	B-X
hour	B-X
of	B-X
exposure	B-X
to	B-X
MLN4924	B-X
,	B-X
which	B-X
was	B-X
sufficient	B-X
to	B-X
elevate	B-X
Cdt1	B-X
for	B-X
4-5	B-X
hours	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
sufficient	B-X
to	B-X
induce	B-X
DNA	B-X
rereplication	B-X
and	B-X
to	B-X
activate	B-X
apoptosis	B-X
and	B-X
senescence	B-X
pathways	B-X
.	B-X
Cells	B-X
in	B-X
S	B-X
phase	B-X
were	B-X
most	B-X
susceptible	B-X
,	B-X
suggesting	B-X
that	B-X
MLN4924	B-X
will	B-X
be	B-X
most	B-X
toxic	B-X
on	B-X
highly	B-X
proliferating	B-X
cancers	B-X
.	B-X
Although	B-X
MLN4924-induced	B-X
cell	B-X
senescence	B-X
seems	B-X
to	B-X
be	B-X
dependent	B-X
on	B-X
induction	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
downstream	B-X
effector	B-X
p21	B-X
(	B-X
Waf1	B-X
)	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
p21	B-X
(	B-X
-/-	B-X
)	B-X
cells	B-X
were	B-X
even	B-X
more	B-X
susceptible	B-X
than	B-X
wild-type	B-X
cells	B-X
to	B-X
MLN4924	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
findings	B-X
show	B-X
that	B-X
transient	B-X
exposure	B-X
to	B-X
this	B-X
new	B-X
investigational	B-X
drug	B-X
should	B-X
be	B-X
useful	B-X
for	B-X
controlling	B-X
p53-negative	B-X
cancer	B-X
cells	B-X
,	B-X
which	B-X
often	B-X
pose	B-X
significant	B-X
clinical	B-X
challenge	B-X
.	B-X

Mechanisms	O
of	O
metal	O
ion	O
incorporation	O
into	O
metalloproteins	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reversible	B-X
binding	B-X
may	B-X
occur	B-X
using	B-X
a	B-X
pre-formed	B-X
organometallic	B-X
cofactor	B-X
such	B-X
as	B-X
a	B-X
metal-tetrapyrrole	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

Although	O
the	O
structure	O
and	O
function	O
of	O
protein	O
metallocenters	O
have	O
been	O
extensively	O
characterized	O
,	O
much	O
less	O
is	O
known	O
about	O
their	O
assembly	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

Here	O
,	O
I	O
describe	O
several	O
general	O
strategies	O
for	O
metallocenter	O
biosynthesis	O
and	O
provide	O
literature	O
precedents	O
for	O
each	O
mechanism	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

The	O
simplest	O
mechanism	O
involves	O
reversible	O
metal	O
ion	O
binding	O
to	O
amino	O
acid	O
ligands	O
of	O
the	O
apo	O
-	O
protein	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reversible	B-X
binding	B-X
may	B-X
occur	B-X
using	B-X
a	B-X
pre-formed	B-X
organometallic	B-X
cofactor	B-X
such	B-X
as	B-X
a	B-X
metal-tetrapyrrole	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

In	O
a	O
variation	O
of	O
this	O
mechanism	O
,	O
the	O
apo	O
-	O
protein	O
first	O
must	O
be	O
phosphorylated	O
,	O
carboxylated	O
or	O
otherwise	O
covalently	O
modified	O
in	O
order	O
to	O
create	O
the	O
metal	O
ion	O
binding	O
site	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reversible	B-X
binding	B-X
may	B-X
occur	B-X
using	B-X
a	B-X
pre-formed	B-X
organometallic	B-X
cofactor	B-X
such	B-X
as	B-X
a	B-X
metal-tetrapyrrole	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

Alternatively	O
,	O
passive	O
metal	O
ion	O
binding	O
may	O
require	O
the	O
presence	O
of	O
an	O
associated	O
compound	O
,	O
such	O
as	O
a	O
nucleotide	O
,	O
carbonate	O
or	O
inorganic	O
sulfide	O
,	O
which	O
is	O
co	O
-	O
incorporated	O
into	O
the	O
protein	O
along	O
with	O
the	O
metal	O
ion	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reversible	B-X
binding	B-X
may	B-X
occur	B-X
using	B-X
a	B-X
pre-formed	B-X
organometallic	B-X
cofactor	B-X
such	B-X
as	B-X
a	B-X
metal-tetrapyrrole	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

In	O
addition	O
,	O
reversible	O
binding	O
may	O
occur	O
using	O
a	O
pre	O
-	O
formed	O
organometallic	O
cofactor	O
such	O
as	O
a	O
metal	O
-	O
tetrapyrrole	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reversible	B-X
binding	B-X
may	B-X
occur	B-X
using	B-X
a	B-X
pre-formed	B-X
organometallic	B-X
cofactor	B-X
such	B-X
as	B-X
a	B-X
metal-tetrapyrrole	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

Electron	O
transfer	O
reactions	O
are	O
coupled	O
to	O
biosynthesis	O
of	O
certain	O
metallocenters	O
,	O
i	O
.	O
e	O
.	O
oxidation	O
or	O
reduction	O
of	O
the	O
metallocenter	O
or	O
apo	O
-	O
protein	O
may	O
be	O
required	O
prior	O
to	O
binding	O
,	O
or	O
once	O
bound	O
the	O
metallocenter	O
may	O
be	O
oxidatively	O
trapped	O
in	O
the	O
protein	O
.	O
<EOS>	B-X
Cytochromes	B-X
A	B-X
facial	B-X
triad	B-X
of	B-X
two	B-X
histidine	B-X
side	B-X
chains	B-X
and	B-X
one	B-X
aspartate	B-X
or	B-X
glutamate	B-X
side	B-X
chain	B-X
forms	B-X
the	B-X
canonical	B-X
metal-coordinating	B-X
motif	B-X
in	B-X
the	B-X
catalytic	B-X
centers	B-X
of	B-X
various	B-X
mononuclear	B-X
non-heme	B-X
Fe	B-X
(	B-X
II	B-X
)	B-X
enzymes	B-X
.	B-X
Although	B-X
these	B-X
active	B-X
sites	B-X
are	B-X
based	B-X
on	B-X
totally	B-X
unrelated	B-X
protein	B-X
folds	B-X
and	B-X
bring	B-X
about	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
chemical	B-X
transformations	B-X
,	B-X
most	B-X
of	B-X
them	B-X
share	B-X
the	B-X
ability	B-X
to	B-X
couple	B-X
dioxygen	B-X
reduction	B-X
with	B-X
the	B-X
oxygenation	B-X
of	B-X
an	B-X
organic	B-X
substrate	B-X
.	B-X
With	B-X
the	B-X
increasing	B-X
number	B-X
of	B-X
protein	B-X
structures	B-X
now	B-X
solved	B-X
,	B-X
it	B-X
has	B-X
become	B-X
clear	B-X
that	B-X
the	B-X
2-His-1-carboxylate	B-X
signature	B-X
is	B-X
less	B-X
of	B-X
a	B-X
paradigm	B-X
for	B-X
non-heme	B-X
Fe	B-X
(	B-X
II	B-X
)	B-X
active	B-X
sites	B-X
than	B-X
had	B-X
long	B-X
been	B-X
thought	B-X
and	B-X
that	B-X
it	B-X
can	B-X
be	B-X
replaced	B-X
by	B-X
alternative	B-X
metal	B-X
centers	B-X
in	B-X
various	B-X
oxygenases	B-X
,	B-X
the	B-X
structure-function	B-X
relationships	B-X
and	B-X
proposed	B-X
catalytic	B-X
mechanisms	B-X
of	B-X
which	B-X
are	B-X
reviewed	B-X
here	B-X
.	B-X
Metal	B-X
coordination	B-X
through	B-X
three	B-X
histidines	B-X
and	B-X
one	B-X
glutamate	B-X
constitutes	B-X
the	B-X
classical	B-X
motif	B-X
described	B-X
for	B-X
enzyme	B-X
members	B-X
of	B-X
the	B-X
cupin	B-X
protein	B-X
superfamily	B-X
,	B-X
such	B-X
as	B-X
aci-reductone	B-X
dioxygenase	B-X
and	B-X
quercetin	B-X
dioxygenase	B-X
,	B-X
multiple	B-X
metal	B-X
forms	B-X
of	B-X
which	B-X
(	B-X
including	B-X
the	B-X
Fe	B-X
(	B-X
II	B-X
)	B-X
type	B-X
)	B-X
are	B-X
found	B-X
in	B-X
nature	B-X
.	B-X
Cysteine	B-X
dioxygenase	B-X
and	B-X
diketone	B-X
dioxygenase	B-X
,	B-X
which	B-X
are	B-X
strictly	B-X
Fe	B-X
(	B-X
II	B-X
)	B-X
-dependent	B-X
oxygenases	B-X
based	B-X
on	B-X
the	B-X
cupin	B-X
fold	B-X
,	B-X
bind	B-X
the	B-X
catalytic	B-X
metal	B-X
through	B-X
the	B-X
homologous	B-X
triad	B-X
of	B-X
histidines	B-X
,	B-X
but	B-X
lack	B-X
the	B-X
fourth	B-X
glutamate	B-X
ligand	B-X
.	B-X
An	B-X
alpha-ketoglutarate-dependent	B-X
Fe	B-X
(	B-X
II	B-X
)	B-X
halogenase	B-X
shows	B-X
metal	B-X
coordination	B-X
by	B-X
two	B-X
histidines	B-X
as	B-X
the	B-X
only	B-X
protein-derived	B-X
ligands	B-X
,	B-X
whilst	B-X
carotene	B-X
oxygenase	B-X
,	B-X
from	B-X
a	B-X
different	B-X
protein	B-X
fold	B-X
family	B-X
,	B-X
features	B-X
an	B-X
Fe	B-X
(	B-X
II	B-X
)	B-X
site	B-X
consisting	B-X
of	B-X
four	B-X
histidine	B-X
side	B-X
chains	B-X
.	B-X
These	B-X
recently	B-X
discovered	B-X
metallocenters	B-X
are	B-X
discussed	B-X
with	B-X
respect	B-X
to	B-X
their	B-X
metal-binding	B-X
properties	B-X
and	B-X
the	B-X
reaction	B-X
coordinates	B-X
of	B-X
the	B-X
O	B-X
(	B-X
2	B-X
)	B-X
-dependent	B-X
conversions	B-X
they	B-X
catalyze	B-X
.	B-X

An	O
effector	O
molecule	O
may	O
bind	O
to	O
apo	O
-	O
protein	O
to	O
open	O
up	O
or	O
stabilize	O
the	O
metallocenter	O
binding	O
site	O
,	O
then	O
after	O
the	O
metallocenter	O
is	O
incorporated	O
the	O
effector	O
molecule	O
dissociates	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reversible	B-X
binding	B-X
may	B-X
occur	B-X
using	B-X
a	B-X
pre-formed	B-X
organometallic	B-X
cofactor	B-X
such	B-X
as	B-X
a	B-X
metal-tetrapyrrole	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

A	O
transferase	O
or	O
insertase	O
protein	O
first	O
may	O
bind	O
the	O
metallocenter	O
and	O
then	O
incorporate	O
it	O
into	O
the	O
appropriate	O
apo	O
-	O
protein	O
.	O
<EOS>	B-X
This	B-X
review	B-X
describes	B-X
the	B-X
three	B-X
mammalian	B-X
glutathione	B-X
transferase	B-X
(	B-X
GST	B-X
)	B-X
families	B-X
,	B-X
namely	B-X
cytosolic	B-X
,	B-X
mitochondrial	B-X
,	B-X
and	B-X
microsomal	B-X
GST	B-X
,	B-X
the	B-X
latter	B-X
now	B-X
designated	B-X
MAPEG	B-X
.	B-X
Besides	B-X
detoxifying	B-X
electrophilic	B-X
xenobiotics	B-X
,	B-X
such	B-X
as	B-X
chemical	B-X
carcinogens	B-X
,	B-X
environmental	B-X
pollutants	B-X
,	B-X
and	B-X
antitumor	B-X
agents	B-X
,	B-X
these	B-X
transferases	B-X
inactivate	B-X
endogenous	B-X
alpha	B-X
,	B-X
beta-unsaturated	B-X
aldehydes	B-X
,	B-X
quinones	B-X
,	B-X
epoxides	B-X
,	B-X
and	B-X
hydroperoxides	B-X
formed	B-X
as	B-X
secondary	B-X
metabolites	B-X
during	B-X
oxidative	B-X
stress	B-X
.	B-X
Through	B-X
metabolism	B-X
of	B-X
15d-PGJ2	B-X
,	B-X
GST	B-X
may	B-X
enhance	B-X
gene	B-X
expression	B-X
driven	B-X
by	B-X
nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
.	B-X
Targeted	B-X
disruption	B-X
of	B-X
murine	B-X
genes	B-X
has	B-X
demonstrated	B-X
that	B-X
cytosolic	B-X
GST	B-X
isoenzymes	B-X
are	B-X
broadly	B-X
cytoprotective	B-X
,	B-X
whereas	B-X
MAPEG	B-X
proteins	B-X
have	B-X
proinflammatory	B-X
activities	B-X
.	B-X
Furthermore	B-X
,	B-X
knockout	B-X
of	B-X
mouse	B-X
GSTA4	B-X
and	B-X
GSTZ1	B-X
leads	B-X
to	B-X
overexpression	B-X
of	B-X
transferases	B-X
in	B-X
the	B-X
Alpha	B-X
,	B-X
Mu	B-X
,	B-X
and	B-X
Pi	B-X
classes	B-X
,	B-X
an	B-X
observation	B-X
suggesting	B-X
they	B-X
are	B-X
part	B-X
of	B-X
an	B-X
adaptive	B-X
mechanism	B-X
that	B-X
responds	B-X
to	B-X
endogenous	B-X
chemical	B-X
cues	B-X
such	B-X
as	B-X
4-hydroxynonenal	B-X
and	B-X
tyrosine	B-X
degradation	B-X
products	B-X
.	B-X

Finally	O
,	O
metal	O
cofactors	O
may	O
be	O
covalently	O
attached	O
to	O
proteins	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reversible	B-X
binding	B-X
may	B-X
occur	B-X
using	B-X
a	B-X
pre-formed	B-X
organometallic	B-X
cofactor	B-X
such	B-X
as	B-X
a	B-X
metal-tetrapyrrole	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

Regardless	O
of	O
the	O
metallocenter	O
biosynthetic	O
mechanism	O
,	O
intracellular	O
metal	O
ion	O
concentrations	O
must	O
be	O
sufficient	O
;	O
hence	O
,	O
metal	O
ion	O
transport	O
systems	O
also	O
are	O
briefly	O
discussed	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
protein	B-X
metallocenters	B-X
have	B-X
been	B-X
extensively	B-X
characterized	B-X
,	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
their	B-X
assembly	B-X
.	B-X
Here	B-X
,	B-X
I	B-X
describe	B-X
several	B-X
general	B-X
strategies	B-X
for	B-X
metallocenter	B-X
biosynthesis	B-X
and	B-X
provide	B-X
literature	B-X
precedents	B-X
for	B-X
each	B-X
mechanism	B-X
.	B-X
The	B-X
simplest	B-X
mechanism	B-X
involves	B-X
reversible	B-X
metal	B-X
ion	B-X
binding	B-X
to	B-X
amino	B-X
acid	B-X
ligands	B-X
of	B-X
the	B-X
apo-protein	B-X
.	B-X
In	B-X
a	B-X
variation	B-X
of	B-X
this	B-X
mechanism	B-X
,	B-X
the	B-X
apo-protein	B-X
first	B-X
must	B-X
be	B-X
phosphorylated	B-X
,	B-X
carboxylated	B-X
or	B-X
otherwise	B-X
covalently	B-X
modified	B-X
in	B-X
order	B-X
to	B-X
create	B-X
the	B-X
metal	B-X
ion	B-X
binding	B-X
site	B-X
.	B-X
Alternatively	B-X
,	B-X
passive	B-X
metal	B-X
ion	B-X
binding	B-X
may	B-X
require	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
associated	B-X
compound	B-X
,	B-X
such	B-X
as	B-X
a	B-X
nucleotide	B-X
,	B-X
carbonate	B-X
or	B-X
inorganic	B-X
sulfide	B-X
,	B-X
which	B-X
is	B-X
co-incorporated	B-X
into	B-X
the	B-X
protein	B-X
along	B-X
with	B-X
the	B-X
metal	B-X
ion	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
reversible	B-X
binding	B-X
may	B-X
occur	B-X
using	B-X
a	B-X
pre-formed	B-X
organometallic	B-X
cofactor	B-X
such	B-X
as	B-X
a	B-X
metal-tetrapyrrole	B-X
.	B-X
Electron	B-X
transfer	B-X
reactions	B-X
are	B-X
coupled	B-X
to	B-X
biosynthesis	B-X
of	B-X
certain	B-X
metallocenters	B-X
,	B-X
i.e	B-X
.	B-X
oxidation	B-X
or	B-X
reduction	B-X
of	B-X
the	B-X
metallocenter	B-X
or	B-X
apo-protein	B-X
may	B-X
be	B-X
required	B-X
prior	B-X
to	B-X
binding	B-X
,	B-X
or	B-X
once	B-X
bound	B-X
the	B-X
metallocenter	B-X
may	B-X
be	B-X
oxidatively	B-X
trapped	B-X
in	B-X
the	B-X
protein	B-X
.	B-X
An	B-X
effector	B-X
molecule	B-X
may	B-X
bind	B-X
to	B-X
apo-protein	B-X
to	B-X
open	B-X
up	B-X
or	B-X
stabilize	B-X
the	B-X
metallocenter	B-X
binding	B-X
site	B-X
,	B-X
then	B-X
after	B-X
the	B-X
metallocenter	B-X
is	B-X
incorporated	B-X
the	B-X
effector	B-X
molecule	B-X
dissociates	B-X
.	B-X
A	B-X
transferase	B-X
or	B-X
insertase	B-X
protein	B-X
first	B-X
may	B-X
bind	B-X
the	B-X
metallocenter	B-X
and	B-X
then	B-X
incorporate	B-X
it	B-X
into	B-X
the	B-X
appropriate	B-X
apo-protein	B-X
.	B-X
Finally	B-X
,	B-X
metal	B-X
cofactors	B-X
may	B-X
be	B-X
covalently	B-X
attached	B-X
to	B-X
proteins	B-X
.	B-X
Regardless	B-X
of	B-X
the	B-X
metallocenter	B-X
biosynthetic	B-X
mechanism	B-X
,	B-X
intracellular	B-X
metal	B-X
ion	B-X
concentrations	B-X
must	B-X
be	B-X
sufficient	B-X
;	B-X
hence	B-X
,	B-X
metal	B-X
ion	B-X
transport	B-X
systems	B-X
also	B-X
are	B-X
briefly	B-X
discussed	B-X
.	B-X

The	O
effect	O
of	O
sulfation	O
on	O
the	O
anticoagulant	O
and	O
antithrombin	B-Protein
III	I-Protein
-	O
binding	O
properties	O
of	O
a	O
heparin	O
fraction	O
with	O
low	O
affinity	O
for	O
antithrombin	B-Protein
III	I-Protein
.	O
<EOS>	B-X
Heparin	B-X
with	B-X
low	B-X
affinity	B-X
for	B-X
antithrombin	B-X
III	B-X
(	B-X
ATIII	B-X
)	B-X
and	B-X
devoid	B-X
of	B-X
anticoagulant	B-X
activity	B-X
was	B-X
chemically	B-X
oversulfated	B-X
and	B-X
fractionated	B-X
by	B-X
affinity	B-X
for	B-X
ATIII	B-X
.	B-X
The	B-X
oversulfated	B-X
material	B-X
showed	B-X
ATIII	B-X
binding	B-X
properties	B-X
,	B-X
as	B-X
monitored	B-X
by	B-X
intrinsic	B-X
fluorescence	B-X
enhancement	B-X
of	B-X
ATIII	B-X
.	B-X
The	B-X
fluorescence	B-X
increase	B-X
was	B-X
comparable	B-X
to	B-X
that	B-X
of	B-X
the	B-X
AT	B-X
III	B-X
high	B-X
affinity	B-X
fraction	B-X
of	B-X
native	B-X
heparin	B-X
.	B-X
The	B-X
estimated	B-X
dissociation	B-X
constants	B-X
however	B-X
,	B-X
showed	B-X
a	B-X
10-fold	B-X
weaker	B-X
binding	B-X
of	B-X
the	B-X
oversulfated	B-X
material	B-X
to	B-X
ATIII	B-X
,	B-X
Kd	B-X
=	B-X
6.4	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M	B-X
,	B-X
as	B-X
compared	B-X
to	B-X
native	B-X
heparin	B-X
,	B-X
Kd	B-X
=	B-X
0.63	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M.	B-X
Concomitant	B-X
with	B-X
the	B-X
binding-induced	B-X
allosteric	B-X
change	B-X
in	B-X
ATIII	B-X
,	B-X
the	B-X
oversulfated	B-X
material	B-X
stimulated	B-X
the	B-X
ATIII-thrombin	B-X
and	B-X
ATIII-factor	B-X
Xa	B-X
reactions	B-X
.	B-X
The	B-X
high	B-X
affinity	B-X
fractions	B-X
of	B-X
native	B-X
heparin	B-X
and	B-X
the	B-X
sulfated	B-X
material	B-X
were	B-X
almost	B-X
equally	B-X
effective	B-X
in	B-X
enhancing	B-X
the	B-X
rate	B-X
of	B-X
thrombin	B-X
neutralization	B-X
by	B-X
ATIII	B-X
.	B-X
However	B-X
,	B-X
a	B-X
3-fold	B-X
faster	B-X
rate	B-X
of	B-X
factor	B-X
Xa	B-X
inactivation	B-X
was	B-X
found	B-X
with	B-X
the	B-X
native	B-X
high	B-X
affinity	B-X
material	B-X
.	B-X

Heparin	O
with	O
low	O
affinity	O
for	O
antithrombin	B-Protein
III	I-Protein
(	O
ATIII	B-Protein
)	O
and	O
devoid	O
of	O
anticoagulant	O
activity	O
was	O
chemically	O
oversulfated	O
and	O
fractionated	O
by	O
affinity	O
for	O
ATIII	B-Protein
.	O
<EOS>	B-X
Heparin	B-X
with	B-X
low	B-X
affinity	B-X
for	B-X
antithrombin	B-X
III	B-X
(	B-X
ATIII	B-X
)	B-X
and	B-X
devoid	B-X
of	B-X
anticoagulant	B-X
activity	B-X
was	B-X
chemically	B-X
oversulfated	B-X
and	B-X
fractionated	B-X
by	B-X
affinity	B-X
for	B-X
ATIII	B-X
.	B-X
The	B-X
oversulfated	B-X
material	B-X
showed	B-X
ATIII	B-X
binding	B-X
properties	B-X
,	B-X
as	B-X
monitored	B-X
by	B-X
intrinsic	B-X
fluorescence	B-X
enhancement	B-X
of	B-X
ATIII	B-X
.	B-X
The	B-X
fluorescence	B-X
increase	B-X
was	B-X
comparable	B-X
to	B-X
that	B-X
of	B-X
the	B-X
AT	B-X
III	B-X
high	B-X
affinity	B-X
fraction	B-X
of	B-X
native	B-X
heparin	B-X
.	B-X
The	B-X
estimated	B-X
dissociation	B-X
constants	B-X
however	B-X
,	B-X
showed	B-X
a	B-X
10-fold	B-X
weaker	B-X
binding	B-X
of	B-X
the	B-X
oversulfated	B-X
material	B-X
to	B-X
ATIII	B-X
,	B-X
Kd	B-X
=	B-X
6.4	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M	B-X
,	B-X
as	B-X
compared	B-X
to	B-X
native	B-X
heparin	B-X
,	B-X
Kd	B-X
=	B-X
0.63	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M.	B-X
Concomitant	B-X
with	B-X
the	B-X
binding-induced	B-X
allosteric	B-X
change	B-X
in	B-X
ATIII	B-X
,	B-X
the	B-X
oversulfated	B-X
material	B-X
stimulated	B-X
the	B-X
ATIII-thrombin	B-X
and	B-X
ATIII-factor	B-X
Xa	B-X
reactions	B-X
.	B-X
The	B-X
high	B-X
affinity	B-X
fractions	B-X
of	B-X
native	B-X
heparin	B-X
and	B-X
the	B-X
sulfated	B-X
material	B-X
were	B-X
almost	B-X
equally	B-X
effective	B-X
in	B-X
enhancing	B-X
the	B-X
rate	B-X
of	B-X
thrombin	B-X
neutralization	B-X
by	B-X
ATIII	B-X
.	B-X
However	B-X
,	B-X
a	B-X
3-fold	B-X
faster	B-X
rate	B-X
of	B-X
factor	B-X
Xa	B-X
inactivation	B-X
was	B-X
found	B-X
with	B-X
the	B-X
native	B-X
high	B-X
affinity	B-X
material	B-X
.	B-X

The	O
oversulfated	O
material	O
showed	O
ATIII	B-Protein
binding	O
properties	O
,	O
as	O
monitored	O
by	O
intrinsic	O
fluorescence	O
enhancement	O
of	O
ATIII	B-Protein
.	O
<EOS>	B-X
Heparin	B-X
with	B-X
low	B-X
affinity	B-X
for	B-X
antithrombin	B-X
III	B-X
(	B-X
ATIII	B-X
)	B-X
and	B-X
devoid	B-X
of	B-X
anticoagulant	B-X
activity	B-X
was	B-X
chemically	B-X
oversulfated	B-X
and	B-X
fractionated	B-X
by	B-X
affinity	B-X
for	B-X
ATIII	B-X
.	B-X
The	B-X
oversulfated	B-X
material	B-X
showed	B-X
ATIII	B-X
binding	B-X
properties	B-X
,	B-X
as	B-X
monitored	B-X
by	B-X
intrinsic	B-X
fluorescence	B-X
enhancement	B-X
of	B-X
ATIII	B-X
.	B-X
The	B-X
fluorescence	B-X
increase	B-X
was	B-X
comparable	B-X
to	B-X
that	B-X
of	B-X
the	B-X
AT	B-X
III	B-X
high	B-X
affinity	B-X
fraction	B-X
of	B-X
native	B-X
heparin	B-X
.	B-X
The	B-X
estimated	B-X
dissociation	B-X
constants	B-X
however	B-X
,	B-X
showed	B-X
a	B-X
10-fold	B-X
weaker	B-X
binding	B-X
of	B-X
the	B-X
oversulfated	B-X
material	B-X
to	B-X
ATIII	B-X
,	B-X
Kd	B-X
=	B-X
6.4	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M	B-X
,	B-X
as	B-X
compared	B-X
to	B-X
native	B-X
heparin	B-X
,	B-X
Kd	B-X
=	B-X
0.63	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M.	B-X
Concomitant	B-X
with	B-X
the	B-X
binding-induced	B-X
allosteric	B-X
change	B-X
in	B-X
ATIII	B-X
,	B-X
the	B-X
oversulfated	B-X
material	B-X
stimulated	B-X
the	B-X
ATIII-thrombin	B-X
and	B-X
ATIII-factor	B-X
Xa	B-X
reactions	B-X
.	B-X
The	B-X
high	B-X
affinity	B-X
fractions	B-X
of	B-X
native	B-X
heparin	B-X
and	B-X
the	B-X
sulfated	B-X
material	B-X
were	B-X
almost	B-X
equally	B-X
effective	B-X
in	B-X
enhancing	B-X
the	B-X
rate	B-X
of	B-X
thrombin	B-X
neutralization	B-X
by	B-X
ATIII	B-X
.	B-X
However	B-X
,	B-X
a	B-X
3-fold	B-X
faster	B-X
rate	B-X
of	B-X
factor	B-X
Xa	B-X
inactivation	B-X
was	B-X
found	B-X
with	B-X
the	B-X
native	B-X
high	B-X
affinity	B-X
material	B-X
.	B-X

The	O
fluorescence	O
increase	O
was	O
comparable	O
to	O
that	O
of	O
the	O
AT	B-Protein
III	I-Protein
high	O
affinity	O
fraction	O
of	O
native	O
heparin	O
.	O
<EOS>	B-X
Heparin	B-X
with	B-X
low	B-X
affinity	B-X
for	B-X
antithrombin	B-X
III	B-X
(	B-X
ATIII	B-X
)	B-X
and	B-X
devoid	B-X
of	B-X
anticoagulant	B-X
activity	B-X
was	B-X
chemically	B-X
oversulfated	B-X
and	B-X
fractionated	B-X
by	B-X
affinity	B-X
for	B-X
ATIII	B-X
.	B-X
The	B-X
oversulfated	B-X
material	B-X
showed	B-X
ATIII	B-X
binding	B-X
properties	B-X
,	B-X
as	B-X
monitored	B-X
by	B-X
intrinsic	B-X
fluorescence	B-X
enhancement	B-X
of	B-X
ATIII	B-X
.	B-X
The	B-X
fluorescence	B-X
increase	B-X
was	B-X
comparable	B-X
to	B-X
that	B-X
of	B-X
the	B-X
AT	B-X
III	B-X
high	B-X
affinity	B-X
fraction	B-X
of	B-X
native	B-X
heparin	B-X
.	B-X
The	B-X
estimated	B-X
dissociation	B-X
constants	B-X
however	B-X
,	B-X
showed	B-X
a	B-X
10-fold	B-X
weaker	B-X
binding	B-X
of	B-X
the	B-X
oversulfated	B-X
material	B-X
to	B-X
ATIII	B-X
,	B-X
Kd	B-X
=	B-X
6.4	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M	B-X
,	B-X
as	B-X
compared	B-X
to	B-X
native	B-X
heparin	B-X
,	B-X
Kd	B-X
=	B-X
0.63	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M.	B-X
Concomitant	B-X
with	B-X
the	B-X
binding-induced	B-X
allosteric	B-X
change	B-X
in	B-X
ATIII	B-X
,	B-X
the	B-X
oversulfated	B-X
material	B-X
stimulated	B-X
the	B-X
ATIII-thrombin	B-X
and	B-X
ATIII-factor	B-X
Xa	B-X
reactions	B-X
.	B-X
The	B-X
high	B-X
affinity	B-X
fractions	B-X
of	B-X
native	B-X
heparin	B-X
and	B-X
the	B-X
sulfated	B-X
material	B-X
were	B-X
almost	B-X
equally	B-X
effective	B-X
in	B-X
enhancing	B-X
the	B-X
rate	B-X
of	B-X
thrombin	B-X
neutralization	B-X
by	B-X
ATIII	B-X
.	B-X
However	B-X
,	B-X
a	B-X
3-fold	B-X
faster	B-X
rate	B-X
of	B-X
factor	B-X
Xa	B-X
inactivation	B-X
was	B-X
found	B-X
with	B-X
the	B-X
native	B-X
high	B-X
affinity	B-X
material	B-X
.	B-X

The	O
estimated	O
dissociation	O
constants	O
however	O
,	O
showed	O
a	O
10	O
-	O
fold	O
weaker	O
binding	O
of	O
the	O
oversulfated	O
material	O
to	O
ATIII	B-Protein
,	O
Kd	O
=	O
6	O
.	O
4	O
x	O
10	O
(	O
-	O
8	O
)	O
M	O
,	O
as	O
compared	O
to	O
native	O
heparin	O
,	O
Kd	O
=	O
0	O
.	O
63	O
x	O
10	O
(	O
-	O
8	O
)	O
M	O
.	O

Concomitant	O
with	O
the	O
binding	O
-	O
induced	O
allosteric	O
change	O
in	O
ATIII	B-Protein
,	O
the	O
oversulfated	O
material	O
stimulated	O
the	O
ATIII	B-Protein
-	O
thrombin	B-Protein
and	O
ATIII	B-Protein
-	O
factor	B-Protein
Xa	I-Protein
reactions	O
.	O
<EOS>	B-X
Heparin	B-X
with	B-X
low	B-X
affinity	B-X
for	B-X
antithrombin	B-X
III	B-X
(	B-X
ATIII	B-X
)	B-X
and	B-X
devoid	B-X
of	B-X
anticoagulant	B-X
activity	B-X
was	B-X
chemically	B-X
oversulfated	B-X
and	B-X
fractionated	B-X
by	B-X
affinity	B-X
for	B-X
ATIII	B-X
.	B-X
The	B-X
oversulfated	B-X
material	B-X
showed	B-X
ATIII	B-X
binding	B-X
properties	B-X
,	B-X
as	B-X
monitored	B-X
by	B-X
intrinsic	B-X
fluorescence	B-X
enhancement	B-X
of	B-X
ATIII	B-X
.	B-X
The	B-X
estimated	B-X
dissociation	B-X
constants	B-X
however	B-X
,	B-X
showed	B-X
a	B-X
10-fold	B-X
weaker	B-X
binding	B-X
of	B-X
the	B-X
oversulfated	B-X
material	B-X
to	B-X
ATIII	B-X
,	B-X
Kd	B-X
=	B-X
6.4	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M	B-X
,	B-X
as	B-X
compared	B-X
to	B-X
native	B-X
heparin	B-X
,	B-X
Kd	B-X
=	B-X
0.63	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M.	B-X
Concomitant	B-X
with	B-X
the	B-X
binding-induced	B-X
allosteric	B-X
change	B-X
in	B-X
ATIII	B-X
,	B-X
the	B-X
oversulfated	B-X
material	B-X
stimulated	B-X
the	B-X
ATIII-thrombin	B-X
and	B-X
ATIII-factor	B-X
Xa	B-X
reactions	B-X
.	B-X
The	B-X
high	B-X
affinity	B-X
fractions	B-X
of	B-X
native	B-X
heparin	B-X
and	B-X
the	B-X
sulfated	B-X
material	B-X
were	B-X
almost	B-X
equally	B-X
effective	B-X
in	B-X
enhancing	B-X
the	B-X
rate	B-X
of	B-X
thrombin	B-X
neutralization	B-X
by	B-X
ATIII	B-X
.	B-X
However	B-X
,	B-X
a	B-X
3-fold	B-X
faster	B-X
rate	B-X
of	B-X
factor	B-X
Xa	B-X
inactivation	B-X
was	B-X
found	B-X
with	B-X
the	B-X
native	B-X
high	B-X
affinity	B-X
material	B-X
.	B-X

The	O
high	O
affinity	O
fractions	O
of	O
native	O
heparin	O
and	O
the	O
sulfated	O
material	O
were	O
almost	O
equally	O
effective	O
in	O
enhancing	O
the	O
rate	O
of	O
thrombin	B-Protein
neutralization	O
by	O
ATIII	B-Protein
.	O
<EOS>	B-X
Heparin	B-X
with	B-X
low	B-X
affinity	B-X
for	B-X
antithrombin	B-X
III	B-X
(	B-X
ATIII	B-X
)	B-X
and	B-X
devoid	B-X
of	B-X
anticoagulant	B-X
activity	B-X
was	B-X
chemically	B-X
oversulfated	B-X
and	B-X
fractionated	B-X
by	B-X
affinity	B-X
for	B-X
ATIII	B-X
.	B-X
The	B-X
oversulfated	B-X
material	B-X
showed	B-X
ATIII	B-X
binding	B-X
properties	B-X
,	B-X
as	B-X
monitored	B-X
by	B-X
intrinsic	B-X
fluorescence	B-X
enhancement	B-X
of	B-X
ATIII	B-X
.	B-X
The	B-X
fluorescence	B-X
increase	B-X
was	B-X
comparable	B-X
to	B-X
that	B-X
of	B-X
the	B-X
AT	B-X
III	B-X
high	B-X
affinity	B-X
fraction	B-X
of	B-X
native	B-X
heparin	B-X
.	B-X
The	B-X
estimated	B-X
dissociation	B-X
constants	B-X
however	B-X
,	B-X
showed	B-X
a	B-X
10-fold	B-X
weaker	B-X
binding	B-X
of	B-X
the	B-X
oversulfated	B-X
material	B-X
to	B-X
ATIII	B-X
,	B-X
Kd	B-X
=	B-X
6.4	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M	B-X
,	B-X
as	B-X
compared	B-X
to	B-X
native	B-X
heparin	B-X
,	B-X
Kd	B-X
=	B-X
0.63	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M.	B-X
Concomitant	B-X
with	B-X
the	B-X
binding-induced	B-X
allosteric	B-X
change	B-X
in	B-X
ATIII	B-X
,	B-X
the	B-X
oversulfated	B-X
material	B-X
stimulated	B-X
the	B-X
ATIII-thrombin	B-X
and	B-X
ATIII-factor	B-X
Xa	B-X
reactions	B-X
.	B-X
The	B-X
high	B-X
affinity	B-X
fractions	B-X
of	B-X
native	B-X
heparin	B-X
and	B-X
the	B-X
sulfated	B-X
material	B-X
were	B-X
almost	B-X
equally	B-X
effective	B-X
in	B-X
enhancing	B-X
the	B-X
rate	B-X
of	B-X
thrombin	B-X
neutralization	B-X
by	B-X
ATIII	B-X
.	B-X
However	B-X
,	B-X
a	B-X
3-fold	B-X
faster	B-X
rate	B-X
of	B-X
factor	B-X
Xa	B-X
inactivation	B-X
was	B-X
found	B-X
with	B-X
the	B-X
native	B-X
high	B-X
affinity	B-X
material	B-X
.	B-X

However	O
,	O
a	O
3	O
-	O
fold	O
faster	O
rate	O
of	O
factor	B-Protein
Xa	I-Protein
inactivation	O
was	O
found	O
with	O
the	O
native	O
high	O
affinity	O
material	O
.	O
<EOS>	B-X
Heparin	B-X
with	B-X
low	B-X
affinity	B-X
for	B-X
antithrombin	B-X
III	B-X
(	B-X
ATIII	B-X
)	B-X
and	B-X
devoid	B-X
of	B-X
anticoagulant	B-X
activity	B-X
was	B-X
chemically	B-X
oversulfated	B-X
and	B-X
fractionated	B-X
by	B-X
affinity	B-X
for	B-X
ATIII	B-X
.	B-X
The	B-X
oversulfated	B-X
material	B-X
showed	B-X
ATIII	B-X
binding	B-X
properties	B-X
,	B-X
as	B-X
monitored	B-X
by	B-X
intrinsic	B-X
fluorescence	B-X
enhancement	B-X
of	B-X
ATIII	B-X
.	B-X
The	B-X
fluorescence	B-X
increase	B-X
was	B-X
comparable	B-X
to	B-X
that	B-X
of	B-X
the	B-X
AT	B-X
III	B-X
high	B-X
affinity	B-X
fraction	B-X
of	B-X
native	B-X
heparin	B-X
.	B-X
The	B-X
estimated	B-X
dissociation	B-X
constants	B-X
however	B-X
,	B-X
showed	B-X
a	B-X
10-fold	B-X
weaker	B-X
binding	B-X
of	B-X
the	B-X
oversulfated	B-X
material	B-X
to	B-X
ATIII	B-X
,	B-X
Kd	B-X
=	B-X
6.4	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M	B-X
,	B-X
as	B-X
compared	B-X
to	B-X
native	B-X
heparin	B-X
,	B-X
Kd	B-X
=	B-X
0.63	B-X
x	B-X
10	B-X
(	B-X
-8	B-X
)	B-X
M.	B-X
Concomitant	B-X
with	B-X
the	B-X
binding-induced	B-X
allosteric	B-X
change	B-X
in	B-X
ATIII	B-X
,	B-X
the	B-X
oversulfated	B-X
material	B-X
stimulated	B-X
the	B-X
ATIII-thrombin	B-X
and	B-X
ATIII-factor	B-X
Xa	B-X
reactions	B-X
.	B-X
The	B-X
high	B-X
affinity	B-X
fractions	B-X
of	B-X
native	B-X
heparin	B-X
and	B-X
the	B-X
sulfated	B-X
material	B-X
were	B-X
almost	B-X
equally	B-X
effective	B-X
in	B-X
enhancing	B-X
the	B-X
rate	B-X
of	B-X
thrombin	B-X
neutralization	B-X
by	B-X
ATIII	B-X
.	B-X
However	B-X
,	B-X
a	B-X
3-fold	B-X
faster	B-X
rate	B-X
of	B-X
factor	B-X
Xa	B-X
inactivation	B-X
was	B-X
found	B-X
with	B-X
the	B-X
native	B-X
high	B-X
affinity	B-X
material	B-X
.	B-X

Acylation	O
and	O
carbamylation	O
of	O
equine	O
muscle	O
carbonic	O
anhydrase	O
(	O
CA	B-Protein
-	I-Protein
III	I-Protein
)	O
upon	O
reaction	O
with	O
p	O
-	O
nitrophenyl	O
esters	O
and	O
carbamoyl	O
phosphate	O
.	O

Equine	O
muscle	O
carbonic	O
anhydrase	O
(	O
CA	B-Protein
-	I-Protein
III	I-Protein
)	O
behaves	O
like	O
ubiquitin	O
in	O
undergoing	O
extensive	O
acylation	O
of	O
N	O
epsilon	O
-	O
lysine	O
residues	O
upon	O
reacting	O
with	O
p	O
-	O
nitrophenyl	O
esters	O
.	O

The	O
enzyme	O
undergoes	O
extensive	O
carbamoylation	O
of	O
lysine	O
residues	O
when	O
reacted	O
with	O
carbamoyl	O
phosphate	O
.	O
<EOS>	B-X
Equine	B-X
muscle	B-X
carbonic	B-X
anhydrase	B-X
(	B-X
CA-III	B-X
)	B-X
behaves	B-X
like	B-X
ubiquitin	B-X
in	B-X
undergoing	B-X
extensive	B-X
acylation	B-X
of	B-X
N	B-X
epsilon-lysine	B-X
residues	B-X
upon	B-X
reacting	B-X
with	B-X
p-nitrophenyl	B-X
esters	B-X
.	B-X
The	B-X
enzyme	B-X
undergoes	B-X
extensive	B-X
carbamoylation	B-X
of	B-X
lysine	B-X
residues	B-X
when	B-X
reacted	B-X
with	B-X
carbamoyl	B-X
phosphate	B-X
.	B-X
The	B-X
modification	B-X
of	B-X
from	B-X
6	B-X
to	B-X
7	B-X
lysine	B-X
residues	B-X
results	B-X
in	B-X
the	B-X
production	B-X
of	B-X
a	B-X
series	B-X
of	B-X
more	B-X
anodic	B-X
electrophoretic	B-X
components	B-X
.	B-X
The	B-X
derivatization	B-X
of	B-X
the	B-X
lysine	B-X
residues	B-X
leads	B-X
to	B-X
a	B-X
marked	B-X
decrease	B-X
in	B-X
the	B-X
enzyme	B-X
's	B-X
ability	B-X
to	B-X
hydrate	B-X
CO2	B-X
.	B-X

The	O
modification	O
of	O
from	O
6	O
to	O
7	O
lysine	O
residues	O
results	O
in	O
the	O
production	O
of	O
a	O
series	O
of	O
more	O
anodic	O
electrophoretic	O
components	O
.	O
<EOS>	B-X
Equine	B-X
muscle	B-X
carbonic	B-X
anhydrase	B-X
(	B-X
CA-III	B-X
)	B-X
behaves	B-X
like	B-X
ubiquitin	B-X
in	B-X
undergoing	B-X
extensive	B-X
acylation	B-X
of	B-X
N	B-X
epsilon-lysine	B-X
residues	B-X
upon	B-X
reacting	B-X
with	B-X
p-nitrophenyl	B-X
esters	B-X
.	B-X
The	B-X
enzyme	B-X
undergoes	B-X
extensive	B-X
carbamoylation	B-X
of	B-X
lysine	B-X
residues	B-X
when	B-X
reacted	B-X
with	B-X
carbamoyl	B-X
phosphate	B-X
.	B-X
The	B-X
modification	B-X
of	B-X
from	B-X
6	B-X
to	B-X
7	B-X
lysine	B-X
residues	B-X
results	B-X
in	B-X
the	B-X
production	B-X
of	B-X
a	B-X
series	B-X
of	B-X
more	B-X
anodic	B-X
electrophoretic	B-X
components	B-X
.	B-X
The	B-X
derivatization	B-X
of	B-X
the	B-X
lysine	B-X
residues	B-X
leads	B-X
to	B-X
a	B-X
marked	B-X
decrease	B-X
in	B-X
the	B-X
enzyme	B-X
's	B-X
ability	B-X
to	B-X
hydrate	B-X
CO2	B-X
.	B-X

The	O
derivatization	O
of	O
the	O
lysine	O
residues	O
leads	O
to	O
a	O
marked	O
decrease	O
in	O
the	O
enzyme	O
'	O
s	O
ability	O
to	O
hydrate	O
CO2	O
.	O
<EOS>	B-X
Equine	B-X
muscle	B-X
carbonic	B-X
anhydrase	B-X
(	B-X
CA-III	B-X
)	B-X
behaves	B-X
like	B-X
ubiquitin	B-X
in	B-X
undergoing	B-X
extensive	B-X
acylation	B-X
of	B-X
N	B-X
epsilon-lysine	B-X
residues	B-X
upon	B-X
reacting	B-X
with	B-X
p-nitrophenyl	B-X
esters	B-X
.	B-X
The	B-X
enzyme	B-X
undergoes	B-X
extensive	B-X
carbamoylation	B-X
of	B-X
lysine	B-X
residues	B-X
when	B-X
reacted	B-X
with	B-X
carbamoyl	B-X
phosphate	B-X
.	B-X
The	B-X
modification	B-X
of	B-X
from	B-X
6	B-X
to	B-X
7	B-X
lysine	B-X
residues	B-X
results	B-X
in	B-X
the	B-X
production	B-X
of	B-X
a	B-X
series	B-X
of	B-X
more	B-X
anodic	B-X
electrophoretic	B-X
components	B-X
.	B-X
The	B-X
derivatization	B-X
of	B-X
the	B-X
lysine	B-X
residues	B-X
leads	B-X
to	B-X
a	B-X
marked	B-X
decrease	B-X
in	B-X
the	B-X
enzyme	B-X
's	B-X
ability	B-X
to	B-X
hydrate	B-X
CO2	B-X
.	B-X

The	O
equine	O
CA	B-Protein
-	I-Protein
III	I-Protein
possesses	O
both	O
acid	O
and	O
alkaline	O
phosphatase	O
activities	O
in	O
contrast	O
to	O
the	O
rabbit	O
which	O
possesses	O
only	O
the	O
former	O
type	O
.	O

Posttranslational	O
processing	O
of	O
human	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
glycoprotein	I-Protein
(	O
human	O
fetuin	O
)	O
.	O
<EOS>	B-X
alpha	B-X
2-HS	B-X
glycoprotein	B-X
(	B-X
alpha	B-X
2-HS	B-X
)	B-X
is	B-X
a	B-X
major	B-X
protein	B-X
occurring	B-X
in	B-X
human	B-X
blood	B-X
and	B-X
calciferous	B-X
tissues	B-X
.	B-X
Due	B-X
to	B-X
extensive	B-X
sequence	B-X
identity	B-X
,	B-X
alpha	B-X
2-HS	B-X
has	B-X
been	B-X
grouped	B-X
with	B-X
the	B-X
fetuins	B-X
,	B-X
a	B-X
family	B-X
of	B-X
proteins	B-X
that	B-X
occur	B-X
in	B-X
fetal	B-X
plasma	B-X
in	B-X
high	B-X
concentrations	B-X
.	B-X
Native	B-X
alpha	B-X
2-HS	B-X
undergoes	B-X
a	B-X
series	B-X
of	B-X
posttranslational	B-X
modifications	B-X
including	B-X
proteolytic	B-X
processing	B-X
,	B-X
multiple	B-X
N-glycosylations	B-X
and	B-X
O-glycosylations	B-X
,	B-X
and	B-X
sulfation	B-X
of	B-X
the	B-X
carbohydrate	B-X
side	B-X
chains	B-X
.	B-X
Various	B-X
two-chain	B-X
forms	B-X
of	B-X
alpha	B-X
2-HS	B-X
have	B-X
been	B-X
prepared	B-X
from	B-X
human	B-X
plasma	B-X
,	B-X
however	B-X
,	B-X
the	B-X
single-chain	B-X
precursor	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
isolated	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
studied	B-X
the	B-X
biosynthesis	B-X
of	B-X
alpha	B-X
2-HS	B-X
by	B-X
a	B-X
human	B-X
hepatoma	B-X
cell	B-X
line	B-X
,	B-X
HepG2	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
a	B-X
single-chain	B-X
form	B-X
and	B-X
the	B-X
two-chain	B-X
form	B-X
of	B-X
alpha	B-X
2-HS	B-X
are	B-X
secreted	B-X
by	B-X
this	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
alpha	B-X
2-HS	B-X
forms	B-X
are	B-X
further	B-X
modified	B-X
by	B-X
phosphorylation	B-X
on	B-X
multiple	B-X
serine	B-X
residues	B-X
.	B-X
Mapping	B-X
studies	B-X
indicate	B-X
that	B-X
the	B-X
connecting	B-X
peptide	B-X
region	B-X
releasable	B-X
from	B-X
the	B-X
heavy	B-X
chain	B-X
of	B-X
alpha	B-X
2-HS	B-X
contains	B-X
at	B-X
least	B-X
one	B-X
such	B-X
phosphorylation	B-X
site	B-X
.	B-X
Our	B-X
results	B-X
identify	B-X
proteolytic	B-X
trimming	B-X
and/or	B-X
phosphorylation	B-X
as	B-X
modifications	B-X
possibly	B-X
regulating	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
alpha	B-X
2-HS	B-X
and	B-X
the	B-X
homologous	B-X
fetuins	B-X
.	B-X

Evidence	O
for	O
the	O
production	O
of	O
a	O
phosphorylated	O
single	O
-	O
chain	O
form	O
by	O
hepatoma	O
cells	O
.	O
<EOS>	B-X
Native	B-X
alpha	B-X
2-HS	B-X
undergoes	B-X
a	B-X
series	B-X
of	B-X
posttranslational	B-X
modifications	B-X
including	B-X
proteolytic	B-X
processing	B-X
,	B-X
multiple	B-X
N-glycosylations	B-X
and	B-X
O-glycosylations	B-X
,	B-X
and	B-X
sulfation	B-X
of	B-X
the	B-X
carbohydrate	B-X
side	B-X
chains	B-X
.	B-X
Various	B-X
two-chain	B-X
forms	B-X
of	B-X
alpha	B-X
2-HS	B-X
have	B-X
been	B-X
prepared	B-X
from	B-X
human	B-X
plasma	B-X
,	B-X
however	B-X
,	B-X
the	B-X
single-chain	B-X
precursor	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
isolated	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
studied	B-X
the	B-X
biosynthesis	B-X
of	B-X
alpha	B-X
2-HS	B-X
by	B-X
a	B-X
human	B-X
hepatoma	B-X
cell	B-X
line	B-X
,	B-X
HepG2	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
a	B-X
single-chain	B-X
form	B-X
and	B-X
the	B-X
two-chain	B-X
form	B-X
of	B-X
alpha	B-X
2-HS	B-X
are	B-X
secreted	B-X
by	B-X
this	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
alpha	B-X
2-HS	B-X
forms	B-X
are	B-X
further	B-X
modified	B-X
by	B-X
phosphorylation	B-X
on	B-X
multiple	B-X
serine	B-X
residues	B-X
.	B-X
Mapping	B-X
studies	B-X
indicate	B-X
that	B-X
the	B-X
connecting	B-X
peptide	B-X
region	B-X
releasable	B-X
from	B-X
the	B-X
heavy	B-X
chain	B-X
of	B-X
alpha	B-X
2-HS	B-X
contains	B-X
at	B-X
least	B-X
one	B-X
such	B-X
phosphorylation	B-X
site	B-X
.	B-X

alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
glycoprotein	I-Protein
(	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
)	O
is	O
a	O
major	O
protein	O
occurring	O
in	O
human	O
blood	O
and	O
calciferous	O
tissues	O
.	O

Due	O
to	O
extensive	O
sequence	O
identity	O
,	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
has	O
been	O
grouped	O
with	O
the	O
fetuins	O
,	O
a	O
family	O
of	O
proteins	O
that	O
occur	O
in	O
fetal	O
plasma	O
in	O
high	O
concentrations	O
.	O
<EOS>	B-X
alpha	B-X
2-HS	B-X
glycoprotein	B-X
(	B-X
alpha	B-X
2-HS	B-X
)	B-X
is	B-X
a	B-X
major	B-X
protein	B-X
occurring	B-X
in	B-X
human	B-X
blood	B-X
and	B-X
calciferous	B-X
tissues	B-X
.	B-X
Due	B-X
to	B-X
extensive	B-X
sequence	B-X
identity	B-X
,	B-X
alpha	B-X
2-HS	B-X
has	B-X
been	B-X
grouped	B-X
with	B-X
the	B-X
fetuins	B-X
,	B-X
a	B-X
family	B-X
of	B-X
proteins	B-X
that	B-X
occur	B-X
in	B-X
fetal	B-X
plasma	B-X
in	B-X
high	B-X
concentrations	B-X
.	B-X
Native	B-X
alpha	B-X
2-HS	B-X
undergoes	B-X
a	B-X
series	B-X
of	B-X
posttranslational	B-X
modifications	B-X
including	B-X
proteolytic	B-X
processing	B-X
,	B-X
multiple	B-X
N-glycosylations	B-X
and	B-X
O-glycosylations	B-X
,	B-X
and	B-X
sulfation	B-X
of	B-X
the	B-X
carbohydrate	B-X
side	B-X
chains	B-X
.	B-X
Various	B-X
two-chain	B-X
forms	B-X
of	B-X
alpha	B-X
2-HS	B-X
have	B-X
been	B-X
prepared	B-X
from	B-X
human	B-X
plasma	B-X
,	B-X
however	B-X
,	B-X
the	B-X
single-chain	B-X
precursor	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
isolated	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
studied	B-X
the	B-X
biosynthesis	B-X
of	B-X
alpha	B-X
2-HS	B-X
by	B-X
a	B-X
human	B-X
hepatoma	B-X
cell	B-X
line	B-X
,	B-X
HepG2	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
a	B-X
single-chain	B-X
form	B-X
and	B-X
the	B-X
two-chain	B-X
form	B-X
of	B-X
alpha	B-X
2-HS	B-X
are	B-X
secreted	B-X
by	B-X
this	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
alpha	B-X
2-HS	B-X
forms	B-X
are	B-X
further	B-X
modified	B-X
by	B-X
phosphorylation	B-X
on	B-X
multiple	B-X
serine	B-X
residues	B-X
.	B-X
Mapping	B-X
studies	B-X
indicate	B-X
that	B-X
the	B-X
connecting	B-X
peptide	B-X
region	B-X
releasable	B-X
from	B-X
the	B-X
heavy	B-X
chain	B-X
of	B-X
alpha	B-X
2-HS	B-X
contains	B-X
at	B-X
least	B-X
one	B-X
such	B-X
phosphorylation	B-X
site	B-X
.	B-X
Our	B-X
results	B-X
identify	B-X
proteolytic	B-X
trimming	B-X
and/or	B-X
phosphorylation	B-X
as	B-X
modifications	B-X
possibly	B-X
regulating	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
alpha	B-X
2-HS	B-X
and	B-X
the	B-X
homologous	B-X
fetuins	B-X
.	B-X

Native	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
undergoes	O
a	O
series	O
of	O
posttranslational	O
modifications	O
including	O
proteolytic	O
processing	O
,	O
multiple	O
N	O
-	O
glycosylations	O
and	O
O	O
-	O
glycosylations	O
,	O
and	O
sulfation	O
of	O
the	O
carbohydrate	O
side	O
chains	O
.	O

Various	O
two	O
-	O
chain	O
forms	O
of	O
alpha	O
2	O
-	O
HS	O
have	O
been	O
prepared	O
from	O
human	O
plasma	O
,	O
however	O
,	O
the	O
single	O
-	O
chain	O
precursor	O
has	O
not	O
yet	O
been	O
isolated	O
.	O

Here	O
,	O
we	O
have	O
studied	O
the	O
biosynthesis	O
of	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
by	O
a	O
human	O
hepatoma	O
cell	O
line	O
,	O
HepG2	O
.	O
<EOS>	B-X
The	B-X
regulation	B-X
of	B-X
the	B-X
synthesis	B-X
of	B-X
alpha-2-HS	B-X
glycoprotein	B-X
(	B-X
AHSG	B-X
)	B-X
by	B-X
inflammatory	B-X
mediators	B-X
from	B-X
activated	B-X
monocytes	B-X
was	B-X
studied	B-X
on	B-X
the	B-X
human	B-X
hepatoma	B-X
cell	B-X
line	B-X
HepG2	B-X
and	B-X
compared	B-X
to	B-X
that	B-X
of	B-X
albumin	B-X
.	B-X
Monocyte-conditioned	B-X
medium	B-X
,	B-X
recombinant	B-X
human	B-X
interleukin-6	B-X
(	B-X
rhIL6	B-X
)	B-X
and	B-X
interleukin-1	B-X
beta	B-X
(	B-X
rhIL1	B-X
beta	B-X
)	B-X
all	B-X
down-regulated	B-X
the	B-X
synthesis	B-X
of	B-X
AHSG	B-X
.	B-X
The	B-X
combination	B-X
of	B-X
rhIL6	B-X
and	B-X
rhIL1	B-X
beta	B-X
resulted	B-X
in	B-X
an	B-X
additive	B-X
down-regulation	B-X
of	B-X
the	B-X
AHSG	B-X
mRNA	B-X
levels	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
AHSG	B-X
is	B-X
a	B-X
negative	B-X
acute-phase	B-X
protein	B-X
whose	B-X
synthesis	B-X
is	B-X
regulated	B-X
by	B-X
cytokines	B-X
in	B-X
a	B-X
manner	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
albumin	B-X
.	B-X

We	O
demonstrate	O
that	O
a	O
single	O
-	O
chain	O
form	O
and	O
the	O
two	O
-	O
chain	O
form	O
of	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
are	O
secreted	O
by	O
this	O
cell	O
line	O
.	O
<EOS>	B-X
alpha	B-X
2-HS	B-X
glycoprotein	B-X
(	B-X
alpha	B-X
2-HS	B-X
)	B-X
is	B-X
a	B-X
major	B-X
protein	B-X
occurring	B-X
in	B-X
human	B-X
blood	B-X
and	B-X
calciferous	B-X
tissues	B-X
.	B-X
Due	B-X
to	B-X
extensive	B-X
sequence	B-X
identity	B-X
,	B-X
alpha	B-X
2-HS	B-X
has	B-X
been	B-X
grouped	B-X
with	B-X
the	B-X
fetuins	B-X
,	B-X
a	B-X
family	B-X
of	B-X
proteins	B-X
that	B-X
occur	B-X
in	B-X
fetal	B-X
plasma	B-X
in	B-X
high	B-X
concentrations	B-X
.	B-X
Native	B-X
alpha	B-X
2-HS	B-X
undergoes	B-X
a	B-X
series	B-X
of	B-X
posttranslational	B-X
modifications	B-X
including	B-X
proteolytic	B-X
processing	B-X
,	B-X
multiple	B-X
N-glycosylations	B-X
and	B-X
O-glycosylations	B-X
,	B-X
and	B-X
sulfation	B-X
of	B-X
the	B-X
carbohydrate	B-X
side	B-X
chains	B-X
.	B-X
Various	B-X
two-chain	B-X
forms	B-X
of	B-X
alpha	B-X
2-HS	B-X
have	B-X
been	B-X
prepared	B-X
from	B-X
human	B-X
plasma	B-X
,	B-X
however	B-X
,	B-X
the	B-X
single-chain	B-X
precursor	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
isolated	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
studied	B-X
the	B-X
biosynthesis	B-X
of	B-X
alpha	B-X
2-HS	B-X
by	B-X
a	B-X
human	B-X
hepatoma	B-X
cell	B-X
line	B-X
,	B-X
HepG2	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
a	B-X
single-chain	B-X
form	B-X
and	B-X
the	B-X
two-chain	B-X
form	B-X
of	B-X
alpha	B-X
2-HS	B-X
are	B-X
secreted	B-X
by	B-X
this	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
alpha	B-X
2-HS	B-X
forms	B-X
are	B-X
further	B-X
modified	B-X
by	B-X
phosphorylation	B-X
on	B-X
multiple	B-X
serine	B-X
residues	B-X
.	B-X
Mapping	B-X
studies	B-X
indicate	B-X
that	B-X
the	B-X
connecting	B-X
peptide	B-X
region	B-X
releasable	B-X
from	B-X
the	B-X
heavy	B-X
chain	B-X
of	B-X
alpha	B-X
2-HS	B-X
contains	B-X
at	B-X
least	B-X
one	B-X
such	B-X
phosphorylation	B-X
site	B-X
.	B-X
Our	B-X
results	B-X
identify	B-X
proteolytic	B-X
trimming	B-X
and/or	B-X
phosphorylation	B-X
as	B-X
modifications	B-X
possibly	B-X
regulating	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
alpha	B-X
2-HS	B-X
and	B-X
the	B-X
homologous	B-X
fetuins	B-X
.	B-X

The	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
forms	O
are	O
further	O
modified	O
by	O
phosphorylation	O
on	O
multiple	O
serine	O
residues	O
.	O
<EOS>	B-X
alpha	B-X
2-HS	B-X
glycoprotein	B-X
(	B-X
alpha	B-X
2-HS	B-X
)	B-X
is	B-X
a	B-X
major	B-X
protein	B-X
occurring	B-X
in	B-X
human	B-X
blood	B-X
and	B-X
calciferous	B-X
tissues	B-X
.	B-X
Due	B-X
to	B-X
extensive	B-X
sequence	B-X
identity	B-X
,	B-X
alpha	B-X
2-HS	B-X
has	B-X
been	B-X
grouped	B-X
with	B-X
the	B-X
fetuins	B-X
,	B-X
a	B-X
family	B-X
of	B-X
proteins	B-X
that	B-X
occur	B-X
in	B-X
fetal	B-X
plasma	B-X
in	B-X
high	B-X
concentrations	B-X
.	B-X
Native	B-X
alpha	B-X
2-HS	B-X
undergoes	B-X
a	B-X
series	B-X
of	B-X
posttranslational	B-X
modifications	B-X
including	B-X
proteolytic	B-X
processing	B-X
,	B-X
multiple	B-X
N-glycosylations	B-X
and	B-X
O-glycosylations	B-X
,	B-X
and	B-X
sulfation	B-X
of	B-X
the	B-X
carbohydrate	B-X
side	B-X
chains	B-X
.	B-X
Various	B-X
two-chain	B-X
forms	B-X
of	B-X
alpha	B-X
2-HS	B-X
have	B-X
been	B-X
prepared	B-X
from	B-X
human	B-X
plasma	B-X
,	B-X
however	B-X
,	B-X
the	B-X
single-chain	B-X
precursor	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
isolated	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
studied	B-X
the	B-X
biosynthesis	B-X
of	B-X
alpha	B-X
2-HS	B-X
by	B-X
a	B-X
human	B-X
hepatoma	B-X
cell	B-X
line	B-X
,	B-X
HepG2	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
a	B-X
single-chain	B-X
form	B-X
and	B-X
the	B-X
two-chain	B-X
form	B-X
of	B-X
alpha	B-X
2-HS	B-X
are	B-X
secreted	B-X
by	B-X
this	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
alpha	B-X
2-HS	B-X
forms	B-X
are	B-X
further	B-X
modified	B-X
by	B-X
phosphorylation	B-X
on	B-X
multiple	B-X
serine	B-X
residues	B-X
.	B-X
Mapping	B-X
studies	B-X
indicate	B-X
that	B-X
the	B-X
connecting	B-X
peptide	B-X
region	B-X
releasable	B-X
from	B-X
the	B-X
heavy	B-X
chain	B-X
of	B-X
alpha	B-X
2-HS	B-X
contains	B-X
at	B-X
least	B-X
one	B-X
such	B-X
phosphorylation	B-X
site	B-X
.	B-X
Our	B-X
results	B-X
identify	B-X
proteolytic	B-X
trimming	B-X
and/or	B-X
phosphorylation	B-X
as	B-X
modifications	B-X
possibly	B-X
regulating	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
alpha	B-X
2-HS	B-X
and	B-X
the	B-X
homologous	B-X
fetuins	B-X
.	B-X

Mapping	O
studies	O
indicate	O
that	O
the	O
connecting	O
peptide	O
region	O
releasable	O
from	O
the	O
heavy	O
chain	O
of	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
contains	O
at	O
least	O
one	O
such	O
phosphorylation	O
site	O
.	O
<EOS>	B-X
alpha	B-X
2-HS	B-X
glycoprotein	B-X
(	B-X
alpha	B-X
2-HS	B-X
)	B-X
is	B-X
a	B-X
major	B-X
protein	B-X
occurring	B-X
in	B-X
human	B-X
blood	B-X
and	B-X
calciferous	B-X
tissues	B-X
.	B-X
Due	B-X
to	B-X
extensive	B-X
sequence	B-X
identity	B-X
,	B-X
alpha	B-X
2-HS	B-X
has	B-X
been	B-X
grouped	B-X
with	B-X
the	B-X
fetuins	B-X
,	B-X
a	B-X
family	B-X
of	B-X
proteins	B-X
that	B-X
occur	B-X
in	B-X
fetal	B-X
plasma	B-X
in	B-X
high	B-X
concentrations	B-X
.	B-X
Native	B-X
alpha	B-X
2-HS	B-X
undergoes	B-X
a	B-X
series	B-X
of	B-X
posttranslational	B-X
modifications	B-X
including	B-X
proteolytic	B-X
processing	B-X
,	B-X
multiple	B-X
N-glycosylations	B-X
and	B-X
O-glycosylations	B-X
,	B-X
and	B-X
sulfation	B-X
of	B-X
the	B-X
carbohydrate	B-X
side	B-X
chains	B-X
.	B-X
Various	B-X
two-chain	B-X
forms	B-X
of	B-X
alpha	B-X
2-HS	B-X
have	B-X
been	B-X
prepared	B-X
from	B-X
human	B-X
plasma	B-X
,	B-X
however	B-X
,	B-X
the	B-X
single-chain	B-X
precursor	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
isolated	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
studied	B-X
the	B-X
biosynthesis	B-X
of	B-X
alpha	B-X
2-HS	B-X
by	B-X
a	B-X
human	B-X
hepatoma	B-X
cell	B-X
line	B-X
,	B-X
HepG2	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
a	B-X
single-chain	B-X
form	B-X
and	B-X
the	B-X
two-chain	B-X
form	B-X
of	B-X
alpha	B-X
2-HS	B-X
are	B-X
secreted	B-X
by	B-X
this	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
alpha	B-X
2-HS	B-X
forms	B-X
are	B-X
further	B-X
modified	B-X
by	B-X
phosphorylation	B-X
on	B-X
multiple	B-X
serine	B-X
residues	B-X
.	B-X
Mapping	B-X
studies	B-X
indicate	B-X
that	B-X
the	B-X
connecting	B-X
peptide	B-X
region	B-X
releasable	B-X
from	B-X
the	B-X
heavy	B-X
chain	B-X
of	B-X
alpha	B-X
2-HS	B-X
contains	B-X
at	B-X
least	B-X
one	B-X
such	B-X
phosphorylation	B-X
site	B-X
.	B-X
Our	B-X
results	B-X
identify	B-X
proteolytic	B-X
trimming	B-X
and/or	B-X
phosphorylation	B-X
as	B-X
modifications	B-X
possibly	B-X
regulating	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
alpha	B-X
2-HS	B-X
and	B-X
the	B-X
homologous	B-X
fetuins	B-X
.	B-X

Our	O
results	O
identify	O
proteolytic	O
trimming	O
and	O
/	O
or	O
phosphorylation	O
as	O
modifications	O
possibly	O
regulating	O
the	O
biological	O
effects	O
of	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
and	O
the	O
homologous	O
fetuins	O
.	O
<EOS>	B-X
Amyloid	B-X
beta	B-X
peptides	B-X
(	B-X
As	B-X
)	B-X
are	B-X
generated	B-X
from	B-X
amyloid	B-X
precursor	B-X
protein	B-X
(	B-X
APP	B-X
)	B-X
through	B-X
multiple	B-X
cleavage	B-X
steps	B-X
mediated	B-X
by	B-X
-secretase	B-X
,	B-X
including	B-X
endoproteolysis	B-X
and	B-X
carboxypeptidase-like	B-X
trimming	B-X
.	B-X
The	B-X
generation	B-X
of	B-X
neurotoxic	B-X
A42/43	B-X
species	B-X
is	B-X
enhanced	B-X
by	B-X
familial	B-X
Alzheimer	B-X
's	B-X
disease	B-X
(	B-X
FAD	B-X
)	B-X
mutations	B-X
within	B-X
the	B-X
catalytic	B-X
subunit	B-X
of	B-X
-secretase	B-X
,	B-X
presenilin	B-X
1	B-X
(	B-X
PS1	B-X
)	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
insights	B-X
into	B-X
the	B-X
regulatory	B-X
function	B-X
of	B-X
Aph1	B-X
in	B-X
-secretase	B-X
activity	B-X
.	B-X
Together	B-X
with	B-X
activation	B-X
of	B-X
costimulatory	B-X
molecules	B-X
like	B-X
CD3	B-X
and	B-X
CD28	B-X
,	B-X
CD8	B-X
(	B-X
+	B-X
)	B-X
T	B-X
cells	B-X
need	B-X
activation	B-X
of	B-X
their	B-X
unique	B-X
T	B-X
cell	B-X
receptor	B-X
via	B-X
recognition	B-X
of	B-X
foreign	B-X
peptide	B-X
epitopes	B-X
in	B-X
combination	B-X
with	B-X
major	B-X
histocompatibility	B-X
complexes	B-X
class	B-X
I	B-X
on	B-X
the	B-X
cell	B-X
surface	B-X
of	B-X
professional	B-X
antigen-presenting	B-X
cells	B-X
.	B-X
Presentation	B-X
of	B-X
pathogen-associated	B-X
proteins	B-X
is	B-X
the	B-X
result	B-X
of	B-X
a	B-X
complex	B-X
proteolytic	B-X
process	B-X
.	B-X
It	B-X
starts	B-X
with	B-X
the	B-X
breakdown	B-X
of	B-X
proteins	B-X
by	B-X
a	B-X
cytosolic	B-X
endopeptidase	B-X
,	B-X
the	B-X
proteasome	B-X
,	B-X
and	B-X
is	B-X
continued	B-X
by	B-X
subsequent	B-X
N-terminal	B-X
trimming	B-X
events	B-X
in	B-X
the	B-X
cytosol	B-X
and/or	B-X
the	B-X
endoplasmic	B-X
reticulum	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
proteolytic	B-X
aminopeptidase	B-X
activity	B-X
in	B-X
the	B-X
former	B-X
cellular	B-X
compartment	B-X
showed	B-X
that	B-X
the	B-X
cytosol	B-X
harbors	B-X
a	B-X
multitude	B-X
of	B-X
aminopeptidases	B-X
that	B-X
have	B-X
singular	B-X
specificities	B-X
,	B-X
but	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
also	B-X
show	B-X
redundancy	B-X
in	B-X
the	B-X
trimming	B-X
of	B-X
N-terminal	B-X
residues	B-X
.	B-X
The	B-X
observed	B-X
pattern	B-X
of	B-X
the	B-X
overall	B-X
trimming	B-X
in	B-X
the	B-X
cytosol	B-X
is	B-X
reflected	B-X
by	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
four	B-X
identified	B-X
aminopeptidases	B-X
,	B-X
and	B-X
the	B-X
administration	B-X
of	B-X
protease	B-X
inhibitors	B-X
made	B-X
it	B-X
possible	B-X
to	B-X
assign	B-X
specificity	B-X
of	B-X
cleaving	B-X
of	B-X
proteinogenic	B-X
amino	B-X
acids	B-X
to	B-X
one	B-X
or	B-X
more	B-X
identified	B-X
aminopeptidase	B-X
.	B-X

P	B-Protein
-	I-Protein
selectin	I-Protein
is	O
acylated	O
with	O
palmitic	O
acid	O
and	O
stearic	O
acid	O
at	O
cysteine	O
766	O
through	O
a	O
thioester	O
linkage	O
.	O
<EOS>	B-X
We	B-X
report	B-X
that	B-X
the	B-X
adhesion	B-X
receptor	B-X
P-selectin	B-X
can	B-X
be	B-X
metabolically	B-X
labeled	B-X
with	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
in	B-X
human	B-X
platelets	B-X
.	B-X
Analysis	B-X
of	B-X
alkaline	B-X
methanolysis	B-X
products	B-X
from	B-X
labeled	B-X
protein	B-X
demonstrated	B-X
that	B-X
the	B-X
radioactivity	B-X
associated	B-X
with	B-X
P-selectin	B-X
was	B-X
covalently	B-X
bound	B-X
palmitic	B-X
acid	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Palmitic	B-X
acid	B-X
was	B-X
cleaved	B-X
by	B-X
hydroxylamine	B-X
treatment	B-X
at	B-X
neutral	B-X
pH	B-X
and	B-X
by	B-X
reducing	B-X
agents	B-X
,	B-X
indicating	B-X
that	B-X
acylation	B-X
occurred	B-X
through	B-X
a	B-X
thioester	B-X
linkage	B-X
.	B-X
Both	B-X
stearic	B-X
acid	B-X
and	B-X
palmitic	B-X
acid	B-X
were	B-X
detected	B-X
by	B-X
gas	B-X
chromatography-mass	B-X
spectrometry	B-X
analysis	B-X
of	B-X
alkaline	B-X
hydrolysates	B-X
of	B-X
purified	B-X
P-selectin	B-X
.	B-X
Deletion	B-X
or	B-X
mutation	B-X
of	B-X
Cys766	B-X
eliminated	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
labeling	B-X
of	B-X
P-selectin	B-X
in	B-X
transfected	B-X
COS-7	B-X
cells	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
cytoplasmic	B-X
domain	B-X
of	B-X
P-selectin	B-X
is	B-X
acylated	B-X
at	B-X
Cys766	B-X
through	B-X
a	B-X
thioester	B-X
bond	B-X
.	B-X
Fatty	B-X
acid	B-X
acylation	B-X
may	B-X
regulate	B-X
intracellular	B-X
trafficking	B-X
or	B-X
other	B-X
functions	B-X
of	B-X
P-selectin	B-X
.	B-X

We	O
report	O
that	O
the	O
adhesion	O
receptor	O
P	B-Protein
-	I-Protein
selectin	I-Protein
can	O
be	O
metabolically	O
labeled	O
with	O
[	O
3H	O
]	O
palmitic	O
acid	O
in	O
human	O
platelets	O
.	O
<EOS>	B-X
We	B-X
report	B-X
that	B-X
the	B-X
adhesion	B-X
receptor	B-X
P-selectin	B-X
can	B-X
be	B-X
metabolically	B-X
labeled	B-X
with	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
in	B-X
human	B-X
platelets	B-X
.	B-X
Analysis	B-X
of	B-X
alkaline	B-X
methanolysis	B-X
products	B-X
from	B-X
labeled	B-X
protein	B-X
demonstrated	B-X
that	B-X
the	B-X
radioactivity	B-X
associated	B-X
with	B-X
P-selectin	B-X
was	B-X
covalently	B-X
bound	B-X
palmitic	B-X
acid	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Palmitic	B-X
acid	B-X
was	B-X
cleaved	B-X
by	B-X
hydroxylamine	B-X
treatment	B-X
at	B-X
neutral	B-X
pH	B-X
and	B-X
by	B-X
reducing	B-X
agents	B-X
,	B-X
indicating	B-X
that	B-X
acylation	B-X
occurred	B-X
through	B-X
a	B-X
thioester	B-X
linkage	B-X
.	B-X
Both	B-X
stearic	B-X
acid	B-X
and	B-X
palmitic	B-X
acid	B-X
were	B-X
detected	B-X
by	B-X
gas	B-X
chromatography-mass	B-X
spectrometry	B-X
analysis	B-X
of	B-X
alkaline	B-X
hydrolysates	B-X
of	B-X
purified	B-X
P-selectin	B-X
.	B-X
Deletion	B-X
or	B-X
mutation	B-X
of	B-X
Cys766	B-X
eliminated	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
labeling	B-X
of	B-X
P-selectin	B-X
in	B-X
transfected	B-X
COS-7	B-X
cells	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
cytoplasmic	B-X
domain	B-X
of	B-X
P-selectin	B-X
is	B-X
acylated	B-X
at	B-X
Cys766	B-X
through	B-X
a	B-X
thioester	B-X
bond	B-X
.	B-X
Fatty	B-X
acid	B-X
acylation	B-X
may	B-X
regulate	B-X
intracellular	B-X
trafficking	B-X
or	B-X
other	B-X
functions	B-X
of	B-X
P-selectin	B-X
.	B-X

Analysis	O
of	O
alkaline	O
methanolysis	O
products	O
from	O
labeled	O
protein	O
demonstrated	O
that	O
the	O
radioactivity	O
associated	O
with	O
P	B-Protein
-	I-Protein
selectin	I-Protein
was	O
covalently	O
bound	O
palmitic	O
acid	O
.	O

[	O
3H	O
]	O
Palmitic	O
acid	O
was	O
cleaved	O
by	O
hydroxylamine	O
treatment	O
at	O
neutral	O
pH	O
and	O
by	O
reducing	O
agents	O
,	O
indicating	O
that	O
acylation	O
occurred	O
through	O
a	O
thioester	O
linkage	O
.	O
<EOS>	B-X
We	B-X
report	B-X
that	B-X
the	B-X
adhesion	B-X
receptor	B-X
P-selectin	B-X
can	B-X
be	B-X
metabolically	B-X
labeled	B-X
with	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
in	B-X
human	B-X
platelets	B-X
.	B-X
Analysis	B-X
of	B-X
alkaline	B-X
methanolysis	B-X
products	B-X
from	B-X
labeled	B-X
protein	B-X
demonstrated	B-X
that	B-X
the	B-X
radioactivity	B-X
associated	B-X
with	B-X
P-selectin	B-X
was	B-X
covalently	B-X
bound	B-X
palmitic	B-X
acid	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Palmitic	B-X
acid	B-X
was	B-X
cleaved	B-X
by	B-X
hydroxylamine	B-X
treatment	B-X
at	B-X
neutral	B-X
pH	B-X
and	B-X
by	B-X
reducing	B-X
agents	B-X
,	B-X
indicating	B-X
that	B-X
acylation	B-X
occurred	B-X
through	B-X
a	B-X
thioester	B-X
linkage	B-X
.	B-X
Both	B-X
stearic	B-X
acid	B-X
and	B-X
palmitic	B-X
acid	B-X
were	B-X
detected	B-X
by	B-X
gas	B-X
chromatography-mass	B-X
spectrometry	B-X
analysis	B-X
of	B-X
alkaline	B-X
hydrolysates	B-X
of	B-X
purified	B-X
P-selectin	B-X
.	B-X
Deletion	B-X
or	B-X
mutation	B-X
of	B-X
Cys766	B-X
eliminated	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
labeling	B-X
of	B-X
P-selectin	B-X
in	B-X
transfected	B-X
COS-7	B-X
cells	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
cytoplasmic	B-X
domain	B-X
of	B-X
P-selectin	B-X
is	B-X
acylated	B-X
at	B-X
Cys766	B-X
through	B-X
a	B-X
thioester	B-X
bond	B-X
.	B-X
Fatty	B-X
acid	B-X
acylation	B-X
may	B-X
regulate	B-X
intracellular	B-X
trafficking	B-X
or	B-X
other	B-X
functions	B-X
of	B-X
P-selectin	B-X
.	B-X

Both	O
stearic	O
acid	O
and	O
palmitic	O
acid	O
were	O
detected	O
by	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
analysis	O
of	O
alkaline	O
hydrolysates	O
of	O
purified	O
P	B-Protein
-	I-Protein
selectin	I-Protein
.	O
<EOS>	B-X
We	B-X
report	B-X
that	B-X
the	B-X
adhesion	B-X
receptor	B-X
P-selectin	B-X
can	B-X
be	B-X
metabolically	B-X
labeled	B-X
with	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
in	B-X
human	B-X
platelets	B-X
.	B-X
Analysis	B-X
of	B-X
alkaline	B-X
methanolysis	B-X
products	B-X
from	B-X
labeled	B-X
protein	B-X
demonstrated	B-X
that	B-X
the	B-X
radioactivity	B-X
associated	B-X
with	B-X
P-selectin	B-X
was	B-X
covalently	B-X
bound	B-X
palmitic	B-X
acid	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Palmitic	B-X
acid	B-X
was	B-X
cleaved	B-X
by	B-X
hydroxylamine	B-X
treatment	B-X
at	B-X
neutral	B-X
pH	B-X
and	B-X
by	B-X
reducing	B-X
agents	B-X
,	B-X
indicating	B-X
that	B-X
acylation	B-X
occurred	B-X
through	B-X
a	B-X
thioester	B-X
linkage	B-X
.	B-X
Both	B-X
stearic	B-X
acid	B-X
and	B-X
palmitic	B-X
acid	B-X
were	B-X
detected	B-X
by	B-X
gas	B-X
chromatography-mass	B-X
spectrometry	B-X
analysis	B-X
of	B-X
alkaline	B-X
hydrolysates	B-X
of	B-X
purified	B-X
P-selectin	B-X
.	B-X
Deletion	B-X
or	B-X
mutation	B-X
of	B-X
Cys766	B-X
eliminated	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
labeling	B-X
of	B-X
P-selectin	B-X
in	B-X
transfected	B-X
COS-7	B-X
cells	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
cytoplasmic	B-X
domain	B-X
of	B-X
P-selectin	B-X
is	B-X
acylated	B-X
at	B-X
Cys766	B-X
through	B-X
a	B-X
thioester	B-X
bond	B-X
.	B-X
Fatty	B-X
acid	B-X
acylation	B-X
may	B-X
regulate	B-X
intracellular	B-X
trafficking	B-X
or	B-X
other	B-X
functions	B-X
of	B-X
P-selectin	B-X
.	B-X

Deletion	O
or	O
mutation	O
of	O
Cys766	O
eliminated	O
[	O
3H	O
]	O
palmitic	O
acid	O
labeling	O
of	O
P	B-Protein
-	I-Protein
selectin	I-Protein
in	O
transfected	O
COS	O
-	O
7	O
cells	O
.	O
<EOS>	B-X
Open-reading	B-X
frame	B-X
coding	B-X
regions	B-X
were	B-X
replaced	B-X
with	B-X
a	B-X
kanamycin	B-X
cassette	B-X
flanked	B-X
by	B-X
FLP	B-X
recognition	B-X
target	B-X
sites	B-X
by	B-X
using	B-X
a	B-X
one-step	B-X
method	B-X
for	B-X
inactivation	B-X
of	B-X
chromosomal	B-X
genes	B-X
and	B-X
primers	B-X
designed	B-X
to	B-X
create	B-X
in-frame	B-X
deletions	B-X
upon	B-X
excision	B-X
of	B-X
the	B-X
resistance	B-X
cassette	B-X
.	B-X
These	B-X
mutants-the	B-X
'Keio	B-X
collection'-provide	B-X
a	B-X
new	B-X
resource	B-X
not	B-X
only	B-X
for	B-X
systematic	B-X
analyses	B-X
of	B-X
unknown	B-X
gene	B-X
functions	B-X
and	B-X
gene	B-X
regulatory	B-X
networks	B-X
but	B-X
also	B-X
for	B-X
genome-wide	B-X
testing	B-X
of	B-X
mutational	B-X
effects	B-X
in	B-X
a	B-X
common	B-X
strain	B-X
background	B-X
,	B-X
E.	B-X
coli	B-X
K-12	B-X
BW25113	B-X
.	B-X
We	B-X
were	B-X
unable	B-X
to	B-X
disrupt	B-X
303	B-X
genes	B-X
,	B-X
including	B-X
37	B-X
of	B-X
unknown	B-X
function	B-X
,	B-X
which	B-X
are	B-X
candidates	B-X
for	B-X
essential	B-X
genes	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
budding	B-X
yeast	B-X
to	B-X
undergo	B-X
efficient	B-X
homologous	B-X
recombination	B-X
with	B-X
short	B-X
stretches	B-X
of	B-X
sequence	B-X
homology	B-X
has	B-X
led	B-X
to	B-X
an	B-X
explosion	B-X
of	B-X
PCR-based	B-X
methods	B-X
to	B-X
delete	B-X
and	B-X
mutate	B-X
yeast	B-X
genes	B-X
and	B-X
to	B-X
create	B-X
fusions	B-X
to	B-X
epitope	B-X
tags	B-X
and	B-X
fluorescent	B-X
proteins	B-X
.	B-X

We	O
conclude	O
that	O
the	O
cytoplasmic	O
domain	O
of	O
P	B-Protein
-	I-Protein
selectin	I-Protein
is	O
acylated	O
at	O
Cys766	O
through	O
a	O
thioester	O
bond	O
.	O
<EOS>	B-X
We	B-X
report	B-X
that	B-X
the	B-X
adhesion	B-X
receptor	B-X
P-selectin	B-X
can	B-X
be	B-X
metabolically	B-X
labeled	B-X
with	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
in	B-X
human	B-X
platelets	B-X
.	B-X
Analysis	B-X
of	B-X
alkaline	B-X
methanolysis	B-X
products	B-X
from	B-X
labeled	B-X
protein	B-X
demonstrated	B-X
that	B-X
the	B-X
radioactivity	B-X
associated	B-X
with	B-X
P-selectin	B-X
was	B-X
covalently	B-X
bound	B-X
palmitic	B-X
acid	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Palmitic	B-X
acid	B-X
was	B-X
cleaved	B-X
by	B-X
hydroxylamine	B-X
treatment	B-X
at	B-X
neutral	B-X
pH	B-X
and	B-X
by	B-X
reducing	B-X
agents	B-X
,	B-X
indicating	B-X
that	B-X
acylation	B-X
occurred	B-X
through	B-X
a	B-X
thioester	B-X
linkage	B-X
.	B-X
Both	B-X
stearic	B-X
acid	B-X
and	B-X
palmitic	B-X
acid	B-X
were	B-X
detected	B-X
by	B-X
gas	B-X
chromatography-mass	B-X
spectrometry	B-X
analysis	B-X
of	B-X
alkaline	B-X
hydrolysates	B-X
of	B-X
purified	B-X
P-selectin	B-X
.	B-X
Deletion	B-X
or	B-X
mutation	B-X
of	B-X
Cys766	B-X
eliminated	B-X
[	B-X
3H	B-X
]	B-X
palmitic	B-X
acid	B-X
labeling	B-X
of	B-X
P-selectin	B-X
in	B-X
transfected	B-X
COS-7	B-X
cells	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
cytoplasmic	B-X
domain	B-X
of	B-X
P-selectin	B-X
is	B-X
acylated	B-X
at	B-X
Cys766	B-X
through	B-X
a	B-X
thioester	B-X
bond	B-X
.	B-X
Fatty	B-X
acid	B-X
acylation	B-X
may	B-X
regulate	B-X
intracellular	B-X
trafficking	B-X
or	B-X
other	B-X
functions	B-X
of	B-X
P-selectin	B-X
.	B-X

Fatty	O
acid	O
acylation	O
may	O
regulate	O
intracellular	O
trafficking	O
or	O
other	O
functions	O
of	O
P	B-Protein
-	I-Protein
selectin	I-Protein
.	O
<EOS>	B-X
The	B-X
up-regulation	B-X
of	B-X
P-selectin	B-X
in	B-X
endothelial	B-X
cells	B-X
and	B-X
platelets	B-X
contributes	B-X
to	B-X
the	B-X
cell-cell	B-X
interactions	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
vaso-occlusion	B-X
and	B-X
sickle	B-X
cell-related	B-X
pain	B-X
crises	B-X
.	B-X
The	B-X
safety	B-X
and	B-X
efficacy	B-X
of	B-X
crizanlizumab	B-X
,	B-X
an	B-X
antibody	B-X
against	B-X
the	B-X
adhesion	B-X
molecule	B-X
P-selectin	B-X
,	B-X
were	B-X
evaluated	B-X
in	B-X
patients	B-X
with	B-X
sickle	B-X
cell	B-X
disease	B-X
.	B-X
Protein	B-X
S-acylation	B-X
,	B-X
the	B-X
only	B-X
fully	B-X
reversible	B-X
posttranslational	B-X
lipid	B-X
modification	B-X
of	B-X
proteins	B-X
,	B-X
is	B-X
emerging	B-X
as	B-X
a	B-X
ubiquitous	B-X
mechanism	B-X
to	B-X
control	B-X
the	B-X
properties	B-X
and	B-X
function	B-X
of	B-X
a	B-X
diverse	B-X
array	B-X
of	B-X
proteins	B-X
and	B-X
consequently	B-X
physiological	B-X
processes	B-X
.	B-X
S-acylation	B-X
results	B-X
from	B-X
the	B-X
enzymatic	B-X
addition	B-X
of	B-X
long-chain	B-X
lipids	B-X
,	B-X
most	B-X
typically	B-X
palmitate	B-X
,	B-X
onto	B-X
intracellular	B-X
cysteine	B-X
residues	B-X
of	B-X
soluble	B-X
and	B-X
transmembrane	B-X
proteins	B-X
via	B-X
a	B-X
labile	B-X
thioester	B-X
linkage	B-X
.	B-X
Addition	B-X
of	B-X
lipid	B-X
results	B-X
in	B-X
increases	B-X
in	B-X
protein	B-X
hydrophobicity	B-X
that	B-X
can	B-X
impact	B-X
on	B-X
protein	B-X
structure	B-X
,	B-X
assembly	B-X
,	B-X
maturation	B-X
,	B-X
trafficking	B-X
,	B-X
and	B-X
function	B-X
.	B-X
The	B-X
recent	B-X
explosion	B-X
in	B-X
global	B-X
S-acylation	B-X
(	B-X
palmitoyl	B-X
)	B-X
proteomic	B-X
profiling	B-X
as	B-X
a	B-X
result	B-X
of	B-X
improved	B-X
biochemical	B-X
tools	B-X
to	B-X
assay	B-X
S-acylation	B-X
,	B-X
in	B-X
conjunction	B-X
with	B-X
the	B-X
recent	B-X
identification	B-X
of	B-X
enzymes	B-X
that	B-X
control	B-X
protein	B-X
S-acylation	B-X
and	B-X
de-acylation	B-X
,	B-X
has	B-X
opened	B-X
a	B-X
new	B-X
vista	B-X
into	B-X
the	B-X
physiological	B-X
function	B-X
of	B-X
S-acylation	B-X
.	B-X
This	B-X
review	B-X
introduces	B-X
key	B-X
features	B-X
of	B-X
S-acylation	B-X
and	B-X
tools	B-X
to	B-X
interrogate	B-X
this	B-X
process	B-X
,	B-X
and	B-X
highlights	B-X
the	B-X
eclectic	B-X
array	B-X
of	B-X
proteins	B-X
regulated	B-X
including	B-X
membrane	B-X
receptors	B-X
,	B-X
ion	B-X
channels	B-X
and	B-X
transporters	B-X
,	B-X
enzymes	B-X
and	B-X
kinases	B-X
,	B-X
signaling	B-X
adapters	B-X
and	B-X
chaperones	B-X
,	B-X
cell	B-X
adhesion	B-X
,	B-X
and	B-X
structural	B-X
proteins	B-X
.	B-X
We	B-X
highlight	B-X
recent	B-X
findings	B-X
correlating	B-X
disruption	B-X
of	B-X
S-acylation	B-X
to	B-X
pathophysiology	B-X
and	B-X
disease	B-X
and	B-X
discuss	B-X
some	B-X
of	B-X
the	B-X
major	B-X
challenges	B-X
and	B-X
opportunities	B-X
in	B-X
this	B-X
rapidly	B-X
expanding	B-X
field	B-X
.	B-X

ADP	O
ribosylation	O
factor	O
and	O
a	O
14	O
-	O
kD	O
polypeptide	O
are	O
associated	O
with	O
heparan	O
sulfate	O
-	O
carrying	O
post	O
-	O
trans	O
-	O
Golgi	O
network	O
secretory	O
vesicles	O
in	O
rat	O
hepatocytes	O
.	O

Constitutive	O
secretory	O
vesicles	O
carrying	O
heparan	B-Protein
sulfate	I-Protein
proteoglycan	I-Protein
(	O
HSPG	B-Protein
)	O
were	O
identified	O
in	O
isolated	O
rat	O
hepatocytes	O
by	O
pulse	O
-	O
chase	O
experiments	O
with	O
[	O
35S	O
]	O
sulfate	O
and	O
purified	O
by	O
velocity	O
-	O
controlled	O
sucrose	O
gradient	O
centrifugation	O
followed	O
by	O
equilibrium	O
density	O
centrifugation	O
in	O
Nycodenz	O
.	O
<EOS>	B-X
Constitutive	B-X
secretory	B-X
vesicles	B-X
carrying	B-X
heparan	B-X
sulfate	B-X
proteoglycan	B-X
(	B-X
HSPG	B-X
)	B-X
were	B-X
identified	B-X
in	B-X
isolated	B-X
rat	B-X
hepatocytes	B-X
by	B-X
pulse-chase	B-X
experiments	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
and	B-X
purified	B-X
by	B-X
velocity-controlled	B-X
sucrose	B-X
gradient	B-X
centrifugation	B-X
followed	B-X
by	B-X
equilibrium	B-X
density	B-X
centrifugation	B-X
in	B-X
Nycodenz	B-X
.	B-X
Using	B-X
this	B-X
procedure	B-X
,	B-X
the	B-X
vesicles	B-X
were	B-X
separated	B-X
from	B-X
plasma	B-X
membranes	B-X
,	B-X
Golgi	B-X
,	B-X
trans-Golgi	B-X
network	B-X
(	B-X
TGN	B-X
)	B-X
,	B-X
ER	B-X
,	B-X
endosomes	B-X
,	B-X
lysosomes	B-X
,	B-X
transcytotic	B-X
vesicles	B-X
,	B-X
and	B-X
mitochondria	B-X
.	B-X
The	B-X
diameter	B-X
of	B-X
these	B-X
vesicles	B-X
was	B-X
approximately	B-X
100-200	B-X
nm	B-X
as	B-X
determined	B-X
by	B-X
electron	B-X
microscopy	B-X
.	B-X
A	B-X
typical	B-X
coat	B-X
structure	B-X
as	B-X
described	B-X
for	B-X
intra-Golgi	B-X
transport	B-X
vesicles	B-X
or	B-X
clathrin-coated	B-X
vesicles	B-X
could	B-X
not	B-X
be	B-X
seen	B-X
,	B-X
and	B-X
the	B-X
vesicles	B-X
were	B-X
not	B-X
associated	B-X
with	B-X
the	B-X
coat	B-X
protein	B-X
beta-COP	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
vesicles	B-X
appear	B-X
to	B-X
represent	B-X
a	B-X
low	B-X
density	B-X
compartment	B-X
(	B-X
1.05-1.06	B-X
g/ml	B-X
)	B-X
.	B-X
Other	B-X
constitutively	B-X
secreted	B-X
proteins	B-X
(	B-X
rat	B-X
serum	B-X
albumin	B-X
,	B-X
apolipoprotein	B-X
E	B-X
,	B-X
and	B-X
fibrinogen	B-X
)	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
purified	B-X
HSPG-carrying	B-X
vesicles	B-X
,	B-X
but	B-X
banded	B-X
in	B-X
the	B-X
denser	B-X
fractions	B-X
of	B-X
the	B-X
Nycodenz	B-X
gradient	B-X
.	B-X
Moreover	B-X
,	B-X
during	B-X
pulse-chase	B-X
labeling	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
methionine	B-X
,	B-X
labeled	B-X
albumin	B-X
did	B-X
not	B-X
appear	B-X
in	B-X
the	B-X
post-TGN	B-X
vesicle	B-X
fraction	B-X
carrying	B-X
HSPGs	B-X
.	B-X
These	B-X
findings	B-X
indicate	B-X
sorting	B-X
of	B-X
HSPGs	B-X
and	B-X
albumin	B-X
into	B-X
different	B-X
types	B-X
of	B-X
constitutive	B-X
secretory	B-X
vesicles	B-X
in	B-X
hepatocytes	B-X
.	B-X
Two	B-X
proteins	B-X
were	B-X
found	B-X
to	B-X
be	B-X
tightly	B-X
associated	B-X
with	B-X
the	B-X
membranes	B-X
of	B-X
the	B-X
HSPG	B-X
carrying	B-X
vesicles	B-X
:	B-X
a	B-X
member	B-X
of	B-X
the	B-X
ADP	B-X
ribosylation	B-X
factor	B-X
family	B-X
of	B-X
small	B-X
guanine	B-X
nucleotide-binding	B-X
proteins	B-X
and	B-X
an	B-X
unknown	B-X
14-kD	B-X
peripheral	B-X
membrane	B-X
protein	B-X
(	B-X
VAPP14	B-X
)	B-X
.	B-X
Concerning	B-X
the	B-X
secretory	B-X
pathway	B-X
,	B-X
we	B-X
conclude	B-X
from	B-X
these	B-X
results	B-X
that	B-X
ADP	B-X
ribosylation	B-X
factor	B-X
proteins	B-X
are	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
vesicular	B-X
transport	B-X
from	B-X
the	B-X
ER	B-X
via	B-X
the	B-X
Golgi	B-X
to	B-X
the	B-X
TGN	B-X
,	B-X
but	B-X
also	B-X
in	B-X
vesicular	B-X
transport	B-X
from	B-X
the	B-X
TGN	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

Using	O
this	O
procedure	O
,	O
the	O
vesicles	O
were	O
separated	O
from	O
plasma	O
membranes	O
,	O
Golgi	O
,	O
trans	O
-	O
Golgi	O
network	O
(	O
TGN	O
)	O
,	O
ER	O
,	O
endosomes	O
,	O
lysosomes	O
,	O
transcytotic	O
vesicles	O
,	O
and	O
mitochondria	O
.	O
<EOS>	B-X
Constitutive	B-X
secretory	B-X
vesicles	B-X
carrying	B-X
heparan	B-X
sulfate	B-X
proteoglycan	B-X
(	B-X
HSPG	B-X
)	B-X
were	B-X
identified	B-X
in	B-X
isolated	B-X
rat	B-X
hepatocytes	B-X
by	B-X
pulse-chase	B-X
experiments	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
and	B-X
purified	B-X
by	B-X
velocity-controlled	B-X
sucrose	B-X
gradient	B-X
centrifugation	B-X
followed	B-X
by	B-X
equilibrium	B-X
density	B-X
centrifugation	B-X
in	B-X
Nycodenz	B-X
.	B-X
Using	B-X
this	B-X
procedure	B-X
,	B-X
the	B-X
vesicles	B-X
were	B-X
separated	B-X
from	B-X
plasma	B-X
membranes	B-X
,	B-X
Golgi	B-X
,	B-X
trans-Golgi	B-X
network	B-X
(	B-X
TGN	B-X
)	B-X
,	B-X
ER	B-X
,	B-X
endosomes	B-X
,	B-X
lysosomes	B-X
,	B-X
transcytotic	B-X
vesicles	B-X
,	B-X
and	B-X
mitochondria	B-X
.	B-X
The	B-X
diameter	B-X
of	B-X
these	B-X
vesicles	B-X
was	B-X
approximately	B-X
100-200	B-X
nm	B-X
as	B-X
determined	B-X
by	B-X
electron	B-X
microscopy	B-X
.	B-X
A	B-X
typical	B-X
coat	B-X
structure	B-X
as	B-X
described	B-X
for	B-X
intra-Golgi	B-X
transport	B-X
vesicles	B-X
or	B-X
clathrin-coated	B-X
vesicles	B-X
could	B-X
not	B-X
be	B-X
seen	B-X
,	B-X
and	B-X
the	B-X
vesicles	B-X
were	B-X
not	B-X
associated	B-X
with	B-X
the	B-X
coat	B-X
protein	B-X
beta-COP	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
vesicles	B-X
appear	B-X
to	B-X
represent	B-X
a	B-X
low	B-X
density	B-X
compartment	B-X
(	B-X
1.05-1.06	B-X
g/ml	B-X
)	B-X
.	B-X
Other	B-X
constitutively	B-X
secreted	B-X
proteins	B-X
(	B-X
rat	B-X
serum	B-X
albumin	B-X
,	B-X
apolipoprotein	B-X
E	B-X
,	B-X
and	B-X
fibrinogen	B-X
)	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
purified	B-X
HSPG-carrying	B-X
vesicles	B-X
,	B-X
but	B-X
banded	B-X
in	B-X
the	B-X
denser	B-X
fractions	B-X
of	B-X
the	B-X
Nycodenz	B-X
gradient	B-X
.	B-X
Moreover	B-X
,	B-X
during	B-X
pulse-chase	B-X
labeling	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
methionine	B-X
,	B-X
labeled	B-X
albumin	B-X
did	B-X
not	B-X
appear	B-X
in	B-X
the	B-X
post-TGN	B-X
vesicle	B-X
fraction	B-X
carrying	B-X
HSPGs	B-X
.	B-X
These	B-X
findings	B-X
indicate	B-X
sorting	B-X
of	B-X
HSPGs	B-X
and	B-X
albumin	B-X
into	B-X
different	B-X
types	B-X
of	B-X
constitutive	B-X
secretory	B-X
vesicles	B-X
in	B-X
hepatocytes	B-X
.	B-X
Two	B-X
proteins	B-X
were	B-X
found	B-X
to	B-X
be	B-X
tightly	B-X
associated	B-X
with	B-X
the	B-X
membranes	B-X
of	B-X
the	B-X
HSPG	B-X
carrying	B-X
vesicles	B-X
:	B-X
a	B-X
member	B-X
of	B-X
the	B-X
ADP	B-X
ribosylation	B-X
factor	B-X
family	B-X
of	B-X
small	B-X
guanine	B-X
nucleotide-binding	B-X
proteins	B-X
and	B-X
an	B-X
unknown	B-X
14-kD	B-X
peripheral	B-X
membrane	B-X
protein	B-X
(	B-X
VAPP14	B-X
)	B-X
.	B-X
Concerning	B-X
the	B-X
secretory	B-X
pathway	B-X
,	B-X
we	B-X
conclude	B-X
from	B-X
these	B-X
results	B-X
that	B-X
ADP	B-X
ribosylation	B-X
factor	B-X
proteins	B-X
are	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
vesicular	B-X
transport	B-X
from	B-X
the	B-X
ER	B-X
via	B-X
the	B-X
Golgi	B-X
to	B-X
the	B-X
TGN	B-X
,	B-X
but	B-X
also	B-X
in	B-X
vesicular	B-X
transport	B-X
from	B-X
the	B-X
TGN	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

The	O
diameter	O
of	O
these	O
vesicles	O
was	O
approximately	O
100	O
-	O
200	O
nm	O
as	O
determined	O
by	O
electron	O
microscopy	O
.	O
<EOS>	B-X
An	B-X
experimental	B-X
study	B-X
with	B-X
extracellular	B-X
vesicles	B-X
(	B-X
EVs	B-X
)	B-X
from	B-X
mesenchymal	B-X
stem	B-X
cell	B-X
(	B-X
MSC	B-X
)	B-X
of	B-X
the	B-X
epidural	B-X
fat	B-X
(	B-X
EF	B-X
)	B-X
of	B-X
the	B-X
spine	B-X
.	B-X
Vesicle	B-X
sizes	B-X
range	B-X
from	B-X
approximately	B-X
40	B-X
to	B-X
200	B-X
nm	B-X
for	B-X
CPB/SPFO	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
negative	B-X
staining	B-X
transmission	B-X
electron	B-X
microscopy	B-X
(	B-X
TEM	B-X
)	B-X
and	B-X
confirmed	B-X
by	B-X
dynamic	B-X
light	B-X
scattering	B-X
.	B-X
The	B-X
primary	B-X
vesicle	B-X
diameter	B-X
observed	B-X
by	B-X
TEM	B-X
in	B-X
the	B-X
catanionic	B-X
fluorinated/fluorinated	B-X
surfactant	B-X
system	B-X
is	B-X
smaller	B-X
(	B-X
20-50	B-X
nm	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
relatively	B-X
few	B-X
larger	B-X
vesicles	B-X
(	B-X
100	B-X
nm	B-X
)	B-X
in	B-X
the	B-X
HFDPC/SPFO	B-X
system	B-X
dominate	B-X
the	B-X
dynamic	B-X
light	B-X
scattering	B-X
measurements	B-X
.	B-X
The	B-X
size	B-X
of	B-X
the	B-X
resulting	B-X
hollow	B-X
silica	B-X
particles	B-X
is	B-X
consistent	B-X
with	B-X
the	B-X
templating	B-X
of	B-X
vesicles	B-X
of	B-X
the	B-X
size	B-X
range	B-X
observed	B-X
by	B-X
TEM	B-X
.	B-X
At	B-X
the	B-X
conditions	B-X
investigated	B-X
(	B-X
TMOS/surfactant	B-X
weight	B-X
ratios	B-X
of	B-X
0.25-1.0	B-X
,	B-X
pH	B-X
3	B-X
)	B-X
,	B-X
the	B-X
colloidal	B-X
silica	B-X
particles	B-X
templated	B-X
from	B-X
fluorinated	B-X
HFDPC/SPFO	B-X
vesicles	B-X
are	B-X
more	B-X
stable	B-X
than	B-X
the	B-X
particles	B-X
templated	B-X
from	B-X
the	B-X
corresponding	B-X
mixed	B-X
fluorinated	B-X
CPB/SPFO	B-X
system	B-X
.	B-X

A	O
typical	O
coat	O
structure	O
as	O
described	O
for	O
intra	O
-	O
Golgi	O
transport	O
vesicles	O
or	O
clathrin	O
-	O
coated	O
vesicles	O
could	O
not	O
be	O
seen	O
,	O
and	O
the	O
vesicles	O
were	O
not	O
associated	O
with	O
the	O
coat	O
protein	O
beta	B-Protein
-	I-Protein
COP	I-Protein
.	O

Furthermore	O
,	O
the	O
vesicles	O
appear	O
to	O
represent	O
a	O
low	O
density	O
compartment	O
(	O
1	O
.	O
05	O
-	O
1	O
.	O
06	O
g	O
/	O
ml	O
)	O
.	O

Other	O
constitutively	O
secreted	O
proteins	O
(	O
rat	O
serum	B-Protein
albumin	I-Protein
,	O
apolipoprotein	B-Protein
E	I-Protein
,	O
and	O
fibrinogen	O
)	O
could	O
not	O
be	O
detected	O
in	O
purified	O
HSPG	B-Protein
-	O
carrying	O
vesicles	O
,	O
but	O
banded	O
in	O
the	O
denser	O
fractions	O
of	O
the	O
Nycodenz	O
gradient	O
.	O

Moreover	O
,	O
during	O
pulse	O
-	O
chase	O
labeling	O
with	O
[	O
35S	O
]	O
methionine	O
,	O
labeled	O
albumin	B-Protein
did	O
not	O
appear	O
in	O
the	O
post	O
-	O
TGN	O
vesicle	O
fraction	O
carrying	O
HSPGs	B-Protein
.	O
<EOS>	B-X
269	B-X
,	B-X
24169-24176	B-X
)	B-X
,	B-X
showed	B-X
a	B-X
10-fold	B-X
increase	B-X
in	B-X
the	B-X
accumulation	B-X
of	B-X
de	B-X
novo	B-X
synthesized	B-X
[	B-X
35S	B-X
]	B-X
methionine-labeled	B-X
apoB	B-X
.	B-X
The	B-X
majority	B-X
(	B-X
80	B-X
%	B-X
)	B-X
of	B-X
the	B-X
apoB	B-X
accumulated	B-X
in	B-X
response	B-X
to	B-X
ALLN	B-X
was	B-X
in	B-X
the	B-X
microsomal	B-X
fraction	B-X
.	B-X
Since	B-X
ALLN	B-X
did	B-X
not	B-X
effect	B-X
the	B-X
intracellular	B-X
accumulation	B-X
of	B-X
[	B-X
35S	B-X
]	B-X
methionine-labeled	B-X
albumin	B-X
and	B-X
other	B-X
proteins	B-X
(	B-X
trichloroacetic	B-X
acid-precipitable	B-X
[	B-X
35S	B-X
]	B-X
methionine-labeled	B-X
proteins	B-X
)	B-X
,	B-X
its	B-X
effect	B-X
on	B-X
apoB	B-X
was	B-X
specific	B-X
.	B-X
Pulse-chase	B-X
studies	B-X
showed	B-X
that	B-X
ALLN	B-X
dramatically	B-X
reduced	B-X
the	B-X
first-order	B-X
rate	B-X
of	B-X
removal	B-X
of	B-X
[	B-X
35S	B-X
]	B-X
methionine-labeled	B-X
apoB	B-X
from	B-X
the	B-X
cell	B-X
but	B-X
did	B-X
not	B-X
effect	B-X
its	B-X
rate	B-X
of	B-X
secretion	B-X
.	B-X
Moreover	B-X
,	B-X
85	B-X
%	B-X
of	B-X
the	B-X
apoB	B-X
that	B-X
accumulated	B-X
in	B-X
isolated	B-X
microsomes	B-X
in	B-X
response	B-X
to	B-X
ALLN	B-X
was	B-X
accessible	B-X
to	B-X
exogenous	B-X
trypsin	B-X
,	B-X
indicating	B-X
this	B-X
pool	B-X
of	B-X
apoB	B-X
was	B-X
incompletely	B-X
translocated	B-X
.	B-X

These	O
findings	O
indicate	O
sorting	O
of	O
HSPGs	B-Protein
and	O
albumin	B-Protein
into	O
different	O
types	O
of	O
constitutive	O
secretory	O
vesicles	O
in	O
hepatocytes	O
.	O
<EOS>	B-X
Constitutive	B-X
secretory	B-X
vesicles	B-X
carrying	B-X
heparan	B-X
sulfate	B-X
proteoglycan	B-X
(	B-X
HSPG	B-X
)	B-X
were	B-X
identified	B-X
in	B-X
isolated	B-X
rat	B-X
hepatocytes	B-X
by	B-X
pulse-chase	B-X
experiments	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
and	B-X
purified	B-X
by	B-X
velocity-controlled	B-X
sucrose	B-X
gradient	B-X
centrifugation	B-X
followed	B-X
by	B-X
equilibrium	B-X
density	B-X
centrifugation	B-X
in	B-X
Nycodenz	B-X
.	B-X
Using	B-X
this	B-X
procedure	B-X
,	B-X
the	B-X
vesicles	B-X
were	B-X
separated	B-X
from	B-X
plasma	B-X
membranes	B-X
,	B-X
Golgi	B-X
,	B-X
trans-Golgi	B-X
network	B-X
(	B-X
TGN	B-X
)	B-X
,	B-X
ER	B-X
,	B-X
endosomes	B-X
,	B-X
lysosomes	B-X
,	B-X
transcytotic	B-X
vesicles	B-X
,	B-X
and	B-X
mitochondria	B-X
.	B-X
The	B-X
diameter	B-X
of	B-X
these	B-X
vesicles	B-X
was	B-X
approximately	B-X
100-200	B-X
nm	B-X
as	B-X
determined	B-X
by	B-X
electron	B-X
microscopy	B-X
.	B-X
A	B-X
typical	B-X
coat	B-X
structure	B-X
as	B-X
described	B-X
for	B-X
intra-Golgi	B-X
transport	B-X
vesicles	B-X
or	B-X
clathrin-coated	B-X
vesicles	B-X
could	B-X
not	B-X
be	B-X
seen	B-X
,	B-X
and	B-X
the	B-X
vesicles	B-X
were	B-X
not	B-X
associated	B-X
with	B-X
the	B-X
coat	B-X
protein	B-X
beta-COP	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
vesicles	B-X
appear	B-X
to	B-X
represent	B-X
a	B-X
low	B-X
density	B-X
compartment	B-X
(	B-X
1.05-1.06	B-X
g/ml	B-X
)	B-X
.	B-X
Other	B-X
constitutively	B-X
secreted	B-X
proteins	B-X
(	B-X
rat	B-X
serum	B-X
albumin	B-X
,	B-X
apolipoprotein	B-X
E	B-X
,	B-X
and	B-X
fibrinogen	B-X
)	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
purified	B-X
HSPG-carrying	B-X
vesicles	B-X
,	B-X
but	B-X
banded	B-X
in	B-X
the	B-X
denser	B-X
fractions	B-X
of	B-X
the	B-X
Nycodenz	B-X
gradient	B-X
.	B-X
Moreover	B-X
,	B-X
during	B-X
pulse-chase	B-X
labeling	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
methionine	B-X
,	B-X
labeled	B-X
albumin	B-X
did	B-X
not	B-X
appear	B-X
in	B-X
the	B-X
post-TGN	B-X
vesicle	B-X
fraction	B-X
carrying	B-X
HSPGs	B-X
.	B-X
These	B-X
findings	B-X
indicate	B-X
sorting	B-X
of	B-X
HSPGs	B-X
and	B-X
albumin	B-X
into	B-X
different	B-X
types	B-X
of	B-X
constitutive	B-X
secretory	B-X
vesicles	B-X
in	B-X
hepatocytes	B-X
.	B-X
Two	B-X
proteins	B-X
were	B-X
found	B-X
to	B-X
be	B-X
tightly	B-X
associated	B-X
with	B-X
the	B-X
membranes	B-X
of	B-X
the	B-X
HSPG	B-X
carrying	B-X
vesicles	B-X
:	B-X
a	B-X
member	B-X
of	B-X
the	B-X
ADP	B-X
ribosylation	B-X
factor	B-X
family	B-X
of	B-X
small	B-X
guanine	B-X
nucleotide-binding	B-X
proteins	B-X
and	B-X
an	B-X
unknown	B-X
14-kD	B-X
peripheral	B-X
membrane	B-X
protein	B-X
(	B-X
VAPP14	B-X
)	B-X
.	B-X
Concerning	B-X
the	B-X
secretory	B-X
pathway	B-X
,	B-X
we	B-X
conclude	B-X
from	B-X
these	B-X
results	B-X
that	B-X
ADP	B-X
ribosylation	B-X
factor	B-X
proteins	B-X
are	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
vesicular	B-X
transport	B-X
from	B-X
the	B-X
ER	B-X
via	B-X
the	B-X
Golgi	B-X
to	B-X
the	B-X
TGN	B-X
,	B-X
but	B-X
also	B-X
in	B-X
vesicular	B-X
transport	B-X
from	B-X
the	B-X
TGN	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

Two	O
proteins	O
were	O
found	O
to	O
be	O
tightly	O
associated	O
with	O
the	O
membranes	O
of	O
the	O
HSPG	B-Protein
carrying	O
vesicles	O
:	O
a	O
member	O
of	O
the	O
ADP	O
ribosylation	O
factor	O
family	O
of	O
small	O
guanine	O
nucleotide	O
-	O
binding	O
proteins	O
and	O
an	O
unknown	O
14	O
-	O
kD	O
peripheral	O
membrane	O
protein	O
(	O
VAPP14	O
)	O
.	O

Concerning	O
the	O
secretory	O
pathway	O
,	O
we	O
conclude	O
from	O
these	O
results	O
that	O
ADP	O
ribosylation	O
factor	O
proteins	O
are	O
not	O
only	O
involved	O
in	O
vesicular	O
transport	O
from	O
the	O
ER	O
via	O
the	O
Golgi	O
to	O
the	O
TGN	O
,	O
but	O
also	O
in	O
vesicular	O
transport	O
from	O
the	O
TGN	O
to	O
the	O
plasma	O
membrane	O
.	O
<EOS>	B-X
Constitutive	B-X
secretory	B-X
vesicles	B-X
carrying	B-X
heparan	B-X
sulfate	B-X
proteoglycan	B-X
(	B-X
HSPG	B-X
)	B-X
were	B-X
identified	B-X
in	B-X
isolated	B-X
rat	B-X
hepatocytes	B-X
by	B-X
pulse-chase	B-X
experiments	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
and	B-X
purified	B-X
by	B-X
velocity-controlled	B-X
sucrose	B-X
gradient	B-X
centrifugation	B-X
followed	B-X
by	B-X
equilibrium	B-X
density	B-X
centrifugation	B-X
in	B-X
Nycodenz	B-X
.	B-X
Using	B-X
this	B-X
procedure	B-X
,	B-X
the	B-X
vesicles	B-X
were	B-X
separated	B-X
from	B-X
plasma	B-X
membranes	B-X
,	B-X
Golgi	B-X
,	B-X
trans-Golgi	B-X
network	B-X
(	B-X
TGN	B-X
)	B-X
,	B-X
ER	B-X
,	B-X
endosomes	B-X
,	B-X
lysosomes	B-X
,	B-X
transcytotic	B-X
vesicles	B-X
,	B-X
and	B-X
mitochondria	B-X
.	B-X
A	B-X
typical	B-X
coat	B-X
structure	B-X
as	B-X
described	B-X
for	B-X
intra-Golgi	B-X
transport	B-X
vesicles	B-X
or	B-X
clathrin-coated	B-X
vesicles	B-X
could	B-X
not	B-X
be	B-X
seen	B-X
,	B-X
and	B-X
the	B-X
vesicles	B-X
were	B-X
not	B-X
associated	B-X
with	B-X
the	B-X
coat	B-X
protein	B-X
beta-COP	B-X
.	B-X
Other	B-X
constitutively	B-X
secreted	B-X
proteins	B-X
(	B-X
rat	B-X
serum	B-X
albumin	B-X
,	B-X
apolipoprotein	B-X
E	B-X
,	B-X
and	B-X
fibrinogen	B-X
)	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
purified	B-X
HSPG-carrying	B-X
vesicles	B-X
,	B-X
but	B-X
banded	B-X
in	B-X
the	B-X
denser	B-X
fractions	B-X
of	B-X
the	B-X
Nycodenz	B-X
gradient	B-X
.	B-X
Moreover	B-X
,	B-X
during	B-X
pulse-chase	B-X
labeling	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
methionine	B-X
,	B-X
labeled	B-X
albumin	B-X
did	B-X
not	B-X
appear	B-X
in	B-X
the	B-X
post-TGN	B-X
vesicle	B-X
fraction	B-X
carrying	B-X
HSPGs	B-X
.	B-X
These	B-X
findings	B-X
indicate	B-X
sorting	B-X
of	B-X
HSPGs	B-X
and	B-X
albumin	B-X
into	B-X
different	B-X
types	B-X
of	B-X
constitutive	B-X
secretory	B-X
vesicles	B-X
in	B-X
hepatocytes	B-X
.	B-X
Two	B-X
proteins	B-X
were	B-X
found	B-X
to	B-X
be	B-X
tightly	B-X
associated	B-X
with	B-X
the	B-X
membranes	B-X
of	B-X
the	B-X
HSPG	B-X
carrying	B-X
vesicles	B-X
:	B-X
a	B-X
member	B-X
of	B-X
the	B-X
ADP	B-X
ribosylation	B-X
factor	B-X
family	B-X
of	B-X
small	B-X
guanine	B-X
nucleotide-binding	B-X
proteins	B-X
and	B-X
an	B-X
unknown	B-X
14-kD	B-X
peripheral	B-X
membrane	B-X
protein	B-X
(	B-X
VAPP14	B-X
)	B-X
.	B-X
Concerning	B-X
the	B-X
secretory	B-X
pathway	B-X
,	B-X
we	B-X
conclude	B-X
from	B-X
these	B-X
results	B-X
that	B-X
ADP	B-X
ribosylation	B-X
factor	B-X
proteins	B-X
are	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
vesicular	B-X
transport	B-X
from	B-X
the	B-X
ER	B-X
via	B-X
the	B-X
Golgi	B-X
to	B-X
the	B-X
TGN	B-X
,	B-X
but	B-X
also	B-X
in	B-X
vesicular	B-X
transport	B-X
from	B-X
the	B-X
TGN	B-X
to	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X

Tyrosine	O
sulfation	O
of	O
varicella	O
-	O
zoster	O
virus	O
envelope	O
glycoprotein	O
gpl	B-Protein
.	O
<EOS>	B-X
I	B-X
have	B-X
shown	B-X
that	B-X
varicella-zoster	B-X
virus	B-X
(	B-X
VZV	B-X
)	B-X
envelope	B-X
glycoproteins	B-X
gpI	B-X
,	B-X
gpII	B-X
,	B-X
and	B-X
gpIII	B-X
can	B-X
be	B-X
labeled	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
.	B-X
The	B-X
predominant	B-X
VZV	B-X
glycoprotein	B-X
,	B-X
gpI	B-X
,	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
sulfated	B-X
on	B-X
asparagine-linked	B-X
glycans	B-X
and	B-X
on	B-X
tyrosine	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
a	B-X
viral	B-X
envelope	B-X
glycoprotein	B-X
.	B-X
Examination	B-X
of	B-X
the	B-X
predicted	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
gpI	B-X
from	B-X
the	B-X
Dumas	B-X
and	B-X
CP-5262	B-X
VZV	B-X
strains	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
single	B-X
consensus	B-X
sequence	B-X
for	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
tyr88	B-X
:	B-X
IWPRNDYDGFLEN	B-X
.	B-X
Consensus	B-X
sequences	B-X
are	B-X
also	B-X
present	B-X
in	B-X
the	B-X
homologues	B-X
of	B-X
gpI	B-X
in	B-X
herpes	B-X
simplex	B-X
type	B-X
1	B-X
,	B-X
herpes	B-X
simplex	B-X
type	B-X
2	B-X
,	B-X
and	B-X
pseudorabies	B-X
virus	B-X
,	B-X
suggesting	B-X
that	B-X
tyrosine	B-X
sulfation	B-X
may	B-X
be	B-X
a	B-X
general	B-X
post-translational	B-X
modification	B-X
of	B-X
the	B-X
neurotropic	B-X
alphaherpesviruses	B-X
.	B-X

Sulfation	O
is	O
a	O
common	O
post	O
-	O
translational	O
modification	O
of	O
secreted	O
and	O
membrane	O
proteins	O
,	O
with	O
the	O
sulfate	O
attached	O
to	O
tyrosine	O
residues	O
or	O
to	O
glycan	O
side	O
-	O
chains	O
.	O
<EOS>	B-X
Proteoglycans	B-X
are	B-X
a	B-X
class	B-X
of	B-X
sulfated	B-X
glycoproteins	B-X
widely	B-X
distributed	B-X
on	B-X
the	B-X
cell	B-X
surface	B-X
and	B-X
in	B-X
the	B-X
extracellular	B-X
matrix	B-X
,	B-X
which	B-X
are	B-X
extensively	B-X
engaged	B-X
in	B-X
cellular	B-X
communication	B-X
events	B-X
.	B-X
Consisting	B-X
of	B-X
protein	B-X
backbone	B-X
and	B-X
glycosaminoglycan	B-X
(	B-X
s	B-X
)	B-X
side	B-X
chain	B-X
,	B-X
proteoglycans	B-X
are	B-X
highly	B-X
complex	B-X
and	B-X
heterogeneous	B-X
in	B-X
nature	B-X
.	B-X
Chemical	B-X
synthesis	B-X
provides	B-X
facile	B-X
and	B-X
reliable	B-X
approach	B-X
to	B-X
these	B-X
molecules	B-X
,	B-X
with	B-X
defined	B-X
glycan	B-X
structure	B-X
and	B-X
sulfation	B-X
pattern	B-X
.	B-X
One	B-X
remaining	B-X
problem	B-X
is	B-X
that	B-X
the	B-X
acid-labile	B-X
sulfates	B-X
could	B-X
hardly	B-X
survive	B-X
during	B-X
the	B-X
typical	B-X
solid	B-X
phase	B-X
peptide	B-X
synthesis	B-X
(	B-X
SPPS	B-X
)	B-X
process	B-X
.	B-X
In	B-X
this	B-X
chapter	B-X
,	B-X
strategic	B-X
design	B-X
of	B-X
a	B-X
``	B-X
glycopeptide	B-X
cassette	B-X
''	B-X
for	B-X
the	B-X
preparation	B-X
of	B-X
sulfated	B-X
glycoprotein	B-X
is	B-X
described	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
we	B-X
provide	B-X
protocols	B-X
for	B-X
the	B-X
chemical	B-X
synthesis	B-X
of	B-X
ectodomain	B-X
fragment	B-X
(	B-X
23-120	B-X
)	B-X
of	B-X
sulfated	B-X
glycoprotein	B-X
syndecan-1	B-X
.	B-X

I	O
have	O
shown	O
that	O
varicella	O
-	O
zoster	O
virus	O
(	O
VZV	O
)	O
envelope	O
glycoproteins	O
gpI	B-Protein
,	O
gpII	B-Protein
,	O
and	O
gpIII	B-Protein
can	O
be	O
labeled	O
with	O
[	O
35S	O
]	O
sulfate	O
.	O
<EOS>	B-X
Sulfation	B-X
is	B-X
a	B-X
common	B-X
post-translational	B-X
modification	B-X
of	B-X
secreted	B-X
and	B-X
membrane	B-X
proteins	B-X
,	B-X
with	B-X
the	B-X
sulfate	B-X
attached	B-X
to	B-X
tyrosine	B-X
residues	B-X
or	B-X
to	B-X
glycan	B-X
side-chains	B-X
.	B-X
I	B-X
have	B-X
shown	B-X
that	B-X
varicella-zoster	B-X
virus	B-X
(	B-X
VZV	B-X
)	B-X
envelope	B-X
glycoproteins	B-X
gpI	B-X
,	B-X
gpII	B-X
,	B-X
and	B-X
gpIII	B-X
can	B-X
be	B-X
labeled	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
.	B-X
The	B-X
predominant	B-X
VZV	B-X
glycoprotein	B-X
,	B-X
gpI	B-X
,	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
sulfated	B-X
on	B-X
asparagine-linked	B-X
glycans	B-X
and	B-X
on	B-X
tyrosine	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
a	B-X
viral	B-X
envelope	B-X
glycoprotein	B-X
.	B-X
Examination	B-X
of	B-X
the	B-X
predicted	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
gpI	B-X
from	B-X
the	B-X
Dumas	B-X
and	B-X
CP-5262	B-X
VZV	B-X
strains	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
single	B-X
consensus	B-X
sequence	B-X
for	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
tyr88	B-X
:	B-X
IWPRNDYDGFLEN	B-X
.	B-X
Consensus	B-X
sequences	B-X
are	B-X
also	B-X
present	B-X
in	B-X
the	B-X
homologues	B-X
of	B-X
gpI	B-X
in	B-X
herpes	B-X
simplex	B-X
type	B-X
1	B-X
,	B-X
herpes	B-X
simplex	B-X
type	B-X
2	B-X
,	B-X
and	B-X
pseudorabies	B-X
virus	B-X
,	B-X
suggesting	B-X
that	B-X
tyrosine	B-X
sulfation	B-X
may	B-X
be	B-X
a	B-X
general	B-X
post-translational	B-X
modification	B-X
of	B-X
the	B-X
neurotropic	B-X
alphaherpesviruses	B-X
.	B-X

The	O
predominant	O
VZV	O
glycoprotein	O
,	O
gpI	B-Protein
,	O
was	O
shown	O
to	O
be	O
sulfated	O
on	O
asparagine	O
-	O
linked	O
glycans	O
and	O
on	O
tyrosine	O
.	O
<EOS>	B-X
Sulfation	B-X
is	B-X
a	B-X
common	B-X
post-translational	B-X
modification	B-X
of	B-X
secreted	B-X
and	B-X
membrane	B-X
proteins	B-X
,	B-X
with	B-X
the	B-X
sulfate	B-X
attached	B-X
to	B-X
tyrosine	B-X
residues	B-X
or	B-X
to	B-X
glycan	B-X
side-chains	B-X
.	B-X
I	B-X
have	B-X
shown	B-X
that	B-X
varicella-zoster	B-X
virus	B-X
(	B-X
VZV	B-X
)	B-X
envelope	B-X
glycoproteins	B-X
gpI	B-X
,	B-X
gpII	B-X
,	B-X
and	B-X
gpIII	B-X
can	B-X
be	B-X
labeled	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
.	B-X
The	B-X
predominant	B-X
VZV	B-X
glycoprotein	B-X
,	B-X
gpI	B-X
,	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
sulfated	B-X
on	B-X
asparagine-linked	B-X
glycans	B-X
and	B-X
on	B-X
tyrosine	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
a	B-X
viral	B-X
envelope	B-X
glycoprotein	B-X
.	B-X
Examination	B-X
of	B-X
the	B-X
predicted	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
gpI	B-X
from	B-X
the	B-X
Dumas	B-X
and	B-X
CP-5262	B-X
VZV	B-X
strains	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
single	B-X
consensus	B-X
sequence	B-X
for	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
tyr88	B-X
:	B-X
IWPRNDYDGFLEN	B-X
.	B-X
Consensus	B-X
sequences	B-X
are	B-X
also	B-X
present	B-X
in	B-X
the	B-X
homologues	B-X
of	B-X
gpI	B-X
in	B-X
herpes	B-X
simplex	B-X
type	B-X
1	B-X
,	B-X
herpes	B-X
simplex	B-X
type	B-X
2	B-X
,	B-X
and	B-X
pseudorabies	B-X
virus	B-X
,	B-X
suggesting	B-X
that	B-X
tyrosine	B-X
sulfation	B-X
may	B-X
be	B-X
a	B-X
general	B-X
post-translational	B-X
modification	B-X
of	B-X
the	B-X
neurotropic	B-X
alphaherpesviruses	B-X
.	B-X

This	O
is	O
the	O
first	O
report	O
of	O
tyrosine	O
sulfation	O
of	O
a	O
viral	O
envelope	O
glycoprotein	O
.	O
<EOS>	B-X
Sulfation	B-X
is	B-X
a	B-X
common	B-X
post-translational	B-X
modification	B-X
of	B-X
secreted	B-X
and	B-X
membrane	B-X
proteins	B-X
,	B-X
with	B-X
the	B-X
sulfate	B-X
attached	B-X
to	B-X
tyrosine	B-X
residues	B-X
or	B-X
to	B-X
glycan	B-X
side-chains	B-X
.	B-X
I	B-X
have	B-X
shown	B-X
that	B-X
varicella-zoster	B-X
virus	B-X
(	B-X
VZV	B-X
)	B-X
envelope	B-X
glycoproteins	B-X
gpI	B-X
,	B-X
gpII	B-X
,	B-X
and	B-X
gpIII	B-X
can	B-X
be	B-X
labeled	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
.	B-X
The	B-X
predominant	B-X
VZV	B-X
glycoprotein	B-X
,	B-X
gpI	B-X
,	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
sulfated	B-X
on	B-X
asparagine-linked	B-X
glycans	B-X
and	B-X
on	B-X
tyrosine	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
a	B-X
viral	B-X
envelope	B-X
glycoprotein	B-X
.	B-X
Examination	B-X
of	B-X
the	B-X
predicted	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
gpI	B-X
from	B-X
the	B-X
Dumas	B-X
and	B-X
CP-5262	B-X
VZV	B-X
strains	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
single	B-X
consensus	B-X
sequence	B-X
for	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
tyr88	B-X
:	B-X
IWPRNDYDGFLEN	B-X
.	B-X
Consensus	B-X
sequences	B-X
are	B-X
also	B-X
present	B-X
in	B-X
the	B-X
homologues	B-X
of	B-X
gpI	B-X
in	B-X
herpes	B-X
simplex	B-X
type	B-X
1	B-X
,	B-X
herpes	B-X
simplex	B-X
type	B-X
2	B-X
,	B-X
and	B-X
pseudorabies	B-X
virus	B-X
,	B-X
suggesting	B-X
that	B-X
tyrosine	B-X
sulfation	B-X
may	B-X
be	B-X
a	B-X
general	B-X
post-translational	B-X
modification	B-X
of	B-X
the	B-X
neurotropic	B-X
alphaherpesviruses	B-X
.	B-X

Examination	O
of	O
the	O
predicted	O
amino	O
acid	O
sequences	O
of	O
gpI	B-Protein
from	O
the	O
Dumas	O
and	O
CP	O
-	O
5262	O
VZV	O
strains	O
revealed	O
the	O
presence	O
of	O
a	O
single	O
consensus	O
sequence	O
for	O
tyrosine	O
sulfation	O
of	O
tyr88	O
:	O
IWPRNDYDGFLEN	O
.	O
<EOS>	B-X
Sulfation	B-X
is	B-X
a	B-X
common	B-X
post-translational	B-X
modification	B-X
of	B-X
secreted	B-X
and	B-X
membrane	B-X
proteins	B-X
,	B-X
with	B-X
the	B-X
sulfate	B-X
attached	B-X
to	B-X
tyrosine	B-X
residues	B-X
or	B-X
to	B-X
glycan	B-X
side-chains	B-X
.	B-X
I	B-X
have	B-X
shown	B-X
that	B-X
varicella-zoster	B-X
virus	B-X
(	B-X
VZV	B-X
)	B-X
envelope	B-X
glycoproteins	B-X
gpI	B-X
,	B-X
gpII	B-X
,	B-X
and	B-X
gpIII	B-X
can	B-X
be	B-X
labeled	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
.	B-X
The	B-X
predominant	B-X
VZV	B-X
glycoprotein	B-X
,	B-X
gpI	B-X
,	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
sulfated	B-X
on	B-X
asparagine-linked	B-X
glycans	B-X
and	B-X
on	B-X
tyrosine	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
a	B-X
viral	B-X
envelope	B-X
glycoprotein	B-X
.	B-X
Examination	B-X
of	B-X
the	B-X
predicted	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
gpI	B-X
from	B-X
the	B-X
Dumas	B-X
and	B-X
CP-5262	B-X
VZV	B-X
strains	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
single	B-X
consensus	B-X
sequence	B-X
for	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
tyr88	B-X
:	B-X
IWPRNDYDGFLEN	B-X
.	B-X
Consensus	B-X
sequences	B-X
are	B-X
also	B-X
present	B-X
in	B-X
the	B-X
homologues	B-X
of	B-X
gpI	B-X
in	B-X
herpes	B-X
simplex	B-X
type	B-X
1	B-X
,	B-X
herpes	B-X
simplex	B-X
type	B-X
2	B-X
,	B-X
and	B-X
pseudorabies	B-X
virus	B-X
,	B-X
suggesting	B-X
that	B-X
tyrosine	B-X
sulfation	B-X
may	B-X
be	B-X
a	B-X
general	B-X
post-translational	B-X
modification	B-X
of	B-X
the	B-X
neurotropic	B-X
alphaherpesviruses	B-X
.	B-X

Consensus	O
sequences	O
are	O
also	O
present	O
in	O
the	O
homologues	O
of	O
gpI	B-Protein
in	O
herpes	O
simplex	O
type	O
1	O
,	O
herpes	O
simplex	O
type	O
2	O
,	O
and	O
pseudorabies	O
virus	O
,	O
suggesting	O
that	O
tyrosine	O
sulfation	O
may	O
be	O
a	O
general	O
post	O
-	O
translational	O
modification	O
of	O
the	O
neurotropic	O
alphaherpesviruses	O
.	O
<EOS>	B-X
Sulfation	B-X
is	B-X
a	B-X
common	B-X
post-translational	B-X
modification	B-X
of	B-X
secreted	B-X
and	B-X
membrane	B-X
proteins	B-X
,	B-X
with	B-X
the	B-X
sulfate	B-X
attached	B-X
to	B-X
tyrosine	B-X
residues	B-X
or	B-X
to	B-X
glycan	B-X
side-chains	B-X
.	B-X
I	B-X
have	B-X
shown	B-X
that	B-X
varicella-zoster	B-X
virus	B-X
(	B-X
VZV	B-X
)	B-X
envelope	B-X
glycoproteins	B-X
gpI	B-X
,	B-X
gpII	B-X
,	B-X
and	B-X
gpIII	B-X
can	B-X
be	B-X
labeled	B-X
with	B-X
[	B-X
35S	B-X
]	B-X
sulfate	B-X
.	B-X
The	B-X
predominant	B-X
VZV	B-X
glycoprotein	B-X
,	B-X
gpI	B-X
,	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
sulfated	B-X
on	B-X
asparagine-linked	B-X
glycans	B-X
and	B-X
on	B-X
tyrosine	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
report	B-X
of	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
a	B-X
viral	B-X
envelope	B-X
glycoprotein	B-X
.	B-X
Examination	B-X
of	B-X
the	B-X
predicted	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
gpI	B-X
from	B-X
the	B-X
Dumas	B-X
and	B-X
CP-5262	B-X
VZV	B-X
strains	B-X
revealed	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
single	B-X
consensus	B-X
sequence	B-X
for	B-X
tyrosine	B-X
sulfation	B-X
of	B-X
tyr88	B-X
:	B-X
IWPRNDYDGFLEN	B-X
.	B-X
Consensus	B-X
sequences	B-X
are	B-X
also	B-X
present	B-X
in	B-X
the	B-X
homologues	B-X
of	B-X
gpI	B-X
in	B-X
herpes	B-X
simplex	B-X
type	B-X
1	B-X
,	B-X
herpes	B-X
simplex	B-X
type	B-X
2	B-X
,	B-X
and	B-X
pseudorabies	B-X
virus	B-X
,	B-X
suggesting	B-X
that	B-X
tyrosine	B-X
sulfation	B-X
may	B-X
be	B-X
a	B-X
general	B-X
post-translational	B-X
modification	B-X
of	B-X
the	B-X
neurotropic	B-X
alphaherpesviruses	B-X
.	B-X

Posttranslational	O
regulation	O
of	O
nitrogenase	O
activity	O
by	O
anaerobiosis	O
and	O
ammonium	O
in	O
Azospirillum	O
brasilense	O
.	O
<EOS>	B-X
In	B-X
the	B-X
microaerophilic	B-X
diazotroph	B-X
Azospirillum	B-X
brasilense	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
fixed	B-X
nitrogen	B-X
or	B-X
a	B-X
shift	B-X
to	B-X
anaerobic	B-X
conditions	B-X
leads	B-X
to	B-X
a	B-X
rapid	B-X
loss	B-X
of	B-X
nitrogenase	B-X
activity	B-X
due	B-X
to	B-X
ADP-ribosylation	B-X
of	B-X
dinitrogenase	B-X
reductase	B-X
.	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
themselves	B-X
subject	B-X
to	B-X
posttranslational	B-X
regulation	B-X
,	B-X
and	B-X
this	B-X
report	B-X
identifies	B-X
features	B-X
of	B-X
that	B-X
regulation	B-X
.	B-X
Finally	B-X
,	B-X
our	B-X
experiments	B-X
suggest	B-X
the	B-X
existence	B-X
of	B-X
a	B-X
temporary	B-X
period	B-X
of	B-X
futile	B-X
cycling	B-X
during	B-X
which	B-X
DRAT	B-X
and	B-X
DRAG	B-X
are	B-X
simultaneously	B-X
adding	B-X
and	B-X
removing	B-X
ADP-ribose	B-X
from	B-X
dinitrogenase	B-X
reductase	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
negative	B-X
stimulus	B-X
.	B-X
Nitrogenase	B-X
activity	B-X
is	B-X
regulated	B-X
by	B-X
reversible	B-X
ADP-ribosylation	B-X
in	B-X
response	B-X
to	B-X
NH4+	B-X
and	B-X
anaerobic	B-X
conditions	B-X
in	B-X
Azospirillum	B-X
brasilense	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
mutations	B-X
in	B-X
ntrBC	B-X
on	B-X
this	B-X
regulation	B-X
was	B-X
examined	B-X
.	B-X
While	B-X
NH4+	B-X
addition	B-X
to	B-X
ntrBC	B-X
mutants	B-X
caused	B-X
a	B-X
partial	B-X
loss	B-X
of	B-X
nitrogenase	B-X
activity	B-X
,	B-X
the	B-X
effect	B-X
was	B-X
substantially	B-X
smaller	B-X
than	B-X
that	B-X
seen	B-X
in	B-X
ntr+	B-X
strains	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
nitrogenase	B-X
activity	B-X
in	B-X
these	B-X
mutants	B-X
was	B-X
normally	B-X
regulated	B-X
in	B-X
response	B-X
to	B-X
anaerobic	B-X
conditions	B-X
.	B-X
The	B-X
analysis	B-X
of	B-X
mutants	B-X
lacking	B-X
both	B-X
the	B-X
ntrBC	B-X
gene	B-X
products	B-X
and	B-X
dinitrogenase	B-X
reductase	B-X
activating	B-X
glycohydrolase	B-X
(	B-X
DRAG	B-X
)	B-X
suggested	B-X
that	B-X
the	B-X
primary	B-X
effect	B-X
of	B-X
the	B-X
ntrBC	B-X
mutations	B-X
was	B-X
to	B-X
alter	B-X
the	B-X
regulation	B-X
of	B-X
DRAG	B-X
activity	B-X
.	B-X
Although	B-X
nif	B-X
expression	B-X
in	B-X
the	B-X
ntr	B-X
mutants	B-X
appeared	B-X
normal	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
activity	B-X
,	B-X
glutamine	B-X
synthetase	B-X
activity	B-X
was	B-X
significantly	B-X
lower	B-X
in	B-X
ntrBC	B-X
mutants	B-X
than	B-X
in	B-X
the	B-X
wild	B-X
type	B-X
.	B-X
We	B-X
hypothesize	B-X
that	B-X
this	B-X
lower	B-X
glutamine	B-X
synthetase	B-X
activity	B-X
may	B-X
delay	B-X
the	B-X
transduction	B-X
of	B-X
the	B-X
NH4+	B-X
signal	B-X
necessary	B-X
for	B-X
the	B-X
inactivation	B-X
of	B-X
DRAG	B-X
,	B-X
resulting	B-X
in	B-X
a	B-X
reduced	B-X
response	B-X
of	B-X
nitrogenase	B-X
activity	B-X
to	B-X
NH4+	B-X
.	B-X

In	O
the	O
microaerophilic	O
diazotroph	O
Azospirillum	O
brasilense	O
,	O
the	O
addition	O
of	O
fixed	O
nitrogen	O
or	O
a	O
shift	O
to	O
anaerobic	O
conditions	O
leads	O
to	O
a	O
rapid	O
loss	O
of	O
nitrogenase	O
activity	O
due	O
to	O
ADP	O
-	O
ribosylation	O
of	O
dinitrogenase	B-Protein
reductase	I-Protein
.	O
<EOS>	B-X
In	B-X
the	B-X
microaerophilic	B-X
diazotroph	B-X
Azospirillum	B-X
brasilense	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
fixed	B-X
nitrogen	B-X
or	B-X
a	B-X
shift	B-X
to	B-X
anaerobic	B-X
conditions	B-X
leads	B-X
to	B-X
a	B-X
rapid	B-X
loss	B-X
of	B-X
nitrogenase	B-X
activity	B-X
due	B-X
to	B-X
ADP-ribosylation	B-X
of	B-X
dinitrogenase	B-X
reductase	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
DRAT	B-X
in	B-X
response	B-X
to	B-X
an	B-X
anaerobic	B-X
shift	B-X
is	B-X
transient	B-X
but	B-X
that	B-X
the	B-X
duration	B-X
of	B-X
DRAT	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
added	B-X
NH4+	B-X
varies	B-X
with	B-X
the	B-X
NH4+	B-X
concentration	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DRAG	B-X
appears	B-X
to	B-X
be	B-X
continuously	B-X
active	B-X
under	B-X
conditions	B-X
favoring	B-X
nitrogen	B-X
fixation	B-X
.	B-X
Finally	B-X
,	B-X
our	B-X
experiments	B-X
suggest	B-X
the	B-X
existence	B-X
of	B-X
a	B-X
temporary	B-X
period	B-X
of	B-X
futile	B-X
cycling	B-X
during	B-X
which	B-X
DRAT	B-X
and	B-X
DRAG	B-X
are	B-X
simultaneously	B-X
adding	B-X
and	B-X
removing	B-X
ADP-ribose	B-X
from	B-X
dinitrogenase	B-X
reductase	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
negative	B-X
stimulus	B-X
.	B-X

The	O
product	O
of	O
draT	B-Protein
(	O
DRAT	B-Protein
)	O
is	O
shown	O
to	O
be	O
necessary	O
for	O
this	O
modification	O
,	O
and	O
the	O
product	O
of	O
draG	B-Protein
(	O
DRAG	B-Protein
)	O
is	O
shown	O
to	O
be	O
necessary	O
for	O
the	O
removal	O
of	O
the	O
modification	O
upon	O
removal	O
of	O
the	O
stimulus	O
.	O
<EOS>	B-X
The	B-X
product	B-X
of	B-X
draT	B-X
(	B-X
DRAT	B-X
)	B-X
is	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
for	B-X
this	B-X
modification	B-X
,	B-X
and	B-X
the	B-X
product	B-X
of	B-X
draG	B-X
(	B-X
DRAG	B-X
)	B-X
is	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
for	B-X
the	B-X
removal	B-X
of	B-X
the	B-X
modification	B-X
upon	B-X
removal	B-X
of	B-X
the	B-X
stimulus	B-X
.	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
themselves	B-X
subject	B-X
to	B-X
posttranslational	B-X
regulation	B-X
,	B-X
and	B-X
this	B-X
report	B-X
identifies	B-X
features	B-X
of	B-X
that	B-X
regulation	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
DRAT	B-X
in	B-X
response	B-X
to	B-X
an	B-X
anaerobic	B-X
shift	B-X
is	B-X
transient	B-X
but	B-X
that	B-X
the	B-X
duration	B-X
of	B-X
DRAT	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
added	B-X
NH4+	B-X
varies	B-X
with	B-X
the	B-X
NH4+	B-X
concentration	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DRAG	B-X
appears	B-X
to	B-X
be	B-X
continuously	B-X
active	B-X
under	B-X
conditions	B-X
favoring	B-X
nitrogen	B-X
fixation	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
activities	B-X
of	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
not	B-X
always	B-X
coordinately	B-X
regulated	B-X
.	B-X
Finally	B-X
,	B-X
our	B-X
experiments	B-X
suggest	B-X
the	B-X
existence	B-X
of	B-X
a	B-X
temporary	B-X
period	B-X
of	B-X
futile	B-X
cycling	B-X
during	B-X
which	B-X
DRAT	B-X
and	B-X
DRAG	B-X
are	B-X
simultaneously	B-X
adding	B-X
and	B-X
removing	B-X
ADP-ribose	B-X
from	B-X
dinitrogenase	B-X
reductase	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
negative	B-X
stimulus	B-X
.	B-X

DRAG	B-Protein
and	O
DRAT	B-Protein
are	O
themselves	O
subject	O
to	O
posttranslational	O
regulation	O
,	O
and	O
this	O
report	O
identifies	O
features	O
of	O
that	O
regulation	O
.	O
<EOS>	B-X
The	B-X
product	B-X
of	B-X
draT	B-X
(	B-X
DRAT	B-X
)	B-X
is	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
for	B-X
this	B-X
modification	B-X
,	B-X
and	B-X
the	B-X
product	B-X
of	B-X
draG	B-X
(	B-X
DRAG	B-X
)	B-X
is	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
for	B-X
the	B-X
removal	B-X
of	B-X
the	B-X
modification	B-X
upon	B-X
removal	B-X
of	B-X
the	B-X
stimulus	B-X
.	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
themselves	B-X
subject	B-X
to	B-X
posttranslational	B-X
regulation	B-X
,	B-X
and	B-X
this	B-X
report	B-X
identifies	B-X
features	B-X
of	B-X
that	B-X
regulation	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
DRAT	B-X
in	B-X
response	B-X
to	B-X
an	B-X
anaerobic	B-X
shift	B-X
is	B-X
transient	B-X
but	B-X
that	B-X
the	B-X
duration	B-X
of	B-X
DRAT	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
added	B-X
NH4+	B-X
varies	B-X
with	B-X
the	B-X
NH4+	B-X
concentration	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DRAG	B-X
appears	B-X
to	B-X
be	B-X
continuously	B-X
active	B-X
under	B-X
conditions	B-X
favoring	B-X
nitrogen	B-X
fixation	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
activities	B-X
of	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
not	B-X
always	B-X
coordinately	B-X
regulated	B-X
.	B-X
Finally	B-X
,	B-X
our	B-X
experiments	B-X
suggest	B-X
the	B-X
existence	B-X
of	B-X
a	B-X
temporary	B-X
period	B-X
of	B-X
futile	B-X
cycling	B-X
during	B-X
which	B-X
DRAT	B-X
and	B-X
DRAG	B-X
are	B-X
simultaneously	B-X
adding	B-X
and	B-X
removing	B-X
ADP-ribose	B-X
from	B-X
dinitrogenase	B-X
reductase	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
negative	B-X
stimulus	B-X
.	B-X

We	O
demonstrate	O
that	O
the	O
activation	O
of	O
DRAT	B-Protein
in	O
response	O
to	O
an	O
anaerobic	O
shift	O
is	O
transient	O
but	O
that	O
the	O
duration	O
of	O
DRAT	B-Protein
activation	O
in	O
response	O
to	O
added	O
NH4	O
+	O
varies	O
with	O
the	O
NH4	O
+	O
concentration	O
.	O

In	O
contrast	O
,	O
DRAG	B-Protein
appears	O
to	O
be	O
continuously	O
active	O
under	O
conditions	O
favoring	O
nitrogen	O
fixation	O
.	O
<EOS>	B-X
In	B-X
the	B-X
microaerophilic	B-X
diazotroph	B-X
Azospirillum	B-X
brasilense	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
fixed	B-X
nitrogen	B-X
or	B-X
a	B-X
shift	B-X
to	B-X
anaerobic	B-X
conditions	B-X
leads	B-X
to	B-X
a	B-X
rapid	B-X
loss	B-X
of	B-X
nitrogenase	B-X
activity	B-X
due	B-X
to	B-X
ADP-ribosylation	B-X
of	B-X
dinitrogenase	B-X
reductase	B-X
.	B-X
The	B-X
product	B-X
of	B-X
draT	B-X
(	B-X
DRAT	B-X
)	B-X
is	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
for	B-X
this	B-X
modification	B-X
,	B-X
and	B-X
the	B-X
product	B-X
of	B-X
draG	B-X
(	B-X
DRAG	B-X
)	B-X
is	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
for	B-X
the	B-X
removal	B-X
of	B-X
the	B-X
modification	B-X
upon	B-X
removal	B-X
of	B-X
the	B-X
stimulus	B-X
.	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
themselves	B-X
subject	B-X
to	B-X
posttranslational	B-X
regulation	B-X
,	B-X
and	B-X
this	B-X
report	B-X
identifies	B-X
features	B-X
of	B-X
that	B-X
regulation	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DRAG	B-X
appears	B-X
to	B-X
be	B-X
continuously	B-X
active	B-X
under	B-X
conditions	B-X
favoring	B-X
nitrogen	B-X
fixation	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
activities	B-X
of	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
not	B-X
always	B-X
coordinately	B-X
regulated	B-X
.	B-X
Finally	B-X
,	B-X
our	B-X
experiments	B-X
suggest	B-X
the	B-X
existence	B-X
of	B-X
a	B-X
temporary	B-X
period	B-X
of	B-X
futile	B-X
cycling	B-X
during	B-X
which	B-X
DRAT	B-X
and	B-X
DRAG	B-X
are	B-X
simultaneously	B-X
adding	B-X
and	B-X
removing	B-X
ADP-ribose	B-X
from	B-X
dinitrogenase	B-X
reductase	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
negative	B-X
stimulus	B-X
.	B-X

Thus	O
,	O
the	O
activities	O
of	O
DRAG	B-Protein
and	O
DRAT	B-Protein
are	O
not	O
always	O
coordinately	O
regulated	O
.	O
<EOS>	B-X
Since	B-X
these	B-X
pioneering	B-X
studies	B-X
,	B-X
the	B-X
number	B-X
of	B-X
pathways	B-X
regulated	B-X
by	B-X
ADP-ribosylation	B-X
in	B-X
organisms	B-X
from	B-X
all	B-X
domains	B-X
of	B-X
life	B-X
expanded	B-X
significantly	B-X
.	B-X
DraT	B-X
and	B-X
DraG	B-X
activities	B-X
are	B-X
reversibly	B-X
regulated	B-X
through	B-X
interaction	B-X
with	B-X
PII	B-X
signaling	B-X
proteins	B-X
.	B-X
Furthermore	B-X
,	B-X
draT	B-X
and	B-X
draG2	B-X
were	B-X
expressed	B-X
under	B-X
all	B-X
studied	B-X
conditions	B-X
,	B-X
whereas	B-X
draG1	B-X
expression	B-X
was	B-X
nitrogen	B-X
regulated	B-X
.	B-X
Mutants	B-X
lacking	B-X
a	B-X
functional	B-X
draT	B-X
gene	B-X
had	B-X
no	B-X
dinitrogenase	B-X
reductase	B-X
ADP-ribosyltransferase	B-X
(	B-X
DRAT	B-X
,	B-X
the	B-X
draT	B-X
gene	B-X
product	B-X
)	B-X
activity	B-X
in	B-X
vitro	B-X
and	B-X
were	B-X
incapable	B-X
of	B-X
modifying	B-X
dinitrogenase	B-X
reductase	B-X
with	B-X
ADP-ribose	B-X
in	B-X
vivo	B-X
.	B-X
Mutants	B-X
lacking	B-X
a	B-X
functional	B-X
draG	B-X
gene	B-X
had	B-X
no	B-X
dinitrogenase	B-X
reductase-activating	B-X
glycohydrolase	B-X
(	B-X
DRAG	B-X
,	B-X
the	B-X
draG	B-X
gene	B-X
product	B-X
)	B-X
activity	B-X
in	B-X
vitro	B-X
and	B-X
were	B-X
unable	B-X
to	B-X
remove	B-X
ADP-ribose	B-X
from	B-X
the	B-X
modified	B-X
dinitrogenase	B-X
reductase	B-X
in	B-X
vivo	B-X
.	B-X
Strains	B-X
containing	B-X
polar	B-X
mutations	B-X
in	B-X
draT	B-X
had	B-X
no	B-X
detectable	B-X
DRAG	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
likely	B-X
cotranscription	B-X
of	B-X
draT	B-X
and	B-X
draG	B-X
.	B-X
Detection	B-X
of	B-X
DRAT	B-X
in	B-X
these	B-X
cells	B-X
in	B-X
vitro	B-X
demonstrated	B-X
that	B-X
DRAT	B-X
is	B-X
itself	B-X
subject	B-X
to	B-X
posttranslational	B-X
regulation	B-X
in	B-X
vivo	B-X
.	B-X

Finally	O
,	O
our	O
experiments	O
suggest	O
the	O
existence	O
of	O
a	O
temporary	O
period	O
of	O
futile	O
cycling	O
during	O
which	O
DRAT	B-Protein
and	O
DRAG	B-Protein
are	O
simultaneously	O
adding	O
and	O
removing	O
ADP	O
-	O
ribose	O
from	O
dinitrogenase	B-Protein
reductase	I-Protein
,	O
immediately	O
following	O
the	O
addition	O
of	O
a	O
negative	O
stimulus	O
.	O
<EOS>	B-X
In	B-X
the	B-X
microaerophilic	B-X
diazotroph	B-X
Azospirillum	B-X
brasilense	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
fixed	B-X
nitrogen	B-X
or	B-X
a	B-X
shift	B-X
to	B-X
anaerobic	B-X
conditions	B-X
leads	B-X
to	B-X
a	B-X
rapid	B-X
loss	B-X
of	B-X
nitrogenase	B-X
activity	B-X
due	B-X
to	B-X
ADP-ribosylation	B-X
of	B-X
dinitrogenase	B-X
reductase	B-X
.	B-X
The	B-X
product	B-X
of	B-X
draT	B-X
(	B-X
DRAT	B-X
)	B-X
is	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
for	B-X
this	B-X
modification	B-X
,	B-X
and	B-X
the	B-X
product	B-X
of	B-X
draG	B-X
(	B-X
DRAG	B-X
)	B-X
is	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
for	B-X
the	B-X
removal	B-X
of	B-X
the	B-X
modification	B-X
upon	B-X
removal	B-X
of	B-X
the	B-X
stimulus	B-X
.	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
themselves	B-X
subject	B-X
to	B-X
posttranslational	B-X
regulation	B-X
,	B-X
and	B-X
this	B-X
report	B-X
identifies	B-X
features	B-X
of	B-X
that	B-X
regulation	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
DRAT	B-X
in	B-X
response	B-X
to	B-X
an	B-X
anaerobic	B-X
shift	B-X
is	B-X
transient	B-X
but	B-X
that	B-X
the	B-X
duration	B-X
of	B-X
DRAT	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
added	B-X
NH4+	B-X
varies	B-X
with	B-X
the	B-X
NH4+	B-X
concentration	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DRAG	B-X
appears	B-X
to	B-X
be	B-X
continuously	B-X
active	B-X
under	B-X
conditions	B-X
favoring	B-X
nitrogen	B-X
fixation	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
activities	B-X
of	B-X
DRAG	B-X
and	B-X
DRAT	B-X
are	B-X
not	B-X
always	B-X
coordinately	B-X
regulated	B-X
.	B-X
Finally	B-X
,	B-X
our	B-X
experiments	B-X
suggest	B-X
the	B-X
existence	B-X
of	B-X
a	B-X
temporary	B-X
period	B-X
of	B-X
futile	B-X
cycling	B-X
during	B-X
which	B-X
DRAT	B-X
and	B-X
DRAG	B-X
are	B-X
simultaneously	B-X
adding	B-X
and	B-X
removing	B-X
ADP-ribose	B-X
from	B-X
dinitrogenase	B-X
reductase	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
negative	B-X
stimulus	B-X
.	B-X

The	O
mevalonate	O
pathway	O
:	O
importance	O
in	O
mesangial	O
cell	O
biology	O
and	O
glomerular	O
disease	O
.	O
<EOS>	B-X
Products	B-X
of	B-X
intracellular	B-X
mevalonate	B-X
metabolism	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
growth	B-X
and	B-X
proliferation	B-X
of	B-X
eukaryotic	B-X
cells	B-X
.	B-X
The	B-X
isoprenoid	B-X
farnesyl	B-X
is	B-X
a	B-X
particularly	B-X
important	B-X
intermediate	B-X
in	B-X
the	B-X
mevalonate	B-X
pathway	B-X
.	B-X
Inhibitors	B-X
of	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl	B-X
coenzyme	B-X
A	B-X
reductase	B-X
,	B-X
such	B-X
as	B-X
lovastatin	B-X
and	B-X
compactin	B-X
,	B-X
block	B-X
the	B-X
production	B-X
of	B-X
mevalonate	B-X
and	B-X
its	B-X
metabolites	B-X
.	B-X
These	B-X
agents	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
proliferation	B-X
of	B-X
many	B-X
cell	B-X
types	B-X
.	B-X
Recently	B-X
we	B-X
demonstrated	B-X
that	B-X
lovastatin	B-X
inhibited	B-X
proliferation	B-X
of	B-X
cultured	B-X
glomerular	B-X
mesangial	B-X
cells	B-X
.	B-X
Lovastatin	B-X
inhibition	B-X
was	B-X
overcome	B-X
by	B-X
the	B-X
simultaneous	B-X
addition	B-X
of	B-X
either	B-X
mevalonate	B-X
or	B-X
farnesol	B-X
,	B-X
but	B-X
not	B-X
by	B-X
exogenous	B-X
low	B-X
density	B-X
lipoprotein	B-X
cholesterol	B-X
.	B-X
These	B-X
results	B-X
suggested	B-X
that	B-X
farnesyl	B-X
is	B-X
critical	B-X
for	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X
In	B-X
several	B-X
experimental	B-X
models	B-X
of	B-X
renal	B-X
disease	B-X
,	B-X
chronic	B-X
lovastatin	B-X
administration	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
glomerular	B-X
injury	B-X
.	B-X
In	B-X
view	B-X
of	B-X
recent	B-X
data	B-X
,	B-X
however	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
lovastatin	B-X
may	B-X
act	B-X
to	B-X
reduce	B-X
glomerular	B-X
injury	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
a	B-X
direct	B-X
action	B-X
on	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

Products	O
of	O
intracellular	O
mevalonate	O
metabolism	O
are	O
critical	O
for	O
the	O
growth	O
and	O
proliferation	O
of	O
eukaryotic	O
cells	O
.	O
<EOS>	B-X
Products	B-X
of	B-X
intracellular	B-X
mevalonate	B-X
metabolism	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
growth	B-X
and	B-X
proliferation	B-X
of	B-X
eukaryotic	B-X
cells	B-X
.	B-X
The	B-X
isoprenoid	B-X
farnesyl	B-X
is	B-X
a	B-X
particularly	B-X
important	B-X
intermediate	B-X
in	B-X
the	B-X
mevalonate	B-X
pathway	B-X
.	B-X
Farnesylated	B-X
p21	B-X
ras	B-X
may	B-X
be	B-X
critical	B-X
for	B-X
mitogenic	B-X
signalling	B-X
stimulated	B-X
by	B-X
growth	B-X
factors	B-X
such	B-X
as	B-X
platelet-derived	B-X
growth	B-X
factor	B-X
.	B-X
Inhibitors	B-X
of	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl	B-X
coenzyme	B-X
A	B-X
reductase	B-X
,	B-X
such	B-X
as	B-X
lovastatin	B-X
and	B-X
compactin	B-X
,	B-X
block	B-X
the	B-X
production	B-X
of	B-X
mevalonate	B-X
and	B-X
its	B-X
metabolites	B-X
.	B-X
These	B-X
agents	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
proliferation	B-X
of	B-X
many	B-X
cell	B-X
types	B-X
.	B-X
Recently	B-X
we	B-X
demonstrated	B-X
that	B-X
lovastatin	B-X
inhibited	B-X
proliferation	B-X
of	B-X
cultured	B-X
glomerular	B-X
mesangial	B-X
cells	B-X
.	B-X
Lovastatin	B-X
inhibition	B-X
was	B-X
overcome	B-X
by	B-X
the	B-X
simultaneous	B-X
addition	B-X
of	B-X
either	B-X
mevalonate	B-X
or	B-X
farnesol	B-X
,	B-X
but	B-X
not	B-X
by	B-X
exogenous	B-X
low	B-X
density	B-X
lipoprotein	B-X
cholesterol	B-X
.	B-X
These	B-X
results	B-X
suggested	B-X
that	B-X
farnesyl	B-X
is	B-X
critical	B-X
for	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X
In	B-X
view	B-X
of	B-X
recent	B-X
data	B-X
,	B-X
however	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
lovastatin	B-X
may	B-X
act	B-X
to	B-X
reduce	B-X
glomerular	B-X
injury	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
a	B-X
direct	B-X
action	B-X
on	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

These	O
products	O
include	O
cholesterol	O
and	O
several	O
nonsterol	O
isoprenoids	O
.	O
<EOS>	B-X
The	B-X
mevalonate	B-X
pathway	B-X
synthesizes	B-X
intermediates	B-X
and	B-X
products	B-X
such	B-X
as	B-X
cholesterol	B-X
and	B-X
nonsterol	B-X
isoprenoids	B-X
that	B-X
are	B-X
crucial	B-X
for	B-X
cell	B-X
survival	B-X
and	B-X
function	B-X
.	B-X
In	B-X
the	B-X
human	B-X
placenta	B-X
,	B-X
the	B-X
prenylation	B-X
of	B-X
proteins	B-X
,	B-X
rather	B-X
than	B-X
cholesterol	B-X
synthesis	B-X
,	B-X
represents	B-X
the	B-X
main	B-X
``	B-X
metabolic	B-X
target	B-X
''	B-X
of	B-X
mevalonate	B-X
metabolism	B-X
.	B-X
Squalene	B-X
synthase	B-X
inhibitors	B-X
(	B-X
SSIs	B-X
)	B-X
,	B-X
such	B-X
as	B-X
squalestatin	B-X
1	B-X
(	B-X
SQ1	B-X
)	B-X
,	B-X
reduce	B-X
cholesterol	B-X
biosynthesis	B-X
but	B-X
cause	B-X
the	B-X
accumulation	B-X
of	B-X
isoprenoids	B-X
derived	B-X
from	B-X
farnesyl	B-X
pyrophosphate	B-X
(	B-X
FPP	B-X
)	B-X
,	B-X
which	B-X
can	B-X
modulate	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
receptors	B-X
,	B-X
including	B-X
the	B-X
constitutive	B-X
androstane	B-X
receptor	B-X
(	B-X
CAR	B-X
)	B-X
,	B-X
farnesoid	B-X
X	B-X
receptor	B-X
,	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptors	B-X
(	B-X
PPARs	B-X
)	B-X
.	B-X
In	B-X
comparison	B-X
,	B-X
3-hydroxy-3-methylglutaryl-coenzyme	B-X
A	B-X
reductase	B-X
inhibitors	B-X
(	B-X
e.g.	B-X
,	B-X
pravastatin	B-X
)	B-X
inhibit	B-X
production	B-X
of	B-X
both	B-X
cholesterol	B-X
and	B-X
nonsterol	B-X
isoprenoids	B-X
.	B-X
To	B-X
characterize	B-X
the	B-X
effects	B-X
of	B-X
isoprenoids	B-X
on	B-X
hepatocellular	B-X
physiology	B-X
,	B-X
microarrays	B-X
were	B-X
used	B-X
to	B-X
compare	B-X
orthologous	B-X
gene	B-X
expression	B-X
from	B-X
primary	B-X
cultured	B-X
mouse	B-X
and	B-X
rat	B-X
hepatocytes	B-X
that	B-X
were	B-X
treated	B-X
with	B-X
either	B-X
SQ1	B-X
or	B-X
pravastatin	B-X
.	B-X
Genes	B-X
involved	B-X
in	B-X
cholesterol	B-X
and	B-X
unsaturated	B-X
fatty	B-X
acid	B-X
biosynthesis	B-X
were	B-X
up-regulated	B-X
by	B-X
both	B-X
inhibitors	B-X
,	B-X
consistent	B-X
with	B-X
cholesterol	B-X
depletion	B-X
;	B-X
however	B-X
,	B-X
the	B-X
extent	B-X
of	B-X
induction	B-X
was	B-X
greater	B-X
in	B-X
rat	B-X
than	B-X
in	B-X
mouse	B-X
hepatocytes	B-X
.	B-X
SQ1	B-X
induced	B-X
several	B-X
orthologs	B-X
associated	B-X
with	B-X
microsomal	B-X
,	B-X
peroxisomal	B-X
,	B-X
and	B-X
mitochondrial	B-X
fatty	B-X
acid	B-X
oxidation	B-X
and	B-X
repressed	B-X
orthologs	B-X
involved	B-X
in	B-X
cell	B-X
cycle	B-X
regulation	B-X
.	B-X
Several	B-X
of	B-X
the	B-X
metabolic	B-X
genes	B-X
altered	B-X
by	B-X
isoprenoids	B-X
were	B-X
inducible	B-X
by	B-X
a	B-X
PPAR	B-X
agonist	B-X
,	B-X
whereas	B-X
cytochrome	B-X
P450	B-X
isoform	B-X
2B	B-X
was	B-X
inducible	B-X
by	B-X
activators	B-X
of	B-X
CAR	B-X
.	B-X

The	O
isoprenoid	O
farnesyl	O
is	O
a	O
particularly	O
important	O
intermediate	O
in	O
the	O
mevalonate	O
pathway	O
.	O
<EOS>	B-X
Products	B-X
of	B-X
intracellular	B-X
mevalonate	B-X
metabolism	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
growth	B-X
and	B-X
proliferation	B-X
of	B-X
eukaryotic	B-X
cells	B-X
.	B-X
These	B-X
products	B-X
include	B-X
cholesterol	B-X
and	B-X
several	B-X
nonsterol	B-X
isoprenoids	B-X
.	B-X
The	B-X
isoprenoid	B-X
farnesyl	B-X
is	B-X
a	B-X
particularly	B-X
important	B-X
intermediate	B-X
in	B-X
the	B-X
mevalonate	B-X
pathway	B-X
.	B-X
Inhibitors	B-X
of	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl	B-X
coenzyme	B-X
A	B-X
reductase	B-X
,	B-X
such	B-X
as	B-X
lovastatin	B-X
and	B-X
compactin	B-X
,	B-X
block	B-X
the	B-X
production	B-X
of	B-X
mevalonate	B-X
and	B-X
its	B-X
metabolites	B-X
.	B-X
Lovastatin	B-X
inhibition	B-X
was	B-X
overcome	B-X
by	B-X
the	B-X
simultaneous	B-X
addition	B-X
of	B-X
either	B-X
mevalonate	B-X
or	B-X
farnesol	B-X
,	B-X
but	B-X
not	B-X
by	B-X
exogenous	B-X
low	B-X
density	B-X
lipoprotein	B-X
cholesterol	B-X
.	B-X
These	B-X
results	B-X
suggested	B-X
that	B-X
farnesyl	B-X
is	B-X
critical	B-X
for	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

Farnesyl	O
can	O
be	O
used	O
to	O
synthesize	O
cholesterol	O
and	O
can	O
also	O
bind	O
covalently	O
to	O
several	O
low	O
molecular	O
mass	O
GTP	O
-	O
binding	O
proteins	O
such	O
as	O
p21	B-Protein
ras	I-Protein
.	O
<EOS>	B-X
These	B-X
products	B-X
include	B-X
cholesterol	B-X
and	B-X
several	B-X
nonsterol	B-X
isoprenoids	B-X
.	B-X
Farnesyl	B-X
can	B-X
be	B-X
used	B-X
to	B-X
synthesize	B-X
cholesterol	B-X
and	B-X
can	B-X
also	B-X
bind	B-X
covalently	B-X
to	B-X
several	B-X
low	B-X
molecular	B-X
mass	B-X
GTP-binding	B-X
proteins	B-X
such	B-X
as	B-X
p21	B-X
ras	B-X
.	B-X
Farnesylated	B-X
p21	B-X
ras	B-X
may	B-X
be	B-X
critical	B-X
for	B-X
mitogenic	B-X
signalling	B-X
stimulated	B-X
by	B-X
growth	B-X
factors	B-X
such	B-X
as	B-X
platelet-derived	B-X
growth	B-X
factor	B-X
.	B-X
Lovastatin	B-X
inhibition	B-X
was	B-X
overcome	B-X
by	B-X
the	B-X
simultaneous	B-X
addition	B-X
of	B-X
either	B-X
mevalonate	B-X
or	B-X
farnesol	B-X
,	B-X
but	B-X
not	B-X
by	B-X
exogenous	B-X
low	B-X
density	B-X
lipoprotein	B-X
cholesterol	B-X
.	B-X
In	B-X
several	B-X
experimental	B-X
models	B-X
of	B-X
renal	B-X
disease	B-X
,	B-X
chronic	B-X
lovastatin	B-X
administration	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
glomerular	B-X
injury	B-X
.	B-X
The	B-X
beneficial	B-X
effects	B-X
of	B-X
lovastatin	B-X
have	B-X
been	B-X
attributed	B-X
to	B-X
lowering	B-X
of	B-X
circulating	B-X
lipid	B-X
and	B-X
lipoprotein	B-X
levels	B-X
.	B-X

Farnesylated	O
p21	B-Protein
ras	I-Protein
may	O
be	O
critical	O
for	O
mitogenic	O
signalling	O
stimulated	O
by	O
growth	O
factors	O
such	O
as	O
platelet	O
-	O
derived	O
growth	O
factor	O
.	O
<EOS>	B-X
Products	B-X
of	B-X
intracellular	B-X
mevalonate	B-X
metabolism	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
growth	B-X
and	B-X
proliferation	B-X
of	B-X
eukaryotic	B-X
cells	B-X
.	B-X
Farnesyl	B-X
can	B-X
be	B-X
used	B-X
to	B-X
synthesize	B-X
cholesterol	B-X
and	B-X
can	B-X
also	B-X
bind	B-X
covalently	B-X
to	B-X
several	B-X
low	B-X
molecular	B-X
mass	B-X
GTP-binding	B-X
proteins	B-X
such	B-X
as	B-X
p21	B-X
ras	B-X
.	B-X
Farnesylated	B-X
p21	B-X
ras	B-X
may	B-X
be	B-X
critical	B-X
for	B-X
mitogenic	B-X
signalling	B-X
stimulated	B-X
by	B-X
growth	B-X
factors	B-X
such	B-X
as	B-X
platelet-derived	B-X
growth	B-X
factor	B-X
.	B-X
These	B-X
results	B-X
suggested	B-X
that	B-X
farnesyl	B-X
is	B-X
critical	B-X
for	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X
In	B-X
view	B-X
of	B-X
recent	B-X
data	B-X
,	B-X
however	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
lovastatin	B-X
may	B-X
act	B-X
to	B-X
reduce	B-X
glomerular	B-X
injury	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
a	B-X
direct	B-X
action	B-X
on	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

Inhibitors	O
of	O
the	O
enzyme	O
3	B-Protein
-	I-Protein
hydroxy	I-Protein
-	I-Protein
3	I-Protein
-	I-Protein
methylglutaryl	I-Protein
coenzyme	I-Protein
A	I-Protein
reductase	I-Protein
,	O
such	O
as	O
lovastatin	O
and	O
compactin	O
,	O
block	O
the	O
production	O
of	O
mevalonate	O
and	O
its	O
metabolites	O
.	O
<EOS>	B-X
Products	B-X
of	B-X
intracellular	B-X
mevalonate	B-X
metabolism	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
growth	B-X
and	B-X
proliferation	B-X
of	B-X
eukaryotic	B-X
cells	B-X
.	B-X
The	B-X
isoprenoid	B-X
farnesyl	B-X
is	B-X
a	B-X
particularly	B-X
important	B-X
intermediate	B-X
in	B-X
the	B-X
mevalonate	B-X
pathway	B-X
.	B-X
Inhibitors	B-X
of	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl	B-X
coenzyme	B-X
A	B-X
reductase	B-X
,	B-X
such	B-X
as	B-X
lovastatin	B-X
and	B-X
compactin	B-X
,	B-X
block	B-X
the	B-X
production	B-X
of	B-X
mevalonate	B-X
and	B-X
its	B-X
metabolites	B-X
.	B-X
Recently	B-X
we	B-X
demonstrated	B-X
that	B-X
lovastatin	B-X
inhibited	B-X
proliferation	B-X
of	B-X
cultured	B-X
glomerular	B-X
mesangial	B-X
cells	B-X
.	B-X
Lovastatin	B-X
inhibition	B-X
was	B-X
overcome	B-X
by	B-X
the	B-X
simultaneous	B-X
addition	B-X
of	B-X
either	B-X
mevalonate	B-X
or	B-X
farnesol	B-X
,	B-X
but	B-X
not	B-X
by	B-X
exogenous	B-X
low	B-X
density	B-X
lipoprotein	B-X
cholesterol	B-X
.	B-X
In	B-X
several	B-X
experimental	B-X
models	B-X
of	B-X
renal	B-X
disease	B-X
,	B-X
chronic	B-X
lovastatin	B-X
administration	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
glomerular	B-X
injury	B-X
.	B-X
The	B-X
beneficial	B-X
effects	B-X
of	B-X
lovastatin	B-X
have	B-X
been	B-X
attributed	B-X
to	B-X
lowering	B-X
of	B-X
circulating	B-X
lipid	B-X
and	B-X
lipoprotein	B-X
levels	B-X
.	B-X
In	B-X
view	B-X
of	B-X
recent	B-X
data	B-X
,	B-X
however	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
lovastatin	B-X
may	B-X
act	B-X
to	B-X
reduce	B-X
glomerular	B-X
injury	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
a	B-X
direct	B-X
action	B-X
on	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

These	O
agents	O
have	O
been	O
shown	O
to	O
inhibit	O
proliferation	O
of	O
many	O
cell	O
types	O
.	O
<EOS>	B-X
Cyclooxygenase-2	B-X
(	B-X
COX-2	B-X
)	B-X
is	B-X
frequently	B-X
expressed	B-X
in	B-X
many	B-X
types	B-X
of	B-X
cancers	B-X
exerting	B-X
a	B-X
pleiotropic	B-X
and	B-X
multifaceted	B-X
role	B-X
in	B-X
genesis	B-X
or	B-X
promotion	B-X
of	B-X
carcinogenesis	B-X
and	B-X
cancer	B-X
cell	B-X
resistance	B-X
to	B-X
chemo-	B-X
and	B-X
radiotherapy	B-X
.	B-X
COX-2	B-X
is	B-X
released	B-X
by	B-X
cancer-associated	B-X
fibroblasts	B-X
(	B-X
CAFs	B-X
)	B-X
,	B-X
macrophage	B-X
type	B-X
2	B-X
(	B-X
M2	B-X
)	B-X
cells	B-X
,	B-X
and	B-X
cancer	B-X
cells	B-X
to	B-X
the	B-X
tumor	B-X
microenvironment	B-X
(	B-X
TME	B-X
)	B-X
.	B-X
COX-2	B-X
induces	B-X
cancer	B-X
stem	B-X
cell	B-X
(	B-X
CSC	B-X
)	B-X
-like	B-X
activity	B-X
,	B-X
and	B-X
promotes	B-X
apoptotic	B-X
resistance	B-X
,	B-X
proliferation	B-X
,	B-X
angiogenesis	B-X
,	B-X
inflammation	B-X
,	B-X
invasion	B-X
,	B-X
and	B-X
metastasis	B-X
of	B-X
cancer	B-X
cells	B-X
.	B-X
COX-2	B-X
mediated	B-X
hypoxia	B-X
within	B-X
the	B-X
TME	B-X
along	B-X
with	B-X
its	B-X
positive	B-X
interactions	B-X
with	B-X
YAP1	B-X
and	B-X
antiapoptotic	B-X
mediators	B-X
are	B-X
all	B-X
in	B-X
favor	B-X
of	B-X
cancer	B-X
cell	B-X
resistance	B-X
to	B-X
chemotherapeutic	B-X
drugs	B-X
.	B-X
Multiple	B-X
signals	B-X
are	B-X
contributed	B-X
to	B-X
the	B-X
functions	B-X
of	B-X
COX-2	B-X
on	B-X
cancer	B-X
cells	B-X
or	B-X
its	B-X
regulation	B-X
.	B-X
Members	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
family	B-X
,	B-X
epidermal	B-X
growth	B-X
factor	B-X
receptor	B-X
(	B-X
EGFR	B-X
)	B-X
,	B-X
and	B-X
nuclear	B-X
factor-	B-X
are	B-X
main	B-X
upstream	B-X
modulators	B-X
for	B-X
COX-2	B-X
in	B-X
cancer	B-X
cells	B-X
.	B-X
Administration	B-X
of	B-X
COX-2	B-X
inhibitors	B-X
in	B-X
a	B-X
preoperative	B-X
setting	B-X
could	B-X
reduce	B-X
the	B-X
risk	B-X
of	B-X
metastasis	B-X
in	B-X
cancer	B-X
patients	B-X
.	B-X
COX-2	B-X
inhibition	B-X
also	B-X
sensitizes	B-X
cancer	B-X
cells	B-X
to	B-X
treatments	B-X
like	B-X
radio-	B-X
and	B-X
chemotherapy	B-X
.	B-X
Chemotherapeutic	B-X
agents	B-X
adversely	B-X
induce	B-X
COX-2	B-X
activity	B-X
.	B-X
Therefore	B-X
,	B-X
choosing	B-X
an	B-X
appropriate	B-X
chemotherapy	B-X
drugs	B-X
along	B-X
with	B-X
adjustment	B-X
of	B-X
the	B-X
type	B-X
and	B-X
does	B-X
for	B-X
COX-2	B-X
inhibitors	B-X
based	B-X
on	B-X
the	B-X
type	B-X
of	B-X
cancer	B-X
would	B-X
be	B-X
an	B-X
effective	B-X
adjuvant	B-X
strategy	B-X
for	B-X
targeting	B-X
cancer	B-X
.	B-X

Recently	O
we	O
demonstrated	O
that	O
lovastatin	O
inhibited	O
proliferation	O
of	O
cultured	O
glomerular	O
mesangial	O
cells	O
.	O
<EOS>	B-X
Products	B-X
of	B-X
intracellular	B-X
mevalonate	B-X
metabolism	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
growth	B-X
and	B-X
proliferation	B-X
of	B-X
eukaryotic	B-X
cells	B-X
.	B-X
Inhibitors	B-X
of	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl	B-X
coenzyme	B-X
A	B-X
reductase	B-X
,	B-X
such	B-X
as	B-X
lovastatin	B-X
and	B-X
compactin	B-X
,	B-X
block	B-X
the	B-X
production	B-X
of	B-X
mevalonate	B-X
and	B-X
its	B-X
metabolites	B-X
.	B-X
These	B-X
agents	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
proliferation	B-X
of	B-X
many	B-X
cell	B-X
types	B-X
.	B-X
Recently	B-X
we	B-X
demonstrated	B-X
that	B-X
lovastatin	B-X
inhibited	B-X
proliferation	B-X
of	B-X
cultured	B-X
glomerular	B-X
mesangial	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggested	B-X
that	B-X
farnesyl	B-X
is	B-X
critical	B-X
for	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X
In	B-X
several	B-X
experimental	B-X
models	B-X
of	B-X
renal	B-X
disease	B-X
,	B-X
chronic	B-X
lovastatin	B-X
administration	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
glomerular	B-X
injury	B-X
.	B-X
The	B-X
beneficial	B-X
effects	B-X
of	B-X
lovastatin	B-X
have	B-X
been	B-X
attributed	B-X
to	B-X
lowering	B-X
of	B-X
circulating	B-X
lipid	B-X
and	B-X
lipoprotein	B-X
levels	B-X
.	B-X
In	B-X
view	B-X
of	B-X
recent	B-X
data	B-X
,	B-X
however	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
lovastatin	B-X
may	B-X
act	B-X
to	B-X
reduce	B-X
glomerular	B-X
injury	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
a	B-X
direct	B-X
action	B-X
on	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

Lovastatin	O
inhibition	O
was	O
overcome	O
by	O
the	O
simultaneous	O
addition	O
of	O
either	O
mevalonate	O
or	O
farnesol	O
,	O
but	O
not	O
by	O
exogenous	O
low	O
density	O
lipoprotein	O
cholesterol	O
.	O
<EOS>	B-X
Polyprenyl	B-X
transferases	B-X
and	B-X
synthases	B-X
use	B-X
polyprenyl	B-X
pyrophosphates	B-X
as	B-X
their	B-X
natural	B-X
substrates	B-X
;	B-X
however	B-X
,	B-X
it	B-X
is	B-X
known	B-X
that	B-X
free	B-X
polyprenols	B-X
,	B-X
such	B-X
as	B-X
farnesol	B-X
(	B-X
FOH	B-X
)	B-X
,	B-X
and	B-X
geranylgeraniol	B-X
(	B-X
GGOH	B-X
)	B-X
can	B-X
be	B-X
incorporated	B-X
into	B-X
prenylated	B-X
proteins	B-X
,	B-X
ubiquinone	B-X
,	B-X
cholesterol	B-X
,	B-X
and	B-X
dolichols	B-X
.	B-X
Despite	B-X
this	B-X
,	B-X
farnesol	B-X
has	B-X
physical	B-X
and	B-X
chemical	B-X
characteristics	B-X
that	B-X
can	B-X
limit	B-X
its	B-X
use	B-X
,	B-X
such	B-X
as	B-X
high	B-X
hydrophobicity	B-X
and	B-X
volatility	B-X
.	B-X
The	B-X
combination	B-X
of	B-X
farnesol	B-X
with	B-X
nanotechnology	B-X
may	B-X
be	B-X
promising	B-X
for	B-X
the	B-X
development	B-X
of	B-X
more	B-X
effective	B-X
antibiofilm	B-X
therapies	B-X
,	B-X
as	B-X
it	B-X
can	B-X
improve	B-X
its	B-X
solubility	B-X
,	B-X
reduce	B-X
volatility	B-X
,	B-X
and	B-X
increase	B-X
bioavailability	B-X
.	B-X
This	B-X
review	B-X
summarizes	B-X
existing	B-X
data	B-X
about	B-X
farnesol	B-X
,	B-X
its	B-X
action	B-X
on	B-X
biofilms	B-X
,	B-X
and	B-X
discusses	B-X
its	B-X
encapsulation	B-X
in	B-X
nanostructured	B-X
systems	B-X
.	B-X

These	O
results	O
suggested	O
that	O
farnesyl	O
is	O
critical	O
for	O
mesangial	O
cell	O
proliferation	O
.	O
<EOS>	B-X
The	B-X
Rho	B-X
family	B-X
of	B-X
guanine	B-X
5'-triphosphatases	B-X
(	B-X
GTPases	B-X
)	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
regulating	B-X
cell	B-X
proliferation	B-X
,	B-X
tubulointerstitial	B-X
fibrosis	B-X
,	B-X
and	B-X
glomerular	B-X
hemodynamics	B-X
.	B-X
The	B-X
post-translational	B-X
prenylation	B-X
of	B-X
RhoGTPases	B-X
by	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
geranylgeranyl	B-X
moiety	B-X
is	B-X
critical	B-X
for	B-X
cellular	B-X
localization	B-X
and	B-X
signaling	B-X
activity	B-X
.	B-X
This	B-X
study	B-X
investigates	B-X
the	B-X
effects	B-X
of	B-X
(	B-X
i	B-X
)	B-X
inhibiting	B-X
geranylgeranylation	B-X
(	B-X
GG	B-X
)	B-X
in	B-X
human	B-X
mesangial	B-X
cell	B-X
(	B-X
HMC	B-X
)	B-X
proliferation	B-X
and	B-X
apoptosis	B-X
,	B-X
using	B-X
GGTI	B-X
298	B-X
,	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
GG	B-X
and	B-X
(	B-X
ii	B-X
)	B-X
lovastatin	B-X
,	B-X
an	B-X
HMG-coacetyl	B-X
A-reductase	B-X
inhibitor	B-X
,	B-X
which	B-X
depletes	B-X
the	B-X
availability	B-X
of	B-X
prenylation	B-X
substrates	B-X
.	B-X
HMC	B-X
proliferation	B-X
was	B-X
assessed	B-X
using	B-X
an	B-X
assay	B-X
of	B-X
viable	B-X
cell	B-X
number	B-X
and	B-X
measuring	B-X
bromodeoxyuridine	B-X
(	B-X
BrdU	B-X
)	B-X
incorporation	B-X
.	B-X
Extracellular	B-X
signal-regulated	B-X
protein	B-X
kinase	B-X
(	B-X
Erk	B-X
)	B-X
1/2	B-X
and	B-X
Akt	B-X
activation	B-X
were	B-X
analysed	B-X
by	B-X
Western	B-X
blotting	B-X
.	B-X
GGTI	B-X
298	B-X
(	B-X
10-20	B-X
muM	B-X
)	B-X
and	B-X
lovastatin	B-X
(	B-X
5-10	B-X
muM	B-X
)	B-X
potently	B-X
inhibited	B-X
platelet-derived	B-X
growth	B-X
factor	B-X
and	B-X
serum-stimulated	B-X
HMC	B-X
proliferation	B-X
and	B-X
induced	B-X
apoptosis	B-X
.	B-X
GGTI	B-X
298	B-X
,	B-X
lovastatin	B-X
,	B-X
and	B-X
C3	B-X
exoenzyme	B-X
inhibit	B-X
HMC	B-X
proliferation	B-X
and	B-X
promote	B-X
apoptosis	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
targeting	B-X
geranylgeranylated	B-X
proteins	B-X
with	B-X
statins	B-X
or	B-X
GGTI	B-X
298	B-X
is	B-X
a	B-X
promising	B-X
therapeutic	B-X
strategy	B-X
in	B-X
human	B-X
mesangioproliferative	B-X
renal	B-X
disease	B-X
.	B-X

In	O
several	O
experimental	O
models	O
of	O
renal	O
disease	O
,	O
chronic	O
lovastatin	O
administration	O
reduced	O
the	O
extent	O
of	O
glomerular	O
injury	O
.	O
<EOS>	B-X
These	B-X
products	B-X
include	B-X
cholesterol	B-X
and	B-X
several	B-X
nonsterol	B-X
isoprenoids	B-X
.	B-X
Farnesyl	B-X
can	B-X
be	B-X
used	B-X
to	B-X
synthesize	B-X
cholesterol	B-X
and	B-X
can	B-X
also	B-X
bind	B-X
covalently	B-X
to	B-X
several	B-X
low	B-X
molecular	B-X
mass	B-X
GTP-binding	B-X
proteins	B-X
such	B-X
as	B-X
p21	B-X
ras	B-X
.	B-X
Inhibitors	B-X
of	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl	B-X
coenzyme	B-X
A	B-X
reductase	B-X
,	B-X
such	B-X
as	B-X
lovastatin	B-X
and	B-X
compactin	B-X
,	B-X
block	B-X
the	B-X
production	B-X
of	B-X
mevalonate	B-X
and	B-X
its	B-X
metabolites	B-X
.	B-X
Recently	B-X
we	B-X
demonstrated	B-X
that	B-X
lovastatin	B-X
inhibited	B-X
proliferation	B-X
of	B-X
cultured	B-X
glomerular	B-X
mesangial	B-X
cells	B-X
.	B-X
In	B-X
several	B-X
experimental	B-X
models	B-X
of	B-X
renal	B-X
disease	B-X
,	B-X
chronic	B-X
lovastatin	B-X
administration	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
glomerular	B-X
injury	B-X
.	B-X
The	B-X
beneficial	B-X
effects	B-X
of	B-X
lovastatin	B-X
have	B-X
been	B-X
attributed	B-X
to	B-X
lowering	B-X
of	B-X
circulating	B-X
lipid	B-X
and	B-X
lipoprotein	B-X
levels	B-X
.	B-X
In	B-X
view	B-X
of	B-X
recent	B-X
data	B-X
,	B-X
however	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
lovastatin	B-X
may	B-X
act	B-X
to	B-X
reduce	B-X
glomerular	B-X
injury	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
a	B-X
direct	B-X
action	B-X
on	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

The	O
beneficial	O
effects	O
of	O
lovastatin	O
have	O
been	O
attributed	O
to	O
lowering	O
of	O
circulating	O
lipid	O
and	O
lipoprotein	O
levels	O
.	O
<EOS>	B-X
Several	B-X
recent	B-X
pieces	B-X
of	B-X
clinical	B-X
evidence	B-X
have	B-X
demonstrated	B-X
that	B-X
reduction	B-X
of	B-X
cholesterol	B-X
levels	B-X
positively	B-X
affects	B-X
outcomes	B-X
in	B-X
both	B-X
primary	B-X
and	B-X
secondary	B-X
prevention	B-X
of	B-X
atherosclerotic	B-X
vascular	B-X
disease	B-X
.	B-X
The	B-X
mechanism	B-X
for	B-X
the	B-X
beneficial	B-X
effects	B-X
of	B-X
cholesterol-lowering	B-X
interventions	B-X
has	B-X
been	B-X
attributed	B-X
to	B-X
decreased	B-X
progression	B-X
or	B-X
actual	B-X
regression	B-X
of	B-X
plaques	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
reduced	B-X
circulating	B-X
LDL	B-X
concentrations	B-X
.	B-X
The	B-X
hypothesis	B-X
of	B-X
a	B-X
direct	B-X
action	B-X
of	B-X
cholesterol-lowering	B-X
agents	B-X
,	B-X
in	B-X
particular	B-X
of	B-X
statins	B-X
,	B-X
on	B-X
endothelial	B-X
functions	B-X
,	B-X
independently	B-X
of	B-X
LDL-lowering	B-X
effects	B-X
,	B-X
will	B-X
be	B-X
discussed	B-X
.	B-X
Inhibitors	B-X
of	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl	B-X
coenzyme	B-X
A	B-X
reductase	B-X
,	B-X
such	B-X
as	B-X
lovastatin	B-X
and	B-X
compactin	B-X
,	B-X
block	B-X
the	B-X
production	B-X
of	B-X
mevalonate	B-X
and	B-X
its	B-X
metabolites	B-X
.	B-X
Recently	B-X
we	B-X
demonstrated	B-X
that	B-X
lovastatin	B-X
inhibited	B-X
proliferation	B-X
of	B-X
cultured	B-X
glomerular	B-X
mesangial	B-X
cells	B-X
.	B-X
Lovastatin	B-X
inhibition	B-X
was	B-X
overcome	B-X
by	B-X
the	B-X
simultaneous	B-X
addition	B-X
of	B-X
either	B-X
mevalonate	B-X
or	B-X
farnesol	B-X
,	B-X
but	B-X
not	B-X
by	B-X
exogenous	B-X
low	B-X
density	B-X
lipoprotein	B-X
cholesterol	B-X
.	B-X
In	B-X
several	B-X
experimental	B-X
models	B-X
of	B-X
renal	B-X
disease	B-X
,	B-X
chronic	B-X
lovastatin	B-X
administration	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
glomerular	B-X
injury	B-X
.	B-X
The	B-X
beneficial	B-X
effects	B-X
of	B-X
lovastatin	B-X
have	B-X
been	B-X
attributed	B-X
to	B-X
lowering	B-X
of	B-X
circulating	B-X
lipid	B-X
and	B-X
lipoprotein	B-X
levels	B-X
.	B-X
In	B-X
view	B-X
of	B-X
recent	B-X
data	B-X
,	B-X
however	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
lovastatin	B-X
may	B-X
act	B-X
to	B-X
reduce	B-X
glomerular	B-X
injury	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
a	B-X
direct	B-X
action	B-X
on	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

In	O
view	O
of	O
recent	O
data	O
,	O
however	O
,	O
it	O
is	O
possible	O
that	O
lovastatin	O
may	O
act	O
to	O
reduce	O
glomerular	O
injury	O
,	O
at	O
least	O
in	O
part	O
,	O
through	O
a	O
direct	O
action	O
on	O
mesangial	O
cell	O
proliferation	O
.	O
<EOS>	B-X
Products	B-X
of	B-X
intracellular	B-X
mevalonate	B-X
metabolism	B-X
are	B-X
critical	B-X
for	B-X
the	B-X
growth	B-X
and	B-X
proliferation	B-X
of	B-X
eukaryotic	B-X
cells	B-X
.	B-X
The	B-X
isoprenoid	B-X
farnesyl	B-X
is	B-X
a	B-X
particularly	B-X
important	B-X
intermediate	B-X
in	B-X
the	B-X
mevalonate	B-X
pathway	B-X
.	B-X
Farnesylated	B-X
p21	B-X
ras	B-X
may	B-X
be	B-X
critical	B-X
for	B-X
mitogenic	B-X
signalling	B-X
stimulated	B-X
by	B-X
growth	B-X
factors	B-X
such	B-X
as	B-X
platelet-derived	B-X
growth	B-X
factor	B-X
.	B-X
Inhibitors	B-X
of	B-X
the	B-X
enzyme	B-X
3-hydroxy-3-methylglutaryl	B-X
coenzyme	B-X
A	B-X
reductase	B-X
,	B-X
such	B-X
as	B-X
lovastatin	B-X
and	B-X
compactin	B-X
,	B-X
block	B-X
the	B-X
production	B-X
of	B-X
mevalonate	B-X
and	B-X
its	B-X
metabolites	B-X
.	B-X
These	B-X
agents	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
proliferation	B-X
of	B-X
many	B-X
cell	B-X
types	B-X
.	B-X
Recently	B-X
we	B-X
demonstrated	B-X
that	B-X
lovastatin	B-X
inhibited	B-X
proliferation	B-X
of	B-X
cultured	B-X
glomerular	B-X
mesangial	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggested	B-X
that	B-X
farnesyl	B-X
is	B-X
critical	B-X
for	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X
In	B-X
several	B-X
experimental	B-X
models	B-X
of	B-X
renal	B-X
disease	B-X
,	B-X
chronic	B-X
lovastatin	B-X
administration	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
glomerular	B-X
injury	B-X
.	B-X
The	B-X
beneficial	B-X
effects	B-X
of	B-X
lovastatin	B-X
have	B-X
been	B-X
attributed	B-X
to	B-X
lowering	B-X
of	B-X
circulating	B-X
lipid	B-X
and	B-X
lipoprotein	B-X
levels	B-X
.	B-X
In	B-X
view	B-X
of	B-X
recent	B-X
data	B-X
,	B-X
however	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
lovastatin	B-X
may	B-X
act	B-X
to	B-X
reduce	B-X
glomerular	B-X
injury	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
a	B-X
direct	B-X
action	B-X
on	B-X
mesangial	B-X
cell	B-X
proliferation	B-X
.	B-X

Use	O
of	O
photoactivatable	O
peptide	O
substrates	O
of	O
Saccharomyces	O
cerevisiae	O
myristoyl	B-Protein
-	I-Protein
CoA	I-Protein
:	I-Protein
protein	I-Protein
N	I-Protein
-	I-Protein
myristoyltransferase	I-Protein
(	O
Nmt1p	B-Protein
)	O
to	O
characterize	O
a	O
myristoyl	O
-	O
CoA	O
-	O
Nmt1p	B-Protein
-	O
peptide	O
ternary	O
complex	O
and	O
to	O
provide	O
evidence	O
for	O
an	O
ordered	O
reaction	O
mechanism	O
.	O
<EOS>	B-X
Nmt1p	B-X
(	B-X
EC	B-X
2.3.1.97	B-X
)	B-X
catalyzes	B-X
the	B-X
transfer	B-X
of	B-X
myristate	B-X
(	B-X
C14:0	B-X
)	B-X
from	B-X
coenzyme	B-X
A	B-X
to	B-X
the	B-X
N-terminal	B-X
glycine	B-X
residue	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
eukaryotic	B-X
cellular	B-X
and	B-X
viral	B-X
proteins	B-X
.	B-X
Our	B-X
recent	B-X
studies	B-X
of	B-X
the	B-X
455-amino	B-X
acid	B-X
Saccharomyces	B-X
cerevisiae	B-X
acyltransferase	B-X
(	B-X
Nmt1p	B-X
)	B-X
suggested	B-X
that	B-X
its	B-X
mechanism	B-X
of	B-X
catalysis	B-X
is	B-X
ordered	B-X
Bi	B-X
Bi	B-X
with	B-X
myristoyl-CoA	B-X
binding	B-X
occurring	B-X
prior	B-X
to	B-X
binding	B-X
of	B-X
peptide	B-X
and	B-X
release	B-X
of	B-X
CoA	B-X
occurring	B-X
prior	B-X
to	B-X
release	B-X
of	B-X
the	B-X
myristoyl-peptide	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
enzyme	B-X
and	B-X
peptide	B-X
has	B-X
now	B-X
been	B-X
examined	B-X
in	B-X
greater	B-X
detail	B-X
by	B-X
using	B-X
photoactivatable	B-X
octapeptide	B-X
substrates	B-X
containing	B-X
125I-labeled	B-X
azidosalicyclic	B-X
acid	B-X
attached	B-X
via	B-X
an	B-X
amide	B-X
bond	B-X
to	B-X
the	B-X
gamma-amino	B-X
group	B-X
of	B-X
a	B-X
diaminobutyrate	B-X
residue	B-X
located	B-X
at	B-X
position	B-X
2	B-X
or	B-X
the	B-X
epsilon-amino	B-X
group	B-X
of	B-X
a	B-X
lysine	B-X
residue	B-X
located	B-X
at	B-X
position	B-X
8	B-X
.	B-X
The	B-X
photopeptides	B-X
can	B-X
be	B-X
specifically	B-X
crosslinked	B-X
to	B-X
chymotryptic	B-X
fragments	B-X
of	B-X
Nmt1p	B-X
in	B-X
the	B-X
presence	B-X
but	B-X
not	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
a	B-X
nonhydrolyzable	B-X
myristoyl-CoA	B-X
analog	B-X
,	B-X
S-	B-X
(	B-X
2-oxo	B-X
)	B-X
pentadecyl-CoA	B-X
.	B-X
Labeling	B-X
of	B-X
the	B-X
chymotryptic	B-X
fragments	B-X
is	B-X
markedly	B-X
reduced	B-X
when	B-X
GLYASKLS	B-X
,	B-X
a	B-X
high-affinity	B-X
substrate	B-X
derived	B-X
from	B-X
residues	B-X
2-9	B-X
of	B-X
S.	B-X
cerevisiae	B-X
ADP-ribosylation	B-X
factor	B-X
2	B-X
,	B-X
or	B-X
ALYASKLS	B-X
,	B-X
a	B-X
competitive	B-X
inhibitor	B-X
(	B-X
for	B-X
peptide	B-X
)	B-X
,	B-X
is	B-X
added	B-X
with	B-X
the	B-X
iodinated	B-X
photopeptide	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
peptide	B-X
affinity	B-X
for	B-X
the	B-X
acyl-CoA-Nmt1p	B-X
binary	B-X
complex	B-X
is	B-X
much	B-X
greater	B-X
than	B-X
it	B-X
is	B-X
for	B-X
apoNmt1p	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ordered	B-X
Bi	B-X
Bi	B-X
mechanism	B-X
ascribed	B-X
to	B-X
Nmt1p	B-X
.	B-X
Finally	B-X
,	B-X
automated	B-X
sequential	B-X
Edman	B-X
degradation	B-X
of	B-X
these	B-X
chymotryptic	B-X
fragments	B-X
suggests	B-X
that	B-X
the	B-X
peptide	B-X
binding	B-X
domain	B-X
of	B-X
Nmt1p	B-X
may	B-X
be	B-X
composed	B-X
of	B-X
elements	B-X
from	B-X
two	B-X
protease-resistant	B-X
domains	B-X
,	B-X
Arg42-Try219	B-X
and	B-X
Thr220-Leu455	B-X
.	B-X

Nmt1p	B-Protein
(	O
EC	O
2	O
.	O
3	O
.	O
1	O
.	O
97	O
)	O
catalyzes	O
the	O
transfer	O
of	O
myristate	O
(	O
C14	O
:	O
0	O
)	O
from	O
coenzyme	O
A	O
to	O
the	O
N	O
-	O
terminal	O
glycine	O
residue	O
of	O
a	O
variety	O
of	O
eukaryotic	O
cellular	O
and	O
viral	O
proteins	O
.	O

Our	O
recent	O
studies	O
of	O
the	O
455	O
-	O
amino	O
acid	O
Saccharomyces	O
cerevisiae	O
acyltransferase	O
(	O
Nmt1p	B-Protein
)	O
suggested	O
that	O
its	O
mechanism	O
of	O
catalysis	O
is	O
ordered	O
Bi	O
Bi	O
with	O
myristoyl	O
-	O
CoA	O
binding	O
occurring	O
prior	O
to	O
binding	O
of	O
peptide	O
and	O
release	O
of	O
CoA	O
occurring	O
prior	O
to	O
release	O
of	O
the	O
myristoyl	O
-	O
peptide	O
.	O

The	O
interaction	O
between	O
enzyme	O
and	O
peptide	O
has	O
now	O
been	O
examined	O
in	O
greater	O
detail	O
by	O
using	O
photoactivatable	O
octapeptide	O
substrates	O
containing	O
125I	O
-	O
labeled	O
azidosalicyclic	O
acid	O
attached	O
via	O
an	O
amide	O
bond	O
to	O
the	O
gamma	O
-	O
amino	O
group	O
of	O
a	O
diaminobutyrate	O
residue	O
located	O
at	O
position	O
2	O
or	O
the	O
epsilon	O
-	O
amino	O
group	O
of	O
a	O
lysine	O
residue	O
located	O
at	O
position	O
8	O
.	O
<EOS>	B-X
Nmt1p	B-X
(	B-X
EC	B-X
2.3.1.97	B-X
)	B-X
catalyzes	B-X
the	B-X
transfer	B-X
of	B-X
myristate	B-X
(	B-X
C14:0	B-X
)	B-X
from	B-X
coenzyme	B-X
A	B-X
to	B-X
the	B-X
N-terminal	B-X
glycine	B-X
residue	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
eukaryotic	B-X
cellular	B-X
and	B-X
viral	B-X
proteins	B-X
.	B-X
Our	B-X
recent	B-X
studies	B-X
of	B-X
the	B-X
455-amino	B-X
acid	B-X
Saccharomyces	B-X
cerevisiae	B-X
acyltransferase	B-X
(	B-X
Nmt1p	B-X
)	B-X
suggested	B-X
that	B-X
its	B-X
mechanism	B-X
of	B-X
catalysis	B-X
is	B-X
ordered	B-X
Bi	B-X
Bi	B-X
with	B-X
myristoyl-CoA	B-X
binding	B-X
occurring	B-X
prior	B-X
to	B-X
binding	B-X
of	B-X
peptide	B-X
and	B-X
release	B-X
of	B-X
CoA	B-X
occurring	B-X
prior	B-X
to	B-X
release	B-X
of	B-X
the	B-X
myristoyl-peptide	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
enzyme	B-X
and	B-X
peptide	B-X
has	B-X
now	B-X
been	B-X
examined	B-X
in	B-X
greater	B-X
detail	B-X
by	B-X
using	B-X
photoactivatable	B-X
octapeptide	B-X
substrates	B-X
containing	B-X
125I-labeled	B-X
azidosalicyclic	B-X
acid	B-X
attached	B-X
via	B-X
an	B-X
amide	B-X
bond	B-X
to	B-X
the	B-X
gamma-amino	B-X
group	B-X
of	B-X
a	B-X
diaminobutyrate	B-X
residue	B-X
located	B-X
at	B-X
position	B-X
2	B-X
or	B-X
the	B-X
epsilon-amino	B-X
group	B-X
of	B-X
a	B-X
lysine	B-X
residue	B-X
located	B-X
at	B-X
position	B-X
8	B-X
.	B-X
The	B-X
photopeptides	B-X
can	B-X
be	B-X
specifically	B-X
crosslinked	B-X
to	B-X
chymotryptic	B-X
fragments	B-X
of	B-X
Nmt1p	B-X
in	B-X
the	B-X
presence	B-X
but	B-X
not	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
a	B-X
nonhydrolyzable	B-X
myristoyl-CoA	B-X
analog	B-X
,	B-X
S-	B-X
(	B-X
2-oxo	B-X
)	B-X
pentadecyl-CoA	B-X
.	B-X
Labeling	B-X
of	B-X
the	B-X
chymotryptic	B-X
fragments	B-X
is	B-X
markedly	B-X
reduced	B-X
when	B-X
GLYASKLS	B-X
,	B-X
a	B-X
high-affinity	B-X
substrate	B-X
derived	B-X
from	B-X
residues	B-X
2-9	B-X
of	B-X
S.	B-X
cerevisiae	B-X
ADP-ribosylation	B-X
factor	B-X
2	B-X
,	B-X
or	B-X
ALYASKLS	B-X
,	B-X
a	B-X
competitive	B-X
inhibitor	B-X
(	B-X
for	B-X
peptide	B-X
)	B-X
,	B-X
is	B-X
added	B-X
with	B-X
the	B-X
iodinated	B-X
photopeptide	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
peptide	B-X
affinity	B-X
for	B-X
the	B-X
acyl-CoA-Nmt1p	B-X
binary	B-X
complex	B-X
is	B-X
much	B-X
greater	B-X
than	B-X
it	B-X
is	B-X
for	B-X
apoNmt1p	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ordered	B-X
Bi	B-X
Bi	B-X
mechanism	B-X
ascribed	B-X
to	B-X
Nmt1p	B-X
.	B-X
Finally	B-X
,	B-X
automated	B-X
sequential	B-X
Edman	B-X
degradation	B-X
of	B-X
these	B-X
chymotryptic	B-X
fragments	B-X
suggests	B-X
that	B-X
the	B-X
peptide	B-X
binding	B-X
domain	B-X
of	B-X
Nmt1p	B-X
may	B-X
be	B-X
composed	B-X
of	B-X
elements	B-X
from	B-X
two	B-X
protease-resistant	B-X
domains	B-X
,	B-X
Arg42-Try219	B-X
and	B-X
Thr220-Leu455	B-X
.	B-X

The	O
photopeptides	O
can	O
be	O
specifically	O
crosslinked	O
to	O
chymotryptic	O
fragments	O
of	O
Nmt1p	B-Protein
in	O
the	O
presence	O
but	O
not	O
in	O
the	O
absence	O
of	O
a	O
nonhydrolyzable	O
myristoyl	O
-	O
CoA	O
analog	O
,	O
S	O
-	O
(	O
2	O
-	O
oxo	O
)	O
pentadecyl	O
-	O
CoA	O
.	O

Labeling	O
of	O
the	O
chymotryptic	O
fragments	O
is	O
markedly	O
reduced	O
when	O
GLYASKLS	O
,	O
a	O
high	O
-	O
affinity	O
substrate	O
derived	O
from	O
residues	O
2	O
-	O
9	O
of	O
S	O
.	O
cerevisiae	O
ADP	B-Protein
-	I-Protein
ribosylation	I-Protein
factor	I-Protein
2	I-Protein
,	O
or	O
ALYASKLS	O
,	O
a	O
competitive	O
inhibitor	O
(	O
for	O
peptide	O
)	O
,	O
is	O
added	O
with	O
the	O
iodinated	O
photopeptide	O
.	O
<EOS>	B-X
Nmt1p	B-X
(	B-X
EC	B-X
2.3.1.97	B-X
)	B-X
catalyzes	B-X
the	B-X
transfer	B-X
of	B-X
myristate	B-X
(	B-X
C14:0	B-X
)	B-X
from	B-X
coenzyme	B-X
A	B-X
to	B-X
the	B-X
N-terminal	B-X
glycine	B-X
residue	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
eukaryotic	B-X
cellular	B-X
and	B-X
viral	B-X
proteins	B-X
.	B-X
Our	B-X
recent	B-X
studies	B-X
of	B-X
the	B-X
455-amino	B-X
acid	B-X
Saccharomyces	B-X
cerevisiae	B-X
acyltransferase	B-X
(	B-X
Nmt1p	B-X
)	B-X
suggested	B-X
that	B-X
its	B-X
mechanism	B-X
of	B-X
catalysis	B-X
is	B-X
ordered	B-X
Bi	B-X
Bi	B-X
with	B-X
myristoyl-CoA	B-X
binding	B-X
occurring	B-X
prior	B-X
to	B-X
binding	B-X
of	B-X
peptide	B-X
and	B-X
release	B-X
of	B-X
CoA	B-X
occurring	B-X
prior	B-X
to	B-X
release	B-X
of	B-X
the	B-X
myristoyl-peptide	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
enzyme	B-X
and	B-X
peptide	B-X
has	B-X
now	B-X
been	B-X
examined	B-X
in	B-X
greater	B-X
detail	B-X
by	B-X
using	B-X
photoactivatable	B-X
octapeptide	B-X
substrates	B-X
containing	B-X
125I-labeled	B-X
azidosalicyclic	B-X
acid	B-X
attached	B-X
via	B-X
an	B-X
amide	B-X
bond	B-X
to	B-X
the	B-X
gamma-amino	B-X
group	B-X
of	B-X
a	B-X
diaminobutyrate	B-X
residue	B-X
located	B-X
at	B-X
position	B-X
2	B-X
or	B-X
the	B-X
epsilon-amino	B-X
group	B-X
of	B-X
a	B-X
lysine	B-X
residue	B-X
located	B-X
at	B-X
position	B-X
8	B-X
.	B-X
The	B-X
photopeptides	B-X
can	B-X
be	B-X
specifically	B-X
crosslinked	B-X
to	B-X
chymotryptic	B-X
fragments	B-X
of	B-X
Nmt1p	B-X
in	B-X
the	B-X
presence	B-X
but	B-X
not	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
a	B-X
nonhydrolyzable	B-X
myristoyl-CoA	B-X
analog	B-X
,	B-X
S-	B-X
(	B-X
2-oxo	B-X
)	B-X
pentadecyl-CoA	B-X
.	B-X
Labeling	B-X
of	B-X
the	B-X
chymotryptic	B-X
fragments	B-X
is	B-X
markedly	B-X
reduced	B-X
when	B-X
GLYASKLS	B-X
,	B-X
a	B-X
high-affinity	B-X
substrate	B-X
derived	B-X
from	B-X
residues	B-X
2-9	B-X
of	B-X
S.	B-X
cerevisiae	B-X
ADP-ribosylation	B-X
factor	B-X
2	B-X
,	B-X
or	B-X
ALYASKLS	B-X
,	B-X
a	B-X
competitive	B-X
inhibitor	B-X
(	B-X
for	B-X
peptide	B-X
)	B-X
,	B-X
is	B-X
added	B-X
with	B-X
the	B-X
iodinated	B-X
photopeptide	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
peptide	B-X
affinity	B-X
for	B-X
the	B-X
acyl-CoA-Nmt1p	B-X
binary	B-X
complex	B-X
is	B-X
much	B-X
greater	B-X
than	B-X
it	B-X
is	B-X
for	B-X
apoNmt1p	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ordered	B-X
Bi	B-X
Bi	B-X
mechanism	B-X
ascribed	B-X
to	B-X
Nmt1p	B-X
.	B-X
Finally	B-X
,	B-X
automated	B-X
sequential	B-X
Edman	B-X
degradation	B-X
of	B-X
these	B-X
chymotryptic	B-X
fragments	B-X
suggests	B-X
that	B-X
the	B-X
peptide	B-X
binding	B-X
domain	B-X
of	B-X
Nmt1p	B-X
may	B-X
be	B-X
composed	B-X
of	B-X
elements	B-X
from	B-X
two	B-X
protease-resistant	B-X
domains	B-X
,	B-X
Arg42-Try219	B-X
and	B-X
Thr220-Leu455	B-X
.	B-X

These	O
findings	O
suggest	O
that	O
peptide	O
affinity	O
for	O
the	O
acyl	O
-	O
CoA	O
-	O
Nmt1p	B-Protein
binary	O
complex	O
is	O
much	O
greater	O
than	O
it	O
is	O
for	O
apoNmt1p	B-Protein
,	O
consistent	O
with	O
the	O
ordered	O
Bi	O
Bi	O
mechanism	O
ascribed	O
to	O
Nmt1p	B-Protein
.	O

Finally	O
,	O
automated	O
sequential	O
Edman	O
degradation	O
of	O
these	O
chymotryptic	O
fragments	O
suggests	O
that	O
the	O
peptide	O
binding	O
domain	O
of	O
Nmt1p	B-Protein
may	O
be	O
composed	O
of	O
elements	O
from	O
two	O
protease	O
-	O
resistant	O
domains	O
,	O
Arg42	O
-	O
Try219	O
and	O
Thr220	O
-	O
Leu455	O
.	O
<EOS>	B-X
Nmt1p	B-X
(	B-X
EC	B-X
2.3.1.97	B-X
)	B-X
catalyzes	B-X
the	B-X
transfer	B-X
of	B-X
myristate	B-X
(	B-X
C14:0	B-X
)	B-X
from	B-X
coenzyme	B-X
A	B-X
to	B-X
the	B-X
N-terminal	B-X
glycine	B-X
residue	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
eukaryotic	B-X
cellular	B-X
and	B-X
viral	B-X
proteins	B-X
.	B-X
Our	B-X
recent	B-X
studies	B-X
of	B-X
the	B-X
455-amino	B-X
acid	B-X
Saccharomyces	B-X
cerevisiae	B-X
acyltransferase	B-X
(	B-X
Nmt1p	B-X
)	B-X
suggested	B-X
that	B-X
its	B-X
mechanism	B-X
of	B-X
catalysis	B-X
is	B-X
ordered	B-X
Bi	B-X
Bi	B-X
with	B-X
myristoyl-CoA	B-X
binding	B-X
occurring	B-X
prior	B-X
to	B-X
binding	B-X
of	B-X
peptide	B-X
and	B-X
release	B-X
of	B-X
CoA	B-X
occurring	B-X
prior	B-X
to	B-X
release	B-X
of	B-X
the	B-X
myristoyl-peptide	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
enzyme	B-X
and	B-X
peptide	B-X
has	B-X
now	B-X
been	B-X
examined	B-X
in	B-X
greater	B-X
detail	B-X
by	B-X
using	B-X
photoactivatable	B-X
octapeptide	B-X
substrates	B-X
containing	B-X
125I-labeled	B-X
azidosalicyclic	B-X
acid	B-X
attached	B-X
via	B-X
an	B-X
amide	B-X
bond	B-X
to	B-X
the	B-X
gamma-amino	B-X
group	B-X
of	B-X
a	B-X
diaminobutyrate	B-X
residue	B-X
located	B-X
at	B-X
position	B-X
2	B-X
or	B-X
the	B-X
epsilon-amino	B-X
group	B-X
of	B-X
a	B-X
lysine	B-X
residue	B-X
located	B-X
at	B-X
position	B-X
8	B-X
.	B-X
The	B-X
photopeptides	B-X
can	B-X
be	B-X
specifically	B-X
crosslinked	B-X
to	B-X
chymotryptic	B-X
fragments	B-X
of	B-X
Nmt1p	B-X
in	B-X
the	B-X
presence	B-X
but	B-X
not	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
a	B-X
nonhydrolyzable	B-X
myristoyl-CoA	B-X
analog	B-X
,	B-X
S-	B-X
(	B-X
2-oxo	B-X
)	B-X
pentadecyl-CoA	B-X
.	B-X
Labeling	B-X
of	B-X
the	B-X
chymotryptic	B-X
fragments	B-X
is	B-X
markedly	B-X
reduced	B-X
when	B-X
GLYASKLS	B-X
,	B-X
a	B-X
high-affinity	B-X
substrate	B-X
derived	B-X
from	B-X
residues	B-X
2-9	B-X
of	B-X
S.	B-X
cerevisiae	B-X
ADP-ribosylation	B-X
factor	B-X
2	B-X
,	B-X
or	B-X
ALYASKLS	B-X
,	B-X
a	B-X
competitive	B-X
inhibitor	B-X
(	B-X
for	B-X
peptide	B-X
)	B-X
,	B-X
is	B-X
added	B-X
with	B-X
the	B-X
iodinated	B-X
photopeptide	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
peptide	B-X
affinity	B-X
for	B-X
the	B-X
acyl-CoA-Nmt1p	B-X
binary	B-X
complex	B-X
is	B-X
much	B-X
greater	B-X
than	B-X
it	B-X
is	B-X
for	B-X
apoNmt1p	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ordered	B-X
Bi	B-X
Bi	B-X
mechanism	B-X
ascribed	B-X
to	B-X
Nmt1p	B-X
.	B-X
Finally	B-X
,	B-X
automated	B-X
sequential	B-X
Edman	B-X
degradation	B-X
of	B-X
these	B-X
chymotryptic	B-X
fragments	B-X
suggests	B-X
that	B-X
the	B-X
peptide	B-X
binding	B-X
domain	B-X
of	B-X
Nmt1p	B-X
may	B-X
be	B-X
composed	B-X
of	B-X
elements	B-X
from	B-X
two	B-X
protease-resistant	B-X
domains	B-X
,	B-X
Arg42-Try219	B-X
and	B-X
Thr220-Leu455	B-X
.	B-X

Prenyl	O
modification	O
of	O
guanine	B-Protein
nucleotide	I-Protein
regulatory	I-Protein
protein	I-Protein
gamma	I-Protein
2	I-Protein
subunits	O
is	O
not	O
required	O
for	O
interaction	O
with	O
the	O
transducin	O
alpha	O
subunit	O
or	O
rhodopsin	B-Protein
.	O
<EOS>	B-X
The	B-X
first	B-X
microbial	B-X
rhodopsin	B-X
,	B-X
a	B-X
light-driven	B-X
proton	B-X
pump	B-X
bacteriorhodopsin	B-X
from	B-X
Halobacterium	B-X
salinarum	B-X
(	B-X
HsBR	B-X
)	B-X
,	B-X
was	B-X
discovered	B-X
in	B-X
1971	B-X
.	B-X
Since	B-X
then	B-X
,	B-X
this	B-X
seven--helical	B-X
protein	B-X
,	B-X
comprising	B-X
a	B-X
retinal	B-X
molecule	B-X
as	B-X
a	B-X
cofactor	B-X
,	B-X
became	B-X
a	B-X
major	B-X
driver	B-X
of	B-X
groundbreaking	B-X
developments	B-X
in	B-X
membrane	B-X
protein	B-X
research	B-X
.	B-X
However	B-X
,	B-X
until	B-X
1999	B-X
only	B-X
a	B-X
few	B-X
archaeal	B-X
rhodopsins	B-X
,	B-X
acting	B-X
as	B-X
light-driven	B-X
proton	B-X
and	B-X
chloride	B-X
pumps	B-X
and	B-X
also	B-X
photosensors	B-X
,	B-X
were	B-X
known	B-X
.	B-X
A	B-X
new	B-X
microbial	B-X
rhodopsin	B-X
era	B-X
started	B-X
in	B-X
2000	B-X
when	B-X
the	B-X
first	B-X
bacterial	B-X
rhodopsin	B-X
,	B-X
a	B-X
proton	B-X
pump	B-X
,	B-X
was	B-X
discovered	B-X
.	B-X
Later	B-X
it	B-X
became	B-X
clear	B-X
that	B-X
there	B-X
are	B-X
unexpectedly	B-X
many	B-X
rhodopsins	B-X
,	B-X
and	B-X
they	B-X
are	B-X
present	B-X
in	B-X
all	B-X
the	B-X
domains	B-X
of	B-X
life	B-X
and	B-X
even	B-X
in	B-X
viruses	B-X
.	B-X
The	B-X
incredible	B-X
evolution	B-X
of	B-X
the	B-X
research	B-X
area	B-X
of	B-X
rhodopsins	B-X
and	B-X
the	B-X
scientific	B-X
and	B-X
technological	B-X
potential	B-X
of	B-X
the	B-X
proteins	B-X
is	B-X
described	B-X
in	B-X
the	B-X
review	B-X
with	B-X
a	B-X
focus	B-X
on	B-X
their	B-X
function-structure	B-X
relationships	B-X
.	B-X

Guanine	O
nucleotide	O
-	O
binding	O
regulatory	O
protein	O
(	O
G	O
protein	O
)	O
beta	O
gamma	O
dimers	O
that	O
were	O
active	O
in	O
reconstitution	O
assays	O
were	O
produced	O
in	O
insect	O
cells	O
using	O
the	O
baculovirus	O
/	O
Sf9	O
insect	O
cell	O
expression	O
system	O
.	O
<EOS>	B-X
Guanine	B-X
nucleotide-binding	B-X
regulatory	B-X
protein	B-X
(	B-X
G	B-X
protein	B-X
)	B-X
beta	B-X
gamma	B-X
dimers	B-X
that	B-X
were	B-X
active	B-X
in	B-X
reconstitution	B-X
assays	B-X
were	B-X
produced	B-X
in	B-X
insect	B-X
cells	B-X
using	B-X
the	B-X
baculovirus/Sf9	B-X
insect	B-X
cell	B-X
expression	B-X
system	B-X
.	B-X
Sf9	B-X
cells	B-X
were	B-X
infected	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
recombinant	B-X
baculoviruses	B-X
containing	B-X
a	B-X
human	B-X
G-protein	B-X
beta	B-X
1	B-X
gene	B-X
or	B-X
a	B-X
bovine	B-X
G-protein	B-X
gamma	B-X
2	B-X
gene	B-X
.	B-X
It	B-X
was	B-X
possible	B-X
to	B-X
express	B-X
the	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
gene	B-X
products	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
in	B-X
this	B-X
system	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
using	B-X
immunological	B-X
and	B-X
metabolic	B-X
labeling	B-X
techniques	B-X
.	B-X
Further	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
recombinant	B-X
beta	B-X
and/or	B-X
gamma	B-X
chains	B-X
to	B-X
function	B-X
in	B-X
defined	B-X
biochemical	B-X
assays	B-X
of	B-X
beta	B-X
gamma	B-X
activity	B-X
was	B-X
assessed	B-X
for	B-X
membrane	B-X
extracts	B-X
and	B-X
supernatant	B-X
fractions	B-X
from	B-X
infected	B-X
Sf9	B-X
cells	B-X
.	B-X
Extracts	B-X
of	B-X
cells	B-X
expressing	B-X
beta	B-X
or	B-X
gamma	B-X
chain	B-X
alone	B-X
were	B-X
inactive	B-X
in	B-X
these	B-X
assays	B-X
,	B-X
whereas	B-X
those	B-X
from	B-X
cells	B-X
coinfected	B-X
with	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
did	B-X
display	B-X
activity	B-X
.	B-X
These	B-X
assays	B-X
were	B-X
used	B-X
to	B-X
identify	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimer	B-X
migration	B-X
during	B-X
chromatographic	B-X
purification	B-X
,	B-X
and	B-X
the	B-X
recombinant	B-X
dimers	B-X
were	B-X
purified	B-X
to	B-X
near	B-X
homogeneity	B-X
.	B-X
Both	B-X
the	B-X
membrane-associated	B-X
and	B-X
soluble	B-X
beta	B-X
gamma	B-X
dimers	B-X
facilitated	B-X
rhodopsin-catalyzed	B-X
guanosine	B-X
5'-	B-X
[	B-X
gamma-thio	B-X
]	B-X
triphosphate	B-X
binding	B-X
to	B-X
Gt	B-X
alpha	B-X
,	B-X
the	B-X
GTP-binding	B-X
subunit	B-X
of	B-X
the	B-X
retinal	B-X
G	B-X
protein	B-X
transducin	B-X
(	B-X
K0.5	B-X
of	B-X
13	B-X
+/-	B-X
2	B-X
and	B-X
36	B-X
+/-	B-X
5	B-X
nM	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
Both	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimers	B-X
also	B-X
facilitated	B-X
the	B-X
pertussis	B-X
toxin-catalyzed	B-X
ADP-ribosylation	B-X
of	B-X
Gt	B-X
alpha	B-X
with	B-X
equal	B-X
potency	B-X
(	B-X
K0.5	B-X
of	B-X
9	B-X
+/-	B-X
1	B-X
and	B-X
10	B-X
+/-	B-X
3	B-X
nM	B-X
for	B-X
membrane	B-X
and	B-X
soluble	B-X
dimers	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Mevalonolactone	B-X
labeling	B-X
showed	B-X
that	B-X
the	B-X
gamma	B-X
2	B-X
subunits	B-X
of	B-X
membrane-associated	B-X
beta	B-X
gamma	B-X
dimers	B-X
incorporated	B-X
radiolabel	B-X
,	B-X
whereas	B-X
in	B-X
the	B-X
soluble	B-X
form	B-X
they	B-X
did	B-X
not	B-X
.	B-X
Thus	B-X
,	B-X
prenyl	B-X
modification	B-X
of	B-X
gamma	B-X
2	B-X
directs	B-X
the	B-X
membrane	B-X
association	B-X
of	B-X
the	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
dimer	B-X
and	B-X
increases	B-X
its	B-X
apparent	B-X
affinity	B-X
for	B-X
receptor	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
required	B-X
for	B-X
the	B-X
functional	B-X
interaction	B-X
(	B-X
s	B-X
)	B-X
of	B-X
the	B-X
dimer	B-X
.	B-X

Sf9	O
cells	O
were	O
infected	O
either	O
singly	O
or	O
in	O
combination	O
with	O
recombinant	O
baculoviruses	O
containing	O
a	O
human	O
G	B-Protein
-	I-Protein
protein	I-Protein
beta	I-Protein
1	I-Protein
gene	O
or	O
a	O
bovine	O
G	B-Protein
-	I-Protein
protein	I-Protein
gamma	I-Protein
2	I-Protein
gene	O
.	O
<EOS>	B-X
The	B-X
36-kDa	B-X
beta	B-X
1	B-X
,	B-X
35-kDa	B-X
beta	B-X
2	B-X
,	B-X
and	B-X
6.5-kDa	B-X
gamma	B-X
2	B-X
subunits	B-X
of	B-X
the	B-X
heterotrimeric	B-X
guanine	B-X
nucleotide-binding	B-X
proteins	B-X
have	B-X
been	B-X
overexpressed	B-X
in	B-X
Sf9	B-X
cells	B-X
using	B-X
a	B-X
baculovirus	B-X
expression	B-X
system	B-X
.	B-X
The	B-X
gamma	B-X
2	B-X
subunit	B-X
expressed	B-X
in	B-X
Sf9	B-X
cells	B-X
incorporated	B-X
label	B-X
derived	B-X
from	B-X
[	B-X
3H	B-X
]	B-X
mevalonate	B-X
and	B-X
is	B-X
therefore	B-X
likely	B-X
to	B-X
be	B-X
isoprenylated	B-X
,	B-X
as	B-X
is	B-X
its	B-X
mammalian	B-X
counterpart	B-X
.	B-X
Extracts	B-X
of	B-X
Sf9	B-X
cells	B-X
doubly	B-X
infected	B-X
with	B-X
viruses	B-X
encoding	B-X
a	B-X
beta	B-X
subunit	B-X
and	B-X
viruses	B-X
encoding	B-X
a	B-X
gamma	B-X
subunit	B-X
are	B-X
active	B-X
in	B-X
promoting	B-X
the	B-X
pertussis	B-X
toxin-catalyzed	B-X
ADP-ribosylation	B-X
of	B-X
a	B-X
G	B-X
protein	B-X
alpha	B-X
subunit	B-X
.	B-X
However	B-X
,	B-X
extracts	B-X
from	B-X
Sf9	B-X
cells	B-X
singly	B-X
infected	B-X
with	B-X
viruses	B-X
encoding	B-X
either	B-X
a	B-X
beta	B-X
or	B-X
gamma	B-X
subunit	B-X
are	B-X
not	B-X
active	B-X
in	B-X
this	B-X
assay	B-X
.	B-X
Results	B-X
demonstrate	B-X
utility	B-X
of	B-X
the	B-X
insect/baculovirus	B-X
system	B-X
for	B-X
expressing	B-X
G	B-X
protein	B-X
beta	B-X
gamma	B-X
subunits	B-X
of	B-X
defined	B-X
composition	B-X
.	B-X

It	O
was	O
possible	O
to	O
express	O
the	O
beta	B-Protein
1	I-Protein
and	O
gamma	B-Protein
2	I-Protein
gene	O
products	O
independently	O
of	O
each	O
other	O
in	O
this	O
system	O
,	O
as	O
determined	O
by	O
using	O
immunological	O
and	O
metabolic	O
labeling	O
techniques	O
.	O
<EOS>	B-X
Guanine	B-X
nucleotide-binding	B-X
regulatory	B-X
protein	B-X
(	B-X
G	B-X
protein	B-X
)	B-X
beta	B-X
gamma	B-X
dimers	B-X
that	B-X
were	B-X
active	B-X
in	B-X
reconstitution	B-X
assays	B-X
were	B-X
produced	B-X
in	B-X
insect	B-X
cells	B-X
using	B-X
the	B-X
baculovirus/Sf9	B-X
insect	B-X
cell	B-X
expression	B-X
system	B-X
.	B-X
Sf9	B-X
cells	B-X
were	B-X
infected	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
recombinant	B-X
baculoviruses	B-X
containing	B-X
a	B-X
human	B-X
G-protein	B-X
beta	B-X
1	B-X
gene	B-X
or	B-X
a	B-X
bovine	B-X
G-protein	B-X
gamma	B-X
2	B-X
gene	B-X
.	B-X
It	B-X
was	B-X
possible	B-X
to	B-X
express	B-X
the	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
gene	B-X
products	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
in	B-X
this	B-X
system	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
using	B-X
immunological	B-X
and	B-X
metabolic	B-X
labeling	B-X
techniques	B-X
.	B-X
Further	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
recombinant	B-X
beta	B-X
and/or	B-X
gamma	B-X
chains	B-X
to	B-X
function	B-X
in	B-X
defined	B-X
biochemical	B-X
assays	B-X
of	B-X
beta	B-X
gamma	B-X
activity	B-X
was	B-X
assessed	B-X
for	B-X
membrane	B-X
extracts	B-X
and	B-X
supernatant	B-X
fractions	B-X
from	B-X
infected	B-X
Sf9	B-X
cells	B-X
.	B-X
Extracts	B-X
of	B-X
cells	B-X
expressing	B-X
beta	B-X
or	B-X
gamma	B-X
chain	B-X
alone	B-X
were	B-X
inactive	B-X
in	B-X
these	B-X
assays	B-X
,	B-X
whereas	B-X
those	B-X
from	B-X
cells	B-X
coinfected	B-X
with	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
did	B-X
display	B-X
activity	B-X
.	B-X
These	B-X
assays	B-X
were	B-X
used	B-X
to	B-X
identify	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimer	B-X
migration	B-X
during	B-X
chromatographic	B-X
purification	B-X
,	B-X
and	B-X
the	B-X
recombinant	B-X
dimers	B-X
were	B-X
purified	B-X
to	B-X
near	B-X
homogeneity	B-X
.	B-X
Both	B-X
the	B-X
membrane-associated	B-X
and	B-X
soluble	B-X
beta	B-X
gamma	B-X
dimers	B-X
facilitated	B-X
rhodopsin-catalyzed	B-X
guanosine	B-X
5'-	B-X
[	B-X
gamma-thio	B-X
]	B-X
triphosphate	B-X
binding	B-X
to	B-X
Gt	B-X
alpha	B-X
,	B-X
the	B-X
GTP-binding	B-X
subunit	B-X
of	B-X
the	B-X
retinal	B-X
G	B-X
protein	B-X
transducin	B-X
(	B-X
K0.5	B-X
of	B-X
13	B-X
+/-	B-X
2	B-X
and	B-X
36	B-X
+/-	B-X
5	B-X
nM	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
Both	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimers	B-X
also	B-X
facilitated	B-X
the	B-X
pertussis	B-X
toxin-catalyzed	B-X
ADP-ribosylation	B-X
of	B-X
Gt	B-X
alpha	B-X
with	B-X
equal	B-X
potency	B-X
(	B-X
K0.5	B-X
of	B-X
9	B-X
+/-	B-X
1	B-X
and	B-X
10	B-X
+/-	B-X
3	B-X
nM	B-X
for	B-X
membrane	B-X
and	B-X
soluble	B-X
dimers	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Mevalonolactone	B-X
labeling	B-X
showed	B-X
that	B-X
the	B-X
gamma	B-X
2	B-X
subunits	B-X
of	B-X
membrane-associated	B-X
beta	B-X
gamma	B-X
dimers	B-X
incorporated	B-X
radiolabel	B-X
,	B-X
whereas	B-X
in	B-X
the	B-X
soluble	B-X
form	B-X
they	B-X
did	B-X
not	B-X
.	B-X
Thus	B-X
,	B-X
prenyl	B-X
modification	B-X
of	B-X
gamma	B-X
2	B-X
directs	B-X
the	B-X
membrane	B-X
association	B-X
of	B-X
the	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
dimer	B-X
and	B-X
increases	B-X
its	B-X
apparent	B-X
affinity	B-X
for	B-X
receptor	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
required	B-X
for	B-X
the	B-X
functional	B-X
interaction	B-X
(	B-X
s	B-X
)	B-X
of	B-X
the	B-X
dimer	B-X
.	B-X

Further	O
,	O
the	O
ability	O
of	O
recombinant	O
beta	O
and	O
/	O
or	O
gamma	O
chains	O
to	O
function	O
in	O
defined	O
biochemical	O
assays	O
of	O
beta	O
gamma	O
activity	O
was	O
assessed	O
for	O
membrane	O
extracts	O
and	O
supernatant	O
fractions	O
from	O
infected	O
Sf9	O
cells	O
.	O
<EOS>	B-X
Beta	B-X
human	B-X
papillomavirus	B-X
(	B-X
beta	B-X
HPV	B-X
)	B-X
infections	B-X
are	B-X
common	B-X
in	B-X
adults	B-X
.	B-X
Certain	B-X
types	B-X
of	B-X
beta	B-X
HPVs	B-X
are	B-X
associated	B-X
with	B-X
nonmelanoma	B-X
skin	B-X
cancer	B-X
(	B-X
NMSC	B-X
)	B-X
in	B-X
immunocompromised	B-X
individuals	B-X
.	B-X
However	B-X
,	B-X
whether	B-X
beta	B-X
HPV	B-X
infections	B-X
promote	B-X
NMSC	B-X
in	B-X
the	B-X
immunocompetent	B-X
population	B-X
is	B-X
unclear	B-X
.	B-X
They	B-X
have	B-X
been	B-X
hypothesized	B-X
to	B-X
increase	B-X
genomic	B-X
instability	B-X
stemming	B-X
from	B-X
ultraviolet	B-X
light	B-X
exposure	B-X
by	B-X
disrupting	B-X
DNA	B-X
damage	B-X
responses	B-X
.	B-X
Fluorescence-based	B-X
reporters	B-X
,	B-X
next-generation	B-X
sequencing	B-X
,	B-X
and	B-X
animal	B-X
models	B-X
have	B-X
been	B-X
used	B-X
to	B-X
test	B-X
this	B-X
primarily	B-X
in	B-X
cells	B-X
expressing	B-X
beta	B-X
HPV	B-X
E6/E7	B-X
.	B-X
Of	B-X
the	B-X
two	B-X
,	B-X
beta	B-X
HPV	B-X
E6	B-X
appears	B-X
to	B-X
have	B-X
the	B-X
greatest	B-X
ability	B-X
to	B-X
increase	B-X
UV	B-X
mutagenesis	B-X
,	B-X
by	B-X
attenuating	B-X
two	B-X
major	B-X
double-strand	B-X
break	B-X
(	B-X
DSB	B-X
)	B-X
repair	B-X
pathways	B-X
,	B-X
homologous	B-X
recombination	B-X
,	B-X
and	B-X
non-homologous	B-X
end-joining	B-X
.	B-X

Extracts	O
of	O
cells	O
expressing	O
beta	O
or	O
gamma	O
chain	O
alone	O
were	O
inactive	O
in	O
these	O
assays	O
,	O
whereas	O
those	O
from	O
cells	O
coinfected	O
with	O
beta	B-Protein
1	I-Protein
and	O
gamma	B-Protein
2	I-Protein
did	O
display	O
activity	O
.	O
<EOS>	B-X
Because	B-X
transfection	B-X
efficiency	B-X
in	B-X
such	B-X
assays	B-X
can	B-X
be	B-X
low	B-X
,	B-X
promoters	B-X
are	B-X
commonly	B-X
fused	B-X
to	B-X
heterologous	B-X
reporter	B-X
genes	B-X
that	B-X
encode	B-X
enzymes	B-X
that	B-X
can	B-X
be	B-X
quantified	B-X
using	B-X
highly	B-X
sensitive	B-X
assays	B-X
.	B-X
The	B-X
reporter	B-X
protein	B-X
's	B-X
activity	B-X
or	B-X
fluorescence	B-X
within	B-X
a	B-X
transfected	B-X
cell	B-X
population	B-X
is	B-X
approximately	B-X
proportional	B-X
to	B-X
the	B-X
steady-state	B-X
mRNA	B-X
level	B-X
.	B-X
Although	B-X
the	B-X
Escherichia	B-X
coli	B-X
lacZ	B-X
gene	B-X
,	B-X
encoding	B-X
beta-galactosidase	B-X
(	B-X
beta-gal	B-X
)	B-X
,	B-X
can	B-X
be	B-X
used	B-X
as	B-X
a	B-X
standard	B-X
reporter	B-X
for	B-X
monitoring	B-X
the	B-X
strength	B-X
of	B-X
a	B-X
promoter	B-X
or	B-X
enhancer	B-X
in	B-X
a	B-X
transient	B-X
or	B-X
stable	B-X
transfection	B-X
assay	B-X
,	B-X
it	B-X
is	B-X
predominantly	B-X
used	B-X
as	B-X
an	B-X
internal	B-X
control	B-X
during	B-X
transient	B-X
transfection	B-X
experiments	B-X
.	B-X
When	B-X
used	B-X
in	B-X
this	B-X
manner	B-X
,	B-X
cells	B-X
are	B-X
usually	B-X
transfected	B-X
with	B-X
the	B-X
control	B-X
plasmid	B-X
(	B-X
containing	B-X
a	B-X
ubiquitously	B-X
active	B-X
viral	B-X
promoter	B-X
fused	B-X
to	B-X
the	B-X
E.	B-X
coli	B-X
lacZ	B-X
gene	B-X
)	B-X
and	B-X
an	B-X
experimental	B-X
plasmid	B-X
containing	B-X
another	B-X
reporter	B-X
gene	B-X
(	B-X
e.g.	B-X
,	B-X
luciferase	B-X
or	B-X
chloramphenicol	B-X
acetyltransferase	B-X
[	B-X
CAT	B-X
]	B-X
)	B-X
under	B-X
the	B-X
control	B-X
of	B-X
the	B-X
promoter	B-X
or	B-X
enhancer	B-X
of	B-X
interest	B-X
.	B-X
The	B-X
basic	B-X
colorimetric	B-X
assay	B-X
described	B-X
here	B-X
is	B-X
the	B-X
simplest	B-X
and	B-X
least	B-X
expensive	B-X
assay	B-X
for	B-X
quantifying	B-X
beta-gal	B-X
activity	B-X
.	B-X
The	B-X
cells	B-X
are	B-X
lysed	B-X
and	B-X
,	B-X
after	B-X
determining	B-X
the	B-X
total	B-X
protein	B-X
concentration	B-X
in	B-X
the	B-X
extracts	B-X
,	B-X
an	B-X
aliquot	B-X
of	B-X
the	B-X
extract	B-X
is	B-X
mixed	B-X
with	B-X
the	B-X
reaction	B-X
substrate	B-X
,	B-X
O-nitrophenyl-beta-D-galactopyranoside	B-X
(	B-X
ONPG	B-X
)	B-X
,	B-X
in	B-X
a	B-X
buffer	B-X
containing	B-X
sodium	B-X
phosphate	B-X
and	B-X
magnesium	B-X
chloride	B-X
.	B-X

These	O
assays	O
were	O
used	O
to	O
identify	O
recombinant	O
beta	O
gamma	O
dimer	O
migration	O
during	O
chromatographic	O
purification	O
,	O
and	O
the	O
recombinant	O
dimers	O
were	O
purified	O
to	O
near	O
homogeneity	O
.	O
<EOS>	B-X
Guanine	B-X
nucleotide-binding	B-X
regulatory	B-X
protein	B-X
(	B-X
G	B-X
protein	B-X
)	B-X
beta	B-X
gamma	B-X
dimers	B-X
that	B-X
were	B-X
active	B-X
in	B-X
reconstitution	B-X
assays	B-X
were	B-X
produced	B-X
in	B-X
insect	B-X
cells	B-X
using	B-X
the	B-X
baculovirus/Sf9	B-X
insect	B-X
cell	B-X
expression	B-X
system	B-X
.	B-X
Sf9	B-X
cells	B-X
were	B-X
infected	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
recombinant	B-X
baculoviruses	B-X
containing	B-X
a	B-X
human	B-X
G-protein	B-X
beta	B-X
1	B-X
gene	B-X
or	B-X
a	B-X
bovine	B-X
G-protein	B-X
gamma	B-X
2	B-X
gene	B-X
.	B-X
It	B-X
was	B-X
possible	B-X
to	B-X
express	B-X
the	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
gene	B-X
products	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
in	B-X
this	B-X
system	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
using	B-X
immunological	B-X
and	B-X
metabolic	B-X
labeling	B-X
techniques	B-X
.	B-X
Further	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
recombinant	B-X
beta	B-X
and/or	B-X
gamma	B-X
chains	B-X
to	B-X
function	B-X
in	B-X
defined	B-X
biochemical	B-X
assays	B-X
of	B-X
beta	B-X
gamma	B-X
activity	B-X
was	B-X
assessed	B-X
for	B-X
membrane	B-X
extracts	B-X
and	B-X
supernatant	B-X
fractions	B-X
from	B-X
infected	B-X
Sf9	B-X
cells	B-X
.	B-X
Extracts	B-X
of	B-X
cells	B-X
expressing	B-X
beta	B-X
or	B-X
gamma	B-X
chain	B-X
alone	B-X
were	B-X
inactive	B-X
in	B-X
these	B-X
assays	B-X
,	B-X
whereas	B-X
those	B-X
from	B-X
cells	B-X
coinfected	B-X
with	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
did	B-X
display	B-X
activity	B-X
.	B-X
These	B-X
assays	B-X
were	B-X
used	B-X
to	B-X
identify	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimer	B-X
migration	B-X
during	B-X
chromatographic	B-X
purification	B-X
,	B-X
and	B-X
the	B-X
recombinant	B-X
dimers	B-X
were	B-X
purified	B-X
to	B-X
near	B-X
homogeneity	B-X
.	B-X
Both	B-X
the	B-X
membrane-associated	B-X
and	B-X
soluble	B-X
beta	B-X
gamma	B-X
dimers	B-X
facilitated	B-X
rhodopsin-catalyzed	B-X
guanosine	B-X
5'-	B-X
[	B-X
gamma-thio	B-X
]	B-X
triphosphate	B-X
binding	B-X
to	B-X
Gt	B-X
alpha	B-X
,	B-X
the	B-X
GTP-binding	B-X
subunit	B-X
of	B-X
the	B-X
retinal	B-X
G	B-X
protein	B-X
transducin	B-X
(	B-X
K0.5	B-X
of	B-X
13	B-X
+/-	B-X
2	B-X
and	B-X
36	B-X
+/-	B-X
5	B-X
nM	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
Both	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimers	B-X
also	B-X
facilitated	B-X
the	B-X
pertussis	B-X
toxin-catalyzed	B-X
ADP-ribosylation	B-X
of	B-X
Gt	B-X
alpha	B-X
with	B-X
equal	B-X
potency	B-X
(	B-X
K0.5	B-X
of	B-X
9	B-X
+/-	B-X
1	B-X
and	B-X
10	B-X
+/-	B-X
3	B-X
nM	B-X
for	B-X
membrane	B-X
and	B-X
soluble	B-X
dimers	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Mevalonolactone	B-X
labeling	B-X
showed	B-X
that	B-X
the	B-X
gamma	B-X
2	B-X
subunits	B-X
of	B-X
membrane-associated	B-X
beta	B-X
gamma	B-X
dimers	B-X
incorporated	B-X
radiolabel	B-X
,	B-X
whereas	B-X
in	B-X
the	B-X
soluble	B-X
form	B-X
they	B-X
did	B-X
not	B-X
.	B-X
Thus	B-X
,	B-X
prenyl	B-X
modification	B-X
of	B-X
gamma	B-X
2	B-X
directs	B-X
the	B-X
membrane	B-X
association	B-X
of	B-X
the	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
dimer	B-X
and	B-X
increases	B-X
its	B-X
apparent	B-X
affinity	B-X
for	B-X
receptor	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
required	B-X
for	B-X
the	B-X
functional	B-X
interaction	B-X
(	B-X
s	B-X
)	B-X
of	B-X
the	B-X
dimer	B-X
.	B-X

Both	O
the	O
membrane	O
-	O
associated	O
and	O
soluble	O
beta	O
gamma	O
dimers	O
facilitated	O
rhodopsin	B-Protein
-	O
catalyzed	O
guanosine	O
5	O
'	O
-	O
[	O
gamma	O
-	O
thio	O
]	O
triphosphate	O
binding	O
to	O
Gt	O
alpha	O
,	O
the	O
GTP	O
-	O
binding	O
subunit	O
of	O
the	O
retinal	O
G	O
protein	O
transducin	O
(	O
K0	O
.	O
5	O
of	O
13	O
+	O
/	O
-	O
2	O
and	O
36	O
+	O
/	O
-	O
5	O
nM	O
,	O
respectively	O
)	O
.	O

Both	O
recombinant	O
beta	O
gamma	O
dimers	O
also	O
facilitated	O
the	O
pertussis	O
toxin	O
-	O
catalyzed	O
ADP	O
-	O
ribosylation	O
of	O
Gt	O
alpha	O
with	O
equal	O
potency	O
(	O
K0	O
.	O
5	O
of	O
9	O
+	O
/	O
-	O
1	O
and	O
10	O
+	O
/	O
-	O
3	O
nM	O
for	O
membrane	O
and	O
soluble	O
dimers	O
,	O
respectively	O
)	O
.	O
<EOS>	B-X
Guanine	B-X
nucleotide-binding	B-X
regulatory	B-X
protein	B-X
(	B-X
G	B-X
protein	B-X
)	B-X
beta	B-X
gamma	B-X
dimers	B-X
that	B-X
were	B-X
active	B-X
in	B-X
reconstitution	B-X
assays	B-X
were	B-X
produced	B-X
in	B-X
insect	B-X
cells	B-X
using	B-X
the	B-X
baculovirus/Sf9	B-X
insect	B-X
cell	B-X
expression	B-X
system	B-X
.	B-X
Sf9	B-X
cells	B-X
were	B-X
infected	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
recombinant	B-X
baculoviruses	B-X
containing	B-X
a	B-X
human	B-X
G-protein	B-X
beta	B-X
1	B-X
gene	B-X
or	B-X
a	B-X
bovine	B-X
G-protein	B-X
gamma	B-X
2	B-X
gene	B-X
.	B-X
It	B-X
was	B-X
possible	B-X
to	B-X
express	B-X
the	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
gene	B-X
products	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
in	B-X
this	B-X
system	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
using	B-X
immunological	B-X
and	B-X
metabolic	B-X
labeling	B-X
techniques	B-X
.	B-X
Further	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
recombinant	B-X
beta	B-X
and/or	B-X
gamma	B-X
chains	B-X
to	B-X
function	B-X
in	B-X
defined	B-X
biochemical	B-X
assays	B-X
of	B-X
beta	B-X
gamma	B-X
activity	B-X
was	B-X
assessed	B-X
for	B-X
membrane	B-X
extracts	B-X
and	B-X
supernatant	B-X
fractions	B-X
from	B-X
infected	B-X
Sf9	B-X
cells	B-X
.	B-X
Extracts	B-X
of	B-X
cells	B-X
expressing	B-X
beta	B-X
or	B-X
gamma	B-X
chain	B-X
alone	B-X
were	B-X
inactive	B-X
in	B-X
these	B-X
assays	B-X
,	B-X
whereas	B-X
those	B-X
from	B-X
cells	B-X
coinfected	B-X
with	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
did	B-X
display	B-X
activity	B-X
.	B-X
These	B-X
assays	B-X
were	B-X
used	B-X
to	B-X
identify	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimer	B-X
migration	B-X
during	B-X
chromatographic	B-X
purification	B-X
,	B-X
and	B-X
the	B-X
recombinant	B-X
dimers	B-X
were	B-X
purified	B-X
to	B-X
near	B-X
homogeneity	B-X
.	B-X
Both	B-X
the	B-X
membrane-associated	B-X
and	B-X
soluble	B-X
beta	B-X
gamma	B-X
dimers	B-X
facilitated	B-X
rhodopsin-catalyzed	B-X
guanosine	B-X
5'-	B-X
[	B-X
gamma-thio	B-X
]	B-X
triphosphate	B-X
binding	B-X
to	B-X
Gt	B-X
alpha	B-X
,	B-X
the	B-X
GTP-binding	B-X
subunit	B-X
of	B-X
the	B-X
retinal	B-X
G	B-X
protein	B-X
transducin	B-X
(	B-X
K0.5	B-X
of	B-X
13	B-X
+/-	B-X
2	B-X
and	B-X
36	B-X
+/-	B-X
5	B-X
nM	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
Both	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimers	B-X
also	B-X
facilitated	B-X
the	B-X
pertussis	B-X
toxin-catalyzed	B-X
ADP-ribosylation	B-X
of	B-X
Gt	B-X
alpha	B-X
with	B-X
equal	B-X
potency	B-X
(	B-X
K0.5	B-X
of	B-X
9	B-X
+/-	B-X
1	B-X
and	B-X
10	B-X
+/-	B-X
3	B-X
nM	B-X
for	B-X
membrane	B-X
and	B-X
soluble	B-X
dimers	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Mevalonolactone	B-X
labeling	B-X
showed	B-X
that	B-X
the	B-X
gamma	B-X
2	B-X
subunits	B-X
of	B-X
membrane-associated	B-X
beta	B-X
gamma	B-X
dimers	B-X
incorporated	B-X
radiolabel	B-X
,	B-X
whereas	B-X
in	B-X
the	B-X
soluble	B-X
form	B-X
they	B-X
did	B-X
not	B-X
.	B-X
Thus	B-X
,	B-X
prenyl	B-X
modification	B-X
of	B-X
gamma	B-X
2	B-X
directs	B-X
the	B-X
membrane	B-X
association	B-X
of	B-X
the	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
dimer	B-X
and	B-X
increases	B-X
its	B-X
apparent	B-X
affinity	B-X
for	B-X
receptor	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
required	B-X
for	B-X
the	B-X
functional	B-X
interaction	B-X
(	B-X
s	B-X
)	B-X
of	B-X
the	B-X
dimer	B-X
.	B-X

[	O
3H	O
]	O
Mevalonolactone	O
labeling	O
showed	O
that	O
the	O
gamma	O
2	O
subunits	O
of	O
membrane	O
-	O
associated	O
beta	O
gamma	O
dimers	O
incorporated	O
radiolabel	O
,	O
whereas	O
in	O
the	O
soluble	O
form	O
they	O
did	O
not	O
.	O
<EOS>	B-X
Guanine	B-X
nucleotide-binding	B-X
regulatory	B-X
protein	B-X
(	B-X
G	B-X
protein	B-X
)	B-X
beta	B-X
gamma	B-X
dimers	B-X
that	B-X
were	B-X
active	B-X
in	B-X
reconstitution	B-X
assays	B-X
were	B-X
produced	B-X
in	B-X
insect	B-X
cells	B-X
using	B-X
the	B-X
baculovirus/Sf9	B-X
insect	B-X
cell	B-X
expression	B-X
system	B-X
.	B-X
Sf9	B-X
cells	B-X
were	B-X
infected	B-X
either	B-X
singly	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
recombinant	B-X
baculoviruses	B-X
containing	B-X
a	B-X
human	B-X
G-protein	B-X
beta	B-X
1	B-X
gene	B-X
or	B-X
a	B-X
bovine	B-X
G-protein	B-X
gamma	B-X
2	B-X
gene	B-X
.	B-X
It	B-X
was	B-X
possible	B-X
to	B-X
express	B-X
the	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
gene	B-X
products	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
in	B-X
this	B-X
system	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
using	B-X
immunological	B-X
and	B-X
metabolic	B-X
labeling	B-X
techniques	B-X
.	B-X
Further	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
recombinant	B-X
beta	B-X
and/or	B-X
gamma	B-X
chains	B-X
to	B-X
function	B-X
in	B-X
defined	B-X
biochemical	B-X
assays	B-X
of	B-X
beta	B-X
gamma	B-X
activity	B-X
was	B-X
assessed	B-X
for	B-X
membrane	B-X
extracts	B-X
and	B-X
supernatant	B-X
fractions	B-X
from	B-X
infected	B-X
Sf9	B-X
cells	B-X
.	B-X
Extracts	B-X
of	B-X
cells	B-X
expressing	B-X
beta	B-X
or	B-X
gamma	B-X
chain	B-X
alone	B-X
were	B-X
inactive	B-X
in	B-X
these	B-X
assays	B-X
,	B-X
whereas	B-X
those	B-X
from	B-X
cells	B-X
coinfected	B-X
with	B-X
beta	B-X
1	B-X
and	B-X
gamma	B-X
2	B-X
did	B-X
display	B-X
activity	B-X
.	B-X
These	B-X
assays	B-X
were	B-X
used	B-X
to	B-X
identify	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimer	B-X
migration	B-X
during	B-X
chromatographic	B-X
purification	B-X
,	B-X
and	B-X
the	B-X
recombinant	B-X
dimers	B-X
were	B-X
purified	B-X
to	B-X
near	B-X
homogeneity	B-X
.	B-X
Both	B-X
the	B-X
membrane-associated	B-X
and	B-X
soluble	B-X
beta	B-X
gamma	B-X
dimers	B-X
facilitated	B-X
rhodopsin-catalyzed	B-X
guanosine	B-X
5'-	B-X
[	B-X
gamma-thio	B-X
]	B-X
triphosphate	B-X
binding	B-X
to	B-X
Gt	B-X
alpha	B-X
,	B-X
the	B-X
GTP-binding	B-X
subunit	B-X
of	B-X
the	B-X
retinal	B-X
G	B-X
protein	B-X
transducin	B-X
(	B-X
K0.5	B-X
of	B-X
13	B-X
+/-	B-X
2	B-X
and	B-X
36	B-X
+/-	B-X
5	B-X
nM	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
Both	B-X
recombinant	B-X
beta	B-X
gamma	B-X
dimers	B-X
also	B-X
facilitated	B-X
the	B-X
pertussis	B-X
toxin-catalyzed	B-X
ADP-ribosylation	B-X
of	B-X
Gt	B-X
alpha	B-X
with	B-X
equal	B-X
potency	B-X
(	B-X
K0.5	B-X
of	B-X
9	B-X
+/-	B-X
1	B-X
and	B-X
10	B-X
+/-	B-X
3	B-X
nM	B-X
for	B-X
membrane	B-X
and	B-X
soluble	B-X
dimers	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
[	B-X
3H	B-X
]	B-X
Mevalonolactone	B-X
labeling	B-X
showed	B-X
that	B-X
the	B-X
gamma	B-X
2	B-X
subunits	B-X
of	B-X
membrane-associated	B-X
beta	B-X
gamma	B-X
dimers	B-X
incorporated	B-X
radiolabel	B-X
,	B-X
whereas	B-X
in	B-X
the	B-X
soluble	B-X
form	B-X
they	B-X
did	B-X
not	B-X
.	B-X
Thus	B-X
,	B-X
prenyl	B-X
modification	B-X
of	B-X
gamma	B-X
2	B-X
directs	B-X
the	B-X
membrane	B-X
association	B-X
of	B-X
the	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
dimer	B-X
and	B-X
increases	B-X
its	B-X
apparent	B-X
affinity	B-X
for	B-X
receptor	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
required	B-X
for	B-X
the	B-X
functional	B-X
interaction	B-X
(	B-X
s	B-X
)	B-X
of	B-X
the	B-X
dimer	B-X
.	B-X

Thus	O
,	O
prenyl	O
modification	O
of	O
gamma	B-Protein
2	I-Protein
directs	O
the	O
membrane	O
association	O
of	O
the	O
beta	B-Protein
1	I-Protein
gamma	I-Protein
2	I-Protein
dimer	O
and	O
increases	O
its	O
apparent	O
affinity	O
for	O
receptor	O
,	O
but	O
it	O
is	O
not	O
required	O
for	O
the	O
functional	O
interaction	O
(	O
s	O
)	O
of	O
the	O
dimer	O
.	O

The	O
role	O
of	O
G	O
protein	O
methylation	O
in	O
the	O
function	O
of	O
a	O
geranylgeranylated	O
beta	O
gamma	O
isoform	O
.	O
<EOS>	B-X
The	B-X
gamma	B-X
subunit	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
is	B-X
isoprenylated	B-X
and	B-X
methylated	B-X
on	B-X
its	B-X
carboxyl	B-X
terminal	B-X
cysteine	B-X
residue	B-X
.	B-X
While	B-X
retinal	B-X
transducin	B-X
is	B-X
farnesylated	B-X
,	B-X
all	B-X
other	B-X
gamma	B-X
subunits	B-X
are	B-X
modified	B-X
by	B-X
geranylgeranylation	B-X
.	B-X
An	B-X
immobilized	B-X
form	B-X
of	B-X
pig	B-X
liver	B-X
esterase	B-X
(	B-X
iPLE	B-X
)	B-X
is	B-X
able	B-X
to	B-X
hydrolyze	B-X
the	B-X
methyl	B-X
ester	B-X
of	B-X
a	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
isoform	B-X
(	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
)	B-X
.	B-X
Since	B-X
methylation	B-X
is	B-X
the	B-X
only	B-X
reversible	B-X
reaction	B-X
in	B-X
the	B-X
isoprenylation	B-X
pathway	B-X
,	B-X
it	B-X
could	B-X
be	B-X
a	B-X
site	B-X
of	B-X
regulation	B-X
of	B-X
G	B-X
protein	B-X
activity	B-X
.	B-X
With	B-X
both	B-X
the	B-X
methylated	B-X
and	B-X
demethylated	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
now	B-X
available	B-X
,	B-X
the	B-X
role	B-X
of	B-X
methylation	B-X
for	B-X
a	B-X
geranylgeranylated	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
may	B-X
be	B-X
addressed	B-X
.	B-X
Here	B-X
,	B-X
it	B-X
is	B-X
reported	B-X
that	B-X
methylation	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
gamma	B-X
to	B-X
interact	B-X
with	B-X
an	B-X
alpha	B-X
subunit	B-X
,	B-X
as	B-X
probed	B-X
by	B-X
ADP-ribosylation	B-X
studies	B-X
with	B-X
pertussis	B-X
toxin	B-X
,	B-X
and	B-X
has	B-X
a	B-X
small	B-X
effect	B-X
(	B-X
less	B-X
than	B-X
2-fold	B-X
)	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
to	B-X
activate	B-X
phosphatidylinositol-specific	B-X
phospholipase	B-X
C	B-X
(	B-X
PIPLC	B-X
)	B-X
and	B-X
phosphoinositide	B-X
3	B-X
kinase	B-X
(	B-X
PI3K	B-X
)	B-X
.	B-X
In	B-X
binding	B-X
studies	B-X
,	B-X
demethylation	B-X
only	B-X
slightly	B-X
decreased	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
to	B-X
adhere	B-X
to	B-X
azolectin	B-X
vesicles	B-X
.	B-X
Therefore	B-X
,	B-X
methylation	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
appears	B-X
to	B-X
have	B-X
only	B-X
a	B-X
minor	B-X
effect	B-X
in	B-X
signal	B-X
transduction	B-X
processes	B-X
which	B-X
can	B-X
be	B-X
correlated	B-X
to	B-X
a	B-X
decrease	B-X
in	B-X
hydrophobicity	B-X
of	B-X
the	B-X
beta	B-X
gamma	B-X
subunit	B-X
.	B-X

The	O
gamma	O
subunit	O
of	O
heterotrimeric	O
G	O
proteins	O
is	O
isoprenylated	O
and	O
methylated	O
on	O
its	O
carboxyl	O
terminal	O
cysteine	O
residue	O
.	O
<EOS>	B-X
The	B-X
gamma-subunit	B-X
of	B-X
the	B-X
vertebrate	B-X
photoreceptor	B-X
GTP-binding	B-X
protein	B-X
(	B-X
transducin	B-X
)	B-X
is	B-X
S-farnesylated	B-X
at	B-X
the	B-X
C-terminal	B-X
cysteine	B-X
residue	B-X
,	B-X
with	B-X
a	B-X
part	B-X
of	B-X
the	B-X
residue	B-X
being	B-X
methyl-esterified	B-X
at	B-X
the	B-X
alpha-carboxyl	B-X
group	B-X
.	B-X
Functionally	B-X
,	B-X
the	B-X
modified	B-X
cysteine	B-X
residue	B-X
is	B-X
implicated	B-X
in	B-X
efficient	B-X
coupling	B-X
of	B-X
the	B-X
alpha-	B-X
and	B-X
beta	B-X
gamma-subunits	B-X
,	B-X
and	B-X
indispensible	B-X
for	B-X
expressing	B-X
GTP-binding	B-X
activity	B-X
.	B-X
Similar	B-X
modifications	B-X
,	B-X
isoprenylation	B-X
and	B-X
methyl-esterification	B-X
of	B-X
the	B-X
C-terminal	B-X
cysteine	B-X
residue	B-X
have	B-X
been	B-X
found	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
proteins	B-X
involved	B-X
in	B-X
signal	B-X
transduction	B-X
and	B-X
growth	B-X
regulation	B-X
processes	B-X
.	B-X
However	B-X
,	B-X
it	B-X
seems	B-X
likely	B-X
that	B-X
the	B-X
physiological	B-X
roles	B-X
of	B-X
the	B-X
modifications	B-X
are	B-X
different	B-X
for	B-X
the	B-X
various	B-X
proteins	B-X
.	B-X

While	O
retinal	O
transducin	O
is	O
farnesylated	O
,	O
all	O
other	O
gamma	O
subunits	O
are	O
modified	O
by	O
geranylgeranylation	O
.	O
<EOS>	B-X
The	B-X
gamma	B-X
subunit	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
is	B-X
isoprenylated	B-X
and	B-X
methylated	B-X
on	B-X
its	B-X
carboxyl	B-X
terminal	B-X
cysteine	B-X
residue	B-X
.	B-X
While	B-X
retinal	B-X
transducin	B-X
is	B-X
farnesylated	B-X
,	B-X
all	B-X
other	B-X
gamma	B-X
subunits	B-X
are	B-X
modified	B-X
by	B-X
geranylgeranylation	B-X
.	B-X
An	B-X
immobilized	B-X
form	B-X
of	B-X
pig	B-X
liver	B-X
esterase	B-X
(	B-X
iPLE	B-X
)	B-X
is	B-X
able	B-X
to	B-X
hydrolyze	B-X
the	B-X
methyl	B-X
ester	B-X
of	B-X
a	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
isoform	B-X
(	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
)	B-X
.	B-X
With	B-X
both	B-X
the	B-X
methylated	B-X
and	B-X
demethylated	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
now	B-X
available	B-X
,	B-X
the	B-X
role	B-X
of	B-X
methylation	B-X
for	B-X
a	B-X
geranylgeranylated	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
may	B-X
be	B-X
addressed	B-X
.	B-X
Here	B-X
,	B-X
it	B-X
is	B-X
reported	B-X
that	B-X
methylation	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
gamma	B-X
to	B-X
interact	B-X
with	B-X
an	B-X
alpha	B-X
subunit	B-X
,	B-X
as	B-X
probed	B-X
by	B-X
ADP-ribosylation	B-X
studies	B-X
with	B-X
pertussis	B-X
toxin	B-X
,	B-X
and	B-X
has	B-X
a	B-X
small	B-X
effect	B-X
(	B-X
less	B-X
than	B-X
2-fold	B-X
)	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
to	B-X
activate	B-X
phosphatidylinositol-specific	B-X
phospholipase	B-X
C	B-X
(	B-X
PIPLC	B-X
)	B-X
and	B-X
phosphoinositide	B-X
3	B-X
kinase	B-X
(	B-X
PI3K	B-X
)	B-X
.	B-X
In	B-X
binding	B-X
studies	B-X
,	B-X
demethylation	B-X
only	B-X
slightly	B-X
decreased	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
to	B-X
adhere	B-X
to	B-X
azolectin	B-X
vesicles	B-X
.	B-X
Therefore	B-X
,	B-X
methylation	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
appears	B-X
to	B-X
have	B-X
only	B-X
a	B-X
minor	B-X
effect	B-X
in	B-X
signal	B-X
transduction	B-X
processes	B-X
which	B-X
can	B-X
be	B-X
correlated	B-X
to	B-X
a	B-X
decrease	B-X
in	B-X
hydrophobicity	B-X
of	B-X
the	B-X
beta	B-X
gamma	B-X
subunit	B-X
.	B-X

An	O
immobilized	O
form	O
of	O
pig	O
liver	O
esterase	O
(	O
iPLE	O
)	O
is	O
able	O
to	O
hydrolyze	O
the	O
methyl	O
ester	O
of	O
a	O
geranylgeranylated	O
beta	O
gamma	O
isoform	O
(	O
beta	B-Protein
1	I-Protein
gamma	B-Protein
2	I-Protein
)	O
.	O
<EOS>	B-X
The	B-X
gamma	B-X
subunit	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
is	B-X
isoprenylated	B-X
and	B-X
methylated	B-X
on	B-X
its	B-X
carboxyl	B-X
terminal	B-X
cysteine	B-X
residue	B-X
.	B-X
While	B-X
retinal	B-X
transducin	B-X
is	B-X
farnesylated	B-X
,	B-X
all	B-X
other	B-X
gamma	B-X
subunits	B-X
are	B-X
modified	B-X
by	B-X
geranylgeranylation	B-X
.	B-X
An	B-X
immobilized	B-X
form	B-X
of	B-X
pig	B-X
liver	B-X
esterase	B-X
(	B-X
iPLE	B-X
)	B-X
is	B-X
able	B-X
to	B-X
hydrolyze	B-X
the	B-X
methyl	B-X
ester	B-X
of	B-X
a	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
isoform	B-X
(	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
)	B-X
.	B-X
Since	B-X
methylation	B-X
is	B-X
the	B-X
only	B-X
reversible	B-X
reaction	B-X
in	B-X
the	B-X
isoprenylation	B-X
pathway	B-X
,	B-X
it	B-X
could	B-X
be	B-X
a	B-X
site	B-X
of	B-X
regulation	B-X
of	B-X
G	B-X
protein	B-X
activity	B-X
.	B-X
With	B-X
both	B-X
the	B-X
methylated	B-X
and	B-X
demethylated	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
now	B-X
available	B-X
,	B-X
the	B-X
role	B-X
of	B-X
methylation	B-X
for	B-X
a	B-X
geranylgeranylated	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
may	B-X
be	B-X
addressed	B-X
.	B-X
Here	B-X
,	B-X
it	B-X
is	B-X
reported	B-X
that	B-X
methylation	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
gamma	B-X
to	B-X
interact	B-X
with	B-X
an	B-X
alpha	B-X
subunit	B-X
,	B-X
as	B-X
probed	B-X
by	B-X
ADP-ribosylation	B-X
studies	B-X
with	B-X
pertussis	B-X
toxin	B-X
,	B-X
and	B-X
has	B-X
a	B-X
small	B-X
effect	B-X
(	B-X
less	B-X
than	B-X
2-fold	B-X
)	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
to	B-X
activate	B-X
phosphatidylinositol-specific	B-X
phospholipase	B-X
C	B-X
(	B-X
PIPLC	B-X
)	B-X
and	B-X
phosphoinositide	B-X
3	B-X
kinase	B-X
(	B-X
PI3K	B-X
)	B-X
.	B-X
In	B-X
binding	B-X
studies	B-X
,	B-X
demethylation	B-X
only	B-X
slightly	B-X
decreased	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
to	B-X
adhere	B-X
to	B-X
azolectin	B-X
vesicles	B-X
.	B-X
Therefore	B-X
,	B-X
methylation	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
appears	B-X
to	B-X
have	B-X
only	B-X
a	B-X
minor	B-X
effect	B-X
in	B-X
signal	B-X
transduction	B-X
processes	B-X
which	B-X
can	B-X
be	B-X
correlated	B-X
to	B-X
a	B-X
decrease	B-X
in	B-X
hydrophobicity	B-X
of	B-X
the	B-X
beta	B-X
gamma	B-X
subunit	B-X
.	B-X

Since	O
methylation	O
is	O
the	O
only	O
reversible	O
reaction	O
in	O
the	O
isoprenylation	O
pathway	O
,	O
it	O
could	O
be	O
a	O
site	O
of	O
regulation	O
of	O
G	O
protein	O
activity	O
.	O
<EOS>	B-X
The	B-X
gamma	B-X
subunit	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
is	B-X
isoprenylated	B-X
and	B-X
methylated	B-X
on	B-X
its	B-X
carboxyl	B-X
terminal	B-X
cysteine	B-X
residue	B-X
.	B-X
Since	B-X
methylation	B-X
is	B-X
the	B-X
only	B-X
reversible	B-X
reaction	B-X
in	B-X
the	B-X
isoprenylation	B-X
pathway	B-X
,	B-X
it	B-X
could	B-X
be	B-X
a	B-X
site	B-X
of	B-X
regulation	B-X
of	B-X
G	B-X
protein	B-X
activity	B-X
.	B-X
With	B-X
both	B-X
the	B-X
methylated	B-X
and	B-X
demethylated	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
now	B-X
available	B-X
,	B-X
the	B-X
role	B-X
of	B-X
methylation	B-X
for	B-X
a	B-X
geranylgeranylated	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
may	B-X
be	B-X
addressed	B-X
.	B-X
Here	B-X
,	B-X
it	B-X
is	B-X
reported	B-X
that	B-X
methylation	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
gamma	B-X
to	B-X
interact	B-X
with	B-X
an	B-X
alpha	B-X
subunit	B-X
,	B-X
as	B-X
probed	B-X
by	B-X
ADP-ribosylation	B-X
studies	B-X
with	B-X
pertussis	B-X
toxin	B-X
,	B-X
and	B-X
has	B-X
a	B-X
small	B-X
effect	B-X
(	B-X
less	B-X
than	B-X
2-fold	B-X
)	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
to	B-X
activate	B-X
phosphatidylinositol-specific	B-X
phospholipase	B-X
C	B-X
(	B-X
PIPLC	B-X
)	B-X
and	B-X
phosphoinositide	B-X
3	B-X
kinase	B-X
(	B-X
PI3K	B-X
)	B-X
.	B-X
In	B-X
binding	B-X
studies	B-X
,	B-X
demethylation	B-X
only	B-X
slightly	B-X
decreased	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
to	B-X
adhere	B-X
to	B-X
azolectin	B-X
vesicles	B-X
.	B-X
Therefore	B-X
,	B-X
methylation	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
appears	B-X
to	B-X
have	B-X
only	B-X
a	B-X
minor	B-X
effect	B-X
in	B-X
signal	B-X
transduction	B-X
processes	B-X
which	B-X
can	B-X
be	B-X
correlated	B-X
to	B-X
a	B-X
decrease	B-X
in	B-X
hydrophobicity	B-X
of	B-X
the	B-X
beta	B-X
gamma	B-X
subunit	B-X
.	B-X

With	O
both	O
the	O
methylated	O
and	O
demethylated	O
beta	B-Protein
1	I-Protein
gamma	B-Protein
2	I-Protein
now	O
available	O
,	O
the	O
role	O
of	O
methylation	O
for	O
a	O
geranylgeranylated	O
heterotrimeric	O
G	O
protein	O
may	O
be	O
addressed	O
.	O
<EOS>	B-X
The	B-X
gamma	B-X
subunit	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
is	B-X
isoprenylated	B-X
and	B-X
methylated	B-X
on	B-X
its	B-X
carboxyl	B-X
terminal	B-X
cysteine	B-X
residue	B-X
.	B-X
While	B-X
retinal	B-X
transducin	B-X
is	B-X
farnesylated	B-X
,	B-X
all	B-X
other	B-X
gamma	B-X
subunits	B-X
are	B-X
modified	B-X
by	B-X
geranylgeranylation	B-X
.	B-X
An	B-X
immobilized	B-X
form	B-X
of	B-X
pig	B-X
liver	B-X
esterase	B-X
(	B-X
iPLE	B-X
)	B-X
is	B-X
able	B-X
to	B-X
hydrolyze	B-X
the	B-X
methyl	B-X
ester	B-X
of	B-X
a	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
isoform	B-X
(	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
)	B-X
.	B-X
Since	B-X
methylation	B-X
is	B-X
the	B-X
only	B-X
reversible	B-X
reaction	B-X
in	B-X
the	B-X
isoprenylation	B-X
pathway	B-X
,	B-X
it	B-X
could	B-X
be	B-X
a	B-X
site	B-X
of	B-X
regulation	B-X
of	B-X
G	B-X
protein	B-X
activity	B-X
.	B-X
With	B-X
both	B-X
the	B-X
methylated	B-X
and	B-X
demethylated	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
now	B-X
available	B-X
,	B-X
the	B-X
role	B-X
of	B-X
methylation	B-X
for	B-X
a	B-X
geranylgeranylated	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
may	B-X
be	B-X
addressed	B-X
.	B-X
Here	B-X
,	B-X
it	B-X
is	B-X
reported	B-X
that	B-X
methylation	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
gamma	B-X
to	B-X
interact	B-X
with	B-X
an	B-X
alpha	B-X
subunit	B-X
,	B-X
as	B-X
probed	B-X
by	B-X
ADP-ribosylation	B-X
studies	B-X
with	B-X
pertussis	B-X
toxin	B-X
,	B-X
and	B-X
has	B-X
a	B-X
small	B-X
effect	B-X
(	B-X
less	B-X
than	B-X
2-fold	B-X
)	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
to	B-X
activate	B-X
phosphatidylinositol-specific	B-X
phospholipase	B-X
C	B-X
(	B-X
PIPLC	B-X
)	B-X
and	B-X
phosphoinositide	B-X
3	B-X
kinase	B-X
(	B-X
PI3K	B-X
)	B-X
.	B-X
In	B-X
binding	B-X
studies	B-X
,	B-X
demethylation	B-X
only	B-X
slightly	B-X
decreased	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
to	B-X
adhere	B-X
to	B-X
azolectin	B-X
vesicles	B-X
.	B-X
Therefore	B-X
,	B-X
methylation	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
appears	B-X
to	B-X
have	B-X
only	B-X
a	B-X
minor	B-X
effect	B-X
in	B-X
signal	B-X
transduction	B-X
processes	B-X
which	B-X
can	B-X
be	B-X
correlated	B-X
to	B-X
a	B-X
decrease	B-X
in	B-X
hydrophobicity	B-X
of	B-X
the	B-X
beta	B-X
gamma	B-X
subunit	B-X
.	B-X

Here	O
,	O
it	O
is	O
reported	O
that	O
methylation	O
has	O
no	O
effect	O
on	O
the	O
ability	O
of	O
beta	O
gamma	O
to	O
interact	O
with	O
an	O
alpha	O
subunit	O
,	O
as	O
probed	O
by	O
ADP	O
-	O
ribosylation	O
studies	O
with	O
pertussis	O
toxin	O
,	O
and	O
has	O
a	O
small	O
effect	O
(	O
less	O
than	O
2	O
-	O
fold	O
)	O
on	O
the	O
ability	O
of	O
geranylgeranylated	O
beta	O
gamma	O
to	O
activate	O
phosphatidylinositol	O
-	O
specific	O
phospholipase	O
C	O
(	O
PIPLC	O
)	O
and	O
phosphoinositide	O
3	O
kinase	O
(	O
PI3K	O
)	O
.	O

In	O
binding	O
studies	O
,	O
demethylation	O
only	O
slightly	O
decreased	O
the	O
ability	O
of	O
beta	B-Protein
1	I-Protein
gamma	B-Protein
2	I-Protein
to	O
adhere	O
to	O
azolectin	O
vesicles	O
.	O
<EOS>	B-X
The	B-X
gamma	B-X
subunit	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
is	B-X
isoprenylated	B-X
and	B-X
methylated	B-X
on	B-X
its	B-X
carboxyl	B-X
terminal	B-X
cysteine	B-X
residue	B-X
.	B-X
While	B-X
retinal	B-X
transducin	B-X
is	B-X
farnesylated	B-X
,	B-X
all	B-X
other	B-X
gamma	B-X
subunits	B-X
are	B-X
modified	B-X
by	B-X
geranylgeranylation	B-X
.	B-X
An	B-X
immobilized	B-X
form	B-X
of	B-X
pig	B-X
liver	B-X
esterase	B-X
(	B-X
iPLE	B-X
)	B-X
is	B-X
able	B-X
to	B-X
hydrolyze	B-X
the	B-X
methyl	B-X
ester	B-X
of	B-X
a	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
isoform	B-X
(	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
)	B-X
.	B-X
With	B-X
both	B-X
the	B-X
methylated	B-X
and	B-X
demethylated	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
now	B-X
available	B-X
,	B-X
the	B-X
role	B-X
of	B-X
methylation	B-X
for	B-X
a	B-X
geranylgeranylated	B-X
heterotrimeric	B-X
G	B-X
protein	B-X
may	B-X
be	B-X
addressed	B-X
.	B-X
Here	B-X
,	B-X
it	B-X
is	B-X
reported	B-X
that	B-X
methylation	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
gamma	B-X
to	B-X
interact	B-X
with	B-X
an	B-X
alpha	B-X
subunit	B-X
,	B-X
as	B-X
probed	B-X
by	B-X
ADP-ribosylation	B-X
studies	B-X
with	B-X
pertussis	B-X
toxin	B-X
,	B-X
and	B-X
has	B-X
a	B-X
small	B-X
effect	B-X
(	B-X
less	B-X
than	B-X
2-fold	B-X
)	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
geranylgeranylated	B-X
beta	B-X
gamma	B-X
to	B-X
activate	B-X
phosphatidylinositol-specific	B-X
phospholipase	B-X
C	B-X
(	B-X
PIPLC	B-X
)	B-X
and	B-X
phosphoinositide	B-X
3	B-X
kinase	B-X
(	B-X
PI3K	B-X
)	B-X
.	B-X
In	B-X
binding	B-X
studies	B-X
,	B-X
demethylation	B-X
only	B-X
slightly	B-X
decreased	B-X
the	B-X
ability	B-X
of	B-X
beta	B-X
1	B-X
gamma	B-X
2	B-X
to	B-X
adhere	B-X
to	B-X
azolectin	B-X
vesicles	B-X
.	B-X
Therefore	B-X
,	B-X
methylation	B-X
of	B-X
heterotrimeric	B-X
G	B-X
proteins	B-X
appears	B-X
to	B-X
have	B-X
only	B-X
a	B-X
minor	B-X
effect	B-X
in	B-X
signal	B-X
transduction	B-X
processes	B-X
which	B-X
can	B-X
be	B-X
correlated	B-X
to	B-X
a	B-X
decrease	B-X
in	B-X
hydrophobicity	B-X
of	B-X
the	B-X
beta	B-X
gamma	B-X
subunit	B-X
.	B-X

Therefore	O
,	O
methylation	O
of	O
heterotrimeric	O
G	O
proteins	O
appears	O
to	O
have	O
only	O
a	O
minor	O
effect	O
in	O
signal	O
transduction	O
processes	O
which	O
can	O
be	O
correlated	O
to	O
a	O
decrease	O
in	O
hydrophobicity	O
of	O
the	O
beta	O
gamma	O
subunit	O
.	O

Purification	O
of	O
a	O
protein	O
palmitoyltransferase	O
that	O
acts	O
on	O
H	B-Protein
-	I-Protein
Ras	I-Protein
protein	O
and	O
on	O
a	O
C	O
-	O
terminal	O
N	B-Protein
-	I-Protein
Ras	I-Protein
peptide	O
.	O

Mammalian	O
H	B-Protein
-	I-Protein
Ras	I-Protein
and	O
N	B-Protein
-	I-Protein
Ras	I-Protein
are	O
GTP	O
-	O
binding	O
proteins	O
that	O
must	O
be	O
post	O
-	O
translationally	O
lipidated	O
to	O
function	O
as	O
molecular	O
switches	O
in	O
signal	O
transduction	O
cascades	O
controlling	O
cell	O
growth	O
and	O
differentiation	O
.	O

These	O
proteins	O
contain	O
a	O
C	O
-	O
terminal	O
farnesyl	O
-	O
cysteine	O
alpha	O
-	O
methyl	O
ester	O
and	O
palmitoyl	O
groups	O
attached	O
to	O
nearby	O
cysteines	O
.	O

Data	O
is	O
presented	O
showing	O
that	O
rat	O
liver	O
microsomes	O
contain	O
an	O
enzyme	O
that	O
transfers	O
the	O
palmitoyl	O
group	O
from	O
palmitoyl	O
-	O
coenzyme	O
A	O
to	O
cysteine	O
residues	O
of	O
H	B-Protein
-	I-Protein
Ras	I-Protein
protein	O
and	O
of	O
a	O
synthetic	O
peptide	O
having	O
the	O
structure	O
of	O
the	O
C	O
terminus	O
of	O
N	B-Protein
-	I-Protein
Ras	I-Protein
.	O

This	O
protein	O
palmitoyltransferase	O
(	O
PPT	O
)	O
was	O
solubilized	O
from	O
membranes	O
and	O
purified	O
10	O
,	O
500	O
-	O
fold	O
to	O
apparent	O
homogeneity	O
with	O
an	O
overall	O
yield	O
of	O
10	O
%	O
.	O
<EOS>	B-X
Mammalian	B-X
H-Ras	B-X
and	B-X
N-Ras	B-X
are	B-X
GTP-binding	B-X
proteins	B-X
that	B-X
must	B-X
be	B-X
post-translationally	B-X
lipidated	B-X
to	B-X
function	B-X
as	B-X
molecular	B-X
switches	B-X
in	B-X
signal	B-X
transduction	B-X
cascades	B-X
controlling	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
.	B-X
These	B-X
proteins	B-X
contain	B-X
a	B-X
C-terminal	B-X
farnesyl-cysteine	B-X
alpha-methyl	B-X
ester	B-X
and	B-X
palmitoyl	B-X
groups	B-X
attached	B-X
to	B-X
nearby	B-X
cysteines	B-X
.	B-X
Data	B-X
is	B-X
presented	B-X
showing	B-X
that	B-X
rat	B-X
liver	B-X
microsomes	B-X
contain	B-X
an	B-X
enzyme	B-X
that	B-X
transfers	B-X
the	B-X
palmitoyl	B-X
group	B-X
from	B-X
palmitoyl-coenzyme	B-X
A	B-X
to	B-X
cysteine	B-X
residues	B-X
of	B-X
H-Ras	B-X
protein	B-X
and	B-X
of	B-X
a	B-X
synthetic	B-X
peptide	B-X
having	B-X
the	B-X
structure	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
N-Ras	B-X
.	B-X
This	B-X
protein	B-X
palmitoyltransferase	B-X
(	B-X
PPT	B-X
)	B-X
was	B-X
solubilized	B-X
from	B-X
membranes	B-X
and	B-X
purified	B-X
10,500-fold	B-X
to	B-X
apparent	B-X
homogeneity	B-X
with	B-X
an	B-X
overall	B-X
yield	B-X
of	B-X
10	B-X
%	B-X
.	B-X
On	B-X
an	B-X
SDS	B-X
gel	B-X
,	B-X
PPT	B-X
appears	B-X
as	B-X
two	B-X
proteins	B-X
of	B-X
molecular	B-X
masses	B-X
of	B-X
approximately	B-X
30	B-X
and	B-X
approximately	B-X
33	B-X
kDa	B-X
.	B-X
If	B-X
the	B-X
palmitoylation	B-X
sites	B-X
of	B-X
the	B-X
N-Ras	B-X
peptide	B-X
(	B-X
the	B-X
non-farnesylated	B-X
cysteine	B-X
)	B-X
or	B-X
H-Ras	B-X
protein	B-X
(	B-X
cysteines	B-X
181	B-X
and	B-X
184	B-X
)	B-X
are	B-X
changed	B-X
to	B-X
serine	B-X
,	B-X
palmitoylation	B-X
by	B-X
PPT	B-X
does	B-X
not	B-X
occur	B-X
.	B-X
Non-farnesylated	B-X
H-Ras	B-X
produced	B-X
in	B-X
bacteria	B-X
as	B-X
well	B-X
as	B-X
in	B-X
vitro	B-X
farnesylated	B-X
bacterial	B-X
H-Ras	B-X
are	B-X
not	B-X
substrates	B-X
for	B-X
PPT	B-X
nor	B-X
is	B-X
the	B-X
non-farnesylated	B-X
,	B-X
methylated	B-X
N-Ras	B-X
peptide	B-X
.	B-X
PPT	B-X
shows	B-X
a	B-X
large	B-X
preference	B-X
for	B-X
palmitoyl-coenzyme	B-X
A	B-X
over	B-X
myristoyl-coenzyme	B-X
as	B-X
the	B-X
acyl	B-X
donor	B-X
.	B-X
PPT	B-X
is	B-X
the	B-X
first	B-X
protein	B-X
palmitoyltransferase	B-X
to	B-X
be	B-X
purified	B-X
,	B-X
and	B-X
the	B-X
availability	B-X
of	B-X
pure	B-X
enzyme	B-X
should	B-X
contribute	B-X
to	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
function	B-X
and	B-X
regulation	B-X
of	B-X
Ras	B-X
palmitoylation	B-X
in	B-X
cells	B-X
.	B-X

On	O
an	O
SDS	O
gel	O
,	O
PPT	O
appears	O
as	O
two	O
proteins	O
of	O
molecular	O
masses	O
of	O
approximately	O
30	O
and	O
approximately	O
33	O
kDa	O
.	O

If	O
the	O
palmitoylation	O
sites	O
of	O
the	O
N	B-Protein
-	I-Protein
Ras	I-Protein
peptide	O
(	O
the	O
non	O
-	O
farnesylated	O
cysteine	O
)	O
or	O
H	B-Protein
-	I-Protein
Ras	I-Protein
protein	O
(	O
cysteines	O
181	O
and	O
184	O
)	O
are	O
changed	O
to	O
serine	O
,	O
palmitoylation	O
by	O
PPT	O
does	O
not	O
occur	O
.	O

Non	O
-	O
farnesylated	O
H	B-Protein
-	I-Protein
Ras	I-Protein
produced	O
in	O
bacteria	O
as	O
well	O
as	O
in	O
vitro	O
farnesylated	O
bacterial	O
H	B-Protein
-	I-Protein
Ras	I-Protein
are	O
not	O
substrates	O
for	O
PPT	O
nor	O
is	O
the	O
non	O
-	O
farnesylated	O
,	O
methylated	O
N	B-Protein
-	I-Protein
Ras	I-Protein
peptide	O
.	O

These	O
results	O
suggest	O
,	O
but	O
do	O
not	O
prove	O
,	O
that	O
farnesylation	O
and	O
possibly	O
C	O
-	O
terminal	O
methylation	O
are	O
prerequisites	O
for	O
Ras	O
palmitoylation	O
.	O
<EOS>	B-X
The	B-X
abeyance	B-X
of	B-X
self-consciousness	B-X
(	B-X
SC	B-X
)	B-X
during	B-X
hypnosis	B-X
has	B-X
been	B-X
discussed	B-X
as	B-X
a	B-X
central	B-X
aspect	B-X
of	B-X
hypnosis	B-X
,	B-X
yet	B-X
dispositional	B-X
SC	B-X
has	B-X
been	B-X
very	B-X
rarely	B-X
evaluated	B-X
as	B-X
a	B-X
correlate	B-X
of	B-X
hypnotizability	B-X
.	B-X
Elevated	B-X
responsiveness	B-X
to	B-X
verbal	B-X
suggestions	B-X
is	B-X
hypothesized	B-X
to	B-X
represent	B-X
a	B-X
predisposing	B-X
factor	B-X
for	B-X
the	B-X
dissociative	B-X
disorders	B-X
(	B-X
DDs	B-X
)	B-X
and	B-X
related	B-X
conditions	B-X
.	B-X
This	B-X
study	B-X
assessed	B-X
whether	B-X
patients	B-X
with	B-X
DDs	B-X
,	B-X
trauma-	B-X
and	B-X
stressor-related	B-X
disorders	B-X
(	B-X
TSDs	B-X
)	B-X
,	B-X
and	B-X
functional	B-X
neurological	B-X
disorder	B-X
(	B-X
FND	B-X
)	B-X
display	B-X
elevated	B-X
hypnotic	B-X
suggestibility	B-X
.	B-X
A	B-X
random-effects	B-X
meta-analysis	B-X
revealed	B-X
that	B-X
patients	B-X
displayed	B-X
greater	B-X
hypnotic	B-X
suggestibility	B-X
than	B-X
controls	B-X
,	B-X
Hedges	B-X
's	B-X
g	B-X
=	B-X
0.92	B-X
[	B-X
0.66	B-X
,	B-X
1.18	B-X
]	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
DDs	B-X
and	B-X
related	B-X
conditions	B-X
are	B-X
characterized	B-X
by	B-X
elevated	B-X
hypnotic	B-X
suggestibility	B-X
and	B-X
have	B-X
implications	B-X
for	B-X
the	B-X
mechanisms	B-X
,	B-X
risk	B-X
factors	B-X
,	B-X
and	B-X
treatment	B-X
of	B-X
dissociative	B-X
psychopathology	B-X
.	B-X

PPT	O
shows	O
a	O
large	O
preference	O
for	O
palmitoyl	O
-	O
coenzyme	O
A	O
over	O
myristoyl	O
-	O
coenzyme	O
as	O
the	O
acyl	O
donor	O
.	O

Values	O
of	O
Km	O
for	O
palmitoyl	O
-	O
CoA	O
and	O
H	B-Protein
-	I-Protein
Ras	I-Protein
are	O
4	O
.	O
3	O
+	O
/	O
-	O
1	O
.	O
2	O
and	O
0	O
.	O
8	O
+	O
/	O
-	O
0	O
.	O
3	O
microM	O
,	O
respectively	O
.	O

PPT	O
is	O
the	O
first	O
protein	O
palmitoyltransferase	O
to	O
be	O
purified	O
,	O
and	O
the	O
availability	O
of	O
pure	O
enzyme	O
should	O
contribute	O
to	O
our	O
understanding	O
of	O
the	O
function	O
and	O
regulation	O
of	O
Ras	O
palmitoylation	O
in	O
cells	O
.	O
<EOS>	B-X
Mammalian	B-X
H-Ras	B-X
and	B-X
N-Ras	B-X
are	B-X
GTP-binding	B-X
proteins	B-X
that	B-X
must	B-X
be	B-X
post-translationally	B-X
lipidated	B-X
to	B-X
function	B-X
as	B-X
molecular	B-X
switches	B-X
in	B-X
signal	B-X
transduction	B-X
cascades	B-X
controlling	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
.	B-X
These	B-X
proteins	B-X
contain	B-X
a	B-X
C-terminal	B-X
farnesyl-cysteine	B-X
alpha-methyl	B-X
ester	B-X
and	B-X
palmitoyl	B-X
groups	B-X
attached	B-X
to	B-X
nearby	B-X
cysteines	B-X
.	B-X
Data	B-X
is	B-X
presented	B-X
showing	B-X
that	B-X
rat	B-X
liver	B-X
microsomes	B-X
contain	B-X
an	B-X
enzyme	B-X
that	B-X
transfers	B-X
the	B-X
palmitoyl	B-X
group	B-X
from	B-X
palmitoyl-coenzyme	B-X
A	B-X
to	B-X
cysteine	B-X
residues	B-X
of	B-X
H-Ras	B-X
protein	B-X
and	B-X
of	B-X
a	B-X
synthetic	B-X
peptide	B-X
having	B-X
the	B-X
structure	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
N-Ras	B-X
.	B-X
This	B-X
protein	B-X
palmitoyltransferase	B-X
(	B-X
PPT	B-X
)	B-X
was	B-X
solubilized	B-X
from	B-X
membranes	B-X
and	B-X
purified	B-X
10,500-fold	B-X
to	B-X
apparent	B-X
homogeneity	B-X
with	B-X
an	B-X
overall	B-X
yield	B-X
of	B-X
10	B-X
%	B-X
.	B-X
On	B-X
an	B-X
SDS	B-X
gel	B-X
,	B-X
PPT	B-X
appears	B-X
as	B-X
two	B-X
proteins	B-X
of	B-X
molecular	B-X
masses	B-X
of	B-X
approximately	B-X
30	B-X
and	B-X
approximately	B-X
33	B-X
kDa	B-X
.	B-X
If	B-X
the	B-X
palmitoylation	B-X
sites	B-X
of	B-X
the	B-X
N-Ras	B-X
peptide	B-X
(	B-X
the	B-X
non-farnesylated	B-X
cysteine	B-X
)	B-X
or	B-X
H-Ras	B-X
protein	B-X
(	B-X
cysteines	B-X
181	B-X
and	B-X
184	B-X
)	B-X
are	B-X
changed	B-X
to	B-X
serine	B-X
,	B-X
palmitoylation	B-X
by	B-X
PPT	B-X
does	B-X
not	B-X
occur	B-X
.	B-X
Non-farnesylated	B-X
H-Ras	B-X
produced	B-X
in	B-X
bacteria	B-X
as	B-X
well	B-X
as	B-X
in	B-X
vitro	B-X
farnesylated	B-X
bacterial	B-X
H-Ras	B-X
are	B-X
not	B-X
substrates	B-X
for	B-X
PPT	B-X
nor	B-X
is	B-X
the	B-X
non-farnesylated	B-X
,	B-X
methylated	B-X
N-Ras	B-X
peptide	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
,	B-X
but	B-X
do	B-X
not	B-X
prove	B-X
,	B-X
that	B-X
farnesylation	B-X
and	B-X
possibly	B-X
C-terminal	B-X
methylation	B-X
are	B-X
prerequisites	B-X
for	B-X
Ras	B-X
palmitoylation	B-X
.	B-X
PPT	B-X
shows	B-X
a	B-X
large	B-X
preference	B-X
for	B-X
palmitoyl-coenzyme	B-X
A	B-X
over	B-X
myristoyl-coenzyme	B-X
as	B-X
the	B-X
acyl	B-X
donor	B-X
.	B-X
Values	B-X
of	B-X
Km	B-X
for	B-X
palmitoyl-CoA	B-X
and	B-X
H-Ras	B-X
are	B-X
4.3	B-X
+/-	B-X
1.2	B-X
and	B-X
0.8	B-X
+/-	B-X
0.3	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
PPT	B-X
is	B-X
the	B-X
first	B-X
protein	B-X
palmitoyltransferase	B-X
to	B-X
be	B-X
purified	B-X
,	B-X
and	B-X
the	B-X
availability	B-X
of	B-X
pure	B-X
enzyme	B-X
should	B-X
contribute	B-X
to	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
function	B-X
and	B-X
regulation	B-X
of	B-X
Ras	B-X
palmitoylation	B-X
in	B-X
cells	B-X
.	B-X

Prenylated	O
isoforms	O
of	O
yeast	O
casein	O
kinase	O
I	O
,	O
including	O
the	O
novel	O
Yck3p	B-Protein
,	O
suppress	O
the	O
gcs1	B-Protein
blockage	O
of	O
cell	O
proliferation	O
from	O
stationary	O
phase	O
.	O
<EOS>	B-X
The	B-X
GCS1	B-X
gene	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
mediate	B-X
the	B-X
resumption	B-X
of	B-X
cell	B-X
proliferation	B-X
from	B-X
the	B-X
starved	B-X
,	B-X
stationary-phase	B-X
state	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
yeast	B-X
genes	B-X
that	B-X
,	B-X
in	B-X
increased	B-X
dosages	B-X
,	B-X
overcome	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
.	B-X
Among	B-X
these	B-X
are	B-X
YCK1	B-X
(	B-X
CK12	B-X
)	B-X
and	B-X
YCK2	B-X
(	B-X
CKI1	B-X
)	B-X
,	B-X
encoding	B-X
membrane-associated	B-X
casein	B-X
kinase	B-X
I	B-X
,	B-X
and	B-X
YCK3	B-X
,	B-X
encoding	B-X
a	B-X
novel	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
.	B-X
Some	B-X
Yck3p	B-X
gene	B-X
product	B-X
was	B-X
found	B-X
associated	B-X
with	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
like	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
,	B-X
but	B-X
most	B-X
confractionated	B-X
with	B-X
the	B-X
nucleus	B-X
,	B-X
like	B-X
another	B-X
yeast	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
,	B-X
Hrr25p	B-X
.	B-X
Genetic	B-X
studies	B-X
showed	B-X
that	B-X
YCK3	B-X
and	B-X
HRR25	B-X
constitute	B-X
an	B-X
essential	B-X
gene	B-X
family	B-X
and	B-X
that	B-X
Yck3p	B-X
can	B-X
weakly	B-X
substitute	B-X
for	B-X
Yck1p-Yck2p	B-X
.	B-X
For	B-X
gcs1	B-X
delta	B-X
suppression	B-X
,	B-X
both	B-X
a	B-X
protein	B-X
kinase	B-X
domain	B-X
and	B-X
a	B-X
C-terminal	B-X
prenylation	B-X
motif	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
.	B-X
An	B-X
impairment	B-X
in	B-X
endocytosis	B-X
was	B-X
found	B-X
for	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
,	B-X
which	B-X
was	B-X
alleviated	B-X
by	B-X
an	B-X
increased	B-X
YCK2	B-X
gene	B-X
dosage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
an	B-X
increased	B-X
casein	B-X
kinase	B-X
I	B-X
gene	B-X
dosage	B-X
to	B-X
suppress	B-X
the	B-X
effects	B-X
caused	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
Gcs1p	B-X
suggests	B-X
that	B-X
Gcs1p	B-X
and	B-X
Yck1p-Yck2p	B-X
affect	B-X
parallel	B-X
pathways	B-X
.	B-X

The	O
GCS1	B-Protein
gene	O
of	O
the	O
budding	O
yeast	O
Saccharomyces	O
cerevisiae	O
mediate	O
the	O
resumption	O
of	O
cell	O
proliferation	O
from	O
the	O
starved	O
,	O
stationary	O
-	O
phase	O
state	O
.	O
<EOS>	B-X
The	B-X
GCS1	B-X
gene	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
mediate	B-X
the	B-X
resumption	B-X
of	B-X
cell	B-X
proliferation	B-X
from	B-X
the	B-X
starved	B-X
,	B-X
stationary-phase	B-X
state	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
yeast	B-X
genes	B-X
that	B-X
,	B-X
in	B-X
increased	B-X
dosages	B-X
,	B-X
overcome	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
.	B-X
Some	B-X
Yck3p	B-X
gene	B-X
product	B-X
was	B-X
found	B-X
associated	B-X
with	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
like	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
,	B-X
but	B-X
most	B-X
confractionated	B-X
with	B-X
the	B-X
nucleus	B-X
,	B-X
like	B-X
another	B-X
yeast	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
,	B-X
Hrr25p	B-X
.	B-X
Genetic	B-X
studies	B-X
showed	B-X
that	B-X
YCK3	B-X
and	B-X
HRR25	B-X
constitute	B-X
an	B-X
essential	B-X
gene	B-X
family	B-X
and	B-X
that	B-X
Yck3p	B-X
can	B-X
weakly	B-X
substitute	B-X
for	B-X
Yck1p-Yck2p	B-X
.	B-X
An	B-X
impairment	B-X
in	B-X
endocytosis	B-X
was	B-X
found	B-X
for	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
,	B-X
which	B-X
was	B-X
alleviated	B-X
by	B-X
an	B-X
increased	B-X
YCK2	B-X
gene	B-X
dosage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
an	B-X
increased	B-X
casein	B-X
kinase	B-X
I	B-X
gene	B-X
dosage	B-X
to	B-X
suppress	B-X
the	B-X
effects	B-X
caused	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
Gcs1p	B-X
suggests	B-X
that	B-X
Gcs1p	B-X
and	B-X
Yck1p-Yck2p	B-X
affect	B-X
parallel	B-X
pathways	B-X
.	B-X

Here	O
we	O
identify	O
yeast	O
genes	O
that	O
,	O
in	O
increased	O
dosages	O
,	O
overcome	O
the	O
growth	O
defect	O
of	O
gcs1	B-Protein
delta	O
mutant	O
cells	O
.	O
<EOS>	B-X
The	B-X
GCS1	B-X
gene	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
mediate	B-X
the	B-X
resumption	B-X
of	B-X
cell	B-X
proliferation	B-X
from	B-X
the	B-X
starved	B-X
,	B-X
stationary-phase	B-X
state	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
yeast	B-X
genes	B-X
that	B-X
,	B-X
in	B-X
increased	B-X
dosages	B-X
,	B-X
overcome	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
.	B-X
Some	B-X
Yck3p	B-X
gene	B-X
product	B-X
was	B-X
found	B-X
associated	B-X
with	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
like	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
,	B-X
but	B-X
most	B-X
confractionated	B-X
with	B-X
the	B-X
nucleus	B-X
,	B-X
like	B-X
another	B-X
yeast	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
,	B-X
Hrr25p	B-X
.	B-X
For	B-X
gcs1	B-X
delta	B-X
suppression	B-X
,	B-X
both	B-X
a	B-X
protein	B-X
kinase	B-X
domain	B-X
and	B-X
a	B-X
C-terminal	B-X
prenylation	B-X
motif	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
.	B-X
An	B-X
impairment	B-X
in	B-X
endocytosis	B-X
was	B-X
found	B-X
for	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
,	B-X
which	B-X
was	B-X
alleviated	B-X
by	B-X
an	B-X
increased	B-X
YCK2	B-X
gene	B-X
dosage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
an	B-X
increased	B-X
casein	B-X
kinase	B-X
I	B-X
gene	B-X
dosage	B-X
to	B-X
suppress	B-X
the	B-X
effects	B-X
caused	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
Gcs1p	B-X
suggests	B-X
that	B-X
Gcs1p	B-X
and	B-X
Yck1p-Yck2p	B-X
affect	B-X
parallel	B-X
pathways	B-X
.	B-X

Among	O
these	O
are	O
YCK1	B-Protein
(	O
CK12	B-Protein
)	O
and	O
YCK2	B-Protein
(	O
CKI1	B-Protein
)	O
,	O
encoding	O
membrane	O
-	O
associated	O
casein	O
kinase	O
I	O
,	O
and	O
YCK3	B-Protein
,	O
encoding	O
a	O
novel	O
casein	O
kinase	O
I	O
isoform	O
.	O
<EOS>	B-X
Among	B-X
these	B-X
are	B-X
YCK1	B-X
(	B-X
CK12	B-X
)	B-X
and	B-X
YCK2	B-X
(	B-X
CKI1	B-X
)	B-X
,	B-X
encoding	B-X
membrane-associated	B-X
casein	B-X
kinase	B-X
I	B-X
,	B-X
and	B-X
YCK3	B-X
,	B-X
encoding	B-X
a	B-X
novel	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
.	B-X
Some	B-X
Yck3p	B-X
gene	B-X
product	B-X
was	B-X
found	B-X
associated	B-X
with	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
like	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
,	B-X
but	B-X
most	B-X
confractionated	B-X
with	B-X
the	B-X
nucleus	B-X
,	B-X
like	B-X
another	B-X
yeast	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
,	B-X
Hrr25p	B-X
.	B-X
Genetic	B-X
studies	B-X
showed	B-X
that	B-X
YCK3	B-X
and	B-X
HRR25	B-X
constitute	B-X
an	B-X
essential	B-X
gene	B-X
family	B-X
and	B-X
that	B-X
Yck3p	B-X
can	B-X
weakly	B-X
substitute	B-X
for	B-X
Yck1p-Yck2p	B-X
.	B-X
For	B-X
gcs1	B-X
delta	B-X
suppression	B-X
,	B-X
both	B-X
a	B-X
protein	B-X
kinase	B-X
domain	B-X
and	B-X
a	B-X
C-terminal	B-X
prenylation	B-X
motif	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
.	B-X
An	B-X
impairment	B-X
in	B-X
endocytosis	B-X
was	B-X
found	B-X
for	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
,	B-X
which	B-X
was	B-X
alleviated	B-X
by	B-X
an	B-X
increased	B-X
YCK2	B-X
gene	B-X
dosage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
an	B-X
increased	B-X
casein	B-X
kinase	B-X
I	B-X
gene	B-X
dosage	B-X
to	B-X
suppress	B-X
the	B-X
effects	B-X
caused	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
Gcs1p	B-X
suggests	B-X
that	B-X
Gcs1p	B-X
and	B-X
Yck1p-Yck2p	B-X
affect	B-X
parallel	B-X
pathways	B-X
.	B-X

Some	O
Yck3p	B-Protein
gene	O
product	O
was	O
found	O
associated	O
with	O
the	O
plasma	O
membrane	O
,	O
like	O
Yck1p	B-Protein
and	O
Yck2p	B-Protein
,	O
but	O
most	O
confractionated	O
with	O
the	O
nucleus	O
,	O
like	O
another	O
yeast	O
casein	O
kinase	O
I	O
isoform	O
,	O
Hrr25p	B-Protein
.	O
<EOS>	B-X
The	B-X
GCS1	B-X
gene	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
mediate	B-X
the	B-X
resumption	B-X
of	B-X
cell	B-X
proliferation	B-X
from	B-X
the	B-X
starved	B-X
,	B-X
stationary-phase	B-X
state	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
yeast	B-X
genes	B-X
that	B-X
,	B-X
in	B-X
increased	B-X
dosages	B-X
,	B-X
overcome	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
.	B-X
Among	B-X
these	B-X
are	B-X
YCK1	B-X
(	B-X
CK12	B-X
)	B-X
and	B-X
YCK2	B-X
(	B-X
CKI1	B-X
)	B-X
,	B-X
encoding	B-X
membrane-associated	B-X
casein	B-X
kinase	B-X
I	B-X
,	B-X
and	B-X
YCK3	B-X
,	B-X
encoding	B-X
a	B-X
novel	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
.	B-X
Some	B-X
Yck3p	B-X
gene	B-X
product	B-X
was	B-X
found	B-X
associated	B-X
with	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
like	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
,	B-X
but	B-X
most	B-X
confractionated	B-X
with	B-X
the	B-X
nucleus	B-X
,	B-X
like	B-X
another	B-X
yeast	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
,	B-X
Hrr25p	B-X
.	B-X
Genetic	B-X
studies	B-X
showed	B-X
that	B-X
YCK3	B-X
and	B-X
HRR25	B-X
constitute	B-X
an	B-X
essential	B-X
gene	B-X
family	B-X
and	B-X
that	B-X
Yck3p	B-X
can	B-X
weakly	B-X
substitute	B-X
for	B-X
Yck1p-Yck2p	B-X
.	B-X
For	B-X
gcs1	B-X
delta	B-X
suppression	B-X
,	B-X
both	B-X
a	B-X
protein	B-X
kinase	B-X
domain	B-X
and	B-X
a	B-X
C-terminal	B-X
prenylation	B-X
motif	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
.	B-X
An	B-X
impairment	B-X
in	B-X
endocytosis	B-X
was	B-X
found	B-X
for	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
,	B-X
which	B-X
was	B-X
alleviated	B-X
by	B-X
an	B-X
increased	B-X
YCK2	B-X
gene	B-X
dosage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
an	B-X
increased	B-X
casein	B-X
kinase	B-X
I	B-X
gene	B-X
dosage	B-X
to	B-X
suppress	B-X
the	B-X
effects	B-X
caused	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
Gcs1p	B-X
suggests	B-X
that	B-X
Gcs1p	B-X
and	B-X
Yck1p-Yck2p	B-X
affect	B-X
parallel	B-X
pathways	B-X
.	B-X

Genetic	O
studies	O
showed	O
that	O
YCK3	B-Protein
and	O
HRR25	B-Protein
constitute	O
an	O
essential	O
gene	O
family	O
and	O
that	O
Yck3p	B-Protein
can	O
weakly	O
substitute	O
for	O
Yck1p	B-Protein
-	O
Yck2p	B-Protein
.	O
<EOS>	B-X
The	B-X
GCS1	B-X
gene	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
mediate	B-X
the	B-X
resumption	B-X
of	B-X
cell	B-X
proliferation	B-X
from	B-X
the	B-X
starved	B-X
,	B-X
stationary-phase	B-X
state	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
yeast	B-X
genes	B-X
that	B-X
,	B-X
in	B-X
increased	B-X
dosages	B-X
,	B-X
overcome	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
.	B-X
Among	B-X
these	B-X
are	B-X
YCK1	B-X
(	B-X
CK12	B-X
)	B-X
and	B-X
YCK2	B-X
(	B-X
CKI1	B-X
)	B-X
,	B-X
encoding	B-X
membrane-associated	B-X
casein	B-X
kinase	B-X
I	B-X
,	B-X
and	B-X
YCK3	B-X
,	B-X
encoding	B-X
a	B-X
novel	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
.	B-X
Some	B-X
Yck3p	B-X
gene	B-X
product	B-X
was	B-X
found	B-X
associated	B-X
with	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
like	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
,	B-X
but	B-X
most	B-X
confractionated	B-X
with	B-X
the	B-X
nucleus	B-X
,	B-X
like	B-X
another	B-X
yeast	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
,	B-X
Hrr25p	B-X
.	B-X
Genetic	B-X
studies	B-X
showed	B-X
that	B-X
YCK3	B-X
and	B-X
HRR25	B-X
constitute	B-X
an	B-X
essential	B-X
gene	B-X
family	B-X
and	B-X
that	B-X
Yck3p	B-X
can	B-X
weakly	B-X
substitute	B-X
for	B-X
Yck1p-Yck2p	B-X
.	B-X
An	B-X
impairment	B-X
in	B-X
endocytosis	B-X
was	B-X
found	B-X
for	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
,	B-X
which	B-X
was	B-X
alleviated	B-X
by	B-X
an	B-X
increased	B-X
YCK2	B-X
gene	B-X
dosage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
an	B-X
increased	B-X
casein	B-X
kinase	B-X
I	B-X
gene	B-X
dosage	B-X
to	B-X
suppress	B-X
the	B-X
effects	B-X
caused	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
Gcs1p	B-X
suggests	B-X
that	B-X
Gcs1p	B-X
and	B-X
Yck1p-Yck2p	B-X
affect	B-X
parallel	B-X
pathways	B-X
.	B-X

For	O
gcs1	B-Protein
delta	O
suppression	O
,	O
both	O
a	O
protein	O
kinase	O
domain	O
and	O
a	O
C	O
-	O
terminal	O
prenylation	O
motif	O
were	O
shown	O
to	O
be	O
necessary	O
.	O

An	O
impairment	O
in	O
endocytosis	O
was	O
found	O
for	O
gcs1	B-Protein
delta	O
mutant	O
cells	O
,	O
which	O
was	O
alleviated	O
by	O
an	O
increased	O
YCK2	B-Protein
gene	O
dosage	O
.	O
<EOS>	B-X
The	B-X
GCS1	B-X
gene	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
mediate	B-X
the	B-X
resumption	B-X
of	B-X
cell	B-X
proliferation	B-X
from	B-X
the	B-X
starved	B-X
,	B-X
stationary-phase	B-X
state	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
yeast	B-X
genes	B-X
that	B-X
,	B-X
in	B-X
increased	B-X
dosages	B-X
,	B-X
overcome	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
.	B-X
Among	B-X
these	B-X
are	B-X
YCK1	B-X
(	B-X
CK12	B-X
)	B-X
and	B-X
YCK2	B-X
(	B-X
CKI1	B-X
)	B-X
,	B-X
encoding	B-X
membrane-associated	B-X
casein	B-X
kinase	B-X
I	B-X
,	B-X
and	B-X
YCK3	B-X
,	B-X
encoding	B-X
a	B-X
novel	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
.	B-X
Some	B-X
Yck3p	B-X
gene	B-X
product	B-X
was	B-X
found	B-X
associated	B-X
with	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
like	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
,	B-X
but	B-X
most	B-X
confractionated	B-X
with	B-X
the	B-X
nucleus	B-X
,	B-X
like	B-X
another	B-X
yeast	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
,	B-X
Hrr25p	B-X
.	B-X
Genetic	B-X
studies	B-X
showed	B-X
that	B-X
YCK3	B-X
and	B-X
HRR25	B-X
constitute	B-X
an	B-X
essential	B-X
gene	B-X
family	B-X
and	B-X
that	B-X
Yck3p	B-X
can	B-X
weakly	B-X
substitute	B-X
for	B-X
Yck1p-Yck2p	B-X
.	B-X
For	B-X
gcs1	B-X
delta	B-X
suppression	B-X
,	B-X
both	B-X
a	B-X
protein	B-X
kinase	B-X
domain	B-X
and	B-X
a	B-X
C-terminal	B-X
prenylation	B-X
motif	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
.	B-X
An	B-X
impairment	B-X
in	B-X
endocytosis	B-X
was	B-X
found	B-X
for	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
,	B-X
which	B-X
was	B-X
alleviated	B-X
by	B-X
an	B-X
increased	B-X
YCK2	B-X
gene	B-X
dosage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
an	B-X
increased	B-X
casein	B-X
kinase	B-X
I	B-X
gene	B-X
dosage	B-X
to	B-X
suppress	B-X
the	B-X
effects	B-X
caused	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
Gcs1p	B-X
suggests	B-X
that	B-X
Gcs1p	B-X
and	B-X
Yck1p-Yck2p	B-X
affect	B-X
parallel	B-X
pathways	B-X
.	B-X

The	O
ability	O
of	O
an	O
increased	O
casein	O
kinase	O
I	O
gene	O
dosage	O
to	O
suppress	O
the	O
effects	O
caused	O
by	O
the	O
absence	O
of	O
Gcs1p	B-Protein
suggests	O
that	O
Gcs1p	B-Protein
and	O
Yck1p	B-Protein
-	O
Yck2p	B-Protein
affect	O
parallel	O
pathways	O
.	O
<EOS>	B-X
The	B-X
GCS1	B-X
gene	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
mediate	B-X
the	B-X
resumption	B-X
of	B-X
cell	B-X
proliferation	B-X
from	B-X
the	B-X
starved	B-X
,	B-X
stationary-phase	B-X
state	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
yeast	B-X
genes	B-X
that	B-X
,	B-X
in	B-X
increased	B-X
dosages	B-X
,	B-X
overcome	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
.	B-X
Among	B-X
these	B-X
are	B-X
YCK1	B-X
(	B-X
CK12	B-X
)	B-X
and	B-X
YCK2	B-X
(	B-X
CKI1	B-X
)	B-X
,	B-X
encoding	B-X
membrane-associated	B-X
casein	B-X
kinase	B-X
I	B-X
,	B-X
and	B-X
YCK3	B-X
,	B-X
encoding	B-X
a	B-X
novel	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
.	B-X
Some	B-X
Yck3p	B-X
gene	B-X
product	B-X
was	B-X
found	B-X
associated	B-X
with	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
like	B-X
Yck1p	B-X
and	B-X
Yck2p	B-X
,	B-X
but	B-X
most	B-X
confractionated	B-X
with	B-X
the	B-X
nucleus	B-X
,	B-X
like	B-X
another	B-X
yeast	B-X
casein	B-X
kinase	B-X
I	B-X
isoform	B-X
,	B-X
Hrr25p	B-X
.	B-X
Genetic	B-X
studies	B-X
showed	B-X
that	B-X
YCK3	B-X
and	B-X
HRR25	B-X
constitute	B-X
an	B-X
essential	B-X
gene	B-X
family	B-X
and	B-X
that	B-X
Yck3p	B-X
can	B-X
weakly	B-X
substitute	B-X
for	B-X
Yck1p-Yck2p	B-X
.	B-X
For	B-X
gcs1	B-X
delta	B-X
suppression	B-X
,	B-X
both	B-X
a	B-X
protein	B-X
kinase	B-X
domain	B-X
and	B-X
a	B-X
C-terminal	B-X
prenylation	B-X
motif	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
necessary	B-X
.	B-X
An	B-X
impairment	B-X
in	B-X
endocytosis	B-X
was	B-X
found	B-X
for	B-X
gcs1	B-X
delta	B-X
mutant	B-X
cells	B-X
,	B-X
which	B-X
was	B-X
alleviated	B-X
by	B-X
an	B-X
increased	B-X
YCK2	B-X
gene	B-X
dosage	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
an	B-X
increased	B-X
casein	B-X
kinase	B-X
I	B-X
gene	B-X
dosage	B-X
to	B-X
suppress	B-X
the	B-X
effects	B-X
caused	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
Gcs1p	B-X
suggests	B-X
that	B-X
Gcs1p	B-X
and	B-X
Yck1p-Yck2p	B-X
affect	B-X
parallel	B-X
pathways	B-X
.	B-X

Protection	O
against	O
Fas	B-Protein
/	O
APO	B-Protein
-	I-Protein
1	I-Protein
-	O
and	O
tumor	O
necrosis	O
factor	O
-	O
mediated	O
cell	O
death	O
by	O
a	O
novel	O
protein	O
,	O
sentrin	B-Protein
.	O
<EOS>	B-X
Fas/APO-1	B-X
and	B-X
TNF	B-X
receptor	B-X
1	B-X
share	B-X
a	B-X
common	B-X
signaling	B-X
motif	B-X
in	B-X
their	B-X
cytoplasmic	B-X
tail	B-X
called	B-X
the	B-X
``	B-X
death	B-X
domain	B-X
.	B-X
''	B-X
Using	B-X
the	B-X
death	B-X
domain	B-X
as	B-X
bait	B-X
in	B-X
the	B-X
yeast	B-X
two-hybrid	B-X
system	B-X
,	B-X
several	B-X
death	B-X
domain-containing	B-X
proteins	B-X
that	B-X
participate	B-X
in	B-X
cell	B-X
death	B-X
signaling	B-X
have	B-X
been	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
novel	B-X
protein	B-X
,	B-X
sentrin	B-X
,	B-X
which	B-X
interacts	B-X
with	B-X
Fas/APO-1	B-X
and	B-X
TNF	B-X
receptor	B-X
1	B-X
but	B-X
not	B-X
with	B-X
FADD/MORT1	B-X
or	B-X
CD40	B-X
.	B-X
Two-hybrid	B-X
interaction	B-X
assays	B-X
reveal	B-X
that	B-X
sentrin	B-X
associates	B-X
only	B-X
with	B-X
the	B-X
signal-competent	B-X
forms	B-X
of	B-X
Fas/APO-1	B-X
or	B-X
TNF	B-X
receptor	B-X
1	B-X
death	B-X
domains	B-X
.	B-X
Sentrin	B-X
is	B-X
a	B-X
novel	B-X
protein	B-X
of	B-X
101	B-X
amino	B-X
acids	B-X
with	B-X
homology	B-X
to	B-X
ubiquitin	B-X
,	B-X
Nedd8	B-X
,	B-X
and	B-X
a	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
,	B-X
Smt3	B-X
.	B-X
When	B-X
overexpressed	B-X
,	B-X
sentrin	B-X
provides	B-X
protection	B-X
against	B-X
both	B-X
anti-Fas/APO-1	B-X
and	B-X
TNF-induced	B-X
cell	B-X
death	B-X
.	B-X

Fas	B-Protein
/	O
APO	B-Protein
-	I-Protein
1	I-Protein
and	O
TNF	B-Protein
receptor	I-Protein
1	I-Protein
share	O
a	O
common	O
signaling	O
motif	O
in	O
their	O
cytoplasmic	O
tail	O
called	O
the	O
"	O
death	O
domain	O
.	O
"	O
Using	O
the	O
death	O
domain	O
as	O
bait	O
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
,	O
several	O
death	O
domain	O
-	O
containing	O
proteins	O
that	O
participate	O
in	O
cell	O
death	O
signaling	O
have	O
been	O
identified	O
.	O

Here	O
we	O
report	O
the	O
isolation	O
of	O
a	O
novel	O
protein	O
,	O
sentrin	B-Protein
,	O
which	O
interacts	O
with	O
Fas	B-Protein
/	O
APO	B-Protein
-	I-Protein
1	I-Protein
and	O
TNF	B-Protein
receptor	I-Protein
1	I-Protein
but	O
not	O
with	O
FADD	B-Protein
/	O
MORT1	B-Protein
or	O
CD40	B-Protein
.	O
<EOS>	B-X
CD40	B-X
is	B-X
a	B-X
TNF	B-X
receptor	B-X
superfamily	B-X
member	B-X
expressed	B-X
on	B-X
both	B-X
immune	B-X
and	B-X
non-immune	B-X
cells	B-X
.	B-X
Interactions	B-X
between	B-X
B	B-X
cell-expressed	B-X
CD40	B-X
and	B-X
its	B-X
binding	B-X
partner	B-X
,	B-X
CD40L	B-X
,	B-X
predominantly	B-X
expressed	B-X
on	B-X
activated	B-X
CD4+	B-X
T	B-X
cells	B-X
,	B-X
play	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
promoting	B-X
germinal	B-X
center	B-X
formation	B-X
and	B-X
the	B-X
production	B-X
of	B-X
class-switched	B-X
antibodies	B-X
.	B-X
Non-hematopoietic	B-X
cells	B-X
expressing	B-X
CD40	B-X
can	B-X
also	B-X
engage	B-X
CD40L	B-X
and	B-X
trigger	B-X
a	B-X
pro-inflammatory	B-X
response	B-X
.	B-X
This	B-X
article	B-X
will	B-X
highlight	B-X
what	B-X
is	B-X
known	B-X
about	B-X
the	B-X
biology	B-X
of	B-X
the	B-X
CD40-CD40L	B-X
axis	B-X
in	B-X
humans	B-X
and	B-X
describe	B-X
the	B-X
potential	B-X
contribution	B-X
of	B-X
CD40	B-X
signaling	B-X
on	B-X
both	B-X
hematopoietic	B-X
and	B-X
non-hematopoietic	B-X
cells	B-X
to	B-X
autoimmune	B-X
disease	B-X
pathogenesis	B-X
.	B-X
Additionally	B-X
,	B-X
novel	B-X
therapeutic	B-X
approaches	B-X
to	B-X
target	B-X
this	B-X
pathway	B-X
,	B-X
currently	B-X
being	B-X
evaluated	B-X
in	B-X
clinical	B-X
trials	B-X
,	B-X
are	B-X
discussed	B-X
.	B-X

Two	O
-	O
hybrid	O
interaction	O
assays	O
reveal	O
that	O
sentrin	B-Protein
associates	O
only	O
with	O
the	O
signal	O
-	O
competent	O
forms	O
of	O
Fas	B-Protein
/	O
APO	B-Protein
-	I-Protein
1	I-Protein
or	O
TNF	B-Protein
receptor	I-Protein
1	I-Protein
death	O
domains	O
.	O
<EOS>	B-X
Cell	B-X
death	B-X
pathways	B-X
have	B-X
evolved	B-X
to	B-X
maintain	B-X
tissue	B-X
homoeostasis	B-X
and	B-X
eliminate	B-X
potentially	B-X
harmful	B-X
cells	B-X
from	B-X
within	B-X
an	B-X
organism	B-X
,	B-X
such	B-X
as	B-X
cells	B-X
with	B-X
damaged	B-X
DNA	B-X
that	B-X
could	B-X
lead	B-X
to	B-X
cancer	B-X
.	B-X
While	B-X
the	B-X
intrinsic	B-X
pathway	B-X
is	B-X
regulated	B-X
by	B-X
the	B-X
Bcl-2	B-X
family	B-X
members	B-X
,	B-X
the	B-X
extrinsic	B-X
pathway	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
Death	B-X
receptors	B-X
,	B-X
members	B-X
of	B-X
the	B-X
tumour	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
receptor	B-X
superfamily	B-X
.	B-X
Death	B-X
receptors	B-X
can	B-X
also	B-X
activate	B-X
a	B-X
pro-inflammatory	B-X
type	B-X
of	B-X
cell	B-X
death	B-X
,	B-X
necroptosis	B-X
,	B-X
when	B-X
Caspase-8	B-X
is	B-X
inhibited	B-X
.	B-X
This	B-X
review	B-X
discusses	B-X
research	B-X
on	B-X
ubiquitination-mediated	B-X
regulation	B-X
of	B-X
apoptotic	B-X
signalling	B-X
.	B-X

Sentrin	B-Protein
is	O
a	O
novel	O
protein	O
of	O
101	O
amino	O
acids	O
with	O
homology	O
to	O
ubiquitin	B-Protein
,	O
Nedd8	B-Protein
,	O
and	O
a	O
Saccharomyces	O
cerevisiae	O
protein	O
,	O
Smt3	B-Protein
.	O

When	O
overexpressed	O
,	O
sentrin	B-Protein
provides	O
protection	O
against	O
both	O
anti	O
-	O
Fas	B-Protein
/	O
APO	B-Protein
-	I-Protein
1	I-Protein
and	O
TNF	O
-	O
induced	O
cell	O
death	O
.	O
<EOS>	B-X
Fas/APO-1	B-X
and	B-X
TNF	B-X
receptor	B-X
1	B-X
share	B-X
a	B-X
common	B-X
signaling	B-X
motif	B-X
in	B-X
their	B-X
cytoplasmic	B-X
tail	B-X
called	B-X
the	B-X
``	B-X
death	B-X
domain	B-X
.	B-X
''	B-X
Using	B-X
the	B-X
death	B-X
domain	B-X
as	B-X
bait	B-X
in	B-X
the	B-X
yeast	B-X
two-hybrid	B-X
system	B-X
,	B-X
several	B-X
death	B-X
domain-containing	B-X
proteins	B-X
that	B-X
participate	B-X
in	B-X
cell	B-X
death	B-X
signaling	B-X
have	B-X
been	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
novel	B-X
protein	B-X
,	B-X
sentrin	B-X
,	B-X
which	B-X
interacts	B-X
with	B-X
Fas/APO-1	B-X
and	B-X
TNF	B-X
receptor	B-X
1	B-X
but	B-X
not	B-X
with	B-X
FADD/MORT1	B-X
or	B-X
CD40	B-X
.	B-X
Two-hybrid	B-X
interaction	B-X
assays	B-X
reveal	B-X
that	B-X
sentrin	B-X
associates	B-X
only	B-X
with	B-X
the	B-X
signal-competent	B-X
forms	B-X
of	B-X
Fas/APO-1	B-X
or	B-X
TNF	B-X
receptor	B-X
1	B-X
death	B-X
domains	B-X
.	B-X
Sentrin	B-X
is	B-X
a	B-X
novel	B-X
protein	B-X
of	B-X
101	B-X
amino	B-X
acids	B-X
with	B-X
homology	B-X
to	B-X
ubiquitin	B-X
,	B-X
Nedd8	B-X
,	B-X
and	B-X
a	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
,	B-X
Smt3	B-X
.	B-X
When	B-X
overexpressed	B-X
,	B-X
sentrin	B-X
provides	B-X
protection	B-X
against	B-X
both	B-X
anti-Fas/APO-1	B-X
and	B-X
TNF-induced	B-X
cell	B-X
death	B-X
.	B-X

Effect	O
of	O
insulin	B-Protein
on	O
farnesyltransferase	O
activity	O
in	O
3T3	O
-	O
L1	O
adipocytes	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
by	B-X
GTP	B-X
loading	B-X
is	B-X
a	B-X
critical	B-X
step	B-X
in	B-X
a	B-X
cascade	B-X
of	B-X
intracellular	B-X
insulin	B-X
signaling	B-X
.	B-X
In	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
FTase	B-X
activities	B-X
were	B-X
studied	B-X
in	B-X
3T3-L1	B-X
adipocytes	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
challenge	B-X
.	B-X
Insulin	B-X
exerted	B-X
a	B-X
biphasic	B-X
stimulatory	B-X
effect	B-X
on	B-X
FTase	B-X
activity	B-X
measured	B-X
in	B-X
vitro	B-X
with	B-X
a	B-X
31	B-X
%	B-X
increase	B-X
at	B-X
5	B-X
min	B-X
and	B-X
a	B-X
130	B-X
%	B-X
increase	B-X
at	B-X
60	B-X
min	B-X
.	B-X
Insulin-stimulated	B-X
farnesylation	B-X
of	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
pools	B-X
in	B-X
vivo	B-X
correlated	B-X
with	B-X
FTase	B-X
activity	B-X
seen	B-X
in	B-X
vitro	B-X
by	B-X
displaying	B-X
an	B-X
increase	B-X
in	B-X
farnesylated	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
from	B-X
40	B-X
%	B-X
of	B-X
total	B-X
cellular	B-X
Ras	B-X
in	B-X
control	B-X
cells	B-X
to	B-X
63	B-X
%	B-X
by	B-X
5	B-X
min	B-X
and	B-X
80	B-X
%	B-X
by	B-X
60	B-X
min	B-X
(	B-X
p	B-X
<	B-X
0.05	B-X
)	B-X
in	B-X
insulin-treated	B-X
cells	B-X
.	B-X
Insulin	B-X
challenge	B-X
of	B-X
3T3-L1	B-X
adipocytes	B-X
increased	B-X
incorporation	B-X
of	B-X
tritiated	B-X
mevalonic	B-X
acid	B-X
in	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
and	B-X
stimulated	B-X
a	B-X
2-fold	B-X
increase	B-X
in	B-X
phosphorylation	B-X
of	B-X
the	B-X
alpha-subunit	B-X
of	B-X
FTase	B-X
at	B-X
5	B-X
min	B-X
and	B-X
a	B-X
4-fold	B-X
increase	B-X
at	B-X
60	B-X
min	B-X
.	B-X

Activation	O
of	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	I-Protein
by	O
GTP	O
loading	O
is	O
a	O
critical	O
step	O
in	O
a	O
cascade	O
of	O
intracellular	O
insulin	B-Protein
signaling	O
.	O

Farnesylation	O
of	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	I-Protein
protein	O
is	O
an	O
obligatory	O
event	O
that	O
facilitates	O
Ras	O
migration	O
to	O
the	O
plasma	O
membrane	O
and	O
subsequent	O
activation	O
.	O

Farnesyltransferase	O
(	O
FTase	O
)	O
is	O
a	O
ubiquitous	O
enzyme	O
that	O
catalyzes	O
the	O
lipid	O
modification	O
of	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	I-Protein
by	O
the	O
addition	O
of	O
farnesyl	O
to	O
the	O
C	O
-	O
terminal	O
"	O
CAAX	O
"	O
motif	O
.	O

In	O
vitro	O
and	O
in	O
vivo	O
FTase	O
activities	O
were	O
studied	O
in	O
3T3	O
-	O
L1	O
adipocytes	O
in	O
response	O
to	O
insulin	B-Protein
challenge	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
by	B-X
GTP	B-X
loading	B-X
is	B-X
a	B-X
critical	B-X
step	B-X
in	B-X
a	B-X
cascade	B-X
of	B-X
intracellular	B-X
insulin	B-X
signaling	B-X
.	B-X
Farnesyltransferase	B-X
(	B-X
FTase	B-X
)	B-X
is	B-X
a	B-X
ubiquitous	B-X
enzyme	B-X
that	B-X
catalyzes	B-X
the	B-X
lipid	B-X
modification	B-X
of	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
by	B-X
the	B-X
addition	B-X
of	B-X
farnesyl	B-X
to	B-X
the	B-X
C-terminal	B-X
``	B-X
CAAX	B-X
''	B-X
motif	B-X
.	B-X
In	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
FTase	B-X
activities	B-X
were	B-X
studied	B-X
in	B-X
3T3-L1	B-X
adipocytes	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
challenge	B-X
.	B-X
Insulin	B-X
exerted	B-X
a	B-X
biphasic	B-X
stimulatory	B-X
effect	B-X
on	B-X
FTase	B-X
activity	B-X
measured	B-X
in	B-X
vitro	B-X
with	B-X
a	B-X
31	B-X
%	B-X
increase	B-X
at	B-X
5	B-X
min	B-X
and	B-X
a	B-X
130	B-X
%	B-X
increase	B-X
at	B-X
60	B-X
min	B-X
.	B-X
Insulin-stimulated	B-X
farnesylation	B-X
of	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
pools	B-X
in	B-X
vivo	B-X
correlated	B-X
with	B-X
FTase	B-X
activity	B-X
seen	B-X
in	B-X
vitro	B-X
by	B-X
displaying	B-X
an	B-X
increase	B-X
in	B-X
farnesylated	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
from	B-X
40	B-X
%	B-X
of	B-X
total	B-X
cellular	B-X
Ras	B-X
in	B-X
control	B-X
cells	B-X
to	B-X
63	B-X
%	B-X
by	B-X
5	B-X
min	B-X
and	B-X
80	B-X
%	B-X
by	B-X
60	B-X
min	B-X
(	B-X
p	B-X
<	B-X
0.05	B-X
)	B-X
in	B-X
insulin-treated	B-X
cells	B-X
.	B-X
Insulin	B-X
challenge	B-X
of	B-X
3T3-L1	B-X
adipocytes	B-X
increased	B-X
incorporation	B-X
of	B-X
tritiated	B-X
mevalonic	B-X
acid	B-X
in	B-X
p21	B-X
(	B-X
ras	B-X
)	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
and	B-X
stimulated	B-X
a	B-X
2-fold	B-X
increase	B-X
in	B-X
phosphorylation	B-X
of	B-X
the	B-X
alpha-subunit	B-X
of	B-X
FTase	B-X
at	B-X
5	B-X
min	B-X
and	B-X
a	B-X
4-fold	B-X
increase	B-X
at	B-X
60	B-X
min	B-X
.	B-X

Insulin	B-Protein
exerted	O
a	O
biphasic	O
stimulatory	O
effect	O
on	O
FTase	O
activity	O
measured	O
in	O
vitro	O
with	O
a	O
31	O
%	O
increase	O
at	O
5	O
min	O
and	O
a	O
130	O
%	O
increase	O
at	O
60	O
min	O
.	O

Insulin	B-Protein
-	O
stimulated	O
farnesylation	O
of	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	I-Protein
pools	O
in	O
vivo	O
correlated	O
with	O
FTase	O
activity	O
seen	O
in	O
vitro	O
by	O
displaying	O
an	O
increase	O
in	O
farnesylated	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	I-Protein
from	O
40	O
%	O
of	O
total	O
cellular	O
Ras	O
in	O
control	O
cells	O
to	O
63	O
%	O
by	O
5	O
min	O
and	O
80	O
%	O
by	O
60	O
min	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
insulin	B-Protein
-	O
treated	O
cells	O
.	O

Insulin	B-Protein
challenge	O
of	O
3T3	O
-	O
L1	O
adipocytes	O
increased	O
incorporation	O
of	O
tritiated	O
mevalonic	O
acid	O
in	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	I-Protein
in	O
a	O
dose	O
-	O
dependent	O
manner	O
and	O
stimulated	O
a	O
2	O
-	O
fold	O
increase	O
in	O
phosphorylation	O
of	O
the	O
alpha	O
-	O
subunit	O
of	O
FTase	O
at	O
5	O
min	O
and	O
a	O
4	O
-	O
fold	O
increase	O
at	O
60	O
min	O
.	O

Caspase	B-Protein
-	I-Protein
2	I-Protein
(	O
Nedd	B-Protein
-	I-Protein
2	I-Protein
)	O
processing	O
and	O
death	O
of	O
trophic	O
factor	O
-	O
deprived	O
PC12	O
cells	O
and	O
sympathetic	O
neurons	O
occur	O
independently	O
of	O
caspase	B-Protein
-	I-Protein
3	I-Protein
(	O
CPP32	B-Protein
)	O
-	O
like	O
activity	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
caspase-2	B-X
(	B-X
Nedd-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
apoptosis	B-X
induced	B-X
by	B-X
withdrawal	B-X
of	B-X
trophic	B-X
support	B-X
from	B-X
PC12	B-X
cells	B-X
and	B-X
sympathetic	B-X
neurons	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
examine	B-X
the	B-X
relationship	B-X
of	B-X
caspase-2	B-X
processing	B-X
and	B-X
cell	B-X
death	B-X
to	B-X
induction	B-X
of	B-X
caspase-3	B-X
(	B-X
CPP32	B-X
)	B-X
-like	B-X
activity	B-X
in	B-X
PC12	B-X
cells	B-X
.	B-X
Caspase-2	B-X
processing	B-X
,	B-X
at	B-X
a	B-X
site	B-X
tentatively	B-X
identified	B-X
as	B-X
D333	B-X
,	B-X
led	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
an	B-X
N-terminal	B-X
37	B-X
kDa	B-X
product	B-X
.	B-X
This	B-X
processing	B-X
correlated	B-X
temporally	B-X
with	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
.	B-X
Agents	B-X
previously	B-X
shown	B-X
to	B-X
inhibit	B-X
caspase-3-like	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
bcl-2	B-X
and	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
flavopiridol	B-X
,	B-X
also	B-X
acted	B-X
upstream	B-X
of	B-X
caspase-2	B-X
processing	B-X
.	B-X
The	B-X
general	B-X
caspase	B-X
inhibitors	B-X
BAF	B-X
and	B-X
zVAD-FMK	B-X
inhibited	B-X
N-terminal	B-X
caspase-2	B-X
processing	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
more	B-X
selective	B-X
caspase	B-X
inhibitor	B-X
DEVD-FMK	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-2	B-X
processing	B-X
or	B-X
significantly	B-X
suppress	B-X
death	B-X
in	B-X
PC12	B-X
cells	B-X
or	B-X
sympathetic	B-X
neurons	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
not	B-X
required	B-X
for	B-X
either	B-X
caspase-2	B-X
processing	B-X
or	B-X
apoptosis	B-X
in	B-X
this	B-X
paradigm	B-X
.	B-X
An	B-X
antisense	B-X
oligonucleotide	B-X
to	B-X
caspase-2	B-X
inhibited	B-X
cell	B-X
death	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-3-like	B-X
activity	B-X
,	B-X
indicating	B-X
that	B-X
caspase-2	B-X
is	B-X
not	B-X
upstream	B-X
of	B-X
this	B-X
activity	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
caspase-3-like	B-X
caspases	B-X
is	B-X
not	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
in	B-X
our	B-X
paradigm	B-X
,	B-X
caspase-2	B-X
processing	B-X
and	B-X
caspase-3-like	B-X
activity	B-X
are	B-X
induced	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
.	B-X
Moreover	B-X
,	B-X
although	B-X
death	B-X
requires	B-X
caspase-2	B-X
,	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
neither	B-X
necessary	B-X
nor	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X

We	O
have	O
previously	O
shown	O
that	O
caspase	B-Protein
-	I-Protein
2	I-Protein
(	O
Nedd	B-Protein
-	I-Protein
2	I-Protein
)	O
is	O
required	O
for	O
apoptosis	O
induced	O
by	O
withdrawal	O
of	O
trophic	O
support	O
from	O
PC12	O
cells	O
and	O
sympathetic	O
neurons	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
caspase-2	B-X
(	B-X
Nedd-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
apoptosis	B-X
induced	B-X
by	B-X
withdrawal	B-X
of	B-X
trophic	B-X
support	B-X
from	B-X
PC12	B-X
cells	B-X
and	B-X
sympathetic	B-X
neurons	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
examine	B-X
the	B-X
relationship	B-X
of	B-X
caspase-2	B-X
processing	B-X
and	B-X
cell	B-X
death	B-X
to	B-X
induction	B-X
of	B-X
caspase-3	B-X
(	B-X
CPP32	B-X
)	B-X
-like	B-X
activity	B-X
in	B-X
PC12	B-X
cells	B-X
.	B-X
Caspase-2	B-X
processing	B-X
,	B-X
at	B-X
a	B-X
site	B-X
tentatively	B-X
identified	B-X
as	B-X
D333	B-X
,	B-X
led	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
an	B-X
N-terminal	B-X
37	B-X
kDa	B-X
product	B-X
.	B-X
This	B-X
processing	B-X
correlated	B-X
temporally	B-X
with	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
.	B-X
Agents	B-X
previously	B-X
shown	B-X
to	B-X
inhibit	B-X
caspase-3-like	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
bcl-2	B-X
and	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
flavopiridol	B-X
,	B-X
also	B-X
acted	B-X
upstream	B-X
of	B-X
caspase-2	B-X
processing	B-X
.	B-X
The	B-X
general	B-X
caspase	B-X
inhibitors	B-X
BAF	B-X
and	B-X
zVAD-FMK	B-X
inhibited	B-X
N-terminal	B-X
caspase-2	B-X
processing	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
more	B-X
selective	B-X
caspase	B-X
inhibitor	B-X
DEVD-FMK	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-2	B-X
processing	B-X
or	B-X
significantly	B-X
suppress	B-X
death	B-X
in	B-X
PC12	B-X
cells	B-X
or	B-X
sympathetic	B-X
neurons	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
not	B-X
required	B-X
for	B-X
either	B-X
caspase-2	B-X
processing	B-X
or	B-X
apoptosis	B-X
in	B-X
this	B-X
paradigm	B-X
.	B-X
An	B-X
antisense	B-X
oligonucleotide	B-X
to	B-X
caspase-2	B-X
inhibited	B-X
cell	B-X
death	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-3-like	B-X
activity	B-X
,	B-X
indicating	B-X
that	B-X
caspase-2	B-X
is	B-X
not	B-X
upstream	B-X
of	B-X
this	B-X
activity	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
caspase-3-like	B-X
caspases	B-X
is	B-X
not	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
in	B-X
our	B-X
paradigm	B-X
,	B-X
caspase-2	B-X
processing	B-X
and	B-X
caspase-3-like	B-X
activity	B-X
are	B-X
induced	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
.	B-X
Moreover	B-X
,	B-X
although	B-X
death	B-X
requires	B-X
caspase-2	B-X
,	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
neither	B-X
necessary	B-X
nor	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X

Here	O
,	O
we	O
examine	O
the	O
relationship	O
of	O
caspase	B-Protein
-	I-Protein
2	I-Protein
processing	O
and	O
cell	O
death	O
to	O
induction	O
of	O
caspase	B-Protein
-	I-Protein
3	I-Protein
(	O
CPP32	B-Protein
)	O
-	O
like	O
activity	O
in	O
PC12	O
cells	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
caspase-2	B-X
(	B-X
Nedd-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
apoptosis	B-X
induced	B-X
by	B-X
withdrawal	B-X
of	B-X
trophic	B-X
support	B-X
from	B-X
PC12	B-X
cells	B-X
and	B-X
sympathetic	B-X
neurons	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
examine	B-X
the	B-X
relationship	B-X
of	B-X
caspase-2	B-X
processing	B-X
and	B-X
cell	B-X
death	B-X
to	B-X
induction	B-X
of	B-X
caspase-3	B-X
(	B-X
CPP32	B-X
)	B-X
-like	B-X
activity	B-X
in	B-X
PC12	B-X
cells	B-X
.	B-X
Caspase-2	B-X
processing	B-X
,	B-X
at	B-X
a	B-X
site	B-X
tentatively	B-X
identified	B-X
as	B-X
D333	B-X
,	B-X
led	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
an	B-X
N-terminal	B-X
37	B-X
kDa	B-X
product	B-X
.	B-X
This	B-X
processing	B-X
correlated	B-X
temporally	B-X
with	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
.	B-X
Agents	B-X
previously	B-X
shown	B-X
to	B-X
inhibit	B-X
caspase-3-like	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
bcl-2	B-X
and	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
flavopiridol	B-X
,	B-X
also	B-X
acted	B-X
upstream	B-X
of	B-X
caspase-2	B-X
processing	B-X
.	B-X
The	B-X
general	B-X
caspase	B-X
inhibitors	B-X
BAF	B-X
and	B-X
zVAD-FMK	B-X
inhibited	B-X
N-terminal	B-X
caspase-2	B-X
processing	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
more	B-X
selective	B-X
caspase	B-X
inhibitor	B-X
DEVD-FMK	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-2	B-X
processing	B-X
or	B-X
significantly	B-X
suppress	B-X
death	B-X
in	B-X
PC12	B-X
cells	B-X
or	B-X
sympathetic	B-X
neurons	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
not	B-X
required	B-X
for	B-X
either	B-X
caspase-2	B-X
processing	B-X
or	B-X
apoptosis	B-X
in	B-X
this	B-X
paradigm	B-X
.	B-X
An	B-X
antisense	B-X
oligonucleotide	B-X
to	B-X
caspase-2	B-X
inhibited	B-X
cell	B-X
death	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-3-like	B-X
activity	B-X
,	B-X
indicating	B-X
that	B-X
caspase-2	B-X
is	B-X
not	B-X
upstream	B-X
of	B-X
this	B-X
activity	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
caspase-3-like	B-X
caspases	B-X
is	B-X
not	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
in	B-X
our	B-X
paradigm	B-X
,	B-X
caspase-2	B-X
processing	B-X
and	B-X
caspase-3-like	B-X
activity	B-X
are	B-X
induced	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
.	B-X
Moreover	B-X
,	B-X
although	B-X
death	B-X
requires	B-X
caspase-2	B-X
,	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
neither	B-X
necessary	B-X
nor	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X

Caspase	B-Protein
-	I-Protein
2	I-Protein
processing	O
,	O
at	O
a	O
site	O
tentatively	O
identified	O
as	O
D333	O
,	O
led	O
to	O
the	O
formation	O
of	O
an	O
N	O
-	O
terminal	O
37	O
kDa	O
product	O
.	O

This	O
processing	O
correlated	O
temporally	O
with	O
induction	O
of	O
caspase	B-Protein
-	I-Protein
3	I-Protein
-	O
like	O
activity	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
caspase-2	B-X
(	B-X
Nedd-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
apoptosis	B-X
induced	B-X
by	B-X
withdrawal	B-X
of	B-X
trophic	B-X
support	B-X
from	B-X
PC12	B-X
cells	B-X
and	B-X
sympathetic	B-X
neurons	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
examine	B-X
the	B-X
relationship	B-X
of	B-X
caspase-2	B-X
processing	B-X
and	B-X
cell	B-X
death	B-X
to	B-X
induction	B-X
of	B-X
caspase-3	B-X
(	B-X
CPP32	B-X
)	B-X
-like	B-X
activity	B-X
in	B-X
PC12	B-X
cells	B-X
.	B-X
Caspase-2	B-X
processing	B-X
,	B-X
at	B-X
a	B-X
site	B-X
tentatively	B-X
identified	B-X
as	B-X
D333	B-X
,	B-X
led	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
an	B-X
N-terminal	B-X
37	B-X
kDa	B-X
product	B-X
.	B-X
This	B-X
processing	B-X
correlated	B-X
temporally	B-X
with	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
.	B-X
Agents	B-X
previously	B-X
shown	B-X
to	B-X
inhibit	B-X
caspase-3-like	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
bcl-2	B-X
and	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
flavopiridol	B-X
,	B-X
also	B-X
acted	B-X
upstream	B-X
of	B-X
caspase-2	B-X
processing	B-X
.	B-X
The	B-X
general	B-X
caspase	B-X
inhibitors	B-X
BAF	B-X
and	B-X
zVAD-FMK	B-X
inhibited	B-X
N-terminal	B-X
caspase-2	B-X
processing	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
more	B-X
selective	B-X
caspase	B-X
inhibitor	B-X
DEVD-FMK	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-2	B-X
processing	B-X
or	B-X
significantly	B-X
suppress	B-X
death	B-X
in	B-X
PC12	B-X
cells	B-X
or	B-X
sympathetic	B-X
neurons	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
not	B-X
required	B-X
for	B-X
either	B-X
caspase-2	B-X
processing	B-X
or	B-X
apoptosis	B-X
in	B-X
this	B-X
paradigm	B-X
.	B-X
An	B-X
antisense	B-X
oligonucleotide	B-X
to	B-X
caspase-2	B-X
inhibited	B-X
cell	B-X
death	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-3-like	B-X
activity	B-X
,	B-X
indicating	B-X
that	B-X
caspase-2	B-X
is	B-X
not	B-X
upstream	B-X
of	B-X
this	B-X
activity	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
caspase-3-like	B-X
caspases	B-X
is	B-X
not	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
in	B-X
our	B-X
paradigm	B-X
,	B-X
caspase-2	B-X
processing	B-X
and	B-X
caspase-3-like	B-X
activity	B-X
are	B-X
induced	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
.	B-X
Moreover	B-X
,	B-X
although	B-X
death	B-X
requires	B-X
caspase-2	B-X
,	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
neither	B-X
necessary	B-X
nor	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X

Agents	O
previously	O
shown	O
to	O
inhibit	O
caspase	B-Protein
-	I-Protein
3	I-Protein
-	O
like	O
activation	O
,	O
such	O
as	O
bcl	B-Protein
-	I-Protein
2	I-Protein
and	O
the	O
Cdk	O
inhibitor	O
flavopiridol	O
,	O
also	O
acted	O
upstream	O
of	O
caspase	B-Protein
-	I-Protein
2	I-Protein
processing	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
caspase-2	B-X
(	B-X
Nedd-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
apoptosis	B-X
induced	B-X
by	B-X
withdrawal	B-X
of	B-X
trophic	B-X
support	B-X
from	B-X
PC12	B-X
cells	B-X
and	B-X
sympathetic	B-X
neurons	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
examine	B-X
the	B-X
relationship	B-X
of	B-X
caspase-2	B-X
processing	B-X
and	B-X
cell	B-X
death	B-X
to	B-X
induction	B-X
of	B-X
caspase-3	B-X
(	B-X
CPP32	B-X
)	B-X
-like	B-X
activity	B-X
in	B-X
PC12	B-X
cells	B-X
.	B-X
Caspase-2	B-X
processing	B-X
,	B-X
at	B-X
a	B-X
site	B-X
tentatively	B-X
identified	B-X
as	B-X
D333	B-X
,	B-X
led	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
an	B-X
N-terminal	B-X
37	B-X
kDa	B-X
product	B-X
.	B-X
This	B-X
processing	B-X
correlated	B-X
temporally	B-X
with	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
.	B-X
Agents	B-X
previously	B-X
shown	B-X
to	B-X
inhibit	B-X
caspase-3-like	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
bcl-2	B-X
and	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
flavopiridol	B-X
,	B-X
also	B-X
acted	B-X
upstream	B-X
of	B-X
caspase-2	B-X
processing	B-X
.	B-X
The	B-X
general	B-X
caspase	B-X
inhibitors	B-X
BAF	B-X
and	B-X
zVAD-FMK	B-X
inhibited	B-X
N-terminal	B-X
caspase-2	B-X
processing	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
more	B-X
selective	B-X
caspase	B-X
inhibitor	B-X
DEVD-FMK	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-2	B-X
processing	B-X
or	B-X
significantly	B-X
suppress	B-X
death	B-X
in	B-X
PC12	B-X
cells	B-X
or	B-X
sympathetic	B-X
neurons	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
not	B-X
required	B-X
for	B-X
either	B-X
caspase-2	B-X
processing	B-X
or	B-X
apoptosis	B-X
in	B-X
this	B-X
paradigm	B-X
.	B-X
An	B-X
antisense	B-X
oligonucleotide	B-X
to	B-X
caspase-2	B-X
inhibited	B-X
cell	B-X
death	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-3-like	B-X
activity	B-X
,	B-X
indicating	B-X
that	B-X
caspase-2	B-X
is	B-X
not	B-X
upstream	B-X
of	B-X
this	B-X
activity	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
caspase-3-like	B-X
caspases	B-X
is	B-X
not	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
in	B-X
our	B-X
paradigm	B-X
,	B-X
caspase-2	B-X
processing	B-X
and	B-X
caspase-3-like	B-X
activity	B-X
are	B-X
induced	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
.	B-X
Moreover	B-X
,	B-X
although	B-X
death	B-X
requires	B-X
caspase-2	B-X
,	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
neither	B-X
necessary	B-X
nor	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X

The	O
general	O
caspase	O
inhibitors	O
BAF	O
and	O
zVAD	O
-	O
FMK	O
inhibited	O
N	O
-	O
terminal	O
caspase	B-Protein
-	I-Protein
2	I-Protein
processing	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
caspase-2	B-X
(	B-X
Nedd-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
apoptosis	B-X
induced	B-X
by	B-X
withdrawal	B-X
of	B-X
trophic	B-X
support	B-X
from	B-X
PC12	B-X
cells	B-X
and	B-X
sympathetic	B-X
neurons	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
examine	B-X
the	B-X
relationship	B-X
of	B-X
caspase-2	B-X
processing	B-X
and	B-X
cell	B-X
death	B-X
to	B-X
induction	B-X
of	B-X
caspase-3	B-X
(	B-X
CPP32	B-X
)	B-X
-like	B-X
activity	B-X
in	B-X
PC12	B-X
cells	B-X
.	B-X
Caspase-2	B-X
processing	B-X
,	B-X
at	B-X
a	B-X
site	B-X
tentatively	B-X
identified	B-X
as	B-X
D333	B-X
,	B-X
led	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
an	B-X
N-terminal	B-X
37	B-X
kDa	B-X
product	B-X
.	B-X
This	B-X
processing	B-X
correlated	B-X
temporally	B-X
with	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
.	B-X
Agents	B-X
previously	B-X
shown	B-X
to	B-X
inhibit	B-X
caspase-3-like	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
bcl-2	B-X
and	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
flavopiridol	B-X
,	B-X
also	B-X
acted	B-X
upstream	B-X
of	B-X
caspase-2	B-X
processing	B-X
.	B-X
The	B-X
general	B-X
caspase	B-X
inhibitors	B-X
BAF	B-X
and	B-X
zVAD-FMK	B-X
inhibited	B-X
N-terminal	B-X
caspase-2	B-X
processing	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
more	B-X
selective	B-X
caspase	B-X
inhibitor	B-X
DEVD-FMK	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-2	B-X
processing	B-X
or	B-X
significantly	B-X
suppress	B-X
death	B-X
in	B-X
PC12	B-X
cells	B-X
or	B-X
sympathetic	B-X
neurons	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
not	B-X
required	B-X
for	B-X
either	B-X
caspase-2	B-X
processing	B-X
or	B-X
apoptosis	B-X
in	B-X
this	B-X
paradigm	B-X
.	B-X
An	B-X
antisense	B-X
oligonucleotide	B-X
to	B-X
caspase-2	B-X
inhibited	B-X
cell	B-X
death	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-3-like	B-X
activity	B-X
,	B-X
indicating	B-X
that	B-X
caspase-2	B-X
is	B-X
not	B-X
upstream	B-X
of	B-X
this	B-X
activity	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
caspase-3-like	B-X
caspases	B-X
is	B-X
not	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
in	B-X
our	B-X
paradigm	B-X
,	B-X
caspase-2	B-X
processing	B-X
and	B-X
caspase-3-like	B-X
activity	B-X
are	B-X
induced	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
.	B-X
Moreover	B-X
,	B-X
although	B-X
death	B-X
requires	B-X
caspase-2	B-X
,	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
neither	B-X
necessary	B-X
nor	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X

In	O
contrast	O
,	O
the	O
more	O
selective	O
caspase	O
inhibitor	O
DEVD	O
-	O
FMK	O
inhibited	O
the	O
induction	O
of	O
caspase	B-Protein
-	I-Protein
3	I-Protein
-	O
like	O
activity	O
but	O
did	O
not	O
affect	O
caspase	B-Protein
-	I-Protein
2	I-Protein
processing	O
or	O
significantly	O
suppress	O
death	O
in	O
PC12	O
cells	O
or	O
sympathetic	O
neurons	O
.	O
<EOS>	B-X
The	B-X
sympathetic	B-X
nervous	B-X
system	B-X
prepares	B-X
the	B-X
body	B-X
for	B-X
'fight	B-X
or	B-X
flight	B-X
'	B-X
responses	B-X
and	B-X
maintains	B-X
homeostasis	B-X
during	B-X
daily	B-X
activities	B-X
such	B-X
as	B-X
exercise	B-X
,	B-X
eating	B-X
a	B-X
meal	B-X
or	B-X
regulation	B-X
of	B-X
body	B-X
temperature	B-X
.	B-X
Sympathetic	B-X
regulation	B-X
of	B-X
bodily	B-X
functions	B-X
requires	B-X
the	B-X
establishment	B-X
and	B-X
refinement	B-X
of	B-X
anatomically	B-X
and	B-X
functionally	B-X
precise	B-X
connections	B-X
between	B-X
postganglionic	B-X
sympathetic	B-X
neurons	B-X
and	B-X
peripheral	B-X
organs	B-X
distributed	B-X
widely	B-X
throughout	B-X
the	B-X
body	B-X
.	B-X
Mechanistic	B-X
studies	B-X
of	B-X
key	B-X
events	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
postganglionic	B-X
sympathetic	B-X
neurons	B-X
during	B-X
embryonic	B-X
and	B-X
early	B-X
postnatal	B-X
life	B-X
,	B-X
including	B-X
axon	B-X
growth	B-X
,	B-X
target	B-X
innervation	B-X
,	B-X
neuron	B-X
survival	B-X
,	B-X
and	B-X
dendrite	B-X
growth	B-X
and	B-X
synapse	B-X
formation	B-X
,	B-X
have	B-X
advanced	B-X
the	B-X
understanding	B-X
of	B-X
how	B-X
neuronal	B-X
development	B-X
is	B-X
shaped	B-X
by	B-X
interactions	B-X
with	B-X
peripheral	B-X
tissues	B-X
and	B-X
organs	B-X
.	B-X
Recent	B-X
progress	B-X
has	B-X
also	B-X
been	B-X
made	B-X
in	B-X
identifying	B-X
how	B-X
the	B-X
cellular	B-X
and	B-X
molecular	B-X
diversity	B-X
of	B-X
sympathetic	B-X
neurons	B-X
is	B-X
established	B-X
to	B-X
meet	B-X
the	B-X
functional	B-X
demands	B-X
of	B-X
peripheral	B-X
organs	B-X
.	B-X
In	B-X
this	B-X
Review	B-X
,	B-X
we	B-X
summarize	B-X
current	B-X
knowledge	B-X
of	B-X
signalling	B-X
pathways	B-X
underlying	B-X
the	B-X
development	B-X
of	B-X
the	B-X
sympathetic	B-X
nervous	B-X
system	B-X
.	B-X
These	B-X
findings	B-X
have	B-X
implications	B-X
for	B-X
unravelling	B-X
the	B-X
contribution	B-X
of	B-X
sympathetic	B-X
dysfunction	B-X
stemming	B-X
,	B-X
in	B-X
part	B-X
,	B-X
from	B-X
developmental	B-X
perturbations	B-X
to	B-X
the	B-X
pathophysiology	B-X
of	B-X
peripheral	B-X
neuropathies	B-X
and	B-X
cardiovascular	B-X
and	B-X
metabolic	B-X
disorders	B-X
.	B-X

This	O
indicates	O
that	O
caspase	B-Protein
-	I-Protein
3	I-Protein
-	O
like	O
activity	O
is	O
not	O
required	O
for	O
either	O
caspase	B-Protein
-	I-Protein
2	I-Protein
processing	O
or	O
apoptosis	O
in	O
this	O
paradigm	O
.	O
<EOS>	B-X
Caspase-3	B-X
is	B-X
a	B-X
widely	B-X
expressed	B-X
member	B-X
of	B-X
a	B-X
conserved	B-X
family	B-X
of	B-X
proteins	B-X
,	B-X
generally	B-X
recognized	B-X
for	B-X
their	B-X
activated	B-X
proteolytic	B-X
roles	B-X
in	B-X
the	B-X
execution	B-X
of	B-X
apoptosis	B-X
in	B-X
cells	B-X
responding	B-X
to	B-X
specific	B-X
extrinsic	B-X
or	B-X
intrinsic	B-X
inducers	B-X
of	B-X
this	B-X
mode	B-X
of	B-X
cell	B-X
death	B-X
.	B-X
However	B-X
,	B-X
accumulating	B-X
evidence	B-X
indicates	B-X
that	B-X
caspase-3	B-X
also	B-X
plays	B-X
key	B-X
roles	B-X
in	B-X
regulating	B-X
the	B-X
growth	B-X
and	B-X
homeostatic	B-X
maintenance	B-X
of	B-X
both	B-X
normal	B-X
and	B-X
malignant	B-X
cells	B-X
and	B-X
tissues	B-X
in	B-X
multicellular	B-X
organisms	B-X
.	B-X
Given	B-X
that	B-X
yeast	B-X
possess	B-X
an	B-X
ancestral	B-X
caspase-like	B-X
gene	B-X
suggests	B-X
that	B-X
the	B-X
caspase-3	B-X
protein	B-X
may	B-X
have	B-X
acquired	B-X
different	B-X
functions	B-X
later	B-X
during	B-X
evolution	B-X
to	B-X
better	B-X
meet	B-X
the	B-X
needs	B-X
of	B-X
more	B-X
complex	B-X
multicellular	B-X
organisms	B-X
,	B-X
but	B-X
without	B-X
necessarily	B-X
losing	B-X
all	B-X
of	B-X
the	B-X
functions	B-X
of	B-X
its	B-X
ancestral	B-X
yeast	B-X
precursor	B-X
.	B-X
This	B-X
review	B-X
provides	B-X
an	B-X
update	B-X
on	B-X
what	B-X
has	B-X
been	B-X
learned	B-X
about	B-X
these	B-X
interesting	B-X
dichotomous	B-X
roles	B-X
of	B-X
caspase-3	B-X
,	B-X
their	B-X
evolution	B-X
,	B-X
and	B-X
their	B-X
potential	B-X
relevance	B-X
to	B-X
malignant	B-X
as	B-X
well	B-X
as	B-X
normal	B-X
cell	B-X
biology	B-X
.	B-X

An	O
antisense	O
oligonucleotide	O
to	O
caspase	B-Protein
-	I-Protein
2	I-Protein
inhibited	O
cell	O
death	O
but	O
did	O
not	O
affect	O
caspase	B-Protein
-	I-Protein
3	I-Protein
-	O
like	O
activity	O
,	O
indicating	O
that	O
caspase	B-Protein
-	I-Protein
2	I-Protein
is	O
not	O
upstream	O
of	O
this	O
activity	O
and	O
that	O
activation	O
of	O
caspase	B-Protein
-	I-Protein
3	I-Protein
-	O
like	O
caspases	O
is	O
not	O
sufficient	O
for	O
death	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
proposed	B-X
that	B-X
Abeta	B-X
induces	B-X
death	B-X
by	B-X
oxidative	B-X
stress	B-X
,	B-X
possibly	B-X
through	B-X
the	B-X
generation	B-X
of	B-X
peroxynitrite	B-X
from	B-X
superoxide	B-X
and	B-X
nitric	B-X
oxide	B-X
.	B-X
In	B-X
our	B-X
current	B-X
study	B-X
,	B-X
treatment	B-X
with	B-X
nitric	B-X
oxide	B-X
generators	B-X
protected	B-X
against	B-X
Abeta-induced	B-X
death	B-X
,	B-X
whereas	B-X
inhibition	B-X
of	B-X
nitric	B-X
oxide	B-X
synthase	B-X
afforded	B-X
no	B-X
protection	B-X
,	B-X
suggesting	B-X
that	B-X
formation	B-X
of	B-X
peroxynitrite	B-X
is	B-X
not	B-X
critical	B-X
for	B-X
Abeta-mediated	B-X
death	B-X
.	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
aggregated	B-X
Abeta	B-X
can	B-X
induce	B-X
caspase-dependent	B-X
apoptosis	B-X
in	B-X
cultured	B-X
neurons	B-X
.	B-X
In	B-X
all	B-X
of	B-X
the	B-X
neuronal	B-X
populations	B-X
studied	B-X
here	B-X
(	B-X
hippocampal	B-X
neurons	B-X
,	B-X
sympathetic	B-X
neurons	B-X
,	B-X
and	B-X
PC12	B-X
cells	B-X
)	B-X
,	B-X
cell	B-X
death	B-X
was	B-X
blocked	B-X
by	B-X
the	B-X
broad	B-X
spectrum	B-X
caspase	B-X
inhibitor	B-X
N-benzyloxycarbonyl-val-ala-asp-fluoromethyl	B-X
ketone	B-X
and	B-X
more	B-X
specifically	B-X
by	B-X
the	B-X
downregulation	B-X
of	B-X
caspase-2	B-X
with	B-X
antisense	B-X
oligonucleotides	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
downregulation	B-X
of	B-X
caspase-1	B-X
or	B-X
caspase-3	B-X
did	B-X
not	B-X
block	B-X
Abeta	B-X
(	B-X
1-42	B-X
)	B-X
-induced	B-X
death	B-X
.	B-X
Neurons	B-X
from	B-X
caspase-2	B-X
null	B-X
mice	B-X
were	B-X
totally	B-X
resistant	B-X
to	B-X
Abeta	B-X
(	B-X
1-42	B-X
)	B-X
toxicity	B-X
,	B-X
confirming	B-X
the	B-X
importance	B-X
of	B-X
this	B-X
caspase	B-X
in	B-X
Abeta-induced	B-X
death	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
caspase-2	B-X
is	B-X
necessary	B-X
for	B-X
Abeta	B-X
(	B-X
1-42	B-X
)	B-X
-induced	B-X
apoptosis	B-X
in	B-X
vitro	B-X
.	B-X

Thus	O
,	O
in	O
our	O
paradigm	O
,	O
caspase	B-Protein
-	I-Protein
2	I-Protein
processing	O
and	O
caspase	B-Protein
-	I-Protein
3	I-Protein
-	O
like	O
activity	O
are	O
induced	O
independently	O
of	O
each	O
other	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
caspase-2	B-X
(	B-X
Nedd-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
apoptosis	B-X
induced	B-X
by	B-X
withdrawal	B-X
of	B-X
trophic	B-X
support	B-X
from	B-X
PC12	B-X
cells	B-X
and	B-X
sympathetic	B-X
neurons	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
examine	B-X
the	B-X
relationship	B-X
of	B-X
caspase-2	B-X
processing	B-X
and	B-X
cell	B-X
death	B-X
to	B-X
induction	B-X
of	B-X
caspase-3	B-X
(	B-X
CPP32	B-X
)	B-X
-like	B-X
activity	B-X
in	B-X
PC12	B-X
cells	B-X
.	B-X
Caspase-2	B-X
processing	B-X
,	B-X
at	B-X
a	B-X
site	B-X
tentatively	B-X
identified	B-X
as	B-X
D333	B-X
,	B-X
led	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
an	B-X
N-terminal	B-X
37	B-X
kDa	B-X
product	B-X
.	B-X
This	B-X
processing	B-X
correlated	B-X
temporally	B-X
with	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
.	B-X
Agents	B-X
previously	B-X
shown	B-X
to	B-X
inhibit	B-X
caspase-3-like	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
bcl-2	B-X
and	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
flavopiridol	B-X
,	B-X
also	B-X
acted	B-X
upstream	B-X
of	B-X
caspase-2	B-X
processing	B-X
.	B-X
The	B-X
general	B-X
caspase	B-X
inhibitors	B-X
BAF	B-X
and	B-X
zVAD-FMK	B-X
inhibited	B-X
N-terminal	B-X
caspase-2	B-X
processing	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
more	B-X
selective	B-X
caspase	B-X
inhibitor	B-X
DEVD-FMK	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-2	B-X
processing	B-X
or	B-X
significantly	B-X
suppress	B-X
death	B-X
in	B-X
PC12	B-X
cells	B-X
or	B-X
sympathetic	B-X
neurons	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
not	B-X
required	B-X
for	B-X
either	B-X
caspase-2	B-X
processing	B-X
or	B-X
apoptosis	B-X
in	B-X
this	B-X
paradigm	B-X
.	B-X
An	B-X
antisense	B-X
oligonucleotide	B-X
to	B-X
caspase-2	B-X
inhibited	B-X
cell	B-X
death	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-3-like	B-X
activity	B-X
,	B-X
indicating	B-X
that	B-X
caspase-2	B-X
is	B-X
not	B-X
upstream	B-X
of	B-X
this	B-X
activity	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
caspase-3-like	B-X
caspases	B-X
is	B-X
not	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
in	B-X
our	B-X
paradigm	B-X
,	B-X
caspase-2	B-X
processing	B-X
and	B-X
caspase-3-like	B-X
activity	B-X
are	B-X
induced	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
.	B-X
Moreover	B-X
,	B-X
although	B-X
death	B-X
requires	B-X
caspase-2	B-X
,	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
neither	B-X
necessary	B-X
nor	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X

Moreover	O
,	O
although	O
death	O
requires	O
caspase	B-Protein
-	I-Protein
2	I-Protein
,	O
caspase	B-Protein
-	I-Protein
3	I-Protein
-	O
like	O
activity	O
is	O
neither	O
necessary	O
nor	O
sufficient	O
for	O
death	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
caspase-2	B-X
(	B-X
Nedd-2	B-X
)	B-X
is	B-X
required	B-X
for	B-X
apoptosis	B-X
induced	B-X
by	B-X
withdrawal	B-X
of	B-X
trophic	B-X
support	B-X
from	B-X
PC12	B-X
cells	B-X
and	B-X
sympathetic	B-X
neurons	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
examine	B-X
the	B-X
relationship	B-X
of	B-X
caspase-2	B-X
processing	B-X
and	B-X
cell	B-X
death	B-X
to	B-X
induction	B-X
of	B-X
caspase-3	B-X
(	B-X
CPP32	B-X
)	B-X
-like	B-X
activity	B-X
in	B-X
PC12	B-X
cells	B-X
.	B-X
Caspase-2	B-X
processing	B-X
,	B-X
at	B-X
a	B-X
site	B-X
tentatively	B-X
identified	B-X
as	B-X
D333	B-X
,	B-X
led	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
an	B-X
N-terminal	B-X
37	B-X
kDa	B-X
product	B-X
.	B-X
This	B-X
processing	B-X
correlated	B-X
temporally	B-X
with	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
.	B-X
Agents	B-X
previously	B-X
shown	B-X
to	B-X
inhibit	B-X
caspase-3-like	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
bcl-2	B-X
and	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
flavopiridol	B-X
,	B-X
also	B-X
acted	B-X
upstream	B-X
of	B-X
caspase-2	B-X
processing	B-X
.	B-X
The	B-X
general	B-X
caspase	B-X
inhibitors	B-X
BAF	B-X
and	B-X
zVAD-FMK	B-X
inhibited	B-X
N-terminal	B-X
caspase-2	B-X
processing	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
more	B-X
selective	B-X
caspase	B-X
inhibitor	B-X
DEVD-FMK	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
caspase-3-like	B-X
activity	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-2	B-X
processing	B-X
or	B-X
significantly	B-X
suppress	B-X
death	B-X
in	B-X
PC12	B-X
cells	B-X
or	B-X
sympathetic	B-X
neurons	B-X
.	B-X
This	B-X
indicates	B-X
that	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
not	B-X
required	B-X
for	B-X
either	B-X
caspase-2	B-X
processing	B-X
or	B-X
apoptosis	B-X
in	B-X
this	B-X
paradigm	B-X
.	B-X
An	B-X
antisense	B-X
oligonucleotide	B-X
to	B-X
caspase-2	B-X
inhibited	B-X
cell	B-X
death	B-X
but	B-X
did	B-X
not	B-X
affect	B-X
caspase-3-like	B-X
activity	B-X
,	B-X
indicating	B-X
that	B-X
caspase-2	B-X
is	B-X
not	B-X
upstream	B-X
of	B-X
this	B-X
activity	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
caspase-3-like	B-X
caspases	B-X
is	B-X
not	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
in	B-X
our	B-X
paradigm	B-X
,	B-X
caspase-2	B-X
processing	B-X
and	B-X
caspase-3-like	B-X
activity	B-X
are	B-X
induced	B-X
independently	B-X
of	B-X
each	B-X
other	B-X
.	B-X
Moreover	B-X
,	B-X
although	B-X
death	B-X
requires	B-X
caspase-2	B-X
,	B-X
caspase-3-like	B-X
activity	B-X
is	B-X
neither	B-X
necessary	B-X
nor	B-X
sufficient	B-X
for	B-X
death	B-X
.	B-X

